data_2kpp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kpp _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.517 ' HA ' ' HB ' ' A' ' 25' ' ' THR . 42.9 mt-10 . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 112.083 0.401 . . . . 73.05 112.083 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 25.7 m -110.8 151.91 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 121.361 0.6 . . . . 64.03 112.184 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 23' ' ' PRO . 34.4 m -128.1 143.04 42.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 115.794 -0.639 . . . . 74.13 111.256 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.49 117.97 30.17 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.43 -0.35 . . . . 72.22 111.216 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.582 HD12 ' HE3' ' A' ' 89' ' ' LYS . 20.0 mm -92.45 112.92 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.464 -0.334 . . . . 72.31 111.21 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.461 HD11 ' N ' ' A' ' 12' ' ' ILE . 3.4 mp -98.31 119.13 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.091 0.472 . . . . 72.22 111.647 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.2 p -123.22 145.18 48.86 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.298 -0.41 . . . . 74.22 110.604 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.472 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 60.6 tt0 -140.28 141.85 35.77 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.128 -0.358 . . . . 72.42 111.329 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.472 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 51.7 m-80 66.28 -12.76 0.18 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.784 0.661 . . . . 65.53 112.784 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 14' ' ' GLN . . . 119.25 26.07 2.55 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.525 -0.369 . . . . 74.52 112.731 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -147.96 146.55 29.01 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.479 -0.424 . . . . 75.14 111.156 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.6 t -74.29 121.41 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.904 0.383 . . . . 72.23 110.769 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 34.9 pt -109.97 -20.95 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 112.721 0.638 . . . . 74.31 112.721 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -170.66 153.04 3.96 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.485 0.183 . . . . 73.13 111.48 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -147.15 122.4 10.23 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.266 0.555 . . . . 73.51 111.546 175.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.486 HG22 HG22 ' A' ' 47' ' ' VAL . 2.5 mp -106.65 129.67 24.07 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-N 116.092 -0.504 . . . . 75.23 111.614 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.52 ' HA ' HG13 ' A' ' 9' ' ' VAL . 56.9 Cg_endo -70.76 126.9 13.13 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.366 2.044 . . . . 62.52 112.109 174.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.91 -62.43 1.32 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 111.901 0.334 . . . . 75.42 111.901 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.517 ' HB ' ' HA ' ' A' ' 7' ' ' GLU . 19.6 m -54.28 127.47 27.27 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.653 0.263 . . . . 71.22 111.567 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.01 -24.38 9.17 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.211 -0.518 . . . . 54.42 113.218 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -75.94 83.0 2.84 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.383 0.611 . . . . 75.15 110.93 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -83.77 164.08 19.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.708 -0.678 . . . . 70.23 111.416 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.19 -163.25 37.5 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 120.827 -0.701 . . . . 43.44 112.631 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -118.53 146.79 44.28 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.001 0.429 . . . . 64.32 111.775 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -150.13 142.24 24.03 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.163 -0.472 . . . . 74.5 110.857 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -132.05 147.82 52.46 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.043 0.386 . . . . 62.05 112.043 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -153.39 139.5 18.33 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.962 0.41 . . . . 74.14 111.439 174.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.6 m -102.45 114.51 28.77 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.127 0.418 . . . . 71.13 112.127 -175.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.1 mt -86.25 104.4 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 116.271 -0.422 . . . . 72.32 111.425 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -101.27 125.21 47.87 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.673 0.273 . . . . 73.05 111.106 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -121.29 -78.27 0.49 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.982 -0.628 . . . . 37.72 114.197 -176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.57 ' HE2' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -114.25 -169.86 1.61 Allowed 'General case' 0 CA--C 1.546 0.811 0 O-C-N 122.46 -0.435 . . . . 73.42 111.304 -173.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -44.67 100.04 0.02 OUTLIER Glycine 0 CA--C 1.528 0.879 0 N-CA-C 114.502 0.561 . . . . 74.5 114.502 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 67.0 -2.82 1.06 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.177 0.806 . . . . 74.2 113.177 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -86.56 112.58 21.7 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.871 0.367 . . . . 72.03 111.915 -175.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -139.99 163.51 32.48 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.284 -0.416 . . . . 61.21 111.649 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -135.4 113.52 11.28 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.479 -0.328 . . . . 75.54 111.291 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.4 tp -84.57 103.82 14.03 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.922 0.392 . . . . 72.0 110.169 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.629 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.7 mmm -95.91 146.37 24.64 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.265 -0.425 . . . . 71.44 111.322 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -132.92 122.94 25.07 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.102 0.477 . . . . 73.23 111.952 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.486 HG22 HG22 ' A' ' 22' ' ' ILE . 58.2 t -103.32 107.57 22.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.941 -0.572 . . . . 72.55 110.207 173.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.449 ' HB3' ' CH2' ' A' ' 69' ' ' TRP . 30.3 t70 -129.84 105.69 8.18 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.859 0.361 . . . . 63.54 111.543 -175.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.438 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . 74.66 55.1 5.61 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.302 -0.475 . . . . 74.4 114.013 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 63.62 23.53 13.59 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.775 0.657 . . . . 73.43 112.775 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 49' ' ' GLY . 7.9 ptt85 -148.5 149.18 31.19 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.806 0.336 . . . . 73.02 110.985 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.0 tt -123.29 148.69 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.148 0.499 . . . . 74.02 112.068 -174.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -152.94 168.88 24.33 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.851 -0.613 . . . . 71.32 110.821 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.629 HG12 ' SD ' ' A' ' 45' ' ' MET . 40.4 mt -84.91 110.67 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 120.977 0.418 . . . . 63.11 110.155 169.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -75.29 -29.94 60.23 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.31 -0.405 . . . . 72.11 111.096 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -175.47 138.65 0.41 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.243 -0.435 . . . . 73.55 111.431 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -161.68 156.42 23.01 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.175 0.512 . . . . 65.41 111.034 172.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -93.39 69.14 4.23 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.2 0.524 . . . . 64.43 111.867 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.3 p -127.33 140.61 38.42 Favored Pre-proline 0 N--CA 1.473 0.7 0 CA-C-N 116.46 -0.336 . . . . 41.03 110.692 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.67 -17.79 29.34 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.981 1.788 . . . . 74.11 111.987 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.507 ' HB3' HG22 ' A' ' 63' ' ' VAL . 2.2 m-20 -80.35 -52.9 7.14 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.607 -0.724 . . . . 65.23 111.755 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 57.45 29.31 16.8 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 120.649 0.261 . . . . 75.11 111.6 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' A' ' 61' ' ' ASP . 65.5 t -53.82 -48.33 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 112.223 0.453 . . . . 75.12 112.223 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.487 ' HA3' HD11 ' A' ' 54' ' ' ILE . . . -59.89 -29.67 68.17 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 120.892 -0.67 . . . . 74.44 113.067 177.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 67.5 t -66.94 -40.24 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.752 0.31 . . . . 70.4 110.713 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -65.62 -37.17 85.83 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.032 0.444 . . . . 74.15 110.832 172.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.592 ' SD ' ' NZ ' ' A' ' 70' ' ' LYS . 23.2 mmt -58.35 -46.41 86.33 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.236 -0.438 . . . . 72.25 111.588 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.58 -143.49 38.77 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.322 -0.466 . . . . 54.03 113.74 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.449 ' CH2' ' HB3' ' A' ' 48' ' ' ASP . 82.4 m95 -69.6 105.22 2.6 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.365 0.506 . . . . 72.22 112.365 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.592 ' NZ ' ' SD ' ' A' ' 67' ' ' MET . 34.4 mmtp -111.85 138.96 47.75 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 116.297 -0.41 . . . . 75.42 110.429 174.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.404 ' HB3' ' HB3' ' A' ' 51' ' ' ARG . 98.8 p -157.49 9.83 0.19 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.339 1.237 . . . . 74.44 114.339 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -118.41 149.67 40.85 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.725 -0.609 . . . . 72.54 112.075 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.31 107.54 0.5 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.021 -0.536 . . . . 74.55 111.041 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 129.07 -20.91 5.3 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 116.125 -0.489 . . . . 73.31 112.52 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 55.7 m-20 -74.48 151.3 39.58 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.009 0.433 . . . . 73.43 111.297 175.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 65.8 p -141.43 158.14 44.25 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.327 0.584 . . . . 74.21 112.372 -176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.545 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 40.0 mm -132.1 116.12 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.493 -0.776 . . . . 73.52 109.434 173.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.1 t -124.83 117.18 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 113.003 0.742 . . . . 65.43 113.003 -173.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 68.8 m -122.97 89.13 3.05 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.34 -0.391 . . . . 64.24 110.947 170.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.0 mt -63.78 -38.92 41.7 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 113.575 0.954 . . . . 63.42 113.575 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.04 -21.14 25.96 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.878 1.719 . . . . 73.34 112.931 174.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -112.49 0.61 15.59 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.899 0.38 . . . . 74.14 110.776 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 92.6 mttt 55.09 34.56 22.83 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.609 0.764 . . . . 72.21 112.434 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -102.62 117.51 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.919 0.39 . . . . 71.34 111.305 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -119.92 123.15 42.86 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.426 -0.352 . . . . 73.31 110.545 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.545 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 48.1 t -123.24 132.63 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 120.57 0.224 . . . . 73.43 111.397 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -132.21 143.64 50.09 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.818 0.342 . . . . 73.45 110.938 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' A' ' 75' ' ' ASP . 57.2 mt -100.95 121.35 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.612 0.244 . . . . 62.44 111.505 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.582 ' HE3' HD12 ' A' ' 11' ' ' ILE . 22.9 pttp -124.25 152.04 43.46 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.829 0.347 . . . . 72.1 111.212 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 43.9 t -89.82 151.06 21.97 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.375 0.607 . . . . 72.02 112.15 -177.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.8 p -73.08 -32.48 65.03 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.994 -0.548 . . . . 73.22 111.552 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.404 ' HG2' ' OG ' ' A' ' 90' ' ' SER . 16.2 pt20 . . . . . 0 CA--C 1.542 0.64 0 CA-C-O 121.669 0.747 . . . . 73.31 112.459 -177.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 N--CA 1.469 0.508 0 CA-C-O 120.589 0.233 . . . . 74.03 110.714 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 26.8 m -123.28 145.01 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 112.592 0.59 . . . . 64.41 112.592 -176.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.489 HG13 ' HA ' ' A' ' 23' ' ' PRO . 26.7 m -122.91 141.96 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 115.802 -0.635 . . . . 70.23 111.318 178.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.5 112.7 24.65 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.367 -0.379 . . . . 72.52 110.95 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.541 HG13 ' HD3' ' A' ' 89' ' ' LYS . 45.6 mm -95.43 115.99 35.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.727 0.298 . . . . 73.3 111.415 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.3 mp -101.62 118.36 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.766 0.317 . . . . 73.4 111.043 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.9 m -117.2 138.11 51.91 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.885 0.374 . . . . 51.44 111.597 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.523 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 34.2 tt0 -134.8 142.55 46.72 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 122.587 0.355 . . . . 65.45 110.183 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.523 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 58.3 m-80 56.29 34.94 24.97 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.049 0.452 . . . . 74.33 111.793 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.85 21.19 79.03 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.372 -0.442 . . . . 63.32 114.094 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -144.5 143.82 31.05 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 122.479 -0.424 . . . . 72.21 111.518 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.75 124.24 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.843 0.354 . . . . 65.14 111.285 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 44.9 pt -111.43 -20.09 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 112.474 0.546 . . . . 71.32 112.474 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -157.81 145.47 18.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.909 0.385 . . . . 75.42 111.977 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.44 125.21 20.98 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.3 -0.409 . . . . 74.43 110.945 172.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 73.7 mt -126.99 124.78 24.05 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 112.253 0.464 . . . . 64.04 112.253 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.489 ' HA ' HG13 ' A' ' 9' ' ' VAL . 6.7 Cg_exo -73.82 117.2 4.94 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.826 2.351 . . . . 74.24 112.293 175.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.57 -47.23 15.86 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.088 0.471 . . . . 73.53 111.149 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 84.8 m -58.9 117.03 4.18 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.929 -0.578 . . . . 73.04 112.024 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.34 3.05 88.93 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.242 -0.504 . . . . 72.44 113.713 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -71.15 129.48 39.05 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.286 0.565 . . . . 74.54 111.43 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.667 ' HZ3' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -97.33 148.08 23.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.14 -0.482 . . . . 64.51 111.601 178.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.32 -164.8 54.46 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 114.814 0.686 . . . . 60.0 114.814 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 25.7 t-20 -118.6 125.83 50.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.945 0.498 . . . . 54.02 110.397 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -118.19 122.51 43.2 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.733 0.301 . . . . 51.32 111.512 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -120.11 139.27 52.83 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.937 0.398 . . . . 75.23 111.566 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -149.91 143.12 25.06 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.027 0.442 . . . . 72.33 111.209 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.0 m -101.59 110.06 21.98 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.174 0.511 . . . . 74.35 112.238 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.547 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 39.7 mt -80.1 90.76 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.917 0.389 . . . . 74.1 110.077 175.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -73.54 128.47 35.59 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.883 0.373 . . . . 74.15 111.674 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.48 -143.72 12.01 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 116.296 -0.411 . . . . 71.44 112.209 175.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -86.49 123.53 31.8 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 122.413 -0.463 . . . . 72.15 111.115 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.14 -137.02 19.92 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.372 -0.442 . . . . 60.02 113.548 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.67 4.85 30.57 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.092 0.473 . . . . 71.44 111.874 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.443 ' HB3' ' CD2' ' A' ' 82' ' ' HIS . 23.9 mt-30 -83.28 119.14 24.21 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.254 -0.43 . . . . 73.31 111.637 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -145.86 155.08 42.66 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.584 -0.28 . . . . 72.52 111.556 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.547 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 18.6 m120 -114.75 110.04 19.12 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.374 -0.376 . . . . 75.44 111.017 173.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.1 tp -89.51 107.04 18.85 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.869 0.366 . . . . 72.23 110.489 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.68 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.1 mmm -95.12 146.93 23.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.87 0.367 . . . . 75.14 111.824 -175.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.457 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 42.6 tt0 -133.44 121.45 22.26 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.139 0.495 . . . . 74.31 111.341 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 30' ' ' ASN . 43.9 t -109.34 114.38 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.151 -0.477 . . . . 74.55 110.587 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 35.9 t70 -108.76 103.88 13.04 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.071 0.463 . . . . 71.15 110.704 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 63.14 -104.26 0.78 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 120.742 -0.742 . . . . 70.41 112.674 -175.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -113.75 18.59 17.34 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.018 0.377 . . . . 75.24 112.018 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 35.5 ptt180 -132.75 149.36 52.29 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.668 0.271 . . . . 75.15 111.242 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.1 tt -133.38 146.04 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 112.319 0.489 . . . . 75.34 112.319 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -148.03 169.28 20.27 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.147 -0.479 . . . . 74.41 110.86 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.68 HG12 ' SD ' ' A' ' 45' ' ' MET . 31.2 mt -85.88 108.89 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.05 0.452 . . . . 71.13 110.232 169.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.457 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 56.4 tttp -67.75 -45.66 74.31 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.285 0.564 . . . . 71.3 111.325 -178.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -152.49 157.89 41.79 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.029 -0.532 . . . . 75.21 110.168 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -160.62 167.69 26.5 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.038 0.446 . . . . 74.33 111.947 -175.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.406 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . 51.3 t-20 -130.7 70.81 1.45 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.1 0.476 . . . . 70.44 110.942 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.7 p -129.06 155.87 79.08 Favored Pre-proline 0 N--CA 1.477 0.905 0 O-C-N 122.117 -0.364 . . . . 70.35 111.766 175.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.26 -17.03 13.47 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.486 2.124 . . . . 65.41 112.888 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.528 ' HB2' HG22 ' A' ' 63' ' ' VAL . 5.9 p-10 -92.15 -47.19 7.37 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 111.917 0.34 . . . . 55.32 111.917 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.404 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 28.2 mm-40 65.94 19.73 11.27 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.791 0.436 . . . . 71.01 111.912 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 61' ' ' ASP . 97.1 t -55.14 -46.96 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.156 0.503 . . . . 71.22 111.11 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.483 ' HA3' HD11 ' A' ' 54' ' ' ILE . . . -57.74 -38.32 87.68 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.037 -0.602 . . . . 54.43 112.746 176.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.15 -30.25 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.106 0.479 . . . . 62.11 111.267 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 5.4 mptp? -73.9 -31.04 62.93 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.387 0.514 . . . . 73.42 112.387 177.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.1 mmt -54.38 -50.71 66.89 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.529 0.566 . . . . 75.12 112.529 -177.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.9 -149.62 21.01 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.913 -0.66 . . . . 64.2 113.58 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -80.95 120.3 24.58 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.279 0.561 . . . . 72.02 112.099 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 75.0 mmtt -116.66 150.53 37.98 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.568 -0.742 . . . . 72.03 110.21 175.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 93.1 p -164.15 9.64 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.306 1.225 . . . . 72.44 114.306 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -132.76 157.14 45.69 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.61 0.641 . . . . 74.34 112.422 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.68 112.71 1.91 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.801 -0.636 . . . . 74.03 111.616 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 130.24 -26.45 4.17 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 116.219 -0.446 . . . . 52.3 112.366 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.518 ' HB2' HD12 ' A' ' 88' ' ' ILE . 76.7 m-20 -69.38 126.2 29.02 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.835 0.35 . . . . 71.31 111.082 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.423 HG21 ' HA ' ' A' ' 87' ' ' GLU . 47.0 p -132.02 145.37 51.4 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.947 0.403 . . . . 72.41 111.901 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 37.8 mm -114.65 130.05 69.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.377 -0.374 . . . . 70.42 110.606 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.7 t -112.96 118.65 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 112.047 0.388 . . . . 74.4 112.047 -177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.477 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 74.9 m -122.61 82.38 1.97 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.158 0.504 . . . . 74.12 110.92 173.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.437 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 84.1 mt -57.22 -58.67 16.37 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 113.565 0.95 . . . . 75.12 113.565 -173.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 59.8 Cg_endo -70.9 -2.14 10.53 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.88 1.72 . . . . 73.43 113.033 -175.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.443 ' CD2' ' HB3' ' A' ' 41' ' ' GLN . 37.9 m170 -109.97 -2.45 17.11 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.497 -0.319 . . . . 73.25 111.297 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 59.78 29.62 19.19 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.916 0.389 . . . . 72.35 111.744 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 57.5 t -115.37 134.05 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.104 0.478 . . . . 74.12 111.811 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -136.56 131.68 34.15 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.011 -0.541 . . . . 72.21 110.229 175.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.502 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 46.7 t -118.38 136.38 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.528 -0.305 . . . . 72.22 111.097 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HA ' HG21 ' A' ' 76' ' ' THR . 11.9 pt-20 -133.09 125.2 29.06 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.201 0.524 . . . . 61.45 111.402 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 75' ' ' ASP . 59.2 mt -89.73 116.96 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.863 0.363 . . . . 74.31 110.331 175.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.541 ' HD3' HG13 ' A' ' 11' ' ' ILE . 13.2 ptmt -131.66 147.5 52.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.363 -0.38 . . . . 64.12 111.238 -174.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 48.4 t -78.5 145.59 34.86 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.14 0.422 . . . . 74.24 112.14 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.5 p -86.21 -7.27 58.67 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.151 0.501 . . . . 71.54 110.825 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 . . . . . 0 CA--C 1.537 0.477 0 CA-C-N 115.881 -0.6 . . . . 72.44 111.051 -178.631 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.434 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 46.2 mt-10 . . . . . 0 CA--C 1.539 0.542 0 CA-C-O 121.348 0.594 . . . . 74.4 112.448 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 33.0 m -126.15 152.85 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.694 -0.684 . . . . 75.25 111.716 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.493 HG13 ' HA ' ' A' ' 23' ' ' PRO . 34.1 m -126.63 144.65 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 116.095 -0.502 . . . . 74.2 111.3 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -102.83 109.81 21.52 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.86 0.362 . . . . 74.1 111.099 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.1 mm -95.19 104.23 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 120.702 0.287 . . . . 71.44 111.37 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.462 ' N ' HD13 ' A' ' 12' ' ' ILE . 3.7 mp -89.11 109.9 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.367 0.603 . . . . 75.45 110.916 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.2 p -116.95 127.43 54.2 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.929 -0.578 . . . . 61.34 111.043 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -119.1 146.53 45.03 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.673 0.273 . . . . 74.13 110.625 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.461 ' OD1' ' HD3' ' A' ' 83' ' ' LYS . 46.9 m-80 64.95 6.83 3.61 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.766 0.426 . . . . 74.03 111.796 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.79 -3.52 52.82 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.225 -0.512 . . . . 64.43 113.213 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -124.98 151.8 45.03 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.951 0.405 . . . . 75.43 111.583 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.3 126.15 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 120.905 0.383 . . . . 74.42 111.883 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 41.0 pt -111.86 -25.77 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 116.5 -0.318 . . . . 74.02 111.845 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.555 ' HA ' ' HE ' ' A' ' 20' ' ' ARG . 1.3 tpm_? -164.74 125.22 2.01 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.467 -0.333 . . . . 73.14 110.708 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -123.21 120.51 33.36 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.161 0.505 . . . . 73.33 110.965 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.408 HD13 ' CE1' ' A' ' 33' ' ' PHE . 73.6 mt -117.72 110.7 40.08 Favored Pre-proline 0 N--CA 1.47 0.525 0 N-CA-C 112.062 0.393 . . . . 75.44 112.062 -175.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.493 ' HA ' HG13 ' A' ' 9' ' ' VAL . 37.1 Cg_exo -59.46 117.69 4.46 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.533 2.155 . . . . 63.41 111.903 171.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.2 mt -74.53 -56.07 5.24 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.974 0.416 . . . . 73.3 111.524 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.434 ' OG1' ' HA ' ' A' ' 7' ' ' GLU . 11.3 m -56.61 133.57 53.77 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.16 -0.473 . . . . 71.51 111.736 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.32 -24.7 31.08 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 116.285 -0.416 . . . . 73.32 112.864 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -74.82 136.16 41.62 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.244 0.545 . . . . 73.32 111.627 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -124.11 145.98 48.92 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.109 -0.496 . . . . 73.53 110.859 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.66 -159.2 31.62 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.18 -0.533 . . . . 42.52 112.793 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -118.84 129.02 54.99 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 122.387 -0.478 . . . . 74.4 111.066 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.412 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 6.3 tp10 -123.5 135.08 53.86 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.328 -0.396 . . . . 62.22 110.302 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -134.55 129.69 35.43 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 122.089 -0.382 . . . . 72.3 111.526 -176.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.408 ' CE1' HD13 ' A' ' 22' ' ' ILE . 48.0 p90 -138.3 136.27 36.28 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.25 0.548 . . . . 73.42 111.72 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 30.9 m -104.12 114.2 28.27 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.074 -0.512 . . . . 72.05 112.165 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 54.8 mt -81.11 139.48 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 116.273 -0.421 . . . . 74.33 110.654 175.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -115.76 112.19 21.65 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.929 0.395 . . . . 74.11 112.042 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.15 -141.16 11.66 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 121.407 -0.425 . . . . 62.25 113.064 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -77.83 86.02 4.09 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.663 0.744 . . . . 65.14 111.856 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.17 -119.87 5.16 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 115.961 -0.563 . . . . 75.22 113.072 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.17 -0.93 23.89 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.073 0.397 . . . . 63.32 112.073 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -77.59 66.14 3.25 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.947 0.404 . . . . 74.43 111.728 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.481 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 17.1 p90 -95.32 167.05 11.58 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.535 -0.302 . . . . 74.31 111.106 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -140.47 110.67 6.61 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.659 -0.246 . . . . 73.43 111.164 174.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.6 tp -85.62 102.79 13.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.212 0.529 . . . . 72.53 110.542 177.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.679 ' SD ' HG12 ' A' ' 54' ' ' ILE . 94.5 mmm -97.03 141.49 30.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.004 -0.544 . . . . 71.4 110.751 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.807 ' HB3' HH21 ' A' ' 53' ' ' ARG . 35.4 tt0 -134.12 125.12 27.29 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.377 0.51 . . . . 64.04 112.377 -176.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 44.6 t -100.34 111.79 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.795 -0.639 . . . . 74.41 110.641 175.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.586 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 30.3 t70 -108.04 105.76 15.68 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.11 0.481 . . . . 64.22 110.035 -178.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.51 -104.49 1.07 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.658 -0.782 . . . . 73.04 111.898 -171.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -123.97 27.71 7.1 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.135 0.493 . . . . 73.22 111.448 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 34.1 ptt180 -134.6 154.45 51.49 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.039 0.535 . . . . 72.21 110.807 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.3 tt -142.37 143.33 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 112.91 0.707 . . . . 73.21 112.91 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.807 HH21 ' HB3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -161.03 168.55 24.25 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.162 -0.472 . . . . 71.31 111.875 169.294 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.679 HG12 ' SD ' ' A' ' 45' ' ' MET . 63.8 mt -69.04 121.27 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.387 -0.37 . . . . 73.52 111.173 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -82.19 -42.38 19.07 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.132 0.491 . . . . 72.31 111.016 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -166.21 138.76 3.92 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.651 -0.704 . . . . 62.23 110.689 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 1.7 p-10 -169.5 168.76 9.21 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.245 0.545 . . . . 75.51 111.472 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -97.19 45.16 1.04 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.214 -0.448 . . . . 72.24 111.994 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.1 t -97.72 122.92 53.65 Favored Pre-proline 0 N--CA 1.474 0.731 0 O-C-N 121.998 -0.439 . . . . 72.54 110.712 173.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -60.46 -27.35 84.69 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.506 2.137 . . . . 75.22 112.264 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -78.13 -34.26 50.02 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 116.005 -0.543 . . . . 64.41 111.609 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 54.66 36.18 25.49 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 111.963 0.357 . . . . 71.21 111.963 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 67' ' ' MET . 64.9 t -53.52 -52.5 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 112.733 0.642 . . . . 73.24 112.733 -174.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.577 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -64.19 -40.86 98.39 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.684 -0.77 . . . . 55.23 113.554 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 51.9 t -60.69 -39.6 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.27 0.557 . . . . 73.21 110.607 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -75.48 -28.27 59.15 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.95 -0.568 . . . . 74.23 111.928 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 18.1 mmt -67.16 -37.46 83.81 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 111.977 0.362 . . . . 75.42 111.977 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.94 -174.38 54.8 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 120.988 -0.625 . . . . 72.32 113.222 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.458 ' CE3' ' HG3' ' A' ' 53' ' ' ARG . 94.4 m95 -59.69 120.01 8.7 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.943 0.402 . . . . 73.44 112.016 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -115.82 127.21 54.89 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.239 0.542 . . . . 75.33 111.86 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.8 p -141.81 17.64 2.15 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.817 -0.629 . . . . 65.45 110.858 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -110.22 130.48 55.54 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.382 -0.372 . . . . 75.45 111.428 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.59 106.74 1.22 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.427 -0.351 . . . . 72.25 111.577 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.84 -36.65 1.74 Allowed Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.061 -0.59 . . . . 73.22 112.34 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -73.51 131.26 41.57 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.09 0.471 . . . . 73.22 111.179 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 69.3 p -120.87 152.17 38.75 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.963 0.411 . . . . 72.11 111.633 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.533 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 43.7 mm -114.25 110.45 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.309 -0.405 . . . . 73.54 110.204 177.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -107.27 116.66 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 112.35 0.5 . . . . 73.44 112.35 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 72.3 m -122.22 76.42 1.31 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.371 -0.377 . . . . 60.4 111.067 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.449 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 86.7 mt -57.21 -46.62 99.82 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 113.061 0.763 . . . . 74.22 113.061 -177.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.449 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 51.8 Cg_exo -55.64 -18.96 22.13 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.945 1.764 . . . . 71.41 113.364 177.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -112.65 -0.15 15.19 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.613 -0.267 . . . . 63.4 111.458 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.461 ' HD3' ' OD1' ' A' ' 15' ' ' ASN . 57.8 mttm 63.67 15.61 9.08 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.091 0.556 . . . . 71.22 112.433 -178.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.9 t -97.03 127.09 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.0 0.429 . . . . 75.42 111.832 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -130.62 113.22 13.92 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.222 -0.445 . . . . 74.14 110.633 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.533 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 46.2 t -100.79 117.02 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.042 0.449 . . . . 73.2 111.292 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -106.79 108.64 20.25 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.175 -0.466 . . . . 71.13 110.938 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 60.0 mt -91.91 121.06 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.149 0.5 . . . . 73.25 111.349 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -139.06 155.5 47.89 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.256 -0.429 . . . . 73.22 111.18 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 41.2 t -95.95 150.14 20.79 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.022 0.439 . . . . 74.3 112.042 -177.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.2 p -87.64 2.61 50.5 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.116 -0.493 . . . . 73.23 111.433 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 . . . . . 0 CA--C 1.541 0.615 0 CA-C-O 121.084 0.469 . . . . 74.35 111.663 -176.606 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 120.968 0.413 . . . . 74.33 111.769 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 26.8 m -122.75 145.12 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.127 0.489 . . . . 63.23 111.876 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.86 146.99 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.017 -0.538 . . . . 75.21 111.29 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.0 112.89 25.45 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.33 -0.396 . . . . 70.4 111.106 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.8 mm -92.34 105.73 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.47 -0.332 . . . . 72.21 111.199 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.431 ' N ' HD13 ' A' ' 12' ' ' ILE . 4.1 mp -91.88 121.83 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 121.07 0.462 . . . . 73.34 111.276 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.0 m -121.51 157.1 31.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.358 -0.383 . . . . 71.42 111.491 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.591 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 53.7 tt0 -152.69 142.83 22.36 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.979 0.418 . . . . 74.0 111.345 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.591 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 62.3 m-80 57.45 19.21 5.02 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.031 0.752 . . . . 75.54 113.031 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.47 -12.78 36.21 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.728 -0.749 . . . . 72.21 114.271 176.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -129.3 156.5 43.91 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 117.635 0.718 . . . . 73.23 112.068 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.63 133.54 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.826 0.346 . . . . 71.23 111.318 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.1 pt -111.92 -31.02 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 112.153 0.427 . . . . 74.33 112.153 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -157.19 133.17 9.51 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 111.979 0.363 . . . . 74.52 111.979 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -117.14 114.43 23.68 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 110.307 -0.256 . . . . 72.05 110.307 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 73.1 mt -115.0 116.04 42.85 Favored Pre-proline 0 N--CA 1.472 0.662 0 N-CA-C 111.826 0.306 . . . . 74.42 111.826 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.42 124.54 11.75 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.437 2.092 . . . . 72.52 112.474 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.7 mt -81.75 -56.49 3.96 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.995 0.426 . . . . 74.53 111.317 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.7 m -62.63 112.78 2.64 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.034 0.445 . . . . 74.2 111.501 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.02 7.77 57.22 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.128 -0.558 . . . . 60.25 113.199 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -85.1 122.91 29.99 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 117.004 0.402 . . . . 73.23 110.846 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.456 ' HD2' ' N ' ' A' ' 28' ' ' LYS . 11.1 mptt -91.24 140.85 29.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.045 0.45 . . . . 75.15 112.009 -176.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.94 -151.69 51.93 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 114.82 0.688 . . . . 41.33 114.82 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -117.3 143.71 45.64 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.882 0.473 . . . . 72.43 110.648 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -144.08 114.64 7.62 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.617 0.246 . . . . 71.22 111.007 -175.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -117.67 137.31 52.74 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.9 0.381 . . . . 75.52 111.434 -175.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -144.13 141.99 30.32 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.994 0.426 . . . . 73.43 111.484 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.2 m -99.89 118.0 35.4 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.033 0.444 . . . . 74.33 111.963 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.1 mt -92.63 97.01 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.326 -0.397 . . . . 70.44 110.701 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.62 148.01 31.83 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.029 0.442 . . . . 71.02 111.574 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -127.63 -152.14 7.83 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.45 -0.405 . . . . 71.42 112.361 177.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -70.94 123.62 22.44 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.24 0.543 . . . . 72.51 111.23 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.65 -134.71 22.59 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.325 -0.464 . . . . 53.32 112.722 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.85 15.47 16.55 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.996 0.427 . . . . 74.43 111.773 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.557 ' HB3' ' CD2' ' A' ' 82' ' ' HIS . 27.1 mt-30 -87.58 100.02 12.48 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.076 0.465 . . . . 75.32 111.526 -177.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -132.79 166.24 22.7 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.102 -0.499 . . . . 73.33 112.024 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -126.68 122.78 35.92 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.858 -0.61 . . . . 71.12 110.682 171.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.5 tp -92.26 110.44 21.83 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.724 0.297 . . . . 75.21 110.362 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.747 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.2 mmm -99.56 136.96 38.73 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.983 0.42 . . . . 73.22 111.869 -175.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -125.34 115.11 19.81 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.298 -0.41 . . . . 74.33 111.27 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.9 t -102.49 107.34 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.434 -0.348 . . . . 75.33 110.477 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -110.57 122.12 46.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.932 0.396 . . . . 63.15 110.987 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.4 -107.78 1.25 Allowed Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.125 -0.56 . . . . 61.44 112.32 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -120.86 25.5 9.64 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.06 0.457 . . . . 73.14 111.531 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -138.51 149.76 45.7 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.937 0.399 . . . . 74.53 111.517 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.6 tt -126.94 146.45 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 112.089 0.403 . . . . 74.34 112.089 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -148.74 168.77 22.01 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.985 0.422 . . . . 74.5 111.311 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.747 HG12 ' SD ' ' A' ' 45' ' ' MET . 33.8 mt -90.87 111.17 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.14 0.495 . . . . 75.32 110.086 169.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -74.45 -39.28 62.65 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.892 -0.595 . . . . 75.22 111.525 -175.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -149.93 148.87 29.63 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.275 -0.42 . . . . 73.53 110.142 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.29 130.73 9.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.353 0.597 . . . . 74.33 111.641 -175.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -96.28 64.35 2.27 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.326 0.584 . . . . 63.13 110.691 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 45.9 t -128.46 139.64 36.11 Favored Pre-proline 0 N--CA 1.473 0.677 0 CA-C-N 116.033 -0.531 . . . . 71.53 111.043 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 59' ' ' SER . 32.1 Cg_exo -58.27 -36.68 97.48 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.532 2.154 . . . . 71.44 112.749 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -76.5 -29.44 56.83 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.821 -0.627 . . . . 75.02 112.622 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 56.59 19.53 4.3 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.938 0.718 . . . . 73.43 112.938 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.5 t -53.94 -41.04 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 112.168 0.433 . . . . 75.45 112.168 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.532 ' HA3' HD11 ' A' ' 54' ' ' ILE . . . -57.83 -43.99 94.47 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.065 -0.588 . . . . 71.2 113.289 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.95 -37.83 81.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.006 0.431 . . . . 63.53 111.143 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -65.65 -40.27 92.31 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.309 0.485 . . . . 64.4 112.309 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.3 mmt -65.26 -41.28 94.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.828 0.347 . . . . 75.52 111.373 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.47 -129.75 28.43 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 114.367 0.507 . . . . 62.54 114.367 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -77.92 136.47 38.02 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.737 0.643 . . . . 73.11 112.737 -174.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 75.1 mmtt -132.58 144.26 50.26 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.902 -0.59 . . . . 72.21 109.883 173.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 95.4 p -162.0 13.57 0.08 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.363 0.875 . . . . 73.4 113.363 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -123.41 151.3 42.76 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.996 0.426 . . . . 74.32 112.056 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.64 111.62 1.49 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.26 0.552 . . . . 72.25 111.276 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 121.37 -21.53 8.12 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 121.314 -0.47 . . . . 74.41 112.435 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.538 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 80.1 m-20 -63.74 123.14 18.12 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.81 0.338 . . . . 62.42 111.226 176.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 65.8 p -130.65 141.93 50.43 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.403 0.621 . . . . 72.14 112.293 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.5 mm -114.8 118.37 58.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.833 -0.621 . . . . 75.02 110.258 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.3 t -112.31 115.73 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.924 0.392 . . . . 74.25 111.778 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 76.6 m -121.66 79.26 1.54 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.029 0.442 . . . . 74.31 110.825 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.49 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 93.1 mt -59.11 -47.02 99.29 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 113.091 0.775 . . . . 73.51 113.091 -175.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.49 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 50.7 Cg_exo -56.07 -17.36 19.42 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 122.255 1.97 . . . . 71.25 113.611 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.557 ' CD2' ' HB3' ' A' ' 41' ' ' GLN . 64.6 m170 -117.33 -1.81 11.7 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 122.14 -0.35 . . . . 71.24 111.612 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 66.4 mttm 59.37 28.33 17.66 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.071 -0.513 . . . . 73.42 112.194 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.7 t -100.56 132.89 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.487 -0.324 . . . . 65.41 111.061 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -136.68 118.21 14.85 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.004 0.431 . . . . 71.32 111.023 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.2 t -112.31 132.14 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 116.374 -0.375 . . . . 74.12 110.851 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -131.96 131.86 42.99 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.126 0.488 . . . . 53.1 111.367 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 58.4 mt -97.68 130.02 46.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.182 0.515 . . . . 75.15 111.307 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -137.74 153.96 49.67 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.058 -0.519 . . . . 74.44 110.932 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 47.7 t -89.86 149.89 22.46 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.09 -0.381 . . . . 64.13 111.264 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.2 p -65.8 -22.02 66.53 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.017 0.437 . . . . 71.44 110.807 175.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 121.194 0.521 . . . . 73.5 111.579 179.69 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.44 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 44.5 mt-10 . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 113.096 0.776 . . . . 75.33 113.096 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 71' ' ' SER . 35.7 m -137.67 160.39 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 115.921 -0.581 . . . . 71.2 112.176 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 23' ' ' PRO . 29.8 m -131.43 146.54 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.064 -0.516 . . . . 71.01 110.788 176.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.97 116.53 30.37 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.918 0.39 . . . . 52.5 111.949 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.5 mm -97.21 124.58 50.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.486 -0.325 . . . . 70.1 110.613 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.486 HD11 ' N ' ' A' ' 12' ' ' ILE . 2.9 mp -104.55 111.81 35.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.755 0.312 . . . . 63.22 111.156 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 18' ' ' VAL . 60.4 m -109.04 126.1 52.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.092 0.472 . . . . 72.41 111.584 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -118.39 133.08 56.18 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.157 -0.339 . . . . 73.13 110.972 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.484 ' N ' HD21 ' A' ' 15' ' ' ASN . 0.8 OUTLIER 65.14 12.4 7.94 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.316 0.488 . . . . 74.11 112.316 177.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.04 10.52 34.33 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.359 -0.448 . . . . 52.31 113.857 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -144.15 146.04 32.49 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.397 0.599 . . . . 74.1 111.734 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 59.2 t -59.95 138.41 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 116.35 -0.386 . . . . 73.23 111.324 177.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 47.1 pt -125.78 -12.39 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.338 0.495 . . . . 75.45 112.338 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -173.76 142.24 0.89 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.812 0.339 . . . . 75.34 111.71 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -125.22 119.0 27.26 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 116.488 -0.324 . . . . 74.24 110.821 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.525 HG22 HG21 ' A' ' 47' ' ' VAL . 3.3 mp -115.53 125.13 29.1 Favored Pre-proline 0 N--CA 1.476 0.861 0 N-CA-C 111.741 0.275 . . . . 74.12 111.741 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.52 ' HA ' HG13 ' A' ' 9' ' ' VAL . 15.3 Cg_exo -69.51 123.02 9.76 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.817 2.345 . . . . 75.42 112.377 173.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.07 -57.28 3.16 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.873 0.368 . . . . 74.52 111.498 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.44 ' OG1' ' HA ' ' A' ' 7' ' ' GLU . 13.2 m -65.26 127.3 31.14 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.086 0.469 . . . . 74.54 111.441 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.62 -1.67 81.75 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.053 -0.594 . . . . 53.14 112.767 -174.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -92.5 90.49 7.19 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.281 -0.541 . . . . 74.43 111.535 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.68 169.47 18.22 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.145 -0.479 . . . . 71.43 111.17 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.18 -165.25 43.1 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 114.626 0.61 . . . . 73.54 114.626 175.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -118.44 126.04 51.21 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.998 0.519 . . . . 71.3 110.825 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -139.6 130.89 26.71 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.768 0.318 . . . . 53.45 111.08 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -122.8 153.71 39.18 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.042 0.449 . . . . 72.43 112.057 -173.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -150.33 138.22 20.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.912 0.387 . . . . 75.34 111.364 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.5 m -101.6 123.53 45.76 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.041 0.448 . . . . 62.5 112.169 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.8 mt -97.84 129.53 47.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.143 -0.48 . . . . 63.14 110.897 176.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -105.75 142.46 35.44 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.079 0.466 . . . . 75.05 111.827 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.29 -157.91 32.5 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 116.253 -0.431 . . . . 73.4 113.531 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -92.82 23.29 4.24 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.154 0.427 . . . . 73.0 112.154 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 175.14 -130.75 1.8 Allowed Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.331 -0.461 . . . . 62.24 112.139 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.03 67.43 3.87 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.415 0.626 . . . . 60.41 110.724 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -144.19 130.15 19.44 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.885 -0.598 . . . . 71.23 111.324 -175.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -147.84 144.62 28.28 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.697 0.284 . . . . 74.25 111.143 172.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -128.85 110.92 12.55 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.325 -0.398 . . . . 65.11 110.623 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.4 tp -87.04 104.85 16.72 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.894 0.378 . . . . 72.15 110.872 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.8 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.0 mmm -90.58 135.91 33.4 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.37 -0.377 . . . . 74.43 111.272 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -126.83 117.14 22.02 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.961 0.41 . . . . 72.43 111.986 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.525 HG21 HG22 ' A' ' 22' ' ' ILE . 21.9 t -101.17 107.45 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.065 -0.516 . . . . 71.03 110.238 175.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.453 ' HB3' ' CZ3' ' A' ' 69' ' ' TRP . 28.2 t70 -128.17 117.66 21.98 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.934 0.397 . . . . 64.23 111.424 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 60.33 60.75 8.01 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 121.205 -0.522 . . . . 62.24 114.169 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 57.76 18.33 4.77 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.914 1.079 . . . . 52.45 113.914 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.537 ' HD2' ' HB3' ' A' ' 69' ' ' TRP . 29.3 ptt180 -146.46 152.33 38.85 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.864 0.364 . . . . 72.21 110.899 174.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.5 tt -129.04 151.25 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.81 0.67 . . . . 74.11 112.81 -170.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.99 168.82 25.77 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.763 -0.653 . . . . 72.32 110.238 170.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.8 HG12 ' SD ' ' A' ' 45' ' ' MET . 59.4 mt -81.38 121.97 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.943 0.402 . . . . 74.41 110.387 174.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -84.35 -37.9 21.0 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 116.216 -0.447 . . . . 65.33 111.895 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -161.07 138.29 8.99 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.389 -0.369 . . . . 72.03 111.291 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.13 162.61 25.7 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.907 0.384 . . . . 71.21 110.51 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -98.59 64.45 1.52 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.567 0.699 . . . . 72.24 111.676 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.0 p -114.03 141.68 26.67 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-N 115.768 -0.651 . . . . 74.55 110.27 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.78 -23.24 26.39 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.183 1.922 . . . . 64.24 112.796 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.469 ' HB3' HG22 ' A' ' 63' ' ' VAL . 3.5 m-20 -87.63 -39.71 14.81 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.12 0.415 . . . . 71.42 112.12 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 61.04 23.24 13.43 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.513 0.56 . . . . 71.32 112.513 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.469 HG22 ' HB3' ' A' ' 61' ' ' ASP . 60.9 t -56.24 -34.79 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.898 0.38 . . . . 71.3 111.15 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.555 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -55.98 -47.1 82.28 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 116.275 -0.42 . . . . 62.01 113.17 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.2 t -73.77 -34.25 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.243 0.544 . . . . 74.14 110.956 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -60.22 -28.76 68.26 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.845 -0.616 . . . . 73.31 111.506 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 23.1 mmt -55.76 -34.27 65.07 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.327 0.491 . . . . 74.34 112.327 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.71 -163.64 53.64 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.977 -0.63 . . . . 50.5 113.425 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.537 ' HB3' ' HD2' ' A' ' 51' ' ' ARG . 94.0 m95 -73.39 110.32 7.58 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.853 0.359 . . . . 74.42 111.793 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -108.41 137.59 46.11 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.053 0.454 . . . . 72.51 111.674 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.404 ' O ' HG22 ' A' ' 8' ' ' VAL . 91.1 p -161.65 25.44 0.12 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.255 -0.43 . . . . 73.42 111.682 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -115.78 141.1 48.54 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.897 0.38 . . . . 72.14 111.599 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.4 106.64 1.16 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.978 0.418 . . . . 75.25 111.15 176.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 125.44 -7.24 7.98 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.011 -0.614 . . . . 74.32 113.342 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -92.71 142.0 27.84 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.138 0.494 . . . . 73.21 111.47 175.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.509 HG21 ' HA ' ' A' ' 87' ' ' GLU . 66.7 p -135.24 153.41 51.93 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.043 -0.526 . . . . 75.41 111.771 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.416 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 32.6 mm -112.97 128.33 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 116.346 -0.388 . . . . 73.34 110.351 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 50.5 t -115.39 120.1 63.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 112.191 0.441 . . . . 75.1 112.191 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.444 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 73.1 m -120.94 81.0 1.71 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.26 0.552 . . . . 71.52 110.3 171.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.429 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 4.3 tt -57.04 -53.75 61.88 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 115.498 -0.774 . . . . 74.55 112.253 -173.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 80' ' ' LEU . 44.1 Cg_endo -65.89 -9.62 23.79 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 122.26 1.973 . . . . 64.33 113.537 -176.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -114.34 -4.91 12.94 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 122.06 -0.4 . . . . 74.41 111.73 177.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 66.8 mttm 57.39 36.64 27.37 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.275 0.559 . . . . 63.13 111.481 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 59.4 t -111.69 138.71 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.875 -0.602 . . . . 71.21 110.979 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -140.93 148.42 40.38 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.358 -0.383 . . . . 71.54 110.475 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 76' ' ' THR . 57.3 t -139.46 113.79 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 122.257 -0.277 . . . . 75.2 111.439 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.509 ' HA ' HG21 ' A' ' 76' ' ' THR . 1.4 pm0 -106.92 126.7 52.66 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.343 0.592 . . . . 72.31 111.788 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.8 mt -95.71 122.3 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-O 121.024 0.44 . . . . 70.05 111.597 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.625 ' HZ3' ' HB2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -122.1 151.76 40.57 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.434 -0.348 . . . . 65.21 111.196 -178.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.0 t -76.3 149.34 37.1 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.868 0.365 . . . . 74.21 111.905 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.446 HG22 HG12 ' A' ' 9' ' ' VAL . 27.5 p -77.09 -27.43 54.19 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.006 0.432 . . . . 64.43 111.246 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 . . . . . 0 CA--C 1.539 0.536 0 CA-C-N 116.324 -0.398 . . . . 74.22 111.075 177.576 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 N--CA 1.473 0.688 0 CA-C-O 121.091 0.472 . . . . 70.21 111.894 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.548 HG23 ' HB2' ' A' ' 24' ' ' LEU . 30.8 m -110.1 144.82 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 121.287 0.565 . . . . 73.13 112.102 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.5 m -124.11 138.88 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.266 -0.425 . . . . 74.41 111.483 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.04 119.97 36.52 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.887 0.375 . . . . 62.12 111.288 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.6 mm -104.27 113.37 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.564 -0.289 . . . . 74.44 111.029 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.502 ' N ' HD13 ' A' ' 12' ' ' ILE . 3.1 mp -98.69 125.74 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 120.841 0.353 . . . . 75.4 110.894 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.5 t -128.8 152.63 48.26 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.068 0.461 . . . . 63.14 112.174 -176.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -146.91 142.87 28.05 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.017 -0.538 . . . . 65.2 110.734 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.7 14.02 5.79 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.407 0.521 . . . . 74.33 112.407 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.17 16.34 47.67 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.197 -0.525 . . . . 62.33 113.577 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -138.41 140.94 39.56 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.415 -0.462 . . . . 74.33 111.256 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -63.02 128.26 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 110.12 -0.326 . . . . 62.41 110.12 174.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.2 pt -109.23 -28.76 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 112.35 0.5 . . . . 74.2 112.35 -177.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -162.65 138.4 7.18 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.921 0.391 . . . . 74.44 111.494 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -124.48 119.45 29.17 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.591 -0.277 . . . . 71.14 111.493 -177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.3 mp -112.81 116.17 47.92 Favored Pre-proline 0 N--CA 1.472 0.648 0 CA-C-O 120.626 0.251 . . . . 73.41 111.148 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.76 113.24 3.31 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.161 1.907 . . . . 74.33 111.579 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.548 ' HB2' HG23 ' A' ' 8' ' ' VAL . 85.4 mt -69.75 -58.68 3.61 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.853 0.316 . . . . 74.53 111.853 -175.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.6 m -54.15 131.04 40.39 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.133 0.492 . . . . 74.24 111.328 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.11 -16.14 56.36 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 121.089 -0.577 . . . . 60.24 113.975 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.501 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 60.3 t-80 -76.4 76.2 3.15 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.716 0.758 . . . . 74.22 110.86 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.622 ' HZ3' ' HB3' ' A' ' 28' ' ' LYS . 7.1 mtpm? -78.23 92.75 4.51 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.972 -0.558 . . . . 74.54 111.43 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.8 -168.48 31.15 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 116.267 -0.424 . . . . 74.14 112.513 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -118.17 150.41 39.44 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.072 0.463 . . . . 71.34 111.42 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.52 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 12.4 tp10 -149.23 148.29 29.41 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.492 -0.322 . . . . 74.42 110.918 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -138.36 129.7 27.45 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.086 0.469 . . . . 74.43 111.689 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -145.82 131.86 19.29 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.209 0.528 . . . . 75.11 110.955 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.9 m -105.53 130.69 53.54 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.27 -0.423 . . . . 72.42 111.752 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.484 ' N ' HD13 ' A' ' 35' ' ' ILE . 3.2 mp -99.16 114.14 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.481 -0.327 . . . . 72.04 110.362 175.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -101.46 108.11 19.6 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.721 0.296 . . . . 73.34 111.505 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.68 -105.21 0.37 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.065 -0.588 . . . . 72.33 112.021 174.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.656 ' HB3' ' HZ1' ' A' ' 38' ' ' LYS . 9.4 mtpm? -82.61 78.65 9.2 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 122.343 -0.504 . . . . 73.42 111.361 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.67 -87.23 0.01 OUTLIER Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.194 -0.457 . . . . 70.23 114.104 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.26 -21.17 62.13 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.136 0.421 . . . . 71.4 112.136 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -78.29 73.72 4.85 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.138 0.494 . . . . 72.32 111.25 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.427 ' CE1' ' HB2' ' A' ' 58' ' ' ASN . 35.4 p90 -100.58 162.56 12.85 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.978 -0.555 . . . . 63.42 111.841 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -136.39 114.04 11.05 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.086 -0.507 . . . . 74.41 110.671 173.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.6 tp -89.64 103.28 15.94 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.989 0.423 . . . . 74.3 111.392 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.797 ' SD ' HG12 ' A' ' 54' ' ' ILE . 88.6 mmm -96.64 138.61 33.94 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.056 -0.52 . . . . 73.35 111.377 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -129.23 126.27 38.76 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.881 0.372 . . . . 75.44 111.466 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 56.4 t -110.54 115.25 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.067 0.46 . . . . 73.33 111.328 178.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.432 ' HB2' ' CH2' ' A' ' 69' ' ' TRP . 14.9 t70 -108.44 171.93 7.13 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.696 -0.483 . . . . 70.42 109.696 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 27' ' ' HIS . . . -37.27 90.38 0.01 OUTLIER Glycine 0 CA--C 1.535 1.282 0 N-CA-C 114.85 0.7 . . . . 71.53 114.85 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 66.08 32.09 8.47 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.506 0.722 . . . . 71.53 112.888 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -155.47 151.26 27.53 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 122.644 0.378 . . . . 71.15 111.144 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 tt -136.83 150.47 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 120.825 0.345 . . . . 63.23 111.919 -177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.546 ' NH2' ' HE3' ' A' ' 55' ' ' LYS . 21.4 ptt180 -155.62 168.58 26.69 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.222 0.535 . . . . 71.31 112.252 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.797 HG12 ' SD ' ' A' ' 45' ' ' MET . 62.1 mt -102.38 119.34 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.764 -0.653 . . . . 70.34 109.9 168.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.546 ' HE3' ' NH2' ' A' ' 53' ' ' ARG . 41.1 mtpt -78.57 -38.12 40.98 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.958 0.409 . . . . 72.14 110.728 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -169.63 138.78 1.93 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.518 -0.764 . . . . 75.2 111.425 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -142.37 161.56 37.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.975 -0.38 . . . . 74.13 109.975 170.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.427 ' HB2' ' CE1' ' A' ' 42' ' ' TYR . 61.2 t30 -84.95 66.29 9.66 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.152 0.501 . . . . 72.42 111.037 -176.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.3 t -129.05 145.75 57.89 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 116.224 -0.444 . . . . 73.22 111.146 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.52 -35.78 12.7 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.536 2.157 . . . . 62.22 113.16 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.468 ' HB2' HG23 ' A' ' 63' ' ' VAL . 1.6 p30 -77.59 -44.2 29.19 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.029 0.381 . . . . 75.11 112.029 -178.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.493 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 24.7 mm-40 63.5 26.6 14.86 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.429 -0.351 . . . . 65.43 111.804 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.468 HG23 ' HB2' ' A' ' 61' ' ' ASP . 87.7 t -53.2 -41.61 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 120.849 0.357 . . . . 55.23 111.61 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.555 ' HA3' HD11 ' A' ' 54' ' ' ILE . . . -58.4 -38.48 90.78 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.32 -0.467 . . . . 74.43 113.258 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.35 -39.96 72.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.969 0.414 . . . . 75.04 111.06 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.493 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 4.6 mptp? -62.59 -29.91 70.95 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.364 -0.38 . . . . 72.2 111.301 176.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 21.2 mmt -61.2 -44.57 97.07 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.086 0.402 . . . . 75.04 112.086 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.26 -148.64 32.99 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.142 -0.552 . . . . 63.31 113.209 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.432 ' CH2' ' HB2' ' A' ' 48' ' ' ASP . 91.3 m95 -76.36 110.94 11.3 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.07 0.462 . . . . 75.23 111.867 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -103.88 143.78 32.38 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.379 -0.373 . . . . 73.44 110.885 175.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 64.2 p -169.19 18.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.502 0.556 . . . . 74.42 112.502 -173.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 72' ' ' LYS . 2.9 mptp? -116.86 144.93 43.93 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.82 0.343 . . . . 74.23 110.39 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.61 93.43 0.08 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.936 0.398 . . . . 74.41 111.346 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.09 -20.19 1.76 Allowed Glycine 0 CA--C 1.529 0.938 0 CA-C-N 116.029 -0.532 . . . . 52.23 113.364 -177.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.486 ' HB2' HD13 ' A' ' 88' ' ' ILE . 75.9 m-20 -66.25 135.35 54.33 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 117.096 0.448 . . . . 43.55 112.025 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.9 p -133.03 145.95 51.29 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.27 0.557 . . . . 73.42 111.692 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.51 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 35.0 mm -117.72 129.9 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 115.852 -0.613 . . . . 55.42 110.48 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.3 t -123.85 117.31 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 112.651 0.611 . . . . 65.33 112.651 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 90.3 m -115.77 81.22 1.56 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.244 0.545 . . . . 71.53 110.006 169.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.522 ' HB3' ' HD3' ' A' ' 81' ' ' PRO . 5.4 tt -55.76 -53.57 61.4 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 115.631 -0.713 . . . . 73.52 112.394 -172.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 80' ' ' LEU . 31.3 Cg_exo -60.04 -14.68 29.44 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.046 1.831 . . . . 72.3 113.381 -176.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -105.2 -3.65 22.69 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.994 0.368 . . . . 72.33 111.994 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.6 mttm 60.81 21.28 11.4 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 120.901 0.382 . . . . 75.43 111.491 -174.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.0 t -104.04 130.12 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 121.186 0.517 . . . . 73.4 111.365 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -135.93 136.57 40.55 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.002 -0.545 . . . . 75.52 111.061 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.51 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 46.4 t -128.7 144.56 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.396 -0.365 . . . . 73.32 110.519 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -143.6 144.74 32.05 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.204 0.526 . . . . 65.43 111.911 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.486 HD13 ' HB2' ' A' ' 75' ' ' ASP . 65.4 mt -106.18 111.7 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 115.941 -0.572 . . . . 74.54 111.096 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -118.09 143.06 46.77 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.022 -0.535 . . . . 74.52 110.654 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 22.8 t -85.54 122.87 30.29 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.861 -0.524 . . . . 73.52 110.471 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.646 HG23 ' HG2' ' A' ' 92' ' ' GLN . 9.7 t -77.86 -24.48 48.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.955 0.407 . . . . 73.03 111.352 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.646 ' HG2' HG23 ' A' ' 91' ' ' THR . 77.0 mm-40 . . . . . 0 CA--C 1.536 0.442 0 CA-C-N 116.172 -0.467 . . . . 75.25 111.042 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.438 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 42.9 mt-10 . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 121.121 0.486 . . . . 52.42 110.292 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.87 150.71 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 113.0 0.741 . . . . 75.15 113.0 -171.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.69 140.15 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 115.643 -0.708 . . . . 73.34 110.905 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.85 111.93 23.78 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.84 0.352 . . . . 74.13 111.431 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.1 mm -96.2 113.66 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.348 -0.387 . . . . 75.31 110.968 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.483 HD12 ' N ' ' A' ' 12' ' ' ILE . 2.9 mp -95.62 123.57 47.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.83 0.347 . . . . 74.11 111.387 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.6 p -125.58 146.61 49.61 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.008 0.432 . . . . 74.21 111.171 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.506 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 63.1 tt0 -130.9 131.25 44.39 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.544 -0.298 . . . . 73.45 110.204 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.477 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 56.5 m-80 57.5 15.58 2.83 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.057 0.391 . . . . 71.13 112.057 -175.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.98 -20.28 31.42 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.314 -0.469 . . . . 52.23 114.034 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -98.35 140.77 32.13 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.323 0.562 . . . . 71.25 111.85 -177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.27 122.64 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.954 0.407 . . . . 71.45 111.529 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.8 pt -111.03 -19.4 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 112.953 0.723 . . . . 74.4 112.953 -175.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -167.81 144.47 4.17 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.001 0.371 . . . . 74.52 112.001 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -128.91 122.73 30.89 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.396 0.278 . . . . 73.44 111.329 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.7 mp -118.32 113.86 36.81 Favored Pre-proline 0 N--CA 1.477 0.888 0 N-CA-C 111.713 0.264 . . . . 61.3 111.713 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.69 124.96 11.63 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.223 1.949 . . . . 74.42 111.851 171.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.9 mt -92.13 -47.78 7.07 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.9 0.704 . . . . 74.11 112.9 -172.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.438 ' OG1' ' HA ' ' A' ' 7' ' ' GLU . 14.8 m -59.53 121.73 12.28 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.303 0.483 . . . . 72.54 112.303 -175.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.79 5.82 88.52 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.442 -0.409 . . . . 62.3 113.437 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.484 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 41.6 t-80 -70.82 87.38 0.7 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.314 0.578 . . . . 74.35 111.267 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -64.17 123.77 19.94 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.62 0.6 . . . . 75.22 112.62 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.5 -164.04 20.97 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 114.189 0.436 . . . . 55.31 114.189 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -118.61 128.86 54.94 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.559 0.343 . . . . 74.02 111.213 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -130.48 114.68 15.81 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.096 0.474 . . . . 73.13 111.634 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.43 ' HG2' ' HG3' ' A' ' 46' ' ' GLU . 68.0 mt-30 -109.82 145.12 37.26 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.281 -0.418 . . . . 72.42 111.126 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -151.19 145.78 25.65 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.002 0.43 . . . . 74.11 111.787 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 28.7 m -103.88 113.63 27.3 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.736 0.643 . . . . 72.14 112.736 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.44 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 61.1 mt -88.39 109.04 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.114 -0.494 . . . . 64.23 110.604 173.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -79.61 106.33 11.55 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.166 -0.334 . . . . 73.32 111.66 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.506 ' HA2' ' NE2' ' A' ' 14' ' ' GLN . . . -73.42 -171.02 21.3 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 120.865 -0.683 . . . . 62.32 112.754 176.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HD2' ' HD2' ' A' ' 83' ' ' LYS . 27.0 mtpp -66.85 99.42 0.62 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.973 0.416 . . . . 74.41 111.751 -177.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.37 -118.22 5.73 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.231 -0.509 . . . . 43.13 113.121 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.01 -4.95 38.82 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.389 0.515 . . . . 64.32 112.389 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.631 ' HA ' ' HB3' ' A' ' 58' ' ' ASN . 14.0 mt-30 -82.49 81.44 8.31 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.463 0.649 . . . . 73.42 111.738 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 22.8 p90 -84.09 166.34 17.76 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.679 -0.691 . . . . 75.02 111.88 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.44 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 22.3 m120 -136.34 109.89 7.99 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.724 0.409 . . . . 70.22 110.715 173.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.9 tp -90.56 103.54 16.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.097 0.475 . . . . 74.4 110.562 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.709 ' SD ' HG12 ' A' ' 54' ' ' ILE . 94.9 mmm -89.94 144.55 25.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.129 -0.487 . . . . 65.22 111.108 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.608 ' HB3' ' NH1' ' A' ' 53' ' ' ARG . 71.6 tt0 -132.99 126.6 32.32 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.179 0.514 . . . . 74.45 111.734 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.1 t -103.81 119.42 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 115.838 -0.619 . . . . 63.34 110.848 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 34.9 t70 -107.9 97.77 7.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.275 0.559 . . . . 72.21 109.782 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 27' ' ' HIS . . . 65.87 -104.67 1.06 Allowed Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.819 -0.705 . . . . 70.43 112.377 -175.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -112.95 15.57 19.65 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.868 0.366 . . . . 75.21 111.949 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 18.6 ptp180 -131.54 150.24 52.22 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.524 -0.307 . . . . 74.22 110.925 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.7 tt -139.72 145.2 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 112.681 0.623 . . . . 70.43 112.681 -175.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.608 ' NH1' ' HB3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -159.41 168.61 25.86 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 116.1 -0.5 . . . . 74.4 111.311 173.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.709 HG12 ' SD ' ' A' ' 45' ' ' MET . 55.2 mt -73.96 122.16 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.107 0.48 . . . . 75.14 111.409 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -82.14 -51.04 8.37 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.093 -0.503 . . . . 75.22 111.441 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -154.04 136.85 15.31 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.223 -0.444 . . . . 63.04 110.317 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -157.15 -177.14 6.39 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.513 0.673 . . . . 74.11 111.962 179.249 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.631 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . 55.1 t-20 -115.15 75.58 0.94 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.423 -0.808 . . . . 73.04 110.593 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.8 t -136.94 148.16 61.9 Favored Pre-proline 0 N--CA 1.472 0.627 0 O-C-N 122.15 -0.344 . . . . 70.31 111.445 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.07 -15.89 23.0 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.116 1.877 . . . . 70.31 111.673 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -105.87 -43.65 4.82 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.89 -0.595 . . . . 63.31 111.566 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 53.17 56.6 7.25 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.517 0.675 . . . . 75.24 110.662 -177.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.3 t -53.46 -46.58 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.378 -0.828 . . . . 72.01 112.772 -171.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.539 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -60.01 -31.31 72.21 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.869 -0.682 . . . . 75.33 113.228 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.75 -38.2 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.035 0.445 . . . . 71.25 110.47 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -76.3 -28.71 57.08 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.191 -0.459 . . . . 71.35 111.944 174.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 17.2 mmt -62.68 -47.49 83.45 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.583 0.586 . . . . 74.45 112.583 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.41 -165.32 27.44 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 120.811 -0.709 . . . . 51.44 113.202 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.411 ' CE3' ' HG3' ' A' ' 51' ' ' ARG . 98.7 m95 -76.26 115.23 15.79 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.378 0.608 . . . . 75.55 112.474 -176.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.779 ' HD3' ' HB3' ' A' ' 75' ' ' ASP . 11.5 mmpt? -94.73 143.57 26.34 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.806 -0.633 . . . . 73.12 110.299 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 89.0 p -167.27 12.18 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.428 1.27 . . . . 72.42 114.428 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -131.63 153.14 50.24 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.808 -0.557 . . . . 71.01 111.865 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.12 100.09 0.11 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.094 0.473 . . . . 72.41 111.841 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.44 -24.16 2.51 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 116.062 -0.517 . . . . 41.43 112.033 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.779 ' HB3' ' HD3' ' A' ' 70' ' ' LYS . 62.8 m-20 -68.32 127.46 33.04 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.783 0.325 . . . . 73.25 111.387 174.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.561 HG21 ' HA ' ' A' ' 87' ' ' GLU . 76.6 p -136.01 148.68 48.51 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.968 0.413 . . . . 71.34 111.271 177.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.2 mm -113.22 110.59 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 120.924 0.392 . . . . 74.44 110.533 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.5 t -98.73 116.88 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 116.14 -0.482 . . . . 61.14 111.322 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 71.5 m -118.99 73.32 0.92 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.94 0.4 . . . . 61.34 110.964 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.523 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 90.9 mt -54.07 -50.18 85.78 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 112.613 0.598 . . . . 75.31 112.613 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 34.7 Cg_exo -59.91 -12.84 20.08 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.018 1.812 . . . . 74.03 113.386 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.421 ' ND1' ' OD1' ' A' ' 43' ' ' ASN . 11.8 m170 -116.65 -11.64 10.99 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.124 0.416 . . . . 74.21 112.124 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.432 ' HD2' ' HD2' ' A' ' 38' ' ' LYS . 63.8 mttm 64.01 29.51 14.29 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.257 0.551 . . . . 71.14 112.05 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.3 t -108.9 135.71 46.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 116.008 -0.542 . . . . 70.43 110.711 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -135.75 128.65 31.27 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.09 0.471 . . . . 73.2 111.11 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.18 130.6 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.587 -0.279 . . . . 74.21 111.133 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.561 ' HA ' HG21 ' A' ' 76' ' ' THR . 3.2 pt-20 -114.19 147.74 38.42 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.011 0.434 . . . . 75.32 111.303 175.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 57.3 mt -111.8 112.14 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.014 0.435 . . . . 73.12 110.226 171.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.48 ' HB3' ' HZ2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -119.65 163.04 17.98 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.275 -0.421 . . . . 74.51 111.649 -174.243 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.7 t -86.11 149.34 25.2 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.622 0.601 . . . . 73.2 112.622 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.2 p -83.68 -16.93 43.17 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.97 -0.559 . . . . 63.15 110.725 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 . . . . . 0 CA--C 1.541 0.606 0 CA-C-N 116.126 -0.488 . . . . 73.22 111.47 179.995 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.404 ' HA ' ' CB ' ' A' ' 25' ' ' THR . 46.0 mt-10 . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 113.339 0.866 . . . . 63.05 113.339 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.01 158.82 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.508 -0.769 . . . . 71.31 111.648 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.527 HG13 ' HA ' ' A' ' 23' ' ' PRO . 23.6 m -134.36 148.6 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 116.262 -0.426 . . . . 74.42 111.053 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.71 115.94 28.4 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.826 0.346 . . . . 64.3 111.568 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.0 mm -99.02 116.07 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.282 -0.417 . . . . 74.42 111.22 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.473 ' N ' HD11 ' A' ' 12' ' ' ILE . 3.0 mp -99.85 115.46 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.023 0.44 . . . . 72.35 111.489 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.9 m -113.88 146.12 40.48 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.014 0.435 . . . . 73.54 111.467 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -141.33 140.19 33.74 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.402 -0.363 . . . . 75.1 110.278 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 61.38 14.75 5.98 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.338 0.496 . . . . 73.33 112.338 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.77 -11.12 41.73 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.272 -0.49 . . . . 75.23 114.037 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -125.72 156.18 39.77 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.229 -0.571 . . . . 74.51 111.91 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.0 t -74.98 132.78 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.781 0.325 . . . . 75.45 111.334 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 43.1 pt -117.28 -27.08 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 N-CA-C 112.586 0.587 . . . . 73.4 112.586 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.451 ' HG3' HD11 ' A' ' 22' ' ' ILE . 3.1 tpm_? -154.3 131.83 11.34 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 122.315 -0.241 . . . . 73.1 111.141 -174.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -130.29 114.28 15.44 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.594 0.235 . . . . 73.42 111.502 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.469 ' N ' HD13 ' A' ' 22' ' ' ILE . 3.7 mp -114.4 130.15 24.26 Favored Pre-proline 0 N--CA 1.476 0.874 0 CA-C-O 120.545 0.212 . . . . 74.05 111.432 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.527 ' HA ' HG13 ' A' ' 9' ' ' VAL . 57.5 Cg_endo -70.77 134.11 25.15 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.189 1.926 . . . . 74.14 112.404 173.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.7 mt -97.64 -65.5 0.96 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.901 0.382 . . . . 75.23 111.654 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.404 ' CB ' ' HA ' ' A' ' 7' ' ' GLU . 8.0 m -63.43 126.87 28.9 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.835 0.35 . . . . 73.52 111.451 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.34 12.25 84.08 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.965 -0.636 . . . . 50.51 112.97 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -90.85 104.22 16.83 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.087 0.47 . . . . 72.34 111.246 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -87.74 123.8 32.92 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.224 -0.443 . . . . 74.51 111.557 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.8 -169.74 14.79 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.253 -0.498 . . . . 54.02 113.539 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -118.49 150.36 39.74 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 122.703 -0.292 . . . . 75.04 110.893 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.435 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 13.6 tp10 -144.7 114.54 7.31 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.625 0.25 . . . . 74.22 110.908 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -118.33 137.87 52.79 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.863 0.363 . . . . 74.44 111.928 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -152.09 136.56 16.84 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.245 0.545 . . . . 74.23 111.82 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.3 m -96.06 116.1 28.45 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.148 -0.478 . . . . 74.12 111.484 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 42' ' ' TYR . 62.0 mt -80.71 103.97 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.566 -0.288 . . . . 73.43 110.809 176.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -92.67 111.35 22.91 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.032 0.444 . . . . 75.15 111.301 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.22 -154.11 7.03 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.248 -0.501 . . . . 74.43 112.764 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -93.43 90.55 6.77 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.203 -0.586 . . . . 74.31 111.064 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.63 75.95 1.28 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 121.239 -0.505 . . . . 38.25 113.986 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 72.96 -41.37 0.5 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.206 1.187 . . . . 71.1 114.206 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -50.85 108.23 0.23 Allowed 'General case' 0 N--CA 1.477 0.903 0 O-C-N 122.155 -0.341 . . . . 74.45 111.605 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 33.6 p90 -131.25 159.99 36.19 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.993 0.738 . . . . 74.21 112.993 -174.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -133.73 109.84 9.42 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.869 -0.605 . . . . 74.12 110.552 170.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.3 tp -82.67 104.04 12.63 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.878 0.371 . . . . 75.2 110.69 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.726 ' SD ' HG12 ' A' ' 54' ' ' ILE . 91.3 mmm -91.73 137.32 32.46 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.361 -0.381 . . . . 74.13 111.502 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -123.38 115.72 22.09 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.047 0.451 . . . . 73.31 111.168 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 44.3 t -105.61 107.53 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.106 -0.497 . . . . 73.5 110.537 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -112.21 117.44 32.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.743 0.306 . . . . 74.21 110.674 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.06 -111.23 3.18 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.831 -0.7 . . . . 74.01 112.809 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -112.51 17.02 19.61 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.9 0.381 . . . . 74.02 111.503 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.1 ptt-85 -133.93 140.94 47.12 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.097 0.475 . . . . 72.3 111.655 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.3 tt -124.32 147.53 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 116.389 -0.368 . . . . 75.44 111.881 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -150.96 168.81 23.4 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.889 0.376 . . . . 74.3 111.444 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.726 HG12 ' SD ' ' A' ' 45' ' ' MET . 26.4 mt -90.68 117.79 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.118 0.485 . . . . 74.2 110.155 168.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -81.13 -41.58 22.23 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.098 -0.501 . . . . 74.42 111.771 -176.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -159.46 138.53 11.08 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.759 0.281 . . . . 71.43 111.759 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -163.61 166.72 22.1 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.99 0.424 . . . . 75.42 111.198 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -111.19 63.66 0.61 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 120.967 0.413 . . . . 73.33 111.882 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.2 t -108.59 138.06 20.16 Favored Pre-proline 0 N--CA 1.477 0.918 0 O-C-N 122.051 -0.406 . . . . 75.02 111.013 175.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.495 ' HD2' ' HG2' ' A' ' 81' ' ' PRO . 36.6 Cg_endo -64.21 -27.14 64.39 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.769 2.313 . . . . 74.34 113.35 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.508 ' HB2' HG21 ' A' ' 63' ' ' VAL . 1.2 p30 -87.25 -43.53 12.12 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 111.945 0.35 . . . . 75.32 111.945 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 65.57 27.33 11.55 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.457 -0.338 . . . . 73.15 111.665 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' A' ' 61' ' ' ASP . 90.2 t -58.01 -41.68 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.037 0.446 . . . . 74.04 110.957 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.556 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -55.37 -48.02 72.07 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 116.036 -0.529 . . . . 44.12 113.074 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.7 t -62.45 -44.01 98.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 120.801 0.334 . . . . 75.43 111.372 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -59.74 -33.77 72.08 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.615 -0.266 . . . . 73.11 111.528 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.674 ' HE1' ' HA ' ' A' ' 67' ' ' MET . 5.3 mmt -57.9 -31.88 67.18 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.832 0.348 . . . . 65.24 111.902 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.96 -136.22 32.83 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.108 -0.567 . . . . 62.53 113.585 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -87.88 126.24 34.93 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.17 0.509 . . . . 75.14 111.879 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 34.4 mmtp -113.66 145.03 41.93 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.317 -0.623 . . . . 72.25 109.317 171.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.1 p -156.31 6.79 0.19 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.327 1.232 . . . . 75.32 114.327 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -130.12 156.26 44.83 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.67 -0.644 . . . . 72.42 112.179 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.06 126.5 27.72 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.004 -0.544 . . . . 63.23 111.239 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.37 -22.12 23.01 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.337 -0.458 . . . . 71.53 112.857 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.499 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 95.7 m-20 -68.2 131.58 45.64 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.964 0.411 . . . . 75.24 111.687 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.9 p -127.99 167.14 17.1 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.59 0.589 . . . . 65.24 112.59 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.566 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 40.0 mm -137.44 123.56 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.69 0.796 . . . . 74.14 109.885 177.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -113.99 117.76 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.256 0.465 . . . . 65.15 112.256 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 73.5 m -122.91 86.5 2.59 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.862 0.363 . . . . 71.22 111.309 174.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.584 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 92.2 mt -61.24 -53.95 58.02 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 112.804 0.668 . . . . 73.22 112.804 -175.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.584 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 17.1 Cg_exo -69.25 0.1 5.73 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.4 2.067 . . . . 71.43 113.362 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -119.1 -6.77 10.42 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 122.205 -0.309 . . . . 72.43 111.509 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.3 mttm 61.85 30.51 18.24 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.15 0.5 . . . . 73.22 111.762 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.51 138.84 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.101 -0.499 . . . . 61.33 111.346 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -141.71 125.8 17.33 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.115 -0.493 . . . . 75.24 110.886 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 57.5 t -116.6 135.44 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.561 0.219 . . . . 73.25 111.148 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.21 141.1 47.89 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.91 0.386 . . . . 71.43 111.278 176.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.493 HD12 ' HB2' ' A' ' 75' ' ' ASP . 60.6 mt -101.5 115.97 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.17 0.509 . . . . 74.44 111.216 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -109.89 166.09 11.2 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.003 -0.544 . . . . 72.32 110.697 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.5 t -97.3 149.29 22.23 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.181 0.515 . . . . 63.33 111.32 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.5 p -80.37 -5.12 55.92 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.216 0.532 . . . . 75.14 110.973 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 . . . . . 0 C--O 1.235 0.298 0 CA-C-O 121.335 0.588 . . . . 73.52 111.528 179.589 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.459 ' HB2' ' OG1' ' A' ' 91' ' ' THR . 47.7 mt-10 . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 120.795 0.331 . . . . 71.54 110.749 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.0 m -123.67 142.17 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.095 0.474 . . . . 64.01 112.033 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.511 HG13 ' HA ' ' A' ' 23' ' ' PRO . 27.5 m -119.93 140.19 44.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.278 -0.419 . . . . 72.25 111.224 177.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.94 114.53 26.37 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.893 0.378 . . . . 73.13 111.681 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.7 mm -98.69 110.79 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.338 -0.392 . . . . 71.33 110.979 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.481 ' N ' HD13 ' A' ' 12' ' ' ILE . 3.2 mp -101.42 125.69 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.06 0.457 . . . . 74.34 111.59 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 55.2 m -123.5 150.6 43.73 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.129 -0.487 . . . . 74.34 111.813 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.572 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 36.1 tt0 -129.01 135.24 48.68 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.412 0.285 . . . . 52.32 110.533 175.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.572 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 53.9 m-80 59.64 8.66 1.34 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.859 0.464 . . . . 53.01 111.976 -174.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.95 -29.25 8.61 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 121.53 -0.367 . . . . 37.68 113.315 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -87.71 139.69 30.28 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.974 0.416 . . . . 71.02 111.486 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -71.22 130.54 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.316 -0.402 . . . . 72.33 111.115 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.432 HD12 HD11 ' A' ' 35' ' ' ILE . 34.2 pt -121.18 -29.24 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 112.897 0.703 . . . . 75.15 112.897 -176.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.439 ' HG3' HD11 ' A' ' 22' ' ' ILE . 9.2 tpm_? -151.29 123.19 8.1 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.125 0.488 . . . . 74.24 111.651 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -122.25 125.97 47.19 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.235 -0.439 . . . . 73.12 110.998 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.439 HD11 ' HG3' ' A' ' 20' ' ' ARG . 4.4 mp -120.63 123.62 27.97 Favored Pre-proline 0 N--CA 1.473 0.717 0 O-C-N 122.191 -0.318 . . . . 73.34 111.786 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.511 ' HA ' HG13 ' A' ' 9' ' ' VAL . 22.3 Cg_exo -66.27 111.88 2.16 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.257 1.971 . . . . 72.21 111.55 169.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 78.2 mt -75.65 -58.64 3.16 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.912 0.387 . . . . 74.15 111.244 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.44 HG21 ' HG2' ' A' ' 7' ' ' GLU . 35.8 m -60.5 118.83 6.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.836 0.351 . . . . 72.33 111.153 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.403 ' H ' ' HG2' ' A' ' 50' ' ' GLU . . . 98.49 -8.28 62.07 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.191 -0.528 . . . . 43.53 113.387 -176.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.404 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 54.2 t-80 -79.5 95.7 5.89 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.285 -0.538 . . . . 73.14 111.345 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.6 ' HZ3' ' HB2' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -69.29 146.61 52.1 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.101 -0.5 . . . . 74.11 111.923 177.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.43 -158.57 53.27 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 116.1 -0.5 . . . . 72.44 114.183 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -118.39 151.34 37.95 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.834 0.349 . . . . 72.04 111.143 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -146.54 135.04 22.02 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.517 0.327 . . . . 74.42 110.462 -176.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -131.94 142.57 49.67 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.889 -0.507 . . . . 70.43 112.319 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -150.96 135.7 17.25 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.004 0.43 . . . . 75.05 111.431 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.8 m -98.74 127.65 44.74 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.396 -0.366 . . . . 70.13 111.139 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.432 HD11 HD12 ' A' ' 19' ' ' ILE . 68.8 mt -110.59 120.6 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 120.766 0.317 . . . . 73.31 111.377 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -97.41 128.72 44.44 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.116 0.484 . . . . 74.52 111.393 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.23 -114.48 3.66 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 116.261 -0.427 . . . . 65.34 112.787 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.631 ' HE2' ' HG3' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -99.17 141.82 31.45 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.911 0.355 . . . . 73.41 111.495 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.37 -100.63 0.19 Allowed Glycine 0 CA--C 1.531 1.068 0 CA-C-N 116.392 -0.367 . . . . 63.32 113.912 177.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.34 18.65 7.58 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.186 0.517 . . . . 74.34 111.664 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.631 ' HG3' ' HE2' ' A' ' 38' ' ' LYS . 12.5 mm100 -85.74 115.69 23.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.984 -0.553 . . . . 70.22 111.386 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -130.0 151.87 50.07 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.081 0.467 . . . . 74.12 112.189 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -127.66 116.8 20.84 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.061 -0.518 . . . . 74.21 110.639 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.6 tp -95.16 103.5 15.35 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.893 0.378 . . . . 72.33 110.501 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.653 ' SD ' HG12 ' A' ' 54' ' ' ILE . 92.5 mmm -92.33 136.74 32.95 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.232 -0.44 . . . . 64.21 111.274 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -124.55 115.35 20.71 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.953 0.406 . . . . 73.33 111.096 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.439 HG11 HG21 ' A' ' 22' ' ' ILE . 47.8 t -97.27 115.64 37.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.105 -0.498 . . . . 61.01 111.063 175.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -109.25 170.72 7.87 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.563 -0.29 . . . . 62.1 110.295 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 27' ' ' HIS . . . -37.53 95.33 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 N-CA-C 114.604 0.602 . . . . 61.43 114.604 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 31.4 mt-10 62.21 37.34 14.31 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.442 0.697 . . . . 75.31 112.682 176.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -165.21 161.95 19.67 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.381 -0.372 . . . . 75.23 111.017 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.3 tt -141.39 151.57 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 112.186 0.439 . . . . 72.44 112.186 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.435 ' HD3' ' CE2' ' A' ' 69' ' ' TRP . 14.1 ptt180 -152.18 168.97 23.61 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.905 0.383 . . . . 72.23 111.541 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.653 HG12 ' SD ' ' A' ' 45' ' ' MET . 46.3 mt -94.85 113.32 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.956 -0.387 . . . . 72.32 109.956 168.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -75.38 -46.73 31.2 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.736 0.303 . . . . 72.33 111.601 -177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -143.15 140.36 30.76 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.834 0.349 . . . . 73.32 111.224 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -162.25 136.59 6.68 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.887 0.375 . . . . 65.25 111.271 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -107.8 51.36 0.74 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.208 0.527 . . . . 72.54 111.967 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.4 m -97.99 124.48 47.49 Favored Pre-proline 0 N--CA 1.473 0.719 0 O-C-N 122.141 -0.349 . . . . 60.2 110.213 172.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -52.78 -32.83 57.62 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.837 2.358 . . . . 74.34 113.226 -175.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -75.08 -31.46 61.22 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.365 -0.379 . . . . 74.11 111.857 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.45 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 28.3 mm-40 60.54 22.28 12.02 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.088 0.773 . . . . 72.3 113.088 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.5 t -53.36 -52.04 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 112.02 0.378 . . . . 71.23 112.02 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.94 -40.7 98.77 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.035 -0.602 . . . . 72.22 113.387 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.5 t -65.97 -33.7 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 120.998 0.428 . . . . 71.14 111.564 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 62' ' ' GLN . 67.5 mttm -70.71 -37.64 73.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.822 0.344 . . . . 65.31 111.398 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.3 mmt -60.35 -35.16 75.03 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.279 -0.418 . . . . 74.43 112.058 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.06 -119.51 8.05 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.251 -0.499 . . . . 55.13 113.948 175.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.435 ' CE2' ' HD3' ' A' ' 53' ' ' ARG . 69.3 m95 -94.92 138.93 32.02 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.173 0.434 . . . . 74.05 112.173 -175.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -131.23 151.4 51.51 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.195 -0.457 . . . . 73.15 110.233 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.4 p -164.97 15.74 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.368 0.877 . . . . 52.45 113.368 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.762 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 9.6 mmpt? -123.43 149.62 44.82 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.24 0.543 . . . . 64.32 112.069 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.64 109.49 1.42 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.029 -0.532 . . . . 62.03 110.587 176.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.24 -18.86 6.47 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 116.234 -0.439 . . . . 75.22 112.503 -176.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -69.84 115.35 8.96 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.779 0.323 . . . . 72.04 111.263 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 82.5 p -119.46 149.67 41.48 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.089 0.471 . . . . 72.12 111.465 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.426 HG22 HD13 ' A' ' 54' ' ' ILE . 46.9 mm -125.56 115.93 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.194 -0.457 . . . . 74.23 110.476 177.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.6 t -108.79 117.76 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 120.867 0.365 . . . . 70.43 111.777 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 71.0 m -120.82 84.54 2.25 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.086 0.469 . . . . 73.53 111.009 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.534 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 98.8 mt -57.98 -49.98 90.64 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 113.24 0.83 . . . . 75.43 113.24 -176.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.534 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 52.0 Cg_exo -56.7 -18.31 26.12 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 122.096 1.864 . . . . 70.32 113.519 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -113.2 -4.78 13.71 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.7 0.286 . . . . 73.11 111.219 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 58.78 28.0 16.77 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.176 0.59 . . . . 72.3 112.292 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.1 t -101.9 133.88 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.02 0.438 . . . . 75.21 111.215 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -130.85 123.52 29.21 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.122 -0.49 . . . . 73.4 110.824 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.411 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 47.5 t -117.1 136.9 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 116.715 -0.221 . . . . 74.1 111.02 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -136.96 132.07 33.86 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.198 0.523 . . . . 73.41 111.092 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 62.1 mt -99.38 127.16 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.264 -0.426 . . . . 71.12 111.205 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -125.74 159.42 32.37 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.905 0.383 . . . . 71.54 111.617 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.1 t -79.66 149.78 31.14 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.253 -0.431 . . . . 55.34 111.059 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.459 ' OG1' ' HB2' ' A' ' 7' ' ' GLU . 80.6 p -71.91 -21.45 61.62 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.864 0.364 . . . . 72.44 110.843 173.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 . . . . . 0 N--CA 1.469 0.525 0 CA-C-N 116.012 -0.54 . . . . 64.53 110.743 175.613 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.552 ' HA ' ' HB ' ' A' ' 25' ' ' THR . 42.7 mt-10 . . . . . 0 CA--C 1.541 0.621 0 N-CA-C 112.597 0.591 . . . . 74.0 112.597 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.48 HG21 ' OG1' ' A' ' 25' ' ' THR . 27.6 m -102.83 152.08 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.287 0.565 . . . . 74.02 111.77 176.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.524 HG13 ' HA ' ' A' ' 23' ' ' PRO . 35.5 m -127.42 142.41 43.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.145 -0.48 . . . . 71.33 111.682 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.39 116.38 28.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.944 0.402 . . . . 53.43 111.237 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 34.4 mm -99.34 107.06 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.27 -0.423 . . . . 70.44 111.711 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.472 HD11 ' N ' ' A' ' 12' ' ' ILE . 3.4 mp -96.7 129.03 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.049 0.452 . . . . 75.12 111.029 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 m -130.99 156.7 44.68 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.055 0.455 . . . . 73.44 111.75 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.505 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 56.3 tt0 -149.77 142.86 24.97 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 116.239 -0.437 . . . . 75.21 110.428 178.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.505 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 44.7 m-80 60.52 19.79 9.59 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.234 0.457 . . . . 74.44 112.234 -177.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.36 4.13 68.68 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 120.994 -0.622 . . . . 70.04 114.034 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -126.62 149.41 49.5 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.355 0.577 . . . . 72.5 111.896 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.6 t -68.6 132.16 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.524 -0.307 . . . . 72.11 110.945 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.5 pt -122.58 -20.14 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.041 0.756 . . . . 72.54 113.041 -176.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -160.12 138.1 9.98 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.027 -0.421 . . . . 75.14 111.737 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -134.79 124.27 24.88 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 120.573 0.225 . . . . 71.52 111.362 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.96 126.51 26.31 Favored Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 111.63 0.233 . . . . 74.53 111.63 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.524 ' HA ' HG13 ' A' ' 9' ' ' VAL . 15.2 Cg_exo -69.12 117.84 5.3 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.694 2.263 . . . . 71.04 112.2 172.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.8 mt -84.79 -61.02 1.88 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.847 0.356 . . . . 73.32 111.826 -175.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.552 ' HB ' ' HA ' ' A' ' 7' ' ' GLU . 60.7 m -61.07 110.66 1.43 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.95 0.405 . . . . 74.51 111.985 -177.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.29 -15.69 35.73 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.235 -0.507 . . . . 73.23 112.993 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -70.58 128.71 37.05 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 122.663 0.385 . . . . 65.51 111.566 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -104.3 155.89 18.37 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.066 0.46 . . . . 73.32 112.016 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.53 -165.68 54.76 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 116.06 -0.518 . . . . 63.52 114.168 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -118.64 137.89 52.98 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.008 0.432 . . . . 74.01 110.667 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -143.53 115.53 8.33 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.788 0.328 . . . . 72.44 111.455 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -111.75 143.48 42.6 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.862 0.363 . . . . 64.24 111.954 -174.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -146.71 137.94 24.23 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.981 0.419 . . . . 53.23 111.201 176.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.9 m -105.06 119.94 40.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.009 0.433 . . . . 72.01 112.088 -175.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.498 ' N ' HD13 ' A' ' 35' ' ' ILE . 3.2 mp -92.43 106.19 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.945 0.403 . . . . 75.54 110.1 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.625 ' HZ1' ' HB2' ' A' ' 36' ' ' LYS . 9.6 mtmp? -86.88 128.05 35.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.079 0.466 . . . . 65.52 111.374 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.56 -178.62 38.2 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.243 -0.503 . . . . 64.33 113.183 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -66.22 93.85 0.23 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.214 0.53 . . . . 75.44 111.297 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.97 -121.4 5.42 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 116.077 -0.51 . . . . 73.33 112.33 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.82 12.09 29.37 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.144 0.497 . . . . 64.21 111.269 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -83.77 67.02 9.36 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.145 -0.48 . . . . 75.5 112.13 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -97.86 158.03 15.75 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.595 0.591 . . . . 73.41 112.595 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -131.36 133.41 45.27 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.461 0.704 . . . . 64.52 110.574 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.8 tp -105.46 107.38 18.33 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.79 0.329 . . . . 74.03 111.271 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.747 ' SD ' HG12 ' A' ' 54' ' ' ILE . 87.7 mmm -94.65 122.61 37.43 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.91 0.386 . . . . 74.35 111.124 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -108.14 117.67 34.75 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.791 0.329 . . . . 72.11 111.381 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.1 t -96.23 109.01 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.373 -0.376 . . . . 72.35 110.429 174.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 31.3 t70 -108.64 107.94 18.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.042 0.449 . . . . 61.33 110.344 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.3 -107.03 1.06 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.901 -0.666 . . . . 74.02 112.679 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -116.42 27.34 9.28 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.268 0.556 . . . . 73.45 111.668 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 17.3 ptt180 -142.76 148.03 36.53 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.043 -0.526 . . . . 74.21 110.898 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.5 tt -129.62 145.67 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 112.018 0.377 . . . . 73.11 112.018 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -149.69 168.96 22.14 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.885 0.374 . . . . 75.32 111.693 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.747 HG12 ' SD ' ' A' ' 45' ' ' MET . 35.3 mt -96.36 118.71 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.502 -0.317 . . . . 72.12 110.46 169.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -85.83 -36.37 20.07 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.912 0.387 . . . . 72.1 111.611 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -153.38 138.75 17.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.538 -0.301 . . . . 71.14 111.53 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -153.51 151.51 29.89 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.997 0.427 . . . . 73.24 110.596 175.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -102.01 74.94 1.49 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.019 0.438 . . . . 65.35 110.994 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.6 p -124.89 150.88 67.5 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-N 116.492 -0.322 . . . . 64.55 110.272 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.02 -29.17 40.79 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.356 2.037 . . . . 75.31 111.708 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.87 -35.82 25.92 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.397 -0.819 . . . . 74.23 111.89 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.466 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 27.2 mm-40 62.95 21.54 12.93 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.385 0.513 . . . . 73.54 112.385 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.537 ' O ' ' HG3' ' A' ' 67' ' ' MET . 89.6 t -57.8 -38.26 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.495 -0.321 . . . . 75.11 111.658 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.43 -57.22 14.22 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.642 -0.313 . . . . 61.33 113.45 -176.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.1 t -62.18 -34.85 65.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 120.952 0.406 . . . . 71.14 111.582 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 14.1 mptt -66.13 -28.38 68.76 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.467 0.543 . . . . 74.23 112.467 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.537 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 53.4 mtp -64.18 -24.12 67.56 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 122.064 -0.397 . . . . 74.44 111.708 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.34 -153.84 41.69 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 114.446 0.538 . . . . 73.41 114.446 173.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -80.82 142.21 33.92 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.125 0.488 . . . . 74.41 112.06 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.534 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 74.2 mmtt -125.61 133.87 52.1 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.01 -0.541 . . . . 73.24 109.672 175.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 54.0 p -155.77 28.35 0.38 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.171 1.174 . . . . 54.0 114.171 -170.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -160.33 162.32 33.45 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.773 0.657 . . . . 75.13 112.773 171.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.04 118.02 5.79 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.057 -0.52 . . . . 61.54 111.216 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 123.01 -17.16 8.12 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.267 -0.492 . . . . 74.34 112.682 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.534 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 64.5 m-20 -75.58 128.15 34.64 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 122.472 -0.428 . . . . 74.12 111.399 176.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 81.7 p -130.76 144.23 51.29 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.893 0.377 . . . . 75.34 111.702 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.538 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 45.5 mm -114.67 128.15 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 122.817 0.447 . . . . 74.24 110.348 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.15 115.83 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.033 0.444 . . . . 73.45 111.664 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 86.2 m -123.4 71.06 1.06 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.448 -0.342 . . . . 63.41 111.277 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.55 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 89.0 mt -53.15 -50.2 83.52 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 112.574 0.583 . . . . 74.33 112.574 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 53.2 Cg_exo -54.24 -20.76 20.46 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.15 1.9 . . . . 74.41 113.387 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -110.01 -1.73 17.46 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.263 0.468 . . . . 74.43 112.263 -175.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 63.41 17.39 10.27 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.539 0.336 . . . . 74.14 111.809 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.91 138.02 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.915 0.388 . . . . 72.4 111.652 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -141.93 131.4 23.8 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.374 -0.375 . . . . 74.14 110.791 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.538 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 47.5 t -127.38 145.76 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.573 0.225 . . . . 74.23 111.059 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -144.13 153.69 42.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.671 0.272 . . . . 75.45 110.883 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.451 HD13 ' HB2' ' A' ' 75' ' ' ASP . 59.5 mt -110.74 126.24 68.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.85 0.357 . . . . 74.4 111.051 175.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.609 ' HZ2' ' HB2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -127.05 177.77 6.43 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.348 -0.387 . . . . 74.21 110.248 176.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 28.4 t -107.07 151.47 25.31 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.213 0.53 . . . . 70.24 111.811 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.5 p -62.07 -23.99 66.83 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.759 -0.655 . . . . 72.23 111.182 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.471 ' HG2' ' OG ' ' A' ' 90' ' ' SER . 2.7 pt20 . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 120.932 0.396 . . . . 74.44 110.578 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 112.053 0.39 . . . . 74.42 112.053 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.4 m -115.96 152.68 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 121.288 0.566 . . . . 72.11 112.02 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 23' ' ' PRO . 27.8 m -127.0 148.51 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.122 -0.49 . . . . 75.13 111.647 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -102.67 115.47 30.65 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.984 0.421 . . . . 73.35 111.512 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.8 mm -100.4 116.51 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.339 -0.391 . . . . 74.11 111.146 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.483 ' N ' HD11 ' A' ' 12' ' ' ILE . 3.0 mp -97.63 127.46 49.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.041 0.448 . . . . 73.42 111.288 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.4 p -124.35 153.03 42.42 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.223 0.535 . . . . 65.25 111.453 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -139.74 127.04 21.31 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.941 -0.572 . . . . 71.21 110.999 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.543 HD21 ' N ' ' A' ' 15' ' ' ASN . 0.8 OUTLIER 61.14 17.0 7.66 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.347 0.499 . . . . 75.15 112.347 178.061 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.16 -31.6 6.16 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.258 -0.496 . . . . 63.54 113.802 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -98.42 147.58 24.57 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 122.202 -0.587 . . . . 74.42 112.102 -177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.17 134.77 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 122.3 -0.25 . . . . 73.54 110.493 173.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.3 pt -120.07 -29.81 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.785 0.661 . . . . 74.4 112.785 -177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -152.95 141.0 20.33 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.879 0.371 . . . . 74.52 111.591 -176.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -131.3 124.93 31.5 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.771 0.319 . . . . 64.42 111.226 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.504 HG22 HG22 ' A' ' 47' ' ' VAL . 4.1 mp -124.79 124.37 25.55 Favored Pre-proline 0 N--CA 1.474 0.772 0 CA-C-O 120.597 0.237 . . . . 74.43 111.467 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.468 ' HA ' HG13 ' A' ' 9' ' ' VAL . 60.2 Cg_endo -72.93 119.59 6.15 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.242 1.961 . . . . 71.14 111.812 172.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.8 mt -80.97 -63.06 1.49 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.073 0.463 . . . . 75.31 111.471 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.3 m -59.77 121.74 12.44 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.35 -0.386 . . . . 64.33 111.423 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.71 3.03 77.93 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.238 -0.506 . . . . 74.43 113.787 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.499 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 42.5 t-80 -77.51 129.12 35.27 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.305 -0.527 . . . . 75.45 111.235 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -94.31 137.52 33.37 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.989 0.423 . . . . 71.34 112.026 -177.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.89 -167.1 54.66 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 114.79 0.676 . . . . 74.21 114.79 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -118.66 122.45 42.56 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.861 0.464 . . . . 64.21 110.502 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -117.05 139.57 50.54 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 122.242 -0.286 . . . . 75.1 111.325 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -131.08 129.47 41.95 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.819 0.343 . . . . 73.42 111.311 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -138.98 141.93 38.37 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.896 0.379 . . . . 74.42 111.692 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.8 m -97.46 119.07 35.33 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.073 0.463 . . . . 74.12 111.767 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.7 mt -81.64 116.91 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.05 -0.523 . . . . 72.34 110.808 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -80.38 123.16 27.78 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.814 0.34 . . . . 74.31 111.664 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -110.85 -163.28 18.36 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.367 -0.444 . . . . 71.13 112.435 175.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -69.95 123.16 20.83 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 122.416 -0.461 . . . . 62.4 111.979 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.05 -103.74 0.43 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.343 -0.456 . . . . 64.45 113.673 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.41 -3.77 46.41 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.75 0.648 . . . . 74.0 112.75 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -76.07 133.55 40.29 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 111.799 0.296 . . . . 71.11 111.799 -176.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -158.2 163.82 37.12 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.899 0.38 . . . . 70.52 111.762 176.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -136.99 115.3 11.74 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.322 -0.399 . . . . 73.24 111.18 175.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.443 HD21 ' HB3' ' A' ' 56' ' ' GLU . 42.3 tp -87.92 103.34 15.59 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.22 0.533 . . . . 72.21 110.814 177.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.803 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.1 mmm -92.86 144.71 25.01 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.9 -0.591 . . . . 71.42 111.468 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -130.16 126.68 38.05 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.944 0.402 . . . . 71.53 111.528 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 22' ' ' ILE . 44.4 t -110.02 107.62 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.163 -0.472 . . . . 75.41 110.319 175.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.469 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 31.0 t70 -108.03 109.42 20.87 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.486 0.315 . . . . 74.31 110.42 -176.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 27' ' ' HIS . . . 57.79 -110.36 2.33 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.775 -0.726 . . . . 54.5 112.355 -175.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -110.24 18.05 20.31 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 120.886 0.375 . . . . 74.31 111.888 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 33.7 ptt180 -131.89 147.04 52.45 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.819 0.342 . . . . 74.42 111.465 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.0 tt -130.36 147.92 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.149 0.499 . . . . 72.11 112.188 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -159.87 165.52 32.06 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.088 -0.506 . . . . 74.32 111.415 177.241 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.803 HG12 ' SD ' ' A' ' 45' ' ' MET . 58.0 mt -89.91 120.42 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.946 0.403 . . . . 72.33 110.569 174.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -87.47 -31.21 20.12 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.493 -0.321 . . . . 63.11 111.746 -175.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.443 ' HB3' HD21 ' A' ' 44' ' ' LEU . 39.5 tt0 -167.95 138.98 2.83 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.086 0.47 . . . . 74.23 112.157 -175.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -161.04 -178.17 6.59 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.236 -0.438 . . . . 73.24 110.477 174.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -115.01 42.12 2.26 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.595 0.591 . . . . 73.0 112.595 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.8 m -88.01 131.75 42.01 Favored Pre-proline 0 N--CA 1.475 0.793 0 O-C-N 121.919 -0.488 . . . . 65.24 110.067 173.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.62 -40.9 71.83 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.342 2.028 . . . . 71.41 112.978 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.9 -13.36 31.35 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.433 0.531 . . . . 61.01 112.433 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 40.02 67.96 0.43 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.294 0.568 . . . . 72.3 112.477 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.2 t -74.05 -46.83 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.141 -0.482 . . . . 72.22 111.553 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.576 ' HA3' HD13 ' A' ' 54' ' ' ILE . . . -56.3 -43.71 89.52 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.436 -0.411 . . . . 73.02 113.722 -178.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -61.44 -38.14 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.091 0.472 . . . . 74.24 111.722 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -71.26 -28.35 64.1 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.047 0.388 . . . . 73.51 112.047 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 25.6 mmt -57.34 -28.94 63.56 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.924 0.393 . . . . 72.34 112.026 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.6 -155.64 39.71 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.294 -0.479 . . . . 63.14 113.781 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -82.48 119.47 24.25 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.957 0.408 . . . . 75.21 111.841 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 75.2 mmtt -111.41 151.01 29.0 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.244 -0.435 . . . . 72.53 110.041 175.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 63.2 p -168.65 6.52 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.546 1.313 . . . . 75.34 114.546 -174.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -124.94 152.46 44.1 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.64 -0.663 . . . . 73.31 112.28 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.4 99.99 0.07 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.719 -0.673 . . . . 74.52 111.25 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.18 -19.91 2.66 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.933 -0.576 . . . . 74.31 112.526 -175.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.424 ' HB2' HD12 ' A' ' 88' ' ' ILE . 76.1 m-20 -76.63 134.72 39.24 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.804 0.335 . . . . 71.2 111.491 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.526 HG23 ' HA ' ' A' ' 87' ' ' GLU . 45.0 p -135.75 150.19 49.42 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.09 0.471 . . . . 74.54 111.665 176.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.449 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 50.2 mm -115.99 127.37 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.198 -0.455 . . . . 71.13 110.75 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -115.22 118.65 59.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.97 0.414 . . . . 73.15 111.874 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 90.1 m -121.75 75.77 1.22 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.411 -0.359 . . . . 64.53 111.331 176.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.534 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 91.9 mt -55.36 -50.65 85.51 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 113.133 0.79 . . . . 62.44 113.133 -176.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.534 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 46.7 Cg_exo -56.93 -17.15 22.88 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.889 1.726 . . . . 74.25 113.461 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 47.8 m170 -114.49 -4.11 12.92 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 122.184 -0.323 . . . . 73.25 111.751 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm 61.36 30.61 19.1 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.847 0.459 . . . . 74.31 111.923 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 80.0 t -110.0 138.75 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.832 0.349 . . . . 64.42 111.294 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -139.12 132.64 30.32 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.79 0.329 . . . . 74.0 111.308 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.449 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 47.7 t -121.29 134.29 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 122.332 -0.23 . . . . 75.01 111.142 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.526 ' HA ' HG23 ' A' ' 76' ' ' THR . 8.6 pt-20 -123.6 126.31 46.4 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.046 0.45 . . . . 72.12 111.709 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.424 HD12 ' HB2' ' A' ' 75' ' ' ASP . 59.8 mt -95.58 116.73 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.212 0.529 . . . . 74.24 110.432 175.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -127.77 160.54 31.42 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.178 0.513 . . . . 73.4 111.899 -172.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.3 t -87.62 149.13 24.49 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.065 0.46 . . . . 75.22 111.76 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.3 p -88.33 -15.49 35.55 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.075 -0.511 . . . . 73.31 111.26 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 . . . . . 0 N--CA 1.469 0.523 0 CA-C-N 116.013 -0.54 . . . . 75.24 111.7 -176.275 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.564 ' HA ' ' HB ' ' A' ' 25' ' ' THR . 46.0 mt-10 . . . . . 0 N--CA 1.467 0.379 0 CA-C-O 120.726 0.298 . . . . 72.31 110.876 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 34.5 m -102.76 161.82 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 113.282 0.845 . . . . 71.43 113.282 -174.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.555 HG13 ' HA ' ' A' ' 23' ' ' PRO . 33.1 m -130.04 153.17 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 115.398 -0.819 . . . . 72.25 111.006 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.37 119.97 41.1 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.406 -0.361 . . . . 71.33 111.146 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.3 mm -101.02 111.4 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.591 -0.277 . . . . 65.13 110.949 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.478 HD11 ' N ' ' A' ' 12' ' ' ILE . 3.6 mp -100.98 111.11 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 120.941 0.4 . . . . 75.3 111.762 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.2 p -108.86 140.56 42.16 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.746 0.308 . . . . 65.42 110.405 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.619 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 54.5 tt0 -141.33 131.67 25.12 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.258 -0.276 . . . . 72.41 111.251 -177.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.509 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 52.1 m-80 58.74 16.85 4.7 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 120.888 0.375 . . . . 60.04 111.961 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.09 -12.61 60.51 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.126 -0.559 . . . . 65.43 113.736 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 14' ' ' GLN . 21.5 pttp -109.61 132.87 53.74 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 117.273 0.536 . . . . 72.51 111.573 -178.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.7 t -71.84 115.94 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.848 0.356 . . . . 75.5 110.719 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.9 pt -102.3 -23.1 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 113.156 0.799 . . . . 70.44 113.156 -173.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.6 tpp85 -157.45 126.99 6.03 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.769 0.655 . . . . 74.41 112.769 -173.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -118.01 119.18 34.0 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.629 -0.508 . . . . 73.45 109.629 173.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.59 126.33 26.49 Favored Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 112.989 0.737 . . . . 74.44 112.989 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.555 ' HA ' HG13 ' A' ' 9' ' ' VAL . 73.8 Cg_endo -76.24 111.79 3.34 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.389 2.059 . . . . 72.03 111.536 169.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.66 -69.32 0.61 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.232 0.456 . . . . 74.13 112.232 -174.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.564 ' HB ' ' HA ' ' A' ' 7' ' ' GLU . 6.7 m -59.41 124.58 20.49 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.002 0.43 . . . . 74.45 111.537 -176.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.06 -22.48 33.19 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.331 -0.462 . . . . 62.33 112.835 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -77.91 91.3 4.17 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.189 -0.595 . . . . 74.43 111.23 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -80.05 153.34 28.86 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.059 -0.518 . . . . 73.44 110.712 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.38 -162.91 27.25 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.051 -0.595 . . . . 63.54 112.971 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -118.18 145.0 45.27 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.197 0.522 . . . . 71.21 111.687 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.57 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 16.8 tp10 -139.75 139.32 36.47 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.915 -0.584 . . . . 60.01 110.209 176.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -141.66 133.4 27.15 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.865 0.364 . . . . 75.22 111.859 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -148.92 142.58 25.49 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.203 0.525 . . . . 62.23 111.772 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.8 m -98.29 115.11 27.72 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.119 -0.491 . . . . 71.02 111.729 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 60.3 mt -80.07 112.93 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.203 0.525 . . . . 74.41 111.188 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.2 mtmt -79.4 108.44 12.93 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.841 -0.618 . . . . 64.03 111.215 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.619 ' HA2' ' NE2' ' A' ' 14' ' ' GLN . . . -91.39 -86.08 1.44 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.178 -0.534 . . . . 61.34 113.722 -176.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -148.2 114.12 5.77 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.643 -0.328 . . . . 75.13 110.759 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.89 -107.9 1.5 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.119 -0.562 . . . . 74.31 112.937 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.97 -10.03 40.86 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.516 -0.402 . . . . 71.13 111.892 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -79.73 125.8 30.13 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.019 0.438 . . . . 74.01 111.925 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -145.67 172.54 13.12 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.084 -0.507 . . . . 73.33 111.308 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.419 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 15.6 m120 -136.99 110.44 7.94 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.554 -0.294 . . . . 75.02 110.681 173.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.3 tp -85.05 107.85 17.36 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.943 0.402 . . . . 75.13 110.908 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.782 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.9 mmm -100.67 150.94 22.22 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.001 0.429 . . . . 55.13 111.669 -176.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -138.84 130.84 28.0 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.209 -0.451 . . . . 75.03 111.84 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.57 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 30.4 t -113.08 107.66 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.313 -0.403 . . . . 74.12 110.492 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.421 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 8.8 t0 -130.93 140.13 50.15 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.517 0.199 . . . . 63.21 110.893 -176.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 51.87 51.08 41.55 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 114.385 0.514 . . . . 73.22 114.385 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 69.03 15.06 8.83 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.473 0.916 . . . . 61.02 113.473 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.431 ' HG3' ' HE3' ' A' ' 69' ' ' TRP . 3.6 ptp180 -147.52 166.9 25.89 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.721 -0.612 . . . . 72.41 112.58 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.1 tt -125.83 150.8 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.292 0.479 . . . . 75.11 112.292 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.464 ' HB3' ' HA ' ' A' ' 69' ' ' TRP . 1.8 ppt_? -155.68 159.16 39.33 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.146 -0.479 . . . . 74.44 111.192 177.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.782 HG12 ' SD ' ' A' ' 45' ' ' MET . 34.5 mt -85.85 115.99 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.153 0.502 . . . . 61.12 110.713 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -78.79 -34.73 45.24 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.879 -0.6 . . . . 73.34 111.895 -175.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -172.93 138.63 0.8 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.558 0.218 . . . . 73.3 111.276 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -152.75 149.93 28.87 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.93 0.395 . . . . 64.33 110.91 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -100.41 74.8 1.74 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.371 0.605 . . . . 75.24 111.599 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.0 p -124.11 149.92 61.79 Favored Pre-proline 0 N--CA 1.475 0.79 0 O-C-N 122.082 -0.387 . . . . 74.51 111.478 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.26 -23.27 45.25 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.37 2.047 . . . . 74.34 111.964 174.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.5 ' HB3' HG22 ' A' ' 63' ' ' VAL . 8.7 m-20 -73.06 -56.82 4.59 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.885 -0.598 . . . . 74.14 111.388 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 62.17 11.87 4.69 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.986 0.515 . . . . 75.12 112.296 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 61' ' ' ASP . 59.9 t -56.62 -36.27 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.059 0.457 . . . . 73.23 111.177 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.538 ' HA3' HD13 ' A' ' 54' ' ' ILE . . . -58.04 -47.58 88.19 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.191 -0.528 . . . . 73.32 112.942 177.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.04 -41.84 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.195 0.521 . . . . 74.24 111.213 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -67.28 -29.28 68.85 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.213 0.449 . . . . 73.34 112.213 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 22.0 mmt -58.84 -42.26 88.87 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.726 0.298 . . . . 74.12 111.785 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.0 -139.37 28.28 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.311 -0.471 . . . . 73.44 113.112 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.464 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . 84.5 m95 -81.84 129.57 34.79 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.76 0.314 . . . . 75.22 111.491 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.413 ' HG3' HD12 ' A' ' 77' ' ' ILE . 74.7 mmtt -129.1 148.59 51.06 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.82 0.448 . . . . 52.43 110.292 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.4 ' HB3' ' CB ' ' A' ' 51' ' ' ARG . 94.7 p -175.25 25.44 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.489 0.922 . . . . 71.54 113.489 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -120.16 144.56 47.61 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.614 -0.679 . . . . 75.33 111.394 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.16 96.26 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.094 0.473 . . . . 44.23 111.189 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.43 -26.42 1.99 Allowed Glycine 0 CA--C 1.525 0.697 0 CA-C-N 116.057 -0.52 . . . . 62.23 112.686 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.48 ' HB2' HD12 ' A' ' 88' ' ' ILE . 75.9 m-20 -64.57 135.35 55.89 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.876 0.37 . . . . 64.12 111.647 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.5 p -138.44 142.36 39.49 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.074 0.464 . . . . 73.31 111.617 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.413 HD12 ' HG3' ' A' ' 70' ' ' LYS . 38.7 mm -114.61 130.96 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.211 -0.449 . . . . 70.43 110.626 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.7 t -123.11 119.62 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 112.051 0.389 . . . . 72.4 112.051 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 97.8 m -121.77 88.79 3.0 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 120.733 0.302 . . . . 73.34 110.873 174.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.572 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 92.6 mt -59.25 -53.89 61.7 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 113.078 0.77 . . . . 72.12 113.078 -175.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.572 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 24.7 Cg_exo -62.81 -19.32 68.22 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.958 1.772 . . . . 65.44 113.007 -176.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -104.28 -5.04 22.22 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.483 -0.326 . . . . 75.1 111.683 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.1 mttm 58.16 34.29 24.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.811 0.445 . . . . 75.44 111.917 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.527 HG23 ' HG3' ' A' ' 14' ' ' GLN . 60.2 t -109.36 132.86 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.137 -0.483 . . . . 74.41 111.33 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -133.33 136.42 45.38 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.729 0.3 . . . . 74.51 110.695 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -132.9 139.49 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.8 -0.182 . . . . 75.0 111.214 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.434 ' CD ' ' HZ1' ' A' ' 89' ' ' LYS . 10.1 pt-20 -126.15 154.52 43.06 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.794 0.331 . . . . 64.04 110.813 174.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.48 HD12 ' HB2' ' A' ' 75' ' ' ASP . 55.1 mt -118.24 123.09 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.094 0.473 . . . . 74.25 110.908 174.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.434 ' HZ1' ' CD ' ' A' ' 87' ' ' GLU . 8.6 ptmt -140.49 151.17 44.6 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.201 -0.454 . . . . 74.14 111.157 -175.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.504 ' OG ' ' HG2' ' A' ' 92' ' ' GLN . 22.9 t -74.2 149.82 40.68 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.064 0.459 . . . . 74.33 111.657 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.1 p -70.31 -21.22 62.95 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 116.25 -0.432 . . . . 75.34 111.837 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.504 ' HG2' ' OG ' ' A' ' 90' ' ' SER . 20.4 pt20 . . . . . 0 CA--C 1.537 0.48 0 CA-C-N 116.414 -0.357 . . . . 74.14 110.72 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.502 ' HG2' HG22 ' A' ' 25' ' ' THR . 42.1 mt-10 . . . . . 0 N--CA 1.465 0.306 0 N-CA-C 112.08 0.4 . . . . 74.14 112.08 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.453 HG23 ' HB2' ' A' ' 24' ' ' LEU . 31.3 m -125.54 139.16 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.164 0.506 . . . . 71.41 111.45 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.3 m -121.96 138.64 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 116.178 -0.465 . . . . 74.11 111.193 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.26 112.64 24.31 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.823 0.344 . . . . 72.01 111.333 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.2 mm -95.04 115.16 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.403 -0.362 . . . . 73.15 110.982 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.2 mp -97.25 114.64 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.047 0.451 . . . . 75.14 111.509 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.5 m -114.39 134.74 54.76 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.219 -0.446 . . . . 73.35 111.448 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.447 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 49.8 tt0 -126.82 131.27 51.27 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 122.337 -0.227 . . . . 75.32 111.051 177.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.516 HD21 ' N ' ' A' ' 15' ' ' ASN . 0.8 OUTLIER 56.42 28.05 13.03 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.429 0.529 . . . . 73.44 112.429 176.355 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.12 21.57 41.43 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.253 -0.498 . . . . 60.32 114.34 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -146.78 140.33 25.75 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.308 0.554 . . . . 75.42 111.657 175.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.9 t -72.36 118.97 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.791 0.329 . . . . 75.3 111.014 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.1 pt -99.43 -23.44 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 112.219 0.451 . . . . 71.53 112.219 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -173.16 148.04 1.64 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.703 0.287 . . . . 75.32 111.014 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -131.33 127.37 37.52 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.179 0.514 . . . . 72.43 111.442 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.405 HD11 ' N ' ' A' ' 22' ' ' ILE . 3.4 mp -113.67 116.12 45.95 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 116.358 -0.383 . . . . 63.41 111.418 -177.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.45 120.59 7.82 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.172 1.915 . . . . 72.44 111.757 172.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.453 ' HB2' HG23 ' A' ' 8' ' ' VAL . 86.9 mt -80.11 -48.89 12.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.056 0.455 . . . . 72.52 111.5 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.502 HG22 ' HG2' ' A' ' 7' ' ' GLU . 86.2 m -60.57 110.16 1.21 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.975 0.417 . . . . 74.03 111.805 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.73 0.53 60.55 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.059 -0.591 . . . . 73.34 113.465 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -72.51 86.49 1.17 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 117.159 0.48 . . . . 74.2 110.547 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -72.95 115.96 12.88 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.184 0.516 . . . . 72.5 111.953 -176.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.5 -166.49 14.37 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.145 -0.479 . . . . 54.2 113.952 177.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -116.89 136.6 52.83 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.763 0.425 . . . . 74.34 110.422 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -145.68 129.91 17.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.902 0.382 . . . . 53.53 111.592 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -121.72 147.6 45.7 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.6 -0.273 . . . . 74.15 111.561 -177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -147.99 143.69 27.45 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.966 0.412 . . . . 71.34 111.307 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -103.39 126.7 50.69 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.17 0.51 . . . . 65.51 112.216 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' A' ' 43' ' ' ASN . 60.7 mt -90.69 132.75 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.121 -0.491 . . . . 75.11 110.66 175.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.58 125.88 48.31 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.997 0.427 . . . . 72.25 111.223 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -113.42 -164.6 15.77 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.29 -0.481 . . . . 54.41 113.831 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -59.07 113.28 2.03 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.895 0.379 . . . . 74.44 112.011 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.54 -125.1 7.86 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.242 -0.504 . . . . 41.4 113.242 178.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.8 9.93 28.15 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.205 0.446 . . . . 72.44 112.205 -178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -74.01 132.75 42.68 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.649 -0.251 . . . . 75.35 111.572 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -137.26 174.36 10.69 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.929 0.395 . . . . 73.43 111.125 174.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.463 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . 2.1 t-20 -152.21 109.64 3.58 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.249 -0.282 . . . . 63.45 111.031 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.2 tp -86.6 105.12 16.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.96 0.41 . . . . 71.42 111.147 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.742 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.4 mmm -95.51 135.62 36.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.147 -0.479 . . . . 75.24 111.05 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.67 127.39 48.13 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.255 0.55 . . . . 75.31 111.96 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.3 t -112.44 107.87 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.03 -0.532 . . . . 64.01 110.586 176.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -112.33 112.35 23.87 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.763 0.316 . . . . 75.4 110.569 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 63.52 -121.46 23.99 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.938 -0.648 . . . . 64.33 112.506 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -106.25 25.81 10.58 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 122.469 -0.43 . . . . 72.34 111.668 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.8 ptt85 -140.92 145.52 36.18 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.204 0.526 . . . . 74.42 111.795 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.9 tt -123.72 153.94 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 116.1 -0.5 . . . . 64.14 111.479 -176.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -157.33 168.47 27.29 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.005 0.431 . . . . 74.14 111.424 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.742 HG12 ' SD ' ' A' ' 45' ' ' MET . 45.3 mt -91.54 123.92 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 109.749 -0.463 . . . . 74.32 109.749 168.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -93.49 -34.06 13.54 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.38 0.511 . . . . 73.43 112.38 -172.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -169.0 139.28 2.29 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.577 -0.283 . . . . 73.54 111.293 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.444 ' HB3' HD21 ' A' ' 43' ' ' ASN . 6.8 p-10 -161.22 160.99 30.68 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.987 0.422 . . . . 72.1 111.536 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -96.09 74.04 2.98 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.45 0.643 . . . . 75.52 111.858 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 84.2 p -125.7 148.84 63.49 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-N 116.381 -0.372 . . . . 70.34 110.92 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.46 -3.18 13.45 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.394 2.062 . . . . 73.24 112.639 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -110.49 -43.81 3.81 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.265 -0.425 . . . . 62.25 111.949 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 63.47 30.42 15.3 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.854 0.359 . . . . 75.5 111.383 -177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.2 t -52.56 -42.19 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 111.955 0.354 . . . . 70.21 111.955 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.552 ' HA3' HD11 ' A' ' 54' ' ' ILE . . . -55.38 -43.98 84.92 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.068 -0.587 . . . . 62.04 112.883 176.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.1 t -64.71 -39.22 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 120.854 0.359 . . . . 73.4 111.069 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -65.05 -41.63 94.98 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.718 0.294 . . . . 73.52 111.402 177.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.9 mmt -57.43 -44.28 84.53 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.447 0.536 . . . . 72.33 112.447 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.96 -160.93 43.31 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 120.933 -0.651 . . . . 54.43 113.683 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -67.09 146.77 53.95 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.692 0.626 . . . . 74.3 112.692 -174.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.494 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 33.3 mmtm -135.63 140.67 44.74 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.89 -0.595 . . . . 71.54 110.33 177.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 82.2 p -164.84 11.06 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.29 0.848 . . . . 75.13 113.29 -176.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -114.13 153.9 28.73 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.938 -0.477 . . . . 72.32 111.653 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 90' ' ' SER . . . -69.11 91.34 0.5 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.211 0.529 . . . . 54.13 111.024 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.27 -22.33 2.41 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.893 -0.594 . . . . 65.2 112.337 -175.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.494 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 94.4 m-20 -63.36 142.86 58.23 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.938 0.399 . . . . 75.24 111.611 177.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.0 p -143.7 161.49 38.43 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.202 0.525 . . . . 71.24 111.645 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.3 mm -128.07 114.0 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.829 -0.623 . . . . 62.11 110.247 176.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.0 t -109.22 115.63 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.817 0.342 . . . . 71.51 111.442 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 74.2 m -123.34 88.09 2.86 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.699 0.285 . . . . 74.25 111.18 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.65 -45.37 88.4 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 113.096 0.776 . . . . 74.04 113.096 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.74 -25.76 35.6 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 122.16 1.907 . . . . 75.44 113.556 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -112.39 -1.24 15.1 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.106 0.41 . . . . 74.01 112.106 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 59.88 33.56 21.59 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.964 0.411 . . . . 74.55 111.791 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 68.0 t -105.65 135.66 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.274 -0.421 . . . . 75.52 111.335 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -139.35 116.21 10.88 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.257 -0.429 . . . . 70.55 110.853 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.1 t -113.35 126.44 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.569 -0.287 . . . . 74.5 111.208 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -120.78 136.79 54.8 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.084 0.469 . . . . 73.13 111.467 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 62.9 mt -103.01 120.79 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.853 0.359 . . . . 74.31 111.331 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -124.4 147.06 48.51 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.106 -0.497 . . . . 73.3 111.064 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 48.1 t -92.45 150.28 20.89 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.188 0.518 . . . . 72.4 112.115 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 7' ' ' GLU . 46.9 p -79.72 -13.78 59.21 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.895 -0.593 . . . . 73.21 110.783 174.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 . . . . . 0 CA--C 1.537 0.479 0 CA-C-N 116.108 -0.496 . . . . 74.22 111.077 177.467 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 . . . . . 0 N--CA 1.468 0.437 0 CA-C-O 121.137 0.494 . . . . 64.04 111.654 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.6 m -120.87 154.26 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 121.155 0.502 . . . . 73.44 112.031 -177.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 23' ' ' PRO . 34.5 m -121.57 147.6 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.03 -0.532 . . . . 72.21 111.282 177.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.99 117.59 34.59 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.835 0.35 . . . . 72.11 111.527 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.9 mm -100.78 122.42 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.561 -0.291 . . . . 72.04 111.051 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.469 ' N ' HD11 ' A' ' 12' ' ' ILE . 3.3 mp -107.8 113.88 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.051 0.453 . . . . 74.32 110.923 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.1 m -120.35 134.91 55.18 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.173 -0.467 . . . . 71.15 111.531 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.529 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 62.8 tt0 -119.29 138.84 52.75 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.648 0.261 . . . . 63.12 110.919 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.529 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 54.7 m-80 59.72 17.25 6.16 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.732 0.413 . . . . 72.54 111.98 -177.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.3 3.4 63.28 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.118 -0.563 . . . . 75.11 113.827 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -124.84 140.33 53.03 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 117.238 0.519 . . . . 74.14 111.23 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.34 129.16 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.844 0.354 . . . . 74.01 111.689 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.5 pt -112.78 -31.49 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 116.414 -0.357 . . . . 73.25 111.663 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -157.62 144.94 18.43 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.681 0.277 . . . . 74.3 111.257 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -138.51 132.08 30.64 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 120.77 0.319 . . . . 75.02 110.739 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.452 ' N ' HD13 ' A' ' 22' ' ' ILE . 4.0 mp -126.3 119.39 23.41 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 120.567 0.222 . . . . 74.22 111.552 -177.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.498 ' HA ' HG12 ' A' ' 9' ' ' VAL . 43.1 Cg_endo -68.29 101.6 0.74 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.075 1.85 . . . . 73.02 111.535 172.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.18 -62.44 1.77 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.354 0.502 . . . . 73.51 112.354 -173.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.0 m -58.58 131.18 50.04 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.94 0.4 . . . . 74.33 111.443 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.62 -33.21 4.9 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.239 -0.505 . . . . 72.54 112.667 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -74.07 85.57 1.82 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.424 0.631 . . . . 71.41 110.82 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -86.74 167.62 14.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.68 -0.691 . . . . 65.12 111.633 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.73 -162.37 51.91 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 120.909 -0.662 . . . . 71.41 112.807 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -117.77 146.59 43.7 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.197 -0.59 . . . . 72.43 111.836 -176.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -161.19 116.92 2.16 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.818 -0.628 . . . . 73.42 110.285 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -113.86 145.96 40.7 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.822 0.344 . . . . 74.31 111.22 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -138.2 139.93 39.52 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.15 0.5 . . . . 71.3 111.481 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.4 m -98.87 121.2 40.52 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.955 -0.566 . . . . 72.34 112.077 -175.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.434 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 75.0 mt -91.58 123.37 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.121 -0.49 . . . . 75.14 111.31 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -103.07 124.39 48.45 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.508 0.194 . . . . 75.52 111.117 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -123.02 -143.23 6.32 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.064 -0.589 . . . . 64.01 113.679 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -60.93 106.78 0.62 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.183 0.438 . . . . 73.35 112.183 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.78 -116.88 8.17 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.216 -0.447 . . . . 74.32 113.454 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.78 6.72 48.13 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.031 0.382 . . . . 65.13 112.031 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -75.26 111.07 10.14 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.619 0.247 . . . . 74.11 111.563 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -127.12 164.89 20.61 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.016 0.436 . . . . 75.14 111.353 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.434 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 17.6 m120 -140.05 123.55 17.13 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.233 -0.439 . . . . 74.21 111.127 176.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.7 tp -96.65 104.19 16.16 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.893 0.378 . . . . 75.12 110.84 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.742 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.4 mmm -94.38 128.8 41.14 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.24 -0.437 . . . . 65.13 111.237 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -115.13 118.81 34.41 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.942 0.401 . . . . 73.22 111.962 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.9 t -104.02 114.33 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.155 -0.475 . . . . 71.41 110.001 171.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -133.67 92.46 2.98 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.924 -0.485 . . . . 72.43 112.167 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.76 67.72 1.72 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.294 -0.479 . . . . 72.2 114.249 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 60.64 26.86 16.58 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.72 0.637 . . . . 53.01 112.72 175.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -149.27 150.66 32.92 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.565 0.346 . . . . 75.23 110.319 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.8 tt -134.62 151.81 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.191 0.441 . . . . 64.54 112.191 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -157.18 168.4 27.54 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.202 -0.454 . . . . 74.54 111.496 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.742 HG12 ' SD ' ' A' ' 45' ' ' MET . 54.4 mt -92.27 110.05 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.47 -0.567 . . . . 73.52 109.47 169.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -86.37 -39.1 16.75 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 111.841 0.311 . . . . 65.41 111.841 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -138.86 146.95 41.82 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.739 0.304 . . . . 74.04 110.695 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -168.5 140.15 2.73 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.575 0.35 . . . . 74.0 110.329 -174.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -106.6 38.01 2.18 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.413 0.523 . . . . 74.31 112.413 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.2 m -84.1 138.5 39.66 Favored Pre-proline 0 N--CA 1.471 0.595 0 O-C-N 122.058 -0.401 . . . . 75.32 110.016 172.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.54 -25.74 68.51 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.307 2.004 . . . . 74.1 112.777 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.456 ' HB3' HG23 ' A' ' 63' ' ' VAL . 10.9 m-20 -84.45 -32.38 24.07 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.31 -0.404 . . . . 50.13 111.957 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.52 ' HB3' ' HZ2' ' A' ' 66' ' ' LYS . 87.8 mm-40 59.54 13.48 3.34 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.136 0.791 . . . . 73.43 113.136 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.456 HG23 ' HB3' ' A' ' 61' ' ' ASP . 97.0 t -56.15 -41.34 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 112.479 0.548 . . . . 74.54 112.479 -176.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.48 -42.48 57.46 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.191 -0.528 . . . . 73.22 113.51 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.2 t -68.82 -33.59 60.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.189 0.519 . . . . 62.23 111.333 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.52 ' HZ2' ' HB3' ' A' ' 62' ' ' GLN . 13.4 mptt -73.15 -28.12 62.05 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.313 0.486 . . . . 64.22 112.313 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 90.7 mmm -52.76 -47.17 67.64 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.342 0.497 . . . . 63.34 112.342 -177.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.42 -163.94 20.0 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.054 -0.593 . . . . 72.15 113.416 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -76.48 138.94 40.6 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.029 0.443 . . . . 75.22 112.014 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -126.69 146.55 50.16 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.28 -0.418 . . . . 72.01 110.639 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 82.2 p -172.2 26.42 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 112.724 0.638 . . . . 65.13 112.724 -176.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -125.16 146.39 49.51 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.686 0.279 . . . . 70.3 111.32 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.15 96.65 0.05 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.079 0.466 . . . . 74.3 111.65 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 138.14 -19.7 3.24 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 116.093 -0.503 . . . . 72.04 112.918 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -63.96 120.16 11.45 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.108 0.48 . . . . 75.13 111.588 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.46 HG23 ' HA ' ' A' ' 87' ' ' GLU . 32.5 p -128.96 141.92 51.1 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.077 0.465 . . . . 73.51 111.421 178.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 mm -122.58 127.64 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 116.269 -0.423 . . . . 74.32 110.687 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.6 t -119.71 119.32 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.836 0.35 . . . . 73.13 111.48 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 98.3 m -117.62 88.2 2.86 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.841 0.353 . . . . 73.44 110.6 173.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.5 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 96.2 mt -54.46 -50.83 83.01 Favored Pre-proline 0 CA--C 1.547 0.827 0 N-CA-C 113.314 0.857 . . . . 73.12 113.314 -175.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 75.5 Cg_exo -50.41 -34.52 41.74 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.156 1.904 . . . . 75.21 113.634 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -103.42 -3.92 24.79 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 111.976 0.361 . . . . 72.34 111.976 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.5 mttp 59.85 33.99 21.71 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.134 0.492 . . . . 61.21 112.276 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.7 t -101.12 133.18 45.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 116.218 -0.446 . . . . 74.53 111.084 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -130.58 125.61 34.61 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.079 -0.51 . . . . 64.02 110.689 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.43 HG21 HG13 ' A' ' 12' ' ' ILE . 47.7 t -118.19 124.1 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.68 -0.236 . . . . 75.54 111.183 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.46 ' HA ' HG23 ' A' ' 76' ' ' THR . 8.9 pt-20 -120.9 122.15 39.6 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.094 0.473 . . . . 74.31 111.467 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.9 mt -97.07 118.16 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 120.98 0.419 . . . . 72.54 110.537 175.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -129.53 150.18 50.98 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.114 0.483 . . . . 74.45 112.122 -173.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.6 t -77.48 150.51 34.9 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.925 -0.58 . . . . 71.54 112.448 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.2 p -85.13 0.18 52.51 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.899 -0.591 . . . . 73.31 111.315 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 121.458 0.647 . . . . 74.41 111.508 176.804 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.516 ' HA ' ' HB ' ' A' ' 25' ' ' THR . 46.0 mt-10 . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 120.784 0.326 . . . . 61.53 111.757 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.432 HG23 ' OG1' ' A' ' 25' ' ' THR . 32.7 m -111.3 151.03 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.073 0.463 . . . . 64.23 111.755 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 23' ' ' PRO . 27.4 m -129.46 141.39 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.168 -0.469 . . . . 64.51 111.488 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.89 115.27 27.08 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.444 -0.344 . . . . 53.32 111.243 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.4 mm -96.42 112.2 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.866 0.365 . . . . 71.41 111.098 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.499 HG13 HG21 ' A' ' 86' ' ' VAL . 2.7 mp -99.19 114.5 37.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 120.972 0.415 . . . . 72.14 111.303 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.0 m -113.07 139.71 48.47 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.798 0.333 . . . . 73.42 111.231 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.413 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 57.5 tt0 -128.9 135.45 49.07 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.587 -0.278 . . . . 75.53 111.2 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 57.01 10.27 0.76 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.981 0.734 . . . . 75.11 112.981 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.07 -6.5 28.97 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 121.256 -0.497 . . . . 73.44 113.882 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -112.76 145.08 41.2 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 117.13 0.465 . . . . 71.53 111.571 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.37 119.6 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 110.059 -0.349 . . . . 75.41 110.059 173.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.4 pt -108.51 -19.53 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 113.465 0.913 . . . . 75.14 113.465 -173.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -168.87 141.29 2.71 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.747 0.647 . . . . 73.03 112.747 -177.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -123.42 130.91 53.39 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.391 -0.368 . . . . 72.43 110.535 174.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.451 HG22 HG21 ' A' ' 47' ' ' VAL . 3.9 mp -121.24 124.43 27.32 Favored Pre-proline 0 N--CA 1.478 0.972 0 O-C-N 121.966 -0.459 . . . . 63.14 111.72 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.56 ' HA ' HG11 ' A' ' 9' ' ' VAL . 59.0 Cg_endo -73.24 121.22 7.04 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.418 2.079 . . . . 65.33 112.068 173.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.7 mt -92.96 -60.08 1.89 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.192 0.52 . . . . 65.12 111.796 -176.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.516 ' HB ' ' HA ' ' A' ' 7' ' ' GLU . 25.1 m -58.05 128.0 34.9 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.327 0.492 . . . . 75.3 112.327 -176.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.98 1.12 72.04 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 121.357 -0.449 . . . . 72.51 113.922 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -84.91 105.13 15.45 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.595 -0.356 . . . . 73.32 111.579 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.63 ' HZ3' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -85.77 137.58 32.69 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.927 0.394 . . . . 71.05 110.913 175.226 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.86 178.89 22.19 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.173 -0.537 . . . . 65.43 113.572 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -118.46 139.63 51.11 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.907 0.384 . . . . 62.42 110.965 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -138.9 124.51 19.54 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.256 -0.429 . . . . 74.21 110.604 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.45 ' HG2' ' HA ' ' A' ' 46' ' ' GLU . 75.3 mt-30 -131.7 148.69 52.6 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.94 0.4 . . . . 73.25 112.003 -176.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -154.64 147.71 24.71 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.104 -0.498 . . . . 72.02 111.21 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.7 m -101.19 136.85 40.37 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.899 0.38 . . . . 71.41 111.528 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' A' ' 43' ' ' ASN . 58.4 mt -113.7 102.32 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.495 -0.32 . . . . 71.44 111.419 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -76.27 107.04 8.23 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.773 0.32 . . . . 72.32 111.141 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.413 ' HA2' ' NE2' ' A' ' 14' ' ' GLN . . . -89.03 -133.81 4.88 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.374 -0.441 . . . . 54.34 113.438 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.55 ' HB3' ' HZ3' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -76.03 115.27 15.56 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.528 -0.396 . . . . 54.34 110.697 -179.732 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.37 -136.72 25.26 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.266 -0.492 . . . . 71.02 113.135 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.16 3.65 34.06 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.161 0.505 . . . . 74.24 111.279 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.534 ' HB3' ' CD2' ' A' ' 82' ' ' HIS . 24.6 mt-30 -73.07 83.78 1.29 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.194 0.521 . . . . 65.35 111.795 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -89.92 165.44 14.09 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.063 -0.517 . . . . 74.32 111.406 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.497 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . 2.4 t-20 -132.7 110.13 10.18 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.311 -0.404 . . . . 74.43 109.93 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.3 tp -95.52 103.82 15.71 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.382 0.61 . . . . 72.4 111.612 -176.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.638 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.1 mmm -93.93 141.61 28.32 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.374 -0.83 . . . . 64.1 111.76 -175.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.45 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 44.7 tt0 -127.07 119.65 27.07 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.99 0.424 . . . . 75.32 111.7 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.451 HG21 HG22 ' A' ' 22' ' ' ILE . 59.4 t -105.53 107.29 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.209 -0.451 . . . . 75.43 110.584 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.497 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 34.8 t70 -109.98 101.56 10.37 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.118 0.485 . . . . 63.22 110.848 -178.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.18 -109.68 3.04 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 120.784 -0.722 . . . . 53.32 112.886 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -108.14 19.16 20.29 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.852 0.358 . . . . 75.13 111.794 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 35.3 ptt180 -136.4 147.07 47.11 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.791 0.329 . . . . 73.33 111.507 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.3 tt -132.37 142.6 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-O 120.868 0.365 . . . . 74.32 111.719 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.485 ' HB3' ' HA ' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -160.67 168.8 24.14 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.849 0.357 . . . . 72.11 111.461 177.441 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.638 HG12 ' SD ' ' A' ' 45' ' ' MET . 71.6 mt -91.62 124.57 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.432 -0.349 . . . . 75.32 111.065 176.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.414 ' HB3' ' HZ1' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -94.86 -33.16 12.93 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.865 0.364 . . . . 65.21 111.406 177.434 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -143.47 139.95 30.12 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.746 0.308 . . . . 72.43 110.748 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -168.07 145.76 4.3 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.991 0.425 . . . . 74.01 112.023 -173.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -109.79 51.06 0.77 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.081 -0.509 . . . . 75.01 111.954 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.4 m -107.05 121.81 43.56 Favored Pre-proline 0 N--CA 1.472 0.667 0 O-C-N 122.063 -0.398 . . . . 72.4 110.192 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.28 -30.82 73.91 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.436 2.091 . . . . 75.42 112.582 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.68 -36.5 67.91 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.693 -0.685 . . . . 75.51 111.712 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 59.26 16.76 5.19 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.041 0.756 . . . . 73.31 113.041 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 65.6 t -55.36 -51.61 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 N-CA-C 112.07 0.396 . . . . 73.13 112.07 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -56.98 -38.66 86.48 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.223 -0.513 . . . . 54.02 113.271 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 42.1 t -67.46 -43.77 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.991 0.424 . . . . 74.42 111.295 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.22 -27.16 68.87 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.031 -0.531 . . . . 74.33 112.112 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.721 ' HE2' ' HA ' ' A' ' 67' ' ' MET . 14.3 mmt -50.45 -35.23 27.88 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.453 0.538 . . . . 73.54 112.453 178.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.05 -159.87 50.91 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.136 -0.554 . . . . 73.02 113.625 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.485 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . 89.1 m95 -70.82 114.71 9.17 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 111.968 0.359 . . . . 73.1 111.968 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.486 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 34.9 mmtp -105.78 150.65 25.35 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.68 -0.237 . . . . 73.35 110.619 175.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.427 ' O ' HG21 ' A' ' 8' ' ' VAL . 92.7 p -159.56 -26.83 0.07 Allowed 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.163 0.801 . . . . 71.42 113.163 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm -82.28 155.96 24.56 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.276 0.56 . . . . 74.45 112.264 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.51 110.74 3.26 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.108 -0.496 . . . . 54.44 110.675 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 121.71 -23.83 7.34 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.982 -0.447 . . . . 71.55 111.982 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.486 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 78.4 m-20 -65.41 129.23 38.99 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.87 0.367 . . . . 74.31 110.783 176.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.466 HG22 ' HA ' ' A' ' 87' ' ' GLU . 41.2 p -128.81 164.38 23.16 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.018 0.747 . . . . 74.2 113.018 -176.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.533 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 39.6 mm -128.15 125.63 64.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.063 -0.971 . . . . 74.4 109.735 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.8 t -117.32 117.59 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 112.291 0.478 . . . . 72.43 112.291 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 75.1 m -119.16 80.79 1.61 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.061 0.458 . . . . 71.42 110.65 174.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.411 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 76.3 mt -52.54 -59.91 7.63 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 113.597 0.962 . . . . 74.25 113.597 -174.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.411 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 38.9 Cg_endo -66.86 -9.5 24.98 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 121.917 1.744 . . . . 74.13 112.98 -176.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.534 ' CD2' ' HB3' ' A' ' 41' ' ' GLN . 24.3 m170 -104.49 -10.94 17.31 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.517 -0.31 . . . . 74.13 111.343 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.4 mttp 59.82 27.06 16.31 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.052 0.453 . . . . 74.32 112.032 -176.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.4 t -104.14 124.44 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.028 -0.533 . . . . 75.33 110.782 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -130.27 118.01 20.68 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.069 0.462 . . . . 70.03 111.119 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.533 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 35.9 t -107.76 124.62 63.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.136 -0.484 . . . . 74.22 110.858 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.466 ' HA ' HG22 ' A' ' 76' ' ' THR . 14.5 pt-20 -124.3 126.76 46.59 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.998 0.427 . . . . 73.23 111.58 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 63.5 mt -89.48 112.71 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 121.093 0.473 . . . . 64.31 110.984 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -116.63 152.36 34.36 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.24 -0.436 . . . . 73.44 111.25 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.9 t -89.41 124.93 34.92 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.946 0.403 . . . . 63.02 111.966 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.1 p -66.27 -28.38 68.66 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.295 0.569 . . . . 72.21 110.507 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 . . . . . 0 CA--C 1.533 0.312 0 CA-C-N 115.715 -0.675 . . . . 54.34 109.67 174.221 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.487 ' HG2' HG23 ' A' ' 25' ' ' THR . 29.6 mt-10 . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 112.365 0.506 . . . . 74.45 112.365 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 27.8 m -130.72 159.24 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.426 0.528 . . . . 75.3 112.426 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.573 HG13 ' HA ' ' A' ' 23' ' ' PRO . 23.3 m -131.56 147.05 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 115.928 -0.578 . . . . 65.24 111.171 178.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.62 115.14 26.93 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.45 -0.341 . . . . 74.41 111.309 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.429 HD12 ' OE2' ' A' ' 21' ' ' GLU . 18.2 mm -99.47 104.8 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.831 0.348 . . . . 65.31 111.397 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.47 ' N ' HD13 ' A' ' 12' ' ' ILE . 3.3 mp -96.22 120.08 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.194 0.521 . . . . 74.42 111.257 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.6 m -121.94 144.36 48.91 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.087 -0.506 . . . . 70.33 111.31 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -135.67 141.82 45.05 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.551 -0.295 . . . . 73.41 110.733 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 59.21 17.4 5.66 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 111.956 0.354 . . . . 72.13 111.956 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.69 -9.75 62.34 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 121.409 -0.424 . . . . 61.41 113.683 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -116.4 145.65 43.08 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 117.296 0.548 . . . . 64.22 111.657 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.7 t -71.99 128.33 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 120.942 0.401 . . . . 75.2 111.147 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.6 HD11 HD11 ' A' ' 35' ' ' ILE . 33.9 pt -112.17 -26.59 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.64 0.607 . . . . 75.13 112.64 -177.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -159.55 133.34 7.33 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.236 0.458 . . . . 72.21 112.236 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.429 ' OE2' HD12 ' A' ' 11' ' ' ILE . 44.8 mt-10 -124.94 115.49 20.67 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.683 0.277 . . . . 75.31 110.802 177.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.481 HD13 ' N ' ' A' ' 22' ' ' ILE . 3.2 mp -104.22 129.86 24.38 Favored Pre-proline 0 N--CA 1.475 0.798 0 N-CA-C 111.852 0.316 . . . . 74.41 111.852 -175.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.573 ' HA ' HG13 ' A' ' 9' ' ' VAL . 67.7 Cg_endo -74.62 111.61 3.36 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.356 2.037 . . . . 72.11 112.194 171.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.63 -62.26 1.7 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.978 0.418 . . . . 75.24 111.749 -176.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.559 ' HA ' ' HG2' ' A' ' 50' ' ' GLU . 51.3 m -63.03 118.57 8.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.992 0.425 . . . . 72.54 112.07 -177.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.35 -15.73 55.92 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 116.154 -0.476 . . . . 61.32 112.81 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -77.11 79.13 3.64 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.19 0.519 . . . . 75.21 110.978 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.614 ' HZ2' ' HB2' ' A' ' 28' ' ' LYS . 10.4 mtmp? -75.18 105.1 6.03 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.291 0.567 . . . . 63.01 111.304 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.77 -169.63 24.31 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 115.971 -0.558 . . . . 71.22 112.655 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -117.84 148.0 42.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.841 0.353 . . . . 74.42 110.679 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -154.14 129.15 9.54 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.795 0.331 . . . . 72.52 111.671 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -124.71 153.65 42.04 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.759 0.314 . . . . 73.25 111.535 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -154.29 140.73 18.75 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.92 0.391 . . . . 61.44 110.708 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.5 m -108.94 111.93 23.88 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.974 0.416 . . . . 72.45 112.07 -172.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.6 HD11 HD11 ' A' ' 19' ' ' ILE . 57.8 mt -94.0 105.61 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.263 -0.426 . . . . 75.42 111.572 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -89.79 110.02 20.97 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.036 0.446 . . . . 74.04 111.307 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.43 -136.9 9.55 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 116.181 -0.463 . . . . 64.11 113.778 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -87.76 151.25 23.04 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.03 0.382 . . . . 74.4 112.03 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.79 36.74 92.44 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 116.098 -0.501 . . . . 71.0 113.479 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 61.99 10.72 3.78 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.388 0.514 . . . . 72.01 112.388 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.533 ' HA ' ' HB3' ' A' ' 58' ' ' ASN . 26.3 mt-30 -82.55 107.02 14.89 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.089 0.403 . . . . 71.42 112.089 -176.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -104.88 153.18 21.7 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 111.981 0.363 . . . . 63.4 111.981 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -111.72 130.23 55.85 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.998 -0.546 . . . . 60.45 110.222 171.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.4 tp -101.85 104.11 14.83 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.873 0.368 . . . . 75.2 110.925 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.747 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.5 mmm -88.73 141.33 28.6 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.559 -0.292 . . . . 64.41 111.286 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -136.09 119.01 16.29 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.155 0.502 . . . . 75.22 111.605 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.9 t -105.85 119.85 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 115.939 -0.573 . . . . 75.12 110.699 177.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -117.44 90.74 3.4 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.163 0.506 . . . . 74.42 110.206 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.97 -116.57 5.07 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.755 -0.736 . . . . 42.03 112.352 -174.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.559 ' HG2' ' HA ' ' A' ' 25' ' ' THR . 40.6 mt-10 -95.13 -15.17 23.56 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.036 0.446 . . . . 73.55 111.806 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.543 ' HA ' ' HB3' ' A' ' 71' ' ' SER . 26.7 ptt180 -97.74 135.29 39.73 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.993 0.425 . . . . 73.33 111.371 -176.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.6 tt -123.89 143.82 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.126 0.489 . . . . 73.33 111.463 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -144.96 169.21 18.52 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.32 -0.4 . . . . 75.53 110.709 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.747 HG12 ' SD ' ' A' ' 45' ' ' MET . 42.7 mt -96.93 122.17 48.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.351 -0.611 . . . . 75.12 109.351 167.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -86.67 -32.39 20.55 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.503 0.557 . . . . 73.33 112.503 -172.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -162.09 138.68 8.0 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.681 0.277 . . . . 65.44 111.383 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.437 ' HB3' ' HG ' ' A' ' 59' ' ' SER . 26.0 m-20 -133.04 144.61 50.15 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.313 0.578 . . . . 74.33 111.816 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.533 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . 48.5 t-20 -81.47 72.17 8.5 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.921 -1.14 . . . . 72.51 107.921 163.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.437 ' HG ' ' HB3' ' A' ' 57' ' ' ASP . 69.1 m -135.98 130.45 18.51 Favored Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 115.634 -0.712 . . . . 73.2 111.373 -174.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 59' ' ' SER . 26.8 Cg_exo -63.35 -27.66 71.51 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.79 2.327 . . . . 65.33 112.315 178.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.406 ' O ' ' HE2' ' A' ' 66' ' ' LYS . 4.3 m-20 -97.3 -15.47 20.75 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.68 -0.691 . . . . 60.45 112.15 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.418 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 27.0 mm-40 52.6 34.04 14.89 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.393 0.516 . . . . 70.43 112.393 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.9 t -53.35 -51.29 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 112.914 0.709 . . . . 73.42 112.914 -174.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -56.43 -55.06 31.63 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.149 -0.548 . . . . 51.34 113.373 -177.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.2 t -52.75 -41.81 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 111.914 0.339 . . . . 65.23 111.914 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 62' ' ' GLN . 67.9 mttm -64.29 -30.82 71.85 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 111.963 0.357 . . . . 74.1 111.963 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.8 mmt -61.2 -40.45 93.99 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.269 0.47 . . . . 72.45 112.269 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.45 -153.55 39.16 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.121 -0.562 . . . . 64.44 113.737 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -81.73 130.79 35.18 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.179 0.437 . . . . 73.42 112.179 -176.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HG3' HD11 ' A' ' 77' ' ' ILE . 75.4 mmtt -127.73 150.17 49.91 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.142 -0.481 . . . . 74.0 110.645 175.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.543 ' HB3' ' HA ' ' A' ' 51' ' ' ARG . 89.1 p -173.68 22.94 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.905 0.706 . . . . 64.11 112.905 -178.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -90.46 162.33 15.12 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.081 -0.387 . . . . 73.11 110.163 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.65 32.83 0.11 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 112.133 0.42 . . . . 65.11 112.133 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -177.24 29.4 0.07 OUTLIER Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.385 -0.436 . . . . 74.31 113.312 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -86.8 146.77 26.11 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.968 0.413 . . . . 72.24 111.243 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.6 p -133.81 141.33 47.41 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.061 0.458 . . . . 71.24 111.604 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.51 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 45.5 mm -125.2 109.64 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.341 -0.39 . . . . 73.33 110.417 177.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.04 116.6 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.067 0.46 . . . . 72.22 111.822 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 91.5 m -120.98 79.75 1.55 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.382 -0.372 . . . . 72.31 111.067 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.491 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 96.2 mt -57.13 -48.17 97.86 Favored Pre-proline 0 CA--C 1.55 0.958 0 N-CA-C 112.825 0.676 . . . . 74.12 112.825 -177.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.491 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 76.7 Cg_exo -51.42 -25.15 17.98 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 122.215 1.943 . . . . 64.23 113.613 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.522 ' NE2' ' HB3' ' A' ' 41' ' ' GLN . 16.0 m170 -111.52 -4.26 14.86 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.035 -0.416 . . . . 75.52 111.735 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 58.33 34.41 24.01 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.285 0.564 . . . . 74.14 111.782 -176.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.4 t -110.43 134.71 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 115.714 -0.675 . . . . 71.51 111.326 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -131.19 130.04 42.47 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.836 0.351 . . . . 75.32 110.885 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.51 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 50.3 t -119.23 120.62 64.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.717 0.294 . . . . 70.43 111.487 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -111.13 136.97 49.39 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 110.451 -0.203 . . . . 72.13 110.451 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.3 mt -105.61 112.17 37.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.985 0.421 . . . . 73.12 110.575 175.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -118.11 159.35 23.4 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.28 -0.418 . . . . 74.13 110.91 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 45.3 t -79.91 145.44 32.67 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.918 0.389 . . . . 75.21 111.444 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.8 p -67.75 -28.31 67.52 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.429 0.633 . . . . 75.42 110.265 174.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 . . . . . 0 CA--C 1.546 0.815 0 CA-C-N 114.934 -1.03 . . . . 72.11 110.749 179.151 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 CA--C 1.542 0.669 0 N-CA-C 113.06 0.763 . . . . 73.13 113.06 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 33.9 m -126.27 148.02 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.022 0.439 . . . . 74.23 111.055 173.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 23' ' ' PRO . 33.8 m -127.27 151.78 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.938 0.399 . . . . 72.31 111.679 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.77 118.21 36.45 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.112 -0.495 . . . . 62.13 110.878 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 31.0 mm -95.26 108.79 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 120.83 0.347 . . . . 74.44 110.992 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.462 ' N ' HD13 ' A' ' 12' ' ' ILE . 3.2 mp -95.17 111.51 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 120.937 0.399 . . . . 73.13 111.123 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.9 p -113.7 147.19 38.63 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.971 0.415 . . . . 74.23 111.236 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -143.88 139.34 29.17 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.286 -0.416 . . . . 72.32 110.284 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 62.19 13.59 5.97 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.089 0.403 . . . . 63.12 112.089 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.02 -16.67 46.05 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 121.199 -0.524 . . . . 73.34 113.956 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.642 ' HZ1' ' HB3' ' A' ' 17' ' ' LYS . 0.4 OUTLIER -113.79 150.1 33.95 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 122.294 -0.533 . . . . 71.43 111.693 -178.436 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.77 120.92 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.412 -0.358 . . . . 65.33 110.834 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.0 pt -99.71 -27.96 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 112.102 0.408 . . . . 65.35 112.102 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.1 tpp85 -157.82 143.51 17.18 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 122.09 -0.381 . . . . 73.24 111.601 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -128.36 113.51 15.68 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.676 0.274 . . . . 73.02 110.871 176.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.504 HG21 HG22 ' A' ' 47' ' ' VAL . 3.0 mp -107.39 119.66 50.08 Favored Pre-proline 0 N--CA 1.473 0.722 0 O-C-N 122.27 -0.269 . . . . 73.44 111.632 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 22.0 Cg_exo -66.03 123.46 11.3 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.366 2.044 . . . . 74.53 111.781 172.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.2 mt -87.13 -54.55 4.26 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.158 0.504 . . . . 75.22 111.447 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.442 ' OG1' HG22 ' A' ' 8' ' ' VAL . 29.1 m -63.1 107.34 1.01 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.039 0.447 . . . . 73.35 111.764 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.13 11.17 57.8 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.266 -0.493 . . . . 62.23 113.081 -178.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.521 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 52.0 t-80 -72.98 87.12 1.33 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.08 0.467 . . . . 74.51 111.154 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -53.8 131.8 40.28 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.884 0.698 . . . . 75.04 112.884 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.38 -161.94 49.02 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 115.931 -0.577 . . . . 73.31 114.501 175.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -118.68 141.98 48.09 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.952 0.501 . . . . 71.33 109.91 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -142.91 125.08 15.38 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 122.25 -0.282 . . . . 72.4 111.626 -175.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -117.83 129.85 55.91 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.668 -0.242 . . . . 74.45 111.459 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -136.69 143.22 43.27 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.244 0.545 . . . . 74.35 111.795 176.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.0 m -101.8 121.52 42.24 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.979 -0.555 . . . . 65.21 111.921 -175.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 54.1 mt -92.86 104.94 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.529 -0.305 . . . . 72.41 110.451 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -101.16 113.8 27.16 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.956 0.407 . . . . 73.35 111.884 -176.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.8 -65.46 1.44 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.299 -0.476 . . . . 63.45 112.551 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -141.39 87.62 2.09 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.543 -0.387 . . . . 75.14 111.438 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.45 -86.82 0.01 OUTLIER Glycine 0 CA--C 1.53 1.017 0 N-CA-C 114.196 0.438 . . . . 63.33 114.196 177.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.41 -22.26 44.53 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.007 0.432 . . . . 73.42 111.612 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -82.56 95.37 7.73 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.235 -0.291 . . . . 75.21 110.904 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -144.59 160.74 40.66 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.354 0.502 . . . . 72.55 112.354 -177.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -129.75 144.71 51.43 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.022 -0.536 . . . . 72.41 110.605 174.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.8 tp -114.12 107.34 15.5 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.989 0.423 . . . . 71.12 111.025 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.754 ' SD ' HG12 ' A' ' 54' ' ' ILE . 84.2 mmm -94.6 140.11 30.29 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.179 -0.464 . . . . 70.35 111.351 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -130.58 120.86 24.65 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.985 0.421 . . . . 74.0 111.324 176.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.504 HG22 HG21 ' A' ' 22' ' ' ILE . 36.0 t -105.0 108.73 25.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.122 -0.49 . . . . 71.45 110.731 176.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -109.31 105.75 15.29 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.965 0.412 . . . . 70.01 110.338 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.521 ' O ' ' HB3' ' A' ' 27' ' ' HIS . . . 58.16 -114.98 6.34 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.837 -0.697 . . . . 65.51 113.048 -177.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -106.17 35.56 2.89 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.882 0.372 . . . . 70.13 111.649 -177.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -155.13 144.65 21.27 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.933 0.397 . . . . 73.14 111.444 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 tt -129.41 147.1 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 112.007 0.373 . . . . 75.1 112.007 -175.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.405 ' HD3' ' CE2' ' A' ' 69' ' ' TRP . 22.5 ptt180 -150.84 169.29 22.05 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.106 0.479 . . . . 65.44 111.428 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.754 HG12 ' SD ' ' A' ' 45' ' ' MET . 43.6 mt -105.6 116.29 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 116.282 -0.417 . . . . 71.13 110.756 173.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.775 ' HZ2' ' HB3' ' A' ' 55' ' ' LYS . 8.5 mtpm? -78.53 -40.4 35.2 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.269 0.557 . . . . 70.44 111.722 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -137.97 143.89 40.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.943 -0.571 . . . . 72.13 111.021 -173.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -161.0 126.14 3.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.384 0.611 . . . . 75.51 110.558 -178.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -100.89 67.95 1.25 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.589 -0.732 . . . . 70.22 110.813 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 53.4 p -129.97 150.99 77.49 Favored Pre-proline 0 N--CA 1.474 0.749 0 CA-C-N 116.294 -0.412 . . . . 73.32 111.105 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -63.88 -28.73 67.29 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.651 2.234 . . . . 73.35 112.752 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.442 ' HB3' HG23 ' A' ' 63' ' ' VAL . 5.1 m-20 -80.67 -36.91 31.76 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.876 -0.602 . . . . 73.43 112.513 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 63.69 20.59 12.3 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.341 0.497 . . . . 74.11 112.341 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.442 HG23 ' HB3' ' A' ' 61' ' ' ASP . 64.6 t -59.76 -39.77 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 112.082 0.401 . . . . 74.33 112.082 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.93 -56.19 19.91 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.2 -0.454 . . . . 74.43 113.714 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.99 -38.06 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 O-C-N 122.66 -0.318 . . . . 72.1 111.683 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -59.79 -28.47 67.46 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.22 0.452 . . . . 61.44 112.22 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 23.0 mmt -57.56 -36.16 71.29 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.333 0.494 . . . . 60.55 112.333 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.87 -149.21 42.66 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.271 -0.49 . . . . 72.44 113.82 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.405 ' CE2' ' HD3' ' A' ' 53' ' ' ARG . 92.4 m95 -82.37 120.7 25.77 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.872 0.367 . . . . 74.22 111.964 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.652 ' HG3' HD12 ' A' ' 77' ' ' ILE . 75.2 mmtt -109.4 157.95 18.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.586 0.354 . . . . 74.42 110.925 175.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 88.0 p -163.76 -28.65 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.871 0.693 . . . . 61.4 112.871 -175.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -81.93 141.6 33.18 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.003 0.43 . . . . 72.23 112.094 -175.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.09 94.5 0.11 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.343 0.592 . . . . 74.15 110.704 175.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.7 -22.83 1.32 Allowed Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.908 -0.587 . . . . 43.13 112.139 -174.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.49 ' HB2' HD13 ' A' ' 88' ' ' ILE . 78.3 m-20 -62.84 123.95 19.78 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.942 0.401 . . . . 64.11 111.127 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.5 p -117.53 142.57 47.01 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.24 0.543 . . . . 72.41 112.01 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.652 HD12 ' HG3' ' A' ' 70' ' ' LYS . 29.8 mm -119.5 117.57 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.734 -0.666 . . . . 74.35 110.212 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.1 t -108.76 116.51 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 111.974 0.361 . . . . 75.12 111.974 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 70.9 m -122.15 71.21 0.99 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.933 0.396 . . . . 65.24 111.024 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.531 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 94.5 mt -55.39 -49.3 93.31 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 112.93 0.715 . . . . 72.42 112.93 -177.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.531 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 51.1 Cg_exo -56.28 -17.38 20.51 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.274 1.983 . . . . 73.45 113.7 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -114.75 -0.07 13.67 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.122 -0.361 . . . . 73.55 111.959 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 60.12 29.27 18.86 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.761 0.425 . . . . 71.41 111.955 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.28 135.82 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.919 0.39 . . . . 75.22 111.396 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -139.91 125.16 18.85 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.329 -0.396 . . . . 73.13 110.944 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 52.7 t -123.31 120.41 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 120.778 0.323 . . . . 73.33 111.341 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -122.38 144.44 49.03 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.956 0.408 . . . . 74.03 111.369 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.49 HD13 ' HB2' ' A' ' 75' ' ' ASP . 60.1 mt -97.84 136.53 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.047 0.451 . . . . 74.32 111.515 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -149.81 150.54 32.14 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.343 -0.39 . . . . 71.54 111.189 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 46.1 t -78.53 150.68 32.81 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.326 0.491 . . . . 75.0 112.326 -178.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.3 p -68.52 -20.17 64.56 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.192 0.52 . . . . 72.51 111.298 175.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 . . . . . 0 CA--C 1.541 0.601 0 CA-C-N 115.728 -0.669 . . . . 74.23 111.323 -175.574 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.457 ' HB2' ' OG1' ' A' ' 91' ' ' THR . 40.8 mt-10 . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 112.429 0.529 . . . . 75.53 112.429 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.46 143.86 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.177 -0.465 . . . . 75.13 111.172 173.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.526 HG13 ' HA ' ' A' ' 23' ' ' PRO . 31.0 m -125.07 141.84 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 120.962 0.411 . . . . 73.4 111.372 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.73 120.47 37.12 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.837 0.351 . . . . 62.11 111.564 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 17.8 mm -99.89 110.85 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.364 -0.38 . . . . 71.21 110.87 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.536 ' HA ' HG21 ' A' ' 86' ' ' VAL . 3.2 mp -95.59 119.38 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.025 0.441 . . . . 74.41 111.917 -177.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.4 t -121.27 139.12 53.82 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.095 0.474 . . . . 74.11 111.327 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.563 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 47.9 tt0 -121.24 116.95 25.85 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.385 -0.371 . . . . 74.13 110.686 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.563 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 43.5 m-80 61.76 2.61 0.75 Allowed 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.574 0.583 . . . . 74.12 112.574 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.86 -6.55 8.93 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.113 -0.565 . . . . 62.23 113.865 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -108.85 126.5 53.11 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 117.43 0.615 . . . . 72.24 111.414 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.6 t -70.52 112.04 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.124 0.488 . . . . 75.35 110.852 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.6 pt -102.44 -23.43 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 112.712 0.634 . . . . 74.33 112.712 -175.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -152.57 136.47 16.3 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.666 0.269 . . . . 73.24 111.641 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -130.66 114.96 16.05 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.759 0.314 . . . . 73.51 110.374 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.4 mt -115.38 124.43 30.12 Favored Pre-proline 0 N--CA 1.472 0.636 0 N-CA-C 112.111 0.411 . . . . 75.42 112.111 -175.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.526 ' HA ' HG13 ' A' ' 9' ' ' VAL . 60.4 Cg_endo -72.66 112.37 3.47 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.239 1.96 . . . . 73.11 111.758 173.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.9 mt -77.22 -57.1 4.02 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.959 0.409 . . . . 73.33 111.544 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 m -62.46 122.85 16.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.947 0.403 . . . . 74.22 111.601 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.16 -11.77 71.28 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.104 -0.57 . . . . 72.53 112.792 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 23' ' ' PRO . 58.5 t-80 -67.78 129.04 38.69 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.869 0.366 . . . . 50.43 110.439 177.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -119.96 136.24 54.61 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 122.021 -0.424 . . . . 75.31 111.294 -177.385 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.34 -172.2 33.02 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.494 -0.384 . . . . 73.14 112.788 -177.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -116.9 127.38 54.2 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 122.351 -0.499 . . . . 74.14 110.208 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -124.61 117.02 23.36 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.955 0.407 . . . . 75.15 111.268 -175.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.539 ' HG2' ' HG3' ' A' ' 46' ' ' GLU . 30.7 mt-30 -115.32 134.99 54.61 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.737 0.303 . . . . 73.51 111.256 -175.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -145.2 140.25 27.77 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.961 0.41 . . . . 55.54 110.904 177.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.2 m -104.11 109.34 21.1 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.997 0.427 . . . . 74.03 111.911 -174.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 62.8 mt -80.51 97.4 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.1 0.476 . . . . 61.3 111.037 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -82.8 104.01 12.72 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.996 0.427 . . . . 75.13 111.199 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.463 ' HA2' ' NE2' ' A' ' 14' ' ' GLN . . . -78.83 -146.04 3.18 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.345 -0.455 . . . . 52.1 113.059 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.655 ' HB2' ' HZ3' ' A' ' 38' ' ' LYS . 10.2 mtmp? -76.31 108.61 9.38 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.95 0.405 . . . . 71.25 111.272 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.51 -129.21 9.41 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.065 -0.588 . . . . 71.04 113.55 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.96 4.32 23.12 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.303 0.483 . . . . 74.03 112.303 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -80.9 73.63 7.9 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.145 0.498 . . . . 73.34 112.232 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -89.53 155.89 18.98 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.964 0.412 . . . . 72.22 111.793 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.53 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 16.3 m120 -132.14 110.19 10.49 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.219 -0.446 . . . . 73.21 110.631 173.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.4 tp -83.38 103.22 12.58 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.064 0.459 . . . . 72.31 110.909 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.804 ' SD ' HG12 ' A' ' 54' ' ' ILE . 85.9 mmm -94.79 139.7 30.91 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.118 -0.492 . . . . 71.43 111.107 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.539 ' HG3' ' HG2' ' A' ' 32' ' ' GLN . 33.7 tt0 -136.72 118.94 15.55 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.086 0.469 . . . . 53.51 111.766 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.8 t -100.81 112.88 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.219 -0.446 . . . . 71.34 110.186 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.533 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 35.6 t70 -108.11 100.36 9.69 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.039 0.447 . . . . 75.0 110.731 -177.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.78 -110.53 3.31 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.842 -0.694 . . . . 73.03 112.258 -174.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -114.5 33.26 5.43 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.313 0.578 . . . . 74.45 111.313 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 14.4 ptt180 -147.56 149.43 32.57 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.08 -0.509 . . . . 73.32 110.745 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.4 tt -123.29 148.47 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 120.791 0.329 . . . . 74.22 111.772 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -151.36 168.76 23.8 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.904 0.383 . . . . 74.2 111.47 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.804 HG12 ' SD ' ' A' ' 45' ' ' MET . 37.1 mt -104.64 118.35 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.842 0.353 . . . . 73.33 110.093 170.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -83.4 -35.05 25.37 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.452 -0.34 . . . . 73.45 111.897 -175.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -161.78 138.51 8.27 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.816 0.341 . . . . 64.53 111.632 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -140.9 178.52 7.3 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.01 0.433 . . . . 61.14 111.394 175.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -112.6 33.87 4.7 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.36 0.6 . . . . 71.44 111.461 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.7 m -89.69 146.47 35.6 Favored Pre-proline 0 N--CA 1.472 0.642 0 O-C-N 121.755 -0.591 . . . . 75.11 110.818 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.24 -32.57 73.4 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.488 2.125 . . . . 73.33 112.295 179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -96.42 -9.19 30.43 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.021 -0.536 . . . . 64.55 111.795 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.503 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 23.6 mm-40 57.5 38.51 28.09 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.01 0.433 . . . . 74.44 111.731 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.3 t -52.75 -36.68 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 116.159 -0.473 . . . . 75.35 112.103 -174.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -58.7 -54.16 40.16 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.053 -0.594 . . . . 60.21 112.766 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.2 -38.22 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-O 120.896 0.379 . . . . 70.32 111.895 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.503 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 5.4 mptp? -65.19 -28.44 69.39 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.395 0.516 . . . . 64.22 112.395 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 25.7 mmt -60.72 -34.83 74.99 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.041 0.386 . . . . 64.11 112.041 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.25 -144.15 38.77 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 114.391 0.516 . . . . 52.34 114.391 175.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -84.39 131.95 34.63 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.734 0.642 . . . . 75.42 112.734 -176.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.437 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 75.3 mmtt -127.2 136.12 51.6 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.941 -0.572 . . . . 74.43 110.971 177.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.1 p -168.42 17.49 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.307 0.484 . . . . 73.24 112.307 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -114.77 150.59 35.16 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.773 0.321 . . . . 75.53 111.116 -177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.28 108.97 0.77 Allowed 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.998 0.427 . . . . 64.13 110.452 173.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 119.03 -16.71 10.84 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.077 -0.583 . . . . 75.53 113.299 -178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.437 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 53.4 m-20 -62.41 133.56 55.21 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.152 0.476 . . . . 72.11 111.551 176.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.8 p -134.24 147.33 50.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.221 0.534 . . . . 63.01 111.845 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.535 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 41.5 mm -114.73 121.85 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.759 -0.655 . . . . 75.23 110.3 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.0 t -121.47 117.44 52.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.929 0.395 . . . . 73.2 111.681 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 97.2 m -116.26 90.03 3.24 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.653 -0.249 . . . . 64.42 110.618 175.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.56 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 98.0 mt -55.81 -55.52 40.12 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 113.202 0.816 . . . . 74.12 113.202 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 16.6 Cg_exo -67.4 -7.34 18.82 Favored 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 122.002 1.801 . . . . 71.3 112.933 -176.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -114.93 -12.75 12.0 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.423 -0.353 . . . . 62.23 111.355 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.9 mttm 59.16 31.79 21.55 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.934 0.493 . . . . 72.04 111.947 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.9 t -100.68 133.51 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.223 -0.444 . . . . 65.22 110.978 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -135.84 129.31 32.19 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.925 0.393 . . . . 61.22 111.053 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.536 HG21 ' HA ' ' A' ' 12' ' ' ILE . 60.9 t -131.3 113.58 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.476 -0.329 . . . . 55.3 111.207 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.0 pm0 -108.31 139.96 42.27 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.056 0.455 . . . . 60.51 111.371 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.8 mt -106.71 119.55 56.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.448 -0.342 . . . . 73.4 111.463 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.445 ' HE3' ' HB2' ' A' ' 89' ' ' LYS . 19.0 ptmt -118.18 162.38 18.33 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.915 0.388 . . . . 75.12 111.664 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.1 t -88.21 149.56 23.79 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 116.312 -0.404 . . . . 63.2 110.95 175.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 7' ' ' GLU . 38.8 p -85.0 -2.72 58.3 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.192 0.441 . . . . 72.3 112.192 -178.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 121.069 0.462 . . . . 65.43 111.798 -179.012 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 120.932 0.396 . . . . 75.04 111.995 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.38 160.28 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.08 0.466 . . . . 73.53 111.933 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.518 HG13 ' HA ' ' A' ' 23' ' ' PRO . 35.5 m -135.14 141.47 42.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 122.615 0.366 . . . . 61.41 111.003 177.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.91 114.61 26.75 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.892 0.377 . . . . 50.11 111.561 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.0 mm -99.34 113.91 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 120.849 0.357 . . . . 71.14 111.192 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.497 HD11 ' N ' ' A' ' 12' ' ' ILE . 3.2 mp -100.52 118.04 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.1 0.476 . . . . 74.01 111.17 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.3 m -121.56 147.75 45.41 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.883 0.373 . . . . 71.52 111.64 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.435 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 63.9 tt0 -138.88 142.99 38.55 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.643 0.259 . . . . 75.51 110.843 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.435 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 56.0 m-80 57.6 17.68 4.15 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.271 0.471 . . . . 74.51 112.271 -177.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.71 18.95 39.03 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.339 -0.457 . . . . 43.53 113.867 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.754 ' HB3' ' HZ3' ' A' ' 17' ' ' LYS . 0.5 OUTLIER -143.91 144.96 31.96 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.46 0.63 . . . . 75.22 111.616 177.458 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.0 t -70.03 120.95 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.827 0.346 . . . . 72.43 111.567 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 37.2 pt -107.94 -15.42 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 112.219 0.452 . . . . 75.32 112.219 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -170.14 142.53 2.29 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.408 0.283 . . . . 72.41 110.8 -177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.01 122.93 10.03 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.153 0.501 . . . . 72.04 111.898 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.469 HD12 ' N ' ' A' ' 22' ' ' ILE . 4.2 mp -117.6 121.54 31.83 Favored Pre-proline 0 N--CA 1.474 0.731 0 CA-C-N 116.431 -0.35 . . . . 74.02 111.609 -176.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.518 ' HA ' HG13 ' A' ' 9' ' ' VAL . 20.4 Cg_exo -66.52 103.15 0.65 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.169 1.913 . . . . 63.32 111.491 170.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.37 -59.33 4.14 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.409 -0.36 . . . . 72.23 111.926 -174.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.0 m -53.76 125.93 20.23 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.967 0.413 . . . . 72.45 111.996 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.01 -21.14 41.45 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.114 -0.565 . . . . 64.12 113.663 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -86.71 103.96 15.66 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 117.46 0.63 . . . . 74.24 112.24 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -86.64 -175.37 5.4 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.185 -0.461 . . . . 73.54 110.541 174.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.72 -164.13 54.17 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.015 -0.612 . . . . 63.22 114.072 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -119.26 131.17 55.75 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.959 0.409 . . . . 73.35 111.508 -176.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.438 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 10.5 tp10 -132.31 114.98 15.05 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.339 -0.391 . . . . 74.22 110.752 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -118.95 140.64 49.66 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 111.935 0.346 . . . . 75.51 111.935 -176.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -146.87 152.24 38.38 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.761 0.315 . . . . 72.44 111.261 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.6 m -113.8 117.63 32.0 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.267 0.556 . . . . 64.41 112.495 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 71.9 mt -86.38 108.26 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.849 -0.614 . . . . 74.2 111.079 177.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -92.78 105.15 17.33 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.711 0.291 . . . . 74.21 111.128 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.5 -66.84 1.19 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.289 -0.482 . . . . 74.12 114.177 -175.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -164.65 125.62 2.09 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.638 -0.33 . . . . 75.11 111.335 -176.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.36 -105.7 0.77 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.228 -0.51 . . . . 74.23 113.2 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.57 -1.18 28.7 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.184 0.439 . . . . 74.53 112.184 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -84.87 88.73 7.44 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.077 0.465 . . . . 73.03 112.008 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.429 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 47.8 p90 -113.05 168.4 9.73 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.054 -0.521 . . . . 73.21 110.798 174.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.541 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 20.0 m120 -135.75 112.68 10.29 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.317 0.247 . . . . 74.5 110.894 173.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 42.5 tp -87.61 109.94 20.02 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.828 0.347 . . . . 73.33 110.818 177.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.789 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.6 mmm -100.74 159.29 15.3 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.0 0.428 . . . . 71.42 111.979 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 40.5 tt0 -147.7 132.26 17.75 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.338 0.495 . . . . 73.22 112.338 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 58.8 t -118.15 107.63 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.126 0.571 . . . . 73.24 110.09 174.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.463 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 11.9 t70 -121.97 93.4 3.98 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.862 0.363 . . . . 73.15 111.592 -174.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.79 75.36 0.49 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.187 -0.53 . . . . 62.43 114.315 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 60.56 17.19 7.15 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.683 0.994 . . . . 73.22 113.683 175.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.509 ' HG3' ' CE3' ' A' ' 69' ' ' TRP . 7.7 ptp180 -144.07 146.59 32.93 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.97 -0.457 . . . . 73.33 111.19 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 tt -127.29 148.09 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 121.096 0.474 . . . . 74.33 112.271 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.516 ' HB3' ' HA ' ' A' ' 69' ' ' TRP . 0.4 OUTLIER -159.6 168.88 25.02 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.181 -0.463 . . . . 74.55 111.454 176.297 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.789 HG12 ' SD ' ' A' ' 45' ' ' MET . 33.7 mt -93.38 130.2 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.925 0.393 . . . . 74.22 110.962 175.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.465 ' HD2' ' HB2' ' A' ' 46' ' ' GLU . 29.5 mtpp -80.94 -47.68 13.36 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.43 -0.35 . . . . 71.51 111.642 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -171.93 144.75 1.77 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.067 0.461 . . . . 70.41 111.77 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 3.9 p-10 -142.2 -177.32 5.19 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.262 -0.426 . . . . 71.4 110.647 176.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -116.78 83.81 2.03 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.481 0.658 . . . . 74.42 111.06 173.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.6 t -130.65 152.75 80.99 Favored Pre-proline 0 N--CA 1.474 0.741 0 CA-C-N 115.692 -0.686 . . . . 73.53 111.371 174.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.72 -13.91 24.46 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 121.868 1.712 . . . . 65.12 112.046 171.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.463 ' HB3' HG22 ' A' ' 63' ' ' VAL . 7.8 m-20 -102.68 -50.91 3.43 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.136 -0.484 . . . . 62.35 111.491 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 53.24 29.84 9.07 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.637 0.606 . . . . 74.41 112.637 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 61' ' ' ASP . 41.5 t -58.55 -36.02 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.846 0.355 . . . . 75.12 111.549 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.419 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -57.09 -45.27 92.64 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 116.406 -0.361 . . . . 65.43 113.593 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 45.4 t -62.56 -40.02 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.34 0.59 . . . . 63.01 110.983 178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -69.52 -27.29 65.05 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.978 -0.556 . . . . 73.35 112.253 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.439 ' HE1' HG13 ' A' ' 63' ' ' VAL . 20.9 mmt -55.06 -39.24 69.0 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.127 0.418 . . . . 74.52 112.127 177.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.26 -175.6 54.88 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.202 -0.523 . . . . 71.22 114.186 175.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.516 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . 96.5 m95 -52.28 138.11 27.24 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.954 0.724 . . . . 73.11 112.954 -175.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -135.56 148.3 49.06 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.7 0.4 . . . . 72.11 110.743 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 89.2 p -170.7 18.97 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.802 0.668 . . . . 71.43 112.802 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -101.44 146.67 27.31 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.035 -0.416 . . . . 72.41 110.59 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.13 88.89 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.089 0.471 . . . . 65.15 111.037 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.85 -19.46 2.55 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.198 -0.525 . . . . 65.01 113.666 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.503 ' HB2' HD12 ' A' ' 88' ' ' ILE . 97.4 m-20 -57.09 139.56 52.01 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 117.573 0.686 . . . . 72.15 112.172 -178.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.3 p -138.79 144.89 39.55 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.95 0.405 . . . . 73.53 111.515 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.8 mm -122.9 127.94 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.3 -0.409 . . . . 75.23 110.315 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.9 t -111.7 117.22 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.013 0.435 . . . . 75.32 111.959 -177.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.541 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 74.8 m -114.03 76.44 0.99 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.128 0.49 . . . . 73.04 110.226 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.451 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 5.2 tt -54.75 -54.14 52.72 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 115.713 -0.676 . . . . 71.43 112.634 -173.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 80' ' ' LEU . 23.7 Cg_endo -59.73 -22.61 68.41 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 122.156 1.904 . . . . 73.11 113.287 -177.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -104.35 -2.13 25.93 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.488 -0.324 . . . . 74.44 111.385 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm 60.02 29.38 18.95 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.263 0.468 . . . . 72.02 112.263 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.541 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 48.4 t -106.15 141.75 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.925 0.393 . . . . 75.53 111.436 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -143.24 126.65 16.74 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.821 0.343 . . . . 73.43 110.984 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -115.35 133.4 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.569 -0.287 . . . . 75.04 111.182 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -132.42 136.75 46.97 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.064 0.459 . . . . 63.03 111.47 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 75' ' ' ASP . 58.7 mt -106.4 110.86 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.311 -0.404 . . . . 74.13 110.797 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -117.58 164.64 14.63 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.248 0.462 . . . . 72.34 112.248 -174.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.9 t -85.12 149.73 25.34 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.189 -0.46 . . . . 74.31 112.209 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.2 p -77.69 -27.84 50.86 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.162 0.506 . . . . 74.12 110.989 174.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 . . . . . 0 CA--C 1.537 0.47 0 CA-C-N 116.171 -0.468 . . . . 75.22 110.951 177.228 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 121.038 0.447 . . . . 64.21 111.295 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 32.7 m -120.88 144.66 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.508 0.67 . . . . 72.22 112.37 -177.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' A' ' 23' ' ' PRO . 34.6 m -125.39 134.2 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 115.677 -0.692 . . . . 72.42 110.815 177.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.43 114.52 25.13 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.794 0.331 . . . . 63.05 111.659 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.3 mm -97.25 137.49 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.551 -0.295 . . . . 73.32 110.474 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.439 ' N ' HD11 ' A' ' 12' ' ' ILE . 3.9 mp -121.97 118.71 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.012 0.434 . . . . 74.23 111.055 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.6 p -112.98 153.02 28.7 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.178 0.513 . . . . 75.05 111.37 177.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -151.91 142.21 22.42 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.328 -0.396 . . . . 73.45 110.846 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 59.77 14.1 3.92 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.628 0.603 . . . . 71.11 112.628 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.68 10.69 43.0 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.032 -0.604 . . . . 71.45 114.166 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -146.13 151.06 37.06 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 117.264 0.532 . . . . 72.42 111.458 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.12 136.79 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.681 0.276 . . . . 73.43 110.899 175.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.1 pt -117.89 -22.07 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 112.14 0.422 . . . . 52.34 112.14 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -169.31 144.99 3.22 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.577 0.227 . . . . 75.02 111.315 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -137.69 128.06 26.37 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.85 0.357 . . . . 73.2 111.254 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.432 ' N ' HD13 ' A' ' 22' ' ' ILE . 3.9 mp -123.83 119.63 26.8 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-N 116.579 -0.282 . . . . 72.14 111.704 -177.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.517 ' HA ' HG13 ' A' ' 9' ' ' VAL . 34.8 Cg_exo -61.97 132.0 37.52 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.406 2.07 . . . . 55.44 112.346 172.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -96.3 -61.72 1.39 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.881 0.372 . . . . 74.41 111.465 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.3 m -60.23 121.12 11.17 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.511 -0.313 . . . . 62.44 111.657 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.05 -8.24 80.18 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.095 -0.574 . . . . 45.14 113.126 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -78.3 86.42 4.39 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.289 0.566 . . . . 74.11 110.886 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -83.57 98.25 9.48 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.248 0.547 . . . . 72.3 111.113 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.88 -168.21 31.17 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.949 -0.568 . . . . 72.11 112.923 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -118.43 145.19 45.41 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 122.307 -0.526 . . . . 74.2 110.874 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.547 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 9.3 tp10 -144.82 117.49 8.65 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.566 -0.288 . . . . 63.13 110.574 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -127.6 129.85 47.99 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.728 0.299 . . . . 60.11 111.13 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -141.35 153.05 44.89 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.075 0.464 . . . . 73.22 111.297 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.6 m -112.49 116.7 30.68 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.948 0.404 . . . . 73.3 111.422 -175.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.2 mt -79.99 108.22 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.859 0.362 . . . . 70.42 111.022 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -99.86 111.13 23.46 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.298 -0.41 . . . . 74.12 111.146 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -110.69 -91.45 2.08 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.242 -0.504 . . . . 73.52 113.493 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.617 ' HE3' ' HA ' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -112.84 85.47 2.18 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.861 0.362 . . . . 72.51 111.494 -176.355 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.33 -97.71 0.02 OUTLIER Glycine 0 CA--C 1.529 0.93 0 CA-C-N 116.277 -0.419 . . . . 73.12 113.817 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.82 -31.53 72.54 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.929 0.395 . . . . 74.42 111.74 177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -72.82 94.17 1.77 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.129 0.418 . . . . 75.44 112.129 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -124.84 176.8 6.38 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.387 -0.369 . . . . 73.21 110.498 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -158.63 114.52 2.66 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.766 0.317 . . . . 74.14 110.92 174.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.6 tp -89.99 111.53 22.64 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.073 0.463 . . . . 74.34 111.477 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.616 ' SD ' HG12 ' A' ' 54' ' ' ILE . 94.3 mmm -97.56 138.1 35.49 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.146 -0.479 . . . . 72.22 111.384 -177.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -123.95 116.61 23.16 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.931 0.396 . . . . 72.21 111.78 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 40.2 t -107.47 112.46 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.232 -0.44 . . . . 74.33 110.652 176.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 20.5 t70 -109.04 101.95 10.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.05 0.452 . . . . 74.04 110.224 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.87 -106.02 1.17 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.846 -0.692 . . . . 72.43 112.772 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -111.51 17.41 20.07 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 120.973 0.416 . . . . 75.53 111.734 -176.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 19.9 ptt180 -130.42 141.96 50.52 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.316 -0.402 . . . . 74.42 111.049 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 tt -130.92 149.41 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 120.987 0.422 . . . . 75.34 111.717 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -157.02 168.89 26.13 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.953 0.406 . . . . 74.53 111.486 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.616 HG12 ' SD ' ' A' ' 45' ' ' MET . 60.5 mt -85.54 113.52 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 109.832 -0.433 . . . . 64.42 109.832 169.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -73.87 -49.66 23.97 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.94 0.4 . . . . 72.44 111.686 -177.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -162.69 138.61 7.24 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.181 0.437 . . . . 70.45 112.181 -175.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -165.43 -172.29 2.41 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.095 -0.502 . . . . 72.43 110.34 173.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -121.72 24.07 9.89 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.77 0.656 . . . . 72.22 112.77 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.3 t -77.18 125.93 85.91 Favored Pre-proline 0 N--CA 1.474 0.761 0 O-C-N 121.869 -0.519 . . . . 74.5 110.968 175.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -59.39 -13.58 21.2 Favored 'Trans proline' 0 N--CA 1.48 0.725 0 C-N-CA 122.998 2.465 . . . . 65.21 113.092 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.484 ' HB3' HG21 ' A' ' 63' ' ' VAL . 3.7 m-20 -83.77 -41.07 18.0 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.036 0.384 . . . . 72.2 112.036 175.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 53.75 32.56 15.05 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.147 0.425 . . . . 73.53 112.147 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 61' ' ' ASP . 97.5 t -52.52 -51.74 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 112.55 0.574 . . . . 62.44 112.55 -173.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.578 ' HA3' HD11 ' A' ' 54' ' ' ILE . . . -62.73 -34.82 90.78 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.743 -0.742 . . . . 70.24 113.446 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.48 -44.67 98.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 120.945 0.402 . . . . 64.0 110.897 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -69.49 -37.7 77.33 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.427 -0.351 . . . . 74.12 111.112 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 21.3 mmt -61.63 -33.57 74.17 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.353 0.501 . . . . 71.31 112.353 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.39 -143.18 29.11 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.021 -0.609 . . . . 74.04 113.426 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -86.99 122.39 30.77 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.058 0.456 . . . . 75.14 112.066 -176.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.401 ' HD2' ' CG ' ' A' ' 75' ' ' ASP . 74.1 mmtt -108.63 154.33 22.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.177 -0.465 . . . . 73.11 110.668 176.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 82.6 p -165.89 12.68 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.987 1.106 . . . . 72.2 113.987 -173.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -131.49 158.9 39.67 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.553 0.692 . . . . 73.41 112.457 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.496 ' HB3' ' HB2' ' A' ' 90' ' ' SER . . . -68.13 108.01 2.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.67 -0.695 . . . . 65.53 111.422 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.28 -16.61 4.89 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.35 -0.452 . . . . 65.53 112.398 -176.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.483 ' HB2' HD11 ' A' ' 88' ' ' ILE . 77.5 m-20 -72.21 106.15 4.29 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.029 0.442 . . . . 74.23 111.242 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 67.7 p -116.24 142.46 46.8 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.784 0.325 . . . . 74.43 111.779 178.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.9 mm -117.06 134.03 61.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 122.673 0.389 . . . . 75.05 110.828 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -112.19 117.34 54.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 111.895 0.332 . . . . 73.03 111.895 -177.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 86.7 m -122.0 68.37 0.93 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.856 0.36 . . . . 73.12 111.126 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.519 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 92.0 mt -53.07 -50.11 83.84 Favored Pre-proline 0 N--CA 1.476 0.847 0 N-CA-C 113.246 0.832 . . . . 71.04 113.246 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.519 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 50.7 Cg_exo -54.54 -24.65 37.17 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.021 1.814 . . . . 64.22 113.374 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -106.58 -1.88 22.45 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 111.869 0.322 . . . . 63.03 111.869 -179.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 59.69 30.93 20.54 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.989 0.423 . . . . 71.53 111.662 -176.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.2 t -112.12 137.17 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 116.079 -0.51 . . . . 71.32 111.178 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -135.81 143.04 44.95 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.528 -0.306 . . . . 65.13 110.291 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 76' ' ' THR . 58.1 t -129.36 120.1 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 122.288 -0.257 . . . . 60.13 111.067 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.22 116.94 25.86 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.456 0.646 . . . . 74.33 111.912 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.483 HD11 ' HB2' ' A' ' 75' ' ' ASP . 57.4 mt -88.78 114.53 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 122.009 -0.432 . . . . 73.15 110.894 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.709 ' HB2' ' HZ1' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -109.85 172.46 6.84 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.942 0.401 . . . . 74.35 111.095 179.552 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.496 ' HB2' ' HB3' ' A' ' 73' ' ' ALA . 40.5 t -111.21 150.27 29.8 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.782 0.325 . . . . 62.12 110.891 175.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.1 p -77.01 -9.65 58.84 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.566 -0.288 . . . . 74.15 111.453 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 121.598 0.713 . . . . 74.43 112.402 -178.651 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ttt . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 111.689 0.255 . . . . 70.14 111.689 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.7 15.86 2.9 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.514 0.931 . . . . 73.51 113.514 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -86.52 89.34 7.87 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.809 -0.557 . . . . 73.54 111.448 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.0 p -124.73 113.1 17.51 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.049 0.452 . . . . 74.34 111.334 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.7 -15.61 52.0 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.182 -0.533 . . . . 43.11 113.583 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -75.77 66.22 2.02 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.5 0.667 . . . . 73.33 111.718 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.517 ' HA ' ' HB ' ' A' ' 25' ' ' THR . 42.9 mt-10 -64.03 99.35 0.26 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.153 -0.476 . . . . 73.05 112.083 -175.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 25.7 m -110.8 151.91 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 121.361 0.6 . . . . 64.03 112.184 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 23' ' ' PRO . 34.4 m -128.1 143.04 42.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 115.794 -0.639 . . . . 74.13 111.256 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.49 117.97 30.17 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.43 -0.35 . . . . 72.22 111.216 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.582 HD12 ' HE3' ' A' ' 89' ' ' LYS . 20.0 mm -92.45 112.92 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.464 -0.334 . . . . 72.31 111.21 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.461 HD11 ' N ' ' A' ' 12' ' ' ILE . 3.4 mp -98.31 119.13 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.091 0.472 . . . . 72.22 111.647 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.2 p -123.22 145.18 48.86 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.298 -0.41 . . . . 74.22 110.604 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.472 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 60.6 tt0 -140.28 141.85 35.77 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.128 -0.358 . . . . 72.42 111.329 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.472 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 51.7 m-80 66.28 -12.76 0.18 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.784 0.661 . . . . 65.53 112.784 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 14' ' ' GLN . . . 119.25 26.07 2.55 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.525 -0.369 . . . . 74.52 112.731 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -147.96 146.55 29.01 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.479 -0.424 . . . . 75.14 111.156 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.6 t -74.29 121.41 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.904 0.383 . . . . 72.23 110.769 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 34.9 pt -109.97 -20.95 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 112.721 0.638 . . . . 74.31 112.721 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -170.66 153.04 3.96 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.485 0.183 . . . . 73.13 111.48 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -147.15 122.4 10.23 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.266 0.555 . . . . 73.51 111.546 175.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.486 HG22 HG22 ' A' ' 47' ' ' VAL . 2.5 mp -106.65 129.67 24.07 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-N 116.092 -0.504 . . . . 75.23 111.614 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.52 ' HA ' HG13 ' A' ' 9' ' ' VAL . 56.9 Cg_endo -70.76 126.9 13.13 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.366 2.044 . . . . 62.52 112.109 174.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.91 -62.43 1.32 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 111.901 0.334 . . . . 75.42 111.901 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.517 ' HB ' ' HA ' ' A' ' 7' ' ' GLU . 19.6 m -54.28 127.47 27.27 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.653 0.263 . . . . 71.22 111.567 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.01 -24.38 9.17 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.211 -0.518 . . . . 54.42 113.218 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -75.94 83.0 2.84 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.383 0.611 . . . . 75.15 110.93 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -83.77 164.08 19.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.708 -0.678 . . . . 70.23 111.416 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.19 -163.25 37.5 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 120.827 -0.701 . . . . 43.44 112.631 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -118.53 146.79 44.28 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.001 0.429 . . . . 64.32 111.775 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -150.13 142.24 24.03 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.163 -0.472 . . . . 74.5 110.857 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -132.05 147.82 52.46 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.043 0.386 . . . . 62.05 112.043 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -153.39 139.5 18.33 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.962 0.41 . . . . 74.14 111.439 174.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.6 m -102.45 114.51 28.77 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.127 0.418 . . . . 71.13 112.127 -175.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.1 mt -86.25 104.4 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 116.271 -0.422 . . . . 72.32 111.425 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -101.27 125.21 47.87 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.673 0.273 . . . . 73.05 111.106 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -121.29 -78.27 0.49 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.982 -0.628 . . . . 37.72 114.197 -176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.57 ' HE2' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -114.25 -169.86 1.61 Allowed 'General case' 0 CA--C 1.546 0.811 0 O-C-N 122.46 -0.435 . . . . 73.42 111.304 -173.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -44.67 100.04 0.02 OUTLIER Glycine 0 CA--C 1.528 0.879 0 N-CA-C 114.502 0.561 . . . . 74.5 114.502 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 67.0 -2.82 1.06 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.177 0.806 . . . . 74.2 113.177 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -86.56 112.58 21.7 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.871 0.367 . . . . 72.03 111.915 -175.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -139.99 163.51 32.48 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.284 -0.416 . . . . 61.21 111.649 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -135.4 113.52 11.28 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.479 -0.328 . . . . 75.54 111.291 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.4 tp -84.57 103.82 14.03 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.922 0.392 . . . . 72.0 110.169 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.629 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.7 mmm -95.91 146.37 24.64 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.265 -0.425 . . . . 71.44 111.322 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -132.92 122.94 25.07 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.102 0.477 . . . . 73.23 111.952 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.486 HG22 HG22 ' A' ' 22' ' ' ILE . 58.2 t -103.32 107.57 22.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.941 -0.572 . . . . 72.55 110.207 173.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.449 ' HB3' ' CH2' ' A' ' 69' ' ' TRP . 30.3 t70 -129.84 105.69 8.18 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.859 0.361 . . . . 63.54 111.543 -175.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.438 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . 74.66 55.1 5.61 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.302 -0.475 . . . . 74.4 114.013 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 63.62 23.53 13.59 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.775 0.657 . . . . 73.43 112.775 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 49' ' ' GLY . 7.9 ptt85 -148.5 149.18 31.19 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.806 0.336 . . . . 73.02 110.985 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.0 tt -123.29 148.69 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.148 0.499 . . . . 74.02 112.068 -174.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -152.94 168.88 24.33 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.851 -0.613 . . . . 71.32 110.821 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.629 HG12 ' SD ' ' A' ' 45' ' ' MET . 40.4 mt -84.91 110.67 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 120.977 0.418 . . . . 63.11 110.155 169.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -75.29 -29.94 60.23 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.31 -0.405 . . . . 72.11 111.096 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -175.47 138.65 0.41 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.243 -0.435 . . . . 73.55 111.431 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -161.68 156.42 23.01 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.175 0.512 . . . . 65.41 111.034 172.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -93.39 69.14 4.23 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.2 0.524 . . . . 64.43 111.867 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.3 p -127.33 140.61 38.42 Favored Pre-proline 0 N--CA 1.473 0.7 0 CA-C-N 116.46 -0.336 . . . . 41.03 110.692 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.67 -17.79 29.34 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.981 1.788 . . . . 74.11 111.987 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.507 ' HB3' HG22 ' A' ' 63' ' ' VAL . 2.2 m-20 -80.35 -52.9 7.14 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.607 -0.724 . . . . 65.23 111.755 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 57.45 29.31 16.8 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 120.649 0.261 . . . . 75.11 111.6 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' A' ' 61' ' ' ASP . 65.5 t -53.82 -48.33 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 112.223 0.453 . . . . 75.12 112.223 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.487 ' HA3' HD11 ' A' ' 54' ' ' ILE . . . -59.89 -29.67 68.17 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 120.892 -0.67 . . . . 74.44 113.067 177.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 67.5 t -66.94 -40.24 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.752 0.31 . . . . 70.4 110.713 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -65.62 -37.17 85.83 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.032 0.444 . . . . 74.15 110.832 172.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.592 ' SD ' ' NZ ' ' A' ' 70' ' ' LYS . 23.2 mmt -58.35 -46.41 86.33 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.236 -0.438 . . . . 72.25 111.588 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.58 -143.49 38.77 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.322 -0.466 . . . . 54.03 113.74 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.449 ' CH2' ' HB3' ' A' ' 48' ' ' ASP . 82.4 m95 -69.6 105.22 2.6 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.365 0.506 . . . . 72.22 112.365 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.592 ' NZ ' ' SD ' ' A' ' 67' ' ' MET . 34.4 mmtp -111.85 138.96 47.75 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 116.297 -0.41 . . . . 75.42 110.429 174.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.404 ' HB3' ' HB3' ' A' ' 51' ' ' ARG . 98.8 p -157.49 9.83 0.19 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.339 1.237 . . . . 74.44 114.339 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -118.41 149.67 40.85 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.725 -0.609 . . . . 72.54 112.075 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.31 107.54 0.5 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.021 -0.536 . . . . 74.55 111.041 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 129.07 -20.91 5.3 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 116.125 -0.489 . . . . 73.31 112.52 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 55.7 m-20 -74.48 151.3 39.58 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.009 0.433 . . . . 73.43 111.297 175.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 65.8 p -141.43 158.14 44.25 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.327 0.584 . . . . 74.21 112.372 -176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.545 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 40.0 mm -132.1 116.12 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.493 -0.776 . . . . 73.52 109.434 173.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.1 t -124.83 117.18 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 113.003 0.742 . . . . 65.43 113.003 -173.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 68.8 m -122.97 89.13 3.05 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.34 -0.391 . . . . 64.24 110.947 170.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.0 mt -63.78 -38.92 41.7 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 113.575 0.954 . . . . 63.42 113.575 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.04 -21.14 25.96 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.878 1.719 . . . . 73.34 112.931 174.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -112.49 0.61 15.59 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.899 0.38 . . . . 74.14 110.776 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 92.6 mttt 55.09 34.56 22.83 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.609 0.764 . . . . 72.21 112.434 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -102.62 117.51 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.919 0.39 . . . . 71.34 111.305 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -119.92 123.15 42.86 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.426 -0.352 . . . . 73.31 110.545 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.545 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 48.1 t -123.24 132.63 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 120.57 0.224 . . . . 73.43 111.397 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -132.21 143.64 50.09 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.818 0.342 . . . . 73.45 110.938 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' A' ' 75' ' ' ASP . 57.2 mt -100.95 121.35 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.612 0.244 . . . . 62.44 111.505 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.582 ' HE3' HD12 ' A' ' 11' ' ' ILE . 22.9 pttp -124.25 152.04 43.46 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.829 0.347 . . . . 72.1 111.212 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' ' 94' ' ' ASP . 43.9 t -89.82 151.06 21.97 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.375 0.607 . . . . 72.02 112.15 -177.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.8 p -73.08 -32.48 65.03 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.994 -0.548 . . . . 73.22 111.552 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.404 ' HG2' ' OG ' ' A' ' 90' ' ' SER . 16.2 pt20 -78.27 83.7 4.5 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.669 0.747 . . . . 73.31 112.459 -177.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 53.33 24.5 3.87 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.932 -1.031 . . . . 60.23 113.777 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.544 ' HB2' ' HB3' ' A' ' 90' ' ' SER . 1.1 t70 -69.98 83.71 0.5 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.642 0.734 . . . . 75.14 110.363 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.3 m -78.95 93.07 5.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.659 -0.7 . . . . 65.04 112.101 -173.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.711 ' HZ2' ' HB3' ' A' ' 96' ' ' LYS . 8.7 mtpm? -95.3 161.12 14.22 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.359 -0.382 . . . . 71.45 110.102 172.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.59 111.1 8.43 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 120.917 0.389 . . . . 74.34 111.507 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -83.84 83.52 1.76 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.638 2.225 . . . . 75.54 113.028 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -74.78 105.22 5.74 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.998 0.428 . . . . 72.42 110.134 174.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 100' ' ' THR . 6.8 m -94.85 7.28 46.47 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.302 0.482 . . . . 73.25 112.302 -173.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -73.04 81.01 1.22 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.543 0.687 . . . . 75.31 110.615 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.1 pp -103.01 -177.2 3.3 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.506 -0.77 . . . . 73.41 112.488 -175.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.8 mm -92.23 137.19 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.084 -0.507 . . . . 75.15 111.477 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.9 m -56.25 159.55 6.0 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 113.014 0.746 . . . . 75.21 113.014 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -53.6 117.34 3.72 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.956 2.438 . . . . 74.11 112.564 174.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -81.12 129.14 34.43 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.065 0.459 . . . . 75.53 110.995 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.48 ' N ' HD13 ' A' ' 107' ' ' LEU . 5.9 mp -79.67 140.11 37.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.143 0.497 . . . . 72.3 111.348 -176.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -80.4 94.28 6.14 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.663 0.744 . . . . 75.43 110.222 175.031 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.469 ' O ' ' HB2' ' A' ' 110' ' ' HIS . 14.1 p-80 -72.41 71.49 0.92 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.335 0.588 . . . . 75.14 112.177 -177.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 109' ' ' HIS . 7.1 t-80 174.21 18.12 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.1 -0.954 . . . . 70.32 110.108 175.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -65.26 100.2 0.45 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.413 0.625 . . . . 73.13 112.123 -174.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 176.16 -33.06 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.842 -1.072 . . . . 75.53 108.419 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -172.11 165.92 6.13 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 114.943 -1.026 . . . . 71.35 109.77 172.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 83.7 t60 . . . . . 0 C--O 1.252 1.211 0 CA-C-O 118.781 -0.628 . . . . 70.31 111.52 176.791 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.2 ttp . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 120.473 0.178 . . . . 73.32 111.155 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt 64.34 71.02 0.48 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.307 0.575 . . . . 54.34 111.019 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -158.81 117.45 2.97 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.993 -0.549 . . . . 72.43 111.47 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.1 t -109.42 138.5 45.69 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.4 -0.364 . . . . 74.24 110.908 174.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.98 -27.77 71.64 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.126 -0.559 . . . . 63.35 113.523 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -84.52 135.49 34.2 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.324 0.583 . . . . 60.42 111.714 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -111.16 112.9 25.02 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.089 -0.505 . . . . 74.03 110.714 175.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 26.8 m -123.28 145.01 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 112.592 0.59 . . . . 64.41 112.592 -176.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.489 HG13 ' HA ' ' A' ' 23' ' ' PRO . 26.7 m -122.91 141.96 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 115.802 -0.635 . . . . 70.23 111.318 178.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.5 112.7 24.65 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.367 -0.379 . . . . 72.52 110.95 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.541 HG13 ' HD3' ' A' ' 89' ' ' LYS . 45.6 mm -95.43 115.99 35.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.727 0.298 . . . . 73.3 111.415 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.3 mp -101.62 118.36 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.766 0.317 . . . . 73.4 111.043 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.9 m -117.2 138.11 51.91 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.885 0.374 . . . . 51.44 111.597 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.523 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 34.2 tt0 -134.8 142.55 46.72 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 122.587 0.355 . . . . 65.45 110.183 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.523 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 58.3 m-80 56.29 34.94 24.97 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.049 0.452 . . . . 74.33 111.793 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.85 21.19 79.03 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.372 -0.442 . . . . 63.32 114.094 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -144.5 143.82 31.05 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 122.479 -0.424 . . . . 72.21 111.518 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.75 124.24 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.843 0.354 . . . . 65.14 111.285 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 44.9 pt -111.43 -20.09 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 112.474 0.546 . . . . 71.32 112.474 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -157.81 145.47 18.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.909 0.385 . . . . 75.42 111.977 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.44 125.21 20.98 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.3 -0.409 . . . . 74.43 110.945 172.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 73.7 mt -126.99 124.78 24.05 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 112.253 0.464 . . . . 64.04 112.253 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.489 ' HA ' HG13 ' A' ' 9' ' ' VAL . 6.7 Cg_exo -73.82 117.2 4.94 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.826 2.351 . . . . 74.24 112.293 175.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.57 -47.23 15.86 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.088 0.471 . . . . 73.53 111.149 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 84.8 m -58.9 117.03 4.18 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.929 -0.578 . . . . 73.04 112.024 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.34 3.05 88.93 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.242 -0.504 . . . . 72.44 113.713 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -71.15 129.48 39.05 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.286 0.565 . . . . 74.54 111.43 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.667 ' HZ3' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -97.33 148.08 23.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.14 -0.482 . . . . 64.51 111.601 178.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.32 -164.8 54.46 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 114.814 0.686 . . . . 60.0 114.814 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 25.7 t-20 -118.6 125.83 50.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.945 0.498 . . . . 54.02 110.397 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -118.19 122.51 43.2 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.733 0.301 . . . . 51.32 111.512 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -120.11 139.27 52.83 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.937 0.398 . . . . 75.23 111.566 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -149.91 143.12 25.06 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.027 0.442 . . . . 72.33 111.209 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.0 m -101.59 110.06 21.98 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.174 0.511 . . . . 74.35 112.238 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.547 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 39.7 mt -80.1 90.76 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.917 0.389 . . . . 74.1 110.077 175.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -73.54 128.47 35.59 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.883 0.373 . . . . 74.15 111.674 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.48 -143.72 12.01 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 116.296 -0.411 . . . . 71.44 112.209 175.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -86.49 123.53 31.8 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 122.413 -0.463 . . . . 72.15 111.115 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.14 -137.02 19.92 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.372 -0.442 . . . . 60.02 113.548 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.67 4.85 30.57 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.092 0.473 . . . . 71.44 111.874 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.443 ' HB3' ' CD2' ' A' ' 82' ' ' HIS . 23.9 mt-30 -83.28 119.14 24.21 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.254 -0.43 . . . . 73.31 111.637 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -145.86 155.08 42.66 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.584 -0.28 . . . . 72.52 111.556 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.547 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 18.6 m120 -114.75 110.04 19.12 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.374 -0.376 . . . . 75.44 111.017 173.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.1 tp -89.51 107.04 18.85 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.869 0.366 . . . . 72.23 110.489 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.68 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.1 mmm -95.12 146.93 23.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.87 0.367 . . . . 75.14 111.824 -175.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.457 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 42.6 tt0 -133.44 121.45 22.26 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.139 0.495 . . . . 74.31 111.341 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 30' ' ' ASN . 43.9 t -109.34 114.38 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.151 -0.477 . . . . 74.55 110.587 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 35.9 t70 -108.76 103.88 13.04 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.071 0.463 . . . . 71.15 110.704 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 63.14 -104.26 0.78 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 120.742 -0.742 . . . . 70.41 112.674 -175.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -113.75 18.59 17.34 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.018 0.377 . . . . 75.24 112.018 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 35.5 ptt180 -132.75 149.36 52.29 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.668 0.271 . . . . 75.15 111.242 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.1 tt -133.38 146.04 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 112.319 0.489 . . . . 75.34 112.319 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -148.03 169.28 20.27 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.147 -0.479 . . . . 74.41 110.86 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.68 HG12 ' SD ' ' A' ' 45' ' ' MET . 31.2 mt -85.88 108.89 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.05 0.452 . . . . 71.13 110.232 169.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.457 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 56.4 tttp -67.75 -45.66 74.31 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.285 0.564 . . . . 71.3 111.325 -178.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -152.49 157.89 41.79 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.029 -0.532 . . . . 75.21 110.168 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -160.62 167.69 26.5 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.038 0.446 . . . . 74.33 111.947 -175.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.406 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . 51.3 t-20 -130.7 70.81 1.45 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.1 0.476 . . . . 70.44 110.942 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.7 p -129.06 155.87 79.08 Favored Pre-proline 0 N--CA 1.477 0.905 0 O-C-N 122.117 -0.364 . . . . 70.35 111.766 175.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.26 -17.03 13.47 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.486 2.124 . . . . 65.41 112.888 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.528 ' HB2' HG22 ' A' ' 63' ' ' VAL . 5.9 p-10 -92.15 -47.19 7.37 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 111.917 0.34 . . . . 55.32 111.917 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.404 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 28.2 mm-40 65.94 19.73 11.27 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.791 0.436 . . . . 71.01 111.912 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 61' ' ' ASP . 97.1 t -55.14 -46.96 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.156 0.503 . . . . 71.22 111.11 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.483 ' HA3' HD11 ' A' ' 54' ' ' ILE . . . -57.74 -38.32 87.68 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.037 -0.602 . . . . 54.43 112.746 176.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.15 -30.25 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.106 0.479 . . . . 62.11 111.267 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 5.4 mptp? -73.9 -31.04 62.93 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.387 0.514 . . . . 73.42 112.387 177.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.1 mmt -54.38 -50.71 66.89 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.529 0.566 . . . . 75.12 112.529 -177.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.9 -149.62 21.01 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.913 -0.66 . . . . 64.2 113.58 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -80.95 120.3 24.58 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.279 0.561 . . . . 72.02 112.099 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 75.0 mmtt -116.66 150.53 37.98 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.568 -0.742 . . . . 72.03 110.21 175.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 93.1 p -164.15 9.64 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.306 1.225 . . . . 72.44 114.306 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -132.76 157.14 45.69 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.61 0.641 . . . . 74.34 112.422 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.68 112.71 1.91 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.801 -0.636 . . . . 74.03 111.616 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 130.24 -26.45 4.17 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 116.219 -0.446 . . . . 52.3 112.366 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.518 ' HB2' HD12 ' A' ' 88' ' ' ILE . 76.7 m-20 -69.38 126.2 29.02 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.835 0.35 . . . . 71.31 111.082 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.423 HG21 ' HA ' ' A' ' 87' ' ' GLU . 47.0 p -132.02 145.37 51.4 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.947 0.403 . . . . 72.41 111.901 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 37.8 mm -114.65 130.05 69.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.377 -0.374 . . . . 70.42 110.606 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.7 t -112.96 118.65 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 112.047 0.388 . . . . 74.4 112.047 -177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.477 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 74.9 m -122.61 82.38 1.97 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.158 0.504 . . . . 74.12 110.92 173.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.437 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 84.1 mt -57.22 -58.67 16.37 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 113.565 0.95 . . . . 75.12 113.565 -173.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 59.8 Cg_endo -70.9 -2.14 10.53 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.88 1.72 . . . . 73.43 113.033 -175.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.443 ' CD2' ' HB3' ' A' ' 41' ' ' GLN . 37.9 m170 -109.97 -2.45 17.11 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.497 -0.319 . . . . 73.25 111.297 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 59.78 29.62 19.19 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.916 0.389 . . . . 72.35 111.744 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 57.5 t -115.37 134.05 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.104 0.478 . . . . 74.12 111.811 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -136.56 131.68 34.15 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.011 -0.541 . . . . 72.21 110.229 175.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.502 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 46.7 t -118.38 136.38 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.528 -0.305 . . . . 72.22 111.097 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HA ' HG21 ' A' ' 76' ' ' THR . 11.9 pt-20 -133.09 125.2 29.06 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.201 0.524 . . . . 61.45 111.402 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 75' ' ' ASP . 59.2 mt -89.73 116.96 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.863 0.363 . . . . 74.31 110.331 175.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.541 ' HD3' HG13 ' A' ' 11' ' ' ILE . 13.2 ptmt -131.66 147.5 52.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.363 -0.38 . . . . 64.12 111.238 -174.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 48.4 t -78.5 145.59 34.86 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.14 0.422 . . . . 74.24 112.14 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.5 p -86.21 -7.27 58.67 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.151 0.501 . . . . 71.54 110.825 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -96.52 -177.69 4.02 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.881 -0.6 . . . . 72.44 111.051 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.428 ' O ' ' HD2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -76.85 157.4 31.49 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.528 0.566 . . . . 75.41 112.528 -177.432 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.581 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 27.4 t0 -174.21 153.46 2.01 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.698 -0.683 . . . . 75.14 110.437 175.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.2 t -77.15 69.98 3.49 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.206 0.527 . . . . 61.35 111.714 -175.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.581 ' HE2' ' HB3' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -173.95 -179.97 1.83 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.999 -0.546 . . . . 73.03 111.118 -179.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -106.19 130.2 23.35 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 120.45 0.167 . . . . 72.01 111.055 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.37 -34.76 93.07 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.757 2.305 . . . . 75.45 113.403 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -130.15 143.16 50.63 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.362 -0.381 . . . . 74.33 110.435 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 t -108.93 -4.43 16.76 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.255 0.835 . . . . 75.1 113.255 -172.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -78.64 142.44 37.2 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.13 0.49 . . . . 74.44 111.268 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.5 tp -106.49 104.18 13.81 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.196 0.522 . . . . 74.34 111.743 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 60.1 mt -86.22 99.42 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.233 0.539 . . . . 72.34 110.371 175.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.2 t -62.07 130.27 92.65 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 115.86 -0.609 . . . . 64.04 111.75 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -51.28 138.07 46.24 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.831 2.354 . . . . 73.22 113.251 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 63.63 64.19 0.81 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.705 0.764 . . . . 72.32 111.525 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.7 tt -123.41 91.4 3.47 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.194 -0.912 . . . . 75.25 108.823 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.87 82.71 5.05 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.259 0.552 . . . . 73.02 112.135 -173.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -90.31 93.63 9.41 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.13 -0.486 . . . . 74.32 110.187 174.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -130.2 -85.52 0.53 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.157 0.428 . . . . 72.04 112.157 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 27.1 m80 59.54 80.96 0.18 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.439 0.637 . . . . 62.44 112.109 -173.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -124.0 114.97 20.47 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.796 -0.638 . . . . 74.53 110.118 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -72.17 83.43 1.01 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.279 0.561 . . . . 73.02 112.353 -175.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 81.5 t60 . . . . . 0 C--O 1.251 1.14 0 CA-C-N 115.701 -0.681 . . . . 75.32 110.993 174.309 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtm . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.648 0.261 . . . . 71.22 111.566 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -175.36 161.55 2.77 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.279 -0.419 . . . . 75.54 110.658 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -89.77 100.8 13.53 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.93 0.395 . . . . 74.44 110.212 174.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.5 m -85.96 100.02 11.83 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.445 0.535 . . . . 74.33 112.445 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -131.49 9.45 5.57 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 116.15 -0.477 . . . . 51.33 112.007 173.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -106.43 44.05 1.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.927 0.491 . . . . 64.31 111.147 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.434 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 46.2 mt-10 -73.72 107.05 5.74 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.348 0.594 . . . . 74.4 112.448 -176.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 33.0 m -126.15 152.85 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.694 -0.684 . . . . 75.25 111.716 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.493 HG13 ' HA ' ' A' ' 23' ' ' PRO . 34.1 m -126.63 144.65 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 116.095 -0.502 . . . . 74.2 111.3 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -102.83 109.81 21.52 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.86 0.362 . . . . 74.1 111.099 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.1 mm -95.19 104.23 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 120.702 0.287 . . . . 71.44 111.37 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.462 ' N ' HD13 ' A' ' 12' ' ' ILE . 3.7 mp -89.11 109.9 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.367 0.603 . . . . 75.45 110.916 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.2 p -116.95 127.43 54.2 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.929 -0.578 . . . . 61.34 111.043 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -119.1 146.53 45.03 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.673 0.273 . . . . 74.13 110.625 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.461 ' OD1' ' HD3' ' A' ' 83' ' ' LYS . 46.9 m-80 64.95 6.83 3.61 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.766 0.426 . . . . 74.03 111.796 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.79 -3.52 52.82 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.225 -0.512 . . . . 64.43 113.213 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -124.98 151.8 45.03 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.951 0.405 . . . . 75.43 111.583 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.3 126.15 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 120.905 0.383 . . . . 74.42 111.883 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 41.0 pt -111.86 -25.77 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 116.5 -0.318 . . . . 74.02 111.845 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.555 ' HA ' ' HE ' ' A' ' 20' ' ' ARG . 1.3 tpm_? -164.74 125.22 2.01 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.467 -0.333 . . . . 73.14 110.708 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -123.21 120.51 33.36 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.161 0.505 . . . . 73.33 110.965 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.408 HD13 ' CE1' ' A' ' 33' ' ' PHE . 73.6 mt -117.72 110.7 40.08 Favored Pre-proline 0 N--CA 1.47 0.525 0 N-CA-C 112.062 0.393 . . . . 75.44 112.062 -175.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.493 ' HA ' HG13 ' A' ' 9' ' ' VAL . 37.1 Cg_exo -59.46 117.69 4.46 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.533 2.155 . . . . 63.41 111.903 171.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.2 mt -74.53 -56.07 5.24 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.974 0.416 . . . . 73.3 111.524 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.434 ' OG1' ' HA ' ' A' ' 7' ' ' GLU . 11.3 m -56.61 133.57 53.77 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.16 -0.473 . . . . 71.51 111.736 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.32 -24.7 31.08 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 116.285 -0.416 . . . . 73.32 112.864 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -74.82 136.16 41.62 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.244 0.545 . . . . 73.32 111.627 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -124.11 145.98 48.92 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.109 -0.496 . . . . 73.53 110.859 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.66 -159.2 31.62 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.18 -0.533 . . . . 42.52 112.793 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -118.84 129.02 54.99 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 122.387 -0.478 . . . . 74.4 111.066 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.412 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 6.3 tp10 -123.5 135.08 53.86 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.328 -0.396 . . . . 62.22 110.302 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -134.55 129.69 35.43 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 122.089 -0.382 . . . . 72.3 111.526 -176.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.408 ' CE1' HD13 ' A' ' 22' ' ' ILE . 48.0 p90 -138.3 136.27 36.28 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.25 0.548 . . . . 73.42 111.72 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 30.9 m -104.12 114.2 28.27 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.074 -0.512 . . . . 72.05 112.165 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 54.8 mt -81.11 139.48 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 116.273 -0.421 . . . . 74.33 110.654 175.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -115.76 112.19 21.65 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.929 0.395 . . . . 74.11 112.042 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.15 -141.16 11.66 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 121.407 -0.425 . . . . 62.25 113.064 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -77.83 86.02 4.09 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.663 0.744 . . . . 65.14 111.856 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.17 -119.87 5.16 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 115.961 -0.563 . . . . 75.22 113.072 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.17 -0.93 23.89 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.073 0.397 . . . . 63.32 112.073 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -77.59 66.14 3.25 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.947 0.404 . . . . 74.43 111.728 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.481 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 17.1 p90 -95.32 167.05 11.58 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.535 -0.302 . . . . 74.31 111.106 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -140.47 110.67 6.61 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.659 -0.246 . . . . 73.43 111.164 174.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.6 tp -85.62 102.79 13.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.212 0.529 . . . . 72.53 110.542 177.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.679 ' SD ' HG12 ' A' ' 54' ' ' ILE . 94.5 mmm -97.03 141.49 30.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.004 -0.544 . . . . 71.4 110.751 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.807 ' HB3' HH21 ' A' ' 53' ' ' ARG . 35.4 tt0 -134.12 125.12 27.29 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.377 0.51 . . . . 64.04 112.377 -176.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 44.6 t -100.34 111.79 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.795 -0.639 . . . . 74.41 110.641 175.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.586 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 30.3 t70 -108.04 105.76 15.68 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.11 0.481 . . . . 64.22 110.035 -178.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.51 -104.49 1.07 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.658 -0.782 . . . . 73.04 111.898 -171.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -123.97 27.71 7.1 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.135 0.493 . . . . 73.22 111.448 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 34.1 ptt180 -134.6 154.45 51.49 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.039 0.535 . . . . 72.21 110.807 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.3 tt -142.37 143.33 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 112.91 0.707 . . . . 73.21 112.91 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.807 HH21 ' HB3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -161.03 168.55 24.25 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.162 -0.472 . . . . 71.31 111.875 169.294 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.679 HG12 ' SD ' ' A' ' 45' ' ' MET . 63.8 mt -69.04 121.27 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.387 -0.37 . . . . 73.52 111.173 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -82.19 -42.38 19.07 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.132 0.491 . . . . 72.31 111.016 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -166.21 138.76 3.92 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.651 -0.704 . . . . 62.23 110.689 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 1.7 p-10 -169.5 168.76 9.21 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.245 0.545 . . . . 75.51 111.472 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -97.19 45.16 1.04 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.214 -0.448 . . . . 72.24 111.994 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.1 t -97.72 122.92 53.65 Favored Pre-proline 0 N--CA 1.474 0.731 0 O-C-N 121.998 -0.439 . . . . 72.54 110.712 173.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -60.46 -27.35 84.69 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.506 2.137 . . . . 75.22 112.264 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -78.13 -34.26 50.02 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 116.005 -0.543 . . . . 64.41 111.609 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 54.66 36.18 25.49 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 111.963 0.357 . . . . 71.21 111.963 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 67' ' ' MET . 64.9 t -53.52 -52.5 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 112.733 0.642 . . . . 73.24 112.733 -174.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.577 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -64.19 -40.86 98.39 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.684 -0.77 . . . . 55.23 113.554 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 51.9 t -60.69 -39.6 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.27 0.557 . . . . 73.21 110.607 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -75.48 -28.27 59.15 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.95 -0.568 . . . . 74.23 111.928 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 18.1 mmt -67.16 -37.46 83.81 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 111.977 0.362 . . . . 75.42 111.977 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.94 -174.38 54.8 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 120.988 -0.625 . . . . 72.32 113.222 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.458 ' CE3' ' HG3' ' A' ' 53' ' ' ARG . 94.4 m95 -59.69 120.01 8.7 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.943 0.402 . . . . 73.44 112.016 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -115.82 127.21 54.89 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.239 0.542 . . . . 75.33 111.86 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.8 p -141.81 17.64 2.15 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.817 -0.629 . . . . 65.45 110.858 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -110.22 130.48 55.54 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.382 -0.372 . . . . 75.45 111.428 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.59 106.74 1.22 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.427 -0.351 . . . . 72.25 111.577 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.84 -36.65 1.74 Allowed Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.061 -0.59 . . . . 73.22 112.34 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -73.51 131.26 41.57 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.09 0.471 . . . . 73.22 111.179 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 69.3 p -120.87 152.17 38.75 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.963 0.411 . . . . 72.11 111.633 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.533 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 43.7 mm -114.25 110.45 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.309 -0.405 . . . . 73.54 110.204 177.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -107.27 116.66 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 112.35 0.5 . . . . 73.44 112.35 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 72.3 m -122.22 76.42 1.31 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.371 -0.377 . . . . 60.4 111.067 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.449 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 86.7 mt -57.21 -46.62 99.82 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 113.061 0.763 . . . . 74.22 113.061 -177.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.449 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 51.8 Cg_exo -55.64 -18.96 22.13 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.945 1.764 . . . . 71.41 113.364 177.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -112.65 -0.15 15.19 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.613 -0.267 . . . . 63.4 111.458 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.466 ' HE2' HD21 ' A' ' 107' ' ' LEU . 57.8 mttm 63.67 15.61 9.08 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.091 0.556 . . . . 71.22 112.433 -178.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.9 t -97.03 127.09 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.0 0.429 . . . . 75.42 111.832 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -130.62 113.22 13.92 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.222 -0.445 . . . . 74.14 110.633 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.533 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 46.2 t -100.79 117.02 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.042 0.449 . . . . 73.2 111.292 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -106.79 108.64 20.25 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.175 -0.466 . . . . 71.13 110.938 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 60.0 mt -91.91 121.06 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.149 0.5 . . . . 73.25 111.349 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -139.06 155.5 47.89 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.256 -0.429 . . . . 73.22 111.18 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 41.2 t -95.95 150.14 20.79 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.022 0.439 . . . . 74.3 112.042 -177.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.2 p -87.64 2.61 50.5 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.116 -0.493 . . . . 73.23 111.433 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -89.31 -167.37 1.85 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.084 0.469 . . . . 74.35 111.663 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.54 ' HB3' ' HZ1' ' A' ' 93' ' ' LYS . 2.5 mmmp? -76.48 104.58 7.07 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.949 0.404 . . . . 62.33 111.957 -175.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -124.8 161.38 26.59 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.803 -0.443 . . . . 71.53 109.803 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.2 t -128.65 14.4 6.48 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.627 0.603 . . . . 60.31 112.627 -174.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.704 ' HZ1' ' HB3' ' A' ' 96' ' ' LYS . 4.4 mmmp? -71.93 137.66 47.53 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.866 0.365 . . . . 71.42 111.641 175.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.49 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 1.6 m-20 -62.51 164.82 10.67 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.191 -0.458 . . . . 65.11 110.538 173.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 97' ' ' ASP . 61.1 Cg_endo -71.94 27.29 0.25 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.236 1.957 . . . . 63.52 113.477 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.56 110.84 12.71 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.654 0.74 . . . . 73.33 111.295 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.1 t -143.89 87.35 1.91 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.744 0.783 . . . . 74.14 109.838 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -94.26 128.1 40.52 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.394 -0.821 . . . . 62.43 111.975 -173.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.445 ' N ' HD23 ' A' ' 102' ' ' LEU . 2.4 pt? -146.82 163.05 37.29 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.823 -0.626 . . . . 72.24 110.53 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 58.5 mt -118.2 99.92 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 121.069 0.461 . . . . 75.32 111.606 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 104' ' ' VAL . 13.3 m -101.84 99.78 12.9 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 116.167 -0.469 . . . . 73.43 111.033 175.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.87 153.35 63.88 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.366 2.044 . . . . 74.12 113.332 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -93.81 106.93 18.87 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.103 -0.499 . . . . 74.44 110.94 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.466 HD21 ' HE2' ' A' ' 83' ' ' LYS . 3.2 mm? -95.09 -177.05 4.01 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.074 0.464 . . . . 75.14 111.51 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.85 132.71 53.95 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.597 -0.728 . . . . 73.11 112.179 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -76.72 64.81 2.37 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.26 0.552 . . . . 75.45 111.023 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -93.46 92.64 7.71 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 122.055 -0.403 . . . . 75.42 111.767 -174.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -105.29 130.47 53.41 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.767 0.318 . . . . 72.45 110.951 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -74.47 145.34 43.67 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.163 0.431 . . . . 74.4 112.163 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -75.72 -35.56 60.21 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.8 -0.815 . . . . 75.53 108.8 166.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 26.0 m80 . . . . . 0 C--O 1.249 1.06 0 CA-C-N 114.882 -1.053 . . . . 74.24 109.947 169.364 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtm . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.803 0.335 . . . . 73.53 111.656 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -159.23 84.53 0.79 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.553 0.692 . . . . 73.25 111.01 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -118.86 138.83 52.46 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.23 -0.441 . . . . 72.35 110.976 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.6 p -135.11 129.67 34.28 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.965 0.412 . . . . 74.15 111.837 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.0 -15.23 42.89 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.15 -0.548 . . . . 73.33 112.273 173.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.22 65.18 2.76 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.97 0.414 . . . . 62.31 111.246 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -92.36 116.97 29.44 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.968 0.413 . . . . 74.33 111.769 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 26.8 m -122.75 145.12 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.127 0.489 . . . . 63.23 111.876 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.86 146.99 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.017 -0.538 . . . . 75.21 111.29 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.0 112.89 25.45 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.33 -0.396 . . . . 70.4 111.106 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.8 mm -92.34 105.73 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.47 -0.332 . . . . 72.21 111.199 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.431 ' N ' HD13 ' A' ' 12' ' ' ILE . 4.1 mp -91.88 121.83 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 121.07 0.462 . . . . 73.34 111.276 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.0 m -121.51 157.1 31.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.358 -0.383 . . . . 71.42 111.491 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.591 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 53.7 tt0 -152.69 142.83 22.36 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.979 0.418 . . . . 74.0 111.345 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.591 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 62.3 m-80 57.45 19.21 5.02 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.031 0.752 . . . . 75.54 113.031 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.47 -12.78 36.21 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.728 -0.749 . . . . 72.21 114.271 176.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -129.3 156.5 43.91 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 117.635 0.718 . . . . 73.23 112.068 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.63 133.54 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.826 0.346 . . . . 71.23 111.318 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.1 pt -111.92 -31.02 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 112.153 0.427 . . . . 74.33 112.153 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -157.19 133.17 9.51 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 111.979 0.363 . . . . 74.52 111.979 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -117.14 114.43 23.68 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 110.307 -0.256 . . . . 72.05 110.307 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 73.1 mt -115.0 116.04 42.85 Favored Pre-proline 0 N--CA 1.472 0.662 0 N-CA-C 111.826 0.306 . . . . 74.42 111.826 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.42 124.54 11.75 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.437 2.092 . . . . 72.52 112.474 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.7 mt -81.75 -56.49 3.96 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.995 0.426 . . . . 74.53 111.317 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.7 m -62.63 112.78 2.64 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.034 0.445 . . . . 74.2 111.501 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.02 7.77 57.22 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.128 -0.558 . . . . 60.25 113.199 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -85.1 122.91 29.99 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 117.004 0.402 . . . . 73.23 110.846 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.456 ' HD2' ' N ' ' A' ' 28' ' ' LYS . 11.1 mptt -91.24 140.85 29.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.045 0.45 . . . . 75.15 112.009 -176.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.94 -151.69 51.93 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 114.82 0.688 . . . . 41.33 114.82 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -117.3 143.71 45.64 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.882 0.473 . . . . 72.43 110.648 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -144.08 114.64 7.62 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.617 0.246 . . . . 71.22 111.007 -175.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -117.67 137.31 52.74 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.9 0.381 . . . . 75.52 111.434 -175.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -144.13 141.99 30.32 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.994 0.426 . . . . 73.43 111.484 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.2 m -99.89 118.0 35.4 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.033 0.444 . . . . 74.33 111.963 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.1 mt -92.63 97.01 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.326 -0.397 . . . . 70.44 110.701 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.62 148.01 31.83 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.029 0.442 . . . . 71.02 111.574 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -127.63 -152.14 7.83 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.45 -0.405 . . . . 71.42 112.361 177.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -70.94 123.62 22.44 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.24 0.543 . . . . 72.51 111.23 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.65 -134.71 22.59 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.325 -0.464 . . . . 53.32 112.722 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.85 15.47 16.55 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.996 0.427 . . . . 74.43 111.773 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.557 ' HB3' ' CD2' ' A' ' 82' ' ' HIS . 27.1 mt-30 -87.58 100.02 12.48 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.076 0.465 . . . . 75.32 111.526 -177.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -132.79 166.24 22.7 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.102 -0.499 . . . . 73.33 112.024 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -126.68 122.78 35.92 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.858 -0.61 . . . . 71.12 110.682 171.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.5 tp -92.26 110.44 21.83 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.724 0.297 . . . . 75.21 110.362 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.747 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.2 mmm -99.56 136.96 38.73 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.983 0.42 . . . . 73.22 111.869 -175.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -125.34 115.11 19.81 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.298 -0.41 . . . . 74.33 111.27 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.9 t -102.49 107.34 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.434 -0.348 . . . . 75.33 110.477 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -110.57 122.12 46.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.932 0.396 . . . . 63.15 110.987 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.4 -107.78 1.25 Allowed Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.125 -0.56 . . . . 61.44 112.32 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -120.86 25.5 9.64 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.06 0.457 . . . . 73.14 111.531 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -138.51 149.76 45.7 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.937 0.399 . . . . 74.53 111.517 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.6 tt -126.94 146.45 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 112.089 0.403 . . . . 74.34 112.089 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -148.74 168.77 22.01 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.985 0.422 . . . . 74.5 111.311 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.747 HG12 ' SD ' ' A' ' 45' ' ' MET . 33.8 mt -90.87 111.17 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.14 0.495 . . . . 75.32 110.086 169.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -74.45 -39.28 62.65 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.892 -0.595 . . . . 75.22 111.525 -175.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -149.93 148.87 29.63 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.275 -0.42 . . . . 73.53 110.142 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.29 130.73 9.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.353 0.597 . . . . 74.33 111.641 -175.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -96.28 64.35 2.27 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.326 0.584 . . . . 63.13 110.691 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 45.9 t -128.46 139.64 36.11 Favored Pre-proline 0 N--CA 1.473 0.677 0 CA-C-N 116.033 -0.531 . . . . 71.53 111.043 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 59' ' ' SER . 32.1 Cg_exo -58.27 -36.68 97.48 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.532 2.154 . . . . 71.44 112.749 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -76.5 -29.44 56.83 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.821 -0.627 . . . . 75.02 112.622 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 56.59 19.53 4.3 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.938 0.718 . . . . 73.43 112.938 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.5 t -53.94 -41.04 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 112.168 0.433 . . . . 75.45 112.168 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.532 ' HA3' HD11 ' A' ' 54' ' ' ILE . . . -57.83 -43.99 94.47 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.065 -0.588 . . . . 71.2 113.289 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.95 -37.83 81.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.006 0.431 . . . . 63.53 111.143 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -65.65 -40.27 92.31 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.309 0.485 . . . . 64.4 112.309 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.3 mmt -65.26 -41.28 94.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.828 0.347 . . . . 75.52 111.373 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.47 -129.75 28.43 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 114.367 0.507 . . . . 62.54 114.367 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -77.92 136.47 38.02 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.737 0.643 . . . . 73.11 112.737 -174.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 75.1 mmtt -132.58 144.26 50.26 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.902 -0.59 . . . . 72.21 109.883 173.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 95.4 p -162.0 13.57 0.08 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.363 0.875 . . . . 73.4 113.363 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -123.41 151.3 42.76 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.996 0.426 . . . . 74.32 112.056 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.64 111.62 1.49 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.26 0.552 . . . . 72.25 111.276 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 121.37 -21.53 8.12 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 121.314 -0.47 . . . . 74.41 112.435 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.538 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 80.1 m-20 -63.74 123.14 18.12 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.81 0.338 . . . . 62.42 111.226 176.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 65.8 p -130.65 141.93 50.43 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.403 0.621 . . . . 72.14 112.293 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.5 mm -114.8 118.37 58.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.833 -0.621 . . . . 75.02 110.258 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.3 t -112.31 115.73 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.924 0.392 . . . . 74.25 111.778 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 76.6 m -121.66 79.26 1.54 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.029 0.442 . . . . 74.31 110.825 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.49 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 93.1 mt -59.11 -47.02 99.29 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 113.091 0.775 . . . . 73.51 113.091 -175.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.49 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 50.7 Cg_exo -56.07 -17.36 19.42 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 122.255 1.97 . . . . 71.25 113.611 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.557 ' CD2' ' HB3' ' A' ' 41' ' ' GLN . 64.6 m170 -117.33 -1.81 11.7 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 122.14 -0.35 . . . . 71.24 111.612 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 66.4 mttm 59.37 28.33 17.66 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.071 -0.513 . . . . 73.42 112.194 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.7 t -100.56 132.89 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.487 -0.324 . . . . 65.41 111.061 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -136.68 118.21 14.85 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.004 0.431 . . . . 71.32 111.023 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.2 t -112.31 132.14 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 116.374 -0.375 . . . . 74.12 110.851 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -131.96 131.86 42.99 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.126 0.488 . . . . 53.1 111.367 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 58.4 mt -97.68 130.02 46.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.182 0.515 . . . . 75.15 111.307 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -137.74 153.96 49.67 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.058 -0.519 . . . . 74.44 110.932 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 47.7 t -89.86 149.89 22.46 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.09 -0.381 . . . . 64.13 111.264 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.2 p -65.8 -22.02 66.53 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.017 0.437 . . . . 71.44 110.807 175.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -94.97 161.94 13.94 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.194 0.521 . . . . 73.5 111.579 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp -67.51 149.16 50.53 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.434 0.531 . . . . 74.51 112.434 -175.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -97.59 115.37 27.75 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.016 0.436 . . . . 71.4 110.493 173.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 65.9 p -85.83 106.53 17.12 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.029 0.443 . . . . 75.14 111.009 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.647 ' HZ2' ' HB3' ' A' ' 96' ' ' LYS . 9.2 mtpm? -116.23 178.74 4.21 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 122.196 0.998 . . . . 74.22 113.15 -175.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -68.74 147.77 97.96 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 114.122 -1.399 . . . . 63.1 112.304 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.12 -18.84 5.96 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.529 2.152 . . . . 63.51 112.869 173.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -128.8 94.42 3.84 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.636 0.255 . . . . 64.14 111.266 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.6 m -76.84 68.17 3.0 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.528 0.68 . . . . 71.2 109.938 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -126.74 -7.39 6.18 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.539 -0.755 . . . . 74.03 111.156 -175.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.43 ' O ' HD13 ' A' ' 102' ' ' LEU . 2.1 pp -144.34 153.07 41.6 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.989 -0.55 . . . . 74.25 111.178 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.2 mt -84.96 -47.46 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.114 0.483 . . . . 74.21 111.164 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.5 m -103.16 123.34 42.18 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.314 -0.403 . . . . 74.4 111.475 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.64 107.24 1.02 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.761 2.307 . . . . 73.4 112.571 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -121.17 175.91 5.87 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.109 0.48 . . . . 71.43 111.95 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 107' ' ' LEU . 2.9 mm? -90.17 -10.39 44.68 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.418 0.525 . . . . 75.3 112.418 -174.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -71.24 101.96 2.44 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.931 0.395 . . . . 74.21 112.008 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -81.17 70.82 8.09 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.182 0.515 . . . . 72.32 110.428 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -57.76 117.63 4.45 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.84 -0.618 . . . . 75.23 112.202 -174.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 73.12 2.97 4.54 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.646 -0.706 . . . . 63.23 112.278 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -118.11 105.01 11.39 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 122.032 -0.417 . . . . 74.53 111.259 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -88.95 -56.94 3.08 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.762 0.315 . . . . 74.54 111.719 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 C--O 1.254 1.313 0 CA-C-O 118.903 -0.57 . . . . 72.32 111.332 -178.697 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtm . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.006 0.431 . . . . 72.24 111.757 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -137.84 112.69 8.99 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.991 -0.549 . . . . 65.22 109.694 171.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -53.85 130.79 38.36 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.355 0.872 . . . . 74.11 113.355 -170.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.4 p -96.64 159.58 14.85 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.77 -0.65 . . . . 71.25 110.834 176.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.24 0.24 1.99 Allowed Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.85 -0.691 . . . . 45.32 113.391 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -82.28 78.66 8.91 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.892 0.377 . . . . 74.31 110.438 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.44 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 44.5 mt-10 -80.79 104.5 11.35 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.096 0.776 . . . . 75.33 113.096 -170.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 71' ' ' SER . 35.7 m -137.67 160.39 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 115.921 -0.581 . . . . 71.2 112.176 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 23' ' ' PRO . 29.8 m -131.43 146.54 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.064 -0.516 . . . . 71.01 110.788 176.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.97 116.53 30.37 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.918 0.39 . . . . 52.5 111.949 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.5 mm -97.21 124.58 50.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.486 -0.325 . . . . 70.1 110.613 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.486 HD11 ' N ' ' A' ' 12' ' ' ILE . 2.9 mp -104.55 111.81 35.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.755 0.312 . . . . 63.22 111.156 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 18' ' ' VAL . 60.4 m -109.04 126.1 52.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.092 0.472 . . . . 72.41 111.584 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -118.39 133.08 56.18 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.157 -0.339 . . . . 73.13 110.972 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.484 ' N ' HD21 ' A' ' 15' ' ' ASN . 0.8 OUTLIER 65.14 12.4 7.94 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.316 0.488 . . . . 74.11 112.316 177.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.04 10.52 34.33 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.359 -0.448 . . . . 52.31 113.857 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -144.15 146.04 32.49 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.397 0.599 . . . . 74.1 111.734 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.477 ' HB ' HD12 ' A' ' 102' ' ' LEU . 59.2 t -59.95 138.41 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 116.35 -0.386 . . . . 73.23 111.324 177.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 47.1 pt -125.78 -12.39 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.338 0.495 . . . . 75.45 112.338 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -173.76 142.24 0.89 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.812 0.339 . . . . 75.34 111.71 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -125.22 119.0 27.26 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 116.488 -0.324 . . . . 74.24 110.821 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.525 HG22 HG21 ' A' ' 47' ' ' VAL . 3.3 mp -115.53 125.13 29.1 Favored Pre-proline 0 N--CA 1.476 0.861 0 N-CA-C 111.741 0.275 . . . . 74.12 111.741 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.52 ' HA ' HG13 ' A' ' 9' ' ' VAL . 15.3 Cg_exo -69.51 123.02 9.76 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.817 2.345 . . . . 75.42 112.377 173.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.07 -57.28 3.16 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.873 0.368 . . . . 74.52 111.498 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.44 ' OG1' ' HA ' ' A' ' 7' ' ' GLU . 13.2 m -65.26 127.3 31.14 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.086 0.469 . . . . 74.54 111.441 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.62 -1.67 81.75 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.053 -0.594 . . . . 53.14 112.767 -174.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -92.5 90.49 7.19 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.281 -0.541 . . . . 74.43 111.535 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.68 169.47 18.22 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.145 -0.479 . . . . 71.43 111.17 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.18 -165.25 43.1 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 114.626 0.61 . . . . 73.54 114.626 175.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -118.44 126.04 51.21 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.998 0.519 . . . . 71.3 110.825 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -139.6 130.89 26.71 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.768 0.318 . . . . 53.45 111.08 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -122.8 153.71 39.18 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.042 0.449 . . . . 72.43 112.057 -173.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -150.33 138.22 20.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.912 0.387 . . . . 75.34 111.364 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.5 m -101.6 123.53 45.76 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.041 0.448 . . . . 62.5 112.169 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.8 mt -97.84 129.53 47.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.143 -0.48 . . . . 63.14 110.897 176.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -105.75 142.46 35.44 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.079 0.466 . . . . 75.05 111.827 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.29 -157.91 32.5 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 116.253 -0.431 . . . . 73.4 113.531 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -92.82 23.29 4.24 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.154 0.427 . . . . 73.0 112.154 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 175.14 -130.75 1.8 Allowed Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.331 -0.461 . . . . 62.24 112.139 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.03 67.43 3.87 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.415 0.626 . . . . 60.41 110.724 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -144.19 130.15 19.44 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.885 -0.598 . . . . 71.23 111.324 -175.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -147.84 144.62 28.28 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.697 0.284 . . . . 74.25 111.143 172.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -128.85 110.92 12.55 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.325 -0.398 . . . . 65.11 110.623 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.4 tp -87.04 104.85 16.72 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.894 0.378 . . . . 72.15 110.872 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.8 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.0 mmm -90.58 135.91 33.4 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.37 -0.377 . . . . 74.43 111.272 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -126.83 117.14 22.02 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.961 0.41 . . . . 72.43 111.986 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.525 HG21 HG22 ' A' ' 22' ' ' ILE . 21.9 t -101.17 107.45 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.065 -0.516 . . . . 71.03 110.238 175.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.453 ' HB3' ' CZ3' ' A' ' 69' ' ' TRP . 28.2 t70 -128.17 117.66 21.98 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.934 0.397 . . . . 64.23 111.424 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 60.33 60.75 8.01 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 121.205 -0.522 . . . . 62.24 114.169 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 57.76 18.33 4.77 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.914 1.079 . . . . 52.45 113.914 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.537 ' HD2' ' HB3' ' A' ' 69' ' ' TRP . 29.3 ptt180 -146.46 152.33 38.85 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.864 0.364 . . . . 72.21 110.899 174.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.5 tt -129.04 151.25 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.81 0.67 . . . . 74.11 112.81 -170.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.99 168.82 25.77 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.763 -0.653 . . . . 72.32 110.238 170.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.8 HG12 ' SD ' ' A' ' 45' ' ' MET . 59.4 mt -81.38 121.97 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.943 0.402 . . . . 74.41 110.387 174.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -84.35 -37.9 21.0 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 116.216 -0.447 . . . . 65.33 111.895 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -161.07 138.29 8.99 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.389 -0.369 . . . . 72.03 111.291 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.13 162.61 25.7 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.907 0.384 . . . . 71.21 110.51 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -98.59 64.45 1.52 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.567 0.699 . . . . 72.24 111.676 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.0 p -114.03 141.68 26.67 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-N 115.768 -0.651 . . . . 74.55 110.27 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.78 -23.24 26.39 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.183 1.922 . . . . 64.24 112.796 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.469 ' HB3' HG22 ' A' ' 63' ' ' VAL . 3.5 m-20 -87.63 -39.71 14.81 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.12 0.415 . . . . 71.42 112.12 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 61.04 23.24 13.43 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.513 0.56 . . . . 71.32 112.513 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.469 HG22 ' HB3' ' A' ' 61' ' ' ASP . 60.9 t -56.24 -34.79 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.898 0.38 . . . . 71.3 111.15 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.555 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -55.98 -47.1 82.28 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 116.275 -0.42 . . . . 62.01 113.17 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.2 t -73.77 -34.25 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.243 0.544 . . . . 74.14 110.956 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -60.22 -28.76 68.26 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.845 -0.616 . . . . 73.31 111.506 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 23.1 mmt -55.76 -34.27 65.07 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.327 0.491 . . . . 74.34 112.327 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.71 -163.64 53.64 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.977 -0.63 . . . . 50.5 113.425 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.537 ' HB3' ' HD2' ' A' ' 51' ' ' ARG . 94.0 m95 -73.39 110.32 7.58 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.853 0.359 . . . . 74.42 111.793 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -108.41 137.59 46.11 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.053 0.454 . . . . 72.51 111.674 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.404 ' O ' HG22 ' A' ' 8' ' ' VAL . 91.1 p -161.65 25.44 0.12 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.255 -0.43 . . . . 73.42 111.682 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -115.78 141.1 48.54 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.897 0.38 . . . . 72.14 111.599 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.4 106.64 1.16 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.978 0.418 . . . . 75.25 111.15 176.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 125.44 -7.24 7.98 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.011 -0.614 . . . . 74.32 113.342 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -92.71 142.0 27.84 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.138 0.494 . . . . 73.21 111.47 175.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.509 HG21 ' HA ' ' A' ' 87' ' ' GLU . 66.7 p -135.24 153.41 51.93 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.043 -0.526 . . . . 75.41 111.771 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.416 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 32.6 mm -112.97 128.33 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 116.346 -0.388 . . . . 73.34 110.351 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 50.5 t -115.39 120.1 63.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 112.191 0.441 . . . . 75.1 112.191 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.444 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 73.1 m -120.94 81.0 1.71 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.26 0.552 . . . . 71.52 110.3 171.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.429 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 4.3 tt -57.04 -53.75 61.88 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 115.498 -0.774 . . . . 74.55 112.253 -173.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 80' ' ' LEU . 44.1 Cg_endo -65.89 -9.62 23.79 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 122.26 1.973 . . . . 64.33 113.537 -176.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -114.34 -4.91 12.94 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 122.06 -0.4 . . . . 74.41 111.73 177.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 66.8 mttm 57.39 36.64 27.37 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.275 0.559 . . . . 63.13 111.481 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 59.4 t -111.69 138.71 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.875 -0.602 . . . . 71.21 110.979 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -140.93 148.42 40.38 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.358 -0.383 . . . . 71.54 110.475 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 76' ' ' THR . 57.3 t -139.46 113.79 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 122.257 -0.277 . . . . 75.2 111.439 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.509 ' HA ' HG21 ' A' ' 76' ' ' THR . 1.4 pm0 -106.92 126.7 52.66 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.343 0.592 . . . . 72.31 111.788 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.8 mt -95.71 122.3 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-O 121.024 0.44 . . . . 70.05 111.597 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.625 ' HZ3' ' HB2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -122.1 151.76 40.57 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.434 -0.348 . . . . 65.21 111.196 -178.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.0 t -76.3 149.34 37.1 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.868 0.365 . . . . 74.21 111.905 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.446 HG22 HG12 ' A' ' 9' ' ' VAL . 27.5 p -77.09 -27.43 54.19 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.006 0.432 . . . . 64.43 111.246 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -69.77 -178.46 1.52 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.324 -0.398 . . . . 74.22 111.075 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.618 ' HB3' ' HZ1' ' A' ' 93' ' ' LYS . 2.8 mmmp? -77.34 60.6 2.03 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.146 0.498 . . . . 70.24 111.536 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -67.47 107.7 2.56 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.765 -0.457 . . . . 61.44 109.765 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.3 m -62.72 81.24 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.054 0.454 . . . . 64.23 112.198 -173.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -132.04 169.13 16.78 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.265 0.555 . . . . 74.42 111.264 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.79 147.17 80.8 Favored Pre-proline 0 CA--C 1.545 0.755 0 CA-C-N 115.883 -0.599 . . . . 75.05 110.675 170.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.77 -70.04 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.259 1.973 . . . . 71.25 114.241 -174.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 55.12 16.92 1.74 Allowed 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.197 0.522 . . . . 62.44 112.099 -173.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.1 m -96.04 12.89 28.95 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.487 0.66 . . . . 74.52 110.396 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.6 87.89 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.485 0.66 . . . . 73.42 110.952 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.477 HD12 ' HB ' ' A' ' 18' ' ' VAL . 51.0 tp -81.67 100.26 9.36 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.387 0.613 . . . . 74.12 112.165 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 64.1 mt -92.49 110.38 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.081 -0.509 . . . . 65.4 110.131 172.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.2 m -61.67 139.85 95.25 Favored Pre-proline 0 CA--C 1.541 0.635 0 CA-C-O 120.511 0.196 . . . . 74.43 111.437 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.652 ' HB2' HD13 ' A' ' 107' ' ' LEU . 36.5 Cg_endo -63.47 145.68 92.42 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.575 2.183 . . . . 72.11 113.097 -177.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -85.11 15.56 4.08 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.899 0.333 . . . . 74.31 111.899 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.652 HD13 ' HB2' ' A' ' 105' ' ' PRO . 10.0 mp -61.1 139.0 58.19 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.961 0.41 . . . . 75.21 111.498 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.41 119.92 14.42 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.375 -0.375 . . . . 72.42 111.079 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -61.72 125.83 25.2 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.335 0.588 . . . . 71.55 111.03 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.533 ' HA ' ' O ' ' A' ' 113' ' ' HIS . 96.9 m-70 -79.98 14.51 1.79 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.362 0.875 . . . . 74.33 113.362 -168.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -86.72 -51.58 6.02 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.893 0.378 . . . . 73.21 110.768 174.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -96.74 4.97 51.5 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.996 0.427 . . . . 72.11 111.073 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.533 ' O ' ' HA ' ' A' ' 110' ' ' HIS . 58.9 t-80 -155.59 93.39 1.48 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.174 -0.467 . . . . 72.33 110.176 177.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 . . . . . 0 C--O 1.254 1.313 0 CA-C-O 118.553 -0.736 . . . . 74.42 112.382 -173.568 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.424 ' HE2' ' H ' ' A' ' 93' ' ' LYS . 74.5 mmm . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 112.408 0.521 . . . . 64.51 112.408 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.96 -33.2 75.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.3 0.571 . . . . 75.01 110.256 172.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -70.58 117.3 11.93 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.659 -0.7 . . . . 64.42 110.058 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.2 p -53.47 121.78 8.38 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.619 0.6 . . . . 74.33 112.619 -175.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -123.92 71.19 0.44 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.301 -0.476 . . . . 55.33 113.682 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.54 73.85 2.56 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 122.376 -0.485 . . . . 74.42 110.417 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -120.13 108.55 14.38 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.091 0.472 . . . . 70.21 111.894 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.548 HG23 ' HB2' ' A' ' 24' ' ' LEU . 30.8 m -110.1 144.82 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 121.287 0.565 . . . . 73.13 112.102 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.5 m -124.11 138.88 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.266 -0.425 . . . . 74.41 111.483 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.04 119.97 36.52 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.887 0.375 . . . . 62.12 111.288 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.6 mm -104.27 113.37 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.564 -0.289 . . . . 74.44 111.029 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.502 ' N ' HD13 ' A' ' 12' ' ' ILE . 3.1 mp -98.69 125.74 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 120.841 0.353 . . . . 75.4 110.894 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.5 t -128.8 152.63 48.26 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.068 0.461 . . . . 63.14 112.174 -176.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -146.91 142.87 28.05 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.017 -0.538 . . . . 65.2 110.734 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.7 14.02 5.79 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.407 0.521 . . . . 74.33 112.407 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.17 16.34 47.67 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.197 -0.525 . . . . 62.33 113.577 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -138.41 140.94 39.56 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.415 -0.462 . . . . 74.33 111.256 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -63.02 128.26 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 110.12 -0.326 . . . . 62.41 110.12 174.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.2 pt -109.23 -28.76 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 112.35 0.5 . . . . 74.2 112.35 -177.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -162.65 138.4 7.18 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.921 0.391 . . . . 74.44 111.494 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -124.48 119.45 29.17 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.591 -0.277 . . . . 71.14 111.493 -177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.3 mp -112.81 116.17 47.92 Favored Pre-proline 0 N--CA 1.472 0.648 0 CA-C-O 120.626 0.251 . . . . 73.41 111.148 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.76 113.24 3.31 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.161 1.907 . . . . 74.33 111.579 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.548 ' HB2' HG23 ' A' ' 8' ' ' VAL . 85.4 mt -69.75 -58.68 3.61 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.853 0.316 . . . . 74.53 111.853 -175.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.6 m -54.15 131.04 40.39 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.133 0.492 . . . . 74.24 111.328 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.11 -16.14 56.36 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 121.089 -0.577 . . . . 60.24 113.975 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.501 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 60.3 t-80 -76.4 76.2 3.15 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.716 0.758 . . . . 74.22 110.86 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.622 ' HZ3' ' HB3' ' A' ' 28' ' ' LYS . 7.1 mtpm? -78.23 92.75 4.51 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.972 -0.558 . . . . 74.54 111.43 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.8 -168.48 31.15 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 116.267 -0.424 . . . . 74.14 112.513 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -118.17 150.41 39.44 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.072 0.463 . . . . 71.34 111.42 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.52 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 12.4 tp10 -149.23 148.29 29.41 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.492 -0.322 . . . . 74.42 110.918 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -138.36 129.7 27.45 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.086 0.469 . . . . 74.43 111.689 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -145.82 131.86 19.29 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.209 0.528 . . . . 75.11 110.955 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.9 m -105.53 130.69 53.54 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.27 -0.423 . . . . 72.42 111.752 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.484 ' N ' HD13 ' A' ' 35' ' ' ILE . 3.2 mp -99.16 114.14 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.481 -0.327 . . . . 72.04 110.362 175.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -101.46 108.11 19.6 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.721 0.296 . . . . 73.34 111.505 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.68 -105.21 0.37 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.065 -0.588 . . . . 72.33 112.021 174.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.656 ' HB3' ' HZ1' ' A' ' 38' ' ' LYS . 9.4 mtpm? -82.61 78.65 9.2 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 122.343 -0.504 . . . . 73.42 111.361 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.67 -87.23 0.01 OUTLIER Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.194 -0.457 . . . . 70.23 114.104 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.26 -21.17 62.13 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.136 0.421 . . . . 71.4 112.136 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -78.29 73.72 4.85 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.138 0.494 . . . . 72.32 111.25 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.427 ' CE1' ' HB2' ' A' ' 58' ' ' ASN . 35.4 p90 -100.58 162.56 12.85 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.978 -0.555 . . . . 63.42 111.841 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -136.39 114.04 11.05 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.086 -0.507 . . . . 74.41 110.671 173.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.6 tp -89.64 103.28 15.94 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.989 0.423 . . . . 74.3 111.392 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.797 ' SD ' HG12 ' A' ' 54' ' ' ILE . 88.6 mmm -96.64 138.61 33.94 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.056 -0.52 . . . . 73.35 111.377 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -129.23 126.27 38.76 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.881 0.372 . . . . 75.44 111.466 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 56.4 t -110.54 115.25 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.067 0.46 . . . . 73.33 111.328 178.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.432 ' HB2' ' CH2' ' A' ' 69' ' ' TRP . 14.9 t70 -108.44 171.93 7.13 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.696 -0.483 . . . . 70.42 109.696 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 27' ' ' HIS . . . -37.27 90.38 0.01 OUTLIER Glycine 0 CA--C 1.535 1.282 0 N-CA-C 114.85 0.7 . . . . 71.53 114.85 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 66.08 32.09 8.47 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.506 0.722 . . . . 71.53 112.888 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -155.47 151.26 27.53 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 122.644 0.378 . . . . 71.15 111.144 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 tt -136.83 150.47 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 120.825 0.345 . . . . 63.23 111.919 -177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.546 ' NH2' ' HE3' ' A' ' 55' ' ' LYS . 21.4 ptt180 -155.62 168.58 26.69 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.222 0.535 . . . . 71.31 112.252 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.797 HG12 ' SD ' ' A' ' 45' ' ' MET . 62.1 mt -102.38 119.34 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.764 -0.653 . . . . 70.34 109.9 168.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.546 ' HE3' ' NH2' ' A' ' 53' ' ' ARG . 41.1 mtpt -78.57 -38.12 40.98 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.958 0.409 . . . . 72.14 110.728 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -169.63 138.78 1.93 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.518 -0.764 . . . . 75.2 111.425 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -142.37 161.56 37.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.975 -0.38 . . . . 74.13 109.975 170.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.427 ' HB2' ' CE1' ' A' ' 42' ' ' TYR . 61.2 t30 -84.95 66.29 9.66 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.152 0.501 . . . . 72.42 111.037 -176.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.3 t -129.05 145.75 57.89 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 116.224 -0.444 . . . . 73.22 111.146 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.52 -35.78 12.7 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.536 2.157 . . . . 62.22 113.16 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.468 ' HB2' HG23 ' A' ' 63' ' ' VAL . 1.6 p30 -77.59 -44.2 29.19 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.029 0.381 . . . . 75.11 112.029 -178.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.493 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 24.7 mm-40 63.5 26.6 14.86 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.429 -0.351 . . . . 65.43 111.804 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.468 HG23 ' HB2' ' A' ' 61' ' ' ASP . 87.7 t -53.2 -41.61 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 120.849 0.357 . . . . 55.23 111.61 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.555 ' HA3' HD11 ' A' ' 54' ' ' ILE . . . -58.4 -38.48 90.78 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.32 -0.467 . . . . 74.43 113.258 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.35 -39.96 72.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.969 0.414 . . . . 75.04 111.06 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.493 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 4.6 mptp? -62.59 -29.91 70.95 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.364 -0.38 . . . . 72.2 111.301 176.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 21.2 mmt -61.2 -44.57 97.07 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.086 0.402 . . . . 75.04 112.086 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.26 -148.64 32.99 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.142 -0.552 . . . . 63.31 113.209 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.432 ' CH2' ' HB2' ' A' ' 48' ' ' ASP . 91.3 m95 -76.36 110.94 11.3 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.07 0.462 . . . . 75.23 111.867 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -103.88 143.78 32.38 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.379 -0.373 . . . . 73.44 110.885 175.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 64.2 p -169.19 18.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.502 0.556 . . . . 74.42 112.502 -173.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 72' ' ' LYS . 2.9 mptp? -116.86 144.93 43.93 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.82 0.343 . . . . 74.23 110.39 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.61 93.43 0.08 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.936 0.398 . . . . 74.41 111.346 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.09 -20.19 1.76 Allowed Glycine 0 CA--C 1.529 0.938 0 CA-C-N 116.029 -0.532 . . . . 52.23 113.364 -177.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' HB2' HD13 ' A' ' 88' ' ' ILE . 75.9 m-20 -66.25 135.35 54.33 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 117.096 0.448 . . . . 43.55 112.025 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.9 p -133.03 145.95 51.29 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.27 0.557 . . . . 73.42 111.692 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.51 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 35.0 mm -117.72 129.9 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 115.852 -0.613 . . . . 55.42 110.48 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.3 t -123.85 117.31 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 112.651 0.611 . . . . 65.33 112.651 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 90.3 m -115.77 81.22 1.56 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.244 0.545 . . . . 71.53 110.006 169.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.522 ' HB3' ' HD3' ' A' ' 81' ' ' PRO . 5.4 tt -55.76 -53.57 61.4 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 115.631 -0.713 . . . . 73.52 112.394 -172.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 80' ' ' LEU . 31.3 Cg_exo -60.04 -14.68 29.44 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.046 1.831 . . . . 72.3 113.381 -176.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -105.2 -3.65 22.69 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.994 0.368 . . . . 72.33 111.994 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.6 mttm 60.81 21.28 11.4 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 120.901 0.382 . . . . 75.43 111.491 -174.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.0 t -104.04 130.12 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 121.186 0.517 . . . . 73.4 111.365 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -135.93 136.57 40.55 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.002 -0.545 . . . . 75.52 111.061 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.51 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 46.4 t -128.7 144.56 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.396 -0.365 . . . . 73.32 110.519 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -143.6 144.74 32.05 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.204 0.526 . . . . 65.43 111.911 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.486 HD13 ' HB2' ' A' ' 75' ' ' ASP . 65.4 mt -106.18 111.7 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 115.941 -0.572 . . . . 74.54 111.096 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -118.09 143.06 46.77 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.022 -0.535 . . . . 74.52 110.654 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 22.8 t -85.54 122.87 30.29 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.861 -0.524 . . . . 73.52 110.471 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.646 HG23 ' HG2' ' A' ' 92' ' ' GLN . 9.7 t -77.86 -24.48 48.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.955 0.407 . . . . 73.03 111.352 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.646 ' HG2' HG23 ' A' ' 91' ' ' THR . 77.0 mm-40 -117.55 155.1 30.37 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.172 -0.467 . . . . 75.25 111.042 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.688 ' HB3' ' HZ1' ' A' ' 93' ' ' LYS . 4.8 mmmp? -97.78 129.31 44.79 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.171 0.51 . . . . 74.31 111.778 175.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -82.05 161.91 22.77 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.157 -0.474 . . . . 62.34 111.442 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 t -105.37 11.32 32.88 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.291 0.848 . . . . 64.42 113.291 -172.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 96' ' ' LYS . 2.0 mppt? -121.34 152.68 38.69 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.657 -0.652 . . . . 72.13 111.819 177.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -90.44 135.4 29.53 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 116.195 -0.457 . . . . 74.34 110.61 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.34 -5.37 16.42 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.569 2.179 . . . . 74.5 114.16 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -98.0 96.63 8.29 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.017 0.437 . . . . 70.5 111.34 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 59.8 p -106.13 133.14 51.3 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.562 -0.29 . . . . 75.11 111.657 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -140.32 162.24 35.76 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.213 0.53 . . . . 73.33 111.632 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 102' ' ' LEU . 0.5 OUTLIER -156.25 113.01 3.13 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.327 0.584 . . . . 74.45 111.82 177.043 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 50.6 mm -89.53 -42.79 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.342 0.591 . . . . 73.01 110.072 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.42 107.2 43.47 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.735 -0.666 . . . . 73.52 111.137 176.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.62 115.59 3.46 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.494 2.129 . . . . 74.42 112.644 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -126.09 159.88 31.64 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.815 0.34 . . . . 74.33 111.717 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 87.4 mt -68.55 159.95 30.88 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.856 0.36 . . . . 75.22 111.723 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.37 127.36 30.97 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.18 0.514 . . . . 65.22 109.673 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -79.08 27.49 0.24 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.738 1.014 . . . . 74.22 113.738 -168.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -58.11 -28.6 64.78 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.048 0.452 . . . . 73.43 111.289 171.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -89.48 121.84 32.09 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.348 -0.387 . . . . 74.42 111.29 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -125.25 147.19 49.19 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.861 0.362 . . . . 74.4 111.107 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -111.27 19.97 17.79 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.548 0.69 . . . . 73.35 110.393 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 . . . . . 0 C--O 1.254 1.32 0 CA-C-N 115.659 -0.7 . . . . 72.31 111.161 -179.833 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 111.83 0.307 . . . . 55.25 111.83 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -87.32 90.92 8.54 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.118 0.485 . . . . 75.42 111.32 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -87.55 86.69 7.24 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.026 0.441 . . . . 65.11 110.521 176.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.7 p -74.94 135.17 41.43 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.514 0.561 . . . . 73.33 112.514 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.05 -30.16 11.56 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.998 -0.546 . . . . 65.25 113.187 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -68.64 96.29 0.71 Allowed 'General case' 0 CA--C 1.536 0.427 0 O-C-N 122.557 -0.378 . . . . 72.25 111.626 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.438 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 42.9 mt-10 -91.29 102.97 15.68 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.121 0.486 . . . . 52.42 110.292 172.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.87 150.71 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 113.0 0.741 . . . . 75.15 113.0 -171.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.69 140.15 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 115.643 -0.708 . . . . 73.34 110.905 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.85 111.93 23.78 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.84 0.352 . . . . 74.13 111.431 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.1 mm -96.2 113.66 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.348 -0.387 . . . . 75.31 110.968 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.483 HD12 ' N ' ' A' ' 12' ' ' ILE . 2.9 mp -95.62 123.57 47.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.83 0.347 . . . . 74.11 111.387 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.6 p -125.58 146.61 49.61 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.008 0.432 . . . . 74.21 111.171 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.506 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 63.1 tt0 -130.9 131.25 44.39 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.544 -0.298 . . . . 73.45 110.204 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.477 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 56.5 m-80 57.5 15.58 2.83 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.057 0.391 . . . . 71.13 112.057 -175.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.98 -20.28 31.42 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.314 -0.469 . . . . 52.23 114.034 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -98.35 140.77 32.13 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.323 0.562 . . . . 71.25 111.85 -177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.27 122.64 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.954 0.407 . . . . 71.45 111.529 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.8 pt -111.03 -19.4 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 112.953 0.723 . . . . 74.4 112.953 -175.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -167.81 144.47 4.17 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.001 0.371 . . . . 74.52 112.001 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -128.91 122.73 30.89 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.396 0.278 . . . . 73.44 111.329 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.7 mp -118.32 113.86 36.81 Favored Pre-proline 0 N--CA 1.477 0.888 0 N-CA-C 111.713 0.264 . . . . 61.3 111.713 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.69 124.96 11.63 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.223 1.949 . . . . 74.42 111.851 171.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.9 mt -92.13 -47.78 7.07 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.9 0.704 . . . . 74.11 112.9 -172.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.438 ' OG1' ' HA ' ' A' ' 7' ' ' GLU . 14.8 m -59.53 121.73 12.28 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.303 0.483 . . . . 72.54 112.303 -175.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.79 5.82 88.52 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.442 -0.409 . . . . 62.3 113.437 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.484 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 41.6 t-80 -70.82 87.38 0.7 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.314 0.578 . . . . 74.35 111.267 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -64.17 123.77 19.94 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.62 0.6 . . . . 75.22 112.62 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.5 -164.04 20.97 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 114.189 0.436 . . . . 55.31 114.189 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -118.61 128.86 54.94 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.559 0.343 . . . . 74.02 111.213 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -130.48 114.68 15.81 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.096 0.474 . . . . 73.13 111.634 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.43 ' HG2' ' HG3' ' A' ' 46' ' ' GLU . 68.0 mt-30 -109.82 145.12 37.26 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.281 -0.418 . . . . 72.42 111.126 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -151.19 145.78 25.65 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.002 0.43 . . . . 74.11 111.787 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 28.7 m -103.88 113.63 27.3 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.736 0.643 . . . . 72.14 112.736 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.44 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 61.1 mt -88.39 109.04 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.114 -0.494 . . . . 64.23 110.604 173.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -79.61 106.33 11.55 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.166 -0.334 . . . . 73.32 111.66 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.506 ' HA2' ' NE2' ' A' ' 14' ' ' GLN . . . -73.42 -171.02 21.3 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 120.865 -0.683 . . . . 62.32 112.754 176.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HD2' ' HD2' ' A' ' 83' ' ' LYS . 27.0 mtpp -66.85 99.42 0.62 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.973 0.416 . . . . 74.41 111.751 -177.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.37 -118.22 5.73 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.231 -0.509 . . . . 43.13 113.121 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.01 -4.95 38.82 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.389 0.515 . . . . 64.32 112.389 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.631 ' HA ' ' HB3' ' A' ' 58' ' ' ASN . 14.0 mt-30 -82.49 81.44 8.31 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.463 0.649 . . . . 73.42 111.738 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 22.8 p90 -84.09 166.34 17.76 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.679 -0.691 . . . . 75.02 111.88 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.44 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 22.3 m120 -136.34 109.89 7.99 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.724 0.409 . . . . 70.22 110.715 173.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.9 tp -90.56 103.54 16.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.097 0.475 . . . . 74.4 110.562 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.709 ' SD ' HG12 ' A' ' 54' ' ' ILE . 94.9 mmm -89.94 144.55 25.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.129 -0.487 . . . . 65.22 111.108 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.608 ' HB3' ' NH1' ' A' ' 53' ' ' ARG . 71.6 tt0 -132.99 126.6 32.32 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.179 0.514 . . . . 74.45 111.734 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.1 t -103.81 119.42 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 115.838 -0.619 . . . . 63.34 110.848 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 34.9 t70 -107.9 97.77 7.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.275 0.559 . . . . 72.21 109.782 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 27' ' ' HIS . . . 65.87 -104.67 1.06 Allowed Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.819 -0.705 . . . . 70.43 112.377 -175.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -112.95 15.57 19.65 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.868 0.366 . . . . 75.21 111.949 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 18.6 ptp180 -131.54 150.24 52.22 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.524 -0.307 . . . . 74.22 110.925 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.7 tt -139.72 145.2 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 112.681 0.623 . . . . 70.43 112.681 -175.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.608 ' NH1' ' HB3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -159.41 168.61 25.86 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 116.1 -0.5 . . . . 74.4 111.311 173.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.709 HG12 ' SD ' ' A' ' 45' ' ' MET . 55.2 mt -73.96 122.16 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.107 0.48 . . . . 75.14 111.409 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -82.14 -51.04 8.37 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.093 -0.503 . . . . 75.22 111.441 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -154.04 136.85 15.31 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.223 -0.444 . . . . 63.04 110.317 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -157.15 -177.14 6.39 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.513 0.673 . . . . 74.11 111.962 179.249 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.631 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . 55.1 t-20 -115.15 75.58 0.94 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.423 -0.808 . . . . 73.04 110.593 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.8 t -136.94 148.16 61.9 Favored Pre-proline 0 N--CA 1.472 0.627 0 O-C-N 122.15 -0.344 . . . . 70.31 111.445 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.07 -15.89 23.0 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.116 1.877 . . . . 70.31 111.673 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -105.87 -43.65 4.82 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.89 -0.595 . . . . 63.31 111.566 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 53.17 56.6 7.25 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.517 0.675 . . . . 75.24 110.662 -177.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.3 t -53.46 -46.58 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.378 -0.828 . . . . 72.01 112.772 -171.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.539 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -60.01 -31.31 72.21 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.869 -0.682 . . . . 75.33 113.228 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.75 -38.2 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.035 0.445 . . . . 71.25 110.47 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -76.3 -28.71 57.08 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.191 -0.459 . . . . 71.35 111.944 174.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 17.2 mmt -62.68 -47.49 83.45 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.583 0.586 . . . . 74.45 112.583 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.41 -165.32 27.44 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 120.811 -0.709 . . . . 51.44 113.202 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.411 ' CE3' ' HG3' ' A' ' 51' ' ' ARG . 98.7 m95 -76.26 115.23 15.79 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.378 0.608 . . . . 75.55 112.474 -176.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.779 ' HD3' ' HB3' ' A' ' 75' ' ' ASP . 11.5 mmpt? -94.73 143.57 26.34 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.806 -0.633 . . . . 73.12 110.299 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 89.0 p -167.27 12.18 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.428 1.27 . . . . 72.42 114.428 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -131.63 153.14 50.24 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.808 -0.557 . . . . 71.01 111.865 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.12 100.09 0.11 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.094 0.473 . . . . 72.41 111.841 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.44 -24.16 2.51 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 116.062 -0.517 . . . . 41.43 112.033 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.779 ' HB3' ' HD3' ' A' ' 70' ' ' LYS . 62.8 m-20 -68.32 127.46 33.04 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.783 0.325 . . . . 73.25 111.387 174.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.561 HG21 ' HA ' ' A' ' 87' ' ' GLU . 76.6 p -136.01 148.68 48.51 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.968 0.413 . . . . 71.34 111.271 177.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.2 mm -113.22 110.59 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 120.924 0.392 . . . . 74.44 110.533 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.5 t -98.73 116.88 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 116.14 -0.482 . . . . 61.14 111.322 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 71.5 m -118.99 73.32 0.92 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.94 0.4 . . . . 61.34 110.964 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.523 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 90.9 mt -54.07 -50.18 85.78 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 112.613 0.598 . . . . 75.31 112.613 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 34.7 Cg_exo -59.91 -12.84 20.08 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.018 1.812 . . . . 74.03 113.386 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.421 ' ND1' ' OD1' ' A' ' 43' ' ' ASN . 11.8 m170 -116.65 -11.64 10.99 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.124 0.416 . . . . 74.21 112.124 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.432 ' HD2' ' HD2' ' A' ' 38' ' ' LYS . 63.8 mttm 64.01 29.51 14.29 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.257 0.551 . . . . 71.14 112.05 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.3 t -108.9 135.71 46.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 116.008 -0.542 . . . . 70.43 110.711 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -135.75 128.65 31.27 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.09 0.471 . . . . 73.2 111.11 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.18 130.6 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.587 -0.279 . . . . 74.21 111.133 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.561 ' HA ' HG21 ' A' ' 76' ' ' THR . 3.2 pt-20 -114.19 147.74 38.42 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.011 0.434 . . . . 75.32 111.303 175.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 57.3 mt -111.8 112.14 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.014 0.435 . . . . 73.12 110.226 171.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.48 ' HB3' ' HZ2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -119.65 163.04 17.98 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.275 -0.421 . . . . 74.51 111.649 -174.243 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.7 t -86.11 149.34 25.2 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.622 0.601 . . . . 73.2 112.622 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.2 p -83.68 -16.93 43.17 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.97 -0.559 . . . . 63.15 110.725 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -81.58 -173.52 4.45 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.126 -0.488 . . . . 73.22 111.47 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -80.87 74.35 7.85 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.192 0.52 . . . . 64.22 111.58 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -119.58 113.46 20.74 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.753 -0.658 . . . . 74.34 110.825 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 77.3 p -104.15 12.76 33.49 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.208 0.528 . . . . 73.42 111.344 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -90.0 35.99 0.86 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.265 -0.425 . . . . 74.44 111.571 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.62 150.03 37.79 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 116.204 -0.453 . . . . 72.42 111.965 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.07 -29.86 11.36 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.342 2.028 . . . . 63.14 113.646 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -124.45 178.62 5.3 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.143 0.424 . . . . 72.12 112.143 -176.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 67.3 p -82.33 112.39 19.26 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.195 0.813 . . . . 73.25 113.195 -172.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -161.54 126.33 3.48 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.351 -0.386 . . . . 75.44 110.522 172.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.9 tp -111.41 116.49 31.02 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.172 0.51 . . . . 74.44 111.994 -176.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.4 mt -63.14 131.23 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.856 -0.611 . . . . 73.44 111.804 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.7 m -86.53 125.11 68.43 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-O 121.058 0.456 . . . . 74.54 111.344 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -87.21 39.23 0.58 Allowed 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.859 2.373 . . . . 74.11 113.377 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -71.82 85.02 0.93 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.123 0.487 . . . . 74.32 112.208 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -80.55 -13.53 59.0 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.302 -0.408 . . . . 71.14 111.314 176.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -70.61 160.08 33.2 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.995 -0.548 . . . . 74.11 111.386 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -95.47 133.67 39.18 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.992 0.425 . . . . 64.13 111.558 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -94.94 110.17 22.09 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.475 -0.329 . . . . 73.42 110.543 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -53.13 -47.65 68.53 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.27 0.47 . . . . 70.52 112.27 -173.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -80.0 130.87 35.61 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.883 0.373 . . . . 73.34 111.826 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -85.49 154.47 21.77 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.394 -0.366 . . . . 74.11 110.704 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.521 -0.752 . . . . 63.11 111.365 178.348 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 120.551 0.215 . . . . 63.23 111.036 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -99.26 99.49 10.46 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.011 0.434 . . . . 74.34 110.273 171.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -98.53 10.91 39.88 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.493 0.553 . . . . 73.41 112.493 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 87.4 m -67.3 127.76 33.85 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.877 0.37 . . . . 73.41 110.764 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.74 65.86 2.63 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.115 -0.564 . . . . 38.25 114.403 -173.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -74.25 78.65 1.81 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.802 0.811 . . . . 72.41 109.996 171.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.404 ' HA ' ' CB ' ' A' ' 25' ' ' THR . 46.0 mt-10 -71.58 128.97 37.56 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.079 -0.964 . . . . 63.05 113.339 -170.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.01 158.82 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.508 -0.769 . . . . 71.31 111.648 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.527 HG13 ' HA ' ' A' ' 23' ' ' PRO . 23.6 m -134.36 148.6 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 116.262 -0.426 . . . . 74.42 111.053 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.71 115.94 28.4 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.826 0.346 . . . . 64.3 111.568 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.0 mm -99.02 116.07 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.282 -0.417 . . . . 74.42 111.22 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.473 ' N ' HD11 ' A' ' 12' ' ' ILE . 3.0 mp -99.85 115.46 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.023 0.44 . . . . 72.35 111.489 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.9 m -113.88 146.12 40.48 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.014 0.435 . . . . 73.54 111.467 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -141.33 140.19 33.74 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.402 -0.363 . . . . 75.1 110.278 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 61.38 14.75 5.98 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.338 0.496 . . . . 73.33 112.338 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.77 -11.12 41.73 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.272 -0.49 . . . . 75.23 114.037 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -125.72 156.18 39.77 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.229 -0.571 . . . . 74.51 111.91 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.0 t -74.98 132.78 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.781 0.325 . . . . 75.45 111.334 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 43.1 pt -117.28 -27.08 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 N-CA-C 112.586 0.587 . . . . 73.4 112.586 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.451 ' HG3' HD11 ' A' ' 22' ' ' ILE . 3.1 tpm_? -154.3 131.83 11.34 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 122.315 -0.241 . . . . 73.1 111.141 -174.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -130.29 114.28 15.44 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.594 0.235 . . . . 73.42 111.502 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.469 ' N ' HD13 ' A' ' 22' ' ' ILE . 3.7 mp -114.4 130.15 24.26 Favored Pre-proline 0 N--CA 1.476 0.874 0 CA-C-O 120.545 0.212 . . . . 74.05 111.432 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.527 ' HA ' HG13 ' A' ' 9' ' ' VAL . 57.5 Cg_endo -70.77 134.11 25.15 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.189 1.926 . . . . 74.14 112.404 173.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.7 mt -97.64 -65.5 0.96 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.901 0.382 . . . . 75.23 111.654 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.404 ' CB ' ' HA ' ' A' ' 7' ' ' GLU . 8.0 m -63.43 126.87 28.9 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.835 0.35 . . . . 73.52 111.451 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.34 12.25 84.08 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.965 -0.636 . . . . 50.51 112.97 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -90.85 104.22 16.83 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.087 0.47 . . . . 72.34 111.246 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -87.74 123.8 32.92 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.224 -0.443 . . . . 74.51 111.557 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.8 -169.74 14.79 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.253 -0.498 . . . . 54.02 113.539 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -118.49 150.36 39.74 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 122.703 -0.292 . . . . 75.04 110.893 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.435 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 13.6 tp10 -144.7 114.54 7.31 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.625 0.25 . . . . 74.22 110.908 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -118.33 137.87 52.79 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.863 0.363 . . . . 74.44 111.928 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -152.09 136.56 16.84 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.245 0.545 . . . . 74.23 111.82 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.3 m -96.06 116.1 28.45 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.148 -0.478 . . . . 74.12 111.484 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 42' ' ' TYR . 62.0 mt -80.71 103.97 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.566 -0.288 . . . . 73.43 110.809 176.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -92.67 111.35 22.91 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.032 0.444 . . . . 75.15 111.301 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.22 -154.11 7.03 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.248 -0.501 . . . . 74.43 112.764 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -93.43 90.55 6.77 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.203 -0.586 . . . . 74.31 111.064 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.63 75.95 1.28 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 121.239 -0.505 . . . . 38.25 113.986 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 72.96 -41.37 0.5 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.206 1.187 . . . . 71.1 114.206 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -50.85 108.23 0.23 Allowed 'General case' 0 N--CA 1.477 0.903 0 O-C-N 122.155 -0.341 . . . . 74.45 111.605 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 33.6 p90 -131.25 159.99 36.19 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.993 0.738 . . . . 74.21 112.993 -174.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -133.73 109.84 9.42 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.869 -0.605 . . . . 74.12 110.552 170.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.3 tp -82.67 104.04 12.63 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.878 0.371 . . . . 75.2 110.69 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.726 ' SD ' HG12 ' A' ' 54' ' ' ILE . 91.3 mmm -91.73 137.32 32.46 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.361 -0.381 . . . . 74.13 111.502 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -123.38 115.72 22.09 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.047 0.451 . . . . 73.31 111.168 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 44.3 t -105.61 107.53 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.106 -0.497 . . . . 73.5 110.537 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -112.21 117.44 32.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.743 0.306 . . . . 74.21 110.674 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.06 -111.23 3.18 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.831 -0.7 . . . . 74.01 112.809 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -112.51 17.02 19.61 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.9 0.381 . . . . 74.02 111.503 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.1 ptt-85 -133.93 140.94 47.12 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.097 0.475 . . . . 72.3 111.655 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.3 tt -124.32 147.53 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 116.389 -0.368 . . . . 75.44 111.881 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -150.96 168.81 23.4 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.889 0.376 . . . . 74.3 111.444 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.726 HG12 ' SD ' ' A' ' 45' ' ' MET . 26.4 mt -90.68 117.79 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.118 0.485 . . . . 74.2 110.155 168.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -81.13 -41.58 22.23 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.098 -0.501 . . . . 74.42 111.771 -176.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -159.46 138.53 11.08 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.759 0.281 . . . . 71.43 111.759 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -163.61 166.72 22.1 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.99 0.424 . . . . 75.42 111.198 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -111.19 63.66 0.61 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 120.967 0.413 . . . . 73.33 111.882 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.2 t -108.59 138.06 20.16 Favored Pre-proline 0 N--CA 1.477 0.918 0 O-C-N 122.051 -0.406 . . . . 75.02 111.013 175.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.495 ' HD2' ' HG2' ' A' ' 81' ' ' PRO . 36.6 Cg_endo -64.21 -27.14 64.39 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.769 2.313 . . . . 74.34 113.35 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.508 ' HB2' HG21 ' A' ' 63' ' ' VAL . 1.2 p30 -87.25 -43.53 12.12 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 111.945 0.35 . . . . 75.32 111.945 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 65.57 27.33 11.55 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.457 -0.338 . . . . 73.15 111.665 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' A' ' 61' ' ' ASP . 90.2 t -58.01 -41.68 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.037 0.446 . . . . 74.04 110.957 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.556 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -55.37 -48.02 72.07 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 116.036 -0.529 . . . . 44.12 113.074 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.7 t -62.45 -44.01 98.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 120.801 0.334 . . . . 75.43 111.372 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -59.74 -33.77 72.08 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.615 -0.266 . . . . 73.11 111.528 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.674 ' HE1' ' HA ' ' A' ' 67' ' ' MET . 5.3 mmt -57.9 -31.88 67.18 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.832 0.348 . . . . 65.24 111.902 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.96 -136.22 32.83 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.108 -0.567 . . . . 62.53 113.585 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -87.88 126.24 34.93 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.17 0.509 . . . . 75.14 111.879 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 34.4 mmtp -113.66 145.03 41.93 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.317 -0.623 . . . . 72.25 109.317 171.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.1 p -156.31 6.79 0.19 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.327 1.232 . . . . 75.32 114.327 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -130.12 156.26 44.83 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.67 -0.644 . . . . 72.42 112.179 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.06 126.5 27.72 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.004 -0.544 . . . . 63.23 111.239 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.37 -22.12 23.01 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.337 -0.458 . . . . 71.53 112.857 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.499 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 95.7 m-20 -68.2 131.58 45.64 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.964 0.411 . . . . 75.24 111.687 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.9 p -127.99 167.14 17.1 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.59 0.589 . . . . 65.24 112.59 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.566 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 40.0 mm -137.44 123.56 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.69 0.796 . . . . 74.14 109.885 177.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -113.99 117.76 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.256 0.465 . . . . 65.15 112.256 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 73.5 m -122.91 86.5 2.59 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.862 0.363 . . . . 71.22 111.309 174.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.584 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 92.2 mt -61.24 -53.95 58.02 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 112.804 0.668 . . . . 73.22 112.804 -175.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.584 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 17.1 Cg_exo -69.25 0.1 5.73 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.4 2.067 . . . . 71.43 113.362 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -119.1 -6.77 10.42 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 122.205 -0.309 . . . . 72.43 111.509 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.3 mttm 61.85 30.51 18.24 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.15 0.5 . . . . 73.22 111.762 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.51 138.84 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.101 -0.499 . . . . 61.33 111.346 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -141.71 125.8 17.33 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.115 -0.493 . . . . 75.24 110.886 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 57.5 t -116.6 135.44 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.561 0.219 . . . . 73.25 111.148 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.21 141.1 47.89 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.91 0.386 . . . . 71.43 111.278 176.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.493 HD12 ' HB2' ' A' ' 75' ' ' ASP . 60.6 mt -101.5 115.97 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.17 0.509 . . . . 74.44 111.216 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -109.89 166.09 11.2 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.003 -0.544 . . . . 72.32 110.697 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.5 t -97.3 149.29 22.23 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.181 0.515 . . . . 63.33 111.32 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.5 p -80.37 -5.12 55.92 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.216 0.532 . . . . 75.14 110.973 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -89.07 -83.5 0.23 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.335 0.588 . . . . 73.52 111.528 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -161.1 129.68 4.51 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.481 -0.781 . . . . 72.52 111.766 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -124.99 136.47 53.76 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.317 -0.401 . . . . 74.04 110.115 174.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 31.8 t -89.08 147.9 23.99 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.027 0.442 . . . . 61.43 111.201 -177.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -139.18 174.96 9.97 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.318 0.58 . . . . 62.23 112.389 -175.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -86.69 156.92 55.68 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 115.479 -0.782 . . . . 63.33 111.208 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.35 -32.72 72.08 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.342 2.028 . . . . 61.25 113.249 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.74 85.65 0.21 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.137 0.494 . . . . 71.42 111.847 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 21.4 m -100.92 75.72 1.71 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.981 0.419 . . . . 64.24 110.998 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -154.97 153.63 31.32 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.357 -0.383 . . . . 74.04 110.955 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.524 ' O ' HD11 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -106.36 120.77 42.76 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.503 0.668 . . . . 64.25 112.366 -177.489 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 52.6 mt -88.96 -20.35 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.354 0.597 . . . . 75.23 110.379 173.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.7 m -69.33 144.86 95.26 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 115.805 -0.634 . . . . 72.12 112.074 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.19 105.89 1.94 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.28 1.986 . . . . 70.45 112.632 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -63.24 94.62 0.08 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.182 0.515 . . . . 73.01 111.501 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 87.4 mt -70.52 160.41 32.51 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.087 -0.506 . . . . 74.4 111.476 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.72 165.44 11.21 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.58 0.705 . . . . 71.42 112.619 -176.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -172.31 105.46 0.18 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.173 -0.921 . . . . 73.22 109.091 169.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -44.37 -43.45 7.6 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.466 0.913 . . . . 75.33 113.466 -169.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 59.91 21.69 10.68 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.652 0.739 . . . . 75.22 110.443 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -101.06 116.19 32.25 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.428 -0.805 . . . . 75.13 111.385 -174.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -83.56 176.24 9.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.234 0.54 . . . . 73.34 111.749 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 39.6 m80 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.605 -0.712 . . . . 74.41 110.927 175.751 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.652 0.263 . . . . 72.22 110.773 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 56.02 69.13 0.77 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.393 -0.367 . . . . 75.34 111.909 -176.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -129.72 95.11 3.9 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.801 0.334 . . . . 75.23 111.881 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 t -106.94 139.33 41.52 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.48 -0.327 . . . . 75.12 111.039 173.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.53 -31.34 56.78 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.443 -0.408 . . . . 65.11 113.565 -177.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -111.73 144.7 40.59 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.081 0.467 . . . . 75.02 111.866 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.459 ' HB2' ' OG1' ' A' ' 91' ' ' THR . 47.7 mt-10 -95.16 130.98 41.67 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.271 -0.422 . . . . 71.54 110.749 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.0 m -123.67 142.17 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.095 0.474 . . . . 64.01 112.033 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.511 HG13 ' HA ' ' A' ' 23' ' ' PRO . 27.5 m -119.93 140.19 44.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.278 -0.419 . . . . 72.25 111.224 177.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.94 114.53 26.37 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.893 0.378 . . . . 73.13 111.681 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.7 mm -98.69 110.79 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.338 -0.392 . . . . 71.33 110.979 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.481 ' N ' HD13 ' A' ' 12' ' ' ILE . 3.2 mp -101.42 125.69 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.06 0.457 . . . . 74.34 111.59 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 55.2 m -123.5 150.6 43.73 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.129 -0.487 . . . . 74.34 111.813 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.572 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 36.1 tt0 -129.01 135.24 48.68 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.412 0.285 . . . . 52.32 110.533 175.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.572 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 53.9 m-80 59.64 8.66 1.34 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.859 0.464 . . . . 53.01 111.976 -174.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.95 -29.25 8.61 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 121.53 -0.367 . . . . 37.68 113.315 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -87.71 139.69 30.28 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.974 0.416 . . . . 71.02 111.486 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -71.22 130.54 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.316 -0.402 . . . . 72.33 111.115 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.432 HD12 HD11 ' A' ' 35' ' ' ILE . 34.2 pt -121.18 -29.24 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 112.897 0.703 . . . . 75.15 112.897 -176.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.439 ' HG3' HD11 ' A' ' 22' ' ' ILE . 9.2 tpm_? -151.29 123.19 8.1 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.125 0.488 . . . . 74.24 111.651 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -122.25 125.97 47.19 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.235 -0.439 . . . . 73.12 110.998 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.439 HD11 ' HG3' ' A' ' 20' ' ' ARG . 4.4 mp -120.63 123.62 27.97 Favored Pre-proline 0 N--CA 1.473 0.717 0 O-C-N 122.191 -0.318 . . . . 73.34 111.786 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.511 ' HA ' HG13 ' A' ' 9' ' ' VAL . 22.3 Cg_exo -66.27 111.88 2.16 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.257 1.971 . . . . 72.21 111.55 169.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 78.2 mt -75.65 -58.64 3.16 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.912 0.387 . . . . 74.15 111.244 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.44 HG21 ' HG2' ' A' ' 7' ' ' GLU . 35.8 m -60.5 118.83 6.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.836 0.351 . . . . 72.33 111.153 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.403 ' H ' ' HG2' ' A' ' 50' ' ' GLU . . . 98.49 -8.28 62.07 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.191 -0.528 . . . . 43.53 113.387 -176.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.404 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 54.2 t-80 -79.5 95.7 5.89 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.285 -0.538 . . . . 73.14 111.345 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.6 ' HZ3' ' HB2' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -69.29 146.61 52.1 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.101 -0.5 . . . . 74.11 111.923 177.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.43 -158.57 53.27 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 116.1 -0.5 . . . . 72.44 114.183 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -118.39 151.34 37.95 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.834 0.349 . . . . 72.04 111.143 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -146.54 135.04 22.02 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.517 0.327 . . . . 74.42 110.462 -176.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -131.94 142.57 49.67 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.889 -0.507 . . . . 70.43 112.319 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -150.96 135.7 17.25 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.004 0.43 . . . . 75.05 111.431 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.8 m -98.74 127.65 44.74 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.396 -0.366 . . . . 70.13 111.139 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.432 HD11 HD12 ' A' ' 19' ' ' ILE . 68.8 mt -110.59 120.6 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 120.766 0.317 . . . . 73.31 111.377 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -97.41 128.72 44.44 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.116 0.484 . . . . 74.52 111.393 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.23 -114.48 3.66 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 116.261 -0.427 . . . . 65.34 112.787 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.631 ' HE2' ' HG3' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -99.17 141.82 31.45 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.911 0.355 . . . . 73.41 111.495 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.37 -100.63 0.19 Allowed Glycine 0 CA--C 1.531 1.068 0 CA-C-N 116.392 -0.367 . . . . 63.32 113.912 177.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.34 18.65 7.58 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.186 0.517 . . . . 74.34 111.664 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.631 ' HG3' ' HE2' ' A' ' 38' ' ' LYS . 12.5 mm100 -85.74 115.69 23.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.984 -0.553 . . . . 70.22 111.386 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -130.0 151.87 50.07 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.081 0.467 . . . . 74.12 112.189 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -127.66 116.8 20.84 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.061 -0.518 . . . . 74.21 110.639 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.6 tp -95.16 103.5 15.35 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.893 0.378 . . . . 72.33 110.501 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.653 ' SD ' HG12 ' A' ' 54' ' ' ILE . 92.5 mmm -92.33 136.74 32.95 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.232 -0.44 . . . . 64.21 111.274 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -124.55 115.35 20.71 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.953 0.406 . . . . 73.33 111.096 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.439 HG11 HG21 ' A' ' 22' ' ' ILE . 47.8 t -97.27 115.64 37.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.105 -0.498 . . . . 61.01 111.063 175.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -109.25 170.72 7.87 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.563 -0.29 . . . . 62.1 110.295 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 27' ' ' HIS . . . -37.53 95.33 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 N-CA-C 114.604 0.602 . . . . 61.43 114.604 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 31.4 mt-10 62.21 37.34 14.31 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.442 0.697 . . . . 75.31 112.682 176.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -165.21 161.95 19.67 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.381 -0.372 . . . . 75.23 111.017 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.3 tt -141.39 151.57 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 112.186 0.439 . . . . 72.44 112.186 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.435 ' HD3' ' CE2' ' A' ' 69' ' ' TRP . 14.1 ptt180 -152.18 168.97 23.61 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.905 0.383 . . . . 72.23 111.541 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.653 HG12 ' SD ' ' A' ' 45' ' ' MET . 46.3 mt -94.85 113.32 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.956 -0.387 . . . . 72.32 109.956 168.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -75.38 -46.73 31.2 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.736 0.303 . . . . 72.33 111.601 -177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -143.15 140.36 30.76 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.834 0.349 . . . . 73.32 111.224 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -162.25 136.59 6.68 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.887 0.375 . . . . 65.25 111.271 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -107.8 51.36 0.74 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.208 0.527 . . . . 72.54 111.967 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.4 m -97.99 124.48 47.49 Favored Pre-proline 0 N--CA 1.473 0.719 0 O-C-N 122.141 -0.349 . . . . 60.2 110.213 172.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -52.78 -32.83 57.62 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.837 2.358 . . . . 74.34 113.226 -175.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -75.08 -31.46 61.22 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.365 -0.379 . . . . 74.11 111.857 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.45 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 28.3 mm-40 60.54 22.28 12.02 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.088 0.773 . . . . 72.3 113.088 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.5 t -53.36 -52.04 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 112.02 0.378 . . . . 71.23 112.02 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.94 -40.7 98.77 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.035 -0.602 . . . . 72.22 113.387 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.5 t -65.97 -33.7 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 120.998 0.428 . . . . 71.14 111.564 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 62' ' ' GLN . 67.5 mttm -70.71 -37.64 73.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.822 0.344 . . . . 65.31 111.398 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.3 mmt -60.35 -35.16 75.03 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.279 -0.418 . . . . 74.43 112.058 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.06 -119.51 8.05 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.251 -0.499 . . . . 55.13 113.948 175.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.435 ' CE2' ' HD3' ' A' ' 53' ' ' ARG . 69.3 m95 -94.92 138.93 32.02 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.173 0.434 . . . . 74.05 112.173 -175.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -131.23 151.4 51.51 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.195 -0.457 . . . . 73.15 110.233 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.4 p -164.97 15.74 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.368 0.877 . . . . 52.45 113.368 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.762 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 9.6 mmpt? -123.43 149.62 44.82 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.24 0.543 . . . . 64.32 112.069 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.64 109.49 1.42 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.029 -0.532 . . . . 62.03 110.587 176.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.24 -18.86 6.47 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 116.234 -0.439 . . . . 75.22 112.503 -176.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -69.84 115.35 8.96 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.779 0.323 . . . . 72.04 111.263 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 82.5 p -119.46 149.67 41.48 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.089 0.471 . . . . 72.12 111.465 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.426 HG22 HD13 ' A' ' 54' ' ' ILE . 46.9 mm -125.56 115.93 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.194 -0.457 . . . . 74.23 110.476 177.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.6 t -108.79 117.76 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 120.867 0.365 . . . . 70.43 111.777 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 71.0 m -120.82 84.54 2.25 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.086 0.469 . . . . 73.53 111.009 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.534 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 98.8 mt -57.98 -49.98 90.64 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 113.24 0.83 . . . . 75.43 113.24 -176.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.534 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 52.0 Cg_exo -56.7 -18.31 26.12 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 122.096 1.864 . . . . 70.32 113.519 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -113.2 -4.78 13.71 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.7 0.286 . . . . 73.11 111.219 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 58.78 28.0 16.77 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.176 0.59 . . . . 72.3 112.292 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.1 t -101.9 133.88 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.02 0.438 . . . . 75.21 111.215 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -130.85 123.52 29.21 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.122 -0.49 . . . . 73.4 110.824 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.411 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 47.5 t -117.1 136.9 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 116.715 -0.221 . . . . 74.1 111.02 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -136.96 132.07 33.86 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.198 0.523 . . . . 73.41 111.092 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 62.1 mt -99.38 127.16 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.264 -0.426 . . . . 71.12 111.205 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -125.74 159.42 32.37 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.905 0.383 . . . . 71.54 111.617 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.1 t -79.66 149.78 31.14 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.253 -0.431 . . . . 55.34 111.059 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.459 ' OG1' ' HB2' ' A' ' 7' ' ' GLU . 80.6 p -71.91 -21.45 61.62 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.864 0.364 . . . . 72.44 110.843 173.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -70.51 170.02 12.96 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.012 -0.54 . . . . 64.53 110.743 175.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -65.58 106.03 1.35 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.682 0.753 . . . . 73.44 109.498 171.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -73.02 161.16 31.01 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.115 -0.493 . . . . 65.53 111.998 -170.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 98.4 p -92.8 -9.37 40.71 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.226 -0.443 . . . . 73.32 112.181 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.409 ' HD2' ' HA ' ' A' ' 96' ' ' LYS . 21.6 mmmt -61.33 152.8 28.37 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.702 0.763 . . . . 74.3 112.845 -178.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 1.0 OUTLIER -74.53 140.28 75.3 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 114.964 -1.016 . . . . 75.35 111.4 -176.275 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 97' ' ' ASP . 37.7 Cg_exo -63.81 78.05 0.15 Allowed 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.069 2.512 . . . . 75.23 112.775 177.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -76.03 136.52 39.95 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.322 -0.854 . . . . 64.55 111.702 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -161.66 20.82 0.11 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.514 -0.766 . . . . 64.23 109.833 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -102.19 114.81 29.29 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.479 -0.782 . . . . 71.25 111.207 -173.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.3 pp -136.43 169.87 16.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.055 0.455 . . . . 72.03 112.043 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 65.1 mt -104.35 114.56 44.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.242 -0.435 . . . . 74.12 110.779 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.7 p -64.21 119.32 54.91 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 120.943 0.402 . . . . 73.31 111.735 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.85 120.66 7.01 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.509 2.139 . . . . 71.22 112.646 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -71.1 97.84 1.56 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.796 0.331 . . . . 72.42 110.441 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.409 ' N ' HD21 ' A' ' 107' ' ' LEU . 2.3 pt? -57.26 138.87 54.22 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.153 0.501 . . . . 74.23 111.494 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -70.25 142.74 52.29 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.163 -0.471 . . . . 75.33 111.408 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -74.71 68.12 1.65 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.558 0.694 . . . . 74.21 109.555 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -81.87 -5.41 58.22 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.038 0.755 . . . . 75.41 113.038 -169.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -74.32 75.25 1.86 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.229 0.538 . . . . 75.0 111.216 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -94.84 135.52 36.25 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.311 -0.404 . . . . 74.44 110.7 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -75.2 -177.76 3.61 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.808 0.337 . . . . 73.43 111.359 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 . . . . . 0 C--O 1.252 1.221 0 CA-C-O 118.964 -0.541 . . . . 74.2 111.987 -178.112 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ptp . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.907 0.384 . . . . 74.24 111.324 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -139.0 114.1 9.45 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.369 -0.378 . . . . 73.1 111.262 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -77.66 151.05 34.45 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.832 0.349 . . . . 74.22 110.445 175.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.6 p -69.95 -40.22 75.57 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.747 0.647 . . . . 75.14 112.747 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.68 1.03 76.07 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.176 -0.535 . . . . 63.5 112.374 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -143.89 147.48 34.07 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 122.876 0.471 . . . . 73.22 109.874 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.552 ' HA ' ' HB ' ' A' ' 25' ' ' THR . 42.7 mt-10 -66.17 96.88 0.35 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.597 0.591 . . . . 74.0 112.597 -174.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.48 HG21 ' OG1' ' A' ' 25' ' ' THR . 27.6 m -102.83 152.08 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.287 0.565 . . . . 74.02 111.77 176.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.524 HG13 ' HA ' ' A' ' 23' ' ' PRO . 35.5 m -127.42 142.41 43.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.145 -0.48 . . . . 71.33 111.682 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.39 116.38 28.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.944 0.402 . . . . 53.43 111.237 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 34.4 mm -99.34 107.06 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.27 -0.423 . . . . 70.44 111.711 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.472 HD11 ' N ' ' A' ' 12' ' ' ILE . 3.4 mp -96.7 129.03 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.049 0.452 . . . . 75.12 111.029 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 m -130.99 156.7 44.68 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.055 0.455 . . . . 73.44 111.75 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.505 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 56.3 tt0 -149.77 142.86 24.97 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 116.239 -0.437 . . . . 75.21 110.428 178.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.505 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 44.7 m-80 60.52 19.79 9.59 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.234 0.457 . . . . 74.44 112.234 -177.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.36 4.13 68.68 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 120.994 -0.622 . . . . 70.04 114.034 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -126.62 149.41 49.5 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.355 0.577 . . . . 72.5 111.896 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.6 t -68.6 132.16 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.524 -0.307 . . . . 72.11 110.945 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.5 pt -122.58 -20.14 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.041 0.756 . . . . 72.54 113.041 -176.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -160.12 138.1 9.98 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.027 -0.421 . . . . 75.14 111.737 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -134.79 124.27 24.88 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 120.573 0.225 . . . . 71.52 111.362 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.96 126.51 26.31 Favored Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 111.63 0.233 . . . . 74.53 111.63 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.524 ' HA ' HG13 ' A' ' 9' ' ' VAL . 15.2 Cg_exo -69.12 117.84 5.3 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.694 2.263 . . . . 71.04 112.2 172.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.8 mt -84.79 -61.02 1.88 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.847 0.356 . . . . 73.32 111.826 -175.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.552 ' HB ' ' HA ' ' A' ' 7' ' ' GLU . 60.7 m -61.07 110.66 1.43 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.95 0.405 . . . . 74.51 111.985 -177.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.29 -15.69 35.73 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.235 -0.507 . . . . 73.23 112.993 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -70.58 128.71 37.05 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 122.663 0.385 . . . . 65.51 111.566 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -104.3 155.89 18.37 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.066 0.46 . . . . 73.32 112.016 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.53 -165.68 54.76 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 116.06 -0.518 . . . . 63.52 114.168 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -118.64 137.89 52.98 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.008 0.432 . . . . 74.01 110.667 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -143.53 115.53 8.33 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.788 0.328 . . . . 72.44 111.455 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -111.75 143.48 42.6 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.862 0.363 . . . . 64.24 111.954 -174.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -146.71 137.94 24.23 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.981 0.419 . . . . 53.23 111.201 176.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.9 m -105.06 119.94 40.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.009 0.433 . . . . 72.01 112.088 -175.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.498 ' N ' HD13 ' A' ' 35' ' ' ILE . 3.2 mp -92.43 106.19 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.945 0.403 . . . . 75.54 110.1 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.625 ' HZ1' ' HB2' ' A' ' 36' ' ' LYS . 9.6 mtmp? -86.88 128.05 35.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.079 0.466 . . . . 65.52 111.374 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.56 -178.62 38.2 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.243 -0.503 . . . . 64.33 113.183 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -66.22 93.85 0.23 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.214 0.53 . . . . 75.44 111.297 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.97 -121.4 5.42 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 116.077 -0.51 . . . . 73.33 112.33 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.82 12.09 29.37 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.144 0.497 . . . . 64.21 111.269 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -83.77 67.02 9.36 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.145 -0.48 . . . . 75.5 112.13 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -97.86 158.03 15.75 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.595 0.591 . . . . 73.41 112.595 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -131.36 133.41 45.27 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.461 0.704 . . . . 64.52 110.574 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.8 tp -105.46 107.38 18.33 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.79 0.329 . . . . 74.03 111.271 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.747 ' SD ' HG12 ' A' ' 54' ' ' ILE . 87.7 mmm -94.65 122.61 37.43 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.91 0.386 . . . . 74.35 111.124 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -108.14 117.67 34.75 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.791 0.329 . . . . 72.11 111.381 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.1 t -96.23 109.01 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.373 -0.376 . . . . 72.35 110.429 174.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 31.3 t70 -108.64 107.94 18.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.042 0.449 . . . . 61.33 110.344 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.3 -107.03 1.06 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.901 -0.666 . . . . 74.02 112.679 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -116.42 27.34 9.28 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.268 0.556 . . . . 73.45 111.668 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 17.3 ptt180 -142.76 148.03 36.53 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.043 -0.526 . . . . 74.21 110.898 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.5 tt -129.62 145.67 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 112.018 0.377 . . . . 73.11 112.018 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -149.69 168.96 22.14 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.885 0.374 . . . . 75.32 111.693 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.747 HG12 ' SD ' ' A' ' 45' ' ' MET . 35.3 mt -96.36 118.71 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.502 -0.317 . . . . 72.12 110.46 169.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -85.83 -36.37 20.07 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.912 0.387 . . . . 72.1 111.611 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -153.38 138.75 17.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.538 -0.301 . . . . 71.14 111.53 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -153.51 151.51 29.89 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.997 0.427 . . . . 73.24 110.596 175.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -102.01 74.94 1.49 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.019 0.438 . . . . 65.35 110.994 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.6 p -124.89 150.88 67.5 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-N 116.492 -0.322 . . . . 64.55 110.272 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.02 -29.17 40.79 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.356 2.037 . . . . 75.31 111.708 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.87 -35.82 25.92 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.397 -0.819 . . . . 74.23 111.89 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.466 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 27.2 mm-40 62.95 21.54 12.93 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.385 0.513 . . . . 73.54 112.385 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.537 ' O ' ' HG3' ' A' ' 67' ' ' MET . 89.6 t -57.8 -38.26 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.495 -0.321 . . . . 75.11 111.658 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.43 -57.22 14.22 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.642 -0.313 . . . . 61.33 113.45 -176.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.1 t -62.18 -34.85 65.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 120.952 0.406 . . . . 71.14 111.582 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 14.1 mptt -66.13 -28.38 68.76 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.467 0.543 . . . . 74.23 112.467 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.537 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 53.4 mtp -64.18 -24.12 67.56 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 122.064 -0.397 . . . . 74.44 111.708 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.34 -153.84 41.69 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 114.446 0.538 . . . . 73.41 114.446 173.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -80.82 142.21 33.92 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.125 0.488 . . . . 74.41 112.06 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.534 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 74.2 mmtt -125.61 133.87 52.1 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.01 -0.541 . . . . 73.24 109.672 175.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 54.0 p -155.77 28.35 0.38 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.171 1.174 . . . . 54.0 114.171 -170.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -160.33 162.32 33.45 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.773 0.657 . . . . 75.13 112.773 171.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.04 118.02 5.79 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.057 -0.52 . . . . 61.54 111.216 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 123.01 -17.16 8.12 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.267 -0.492 . . . . 74.34 112.682 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.534 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 64.5 m-20 -75.58 128.15 34.64 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 122.472 -0.428 . . . . 74.12 111.399 176.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 81.7 p -130.76 144.23 51.29 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.893 0.377 . . . . 75.34 111.702 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.538 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 45.5 mm -114.67 128.15 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 122.817 0.447 . . . . 74.24 110.348 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.15 115.83 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.033 0.444 . . . . 73.45 111.664 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 86.2 m -123.4 71.06 1.06 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.448 -0.342 . . . . 63.41 111.277 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.55 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 89.0 mt -53.15 -50.2 83.52 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 112.574 0.583 . . . . 74.33 112.574 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 53.2 Cg_exo -54.24 -20.76 20.46 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.15 1.9 . . . . 74.41 113.387 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -110.01 -1.73 17.46 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.263 0.468 . . . . 74.43 112.263 -175.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 63.41 17.39 10.27 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.539 0.336 . . . . 74.14 111.809 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.91 138.02 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.915 0.388 . . . . 72.4 111.652 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -141.93 131.4 23.8 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.374 -0.375 . . . . 74.14 110.791 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.538 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 47.5 t -127.38 145.76 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.573 0.225 . . . . 74.23 111.059 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -144.13 153.69 42.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.671 0.272 . . . . 75.45 110.883 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.451 HD13 ' HB2' ' A' ' 75' ' ' ASP . 59.5 mt -110.74 126.24 68.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.85 0.357 . . . . 74.4 111.051 175.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.609 ' HZ2' ' HB2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -127.05 177.77 6.43 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.348 -0.387 . . . . 74.21 110.248 176.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 28.4 t -107.07 151.47 25.31 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.213 0.53 . . . . 70.24 111.811 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.5 p -62.07 -23.99 66.83 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.759 -0.655 . . . . 72.23 111.182 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.471 ' HG2' ' OG ' ' A' ' 90' ' ' SER . 2.7 pt20 -72.5 166.84 21.85 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.932 0.396 . . . . 74.44 110.578 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -59.97 148.13 36.41 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.136 0.493 . . . . 73.52 112.176 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -133.31 141.21 47.86 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.276 0.56 . . . . 71.15 111.293 172.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 66.7 p -82.11 134.01 35.31 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.029 -0.532 . . . . 75.43 112.0 -176.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.809 ' HZ2' ' HB3' ' A' ' 96' ' ' LYS . 9.1 mtpm? -138.38 158.39 44.36 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.257 0.551 . . . . 65.2 112.164 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -97.05 149.0 35.21 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.817 -0.629 . . . . 53.41 109.83 171.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -51.67 -52.27 9.36 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.316 2.01 . . . . 62.33 111.966 175.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -141.31 130.35 23.29 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.406 0.622 . . . . 75.0 112.06 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 47.9 p -120.58 44.0 2.59 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.755 -0.657 . . . . 71.3 109.582 170.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 65.33 31.63 10.37 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.275 -0.875 . . . . 74.22 111.086 -172.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.9 tp -76.46 93.62 3.55 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.735 -0.666 . . . . 73.32 110.484 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 45.6 mm -74.7 89.38 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.275 0.56 . . . . 73.34 110.86 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.6 m -66.32 140.45 96.76 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.084 -0.507 . . . . 65.25 110.965 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.82 99.75 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.101 2.534 . . . . 74.33 114.245 -174.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -89.6 105.21 17.65 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.207 -0.451 . . . . 65.21 109.836 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -53.84 113.78 1.33 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.957 0.408 . . . . 72.32 111.989 -176.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -46.85 -50.06 19.14 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.715 -0.675 . . . . 75.42 111.813 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -164.49 168.6 18.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.908 -0.587 . . . . 65.14 110.959 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -69.34 144.57 53.45 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.138 0.494 . . . . 72.12 111.638 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -112.59 99.82 8.25 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.102 -0.499 . . . . 72.13 110.484 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -57.68 107.23 0.43 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.242 0.544 . . . . 72.34 111.106 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -84.52 -61.16 1.86 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.919 -0.582 . . . . 73.33 112.151 -173.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.894 -0.574 . . . . 72.42 112.003 -176.457 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 tpt . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 110.44 -0.207 . . . . 72.21 110.44 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt 55.63 71.28 0.56 Allowed 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.223 0.535 . . . . 74.52 111.277 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -111.65 122.65 48.38 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.173 -0.467 . . . . 71.22 111.381 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.8 m -106.1 138.99 41.33 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.963 0.411 . . . . 74.4 112.039 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.5 -64.85 1.78 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.253 -0.498 . . . . 54.34 112.438 175.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -123.15 151.69 41.88 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.508 0.323 . . . . 75.21 111.281 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -122.67 124.21 42.91 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.053 0.39 . . . . 74.42 112.053 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.4 m -115.96 152.68 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 121.288 0.566 . . . . 72.11 112.02 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 23' ' ' PRO . 27.8 m -127.0 148.51 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.122 -0.49 . . . . 75.13 111.647 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -102.67 115.47 30.65 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.984 0.421 . . . . 73.35 111.512 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.8 mm -100.4 116.51 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.339 -0.391 . . . . 74.11 111.146 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.483 ' N ' HD11 ' A' ' 12' ' ' ILE . 3.0 mp -97.63 127.46 49.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.041 0.448 . . . . 73.42 111.288 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.4 p -124.35 153.03 42.42 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.223 0.535 . . . . 65.25 111.453 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -139.74 127.04 21.31 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.941 -0.572 . . . . 71.21 110.999 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.543 HD21 ' N ' ' A' ' 15' ' ' ASN . 0.8 OUTLIER 61.14 17.0 7.66 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.347 0.499 . . . . 75.15 112.347 178.061 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.16 -31.6 6.16 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.258 -0.496 . . . . 63.54 113.802 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -98.42 147.58 24.57 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 122.202 -0.587 . . . . 74.42 112.102 -177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.17 134.77 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 122.3 -0.25 . . . . 73.54 110.493 173.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.3 pt -120.07 -29.81 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.785 0.661 . . . . 74.4 112.785 -177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -152.95 141.0 20.33 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.879 0.371 . . . . 74.52 111.591 -176.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -131.3 124.93 31.5 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.771 0.319 . . . . 64.42 111.226 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.504 HG22 HG22 ' A' ' 47' ' ' VAL . 4.1 mp -124.79 124.37 25.55 Favored Pre-proline 0 N--CA 1.474 0.772 0 CA-C-O 120.597 0.237 . . . . 74.43 111.467 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.468 ' HA ' HG13 ' A' ' 9' ' ' VAL . 60.2 Cg_endo -72.93 119.59 6.15 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.242 1.961 . . . . 71.14 111.812 172.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.8 mt -80.97 -63.06 1.49 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.073 0.463 . . . . 75.31 111.471 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.3 m -59.77 121.74 12.44 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.35 -0.386 . . . . 64.33 111.423 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.71 3.03 77.93 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.238 -0.506 . . . . 74.43 113.787 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.499 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 42.5 t-80 -77.51 129.12 35.27 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.305 -0.527 . . . . 75.45 111.235 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -94.31 137.52 33.37 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.989 0.423 . . . . 71.34 112.026 -177.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.89 -167.1 54.66 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 114.79 0.676 . . . . 74.21 114.79 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -118.66 122.45 42.56 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.861 0.464 . . . . 64.21 110.502 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -117.05 139.57 50.54 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 122.242 -0.286 . . . . 75.1 111.325 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -131.08 129.47 41.95 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.819 0.343 . . . . 73.42 111.311 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -138.98 141.93 38.37 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.896 0.379 . . . . 74.42 111.692 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.8 m -97.46 119.07 35.33 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.073 0.463 . . . . 74.12 111.767 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.7 mt -81.64 116.91 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.05 -0.523 . . . . 72.34 110.808 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -80.38 123.16 27.78 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.814 0.34 . . . . 74.31 111.664 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -110.85 -163.28 18.36 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.367 -0.444 . . . . 71.13 112.435 175.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -69.95 123.16 20.83 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 122.416 -0.461 . . . . 62.4 111.979 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.05 -103.74 0.43 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.343 -0.456 . . . . 64.45 113.673 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.41 -3.77 46.41 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.75 0.648 . . . . 74.0 112.75 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -76.07 133.55 40.29 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 111.799 0.296 . . . . 71.11 111.799 -176.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -158.2 163.82 37.12 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.899 0.38 . . . . 70.52 111.762 176.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -136.99 115.3 11.74 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.322 -0.399 . . . . 73.24 111.18 175.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.443 HD21 ' HB3' ' A' ' 56' ' ' GLU . 42.3 tp -87.92 103.34 15.59 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.22 0.533 . . . . 72.21 110.814 177.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.803 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.1 mmm -92.86 144.71 25.01 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.9 -0.591 . . . . 71.42 111.468 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -130.16 126.68 38.05 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.944 0.402 . . . . 71.53 111.528 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 22' ' ' ILE . 44.4 t -110.02 107.62 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.163 -0.472 . . . . 75.41 110.319 175.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.469 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 31.0 t70 -108.03 109.42 20.87 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.486 0.315 . . . . 74.31 110.42 -176.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 27' ' ' HIS . . . 57.79 -110.36 2.33 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.775 -0.726 . . . . 54.5 112.355 -175.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -110.24 18.05 20.31 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 120.886 0.375 . . . . 74.31 111.888 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 33.7 ptt180 -131.89 147.04 52.45 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.819 0.342 . . . . 74.42 111.465 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.0 tt -130.36 147.92 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.149 0.499 . . . . 72.11 112.188 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -159.87 165.52 32.06 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.088 -0.506 . . . . 74.32 111.415 177.241 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.803 HG12 ' SD ' ' A' ' 45' ' ' MET . 58.0 mt -89.91 120.42 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.946 0.403 . . . . 72.33 110.569 174.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -87.47 -31.21 20.12 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.493 -0.321 . . . . 63.11 111.746 -175.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.443 ' HB3' HD21 ' A' ' 44' ' ' LEU . 39.5 tt0 -167.95 138.98 2.83 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.086 0.47 . . . . 74.23 112.157 -175.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -161.04 -178.17 6.59 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.236 -0.438 . . . . 73.24 110.477 174.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -115.01 42.12 2.26 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.595 0.591 . . . . 73.0 112.595 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.8 m -88.01 131.75 42.01 Favored Pre-proline 0 N--CA 1.475 0.793 0 O-C-N 121.919 -0.488 . . . . 65.24 110.067 173.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.62 -40.9 71.83 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.342 2.028 . . . . 71.41 112.978 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.9 -13.36 31.35 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.433 0.531 . . . . 61.01 112.433 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 40.02 67.96 0.43 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.294 0.568 . . . . 72.3 112.477 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.2 t -74.05 -46.83 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.141 -0.482 . . . . 72.22 111.553 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.576 ' HA3' HD13 ' A' ' 54' ' ' ILE . . . -56.3 -43.71 89.52 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.436 -0.411 . . . . 73.02 113.722 -178.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -61.44 -38.14 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.091 0.472 . . . . 74.24 111.722 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -71.26 -28.35 64.1 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.047 0.388 . . . . 73.51 112.047 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 25.6 mmt -57.34 -28.94 63.56 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.924 0.393 . . . . 72.34 112.026 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.6 -155.64 39.71 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.294 -0.479 . . . . 63.14 113.781 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -82.48 119.47 24.25 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.957 0.408 . . . . 75.21 111.841 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 75.2 mmtt -111.41 151.01 29.0 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.244 -0.435 . . . . 72.53 110.041 175.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 63.2 p -168.65 6.52 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.546 1.313 . . . . 75.34 114.546 -174.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -124.94 152.46 44.1 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.64 -0.663 . . . . 73.31 112.28 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.4 99.99 0.07 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.719 -0.673 . . . . 74.52 111.25 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.18 -19.91 2.66 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.933 -0.576 . . . . 74.31 112.526 -175.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.424 ' HB2' HD12 ' A' ' 88' ' ' ILE . 76.1 m-20 -76.63 134.72 39.24 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.804 0.335 . . . . 71.2 111.491 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.526 HG23 ' HA ' ' A' ' 87' ' ' GLU . 45.0 p -135.75 150.19 49.42 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.09 0.471 . . . . 74.54 111.665 176.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.449 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 50.2 mm -115.99 127.37 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.198 -0.455 . . . . 71.13 110.75 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -115.22 118.65 59.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.97 0.414 . . . . 73.15 111.874 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 90.1 m -121.75 75.77 1.22 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.411 -0.359 . . . . 64.53 111.331 176.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.534 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 91.9 mt -55.36 -50.65 85.51 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 113.133 0.79 . . . . 62.44 113.133 -176.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.534 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 46.7 Cg_exo -56.93 -17.15 22.88 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.889 1.726 . . . . 74.25 113.461 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 47.8 m170 -114.49 -4.11 12.92 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 122.184 -0.323 . . . . 73.25 111.751 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm 61.36 30.61 19.1 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.847 0.459 . . . . 74.31 111.923 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 80.0 t -110.0 138.75 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.832 0.349 . . . . 64.42 111.294 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -139.12 132.64 30.32 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.79 0.329 . . . . 74.0 111.308 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.449 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 47.7 t -121.29 134.29 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 122.332 -0.23 . . . . 75.01 111.142 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.526 ' HA ' HG23 ' A' ' 76' ' ' THR . 8.6 pt-20 -123.6 126.31 46.4 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.046 0.45 . . . . 72.12 111.709 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.424 HD12 ' HB2' ' A' ' 75' ' ' ASP . 59.8 mt -95.58 116.73 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.212 0.529 . . . . 74.24 110.432 175.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -127.77 160.54 31.42 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.178 0.513 . . . . 73.4 111.899 -172.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.3 t -87.62 149.13 24.49 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.065 0.46 . . . . 75.22 111.76 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.3 p -88.33 -15.49 35.55 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.075 -0.511 . . . . 73.31 111.26 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -107.83 -178.25 3.57 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.013 -0.54 . . . . 75.24 111.7 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -83.0 125.54 31.54 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.859 0.361 . . . . 73.34 111.767 177.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -162.14 172.41 15.88 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.964 0.412 . . . . 63.0 111.442 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 79.0 p -89.33 109.95 20.8 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.314 0.487 . . . . 75.0 112.314 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -141.69 170.12 16.32 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.056 0.455 . . . . 73.54 111.632 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -100.22 111.81 63.02 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.041 -0.527 . . . . 75.12 111.02 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.73 -20.35 46.35 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.681 2.254 . . . . 74.21 112.681 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -122.32 132.07 54.22 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.009 -0.541 . . . . 64.23 110.61 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.1 m -153.32 123.15 6.85 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.132 0.419 . . . . 73.21 112.132 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -151.51 136.22 17.12 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.123 -0.489 . . . . 64.32 110.787 173.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.0 tp -153.34 83.72 1.19 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.385 0.612 . . . . 74.1 111.037 175.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 56.9 mt -84.5 105.73 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 116.277 -0.42 . . . . 75.54 110.558 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.5 m -80.59 139.86 51.29 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 112.71 0.633 . . . . 65.53 112.71 -174.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.97 145.82 96.6 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.751 2.3 . . . . 73.25 112.3 175.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -149.08 167.01 27.03 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.483 0.659 . . . . 73.14 112.693 -175.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 tt -71.66 131.07 42.64 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.347 -0.842 . . . . 63.14 112.026 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -71.29 121.63 18.81 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.089 0.471 . . . . 63.14 111.207 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -86.98 102.66 14.6 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.271 0.557 . . . . 75.03 111.549 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -122.88 145.35 48.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.983 0.421 . . . . 73.23 111.331 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -87.67 138.55 31.37 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.079 -0.509 . . . . 72.14 112.193 -172.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -94.59 130.67 40.94 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.24 -0.436 . . . . 73.23 111.183 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -104.2 -42.17 5.59 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.085 0.469 . . . . 72.22 110.692 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 . . . . . 0 C--O 1.251 1.15 0 CA-C-N 115.851 -0.613 . . . . 53.34 110.744 176.901 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.919 0.39 . . . . 72.45 111.797 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -82.6 83.5 7.59 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.974 0.416 . . . . 71.02 110.9 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -80.5 42.74 0.61 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.251 0.548 . . . . 74.02 111.767 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.6 m -73.77 117.3 15.37 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.83 -0.623 . . . . 73.43 111.772 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.49 -86.52 1.78 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.329 -0.462 . . . . 74.53 113.06 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -86.73 111.51 20.78 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.487 0.66 . . . . 73.1 112.152 -177.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.564 ' HA ' ' HB ' ' A' ' 25' ' ' THR . 46.0 mt-10 -87.98 99.65 12.31 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.178 -0.465 . . . . 72.31 110.876 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 34.5 m -102.76 161.82 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 113.282 0.845 . . . . 71.43 113.282 -174.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.555 HG13 ' HA ' ' A' ' 23' ' ' PRO . 33.1 m -130.04 153.17 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 115.398 -0.819 . . . . 72.25 111.006 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.37 119.97 41.1 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.406 -0.361 . . . . 71.33 111.146 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.3 mm -101.02 111.4 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.591 -0.277 . . . . 65.13 110.949 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.478 HD11 ' N ' ' A' ' 12' ' ' ILE . 3.6 mp -100.98 111.11 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 120.941 0.4 . . . . 75.3 111.762 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.2 p -108.86 140.56 42.16 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.746 0.308 . . . . 65.42 110.405 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.619 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 54.5 tt0 -141.33 131.67 25.12 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.258 -0.276 . . . . 72.41 111.251 -177.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.509 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 52.1 m-80 58.74 16.85 4.7 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 120.888 0.375 . . . . 60.04 111.961 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.09 -12.61 60.51 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.126 -0.559 . . . . 65.43 113.736 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 14' ' ' GLN . 21.5 pttp -109.61 132.87 53.74 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 117.273 0.536 . . . . 72.51 111.573 -178.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.7 t -71.84 115.94 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.848 0.356 . . . . 75.5 110.719 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.9 pt -102.3 -23.1 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 113.156 0.799 . . . . 70.44 113.156 -173.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.6 tpp85 -157.45 126.99 6.03 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.769 0.655 . . . . 74.41 112.769 -173.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -118.01 119.18 34.0 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.629 -0.508 . . . . 73.45 109.629 173.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.59 126.33 26.49 Favored Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 112.989 0.737 . . . . 74.44 112.989 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.555 ' HA ' HG13 ' A' ' 9' ' ' VAL . 73.8 Cg_endo -76.24 111.79 3.34 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.389 2.059 . . . . 72.03 111.536 169.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.66 -69.32 0.61 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.232 0.456 . . . . 74.13 112.232 -174.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.564 ' HB ' ' HA ' ' A' ' 7' ' ' GLU . 6.7 m -59.41 124.58 20.49 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.002 0.43 . . . . 74.45 111.537 -176.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.06 -22.48 33.19 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.331 -0.462 . . . . 62.33 112.835 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -77.91 91.3 4.17 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.189 -0.595 . . . . 74.43 111.23 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -80.05 153.34 28.86 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.059 -0.518 . . . . 73.44 110.712 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.38 -162.91 27.25 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.051 -0.595 . . . . 63.54 112.971 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -118.18 145.0 45.27 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.197 0.522 . . . . 71.21 111.687 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.57 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 16.8 tp10 -139.75 139.32 36.47 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.915 -0.584 . . . . 60.01 110.209 176.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -141.66 133.4 27.15 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.865 0.364 . . . . 75.22 111.859 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -148.92 142.58 25.49 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.203 0.525 . . . . 62.23 111.772 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.8 m -98.29 115.11 27.72 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.119 -0.491 . . . . 71.02 111.729 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 60.3 mt -80.07 112.93 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.203 0.525 . . . . 74.41 111.188 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.2 mtmt -79.4 108.44 12.93 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.841 -0.618 . . . . 64.03 111.215 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.619 ' HA2' ' NE2' ' A' ' 14' ' ' GLN . . . -91.39 -86.08 1.44 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.178 -0.534 . . . . 61.34 113.722 -176.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -148.2 114.12 5.77 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.643 -0.328 . . . . 75.13 110.759 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.89 -107.9 1.5 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.119 -0.562 . . . . 74.31 112.937 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.97 -10.03 40.86 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.516 -0.402 . . . . 71.13 111.892 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -79.73 125.8 30.13 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.019 0.438 . . . . 74.01 111.925 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -145.67 172.54 13.12 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.084 -0.507 . . . . 73.33 111.308 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.419 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 15.6 m120 -136.99 110.44 7.94 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.554 -0.294 . . . . 75.02 110.681 173.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.3 tp -85.05 107.85 17.36 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.943 0.402 . . . . 75.13 110.908 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.782 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.9 mmm -100.67 150.94 22.22 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.001 0.429 . . . . 55.13 111.669 -176.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -138.84 130.84 28.0 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.209 -0.451 . . . . 75.03 111.84 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.57 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 30.4 t -113.08 107.66 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.313 -0.403 . . . . 74.12 110.492 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.421 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 8.8 t0 -130.93 140.13 50.15 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.517 0.199 . . . . 63.21 110.893 -176.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 51.87 51.08 41.55 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 114.385 0.514 . . . . 73.22 114.385 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 69.03 15.06 8.83 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.473 0.916 . . . . 61.02 113.473 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.431 ' HG3' ' HE3' ' A' ' 69' ' ' TRP . 3.6 ptp180 -147.52 166.9 25.89 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.721 -0.612 . . . . 72.41 112.58 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.1 tt -125.83 150.8 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.292 0.479 . . . . 75.11 112.292 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.464 ' HB3' ' HA ' ' A' ' 69' ' ' TRP . 1.8 ppt_? -155.68 159.16 39.33 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.146 -0.479 . . . . 74.44 111.192 177.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.782 HG12 ' SD ' ' A' ' 45' ' ' MET . 34.5 mt -85.85 115.99 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.153 0.502 . . . . 61.12 110.713 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -78.79 -34.73 45.24 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.879 -0.6 . . . . 73.34 111.895 -175.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -172.93 138.63 0.8 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.558 0.218 . . . . 73.3 111.276 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -152.75 149.93 28.87 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.93 0.395 . . . . 64.33 110.91 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -100.41 74.8 1.74 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.371 0.605 . . . . 75.24 111.599 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.0 p -124.11 149.92 61.79 Favored Pre-proline 0 N--CA 1.475 0.79 0 O-C-N 122.082 -0.387 . . . . 74.51 111.478 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.26 -23.27 45.25 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.37 2.047 . . . . 74.34 111.964 174.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.5 ' HB3' HG22 ' A' ' 63' ' ' VAL . 8.7 m-20 -73.06 -56.82 4.59 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.885 -0.598 . . . . 74.14 111.388 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 62.17 11.87 4.69 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.986 0.515 . . . . 75.12 112.296 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 61' ' ' ASP . 59.9 t -56.62 -36.27 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.059 0.457 . . . . 73.23 111.177 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.538 ' HA3' HD13 ' A' ' 54' ' ' ILE . . . -58.04 -47.58 88.19 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.191 -0.528 . . . . 73.32 112.942 177.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.04 -41.84 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.195 0.521 . . . . 74.24 111.213 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -67.28 -29.28 68.85 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.213 0.449 . . . . 73.34 112.213 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 22.0 mmt -58.84 -42.26 88.87 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.726 0.298 . . . . 74.12 111.785 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.0 -139.37 28.28 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.311 -0.471 . . . . 73.44 113.112 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.464 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . 84.5 m95 -81.84 129.57 34.79 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.76 0.314 . . . . 75.22 111.491 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.413 ' HG3' HD12 ' A' ' 77' ' ' ILE . 74.7 mmtt -129.1 148.59 51.06 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.82 0.448 . . . . 52.43 110.292 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.4 ' HB3' ' CB ' ' A' ' 51' ' ' ARG . 94.7 p -175.25 25.44 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.489 0.922 . . . . 71.54 113.489 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -120.16 144.56 47.61 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.614 -0.679 . . . . 75.33 111.394 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.16 96.26 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.094 0.473 . . . . 44.23 111.189 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.43 -26.42 1.99 Allowed Glycine 0 CA--C 1.525 0.697 0 CA-C-N 116.057 -0.52 . . . . 62.23 112.686 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.48 ' HB2' HD12 ' A' ' 88' ' ' ILE . 75.9 m-20 -64.57 135.35 55.89 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.876 0.37 . . . . 64.12 111.647 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.5 p -138.44 142.36 39.49 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.074 0.464 . . . . 73.31 111.617 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.413 HD12 ' HG3' ' A' ' 70' ' ' LYS . 38.7 mm -114.61 130.96 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.211 -0.449 . . . . 70.43 110.626 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.7 t -123.11 119.62 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 112.051 0.389 . . . . 72.4 112.051 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 97.8 m -121.77 88.79 3.0 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 120.733 0.302 . . . . 73.34 110.873 174.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.572 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 92.6 mt -59.25 -53.89 61.7 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 113.078 0.77 . . . . 72.12 113.078 -175.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.572 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 24.7 Cg_exo -62.81 -19.32 68.22 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.958 1.772 . . . . 65.44 113.007 -176.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -104.28 -5.04 22.22 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.483 -0.326 . . . . 75.1 111.683 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.1 mttm 58.16 34.29 24.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.811 0.445 . . . . 75.44 111.917 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.527 HG23 ' HG3' ' A' ' 14' ' ' GLN . 60.2 t -109.36 132.86 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.137 -0.483 . . . . 74.41 111.33 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -133.33 136.42 45.38 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.729 0.3 . . . . 74.51 110.695 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -132.9 139.49 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.8 -0.182 . . . . 75.0 111.214 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.434 ' CD ' ' HZ1' ' A' ' 89' ' ' LYS . 10.1 pt-20 -126.15 154.52 43.06 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.794 0.331 . . . . 64.04 110.813 174.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.48 HD12 ' HB2' ' A' ' 75' ' ' ASP . 55.1 mt -118.24 123.09 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.094 0.473 . . . . 74.25 110.908 174.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.468 ' HE3' ' HG3' ' A' ' 96' ' ' LYS . 8.6 ptmt -140.49 151.17 44.6 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.201 -0.454 . . . . 74.14 111.157 -175.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.504 ' OG ' ' HG2' ' A' ' 92' ' ' GLN . 22.9 t -74.2 149.82 40.68 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.064 0.459 . . . . 74.33 111.657 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.1 p -70.31 -21.22 62.95 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 116.25 -0.432 . . . . 75.34 111.837 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.504 ' HG2' ' OG ' ' A' ' 90' ' ' SER . 20.4 pt20 -87.92 -170.09 2.85 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.414 -0.357 . . . . 74.14 110.72 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -61.92 115.82 4.36 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.276 0.56 . . . . 74.45 111.286 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.468 ' OD1' ' HG2' ' A' ' 96' ' ' LYS . 9.5 t70 -107.24 164.93 11.76 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.571 -0.74 . . . . 73.21 110.765 -174.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 64.3 p -84.06 30.84 0.5 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.302 -0.408 . . . . 73.41 111.818 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.468 ' HG2' ' OD1' ' A' ' 94' ' ' ASP . 48.5 mmtm -88.3 160.72 17.52 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.041 0.448 . . . . 75.53 111.503 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -83.79 147.73 52.55 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 116.289 -0.414 . . . . 73.14 111.718 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -86.12 10.24 3.74 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.817 2.345 . . . . 71.4 113.759 -177.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -82.45 17.23 1.8 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.268 0.47 . . . . 54.23 112.268 -178.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 82.7 p -110.94 153.85 24.93 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.248 0.462 . . . . 73.23 112.248 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.9 t70 71.04 101.83 0.06 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.865 -0.607 . . . . 64.23 112.554 173.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.7 pp -168.77 -176.1 2.61 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.723 -0.672 . . . . 74.51 110.93 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 65.3 mt -67.47 105.27 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.148 0.499 . . . . 72.41 111.244 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.1 p -69.28 131.14 90.5 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 116.141 -0.482 . . . . 74.43 111.759 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.07 107.04 1.64 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.579 2.186 . . . . 74.21 112.871 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -69.6 86.47 0.47 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.085 0.469 . . . . 73.43 110.93 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -65.58 140.4 58.53 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.031 0.443 . . . . 75.11 111.807 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -70.76 81.03 0.62 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.186 0.517 . . . . 74.4 111.674 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -133.03 119.5 20.13 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.915 0.388 . . . . 75.3 110.359 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -72.92 116.26 13.21 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.491 0.552 . . . . 75.35 112.491 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -154.15 110.11 3.24 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.154 0.502 . . . . 74.44 110.775 173.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -60.97 105.79 0.51 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.05 0.452 . . . . 73.43 111.921 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -97.4 116.2 29.17 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.091 -0.504 . . . . 74.14 110.92 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.652 -0.69 . . . . 73.41 111.506 -179.468 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.0 mmm . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 112.077 0.399 . . . . 55.44 112.077 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.604 ' HA ' ' HE2' ' A' ' 2' ' ' LYS . 0.6 OUTLIER -79.0 99.47 6.87 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.045 0.45 . . . . 74.4 110.801 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -68.14 149.36 49.69 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.21 -0.45 . . . . 74.54 111.251 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.601 ' HB ' HG23 ' A' ' 25' ' ' THR . 25.1 m -61.41 128.04 34.41 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.671 -0.24 . . . . 73.22 111.159 178.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.19 -44.18 67.61 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.885 -0.674 . . . . 64.33 112.461 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.01 87.63 4.81 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.184 0.516 . . . . 75.53 110.437 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.502 ' HG2' HG22 ' A' ' 25' ' ' THR . 42.1 mt-10 -81.08 136.31 35.93 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.185 -0.462 . . . . 74.14 112.08 -175.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.453 HG23 ' HB2' ' A' ' 24' ' ' LEU . 31.3 m -125.54 139.16 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.164 0.506 . . . . 71.41 111.45 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.3 m -121.96 138.64 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 116.178 -0.465 . . . . 74.11 111.193 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.26 112.64 24.31 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.823 0.344 . . . . 72.01 111.333 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.2 mm -95.04 115.16 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.403 -0.362 . . . . 73.15 110.982 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.2 mp -97.25 114.64 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.047 0.451 . . . . 75.14 111.509 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.5 m -114.39 134.74 54.76 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.219 -0.446 . . . . 73.35 111.448 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.447 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 49.8 tt0 -126.82 131.27 51.27 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 122.337 -0.227 . . . . 75.32 111.051 177.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.516 HD21 ' N ' ' A' ' 15' ' ' ASN . 0.8 OUTLIER 56.42 28.05 13.03 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.429 0.529 . . . . 73.44 112.429 176.355 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.12 21.57 41.43 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.253 -0.498 . . . . 60.32 114.34 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -146.78 140.33 25.75 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.308 0.554 . . . . 75.42 111.657 175.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.9 t -72.36 118.97 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.791 0.329 . . . . 75.3 111.014 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.1 pt -99.43 -23.44 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 112.219 0.451 . . . . 71.53 112.219 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -173.16 148.04 1.64 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.703 0.287 . . . . 75.32 111.014 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -131.33 127.37 37.52 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.179 0.514 . . . . 72.43 111.442 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.405 HD11 ' N ' ' A' ' 22' ' ' ILE . 3.4 mp -113.67 116.12 45.95 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 116.358 -0.383 . . . . 63.41 111.418 -177.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.45 120.59 7.82 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.172 1.915 . . . . 72.44 111.757 172.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.453 ' HB2' HG23 ' A' ' 8' ' ' VAL . 86.9 mt -80.11 -48.89 12.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.056 0.455 . . . . 72.52 111.5 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.601 HG23 ' HB ' ' A' ' 4' ' ' THR . 86.2 m -60.57 110.16 1.21 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.975 0.417 . . . . 74.03 111.805 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.73 0.53 60.55 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.059 -0.591 . . . . 73.34 113.465 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -72.51 86.49 1.17 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 117.159 0.48 . . . . 74.2 110.547 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -72.95 115.96 12.88 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.184 0.516 . . . . 72.5 111.953 -176.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.5 -166.49 14.37 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.145 -0.479 . . . . 54.2 113.952 177.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -116.89 136.6 52.83 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.763 0.425 . . . . 74.34 110.422 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -145.68 129.91 17.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.902 0.382 . . . . 53.53 111.592 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -121.72 147.6 45.7 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.6 -0.273 . . . . 74.15 111.561 -177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -147.99 143.69 27.45 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.966 0.412 . . . . 71.34 111.307 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -103.39 126.7 50.69 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.17 0.51 . . . . 65.51 112.216 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' A' ' 43' ' ' ASN . 60.7 mt -90.69 132.75 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.121 -0.491 . . . . 75.11 110.66 175.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.58 125.88 48.31 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.997 0.427 . . . . 72.25 111.223 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -113.42 -164.6 15.77 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.29 -0.481 . . . . 54.41 113.831 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -59.07 113.28 2.03 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.895 0.379 . . . . 74.44 112.011 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.54 -125.1 7.86 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.242 -0.504 . . . . 41.4 113.242 178.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.8 9.93 28.15 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.205 0.446 . . . . 72.44 112.205 -178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -74.01 132.75 42.68 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.649 -0.251 . . . . 75.35 111.572 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -137.26 174.36 10.69 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.929 0.395 . . . . 73.43 111.125 174.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.463 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . 2.1 t-20 -152.21 109.64 3.58 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.249 -0.282 . . . . 63.45 111.031 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.2 tp -86.6 105.12 16.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.96 0.41 . . . . 71.42 111.147 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.742 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.4 mmm -95.51 135.62 36.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.147 -0.479 . . . . 75.24 111.05 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.67 127.39 48.13 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.255 0.55 . . . . 75.31 111.96 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.3 t -112.44 107.87 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.03 -0.532 . . . . 64.01 110.586 176.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -112.33 112.35 23.87 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.763 0.316 . . . . 75.4 110.569 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 63.52 -121.46 23.99 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.938 -0.648 . . . . 64.33 112.506 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -106.25 25.81 10.58 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 122.469 -0.43 . . . . 72.34 111.668 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.8 ptt85 -140.92 145.52 36.18 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.204 0.526 . . . . 74.42 111.795 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.9 tt -123.72 153.94 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 116.1 -0.5 . . . . 64.14 111.479 -176.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -157.33 168.47 27.29 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.005 0.431 . . . . 74.14 111.424 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.742 HG12 ' SD ' ' A' ' 45' ' ' MET . 45.3 mt -91.54 123.92 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 109.749 -0.463 . . . . 74.32 109.749 168.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -93.49 -34.06 13.54 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.38 0.511 . . . . 73.43 112.38 -172.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -169.0 139.28 2.29 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.577 -0.283 . . . . 73.54 111.293 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.444 ' HB3' HD21 ' A' ' 43' ' ' ASN . 6.8 p-10 -161.22 160.99 30.68 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.987 0.422 . . . . 72.1 111.536 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -96.09 74.04 2.98 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.45 0.643 . . . . 75.52 111.858 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 84.2 p -125.7 148.84 63.49 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-N 116.381 -0.372 . . . . 70.34 110.92 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.46 -3.18 13.45 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.394 2.062 . . . . 73.24 112.639 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -110.49 -43.81 3.81 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.265 -0.425 . . . . 62.25 111.949 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 63.47 30.42 15.3 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.854 0.359 . . . . 75.5 111.383 -177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.2 t -52.56 -42.19 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 111.955 0.354 . . . . 70.21 111.955 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.552 ' HA3' HD11 ' A' ' 54' ' ' ILE . . . -55.38 -43.98 84.92 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.068 -0.587 . . . . 62.04 112.883 176.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.1 t -64.71 -39.22 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 120.854 0.359 . . . . 73.4 111.069 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -65.05 -41.63 94.98 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.718 0.294 . . . . 73.52 111.402 177.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.9 mmt -57.43 -44.28 84.53 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.447 0.536 . . . . 72.33 112.447 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.96 -160.93 43.31 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 120.933 -0.651 . . . . 54.43 113.683 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -67.09 146.77 53.95 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.692 0.626 . . . . 74.3 112.692 -174.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.494 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 33.3 mmtm -135.63 140.67 44.74 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.89 -0.595 . . . . 71.54 110.33 177.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 82.2 p -164.84 11.06 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.29 0.848 . . . . 75.13 113.29 -176.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -114.13 153.9 28.73 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.938 -0.477 . . . . 72.32 111.653 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 90' ' ' SER . . . -69.11 91.34 0.5 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.211 0.529 . . . . 54.13 111.024 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.27 -22.33 2.41 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.893 -0.594 . . . . 65.2 112.337 -175.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.494 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 94.4 m-20 -63.36 142.86 58.23 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.938 0.399 . . . . 75.24 111.611 177.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.0 p -143.7 161.49 38.43 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.202 0.525 . . . . 71.24 111.645 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.3 mm -128.07 114.0 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.829 -0.623 . . . . 62.11 110.247 176.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.0 t -109.22 115.63 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.817 0.342 . . . . 71.51 111.442 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 74.2 m -123.34 88.09 2.86 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.699 0.285 . . . . 74.25 111.18 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.65 -45.37 88.4 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 113.096 0.776 . . . . 74.04 113.096 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.74 -25.76 35.6 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 122.16 1.907 . . . . 75.44 113.556 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -112.39 -1.24 15.1 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.106 0.41 . . . . 74.01 112.106 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 59.88 33.56 21.59 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.964 0.411 . . . . 74.55 111.791 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 68.0 t -105.65 135.66 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.274 -0.421 . . . . 75.52 111.335 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -139.35 116.21 10.88 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.257 -0.429 . . . . 70.55 110.853 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.1 t -113.35 126.44 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.569 -0.287 . . . . 74.5 111.208 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -120.78 136.79 54.8 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.084 0.469 . . . . 73.13 111.467 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 62.9 mt -103.01 120.79 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.853 0.359 . . . . 74.31 111.331 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -124.4 147.06 48.51 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.106 -0.497 . . . . 73.3 111.064 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 48.1 t -92.45 150.28 20.89 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.188 0.518 . . . . 72.4 112.115 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 7' ' ' GLU . 46.9 p -79.72 -13.78 59.21 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.895 -0.593 . . . . 73.21 110.783 174.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -88.32 134.0 33.92 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.108 -0.496 . . . . 74.22 111.077 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.8 152.23 23.55 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.013 0.745 . . . . 70.43 113.013 -178.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -90.03 -177.58 5.22 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.557 -0.747 . . . . 72.32 112.058 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.3 t -165.81 166.92 17.37 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 116.222 -0.445 . . . . 62.3 111.47 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.95 162.46 40.3 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.423 -0.353 . . . . 73.44 111.821 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -95.34 115.41 65.42 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 111.687 0.254 . . . . 73.04 111.687 177.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.26 -24.72 50.53 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.462 2.108 . . . . 74.53 111.581 170.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -71.57 90.95 1.04 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.819 -0.628 . . . . 75.23 111.544 178.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.6 p -80.83 160.31 24.84 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.939 0.4 . . . . 74.25 111.268 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -89.15 124.97 34.84 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.101 0.477 . . . . 73.1 111.194 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.5 tp -95.49 110.4 22.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.467 -0.333 . . . . 73.35 110.675 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.2 mm -112.35 106.61 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.805 0.336 . . . . 74.22 111.171 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.4 t 54.2 96.17 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 112.91 0.707 . . . . 75.31 112.91 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -75.99 155.63 38.48 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.238 2.625 . . . . 73.44 112.311 172.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -69.22 148.92 49.16 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.236 0.541 . . . . 64.25 112.141 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.407 ' N ' HD23 ' A' ' 107' ' ' LEU . 3.1 mm? -93.79 -173.85 3.27 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.158 -0.474 . . . . 73.04 110.715 176.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.52 -168.81 1.7 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.776 0.322 . . . . 64.4 111.477 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -119.59 102.84 8.92 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.088 0.47 . . . . 75.25 111.125 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.65 92.22 0.46 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.621 0.6 . . . . 73.42 112.621 -177.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -120.08 -10.92 9.34 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.883 -0.599 . . . . 75.02 110.753 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -77.7 127.35 32.3 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.232 0.539 . . . . 75.22 112.177 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -164.72 121.42 1.54 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.492 -0.776 . . . . 72.2 110.386 176.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 . . . . . 0 C--O 1.249 1.05 0 N-CA-C 112.623 0.601 . . . . 74.03 112.623 -176.518 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.717 0.294 . . . . 73.13 111.607 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -91.85 101.07 13.66 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.812 0.339 . . . . 75.54 110.194 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -73.52 83.49 1.51 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.409 0.624 . . . . 73.11 111.102 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.508 HG22 HG22 ' A' ' 25' ' ' THR . 32.8 m -63.14 133.45 54.42 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.58 -0.736 . . . . 72.24 111.711 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.04 -51.23 46.73 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 121.339 -0.457 . . . . 74.11 114.087 -176.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -148.57 163.16 38.05 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 120.851 0.357 . . . . 74.13 111.74 -175.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -91.24 107.03 18.93 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.137 0.494 . . . . 64.04 111.654 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.6 m -120.87 154.26 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 121.155 0.502 . . . . 73.44 112.031 -177.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 23' ' ' PRO . 34.5 m -121.57 147.6 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.03 -0.532 . . . . 72.21 111.282 177.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.99 117.59 34.59 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.835 0.35 . . . . 72.11 111.527 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.9 mm -100.78 122.42 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.561 -0.291 . . . . 72.04 111.051 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.469 ' N ' HD11 ' A' ' 12' ' ' ILE . 3.3 mp -107.8 113.88 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.051 0.453 . . . . 74.32 110.923 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.1 m -120.35 134.91 55.18 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.173 -0.467 . . . . 71.15 111.531 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.529 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 62.8 tt0 -119.29 138.84 52.75 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.648 0.261 . . . . 63.12 110.919 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.529 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 54.7 m-80 59.72 17.25 6.16 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.732 0.413 . . . . 72.54 111.98 -177.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.3 3.4 63.28 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.118 -0.563 . . . . 75.11 113.827 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -124.84 140.33 53.03 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 117.238 0.519 . . . . 74.14 111.23 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.34 129.16 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.844 0.354 . . . . 74.01 111.689 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.5 pt -112.78 -31.49 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 116.414 -0.357 . . . . 73.25 111.663 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -157.62 144.94 18.43 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.681 0.277 . . . . 74.3 111.257 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -138.51 132.08 30.64 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 120.77 0.319 . . . . 75.02 110.739 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.452 ' N ' HD13 ' A' ' 22' ' ' ILE . 4.0 mp -126.3 119.39 23.41 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 120.567 0.222 . . . . 74.22 111.552 -177.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.498 ' HA ' HG12 ' A' ' 9' ' ' VAL . 43.1 Cg_endo -68.29 101.6 0.74 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.075 1.85 . . . . 73.02 111.535 172.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.18 -62.44 1.77 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.354 0.502 . . . . 73.51 112.354 -173.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.508 HG22 HG22 ' A' ' 4' ' ' THR . 15.0 m -58.58 131.18 50.04 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.94 0.4 . . . . 74.33 111.443 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.62 -33.21 4.9 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.239 -0.505 . . . . 72.54 112.667 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -74.07 85.57 1.82 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.424 0.631 . . . . 71.41 110.82 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -86.74 167.62 14.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.68 -0.691 . . . . 65.12 111.633 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.73 -162.37 51.91 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 120.909 -0.662 . . . . 71.41 112.807 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -117.77 146.59 43.7 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.197 -0.59 . . . . 72.43 111.836 -176.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -161.19 116.92 2.16 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.818 -0.628 . . . . 73.42 110.285 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -113.86 145.96 40.7 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.822 0.344 . . . . 74.31 111.22 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -138.2 139.93 39.52 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.15 0.5 . . . . 71.3 111.481 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.4 m -98.87 121.2 40.52 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.955 -0.566 . . . . 72.34 112.077 -175.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.434 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 75.0 mt -91.58 123.37 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.121 -0.49 . . . . 75.14 111.31 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -103.07 124.39 48.45 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.508 0.194 . . . . 75.52 111.117 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -123.02 -143.23 6.32 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.064 -0.589 . . . . 64.01 113.679 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -60.93 106.78 0.62 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.183 0.438 . . . . 73.35 112.183 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.78 -116.88 8.17 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.216 -0.447 . . . . 74.32 113.454 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.78 6.72 48.13 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.031 0.382 . . . . 65.13 112.031 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -75.26 111.07 10.14 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.619 0.247 . . . . 74.11 111.563 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -127.12 164.89 20.61 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.016 0.436 . . . . 75.14 111.353 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.434 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 17.6 m120 -140.05 123.55 17.13 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.233 -0.439 . . . . 74.21 111.127 176.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.7 tp -96.65 104.19 16.16 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.893 0.378 . . . . 75.12 110.84 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.742 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.4 mmm -94.38 128.8 41.14 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.24 -0.437 . . . . 65.13 111.237 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -115.13 118.81 34.41 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.942 0.401 . . . . 73.22 111.962 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.9 t -104.02 114.33 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.155 -0.475 . . . . 71.41 110.001 171.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -133.67 92.46 2.98 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.924 -0.485 . . . . 72.43 112.167 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.76 67.72 1.72 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.294 -0.479 . . . . 72.2 114.249 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 60.64 26.86 16.58 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.72 0.637 . . . . 53.01 112.72 175.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -149.27 150.66 32.92 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.565 0.346 . . . . 75.23 110.319 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.8 tt -134.62 151.81 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.191 0.441 . . . . 64.54 112.191 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -157.18 168.4 27.54 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.202 -0.454 . . . . 74.54 111.496 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.742 HG12 ' SD ' ' A' ' 45' ' ' MET . 54.4 mt -92.27 110.05 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.47 -0.567 . . . . 73.52 109.47 169.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -86.37 -39.1 16.75 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 111.841 0.311 . . . . 65.41 111.841 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -138.86 146.95 41.82 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.739 0.304 . . . . 74.04 110.695 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -168.5 140.15 2.73 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.575 0.35 . . . . 74.0 110.329 -174.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -106.6 38.01 2.18 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.413 0.523 . . . . 74.31 112.413 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.2 m -84.1 138.5 39.66 Favored Pre-proline 0 N--CA 1.471 0.595 0 O-C-N 122.058 -0.401 . . . . 75.32 110.016 172.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.54 -25.74 68.51 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.307 2.004 . . . . 74.1 112.777 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.456 ' HB3' HG23 ' A' ' 63' ' ' VAL . 10.9 m-20 -84.45 -32.38 24.07 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.31 -0.404 . . . . 50.13 111.957 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.52 ' HB3' ' HZ2' ' A' ' 66' ' ' LYS . 87.8 mm-40 59.54 13.48 3.34 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.136 0.791 . . . . 73.43 113.136 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.456 HG23 ' HB3' ' A' ' 61' ' ' ASP . 97.0 t -56.15 -41.34 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 112.479 0.548 . . . . 74.54 112.479 -176.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.48 -42.48 57.46 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.191 -0.528 . . . . 73.22 113.51 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.2 t -68.82 -33.59 60.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.189 0.519 . . . . 62.23 111.333 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.52 ' HZ2' ' HB3' ' A' ' 62' ' ' GLN . 13.4 mptt -73.15 -28.12 62.05 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.313 0.486 . . . . 64.22 112.313 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 90.7 mmm -52.76 -47.17 67.64 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.342 0.497 . . . . 63.34 112.342 -177.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.42 -163.94 20.0 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.054 -0.593 . . . . 72.15 113.416 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -76.48 138.94 40.6 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.029 0.443 . . . . 75.22 112.014 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -126.69 146.55 50.16 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.28 -0.418 . . . . 72.01 110.639 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 82.2 p -172.2 26.42 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 112.724 0.638 . . . . 65.13 112.724 -176.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -125.16 146.39 49.51 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.686 0.279 . . . . 70.3 111.32 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.15 96.65 0.05 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.079 0.466 . . . . 74.3 111.65 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 138.14 -19.7 3.24 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 116.093 -0.503 . . . . 72.04 112.918 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -63.96 120.16 11.45 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.108 0.48 . . . . 75.13 111.588 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.46 HG23 ' HA ' ' A' ' 87' ' ' GLU . 32.5 p -128.96 141.92 51.1 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.077 0.465 . . . . 73.51 111.421 178.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 mm -122.58 127.64 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 116.269 -0.423 . . . . 74.32 110.687 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.6 t -119.71 119.32 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.836 0.35 . . . . 73.13 111.48 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 98.3 m -117.62 88.2 2.86 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.841 0.353 . . . . 73.44 110.6 173.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.5 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 96.2 mt -54.46 -50.83 83.01 Favored Pre-proline 0 CA--C 1.547 0.827 0 N-CA-C 113.314 0.857 . . . . 73.12 113.314 -175.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 75.5 Cg_exo -50.41 -34.52 41.74 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.156 1.904 . . . . 75.21 113.634 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -103.42 -3.92 24.79 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 111.976 0.361 . . . . 72.34 111.976 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.5 mttp 59.85 33.99 21.71 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.134 0.492 . . . . 61.21 112.276 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.7 t -101.12 133.18 45.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 116.218 -0.446 . . . . 74.53 111.084 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -130.58 125.61 34.61 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.079 -0.51 . . . . 64.02 110.689 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.43 HG21 HG13 ' A' ' 12' ' ' ILE . 47.7 t -118.19 124.1 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.68 -0.236 . . . . 75.54 111.183 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.46 ' HA ' HG23 ' A' ' 76' ' ' THR . 8.9 pt-20 -120.9 122.15 39.6 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.094 0.473 . . . . 74.31 111.467 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.9 mt -97.07 118.16 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 120.98 0.419 . . . . 72.54 110.537 175.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -129.53 150.18 50.98 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.114 0.483 . . . . 74.45 112.122 -173.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.6 t -77.48 150.51 34.9 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.925 -0.58 . . . . 71.54 112.448 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.2 p -85.13 0.18 52.51 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.899 -0.591 . . . . 73.31 111.315 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -88.47 -177.82 5.71 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.458 0.647 . . . . 74.41 111.508 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.622 ' HZ2' ' HB2' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -134.64 145.69 48.83 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.775 -0.648 . . . . 75.0 109.533 171.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -142.52 118.9 10.88 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.97 0.414 . . . . 74.24 111.383 -174.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.9 t -131.8 95.46 3.71 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.986 0.422 . . . . 73.11 111.122 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -103.7 97.68 7.67 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.421 0.629 . . . . 72.43 111.204 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -67.41 142.86 96.84 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 115.419 -0.81 . . . . 72.31 112.352 -174.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.42 -48.09 14.63 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.467 2.111 . . . . 74.22 112.52 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.12 -95.16 0.21 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 116.458 -0.337 . . . . 74.34 111.57 176.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.2 t 173.04 -28.7 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 111.92 0.341 . . . . 71.14 111.92 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -86.33 179.59 6.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.178 0.513 . . . . 72.05 112.067 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.3 pp -156.51 -171.69 3.79 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.138 -0.483 . . . . 74.3 111.581 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 62.2 mt -97.2 117.24 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.827 0.346 . . . . 72.32 110.755 175.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.4 p -65.92 133.37 94.87 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 112.13 0.419 . . . . 75.34 112.13 -175.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -58.99 172.43 1.67 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.718 2.279 . . . . 74.42 113.648 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.521 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.1 OUTLIER -59.39 -174.42 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.56 0.578 . . . . 73.14 112.56 179.335 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 97.1 mt -57.08 99.84 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.104 -0.498 . . . . 74.3 111.549 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 106' ' ' ASN . 41.2 mt-10 -84.77 146.81 27.18 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.048 -0.523 . . . . 71.21 111.561 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -90.08 -15.83 30.91 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.432 0.53 . . . . 74.32 112.432 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -70.1 103.63 2.36 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.576 0.703 . . . . 74.12 111.538 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -86.58 98.72 11.24 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.847 -0.615 . . . . 73.51 110.791 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -55.48 118.24 4.29 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.91 0.386 . . . . 63.22 111.836 -176.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -58.61 146.13 37.15 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.088 -0.505 . . . . 72.24 111.69 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 66.4 m80 . . . . . 0 C--O 1.252 1.224 0 CA-C-O 118.582 -0.723 . . . . 72.43 111.406 179.983 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.5 mtm . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.726 0.298 . . . . 74.21 110.959 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.668 ' HA ' ' HE2' ' A' ' 2' ' ' LYS . 10.3 mmpt? -114.49 154.82 27.54 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.164 0.507 . . . . 72.33 111.962 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -111.15 114.4 27.62 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.148 -0.478 . . . . 41.44 110.646 174.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.2 t -140.11 135.89 32.99 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.352 -0.385 . . . . 74.25 111.259 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.36 -49.33 3.04 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 114.781 0.672 . . . . 54.1 114.781 -171.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -72.64 82.15 1.12 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.537 0.684 . . . . 72.21 112.092 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.516 ' HA ' ' HB ' ' A' ' 25' ' ' THR . 46.0 mt-10 -76.44 106.75 8.26 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.73 -0.668 . . . . 61.53 111.757 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.432 HG23 ' OG1' ' A' ' 25' ' ' THR . 32.7 m -111.3 151.03 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.073 0.463 . . . . 64.23 111.755 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 23' ' ' PRO . 27.4 m -129.46 141.39 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.168 -0.469 . . . . 64.51 111.488 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.89 115.27 27.08 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.444 -0.344 . . . . 53.32 111.243 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.4 mm -96.42 112.2 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.866 0.365 . . . . 71.41 111.098 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.499 HG13 HG21 ' A' ' 86' ' ' VAL . 2.7 mp -99.19 114.5 37.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 120.972 0.415 . . . . 72.14 111.303 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.0 m -113.07 139.71 48.47 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.798 0.333 . . . . 73.42 111.231 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.413 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 57.5 tt0 -128.9 135.45 49.07 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.587 -0.278 . . . . 75.53 111.2 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 57.01 10.27 0.76 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.981 0.734 . . . . 75.11 112.981 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.07 -6.5 28.97 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 121.256 -0.497 . . . . 73.44 113.882 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -112.76 145.08 41.2 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 117.13 0.465 . . . . 71.53 111.571 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.37 119.6 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 110.059 -0.349 . . . . 75.41 110.059 173.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.4 pt -108.51 -19.53 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 113.465 0.913 . . . . 75.14 113.465 -173.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -168.87 141.29 2.71 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.747 0.647 . . . . 73.03 112.747 -177.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -123.42 130.91 53.39 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.391 -0.368 . . . . 72.43 110.535 174.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.451 HG22 HG21 ' A' ' 47' ' ' VAL . 3.9 mp -121.24 124.43 27.32 Favored Pre-proline 0 N--CA 1.478 0.972 0 O-C-N 121.966 -0.459 . . . . 63.14 111.72 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.56 ' HA ' HG11 ' A' ' 9' ' ' VAL . 59.0 Cg_endo -73.24 121.22 7.04 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.418 2.079 . . . . 65.33 112.068 173.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.7 mt -92.96 -60.08 1.89 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.192 0.52 . . . . 65.12 111.796 -176.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.516 ' HB ' ' HA ' ' A' ' 7' ' ' GLU . 25.1 m -58.05 128.0 34.9 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.327 0.492 . . . . 75.3 112.327 -176.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.98 1.12 72.04 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 121.357 -0.449 . . . . 72.51 113.922 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -84.91 105.13 15.45 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.595 -0.356 . . . . 73.32 111.579 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.63 ' HZ3' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -85.77 137.58 32.69 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.927 0.394 . . . . 71.05 110.913 175.226 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.86 178.89 22.19 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.173 -0.537 . . . . 65.43 113.572 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -118.46 139.63 51.11 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.907 0.384 . . . . 62.42 110.965 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -138.9 124.51 19.54 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.256 -0.429 . . . . 74.21 110.604 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.45 ' HG2' ' HA ' ' A' ' 46' ' ' GLU . 75.3 mt-30 -131.7 148.69 52.6 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.94 0.4 . . . . 73.25 112.003 -176.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -154.64 147.71 24.71 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.104 -0.498 . . . . 72.02 111.21 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.7 m -101.19 136.85 40.37 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.899 0.38 . . . . 71.41 111.528 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' A' ' 43' ' ' ASN . 58.4 mt -113.7 102.32 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.495 -0.32 . . . . 71.44 111.419 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -76.27 107.04 8.23 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.773 0.32 . . . . 72.32 111.141 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.413 ' HA2' ' NE2' ' A' ' 14' ' ' GLN . . . -89.03 -133.81 4.88 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.374 -0.441 . . . . 54.34 113.438 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.55 ' HB3' ' HZ3' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -76.03 115.27 15.56 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.528 -0.396 . . . . 54.34 110.697 -179.732 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.37 -136.72 25.26 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.266 -0.492 . . . . 71.02 113.135 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.16 3.65 34.06 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.161 0.505 . . . . 74.24 111.279 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.534 ' HB3' ' CD2' ' A' ' 82' ' ' HIS . 24.6 mt-30 -73.07 83.78 1.29 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.194 0.521 . . . . 65.35 111.795 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -89.92 165.44 14.09 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.063 -0.517 . . . . 74.32 111.406 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.497 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . 2.4 t-20 -132.7 110.13 10.18 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.311 -0.404 . . . . 74.43 109.93 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.3 tp -95.52 103.82 15.71 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.382 0.61 . . . . 72.4 111.612 -176.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.638 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.1 mmm -93.93 141.61 28.32 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.374 -0.83 . . . . 64.1 111.76 -175.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.45 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 44.7 tt0 -127.07 119.65 27.07 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.99 0.424 . . . . 75.32 111.7 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.451 HG21 HG22 ' A' ' 22' ' ' ILE . 59.4 t -105.53 107.29 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.209 -0.451 . . . . 75.43 110.584 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.497 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 34.8 t70 -109.98 101.56 10.37 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.118 0.485 . . . . 63.22 110.848 -178.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.18 -109.68 3.04 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 120.784 -0.722 . . . . 53.32 112.886 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -108.14 19.16 20.29 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.852 0.358 . . . . 75.13 111.794 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 35.3 ptt180 -136.4 147.07 47.11 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.791 0.329 . . . . 73.33 111.507 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.3 tt -132.37 142.6 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-O 120.868 0.365 . . . . 74.32 111.719 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.485 ' HB3' ' HA ' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -160.67 168.8 24.14 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.849 0.357 . . . . 72.11 111.461 177.441 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.638 HG12 ' SD ' ' A' ' 45' ' ' MET . 71.6 mt -91.62 124.57 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.432 -0.349 . . . . 75.32 111.065 176.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.414 ' HB3' ' HZ1' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -94.86 -33.16 12.93 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.865 0.364 . . . . 65.21 111.406 177.434 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -143.47 139.95 30.12 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.746 0.308 . . . . 72.43 110.748 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -168.07 145.76 4.3 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.991 0.425 . . . . 74.01 112.023 -173.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -109.79 51.06 0.77 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.081 -0.509 . . . . 75.01 111.954 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.4 m -107.05 121.81 43.56 Favored Pre-proline 0 N--CA 1.472 0.667 0 O-C-N 122.063 -0.398 . . . . 72.4 110.192 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.28 -30.82 73.91 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.436 2.091 . . . . 75.42 112.582 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.68 -36.5 67.91 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.693 -0.685 . . . . 75.51 111.712 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 59.26 16.76 5.19 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.041 0.756 . . . . 73.31 113.041 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 65.6 t -55.36 -51.61 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 N-CA-C 112.07 0.396 . . . . 73.13 112.07 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -56.98 -38.66 86.48 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.223 -0.513 . . . . 54.02 113.271 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 42.1 t -67.46 -43.77 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.991 0.424 . . . . 74.42 111.295 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.22 -27.16 68.87 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.031 -0.531 . . . . 74.33 112.112 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.721 ' HE2' ' HA ' ' A' ' 67' ' ' MET . 14.3 mmt -50.45 -35.23 27.88 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.453 0.538 . . . . 73.54 112.453 178.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.05 -159.87 50.91 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.136 -0.554 . . . . 73.02 113.625 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.485 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . 89.1 m95 -70.82 114.71 9.17 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 111.968 0.359 . . . . 73.1 111.968 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.486 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 34.9 mmtp -105.78 150.65 25.35 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.68 -0.237 . . . . 73.35 110.619 175.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.427 ' O ' HG21 ' A' ' 8' ' ' VAL . 92.7 p -159.56 -26.83 0.07 Allowed 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.163 0.801 . . . . 71.42 113.163 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm -82.28 155.96 24.56 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.276 0.56 . . . . 74.45 112.264 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.51 110.74 3.26 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.108 -0.496 . . . . 54.44 110.675 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 121.71 -23.83 7.34 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.982 -0.447 . . . . 71.55 111.982 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 78.4 m-20 -65.41 129.23 38.99 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.87 0.367 . . . . 74.31 110.783 176.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.466 HG22 ' HA ' ' A' ' 87' ' ' GLU . 41.2 p -128.81 164.38 23.16 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.018 0.747 . . . . 74.2 113.018 -176.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.533 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 39.6 mm -128.15 125.63 64.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.063 -0.971 . . . . 74.4 109.735 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.8 t -117.32 117.59 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 112.291 0.478 . . . . 72.43 112.291 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 75.1 m -119.16 80.79 1.61 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.061 0.458 . . . . 71.42 110.65 174.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.411 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 76.3 mt -52.54 -59.91 7.63 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 113.597 0.962 . . . . 74.25 113.597 -174.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.411 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 38.9 Cg_endo -66.86 -9.5 24.98 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 121.917 1.744 . . . . 74.13 112.98 -176.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.534 ' CD2' ' HB3' ' A' ' 41' ' ' GLN . 24.3 m170 -104.49 -10.94 17.31 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.517 -0.31 . . . . 74.13 111.343 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.4 mttp 59.82 27.06 16.31 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.052 0.453 . . . . 74.32 112.032 -176.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.4 t -104.14 124.44 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.028 -0.533 . . . . 75.33 110.782 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -130.27 118.01 20.68 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.069 0.462 . . . . 70.03 111.119 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.533 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 35.9 t -107.76 124.62 63.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.136 -0.484 . . . . 74.22 110.858 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.466 ' HA ' HG22 ' A' ' 76' ' ' THR . 14.5 pt-20 -124.3 126.76 46.59 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.998 0.427 . . . . 73.23 111.58 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 63.5 mt -89.48 112.71 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 121.093 0.473 . . . . 64.31 110.984 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -116.63 152.36 34.36 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.24 -0.436 . . . . 73.44 111.25 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.9 t -89.41 124.93 34.92 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.946 0.403 . . . . 63.02 111.966 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.1 p -66.27 -28.38 68.66 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.295 0.569 . . . . 72.21 110.507 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -82.55 124.76 30.42 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.715 -0.675 . . . . 54.34 109.67 174.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.518 ' HD3' ' O ' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -42.37 120.85 1.75 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.708 0.766 . . . . 75.2 112.647 -176.402 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -90.48 177.22 6.43 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.929 0.714 . . . . 73.33 112.929 -173.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.5 t -164.15 104.55 0.88 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.288 -0.869 . . . . 65.0 110.111 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.763 ' HZ2' ' HB3' ' A' ' 96' ' ' LYS . 9.0 mtpm? -123.24 164.27 19.06 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 122.2 1.0 . . . . 71.21 113.155 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -51.04 125.88 24.44 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 113.699 -1.592 . . . . 72.2 111.794 169.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.43 2.31 8.65 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.532 2.154 . . . . 74.33 112.578 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -79.09 69.84 5.34 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.239 0.542 . . . . 73.21 110.413 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 62.1 p -87.26 93.06 9.28 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.203 0.525 . . . . 64.32 112.352 -174.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -117.53 145.48 44.22 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.671 -0.492 . . . . 71.1 109.671 173.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.413 ' O ' HD12 ' A' ' 102' ' ' LEU . 2.1 pp -135.18 152.73 51.86 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.226 0.824 . . . . 75.35 113.226 -171.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 103' ' ' ILE . 2.6 mp -89.1 112.35 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 115.666 -0.697 . . . . 75.45 109.791 173.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.8 m -63.34 122.53 76.35 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 112.653 0.612 . . . . 74.42 112.653 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -85.8 106.61 0.88 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.706 2.271 . . . . 75.3 112.426 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -77.18 119.19 20.52 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 122.03 -0.419 . . . . 70.42 111.262 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 58.4 tp -79.57 101.53 8.35 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.023 0.44 . . . . 74.0 111.094 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -84.16 83.64 7.89 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.389 0.614 . . . . 71.33 111.821 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -80.43 79.55 7.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.281 0.562 . . . . 74.22 111.12 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -104.45 125.67 50.85 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.028 -0.533 . . . . 64.41 111.967 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -73.51 154.86 39.72 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.25 -0.432 . . . . 73.35 111.167 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -154.78 116.17 4.07 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.059 0.457 . . . . 74.35 111.927 -175.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -128.4 170.41 13.14 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.342 -0.39 . . . . 71.14 111.294 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 41.1 m80 . . . . . 0 C--O 1.256 1.435 0 CA-C-O 118.72 -0.657 . . . . 74.54 111.19 175.503 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.58 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.848 0.356 . . . . 72.44 111.359 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -87.73 116.99 26.26 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.896 -0.409 . . . . 74.34 109.896 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -54.8 131.18 43.41 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.437 0.532 . . . . 63.04 112.437 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.7 p -118.17 139.36 51.39 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.161 -0.472 . . . . 63.3 111.467 177.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.44 -6.79 46.98 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.022 -0.609 . . . . 43.23 113.02 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.26 86.44 5.65 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.634 0.254 . . . . 73.44 110.67 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.487 ' HG2' HG23 ' A' ' 25' ' ' THR . 29.6 mt-10 -84.51 120.58 26.49 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.365 0.506 . . . . 74.45 112.365 -175.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 27.8 m -130.72 159.24 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.426 0.528 . . . . 75.3 112.426 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.573 HG13 ' HA ' ' A' ' 23' ' ' PRO . 23.3 m -131.56 147.05 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 115.928 -0.578 . . . . 65.24 111.171 178.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.62 115.14 26.93 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.45 -0.341 . . . . 74.41 111.309 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.429 HD12 ' OE2' ' A' ' 21' ' ' GLU . 18.2 mm -99.47 104.8 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.831 0.348 . . . . 65.31 111.397 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.47 ' N ' HD13 ' A' ' 12' ' ' ILE . 3.3 mp -96.22 120.08 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.194 0.521 . . . . 74.42 111.257 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.6 m -121.94 144.36 48.91 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.087 -0.506 . . . . 70.33 111.31 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -135.67 141.82 45.05 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.551 -0.295 . . . . 73.41 110.733 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 59.21 17.4 5.66 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 111.956 0.354 . . . . 72.13 111.956 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.69 -9.75 62.34 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 121.409 -0.424 . . . . 61.41 113.683 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -116.4 145.65 43.08 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 117.296 0.548 . . . . 64.22 111.657 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.7 t -71.99 128.33 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 120.942 0.401 . . . . 75.2 111.147 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.6 HD11 HD11 ' A' ' 35' ' ' ILE . 33.9 pt -112.17 -26.59 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.64 0.607 . . . . 75.13 112.64 -177.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -159.55 133.34 7.33 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.236 0.458 . . . . 72.21 112.236 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.429 ' OE2' HD12 ' A' ' 11' ' ' ILE . 44.8 mt-10 -124.94 115.49 20.67 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.683 0.277 . . . . 75.31 110.802 177.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.481 HD13 ' N ' ' A' ' 22' ' ' ILE . 3.2 mp -104.22 129.86 24.38 Favored Pre-proline 0 N--CA 1.475 0.798 0 N-CA-C 111.852 0.316 . . . . 74.41 111.852 -175.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.573 ' HA ' HG13 ' A' ' 9' ' ' VAL . 67.7 Cg_endo -74.62 111.61 3.36 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.356 2.037 . . . . 72.11 112.194 171.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.63 -62.26 1.7 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.978 0.418 . . . . 75.24 111.749 -176.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.559 ' HA ' ' HG2' ' A' ' 50' ' ' GLU . 51.3 m -63.03 118.57 8.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.992 0.425 . . . . 72.54 112.07 -177.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.35 -15.73 55.92 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 116.154 -0.476 . . . . 61.32 112.81 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -77.11 79.13 3.64 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.19 0.519 . . . . 75.21 110.978 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.614 ' HZ2' ' HB2' ' A' ' 28' ' ' LYS . 10.4 mtmp? -75.18 105.1 6.03 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.291 0.567 . . . . 63.01 111.304 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.77 -169.63 24.31 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 115.971 -0.558 . . . . 71.22 112.655 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -117.84 148.0 42.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.841 0.353 . . . . 74.42 110.679 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -154.14 129.15 9.54 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.795 0.331 . . . . 72.52 111.671 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -124.71 153.65 42.04 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.759 0.314 . . . . 73.25 111.535 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -154.29 140.73 18.75 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.92 0.391 . . . . 61.44 110.708 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.5 m -108.94 111.93 23.88 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.974 0.416 . . . . 72.45 112.07 -172.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.6 HD11 HD11 ' A' ' 19' ' ' ILE . 57.8 mt -94.0 105.61 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.263 -0.426 . . . . 75.42 111.572 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -89.79 110.02 20.97 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.036 0.446 . . . . 74.04 111.307 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.43 -136.9 9.55 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 116.181 -0.463 . . . . 64.11 113.778 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -87.76 151.25 23.04 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.03 0.382 . . . . 74.4 112.03 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.79 36.74 92.44 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 116.098 -0.501 . . . . 71.0 113.479 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 61.99 10.72 3.78 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.388 0.514 . . . . 72.01 112.388 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.533 ' HA ' ' HB3' ' A' ' 58' ' ' ASN . 26.3 mt-30 -82.55 107.02 14.89 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.089 0.403 . . . . 71.42 112.089 -176.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -104.88 153.18 21.7 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 111.981 0.363 . . . . 63.4 111.981 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -111.72 130.23 55.85 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.998 -0.546 . . . . 60.45 110.222 171.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.4 tp -101.85 104.11 14.83 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.873 0.368 . . . . 75.2 110.925 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.747 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.5 mmm -88.73 141.33 28.6 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.559 -0.292 . . . . 64.41 111.286 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -136.09 119.01 16.29 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.155 0.502 . . . . 75.22 111.605 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.9 t -105.85 119.85 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 115.939 -0.573 . . . . 75.12 110.699 177.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -117.44 90.74 3.4 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.163 0.506 . . . . 74.42 110.206 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.97 -116.57 5.07 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.755 -0.736 . . . . 42.03 112.352 -174.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.559 ' HG2' ' HA ' ' A' ' 25' ' ' THR . 40.6 mt-10 -95.13 -15.17 23.56 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.036 0.446 . . . . 73.55 111.806 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.543 ' HA ' ' HB3' ' A' ' 71' ' ' SER . 26.7 ptt180 -97.74 135.29 39.73 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.993 0.425 . . . . 73.33 111.371 -176.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.6 tt -123.89 143.82 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.126 0.489 . . . . 73.33 111.463 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -144.96 169.21 18.52 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.32 -0.4 . . . . 75.53 110.709 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.747 HG12 ' SD ' ' A' ' 45' ' ' MET . 42.7 mt -96.93 122.17 48.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.351 -0.611 . . . . 75.12 109.351 167.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -86.67 -32.39 20.55 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.503 0.557 . . . . 73.33 112.503 -172.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -162.09 138.68 8.0 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.681 0.277 . . . . 65.44 111.383 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.437 ' HB3' ' HG ' ' A' ' 59' ' ' SER . 26.0 m-20 -133.04 144.61 50.15 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.313 0.578 . . . . 74.33 111.816 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.533 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . 48.5 t-20 -81.47 72.17 8.5 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.921 -1.14 . . . . 72.51 107.921 163.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.437 ' HG ' ' HB3' ' A' ' 57' ' ' ASP . 69.1 m -135.98 130.45 18.51 Favored Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 115.634 -0.712 . . . . 73.2 111.373 -174.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 59' ' ' SER . 26.8 Cg_exo -63.35 -27.66 71.51 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.79 2.327 . . . . 65.33 112.315 178.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.406 ' O ' ' HE2' ' A' ' 66' ' ' LYS . 4.3 m-20 -97.3 -15.47 20.75 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.68 -0.691 . . . . 60.45 112.15 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.418 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 27.0 mm-40 52.6 34.04 14.89 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.393 0.516 . . . . 70.43 112.393 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.9 t -53.35 -51.29 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 112.914 0.709 . . . . 73.42 112.914 -174.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -56.43 -55.06 31.63 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.149 -0.548 . . . . 51.34 113.373 -177.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.2 t -52.75 -41.81 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 111.914 0.339 . . . . 65.23 111.914 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 62' ' ' GLN . 67.9 mttm -64.29 -30.82 71.85 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 111.963 0.357 . . . . 74.1 111.963 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.8 mmt -61.2 -40.45 93.99 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.269 0.47 . . . . 72.45 112.269 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.45 -153.55 39.16 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.121 -0.562 . . . . 64.44 113.737 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -81.73 130.79 35.18 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.179 0.437 . . . . 73.42 112.179 -176.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HG3' HD11 ' A' ' 77' ' ' ILE . 75.4 mmtt -127.73 150.17 49.91 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.142 -0.481 . . . . 74.0 110.645 175.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.543 ' HB3' ' HA ' ' A' ' 51' ' ' ARG . 89.1 p -173.68 22.94 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.905 0.706 . . . . 64.11 112.905 -178.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -90.46 162.33 15.12 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.081 -0.387 . . . . 73.11 110.163 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.65 32.83 0.11 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 112.133 0.42 . . . . 65.11 112.133 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -177.24 29.4 0.07 OUTLIER Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.385 -0.436 . . . . 74.31 113.312 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -86.8 146.77 26.11 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.968 0.413 . . . . 72.24 111.243 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.6 p -133.81 141.33 47.41 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.061 0.458 . . . . 71.24 111.604 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.51 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 45.5 mm -125.2 109.64 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.341 -0.39 . . . . 73.33 110.417 177.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.04 116.6 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.067 0.46 . . . . 72.22 111.822 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 91.5 m -120.98 79.75 1.55 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.382 -0.372 . . . . 72.31 111.067 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.491 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 96.2 mt -57.13 -48.17 97.86 Favored Pre-proline 0 CA--C 1.55 0.958 0 N-CA-C 112.825 0.676 . . . . 74.12 112.825 -177.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.491 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 76.7 Cg_exo -51.42 -25.15 17.98 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 122.215 1.943 . . . . 64.23 113.613 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.522 ' NE2' ' HB3' ' A' ' 41' ' ' GLN . 16.0 m170 -111.52 -4.26 14.86 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.035 -0.416 . . . . 75.52 111.735 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 58.33 34.41 24.01 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.285 0.564 . . . . 74.14 111.782 -176.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.4 t -110.43 134.71 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 115.714 -0.675 . . . . 71.51 111.326 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -131.19 130.04 42.47 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.836 0.351 . . . . 75.32 110.885 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.51 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 50.3 t -119.23 120.62 64.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.717 0.294 . . . . 70.43 111.487 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -111.13 136.97 49.39 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 110.451 -0.203 . . . . 72.13 110.451 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.3 mt -105.61 112.17 37.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.985 0.421 . . . . 73.12 110.575 175.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -118.11 159.35 23.4 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.28 -0.418 . . . . 74.13 110.91 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 45.3 t -79.91 145.44 32.67 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.918 0.389 . . . . 75.21 111.444 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.8 p -67.75 -28.31 67.52 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.429 0.633 . . . . 75.42 110.265 174.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -80.48 -138.85 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.934 -1.03 . . . . 72.11 110.749 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -70.97 142.67 51.01 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.44 0.638 . . . . 70.34 112.008 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -152.1 139.45 19.45 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.941 -0.572 . . . . 64.15 109.906 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.8 t -153.85 119.29 5.18 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.289 0.477 . . . . 73.31 112.289 -176.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -127.66 150.74 49.62 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.032 -0.531 . . . . 71.44 109.674 173.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -57.9 141.0 81.3 Favored Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 122.27 -0.269 . . . . 74.33 110.562 175.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -35.11 -55.31 0.59 Allowed 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 123.736 2.957 . . . . 75.23 114.055 -175.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -174.15 101.2 0.1 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.84 0.352 . . . . 74.33 110.63 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.2 t -159.45 151.56 20.87 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.333 0.587 . . . . 73.14 112.264 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -113.81 114.07 25.79 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.353 -0.84 . . . . 62.0 109.884 175.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.3 tp -116.71 118.18 31.84 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.042 0.449 . . . . 72.33 112.142 -174.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.0 mm -102.7 131.95 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.022 0.439 . . . . 74.51 111.033 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.7 m -103.68 146.95 33.47 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 116.371 -0.377 . . . . 64.33 111.526 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.99 144.02 80.49 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.765 2.31 . . . . 74.33 112.959 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -88.64 132.28 34.63 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.029 0.443 . . . . 73.04 111.215 -176.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -86.95 155.6 20.13 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.092 0.472 . . . . 75.51 111.84 -177.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -103.16 128.28 50.16 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.388 -0.369 . . . . 65.01 110.525 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -91.79 22.54 4.11 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.241 0.459 . . . . 75.53 112.241 -174.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.92 105.02 0.27 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 112.664 0.616 . . . . 64.42 112.664 -177.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -134.08 106.41 7.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.635 0.374 . . . . 75.34 110.355 173.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -101.27 60.97 0.92 Allowed 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.897 -0.502 . . . . 72.24 112.025 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -176.16 178.4 1.41 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.231 -0.441 . . . . 73.35 111.447 176.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 78.3 t60 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.476 -0.773 . . . . 62.04 111.182 173.584 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.769 0.318 . . . . 74.44 111.601 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.92 145.61 40.44 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.882 0.372 . . . . 73.12 110.68 173.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -88.42 90.69 8.5 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.162 0.506 . . . . 65.12 110.466 176.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.6 m -130.93 114.2 14.95 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.029 -0.532 . . . . 65.32 111.243 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -146.53 -40.36 0.04 OUTLIER Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.946 -0.645 . . . . 53.2 114.004 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -69.89 92.11 0.69 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.313 0.556 . . . . 61.22 111.036 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -73.47 114.89 12.21 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.06 0.763 . . . . 73.13 113.06 -173.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 33.9 m -126.27 148.02 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.022 0.439 . . . . 74.23 111.055 173.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 23' ' ' PRO . 33.8 m -127.27 151.78 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.938 0.399 . . . . 72.31 111.679 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.77 118.21 36.45 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.112 -0.495 . . . . 62.13 110.878 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 31.0 mm -95.26 108.79 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 120.83 0.347 . . . . 74.44 110.992 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.462 ' N ' HD13 ' A' ' 12' ' ' ILE . 3.2 mp -95.17 111.51 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 120.937 0.399 . . . . 73.13 111.123 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.9 p -113.7 147.19 38.63 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.971 0.415 . . . . 74.23 111.236 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -143.88 139.34 29.17 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.286 -0.416 . . . . 72.32 110.284 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 62.19 13.59 5.97 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.089 0.403 . . . . 63.12 112.089 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.02 -16.67 46.05 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 121.199 -0.524 . . . . 73.34 113.956 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.642 ' HZ1' ' HB3' ' A' ' 17' ' ' LYS . 0.4 OUTLIER -113.79 150.1 33.95 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 122.294 -0.533 . . . . 71.43 111.693 -178.436 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.77 120.92 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.412 -0.358 . . . . 65.33 110.834 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.0 pt -99.71 -27.96 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 112.102 0.408 . . . . 65.35 112.102 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.1 tpp85 -157.82 143.51 17.18 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 122.09 -0.381 . . . . 73.24 111.601 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -128.36 113.51 15.68 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.676 0.274 . . . . 73.02 110.871 176.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.504 HG21 HG22 ' A' ' 47' ' ' VAL . 3.0 mp -107.39 119.66 50.08 Favored Pre-proline 0 N--CA 1.473 0.722 0 O-C-N 122.27 -0.269 . . . . 73.44 111.632 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 22.0 Cg_exo -66.03 123.46 11.3 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.366 2.044 . . . . 74.53 111.781 172.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.2 mt -87.13 -54.55 4.26 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.158 0.504 . . . . 75.22 111.447 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.442 ' OG1' HG22 ' A' ' 8' ' ' VAL . 29.1 m -63.1 107.34 1.01 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.039 0.447 . . . . 73.35 111.764 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.13 11.17 57.8 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.266 -0.493 . . . . 62.23 113.081 -178.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.521 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 52.0 t-80 -72.98 87.12 1.33 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.08 0.467 . . . . 74.51 111.154 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -53.8 131.8 40.28 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.884 0.698 . . . . 75.04 112.884 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.38 -161.94 49.02 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 115.931 -0.577 . . . . 73.31 114.501 175.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -118.68 141.98 48.09 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.952 0.501 . . . . 71.33 109.91 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -142.91 125.08 15.38 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 122.25 -0.282 . . . . 72.4 111.626 -175.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -117.83 129.85 55.91 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.668 -0.242 . . . . 74.45 111.459 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -136.69 143.22 43.27 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.244 0.545 . . . . 74.35 111.795 176.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.0 m -101.8 121.52 42.24 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.979 -0.555 . . . . 65.21 111.921 -175.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 54.1 mt -92.86 104.94 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.529 -0.305 . . . . 72.41 110.451 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -101.16 113.8 27.16 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.956 0.407 . . . . 73.35 111.884 -176.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.8 -65.46 1.44 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.299 -0.476 . . . . 63.45 112.551 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -141.39 87.62 2.09 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.543 -0.387 . . . . 75.14 111.438 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.45 -86.82 0.01 OUTLIER Glycine 0 CA--C 1.53 1.017 0 N-CA-C 114.196 0.438 . . . . 63.33 114.196 177.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.41 -22.26 44.53 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.007 0.432 . . . . 73.42 111.612 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -82.56 95.37 7.73 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.235 -0.291 . . . . 75.21 110.904 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -144.59 160.74 40.66 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.354 0.502 . . . . 72.55 112.354 -177.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -129.75 144.71 51.43 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.022 -0.536 . . . . 72.41 110.605 174.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.8 tp -114.12 107.34 15.5 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.989 0.423 . . . . 71.12 111.025 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.754 ' SD ' HG12 ' A' ' 54' ' ' ILE . 84.2 mmm -94.6 140.11 30.29 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.179 -0.464 . . . . 70.35 111.351 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -130.58 120.86 24.65 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.985 0.421 . . . . 74.0 111.324 176.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.504 HG22 HG21 ' A' ' 22' ' ' ILE . 36.0 t -105.0 108.73 25.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.122 -0.49 . . . . 71.45 110.731 176.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -109.31 105.75 15.29 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.965 0.412 . . . . 70.01 110.338 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.521 ' O ' ' HB3' ' A' ' 27' ' ' HIS . . . 58.16 -114.98 6.34 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.837 -0.697 . . . . 65.51 113.048 -177.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -106.17 35.56 2.89 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.882 0.372 . . . . 70.13 111.649 -177.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -155.13 144.65 21.27 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.933 0.397 . . . . 73.14 111.444 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 tt -129.41 147.1 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 112.007 0.373 . . . . 75.1 112.007 -175.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.405 ' HD3' ' CE2' ' A' ' 69' ' ' TRP . 22.5 ptt180 -150.84 169.29 22.05 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.106 0.479 . . . . 65.44 111.428 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.754 HG12 ' SD ' ' A' ' 45' ' ' MET . 43.6 mt -105.6 116.29 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 116.282 -0.417 . . . . 71.13 110.756 173.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.775 ' HB3' ' HZ2' ' A' ' 55' ' ' LYS . 8.5 mtpm? -78.53 -40.4 35.2 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.269 0.557 . . . . 70.44 111.722 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -137.97 143.89 40.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.943 -0.571 . . . . 72.13 111.021 -173.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -161.0 126.14 3.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.384 0.611 . . . . 75.51 110.558 -178.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -100.89 67.95 1.25 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.589 -0.732 . . . . 70.22 110.813 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 53.4 p -129.97 150.99 77.49 Favored Pre-proline 0 N--CA 1.474 0.749 0 CA-C-N 116.294 -0.412 . . . . 73.32 111.105 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -63.88 -28.73 67.29 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.651 2.234 . . . . 73.35 112.752 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.442 ' HB3' HG23 ' A' ' 63' ' ' VAL . 5.1 m-20 -80.67 -36.91 31.76 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.876 -0.602 . . . . 73.43 112.513 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 63.69 20.59 12.3 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.341 0.497 . . . . 74.11 112.341 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.442 HG23 ' HB3' ' A' ' 61' ' ' ASP . 64.6 t -59.76 -39.77 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 112.082 0.401 . . . . 74.33 112.082 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.93 -56.19 19.91 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.2 -0.454 . . . . 74.43 113.714 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.99 -38.06 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 O-C-N 122.66 -0.318 . . . . 72.1 111.683 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -59.79 -28.47 67.46 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.22 0.452 . . . . 61.44 112.22 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 23.0 mmt -57.56 -36.16 71.29 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.333 0.494 . . . . 60.55 112.333 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.87 -149.21 42.66 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.271 -0.49 . . . . 72.44 113.82 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.405 ' CE2' ' HD3' ' A' ' 53' ' ' ARG . 92.4 m95 -82.37 120.7 25.77 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.872 0.367 . . . . 74.22 111.964 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.652 ' HG3' HD12 ' A' ' 77' ' ' ILE . 75.2 mmtt -109.4 157.95 18.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.586 0.354 . . . . 74.42 110.925 175.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 88.0 p -163.76 -28.65 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.871 0.693 . . . . 61.4 112.871 -175.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -81.93 141.6 33.18 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.003 0.43 . . . . 72.23 112.094 -175.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.09 94.5 0.11 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.343 0.592 . . . . 74.15 110.704 175.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.619 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . 148.7 -22.83 1.32 Allowed Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.908 -0.587 . . . . 43.13 112.139 -174.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.49 ' HB2' HD13 ' A' ' 88' ' ' ILE . 78.3 m-20 -62.84 123.95 19.78 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.942 0.401 . . . . 64.11 111.127 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.5 p -117.53 142.57 47.01 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.24 0.543 . . . . 72.41 112.01 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.652 HD12 ' HG3' ' A' ' 70' ' ' LYS . 29.8 mm -119.5 117.57 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.734 -0.666 . . . . 74.35 110.212 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.1 t -108.76 116.51 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 111.974 0.361 . . . . 75.12 111.974 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 70.9 m -122.15 71.21 0.99 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.933 0.396 . . . . 65.24 111.024 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.531 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 94.5 mt -55.39 -49.3 93.31 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 112.93 0.715 . . . . 72.42 112.93 -177.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.531 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 51.1 Cg_exo -56.28 -17.38 20.51 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.274 1.983 . . . . 73.45 113.7 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -114.75 -0.07 13.67 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.122 -0.361 . . . . 73.55 111.959 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 60.12 29.27 18.86 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.761 0.425 . . . . 71.41 111.955 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.28 135.82 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.919 0.39 . . . . 75.22 111.396 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -139.91 125.16 18.85 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.329 -0.396 . . . . 73.13 110.944 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 52.7 t -123.31 120.41 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 120.778 0.323 . . . . 73.33 111.341 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -122.38 144.44 49.03 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.956 0.408 . . . . 74.03 111.369 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.49 HD13 ' HB2' ' A' ' 75' ' ' ASP . 60.1 mt -97.84 136.53 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.047 0.451 . . . . 74.32 111.515 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -149.81 150.54 32.14 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.343 -0.39 . . . . 71.54 111.189 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 46.1 t -78.53 150.68 32.81 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.326 0.491 . . . . 75.0 112.326 -178.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.3 p -68.52 -20.17 64.56 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.192 0.52 . . . . 72.51 111.298 175.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -122.58 -167.88 1.65 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.728 -0.669 . . . . 74.23 111.323 -175.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -67.17 116.3 7.81 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.919 0.39 . . . . 75.42 111.576 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -135.74 156.6 48.57 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.166 -0.47 . . . . 72.23 110.839 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.4 m -119.44 101.18 7.77 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.707 0.289 . . . . 71.0 111.137 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.619 ' HD2' ' HA2' ' A' ' 74' ' ' GLY . 38.2 mtmt -78.95 -172.81 3.24 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.945 0.402 . . . . 75.15 111.356 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -58.79 141.75 84.86 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.331 -0.395 . . . . 65.11 110.737 172.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -55.74 -51.11 10.5 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.824 2.349 . . . . 64.33 113.07 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -84.46 100.63 11.46 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.173 0.511 . . . . 63.1 111.697 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 t -160.17 127.82 4.59 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.94 -0.573 . . . . 70.32 111.178 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -107.01 115.26 29.86 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.302 0.572 . . . . 71.34 112.132 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.436 ' N ' HD21 ' A' ' 102' ' ' LEU . 2.3 pt? -144.17 156.69 44.42 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.972 -0.558 . . . . 74.24 110.772 176.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.8 mt -126.41 110.0 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.039 0.447 . . . . 72.4 112.106 -177.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.7 t -89.33 112.91 54.21 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.279 -0.419 . . . . 74.14 109.894 170.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.44 -164.63 0.21 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.666 2.244 . . . . 73.02 113.492 -175.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -52.13 104.21 0.08 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.25 -0.432 . . . . 73.54 111.514 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.412 ' N ' HD21 ' A' ' 107' ' ' LEU . 2.3 pt? -55.07 146.53 18.0 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.115 0.483 . . . . 74.43 111.63 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -78.53 164.86 24.35 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.434 -0.348 . . . . 70.21 111.515 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -47.98 114.15 0.87 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.529 0.566 . . . . 63.23 112.529 -173.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -129.99 149.3 51.77 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.908 -0.587 . . . . 72.43 110.781 -178.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -82.89 163.87 20.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.962 0.411 . . . . 75.33 111.632 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -97.29 114.34 26.09 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.918 0.39 . . . . 75.2 111.636 -175.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -133.94 116.01 15.08 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.488 -0.323 . . . . 73.51 111.396 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.3 p80 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.998 -0.525 . . . . 72.52 111.885 178.292 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.645 0.26 . . . . 71.52 111.485 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -87.81 -52.17 5.45 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.095 0.474 . . . . 75.34 111.369 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -70.62 119.02 14.17 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.071 0.462 . . . . 62.14 111.958 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.3 m -91.97 86.38 5.84 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.522 -0.547 . . . . 74.13 109.522 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.09 -86.02 0.54 Allowed Glycine 0 CA--C 1.524 0.613 0 C-N-CA 121.101 -0.571 . . . . 73.22 113.624 -173.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -129.11 93.53 3.61 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 122.738 -0.272 . . . . 63.2 111.016 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.457 ' HB2' ' OG1' ' A' ' 91' ' ' THR . 40.8 mt-10 -84.61 116.5 23.2 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.429 0.529 . . . . 75.53 112.429 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.46 143.86 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.177 -0.465 . . . . 75.13 111.172 173.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.526 HG13 ' HA ' ' A' ' 23' ' ' PRO . 31.0 m -125.07 141.84 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 120.962 0.411 . . . . 73.4 111.372 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.73 120.47 37.12 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.837 0.351 . . . . 62.11 111.564 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 17.8 mm -99.89 110.85 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.364 -0.38 . . . . 71.21 110.87 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.536 ' HA ' HG21 ' A' ' 86' ' ' VAL . 3.2 mp -95.59 119.38 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.025 0.441 . . . . 74.41 111.917 -177.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.4 t -121.27 139.12 53.82 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.095 0.474 . . . . 74.11 111.327 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.563 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 47.9 tt0 -121.24 116.95 25.85 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.385 -0.371 . . . . 74.13 110.686 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.563 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 43.5 m-80 61.76 2.61 0.75 Allowed 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.574 0.583 . . . . 74.12 112.574 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.86 -6.55 8.93 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.113 -0.565 . . . . 62.23 113.865 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -108.85 126.5 53.11 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 117.43 0.615 . . . . 72.24 111.414 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.6 t -70.52 112.04 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.124 0.488 . . . . 75.35 110.852 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.6 pt -102.44 -23.43 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 112.712 0.634 . . . . 74.33 112.712 -175.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -152.57 136.47 16.3 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.666 0.269 . . . . 73.24 111.641 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -130.66 114.96 16.05 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.759 0.314 . . . . 73.51 110.374 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.4 mt -115.38 124.43 30.12 Favored Pre-proline 0 N--CA 1.472 0.636 0 N-CA-C 112.111 0.411 . . . . 75.42 112.111 -175.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.526 ' HA ' HG13 ' A' ' 9' ' ' VAL . 60.4 Cg_endo -72.66 112.37 3.47 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.239 1.96 . . . . 73.11 111.758 173.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.9 mt -77.22 -57.1 4.02 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.959 0.409 . . . . 73.33 111.544 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 m -62.46 122.85 16.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.947 0.403 . . . . 74.22 111.601 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.16 -11.77 71.28 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.104 -0.57 . . . . 72.53 112.792 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 23' ' ' PRO . 58.5 t-80 -67.78 129.04 38.69 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.869 0.366 . . . . 50.43 110.439 177.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.457 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -119.96 136.24 54.61 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 122.021 -0.424 . . . . 75.31 111.294 -177.385 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.34 -172.2 33.02 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.494 -0.384 . . . . 73.14 112.788 -177.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -116.9 127.38 54.2 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 122.351 -0.499 . . . . 74.14 110.208 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -124.61 117.02 23.36 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.955 0.407 . . . . 75.15 111.268 -175.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.539 ' HG2' ' HG3' ' A' ' 46' ' ' GLU . 30.7 mt-30 -115.32 134.99 54.61 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.737 0.303 . . . . 73.51 111.256 -175.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -145.2 140.25 27.77 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.961 0.41 . . . . 55.54 110.904 177.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.2 m -104.11 109.34 21.1 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.997 0.427 . . . . 74.03 111.911 -174.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 62.8 mt -80.51 97.4 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.1 0.476 . . . . 61.3 111.037 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -82.8 104.01 12.72 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.996 0.427 . . . . 75.13 111.199 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.463 ' HA2' ' NE2' ' A' ' 14' ' ' GLN . . . -78.83 -146.04 3.18 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.345 -0.455 . . . . 52.1 113.059 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.655 ' HB2' ' HZ3' ' A' ' 38' ' ' LYS . 10.2 mtmp? -76.31 108.61 9.38 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.95 0.405 . . . . 71.25 111.272 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.51 -129.21 9.41 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.065 -0.588 . . . . 71.04 113.55 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.96 4.32 23.12 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.303 0.483 . . . . 74.03 112.303 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -80.9 73.63 7.9 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.145 0.498 . . . . 73.34 112.232 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -89.53 155.89 18.98 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.964 0.412 . . . . 72.22 111.793 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.53 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 16.3 m120 -132.14 110.19 10.49 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.219 -0.446 . . . . 73.21 110.631 173.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.4 tp -83.38 103.22 12.58 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.064 0.459 . . . . 72.31 110.909 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.804 ' SD ' HG12 ' A' ' 54' ' ' ILE . 85.9 mmm -94.79 139.7 30.91 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.118 -0.492 . . . . 71.43 111.107 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.539 ' HG3' ' HG2' ' A' ' 32' ' ' GLN . 33.7 tt0 -136.72 118.94 15.55 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.086 0.469 . . . . 53.51 111.766 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.8 t -100.81 112.88 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.219 -0.446 . . . . 71.34 110.186 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.533 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 35.6 t70 -108.11 100.36 9.69 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.039 0.447 . . . . 75.0 110.731 -177.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.78 -110.53 3.31 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.842 -0.694 . . . . 73.03 112.258 -174.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -114.5 33.26 5.43 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.313 0.578 . . . . 74.45 111.313 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 14.4 ptt180 -147.56 149.43 32.57 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.08 -0.509 . . . . 73.32 110.745 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.4 tt -123.29 148.47 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 120.791 0.329 . . . . 74.22 111.772 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -151.36 168.76 23.8 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.904 0.383 . . . . 74.2 111.47 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.804 HG12 ' SD ' ' A' ' 45' ' ' MET . 37.1 mt -104.64 118.35 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.842 0.353 . . . . 73.33 110.093 170.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -83.4 -35.05 25.37 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.452 -0.34 . . . . 73.45 111.897 -175.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -161.78 138.51 8.27 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.816 0.341 . . . . 64.53 111.632 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -140.9 178.52 7.3 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.01 0.433 . . . . 61.14 111.394 175.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -112.6 33.87 4.7 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.36 0.6 . . . . 71.44 111.461 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.7 m -89.69 146.47 35.6 Favored Pre-proline 0 N--CA 1.472 0.642 0 O-C-N 121.755 -0.591 . . . . 75.11 110.818 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.24 -32.57 73.4 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.488 2.125 . . . . 73.33 112.295 179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -96.42 -9.19 30.43 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.021 -0.536 . . . . 64.55 111.795 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.503 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 23.6 mm-40 57.5 38.51 28.09 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.01 0.433 . . . . 74.44 111.731 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.3 t -52.75 -36.68 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 116.159 -0.473 . . . . 75.35 112.103 -174.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -58.7 -54.16 40.16 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.053 -0.594 . . . . 60.21 112.766 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.2 -38.22 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-O 120.896 0.379 . . . . 70.32 111.895 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.503 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 5.4 mptp? -65.19 -28.44 69.39 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.395 0.516 . . . . 64.22 112.395 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 25.7 mmt -60.72 -34.83 74.99 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.041 0.386 . . . . 64.11 112.041 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.25 -144.15 38.77 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 114.391 0.516 . . . . 52.34 114.391 175.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -84.39 131.95 34.63 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.734 0.642 . . . . 75.42 112.734 -176.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.437 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 75.3 mmtt -127.2 136.12 51.6 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.941 -0.572 . . . . 74.43 110.971 177.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.1 p -168.42 17.49 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.307 0.484 . . . . 73.24 112.307 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -114.77 150.59 35.16 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.773 0.321 . . . . 75.53 111.116 -177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.28 108.97 0.77 Allowed 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.998 0.427 . . . . 64.13 110.452 173.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 119.03 -16.71 10.84 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.077 -0.583 . . . . 75.53 113.299 -178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.437 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 53.4 m-20 -62.41 133.56 55.21 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.152 0.476 . . . . 72.11 111.551 176.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.8 p -134.24 147.33 50.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.221 0.534 . . . . 63.01 111.845 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.535 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 41.5 mm -114.73 121.85 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.759 -0.655 . . . . 75.23 110.3 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.0 t -121.47 117.44 52.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.929 0.395 . . . . 73.2 111.681 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 97.2 m -116.26 90.03 3.24 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.653 -0.249 . . . . 64.42 110.618 175.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.56 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 98.0 mt -55.81 -55.52 40.12 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 113.202 0.816 . . . . 74.12 113.202 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 16.6 Cg_exo -67.4 -7.34 18.82 Favored 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 122.002 1.801 . . . . 71.3 112.933 -176.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -114.93 -12.75 12.0 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.423 -0.353 . . . . 62.23 111.355 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.9 mttm 59.16 31.79 21.55 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.934 0.493 . . . . 72.04 111.947 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.9 t -100.68 133.51 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.223 -0.444 . . . . 65.22 110.978 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -135.84 129.31 32.19 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.925 0.393 . . . . 61.22 111.053 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.536 HG21 ' HA ' ' A' ' 12' ' ' ILE . 60.9 t -131.3 113.58 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.476 -0.329 . . . . 55.3 111.207 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.0 pm0 -108.31 139.96 42.27 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.056 0.455 . . . . 60.51 111.371 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.8 mt -106.71 119.55 56.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.448 -0.342 . . . . 73.4 111.463 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.445 ' HE3' ' HB2' ' A' ' 89' ' ' LYS . 19.0 ptmt -118.18 162.38 18.33 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.915 0.388 . . . . 75.12 111.664 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.1 t -88.21 149.56 23.79 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 116.312 -0.404 . . . . 63.2 110.95 175.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 7' ' ' GLU . 38.8 p -85.0 -2.72 58.3 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.192 0.441 . . . . 72.3 112.192 -178.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -72.82 -175.26 1.67 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.069 0.462 . . . . 65.43 111.798 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -68.99 73.4 0.28 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.39 -0.368 . . . . 74.14 111.975 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 63.6 136.43 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.175 0.805 . . . . 63.53 113.175 176.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.1 t -143.57 108.45 4.93 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.204 -0.453 . . . . 74.33 111.721 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -97.51 105.37 17.51 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.068 0.461 . . . . 72.02 110.561 173.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -87.97 160.96 45.4 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 115.893 -0.594 . . . . 62.42 112.302 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -49.42 -61.2 0.62 Allowed 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.719 2.946 . . . . 72.43 116.064 -169.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.63 151.56 42.23 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.556 0.947 . . . . 73.42 113.556 -170.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.0 t -112.15 170.7 7.98 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.573 -0.74 . . . . 73.23 111.788 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -90.32 44.24 1.19 Allowed 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.292 0.479 . . . . 71.22 112.292 -174.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -71.82 123.96 23.78 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.197 0.522 . . . . 74.21 112.2 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 65.9 mt -137.79 127.2 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 116.32 -0.4 . . . . 75.4 111.164 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.3 p -105.43 134.43 19.69 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 111.708 0.262 . . . . 64.44 111.708 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.84 149.48 60.37 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.856 2.371 . . . . 72.13 113.974 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -143.46 178.61 7.64 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.255 -0.429 . . . . 73.05 111.651 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.64 170.14 11.38 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.309 0.576 . . . . 71.54 112.378 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.82 159.31 37.72 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.024 -0.534 . . . . 71.43 111.008 176.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 112' ' ' HIS . 29.6 m-70 -100.56 109.96 22.09 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.242 -0.286 . . . . 75.24 111.157 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.425 ' C ' ' H ' ' A' ' 112' ' ' HIS . 16.1 t-80 -112.19 132.64 54.78 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 122.346 -0.221 . . . . 75.0 110.638 179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 69.76 -29.97 0.19 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.248 0.619 . . . . 74.15 112.377 -172.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 109' ' ' HIS . 13.8 t60 -52.7 99.62 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.755 -0.461 . . . . 73.23 109.755 169.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -71.23 154.96 41.26 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.856 0.688 . . . . 74.25 112.856 -168.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 . . . . . 0 C--O 1.25 1.112 0 CA-C-N 115.913 -0.585 . . . . 62.32 111.323 175.259 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.649 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.357 0.599 . . . . 55.23 110.931 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -161.87 129.58 4.05 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.15 -0.477 . . . . 73.22 111.447 -176.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -73.82 79.69 1.6 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.105 0.478 . . . . 75.04 110.203 174.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.7 t -79.81 143.19 34.63 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.009 -0.541 . . . . 55.22 111.562 -177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.7 -60.01 1.11 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.276 -0.488 . . . . 63.2 113.649 -175.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -110.43 137.57 47.96 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.186 0.517 . . . . 64.34 112.092 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -93.53 115.66 28.16 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.035 -0.53 . . . . 75.04 111.995 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.38 160.28 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.08 0.466 . . . . 73.53 111.933 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.518 HG13 ' HA ' ' A' ' 23' ' ' PRO . 35.5 m -135.14 141.47 42.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 122.615 0.366 . . . . 61.41 111.003 177.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.91 114.61 26.75 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.892 0.377 . . . . 50.11 111.561 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.0 mm -99.34 113.91 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 120.849 0.357 . . . . 71.14 111.192 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.497 HD11 ' N ' ' A' ' 12' ' ' ILE . 3.2 mp -100.52 118.04 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.1 0.476 . . . . 74.01 111.17 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.3 m -121.56 147.75 45.41 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.883 0.373 . . . . 71.52 111.64 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.435 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 63.9 tt0 -138.88 142.99 38.55 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.643 0.259 . . . . 75.51 110.843 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.435 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 56.0 m-80 57.6 17.68 4.15 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.271 0.471 . . . . 74.51 112.271 -177.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.71 18.95 39.03 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.339 -0.457 . . . . 43.53 113.867 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.754 ' HB3' ' HZ3' ' A' ' 17' ' ' LYS . 0.5 OUTLIER -143.91 144.96 31.96 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.46 0.63 . . . . 75.22 111.616 177.458 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.0 t -70.03 120.95 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.827 0.346 . . . . 72.43 111.567 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 37.2 pt -107.94 -15.42 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 112.219 0.452 . . . . 75.32 112.219 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -170.14 142.53 2.29 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.408 0.283 . . . . 72.41 110.8 -177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.01 122.93 10.03 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.153 0.501 . . . . 72.04 111.898 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.469 HD12 ' N ' ' A' ' 22' ' ' ILE . 4.2 mp -117.6 121.54 31.83 Favored Pre-proline 0 N--CA 1.474 0.731 0 CA-C-N 116.431 -0.35 . . . . 74.02 111.609 -176.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.518 ' HA ' HG13 ' A' ' 9' ' ' VAL . 20.4 Cg_exo -66.52 103.15 0.65 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.169 1.913 . . . . 63.32 111.491 170.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.37 -59.33 4.14 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.409 -0.36 . . . . 72.23 111.926 -174.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.0 m -53.76 125.93 20.23 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.967 0.413 . . . . 72.45 111.996 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.01 -21.14 41.45 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.114 -0.565 . . . . 64.12 113.663 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -86.71 103.96 15.66 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 117.46 0.63 . . . . 74.24 112.24 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -86.64 -175.37 5.4 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.185 -0.461 . . . . 73.54 110.541 174.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.72 -164.13 54.17 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.015 -0.612 . . . . 63.22 114.072 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -119.26 131.17 55.75 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.959 0.409 . . . . 73.35 111.508 -176.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.438 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 10.5 tp10 -132.31 114.98 15.05 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.339 -0.391 . . . . 74.22 110.752 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -118.95 140.64 49.66 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 111.935 0.346 . . . . 75.51 111.935 -176.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -146.87 152.24 38.38 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.761 0.315 . . . . 72.44 111.261 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.6 m -113.8 117.63 32.0 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.267 0.556 . . . . 64.41 112.495 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 71.9 mt -86.38 108.26 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.849 -0.614 . . . . 74.2 111.079 177.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -92.78 105.15 17.33 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.711 0.291 . . . . 74.21 111.128 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.5 -66.84 1.19 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.289 -0.482 . . . . 74.12 114.177 -175.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -164.65 125.62 2.09 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.638 -0.33 . . . . 75.11 111.335 -176.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.36 -105.7 0.77 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.228 -0.51 . . . . 74.23 113.2 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.57 -1.18 28.7 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.184 0.439 . . . . 74.53 112.184 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -84.87 88.73 7.44 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.077 0.465 . . . . 73.03 112.008 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.429 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 47.8 p90 -113.05 168.4 9.73 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.054 -0.521 . . . . 73.21 110.798 174.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.541 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 20.0 m120 -135.75 112.68 10.29 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.317 0.247 . . . . 74.5 110.894 173.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 42.5 tp -87.61 109.94 20.02 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.828 0.347 . . . . 73.33 110.818 177.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.789 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.6 mmm -100.74 159.29 15.3 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.0 0.428 . . . . 71.42 111.979 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 40.5 tt0 -147.7 132.26 17.75 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.338 0.495 . . . . 73.22 112.338 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 58.8 t -118.15 107.63 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.126 0.571 . . . . 73.24 110.09 174.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.463 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 11.9 t70 -121.97 93.4 3.98 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.862 0.363 . . . . 73.15 111.592 -174.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.79 75.36 0.49 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.187 -0.53 . . . . 62.43 114.315 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 60.56 17.19 7.15 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.683 0.994 . . . . 73.22 113.683 175.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.509 ' HG3' ' CE3' ' A' ' 69' ' ' TRP . 7.7 ptp180 -144.07 146.59 32.93 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.97 -0.457 . . . . 73.33 111.19 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 tt -127.29 148.09 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 121.096 0.474 . . . . 74.33 112.271 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.516 ' HB3' ' HA ' ' A' ' 69' ' ' TRP . 0.4 OUTLIER -159.6 168.88 25.02 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.181 -0.463 . . . . 74.55 111.454 176.297 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.789 HG12 ' SD ' ' A' ' 45' ' ' MET . 33.7 mt -93.38 130.2 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.925 0.393 . . . . 74.22 110.962 175.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.465 ' HD2' ' HB2' ' A' ' 46' ' ' GLU . 29.5 mtpp -80.94 -47.68 13.36 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.43 -0.35 . . . . 71.51 111.642 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -171.93 144.75 1.77 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.067 0.461 . . . . 70.41 111.77 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 3.9 p-10 -142.2 -177.32 5.19 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.262 -0.426 . . . . 71.4 110.647 176.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -116.78 83.81 2.03 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.481 0.658 . . . . 74.42 111.06 173.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.6 t -130.65 152.75 80.99 Favored Pre-proline 0 N--CA 1.474 0.741 0 CA-C-N 115.692 -0.686 . . . . 73.53 111.371 174.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.72 -13.91 24.46 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 121.868 1.712 . . . . 65.12 112.046 171.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.463 ' HB3' HG22 ' A' ' 63' ' ' VAL . 7.8 m-20 -102.68 -50.91 3.43 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.136 -0.484 . . . . 62.35 111.491 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 53.24 29.84 9.07 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.637 0.606 . . . . 74.41 112.637 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 61' ' ' ASP . 41.5 t -58.55 -36.02 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.846 0.355 . . . . 75.12 111.549 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.419 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -57.09 -45.27 92.64 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 116.406 -0.361 . . . . 65.43 113.593 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 45.4 t -62.56 -40.02 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.34 0.59 . . . . 63.01 110.983 178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -69.52 -27.29 65.05 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.978 -0.556 . . . . 73.35 112.253 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.439 ' HE1' HG13 ' A' ' 63' ' ' VAL . 20.9 mmt -55.06 -39.24 69.0 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.127 0.418 . . . . 74.52 112.127 177.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.26 -175.6 54.88 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.202 -0.523 . . . . 71.22 114.186 175.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.516 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . 96.5 m95 -52.28 138.11 27.24 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.954 0.724 . . . . 73.11 112.954 -175.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -135.56 148.3 49.06 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.7 0.4 . . . . 72.11 110.743 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 89.2 p -170.7 18.97 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.802 0.668 . . . . 71.43 112.802 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -101.44 146.67 27.31 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.035 -0.416 . . . . 72.41 110.59 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.13 88.89 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.089 0.471 . . . . 65.15 111.037 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.85 -19.46 2.55 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.198 -0.525 . . . . 65.01 113.666 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.503 ' HB2' HD12 ' A' ' 88' ' ' ILE . 97.4 m-20 -57.09 139.56 52.01 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 117.573 0.686 . . . . 72.15 112.172 -178.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.3 p -138.79 144.89 39.55 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.95 0.405 . . . . 73.53 111.515 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.8 mm -122.9 127.94 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.3 -0.409 . . . . 75.23 110.315 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.9 t -111.7 117.22 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.013 0.435 . . . . 75.32 111.959 -177.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.541 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 74.8 m -114.03 76.44 0.99 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.128 0.49 . . . . 73.04 110.226 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.451 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 5.2 tt -54.75 -54.14 52.72 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 115.713 -0.676 . . . . 71.43 112.634 -173.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 80' ' ' LEU . 23.7 Cg_endo -59.73 -22.61 68.41 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 122.156 1.904 . . . . 73.11 113.287 -177.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -104.35 -2.13 25.93 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.488 -0.324 . . . . 74.44 111.385 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm 60.02 29.38 18.95 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.263 0.468 . . . . 72.02 112.263 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.541 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 48.4 t -106.15 141.75 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.925 0.393 . . . . 75.53 111.436 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -143.24 126.65 16.74 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.821 0.343 . . . . 73.43 110.984 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -115.35 133.4 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.569 -0.287 . . . . 75.04 111.182 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -132.42 136.75 46.97 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.064 0.459 . . . . 63.03 111.47 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 75' ' ' ASP . 58.7 mt -106.4 110.86 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.311 -0.404 . . . . 74.13 110.797 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -117.58 164.64 14.63 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.248 0.462 . . . . 72.34 112.248 -174.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.9 t -85.12 149.73 25.34 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.189 -0.46 . . . . 74.31 112.209 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.2 p -77.69 -27.84 50.86 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.162 0.506 . . . . 74.12 110.989 174.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -86.29 165.72 16.22 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.171 -0.468 . . . . 75.22 110.951 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -80.76 125.88 30.62 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.446 0.535 . . . . 63.54 112.446 -175.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -105.84 -178.29 3.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.064 -0.516 . . . . 72.41 110.47 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.9 t -88.9 49.17 1.74 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.345 0.593 . . . . 71.32 110.111 173.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -91.67 176.29 6.59 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.367 0.603 . . . . 75.34 112.244 -176.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.44 146.67 84.21 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 115.657 -0.701 . . . . 74.41 110.814 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.65 -52.89 7.06 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.282 1.988 . . . . 71.23 111.825 175.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -171.94 179.28 2.75 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.603 -0.726 . . . . 74.51 110.315 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.4 t -150.18 130.98 14.14 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.084 0.468 . . . . 74.4 111.514 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -129.75 133.55 47.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.376 -0.375 . . . . 73.41 110.899 178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.7 pp -165.39 162.16 19.34 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.953 0.406 . . . . 73.41 111.332 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.1 mm -115.11 109.11 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.002 0.429 . . . . 73.24 110.975 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 34.5 m -75.38 142.26 74.57 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 120.832 0.349 . . . . 73.02 111.933 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 104' ' ' VAL . 27.3 Cg_exo -62.41 113.12 1.79 Allowed 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.5 2.133 . . . . 70.51 112.165 175.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -76.97 136.68 38.75 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.075 -0.512 . . . . 72.32 111.631 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.6 pp -85.99 162.68 18.39 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.931 0.396 . . . . 75.51 111.56 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -94.85 -178.51 4.53 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.162 0.506 . . . . 41.5 111.814 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -142.68 105.47 4.52 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.012 -0.54 . . . . 72.4 110.498 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -76.87 82.54 3.44 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.27 0.557 . . . . 75.45 110.25 176.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -134.1 149.51 51.11 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.036 -0.529 . . . . 73.01 111.708 -173.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -122.03 158.37 29.33 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.411 -0.359 . . . . 75.45 110.592 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -83.67 145.32 28.85 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.864 0.364 . . . . 71.32 111.843 -177.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 73.8 m80 . . . . . 0 C--O 1.253 1.254 0 CA-C-O 118.62 -0.705 . . . . 61.13 111.455 178.541 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 111.889 0.329 . . . . 74.22 111.889 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -117.24 111.72 19.81 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.259 0.466 . . . . 72.23 112.259 -173.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -127.11 108.36 10.84 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.864 0.364 . . . . 73.33 110.361 174.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 57.8 p -106.5 117.93 35.32 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.916 0.388 . . . . 74.34 111.866 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -82.0 -17.49 69.71 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.273 -0.489 . . . . 74.14 112.948 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.75 83.55 0.89 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.796 0.331 . . . . 72.14 111.332 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -79.82 104.89 10.71 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.038 0.447 . . . . 64.21 111.295 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 32.7 m -120.88 144.66 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.508 0.67 . . . . 72.22 112.37 -177.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' A' ' 23' ' ' PRO . 34.6 m -125.39 134.2 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 115.677 -0.692 . . . . 72.42 110.815 177.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.43 114.52 25.13 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.794 0.331 . . . . 63.05 111.659 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.3 mm -97.25 137.49 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.551 -0.295 . . . . 73.32 110.474 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.439 ' N ' HD11 ' A' ' 12' ' ' ILE . 3.9 mp -121.97 118.71 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.012 0.434 . . . . 74.23 111.055 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.6 p -112.98 153.02 28.7 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.178 0.513 . . . . 75.05 111.37 177.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -151.91 142.21 22.42 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.328 -0.396 . . . . 73.45 110.846 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 59.77 14.1 3.92 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.628 0.603 . . . . 71.11 112.628 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.68 10.69 43.0 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.032 -0.604 . . . . 71.45 114.166 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -146.13 151.06 37.06 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 117.264 0.532 . . . . 72.42 111.458 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.12 136.79 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.681 0.276 . . . . 73.43 110.899 175.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.1 pt -117.89 -22.07 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 112.14 0.422 . . . . 52.34 112.14 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -169.31 144.99 3.22 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.577 0.227 . . . . 75.02 111.315 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -137.69 128.06 26.37 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.85 0.357 . . . . 73.2 111.254 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.432 ' N ' HD13 ' A' ' 22' ' ' ILE . 3.9 mp -123.83 119.63 26.8 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-N 116.579 -0.282 . . . . 72.14 111.704 -177.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.517 ' HA ' HG13 ' A' ' 9' ' ' VAL . 34.8 Cg_exo -61.97 132.0 37.52 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.406 2.07 . . . . 55.44 112.346 172.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -96.3 -61.72 1.39 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.881 0.372 . . . . 74.41 111.465 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.3 m -60.23 121.12 11.17 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.511 -0.313 . . . . 62.44 111.657 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.05 -8.24 80.18 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.095 -0.574 . . . . 45.14 113.126 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -78.3 86.42 4.39 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.289 0.566 . . . . 74.11 110.886 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -83.57 98.25 9.48 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.248 0.547 . . . . 72.3 111.113 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.88 -168.21 31.17 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.949 -0.568 . . . . 72.11 112.923 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -118.43 145.19 45.41 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 122.307 -0.526 . . . . 74.2 110.874 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.547 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 9.3 tp10 -144.82 117.49 8.65 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.566 -0.288 . . . . 63.13 110.574 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -127.6 129.85 47.99 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.728 0.299 . . . . 60.11 111.13 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -141.35 153.05 44.89 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.075 0.464 . . . . 73.22 111.297 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.6 m -112.49 116.7 30.68 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.948 0.404 . . . . 73.3 111.422 -175.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.2 mt -79.99 108.22 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.859 0.362 . . . . 70.42 111.022 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -99.86 111.13 23.46 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.298 -0.41 . . . . 74.12 111.146 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -110.69 -91.45 2.08 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.242 -0.504 . . . . 73.52 113.493 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.617 ' HE3' ' HA ' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -112.84 85.47 2.18 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.861 0.362 . . . . 72.51 111.494 -176.355 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.33 -97.71 0.02 OUTLIER Glycine 0 CA--C 1.529 0.93 0 CA-C-N 116.277 -0.419 . . . . 73.12 113.817 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.82 -31.53 72.54 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.929 0.395 . . . . 74.42 111.74 177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -72.82 94.17 1.77 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.129 0.418 . . . . 75.44 112.129 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -124.84 176.8 6.38 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.387 -0.369 . . . . 73.21 110.498 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -158.63 114.52 2.66 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.766 0.317 . . . . 74.14 110.92 174.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.6 tp -89.99 111.53 22.64 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.073 0.463 . . . . 74.34 111.477 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.616 ' SD ' HG12 ' A' ' 54' ' ' ILE . 94.3 mmm -97.56 138.1 35.49 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.146 -0.479 . . . . 72.22 111.384 -177.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -123.95 116.61 23.16 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.931 0.396 . . . . 72.21 111.78 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 40.2 t -107.47 112.46 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.232 -0.44 . . . . 74.33 110.652 176.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 20.5 t70 -109.04 101.95 10.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.05 0.452 . . . . 74.04 110.224 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.87 -106.02 1.17 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.846 -0.692 . . . . 72.43 112.772 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -111.51 17.41 20.07 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 120.973 0.416 . . . . 75.53 111.734 -176.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 19.9 ptt180 -130.42 141.96 50.52 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.316 -0.402 . . . . 74.42 111.049 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 tt -130.92 149.41 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 120.987 0.422 . . . . 75.34 111.717 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -157.02 168.89 26.13 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.953 0.406 . . . . 74.53 111.486 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.616 HG12 ' SD ' ' A' ' 45' ' ' MET . 60.5 mt -85.54 113.52 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 109.832 -0.433 . . . . 64.42 109.832 169.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -73.87 -49.66 23.97 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.94 0.4 . . . . 72.44 111.686 -177.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -162.69 138.61 7.24 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.181 0.437 . . . . 70.45 112.181 -175.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -165.43 -172.29 2.41 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.095 -0.502 . . . . 72.43 110.34 173.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -121.72 24.07 9.89 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.77 0.656 . . . . 72.22 112.77 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.3 t -77.18 125.93 85.91 Favored Pre-proline 0 N--CA 1.474 0.761 0 O-C-N 121.869 -0.519 . . . . 74.5 110.968 175.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -59.39 -13.58 21.2 Favored 'Trans proline' 0 N--CA 1.48 0.725 0 C-N-CA 122.998 2.465 . . . . 65.21 113.092 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.484 ' HB3' HG21 ' A' ' 63' ' ' VAL . 3.7 m-20 -83.77 -41.07 18.0 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.036 0.384 . . . . 72.2 112.036 175.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 53.75 32.56 15.05 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.147 0.425 . . . . 73.53 112.147 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 61' ' ' ASP . 97.5 t -52.52 -51.74 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 112.55 0.574 . . . . 62.44 112.55 -173.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.578 ' HA3' HD11 ' A' ' 54' ' ' ILE . . . -62.73 -34.82 90.78 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.743 -0.742 . . . . 70.24 113.446 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.48 -44.67 98.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 120.945 0.402 . . . . 64.0 110.897 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -69.49 -37.7 77.33 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.427 -0.351 . . . . 74.12 111.112 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 21.3 mmt -61.63 -33.57 74.17 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.353 0.501 . . . . 71.31 112.353 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.39 -143.18 29.11 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.021 -0.609 . . . . 74.04 113.426 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -86.99 122.39 30.77 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.058 0.456 . . . . 75.14 112.066 -176.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.401 ' HD2' ' CG ' ' A' ' 75' ' ' ASP . 74.1 mmtt -108.63 154.33 22.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.177 -0.465 . . . . 73.11 110.668 176.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 82.6 p -165.89 12.68 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.987 1.106 . . . . 72.2 113.987 -173.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -131.49 158.9 39.67 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.553 0.692 . . . . 73.41 112.457 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.496 ' HB3' ' HB2' ' A' ' 90' ' ' SER . . . -68.13 108.01 2.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.67 -0.695 . . . . 65.53 111.422 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.28 -16.61 4.89 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.35 -0.452 . . . . 65.53 112.398 -176.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.483 ' HB2' HD11 ' A' ' 88' ' ' ILE . 77.5 m-20 -72.21 106.15 4.29 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.029 0.442 . . . . 74.23 111.242 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 67.7 p -116.24 142.46 46.8 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.784 0.325 . . . . 74.43 111.779 178.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.9 mm -117.06 134.03 61.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 122.673 0.389 . . . . 75.05 110.828 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -112.19 117.34 54.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 111.895 0.332 . . . . 73.03 111.895 -177.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 86.7 m -122.0 68.37 0.93 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.856 0.36 . . . . 73.12 111.126 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.519 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 92.0 mt -53.07 -50.11 83.84 Favored Pre-proline 0 N--CA 1.476 0.847 0 N-CA-C 113.246 0.832 . . . . 71.04 113.246 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.519 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 50.7 Cg_exo -54.54 -24.65 37.17 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.021 1.814 . . . . 64.22 113.374 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -106.58 -1.88 22.45 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 111.869 0.322 . . . . 63.03 111.869 -179.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 59.69 30.93 20.54 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.989 0.423 . . . . 71.53 111.662 -176.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.2 t -112.12 137.17 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 116.079 -0.51 . . . . 71.32 111.178 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -135.81 143.04 44.95 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.528 -0.306 . . . . 65.13 110.291 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 76' ' ' THR . 58.1 t -129.36 120.1 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 122.288 -0.257 . . . . 60.13 111.067 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.22 116.94 25.86 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.456 0.646 . . . . 74.33 111.912 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.483 HD11 ' HB2' ' A' ' 75' ' ' ASP . 57.4 mt -88.78 114.53 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 122.009 -0.432 . . . . 73.15 110.894 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.709 ' HB2' ' HZ1' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -109.85 172.46 6.84 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.942 0.401 . . . . 74.35 111.095 179.552 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.496 ' HB2' ' HB3' ' A' ' 73' ' ' ALA . 40.5 t -111.21 150.27 29.8 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.782 0.325 . . . . 62.12 110.891 175.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.1 p -77.01 -9.65 58.84 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.566 -0.288 . . . . 74.15 111.453 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -66.08 170.01 6.22 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.598 0.713 . . . . 74.43 112.402 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -86.58 139.82 30.46 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.469 -0.787 . . . . 73.14 110.357 173.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -143.98 176.48 9.25 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 122.118 -0.364 . . . . 71.53 110.845 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.4 t -105.43 -23.51 12.81 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.754 0.65 . . . . 53.43 112.754 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -83.93 143.8 29.6 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.36 0.6 . . . . 75.52 112.227 -174.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -109.44 122.47 39.37 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.82 -0.627 . . . . 75.1 110.923 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -84.87 -44.03 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.425 2.083 . . . . 75.05 113.946 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -96.35 162.85 13.32 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.481 0.548 . . . . 74.34 112.481 -172.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.2 p -107.07 -62.73 1.37 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.483 0.658 . . . . 73.3 110.511 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -93.34 124.17 37.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.225 -0.898 . . . . 61.52 110.903 176.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.4 tp -91.43 128.72 37.37 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.301 -0.409 . . . . 73.4 111.984 -176.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 51.3 mm -102.17 116.73 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.532 -0.304 . . . . 64.42 110.946 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 68.8 t -116.55 121.4 33.24 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 112.176 0.436 . . . . 74.12 112.176 -177.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.61 98.57 1.14 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 122.464 2.11 . . . . 75.1 112.446 175.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -123.02 26.73 7.97 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.179 0.437 . . . . 75.4 112.179 -177.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.433 HD21 ' N ' ' A' ' 107' ' ' LEU . 3.2 mm? -70.09 134.6 48.38 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.642 0.258 . . . . 75.54 111.441 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -121.49 139.95 52.82 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.401 0.519 . . . . 72.22 112.401 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -149.82 136.46 19.25 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.97 -0.559 . . . . 71.04 110.257 175.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -147.14 149.3 32.73 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.936 0.398 . . . . 75.33 112.01 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -135.72 141.94 44.97 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.413 -0.358 . . . . 73.42 111.135 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -87.82 94.07 9.65 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.988 0.423 . . . . 74.22 111.086 176.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -90.96 174.49 7.4 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.39 -0.368 . . . . 73.24 111.533 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 34.0 m170 . . . . . 0 C--O 1.253 1.274 0 CA-C-O 118.399 -0.81 . . . . 72.23 112.286 179.643 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.529 ' HA ' ' HB ' ' A' ' 25' ' ' THR . 42.9 mt-10 . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 112.083 0.401 . . . . 73.049999999999997 112.083 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 25.7 m -110.8 151.91 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 121.361 0.6 . . . . 60.420000000000002 112.184 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 23' ' ' PRO . 34.4 m -128.1 143.04 42.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 115.794 -0.639 . . . . 70.409999999999997 111.256 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.49 117.97 30.17 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.43 -0.35 . . . . 63.149999999999999 111.216 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.51 HD11 ' HE3' ' A' ' 89' ' ' LYS . 20.0 mm -92.45 112.92 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.464 -0.334 . . . . 70.230000000000004 111.21 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 12' ' ' ILE . 3.4 mp -98.31 119.13 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.091 0.472 . . . . 72.219999999999999 111.647 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.2 p -123.22 145.18 48.86 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.298 -0.41 . . . . 50.130000000000003 110.604 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 60.6 tt0 -140.28 141.85 35.77 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.128 -0.358 . . . . 72.420000000000002 111.329 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.0 m120 66.28 -12.76 0.18 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.784 0.661 . . . . 65.530000000000001 112.784 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 14' ' ' GLN . . . 119.25 26.07 2.55 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.525 -0.369 . . . . 74.519999999999996 112.731 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -147.96 146.55 29.01 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.479 -0.424 . . . . 75.140000000000001 111.156 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.6 t -74.29 121.41 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.904 0.383 . . . . 62.32 110.769 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 34.9 pt -109.97 -20.95 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 112.721 0.638 . . . . 74.310000000000002 112.721 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -170.66 153.04 3.96 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.485 0.183 . . . . 65.239999999999995 111.48 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -147.15 122.4 10.23 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.266 0.555 . . . . 73.510000000000005 111.546 175.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.521 HG21 HG21 ' A' ' 47' ' ' VAL . 2.5 mp -106.65 129.67 24.07 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-N 116.092 -0.504 . . . . 71.439999999999998 111.614 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.461 ' HA ' HG12 ' A' ' 9' ' ' VAL . 56.9 Cg_endo -70.76 126.9 13.13 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.366 2.044 . . . . 62.520000000000003 112.109 174.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.91 -62.43 1.32 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 111.901 0.334 . . . . 65.400000000000006 111.901 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.529 ' HB ' ' HA ' ' A' ' 7' ' ' GLU . 19.6 m -54.28 127.47 27.27 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.653 0.263 . . . . 64.409999999999997 111.567 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.01 -24.38 9.17 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.211 -0.518 . . . . 54.420000000000002 113.218 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -75.94 83.0 2.84 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.383 0.611 . . . . 64.549999999999997 110.93 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -83.77 164.08 19.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.708 -0.678 . . . . 70.230000000000004 111.416 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.19 -163.25 37.5 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 120.827 -0.701 . . . . 43.439999999999998 112.631 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -118.53 146.79 44.28 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.001 0.429 . . . . 64.319999999999993 111.775 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -150.13 142.24 24.03 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.163 -0.472 . . . . 74.5 110.857 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -132.05 147.82 52.46 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.043 0.386 . . . . 62.049999999999997 112.043 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -153.39 139.5 18.33 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.962 0.41 . . . . 74.140000000000001 111.439 174.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.6 m -102.45 114.51 28.77 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.127 0.418 . . . . 63.32 112.127 -175.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.1 mt -86.25 104.4 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 116.271 -0.422 . . . . 72.319999999999993 111.425 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -101.27 125.21 47.87 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.673 0.273 . . . . 63.329999999999998 111.106 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -121.29 -78.27 0.49 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.982 -0.628 . . . . 22.550000000000001 114.197 -176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.555 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -114.25 -169.86 1.61 Allowed 'General case' 0 CA--C 1.546 0.811 0 O-C-N 122.46 -0.435 . . . . 73.420000000000002 111.304 -173.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -44.67 100.04 0.02 OUTLIER Glycine 0 CA--C 1.528 0.879 0 N-CA-C 114.502 0.561 . . . . 74.5 114.502 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 67.0 -2.82 1.06 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.177 0.806 . . . . 54.020000000000003 113.177 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -86.56 112.58 21.7 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.871 0.367 . . . . 72.030000000000001 111.915 -175.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -139.99 163.51 32.48 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.284 -0.416 . . . . 61.210000000000001 111.649 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -135.4 113.52 11.28 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.479 -0.328 . . . . 75.540000000000006 111.291 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.4 tp -84.57 103.82 14.03 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.922 0.392 . . . . 72.0 110.169 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.646 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.7 mmm -95.91 146.37 24.64 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.265 -0.425 . . . . 71.439999999999998 111.322 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -132.92 122.94 25.07 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.102 0.477 . . . . 72.400000000000006 111.952 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.521 HG21 HG21 ' A' ' 22' ' ' ILE . 58.2 t -103.32 107.57 22.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.941 -0.572 . . . . 72.549999999999997 110.207 173.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.463 ' HB3' ' CH2' ' A' ' 69' ' ' TRP . 30.3 t70 -129.84 105.69 8.18 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.859 0.361 . . . . 63.539999999999999 111.543 -175.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . 74.66 55.1 5.61 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.302 -0.475 . . . . 74.400000000000006 114.013 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 63.62 23.53 13.59 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.775 0.657 . . . . 73.430000000000007 112.775 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 49' ' ' GLY . 7.9 ptt85 -148.5 149.18 31.19 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.806 0.336 . . . . 73.019999999999996 110.985 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.0 tt -123.29 148.69 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.148 0.499 . . . . 51.229999999999997 112.068 -174.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -152.94 168.88 24.33 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.851 -0.613 . . . . 71.319999999999993 110.821 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.646 HG12 ' SD ' ' A' ' 45' ' ' MET . 40.4 mt -84.91 110.67 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 120.977 0.418 . . . . 55.109999999999999 110.155 169.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -75.29 -29.94 60.23 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.31 -0.405 . . . . 71.099999999999994 111.096 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -175.47 138.65 0.41 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.243 -0.435 . . . . 73.549999999999997 111.431 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -161.68 156.42 23.01 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.175 0.512 . . . . 65.409999999999997 111.034 172.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -93.39 69.14 4.23 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.2 0.524 . . . . 63.420000000000002 111.867 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.3 p -127.33 140.61 38.42 Favored Pre-proline 0 N--CA 1.473 0.7 0 CA-C-N 116.46 -0.336 . . . . 41.030000000000001 110.692 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.67 -17.79 29.34 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.981 1.788 . . . . 74.109999999999999 111.987 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.536 ' HB3' HG23 ' A' ' 63' ' ' VAL . 2.2 m-20 -80.35 -52.9 7.14 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.607 -0.724 . . . . 65.230000000000004 111.755 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 57.45 29.31 16.8 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 120.649 0.261 . . . . 75.109999999999999 111.6 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 61' ' ' ASP . 65.5 t -53.82 -48.33 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 112.223 0.453 . . . . 53.210000000000001 112.223 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.557 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -59.89 -29.67 68.17 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 120.892 -0.67 . . . . 74.439999999999998 113.067 177.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 67.5 t -66.94 -40.24 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.752 0.31 . . . . 61.420000000000002 110.713 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -65.62 -37.17 85.83 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.032 0.444 . . . . 74.150000000000006 110.832 172.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.58 ' SD ' ' NZ ' ' A' ' 70' ' ' LYS . 23.2 mmt -58.35 -46.41 86.33 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.236 -0.438 . . . . 54.210000000000001 111.588 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.58 -143.49 38.77 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.322 -0.466 . . . . 54.030000000000001 113.74 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.463 ' CH2' ' HB3' ' A' ' 48' ' ' ASP . 82.4 m95 -69.6 105.22 2.6 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.365 0.506 . . . . 72.219999999999999 112.365 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.58 ' NZ ' ' SD ' ' A' ' 67' ' ' MET . 34.4 mmtp -111.85 138.96 47.75 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 116.297 -0.41 . . . . 71.150000000000006 110.429 174.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' A' ' 51' ' ' ARG . 98.8 p -157.49 9.83 0.19 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.339 1.237 . . . . 74.439999999999998 114.339 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -118.41 149.67 40.85 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.725 -0.609 . . . . 72.540000000000006 112.075 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.31 107.54 0.5 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.021 -0.536 . . . . 74.549999999999997 111.041 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 129.07 -20.91 5.3 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 116.125 -0.489 . . . . 72.049999999999997 112.52 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.556 ' HB2' HD12 ' A' ' 88' ' ' ILE . 55.7 m-20 -74.48 151.3 39.58 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.009 0.433 . . . . 73.430000000000007 111.297 175.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 65.8 p -141.43 158.14 44.25 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.327 0.584 . . . . 74.209999999999994 112.372 -176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 40.0 mm -132.1 116.12 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.493 -0.776 . . . . 62.439999999999998 109.434 173.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.1 t -124.83 117.18 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 113.003 0.742 . . . . 65.430000000000007 113.003 -173.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 68.8 m -122.97 89.13 3.05 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.34 -0.391 . . . . 64.239999999999995 110.947 170.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.0 mt -63.78 -38.92 41.7 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 113.575 0.954 . . . . 63.420000000000002 113.575 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.04 -21.14 25.96 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.878 1.719 . . . . 72.099999999999994 112.931 174.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -112.49 0.61 15.59 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.899 0.38 . . . . 74.140000000000001 110.776 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 92.6 mttt 55.09 34.56 22.83 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.609 0.764 . . . . 72.209999999999994 112.434 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -102.62 117.51 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.919 0.39 . . . . 71.340000000000003 111.305 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -119.92 123.15 42.86 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.426 -0.352 . . . . 73.310000000000002 110.545 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.565 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 48.1 t -123.24 132.63 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 120.57 0.224 . . . . 62.530000000000001 111.397 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -132.21 143.64 50.09 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.818 0.342 . . . . 73.450000000000003 110.938 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.556 HD12 ' HB2' ' A' ' 75' ' ' ASP . 57.2 mt -100.95 121.35 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.612 0.244 . . . . 62.439999999999998 111.505 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.51 ' HE3' HD11 ' A' ' 11' ' ' ILE . 22.9 pttp -124.25 152.04 43.46 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.829 0.347 . . . . 71.140000000000001 111.212 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 43.9 t -89.82 151.06 21.97 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.375 0.607 . . . . 71.510000000000005 112.15 -177.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.8 p -73.08 -32.48 65.03 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.994 -0.548 . . . . 73.219999999999999 111.552 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HG2' ' OG ' ' A' ' 90' ' ' SER . 16.2 pt20 . . . . . 0 CA--C 1.542 0.64 0 CA-C-O 121.669 0.747 . . . . 54.119999999999997 112.459 -177.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 N--CA 1.469 0.508 0 CA-C-O 120.589 0.233 . . . . 74.030000000000001 110.714 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 26.8 m -123.28 145.01 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 112.592 0.59 . . . . 64.409999999999997 112.592 -176.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 23' ' ' PRO . 26.7 m -122.91 141.96 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 115.802 -0.635 . . . . 63.149999999999999 111.318 178.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.5 112.7 24.65 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.367 -0.379 . . . . 41.229999999999997 110.95 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.578 HG13 ' HD3' ' A' ' 89' ' ' LYS . 45.6 mm -95.43 115.99 35.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.727 0.298 . . . . 73.299999999999997 111.415 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.491 ' N ' HD12 ' A' ' 12' ' ' ILE . 3.3 mp -101.62 118.36 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.766 0.317 . . . . 73.400000000000006 111.043 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.9 m -117.2 138.11 51.91 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.885 0.374 . . . . 51.439999999999998 111.597 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -134.8 142.55 46.72 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 122.587 0.355 . . . . 65.450000000000003 110.183 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.6 m120 56.29 34.94 24.97 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.049 0.452 . . . . 74.329999999999998 111.793 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.85 21.19 79.03 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.372 -0.442 . . . . 63.32 114.094 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -144.5 143.82 31.05 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 122.479 -0.424 . . . . 72.209999999999994 111.518 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.75 124.24 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.843 0.354 . . . . 62.130000000000003 111.285 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 44.9 pt -111.43 -20.09 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 112.474 0.546 . . . . 42.210000000000001 112.474 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -157.81 145.47 18.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.909 0.385 . . . . 73.530000000000001 111.977 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.44 125.21 20.98 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.3 -0.409 . . . . 74.430000000000007 110.945 172.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.459 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 73.7 mt -126.99 124.78 24.05 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 112.253 0.464 . . . . 60.130000000000003 112.253 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 22' ' ' ILE . 6.7 Cg_exo -73.82 117.2 4.94 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.826 2.351 . . . . 74.239999999999995 112.293 175.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.57 -47.23 15.86 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.088 0.471 . . . . 73.530000000000001 111.149 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 84.8 m -58.9 117.03 4.18 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.929 -0.578 . . . . 73.040000000000006 112.024 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.34 3.05 88.93 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.242 -0.504 . . . . 72.439999999999998 113.713 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -71.15 129.48 39.05 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.286 0.565 . . . . 65.209999999999994 111.43 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.42 ' HB2' ' NZ ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -97.33 148.08 23.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.14 -0.482 . . . . 64.239999999999995 111.601 178.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.32 -164.8 54.46 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 114.814 0.686 . . . . 60.0 114.814 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 25.7 t-20 -118.6 125.83 50.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.945 0.498 . . . . 54.020000000000003 110.397 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -118.19 122.51 43.2 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.733 0.301 . . . . 51.32 111.512 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -120.11 139.27 52.83 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.937 0.398 . . . . 75.230000000000004 111.566 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -149.91 143.12 25.06 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.027 0.442 . . . . 71.109999999999999 111.209 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.0 m -101.59 110.06 21.98 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.174 0.511 . . . . 74.349999999999994 112.238 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 39.7 mt -80.1 90.76 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.917 0.389 . . . . 74.099999999999994 110.077 175.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -73.54 128.47 35.59 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.883 0.373 . . . . 74.150000000000006 111.674 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.48 -143.72 12.01 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 116.296 -0.411 . . . . 71.439999999999998 112.209 175.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -86.49 123.53 31.8 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 122.413 -0.463 . . . . 72.150000000000006 111.115 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.14 -137.02 19.92 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.372 -0.442 . . . . 60.020000000000003 113.548 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.67 4.85 30.57 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.092 0.473 . . . . 71.439999999999998 111.874 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.449 ' HB3' ' CD2' ' A' ' 82' ' ' HIS . 98.5 mt-30 -83.28 119.14 24.21 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.254 -0.43 . . . . 73.310000000000002 111.637 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -145.86 155.08 42.66 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.584 -0.28 . . . . 72.519999999999996 111.556 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.572 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 48.8 m-80 -114.75 110.04 19.12 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.374 -0.376 . . . . 64.329999999999998 111.017 173.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.1 tp -89.51 107.04 18.85 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.869 0.366 . . . . 71.540000000000006 110.489 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.694 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.1 mmm -95.12 146.93 23.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.87 0.367 . . . . 75.140000000000001 111.824 -175.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 42.6 tt0 -133.44 121.45 22.26 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.139 0.495 . . . . 74.310000000000002 111.341 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 30' ' ' ASN . 43.9 t -109.34 114.38 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.151 -0.477 . . . . 71.450000000000003 110.587 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.474 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 35.9 t70 -108.76 103.88 13.04 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.071 0.463 . . . . 54.219999999999999 110.704 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 63.14 -104.26 0.78 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 120.742 -0.742 . . . . 70.409999999999997 112.674 -175.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -113.75 18.59 17.34 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.018 0.377 . . . . 75.239999999999995 112.018 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 35.5 ptt180 -132.75 149.36 52.29 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.668 0.271 . . . . 75.150000000000006 111.242 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.1 tt -133.38 146.04 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 112.319 0.489 . . . . 75.340000000000003 112.319 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -148.03 169.28 20.27 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.147 -0.479 . . . . 74.409999999999997 110.86 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.694 HG12 ' SD ' ' A' ' 45' ' ' MET . 31.2 mt -85.88 108.89 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.05 0.452 . . . . 71.129999999999995 110.232 169.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 56.4 tttp -67.75 -45.66 74.31 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.285 0.564 . . . . 64.030000000000001 111.325 -178.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -152.49 157.89 41.79 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.029 -0.532 . . . . 75.209999999999994 110.168 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -160.62 167.69 26.5 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.038 0.446 . . . . 74.329999999999998 111.947 -175.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . 51.3 t-20 -130.7 70.81 1.45 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.1 0.476 . . . . 70.439999999999998 110.942 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.7 p -129.06 155.87 79.08 Favored Pre-proline 0 N--CA 1.477 0.905 0 O-C-N 122.117 -0.364 . . . . 70.349999999999994 111.766 175.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.26 -17.03 13.47 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.486 2.124 . . . . 63.350000000000001 112.888 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.542 ' HB2' HG23 ' A' ' 63' ' ' VAL . 5.9 p-10 -92.15 -47.19 7.37 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 111.917 0.34 . . . . 55.32 111.917 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.425 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 15.8 mm100 65.94 19.73 11.27 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.791 0.436 . . . . 71.010000000000005 111.912 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.542 HG23 ' HB2' ' A' ' 61' ' ' ASP . 97.1 t -55.14 -46.96 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.156 0.503 . . . . 64.099999999999994 111.11 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.498 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -57.74 -38.32 87.68 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.037 -0.602 . . . . 51.340000000000003 112.746 176.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.15 -30.25 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.106 0.479 . . . . 62.109999999999999 111.267 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.425 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 5.4 mptp? -73.9 -31.04 62.93 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.387 0.514 . . . . 73.420000000000002 112.387 177.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.1 mmt -54.38 -50.71 66.89 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.529 0.566 . . . . 75.120000000000005 112.529 -177.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.9 -149.62 21.01 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.913 -0.66 . . . . 44.420000000000002 113.58 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -80.95 120.3 24.58 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.279 0.561 . . . . 65.319999999999993 112.099 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 75.0 mmtt -116.66 150.53 37.98 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.568 -0.742 . . . . 71.430000000000007 110.21 175.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 93.1 p -164.15 9.64 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.306 1.225 . . . . 72.439999999999998 114.306 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -132.76 157.14 45.69 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.61 0.641 . . . . 72.010000000000005 112.422 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.68 112.71 1.91 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.801 -0.636 . . . . 74.030000000000001 111.616 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 130.24 -26.45 4.17 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 116.219 -0.446 . . . . 52.299999999999997 112.366 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.538 ' HB2' HD12 ' A' ' 88' ' ' ILE . 76.7 m-20 -69.38 126.2 29.02 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.835 0.35 . . . . 71.310000000000002 111.082 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 87' ' ' GLU . 47.0 p -132.02 145.37 51.4 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.947 0.403 . . . . 72.409999999999997 111.901 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.524 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 37.8 mm -114.65 130.05 69.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.377 -0.374 . . . . 64.239999999999995 110.606 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.7 t -112.96 118.65 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 112.047 0.388 . . . . 73.400000000000006 112.047 -177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.494 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 74.9 m -122.61 82.38 1.97 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.158 0.504 . . . . 74.120000000000005 110.92 173.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.468 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 84.1 mt -57.22 -58.67 16.37 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 113.565 0.95 . . . . 60.140000000000001 113.565 -173.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 59.8 Cg_endo -70.9 -2.14 10.53 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.88 1.72 . . . . 61.409999999999997 113.033 -175.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.449 ' CD2' ' HB3' ' A' ' 41' ' ' GLN . 37.9 m170 -109.97 -2.45 17.11 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.497 -0.319 . . . . 73.25 111.297 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 59.78 29.62 19.19 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.916 0.389 . . . . 72.349999999999994 111.744 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 57.5 t -115.37 134.05 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.104 0.478 . . . . 73.219999999999999 111.811 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -136.56 131.68 34.15 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.011 -0.541 . . . . 72.209999999999994 110.229 175.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.524 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 46.7 t -118.38 136.38 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.528 -0.305 . . . . 71.040000000000006 111.097 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.436 ' HA ' HG22 ' A' ' 76' ' ' THR . 11.9 pt-20 -133.09 125.2 29.06 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.201 0.524 . . . . 53.509999999999998 111.402 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.538 HD12 ' HB2' ' A' ' 75' ' ' ASP . 59.2 mt -89.73 116.96 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.863 0.363 . . . . 74.310000000000002 110.331 175.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.578 ' HD3' HG13 ' A' ' 11' ' ' ILE . 13.2 ptmt -131.66 147.5 52.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.363 -0.38 . . . . 64.120000000000005 111.238 -174.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 48.4 t -78.5 145.59 34.86 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.14 0.422 . . . . 60.439999999999998 112.14 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.5 p -86.21 -7.27 58.67 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.151 0.501 . . . . 71.540000000000006 110.825 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 . . . . . 0 CA--C 1.537 0.477 0 CA-C-N 115.881 -0.6 . . . . 72.439999999999998 111.051 -178.631 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.458 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 46.2 mt-10 . . . . . 0 CA--C 1.539 0.542 0 CA-C-O 121.348 0.594 . . . . 72.329999999999998 112.448 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 33.0 m -126.15 152.85 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.694 -0.684 . . . . 71.109999999999999 111.716 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 23' ' ' PRO . 34.1 m -126.63 144.65 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 116.095 -0.502 . . . . 74.200000000000003 111.3 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -102.83 109.81 21.52 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.86 0.362 . . . . 41.219999999999999 111.099 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.1 mm -95.19 104.23 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 120.702 0.287 . . . . 70.549999999999997 111.37 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.7 mp -89.11 109.9 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.367 0.603 . . . . 74.450000000000003 110.916 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.2 p -116.95 127.43 54.2 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.929 -0.578 . . . . 61.340000000000003 111.043 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -119.1 146.53 45.03 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.673 0.273 . . . . 64.430000000000007 110.625 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.475 ' OD1' ' HD3' ' A' ' 83' ' ' LYS . 46.9 m-80 64.95 6.83 3.61 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.766 0.426 . . . . 74.030000000000001 111.796 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.79 -3.52 52.82 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.225 -0.512 . . . . 64.430000000000007 113.213 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -124.98 151.8 45.03 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.951 0.405 . . . . 73.019999999999996 111.583 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.3 126.15 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 120.905 0.383 . . . . 73.019999999999996 111.883 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 41.0 pt -111.86 -25.77 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 116.5 -0.318 . . . . 71.329999999999998 111.845 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.604 ' HE ' ' HA ' ' A' ' 20' ' ' ARG . 1.3 tpm_? -164.74 125.22 2.01 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.467 -0.333 . . . . 54.210000000000001 110.708 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -123.21 120.51 33.36 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.161 0.505 . . . . 70.219999999999999 110.965 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.41 HD12 ' CE1' ' A' ' 33' ' ' PHE . 73.6 mt -117.72 110.7 40.08 Favored Pre-proline 0 N--CA 1.47 0.525 0 N-CA-C 112.062 0.393 . . . . 73.310000000000002 112.062 -175.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.44 ' HA ' HG12 ' A' ' 9' ' ' VAL . 37.1 Cg_exo -59.46 117.69 4.46 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.533 2.155 . . . . 63.409999999999997 111.903 171.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.2 mt -74.53 -56.07 5.24 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.974 0.416 . . . . 73.299999999999997 111.524 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.458 ' OG1' ' HA ' ' A' ' 7' ' ' GLU . 11.3 m -56.61 133.57 53.77 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.16 -0.473 . . . . 71.510000000000005 111.736 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.32 -24.7 31.08 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 116.285 -0.416 . . . . 65.430000000000007 112.864 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -74.82 136.16 41.62 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.244 0.545 . . . . 64.540000000000006 111.627 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -124.11 145.98 48.92 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.109 -0.496 . . . . 73.129999999999995 110.859 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.66 -159.2 31.62 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.18 -0.533 . . . . 22.0 112.793 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -118.84 129.02 54.99 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 122.387 -0.478 . . . . 52.229999999999997 111.066 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.432 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 6.3 tp10 -123.5 135.08 53.86 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.328 -0.396 . . . . 62.219999999999999 110.302 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.402 ' HG2' ' HG3' ' A' ' 46' ' ' GLU . 35.7 mt-30 -134.55 129.69 35.43 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 122.089 -0.382 . . . . 60.140000000000001 111.526 -176.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.41 ' CE1' HD12 ' A' ' 22' ' ' ILE . 48.0 p90 -138.3 136.27 36.28 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.25 0.548 . . . . 73.420000000000002 111.72 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 30.9 m -104.12 114.2 28.27 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.074 -0.512 . . . . 72.049999999999997 112.165 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 54.8 mt -81.11 139.48 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 116.273 -0.421 . . . . 74.329999999999998 110.654 175.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -115.76 112.19 21.65 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.929 0.395 . . . . 74.109999999999999 112.042 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.15 -141.16 11.66 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 121.407 -0.425 . . . . 42.439999999999998 113.064 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -77.83 86.02 4.09 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.663 0.744 . . . . 64.329999999999998 111.856 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.17 -119.87 5.16 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 115.961 -0.563 . . . . 75.219999999999999 113.072 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.17 -0.93 23.89 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.073 0.397 . . . . 55.340000000000003 112.073 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -77.59 66.14 3.25 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.947 0.404 . . . . 71.430000000000007 111.728 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.49 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 17.1 p90 -95.32 167.05 11.58 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.535 -0.302 . . . . 73.040000000000006 111.106 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -140.47 110.67 6.61 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.659 -0.246 . . . . 73.430000000000007 111.164 174.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.6 tp -85.62 102.79 13.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.212 0.529 . . . . 61.329999999999998 110.542 177.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.701 ' SD ' HG12 ' A' ' 54' ' ' ILE . 94.5 mmm -97.03 141.49 30.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.004 -0.544 . . . . 71.400000000000006 110.751 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.846 ' HB3' HH21 ' A' ' 53' ' ' ARG . 35.4 tt0 -134.12 125.12 27.29 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.377 0.51 . . . . 63.119999999999997 112.377 -176.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 44.6 t -100.34 111.79 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.795 -0.639 . . . . 44.5 110.641 175.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.609 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 30.3 t70 -108.04 105.76 15.68 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.11 0.481 . . . . 64.219999999999999 110.035 -178.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.51 -104.49 1.07 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.658 -0.782 . . . . 73.040000000000006 111.898 -171.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -123.97 27.71 7.1 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.135 0.493 . . . . 73.219999999999999 111.448 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 34.1 ptt180 -134.6 154.45 51.49 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.039 0.535 . . . . 72.209999999999994 110.807 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.3 tt -142.37 143.33 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 112.91 0.707 . . . . 71.109999999999999 112.91 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.846 HH21 ' HB3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -161.03 168.55 24.25 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.162 -0.472 . . . . 70.109999999999999 111.875 169.294 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.701 HG12 ' SD ' ' A' ' 45' ' ' MET . 63.8 mt -69.04 121.27 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.387 -0.37 . . . . 62.200000000000003 111.173 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -82.19 -42.38 19.07 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.132 0.491 . . . . 45.329999999999998 111.016 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -166.21 138.76 3.92 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.651 -0.704 . . . . 62.229999999999997 110.689 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 1.7 p-10 -169.5 168.76 9.21 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.245 0.545 . . . . 75.510000000000005 111.472 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -97.19 45.16 1.04 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.214 -0.448 . . . . 63.119999999999997 111.994 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.1 t -97.72 122.92 53.65 Favored Pre-proline 0 N--CA 1.474 0.731 0 O-C-N 121.998 -0.439 . . . . 63.539999999999999 110.712 173.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -60.46 -27.35 84.69 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.506 2.137 . . . . 75.219999999999999 112.264 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -78.13 -34.26 50.02 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 116.005 -0.543 . . . . 64.409999999999997 111.609 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 54.66 36.18 25.49 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 111.963 0.357 . . . . 52.140000000000001 111.963 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.426 ' O ' ' HG2' ' A' ' 67' ' ' MET . 64.9 t -53.52 -52.5 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 112.733 0.642 . . . . 71.420000000000002 112.733 -174.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.594 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -64.19 -40.86 98.39 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.684 -0.77 . . . . 52.329999999999998 113.554 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 51.9 t -60.69 -39.6 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.27 0.557 . . . . 53.340000000000003 110.607 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -75.48 -28.27 59.15 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.95 -0.568 . . . . 74.230000000000004 111.928 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 18.1 mmt -67.16 -37.46 83.81 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 111.977 0.362 . . . . 75.420000000000002 111.977 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.94 -174.38 54.8 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 120.988 -0.625 . . . . 23.399999999999999 113.222 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.472 ' CE3' ' HG3' ' A' ' 53' ' ' ARG . 94.4 m95 -59.69 120.01 8.7 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.943 0.402 . . . . 73.439999999999998 112.016 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -115.82 127.21 54.89 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.239 0.542 . . . . 73.409999999999997 111.86 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.8 p -141.81 17.64 2.15 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.817 -0.629 . . . . 65.450000000000003 110.858 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -110.22 130.48 55.54 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.382 -0.372 . . . . 62.439999999999998 111.428 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.59 106.74 1.22 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.427 -0.351 . . . . 72.25 111.577 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.84 -36.65 1.74 Allowed Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.061 -0.59 . . . . 73.219999999999999 112.34 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -73.51 131.26 41.57 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.09 0.471 . . . . 71.120000000000005 111.179 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 69.3 p -120.87 152.17 38.75 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.963 0.411 . . . . 72.109999999999999 111.633 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.556 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 43.7 mm -114.25 110.45 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.309 -0.405 . . . . 71.040000000000006 110.204 177.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -107.27 116.66 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 112.35 0.5 . . . . 73.439999999999998 112.35 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 72.3 m -122.22 76.42 1.31 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.371 -0.377 . . . . 60.399999999999999 111.067 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.455 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 86.7 mt -57.21 -46.62 99.82 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 113.061 0.763 . . . . 74.219999999999999 113.061 -177.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.455 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 51.8 Cg_exo -55.64 -18.96 22.13 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.945 1.764 . . . . 61.32 113.364 177.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -112.65 -0.15 15.19 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.613 -0.267 . . . . 60.310000000000002 111.458 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.475 ' HD3' ' OD1' ' A' ' 15' ' ' ASN . 57.8 mttm 63.67 15.61 9.08 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.091 0.556 . . . . 71.219999999999999 112.433 -178.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.9 t -97.03 127.09 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.0 0.429 . . . . 75.420000000000002 111.832 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -130.62 113.22 13.92 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.222 -0.445 . . . . 73.340000000000003 110.633 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 46.2 t -100.79 117.02 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.042 0.449 . . . . 65.319999999999993 111.292 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -106.79 108.64 20.25 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.175 -0.466 . . . . 65.409999999999997 110.938 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 60.0 mt -91.91 121.06 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.149 0.5 . . . . 42.240000000000002 111.349 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -139.06 155.5 47.89 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.256 -0.429 . . . . 60.219999999999999 111.18 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 41.2 t -95.95 150.14 20.79 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.022 0.439 . . . . 74.299999999999997 112.042 -177.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.2 p -87.64 2.61 50.5 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.116 -0.493 . . . . 65.400000000000006 111.433 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 . . . . . 0 CA--C 1.541 0.615 0 CA-C-O 121.084 0.469 . . . . 74.349999999999994 111.663 -176.606 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 120.968 0.413 . . . . 74.329999999999998 111.769 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 26.8 m -122.75 145.12 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.127 0.489 . . . . 63.229999999999997 111.876 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.86 146.99 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.017 -0.538 . . . . 75.209999999999994 111.29 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.0 112.89 25.45 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.33 -0.396 . . . . 61.140000000000001 111.106 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.8 mm -92.34 105.73 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.47 -0.332 . . . . 72.209999999999994 111.199 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 12' ' ' ILE . 4.1 mp -91.88 121.83 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 121.07 0.462 . . . . 73.340000000000003 111.276 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.0 m -121.51 157.1 31.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.358 -0.383 . . . . 71.420000000000002 111.491 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.437 ' HG2' ' OD1' ' A' ' 15' ' ' ASN . 53.7 tt0 -152.69 142.83 22.36 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.979 0.418 . . . . 63.329999999999998 111.345 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.437 ' OD1' ' HG2' ' A' ' 14' ' ' GLN . 29.9 m120 57.45 19.21 5.02 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.031 0.752 . . . . 75.540000000000006 113.031 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.47 -12.78 36.21 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.728 -0.749 . . . . 72.209999999999994 114.271 176.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -129.3 156.5 43.91 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 117.635 0.718 . . . . 73.230000000000004 112.068 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.63 133.54 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.826 0.346 . . . . 62.229999999999997 111.318 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.1 pt -111.92 -31.02 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 112.153 0.427 . . . . 74.329999999999998 112.153 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -157.19 133.17 9.51 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 111.979 0.363 . . . . 73.129999999999995 111.979 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -117.14 114.43 23.68 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 110.307 -0.256 . . . . 72.049999999999997 110.307 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 73.1 mt -115.0 116.04 42.85 Favored Pre-proline 0 N--CA 1.472 0.662 0 N-CA-C 111.826 0.306 . . . . 74.420000000000002 111.826 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.42 124.54 11.75 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.437 2.092 . . . . 70.140000000000001 112.474 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.402 ' HB2' HG23 ' A' ' 8' ' ' VAL . 88.7 mt -81.75 -56.49 3.96 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.995 0.426 . . . . 74.530000000000001 111.317 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.7 m -62.63 112.78 2.64 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.034 0.445 . . . . 63.119999999999997 111.501 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.02 7.77 57.22 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.128 -0.558 . . . . 60.25 113.199 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -85.1 122.91 29.99 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 117.004 0.402 . . . . 70.129999999999995 110.846 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.466 ' N ' ' HD2' ' A' ' 28' ' ' LYS . 11.1 mptt -91.24 140.85 29.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.045 0.45 . . . . 65.420000000000002 112.009 -176.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.94 -151.69 51.93 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 114.82 0.688 . . . . 41.329999999999998 114.82 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -117.3 143.71 45.64 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.882 0.473 . . . . 72.430000000000007 110.648 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -144.08 114.64 7.62 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.617 0.246 . . . . 71.019999999999996 111.007 -175.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -117.67 137.31 52.74 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.9 0.381 . . . . 63.109999999999999 111.434 -175.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -144.13 141.99 30.32 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.994 0.426 . . . . 73.430000000000007 111.484 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.2 m -99.89 118.0 35.4 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.033 0.444 . . . . 74.329999999999998 111.963 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.417 HD11 HG21 ' A' ' 12' ' ' ILE . 61.1 mt -92.63 97.01 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.326 -0.397 . . . . 70.439999999999998 110.701 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.62 148.01 31.83 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.029 0.442 . . . . 64.200000000000003 111.574 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -127.63 -152.14 7.83 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.45 -0.405 . . . . 71.420000000000002 112.361 177.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -70.94 123.62 22.44 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.24 0.543 . . . . 62.240000000000002 111.23 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.65 -134.71 22.59 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.325 -0.464 . . . . 52.310000000000002 112.722 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.85 15.47 16.55 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.996 0.427 . . . . 42.109999999999999 111.773 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.562 ' HB3' ' CD2' ' A' ' 82' ' ' HIS . 76.4 mt-30 -87.58 100.02 12.48 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.076 0.465 . . . . 75.319999999999993 111.526 -177.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -132.79 166.24 22.7 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.102 -0.499 . . . . 71.450000000000003 112.024 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -126.68 122.78 35.92 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.858 -0.61 . . . . 71.120000000000005 110.682 171.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.5 tp -92.26 110.44 21.83 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.724 0.297 . . . . 75.209999999999994 110.362 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.762 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.2 mmm -99.56 136.96 38.73 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.983 0.42 . . . . 63.329999999999998 111.869 -175.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -125.34 115.11 19.81 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.298 -0.41 . . . . 74.329999999999998 111.27 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.9 t -102.49 107.34 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.434 -0.348 . . . . 74.019999999999996 110.477 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -110.57 122.12 46.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.932 0.396 . . . . 63.149999999999999 110.987 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.4 -107.78 1.25 Allowed Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.125 -0.56 . . . . 61.439999999999998 112.32 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -120.86 25.5 9.64 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.06 0.457 . . . . 73.140000000000001 111.531 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -138.51 149.76 45.7 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.937 0.399 . . . . 64.310000000000002 111.517 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.6 tt -126.94 146.45 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 112.089 0.403 . . . . 74.299999999999997 112.089 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -148.74 168.77 22.01 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.985 0.422 . . . . 74.5 111.311 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.762 HG12 ' SD ' ' A' ' 45' ' ' MET . 33.8 mt -90.87 111.17 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.14 0.495 . . . . 54.509999999999998 110.086 169.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -74.45 -39.28 62.65 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.892 -0.595 . . . . 62.549999999999997 111.525 -175.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -149.93 148.87 29.63 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.275 -0.42 . . . . 73.530000000000001 110.142 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.29 130.73 9.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.353 0.597 . . . . 74.329999999999998 111.641 -175.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -96.28 64.35 2.27 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.326 0.584 . . . . 53.439999999999998 110.691 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 45.9 t -128.46 139.64 36.11 Favored Pre-proline 0 N--CA 1.473 0.677 0 CA-C-N 116.033 -0.531 . . . . 24.300000000000001 111.043 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 59' ' ' SER . 32.1 Cg_exo -58.27 -36.68 97.48 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.532 2.154 . . . . 71.439999999999998 112.749 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -76.5 -29.44 56.83 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.821 -0.627 . . . . 75.019999999999996 112.622 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 56.59 19.53 4.3 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.938 0.718 . . . . 71.109999999999999 112.938 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.5 t -53.94 -41.04 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 112.168 0.433 . . . . 72.200000000000003 112.168 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.558 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -57.83 -43.99 94.47 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.065 -0.588 . . . . 71.200000000000003 113.289 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.95 -37.83 81.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.006 0.431 . . . . 63.530000000000001 111.143 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -65.65 -40.27 92.31 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.309 0.485 . . . . 64.230000000000004 112.309 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.3 mmt -65.26 -41.28 94.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.828 0.347 . . . . 75.519999999999996 111.373 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.47 -129.75 28.43 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 114.367 0.507 . . . . 62.539999999999999 114.367 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -77.92 136.47 38.02 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.737 0.643 . . . . 71.340000000000003 112.737 -174.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 75.1 mmtt -132.58 144.26 50.26 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.902 -0.59 . . . . 72.209999999999994 109.883 173.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 95.4 p -162.0 13.57 0.08 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.363 0.875 . . . . 73.400000000000006 113.363 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -123.41 151.3 42.76 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.996 0.426 . . . . 64.530000000000001 112.056 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.64 111.62 1.49 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.26 0.552 . . . . 72.25 111.276 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 121.37 -21.53 8.12 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 121.314 -0.47 . . . . 62.329999999999998 112.435 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.527 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 80.1 m-20 -63.74 123.14 18.12 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.81 0.338 . . . . 62.420000000000002 111.226 176.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 65.8 p -130.65 141.93 50.43 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.403 0.621 . . . . 72.140000000000001 112.293 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.5 mm -114.8 118.37 58.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.833 -0.621 . . . . 75.019999999999996 110.258 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.3 t -112.31 115.73 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.924 0.392 . . . . 72.519999999999996 111.778 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 76.6 m -121.66 79.26 1.54 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.029 0.442 . . . . 51.32 110.825 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.498 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 93.1 mt -59.11 -47.02 99.29 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 113.091 0.775 . . . . 73.510000000000005 113.091 -175.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.498 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 50.7 Cg_exo -56.07 -17.36 19.42 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 122.255 1.97 . . . . 71.25 113.611 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.562 ' CD2' ' HB3' ' A' ' 41' ' ' GLN . 64.6 m170 -117.33 -1.81 11.7 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 122.14 -0.35 . . . . 64.540000000000006 111.612 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 66.4 mttm 59.37 28.33 17.66 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.071 -0.513 . . . . 73.420000000000002 112.194 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.7 t -100.56 132.89 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.487 -0.324 . . . . 65.409999999999997 111.061 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -136.68 118.21 14.85 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.004 0.431 . . . . 71.319999999999993 111.023 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.2 t -112.31 132.14 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 116.374 -0.375 . . . . 74.120000000000005 110.851 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -131.96 131.86 42.99 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.126 0.488 . . . . 53.100000000000001 111.367 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 58.4 mt -97.68 130.02 46.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.182 0.515 . . . . 74.519999999999996 111.307 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -137.74 153.96 49.67 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.058 -0.519 . . . . 61.240000000000002 110.932 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 47.7 t -89.86 149.89 22.46 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.09 -0.381 . . . . 64.129999999999995 111.264 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.2 p -65.8 -22.02 66.53 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.017 0.437 . . . . 71.430000000000007 110.807 175.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 121.194 0.521 . . . . 61.539999999999999 111.579 179.69 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.466 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 44.5 mt-10 . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 113.096 0.776 . . . . 75.329999999999998 113.096 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 71' ' ' SER . 35.7 m -137.67 160.39 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 115.921 -0.581 . . . . 62.43 112.176 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 23' ' ' PRO . 29.8 m -131.43 146.54 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.064 -0.516 . . . . 71.010000000000005 110.788 176.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.97 116.53 30.37 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.918 0.39 . . . . 52.5 111.949 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.403 ' HB ' ' HG2' ' A' ' 87' ' ' GLU . 44.5 mm -97.21 124.58 50.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.486 -0.325 . . . . 65.239999999999995 110.613 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.507 ' N ' HD12 ' A' ' 12' ' ' ILE . 2.9 mp -104.55 111.81 35.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.755 0.312 . . . . 61.299999999999997 111.156 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 18' ' ' VAL . 60.4 m -109.04 126.1 52.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.092 0.472 . . . . 72.409999999999997 111.584 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -118.39 133.08 56.18 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.157 -0.339 . . . . 72.25 110.972 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 65.14 12.4 7.94 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.316 0.488 . . . . 74.109999999999999 112.316 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.04 10.52 34.33 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.359 -0.448 . . . . 52.310000000000002 113.857 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -144.15 146.04 32.49 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.397 0.599 . . . . 72.420000000000002 111.734 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 59.2 t -59.95 138.41 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 116.35 -0.386 . . . . 73.230000000000004 111.324 177.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 47.1 pt -125.78 -12.39 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.338 0.495 . . . . 73.430000000000007 112.338 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -173.76 142.24 0.89 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.812 0.339 . . . . 75.340000000000003 111.71 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -125.22 119.0 27.26 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 116.488 -0.324 . . . . 74.239999999999995 110.821 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.547 HG21 HG21 ' A' ' 47' ' ' VAL . 3.3 mp -115.53 125.13 29.1 Favored Pre-proline 0 N--CA 1.476 0.861 0 N-CA-C 111.741 0.275 . . . . 74.120000000000005 111.741 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.523 ' HA ' HG12 ' A' ' 9' ' ' VAL . 15.3 Cg_exo -69.51 123.02 9.76 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.817 2.345 . . . . 45.229999999999997 112.377 173.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.07 -57.28 3.16 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.873 0.368 . . . . 74.209999999999994 111.498 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.466 ' OG1' ' HA ' ' A' ' 7' ' ' GLU . 13.2 m -65.26 127.3 31.14 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.086 0.469 . . . . 71.230000000000004 111.441 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.62 -1.67 81.75 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.053 -0.594 . . . . 53.140000000000001 112.767 -174.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -92.5 90.49 7.19 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.281 -0.541 . . . . 74.430000000000007 111.535 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.68 169.47 18.22 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.145 -0.479 . . . . 52.43 111.17 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.18 -165.25 43.1 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 114.626 0.61 . . . . 73.540000000000006 114.626 175.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -118.44 126.04 51.21 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.998 0.519 . . . . 71.299999999999997 110.825 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -139.6 130.89 26.71 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.768 0.318 . . . . 53.450000000000003 111.08 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -122.8 153.71 39.18 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.042 0.449 . . . . 70.099999999999994 112.057 -173.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -150.33 138.22 20.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.912 0.387 . . . . 74.519999999999996 111.364 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.5 m -101.6 123.53 45.76 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.041 0.448 . . . . 62.210000000000001 112.169 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.8 mt -97.84 129.53 47.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.143 -0.48 . . . . 63.140000000000001 110.897 176.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -105.75 142.46 35.44 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.079 0.466 . . . . 75.049999999999997 111.827 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.29 -157.91 32.5 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 116.253 -0.431 . . . . 73.400000000000006 113.531 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -92.82 23.29 4.24 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.154 0.427 . . . . 71.349999999999994 112.154 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 175.14 -130.75 1.8 Allowed Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.331 -0.461 . . . . 62.240000000000002 112.139 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.03 67.43 3.87 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.415 0.626 . . . . 60.409999999999997 110.724 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -144.19 130.15 19.44 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.885 -0.598 . . . . 62.25 111.324 -175.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -147.84 144.62 28.28 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.697 0.284 . . . . 74.25 111.143 172.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -128.85 110.92 12.55 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.325 -0.398 . . . . 65.109999999999999 110.623 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.4 tp -87.04 104.85 16.72 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.894 0.378 . . . . 72.150000000000006 110.872 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.815 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.0 mmm -90.58 135.91 33.4 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.37 -0.377 . . . . 72.239999999999995 111.272 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -126.83 117.14 22.02 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.961 0.41 . . . . 72.430000000000007 111.986 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.547 HG21 HG21 ' A' ' 22' ' ' ILE . 21.9 t -101.17 107.45 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.065 -0.516 . . . . 63.009999999999998 110.238 175.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.46 ' HB3' ' CZ3' ' A' ' 69' ' ' TRP . 28.2 t70 -128.17 117.66 21.98 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.934 0.397 . . . . 44.109999999999999 111.424 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 60.33 60.75 8.01 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 121.205 -0.522 . . . . 50.219999999999999 114.169 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 57.76 18.33 4.77 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.914 1.079 . . . . 52.450000000000003 113.914 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.545 ' HD2' ' HB3' ' A' ' 69' ' ' TRP . 29.3 ptt180 -146.46 152.33 38.85 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.864 0.364 . . . . 72.209999999999994 110.899 174.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.5 tt -129.04 151.25 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.81 0.67 . . . . 65.140000000000001 112.81 -170.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.99 168.82 25.77 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.763 -0.653 . . . . 72.319999999999993 110.238 170.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.815 HG12 ' SD ' ' A' ' 45' ' ' MET . 59.4 mt -81.38 121.97 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.943 0.402 . . . . 74.030000000000001 110.387 174.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -84.35 -37.9 21.0 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 116.216 -0.447 . . . . 65.329999999999998 111.895 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -161.07 138.29 8.99 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.389 -0.369 . . . . 72.030000000000001 111.291 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.13 162.61 25.7 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.907 0.384 . . . . 64.319999999999993 110.51 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -98.59 64.45 1.52 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.567 0.699 . . . . 71.319999999999993 111.676 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.0 p -114.03 141.68 26.67 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-N 115.768 -0.651 . . . . 64.129999999999995 110.27 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.78 -23.24 26.39 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.183 1.922 . . . . 64.239999999999995 112.796 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.497 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.5 m-20 -87.63 -39.71 14.81 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.12 0.415 . . . . 71.420000000000002 112.12 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 61.04 23.24 13.43 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.513 0.56 . . . . 71.319999999999993 112.513 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.497 HG23 ' HB3' ' A' ' 61' ' ' ASP . 60.9 t -56.24 -34.79 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.898 0.38 . . . . 71.299999999999997 111.15 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.626 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -55.98 -47.1 82.28 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 116.275 -0.42 . . . . 62.009999999999998 113.17 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.2 t -73.77 -34.25 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.243 0.544 . . . . 74.140000000000001 110.956 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -60.22 -28.76 68.26 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.845 -0.616 . . . . 64.310000000000002 111.506 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 23.1 mmt -55.76 -34.27 65.07 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.327 0.491 . . . . 74.340000000000003 112.327 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.71 -163.64 53.64 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.977 -0.63 . . . . 50.5 113.425 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.545 ' HB3' ' HD2' ' A' ' 51' ' ' ARG . 94.0 m95 -73.39 110.32 7.58 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.853 0.359 . . . . 74.420000000000002 111.793 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -108.41 137.59 46.11 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.053 0.454 . . . . 72.510000000000005 111.674 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.404 ' O ' HG21 ' A' ' 8' ' ' VAL . 91.1 p -161.65 25.44 0.12 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.255 -0.43 . . . . 73.420000000000002 111.682 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -115.78 141.1 48.54 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.897 0.38 . . . . 72.140000000000001 111.599 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.4 106.64 1.16 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.978 0.418 . . . . 75.25 111.15 176.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 125.44 -7.24 7.98 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.011 -0.614 . . . . 74.319999999999993 113.342 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -92.71 142.0 27.84 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.138 0.494 . . . . 54.530000000000001 111.47 175.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.52 HG22 ' HA ' ' A' ' 87' ' ' GLU . 66.7 p -135.24 153.41 51.93 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.043 -0.526 . . . . 73.299999999999997 111.771 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 32.6 mm -112.97 128.33 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 116.346 -0.388 . . . . 73.340000000000003 110.351 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 50.5 t -115.39 120.1 63.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 112.191 0.441 . . . . 74.150000000000006 112.191 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.461 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 73.1 m -120.94 81.0 1.71 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.26 0.552 . . . . 71.519999999999996 110.3 171.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.445 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 4.3 tt -57.04 -53.75 61.88 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 115.498 -0.774 . . . . 74.099999999999994 112.253 -173.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 80' ' ' LEU . 44.1 Cg_endo -65.89 -9.62 23.79 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 122.26 1.973 . . . . 52.350000000000001 113.537 -176.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -114.34 -4.91 12.94 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 122.06 -0.4 . . . . 74.409999999999997 111.73 177.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 66.8 mttm 57.39 36.64 27.37 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.275 0.559 . . . . 63.130000000000003 111.481 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 59.4 t -111.69 138.71 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.875 -0.602 . . . . 62.549999999999997 110.979 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -140.93 148.42 40.38 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.358 -0.383 . . . . 64.530000000000001 110.475 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.439 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 57.3 t -139.46 113.79 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 122.257 -0.277 . . . . 74.430000000000007 111.439 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.52 ' HA ' HG22 ' A' ' 76' ' ' THR . 1.4 pm0 -106.92 126.7 52.66 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.343 0.592 . . . . 72.310000000000002 111.788 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.8 mt -95.71 122.3 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-O 121.024 0.44 . . . . 70.049999999999997 111.597 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.1 151.76 40.57 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.434 -0.348 . . . . 62.109999999999999 111.196 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.0 t -76.3 149.34 37.1 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.868 0.365 . . . . 74.209999999999994 111.905 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.442 HG22 HG13 ' A' ' 9' ' ' VAL . 27.5 p -77.09 -27.43 54.19 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.006 0.432 . . . . 64.430000000000007 111.246 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 . . . . . 0 CA--C 1.539 0.536 0 CA-C-N 116.324 -0.398 . . . . 74.219999999999999 111.075 177.576 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 N--CA 1.473 0.688 0 CA-C-O 121.091 0.472 . . . . 70.209999999999994 111.894 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.567 HG23 ' HB2' ' A' ' 24' ' ' LEU . 30.8 m -110.1 144.82 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 121.287 0.565 . . . . 62.409999999999997 112.102 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.5 m -124.11 138.88 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.266 -0.425 . . . . 54.32 111.483 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.04 119.97 36.52 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.887 0.375 . . . . 54.5 111.288 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.6 mm -104.27 113.37 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.564 -0.289 . . . . 74.439999999999998 111.029 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 12' ' ' ILE . 3.1 mp -98.69 125.74 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 120.841 0.353 . . . . 75.400000000000006 110.894 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.5 t -128.8 152.63 48.26 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.068 0.461 . . . . 42.119999999999997 112.174 -176.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -146.91 142.87 28.05 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.017 -0.538 . . . . 65.200000000000003 110.734 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.7 14.02 5.79 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.407 0.521 . . . . 74.329999999999998 112.407 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.17 16.34 47.67 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.197 -0.525 . . . . 62.329999999999998 113.577 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -138.41 140.94 39.56 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.415 -0.462 . . . . 61.350000000000001 111.256 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -63.02 128.26 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 110.12 -0.326 . . . . 55.200000000000003 110.12 174.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.2 pt -109.23 -28.76 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 112.35 0.5 . . . . 74.030000000000001 112.35 -177.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -162.65 138.4 7.18 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.921 0.391 . . . . 71.340000000000003 111.494 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -124.48 119.45 29.17 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.591 -0.277 . . . . 71.140000000000001 111.493 -177.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.412 HG21 HG11 ' A' ' 47' ' ' VAL . 3.3 mp -112.81 116.17 47.92 Favored Pre-proline 0 N--CA 1.472 0.648 0 CA-C-O 120.626 0.251 . . . . 73.409999999999997 111.148 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.76 113.24 3.31 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.161 1.907 . . . . 52.25 111.579 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.567 ' HB2' HG23 ' A' ' 8' ' ' VAL . 85.4 mt -69.75 -58.68 3.61 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.853 0.316 . . . . 74.299999999999997 111.853 -175.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.6 m -54.15 131.04 40.39 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.133 0.492 . . . . 74.209999999999994 111.328 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.11 -16.14 56.36 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 121.089 -0.577 . . . . 60.240000000000002 113.975 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.506 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 60.3 t-80 -76.4 76.2 3.15 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.716 0.758 . . . . 74.219999999999999 110.86 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -78.23 92.75 4.51 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.972 -0.558 . . . . 74.540000000000006 111.43 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.8 -168.48 31.15 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 116.267 -0.424 . . . . 63.420000000000002 112.513 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -118.17 150.41 39.44 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.072 0.463 . . . . 71.340000000000003 111.42 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.536 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 12.4 tp10 -149.23 148.29 29.41 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.492 -0.322 . . . . 62.420000000000002 110.918 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -138.36 129.7 27.45 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.086 0.469 . . . . 72.420000000000002 111.689 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -145.82 131.86 19.29 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.209 0.528 . . . . 75.109999999999999 110.955 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.9 m -105.53 130.69 53.54 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.27 -0.423 . . . . 70.010000000000005 111.752 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.525 ' N ' HD12 ' A' ' 35' ' ' ILE . 3.2 mp -99.16 114.14 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.481 -0.327 . . . . 65.010000000000005 110.362 175.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -101.46 108.11 19.6 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.721 0.296 . . . . 73.340000000000003 111.505 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.68 -105.21 0.37 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.065 -0.588 . . . . 72.329999999999998 112.021 174.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -82.61 78.65 9.2 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 122.343 -0.504 . . . . 73.420000000000002 111.361 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.67 -87.23 0.01 OUTLIER Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.194 -0.457 . . . . 70.230000000000004 114.104 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.26 -21.17 62.13 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.136 0.421 . . . . 71.400000000000006 112.136 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -78.29 73.72 4.85 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.138 0.494 . . . . 72.319999999999993 111.25 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 58' ' ' ASN . 35.4 p90 -100.58 162.56 12.85 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.978 -0.555 . . . . 63.420000000000002 111.841 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -136.39 114.04 11.05 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.086 -0.507 . . . . 71.310000000000002 110.671 173.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.6 tp -89.64 103.28 15.94 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.989 0.423 . . . . 74.299999999999997 111.392 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.809 ' SD ' HG12 ' A' ' 54' ' ' ILE . 88.6 mmm -96.64 138.61 33.94 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.056 -0.52 . . . . 71.120000000000005 111.377 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -129.23 126.27 38.76 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.881 0.372 . . . . 75.439999999999998 111.466 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 56.4 t -110.54 115.25 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.067 0.46 . . . . 65.239999999999995 111.328 178.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.456 ' HB2' ' CH2' ' A' ' 69' ' ' TRP . 14.9 t70 -108.44 171.93 7.13 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.696 -0.483 . . . . 70.420000000000002 109.696 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 27' ' ' HIS . . . -37.27 90.38 0.01 OUTLIER Glycine 0 CA--C 1.535 1.282 0 N-CA-C 114.85 0.7 . . . . 34.109999999999999 114.85 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 66.08 32.09 8.47 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.506 0.722 . . . . 71.530000000000001 112.888 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.419 ' HG3' ' HB3' ' A' ' 48' ' ' ASP . 23.3 ptt180 -155.47 151.26 27.53 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 122.644 0.378 . . . . 71.140000000000001 111.144 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 tt -136.83 150.47 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 120.825 0.345 . . . . 63.229999999999997 111.919 -177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.552 ' NH2' ' HE3' ' A' ' 55' ' ' LYS . 21.4 ptt180 -155.62 168.58 26.69 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.222 0.535 . . . . 64.430000000000007 112.252 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.809 HG12 ' SD ' ' A' ' 45' ' ' MET . 62.1 mt -102.38 119.34 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.764 -0.653 . . . . 64.310000000000002 109.9 168.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.552 ' HE3' ' NH2' ' A' ' 53' ' ' ARG . 41.1 mtpt -78.57 -38.12 40.98 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.958 0.409 . . . . 72.140000000000001 110.728 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -169.63 138.78 1.93 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.518 -0.764 . . . . 70.420000000000002 111.425 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -142.37 161.56 37.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.975 -0.38 . . . . 74.129999999999995 109.975 170.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.439 ' HB2' ' CE1' ' A' ' 42' ' ' TYR . 61.2 t30 -84.95 66.29 9.66 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.152 0.501 . . . . 72.420000000000002 111.037 -176.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.3 t -129.05 145.75 57.89 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 116.224 -0.444 . . . . 73.219999999999999 111.146 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.52 -35.78 12.7 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.536 2.157 . . . . 62.219999999999999 113.16 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.467 ' HB2' HG23 ' A' ' 63' ' ' VAL . 1.6 p30 -77.59 -44.2 29.19 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.029 0.381 . . . . 75.109999999999999 112.029 -178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.513 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 24.7 mm-40 63.5 26.6 14.86 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.429 -0.351 . . . . 63.509999999999998 111.804 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.467 HG23 ' HB2' ' A' ' 61' ' ' ASP . 87.7 t -53.2 -41.61 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 120.849 0.357 . . . . 55.229999999999997 111.61 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.588 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -58.4 -38.48 90.78 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.32 -0.467 . . . . 74.430000000000007 113.258 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.35 -39.96 72.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.969 0.414 . . . . 74.530000000000001 111.06 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.513 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 4.6 mptp? -62.59 -29.91 70.95 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.364 -0.38 . . . . 60.520000000000003 111.301 176.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 21.2 mmt -61.2 -44.57 97.07 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.086 0.402 . . . . 70.340000000000003 112.086 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.26 -148.64 32.99 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.142 -0.552 . . . . 52.229999999999997 113.209 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.456 ' CH2' ' HB2' ' A' ' 48' ' ' ASP . 91.3 m95 -76.36 110.94 11.3 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.07 0.462 . . . . 75.230000000000004 111.867 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -103.88 143.78 32.38 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.379 -0.373 . . . . 73.439999999999998 110.885 175.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 64.2 p -169.19 18.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.502 0.556 . . . . 72.319999999999993 112.502 -173.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 72' ' ' LYS . 2.9 mptp? -116.86 144.93 43.93 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.82 0.343 . . . . 74.230000000000004 110.39 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.61 93.43 0.08 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.936 0.398 . . . . 74.109999999999999 111.346 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.09 -20.19 1.76 Allowed Glycine 0 CA--C 1.529 0.938 0 CA-C-N 116.029 -0.532 . . . . 52.229999999999997 113.364 -177.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.51 ' HB2' HD12 ' A' ' 88' ' ' ILE . 75.9 m-20 -66.25 135.35 54.33 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 117.096 0.448 . . . . 43.549999999999997 112.025 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.9 p -133.03 145.95 51.29 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.27 0.557 . . . . 73.349999999999994 111.692 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.53 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 35.0 mm -117.72 129.9 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 115.852 -0.613 . . . . 51.509999999999998 110.48 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.3 t -123.85 117.31 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 112.651 0.611 . . . . 61.219999999999999 112.651 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 90.3 m -115.77 81.22 1.56 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.244 0.545 . . . . 71.530000000000001 110.006 169.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.527 ' HB3' ' HD3' ' A' ' 81' ' ' PRO . 5.4 tt -55.76 -53.57 61.4 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 115.631 -0.713 . . . . 73.519999999999996 112.394 -172.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 80' ' ' LEU . 31.3 Cg_exo -60.04 -14.68 29.44 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.046 1.831 . . . . 72.299999999999997 113.381 -176.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -105.2 -3.65 22.69 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.994 0.368 . . . . 72.329999999999998 111.994 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.6 mttm 60.81 21.28 11.4 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 120.901 0.382 . . . . 75.430000000000007 111.491 -174.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.0 t -104.04 130.12 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 121.186 0.517 . . . . 54.219999999999999 111.365 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -135.93 136.57 40.55 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.002 -0.545 . . . . 75.519999999999996 111.061 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.53 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 46.4 t -128.7 144.56 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.396 -0.365 . . . . 73.319999999999993 110.519 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -143.6 144.74 32.05 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.204 0.526 . . . . 54.030000000000001 111.911 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.51 HD12 ' HB2' ' A' ' 75' ' ' ASP . 65.4 mt -106.18 111.7 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 115.941 -0.572 . . . . 74.540000000000006 111.096 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -118.09 143.06 46.77 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.022 -0.535 . . . . 74.519999999999996 110.654 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 22.8 t -85.54 122.87 30.29 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.861 -0.524 . . . . 73.519999999999996 110.471 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.661 HG23 ' HG2' ' A' ' 92' ' ' GLN . 9.7 t -77.86 -24.48 48.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.955 0.407 . . . . 73.030000000000001 111.352 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.661 ' HG2' HG23 ' A' ' 91' ' ' THR . 77.0 mm-40 . . . . . 0 CA--C 1.536 0.442 0 CA-C-N 116.172 -0.467 . . . . 75.25 111.042 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.441 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 42.9 mt-10 . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 121.121 0.486 . . . . 52.420000000000002 110.292 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.87 150.71 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 113.0 0.741 . . . . 65.230000000000004 113.0 -171.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.69 140.15 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 115.643 -0.708 . . . . 73.340000000000003 110.905 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.85 111.93 23.78 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.84 0.352 . . . . 62.32 111.431 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.1 mm -96.2 113.66 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.348 -0.387 . . . . 64.109999999999999 110.968 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.524 ' N ' HD12 ' A' ' 12' ' ' ILE . 2.9 mp -95.62 123.57 47.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.83 0.347 . . . . 41.329999999999998 111.387 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.6 p -125.58 146.61 49.61 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.008 0.432 . . . . 74.209999999999994 111.171 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.51 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 63.1 tt0 -130.9 131.25 44.39 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.544 -0.298 . . . . 62.119999999999997 110.204 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.1 m120 57.5 15.58 2.83 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.057 0.391 . . . . 61.020000000000003 112.057 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.98 -20.28 31.42 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.314 -0.469 . . . . 52.229999999999997 114.034 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -98.35 140.77 32.13 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.323 0.562 . . . . 60.420000000000002 111.85 -177.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.27 122.64 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.954 0.407 . . . . 65.510000000000005 111.529 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.8 pt -111.03 -19.4 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 112.953 0.723 . . . . 74.0 112.953 -175.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -167.81 144.47 4.17 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.001 0.371 . . . . 74.519999999999996 112.001 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -128.91 122.73 30.89 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.396 0.278 . . . . 73.439999999999998 111.329 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.419 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.7 mp -118.32 113.86 36.81 Favored Pre-proline 0 N--CA 1.477 0.888 0 N-CA-C 111.713 0.264 . . . . 61.299999999999997 111.713 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.69 124.96 11.63 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.223 1.949 . . . . 74.420000000000002 111.851 171.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.9 mt -92.13 -47.78 7.07 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.9 0.704 . . . . 62.229999999999997 112.9 -172.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 7' ' ' GLU . 14.8 m -59.53 121.73 12.28 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.303 0.483 . . . . 72.540000000000006 112.303 -175.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.79 5.82 88.52 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.442 -0.409 . . . . 62.299999999999997 113.437 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.48 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 41.6 t-80 -70.82 87.38 0.7 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.314 0.578 . . . . 65.530000000000001 111.267 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -64.17 123.77 19.94 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.62 0.6 . . . . 75.219999999999999 112.62 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.5 -164.04 20.97 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 114.189 0.436 . . . . 55.310000000000002 114.189 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -118.61 128.86 54.94 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.559 0.343 . . . . 74.019999999999996 111.213 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -130.48 114.68 15.81 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.096 0.474 . . . . 72.129999999999995 111.634 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.439 ' HG2' ' HG3' ' A' ' 46' ' ' GLU . 68.0 mt-30 -109.82 145.12 37.26 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.281 -0.418 . . . . 72.420000000000002 111.126 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -151.19 145.78 25.65 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.002 0.43 . . . . 74.109999999999999 111.787 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 28.7 m -103.88 113.63 27.3 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.736 0.643 . . . . 72.140000000000001 112.736 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 61.1 mt -88.39 109.04 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.114 -0.494 . . . . 63.450000000000003 110.604 173.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -79.61 106.33 11.55 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.166 -0.334 . . . . 73.319999999999993 111.66 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.51 ' HA2' ' NE2' ' A' ' 14' ' ' GLN . . . -73.42 -171.02 21.3 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 120.865 -0.683 . . . . 62.32 112.754 176.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.465 ' HD2' ' HD2' ' A' ' 83' ' ' LYS . 27.0 mtpp -66.85 99.42 0.62 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.973 0.416 . . . . 74.409999999999997 111.751 -177.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.37 -118.22 5.73 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.231 -0.509 . . . . 43.130000000000003 113.121 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.01 -4.95 38.82 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.389 0.515 . . . . 63.409999999999997 112.389 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.645 ' HA ' ' HB3' ' A' ' 58' ' ' ASN . 59.0 mt-30 -82.49 81.44 8.31 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.463 0.649 . . . . 73.420000000000002 111.738 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.417 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 22.8 p90 -84.09 166.34 17.76 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.679 -0.691 . . . . 73.430000000000007 111.88 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.462 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 22.3 m120 -136.34 109.89 7.99 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.724 0.409 . . . . 63.130000000000003 110.715 173.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.9 tp -90.56 103.54 16.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.097 0.475 . . . . 74.400000000000006 110.562 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.729 ' SD ' HG12 ' A' ' 54' ' ' ILE . 94.9 mmm -89.94 144.55 25.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.129 -0.487 . . . . 65.219999999999999 111.108 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.616 ' HB3' ' NH1' ' A' ' 53' ' ' ARG . 71.6 tt0 -132.99 126.6 32.32 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.179 0.514 . . . . 72.010000000000005 111.734 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.1 t -103.81 119.42 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 115.838 -0.619 . . . . 63.340000000000003 110.848 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.481 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 34.9 t70 -107.9 97.77 7.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.275 0.559 . . . . 72.209999999999994 109.782 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 27' ' ' HIS . . . 65.87 -104.67 1.06 Allowed Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.819 -0.705 . . . . 70.430000000000007 112.377 -175.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -112.95 15.57 19.65 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.868 0.366 . . . . 75.209999999999994 111.949 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 18.6 ptp180 -131.54 150.24 52.22 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.524 -0.307 . . . . 73.200000000000003 110.925 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.7 tt -139.72 145.2 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 112.681 0.623 . . . . 63.43 112.681 -175.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.616 ' NH1' ' HB3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -159.41 168.61 25.86 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 116.1 -0.5 . . . . 74.400000000000006 111.311 173.44 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.729 HG12 ' SD ' ' A' ' 45' ' ' MET . 55.2 mt -73.96 122.16 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.107 0.48 . . . . 62.409999999999997 111.409 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -82.14 -51.04 8.37 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.093 -0.503 . . . . 75.219999999999999 111.441 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -154.04 136.85 15.31 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.223 -0.444 . . . . 63.039999999999999 110.317 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -157.15 -177.14 6.39 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.513 0.673 . . . . 74.109999999999999 111.962 179.249 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.645 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . 55.1 t-20 -115.15 75.58 0.94 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.423 -0.808 . . . . 73.040000000000006 110.593 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.8 t -136.94 148.16 61.9 Favored Pre-proline 0 N--CA 1.472 0.627 0 O-C-N 122.15 -0.344 . . . . 70.310000000000002 111.445 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.07 -15.89 23.0 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.116 1.877 . . . . 70.310000000000002 111.673 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -105.87 -43.65 4.82 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.89 -0.595 . . . . 63.310000000000002 111.566 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 53.17 56.6 7.25 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.517 0.675 . . . . 64.25 110.662 -177.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.3 t -53.46 -46.58 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.378 -0.828 . . . . 64.349999999999994 112.772 -171.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.564 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -60.01 -31.31 72.21 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.869 -0.682 . . . . 75.329999999999998 113.228 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.75 -38.2 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.035 0.445 . . . . 71.25 110.47 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -76.3 -28.71 57.08 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.191 -0.459 . . . . 71.209999999999994 111.944 174.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 17.2 mmt -62.68 -47.49 83.45 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.583 0.586 . . . . 73.030000000000001 112.583 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.41 -165.32 27.44 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 120.811 -0.709 . . . . 51.439999999999998 113.202 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.403 ' CE3' ' HG3' ' A' ' 51' ' ' ARG . 98.7 m95 -76.26 115.23 15.79 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.378 0.608 . . . . 75.549999999999997 112.474 -176.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.769 ' HD3' ' HB3' ' A' ' 75' ' ' ASP . 11.5 mmpt? -94.73 143.57 26.34 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.806 -0.633 . . . . 73.120000000000005 110.299 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 89.0 p -167.27 12.18 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.428 1.27 . . . . 63.329999999999998 114.428 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -131.63 153.14 50.24 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.808 -0.557 . . . . 65.120000000000005 111.865 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.12 100.09 0.11 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.094 0.473 . . . . 65.519999999999996 111.841 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.44 -24.16 2.51 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 116.062 -0.517 . . . . 41.43 112.033 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.769 ' HB3' ' HD3' ' A' ' 70' ' ' LYS . 62.8 m-20 -68.32 127.46 33.04 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.783 0.325 . . . . 71.409999999999997 111.387 174.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 87' ' ' GLU . 76.6 p -136.01 148.68 48.51 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.968 0.413 . . . . 65.319999999999993 111.271 177.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.2 mm -113.22 110.59 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 120.924 0.392 . . . . 74.439999999999998 110.533 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.5 t -98.73 116.88 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 116.14 -0.482 . . . . 51.100000000000001 111.322 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 71.5 m -118.99 73.32 0.92 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.94 0.4 . . . . 61.340000000000003 110.964 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.538 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 90.9 mt -54.07 -50.18 85.78 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 112.613 0.598 . . . . 71.310000000000002 112.613 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 34.7 Cg_exo -59.91 -12.84 20.08 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.018 1.812 . . . . 74.030000000000001 113.386 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.411 ' ND1' ' OD1' ' A' ' 43' ' ' ASN . 11.8 m170 -116.65 -11.64 10.99 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.124 0.416 . . . . 74.209999999999994 112.124 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.465 ' HD2' ' HD2' ' A' ' 38' ' ' LYS . 63.8 mttm 64.01 29.51 14.29 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.257 0.551 . . . . 71.140000000000001 112.05 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.4 HG22 ' HG3' ' A' ' 14' ' ' GLN . 59.3 t -108.9 135.71 46.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 116.008 -0.542 . . . . 62.140000000000001 110.711 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -135.75 128.65 31.27 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.09 0.471 . . . . 73.200000000000003 111.11 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.18 130.6 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.587 -0.279 . . . . 74.209999999999994 111.133 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.574 ' HA ' HG22 ' A' ' 76' ' ' THR . 3.2 pt-20 -114.19 147.74 38.42 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.011 0.434 . . . . 71.310000000000002 111.303 175.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 57.3 mt -111.8 112.14 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.014 0.435 . . . . 73.120000000000005 110.226 171.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.44 ' HZ2' ' HB3' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -119.65 163.04 17.98 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.275 -0.421 . . . . 74.510000000000005 111.649 -174.243 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.7 t -86.11 149.34 25.2 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.622 0.601 . . . . 73.200000000000003 112.622 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.2 p -83.68 -16.93 43.17 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.97 -0.559 . . . . 55.310000000000002 110.725 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 . . . . . 0 CA--C 1.541 0.606 0 CA-C-N 116.126 -0.488 . . . . 64.120000000000005 111.47 179.995 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.407 ' HA ' ' CB ' ' A' ' 25' ' ' THR . 46.0 mt-10 . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 113.339 0.866 . . . . 63.049999999999997 113.339 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.01 158.82 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.508 -0.769 . . . . 71.310000000000002 111.648 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 23' ' ' PRO . 23.6 m -134.36 148.6 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 116.262 -0.426 . . . . 54.219999999999999 111.053 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.71 115.94 28.4 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.826 0.346 . . . . 64.299999999999997 111.568 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.0 mm -99.02 116.07 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.282 -0.417 . . . . 74.420000000000002 111.22 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.49 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.0 mp -99.85 115.46 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.023 0.44 . . . . 72.040000000000006 111.489 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 18' ' ' VAL . 66.9 m -113.88 146.12 40.48 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.014 0.435 . . . . 73.540000000000006 111.467 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -141.33 140.19 33.74 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.402 -0.363 . . . . 75.099999999999994 110.278 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 61.38 14.75 5.98 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.338 0.496 . . . . 72.230000000000004 112.338 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.77 -11.12 41.73 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.272 -0.49 . . . . 75.230000000000004 114.037 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -125.72 156.18 39.77 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.229 -0.571 . . . . 74.510000000000005 111.91 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 62.0 t -74.98 132.78 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.781 0.325 . . . . 75.450000000000003 111.334 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 43.1 pt -117.28 -27.08 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 N-CA-C 112.586 0.587 . . . . 73.040000000000006 112.586 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.529 ' HG3' HD11 ' A' ' 22' ' ' ILE . 3.1 tpm_? -154.3 131.83 11.34 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 122.315 -0.241 . . . . 64.25 111.141 -174.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -130.29 114.28 15.44 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.594 0.235 . . . . 73.420000000000002 111.502 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.529 HD11 ' HG3' ' A' ' 20' ' ' ARG . 3.7 mp -114.4 130.15 24.26 Favored Pre-proline 0 N--CA 1.476 0.874 0 CA-C-O 120.545 0.212 . . . . 72.010000000000005 111.432 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.533 ' HA ' HG12 ' A' ' 9' ' ' VAL . 57.5 Cg_endo -70.77 134.11 25.15 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.189 1.926 . . . . 74.140000000000001 112.404 173.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.7 mt -97.64 -65.5 0.96 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.901 0.382 . . . . 75.230000000000004 111.654 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.407 ' CB ' ' HA ' ' A' ' 7' ' ' GLU . 8.0 m -63.43 126.87 28.9 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.835 0.35 . . . . 60.020000000000003 111.451 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.34 12.25 84.08 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.965 -0.636 . . . . 50.509999999999998 112.97 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -90.85 104.22 16.83 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.087 0.47 . . . . 55.350000000000001 111.246 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -87.74 123.8 32.92 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.224 -0.443 . . . . 74.510000000000005 111.557 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.8 -169.74 14.79 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.253 -0.498 . . . . 54.020000000000003 113.539 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -118.49 150.36 39.74 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 122.703 -0.292 . . . . 64.510000000000005 110.893 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 13.6 tp10 -144.7 114.54 7.31 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.625 0.25 . . . . 72.519999999999996 110.908 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -118.33 137.87 52.79 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.863 0.363 . . . . 74.439999999999998 111.928 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -152.09 136.56 16.84 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.245 0.545 . . . . 73.0 111.82 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.3 m -96.06 116.1 28.45 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.148 -0.478 . . . . 70.530000000000001 111.484 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 42' ' ' TYR . 62.0 mt -80.71 103.97 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.566 -0.288 . . . . 73.430000000000007 110.809 176.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -92.67 111.35 22.91 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.032 0.444 . . . . 75.150000000000006 111.301 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.22 -154.11 7.03 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.248 -0.501 . . . . 74.430000000000007 112.764 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -93.43 90.55 6.77 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.203 -0.586 . . . . 74.310000000000002 111.064 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.63 75.95 1.28 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 121.239 -0.505 . . . . 15.4 113.986 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 72.96 -41.37 0.5 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.206 1.187 . . . . 71.099999999999994 114.206 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -50.85 108.23 0.23 Allowed 'General case' 0 N--CA 1.477 0.903 0 O-C-N 122.155 -0.341 . . . . 74.450000000000003 111.605 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 33.6 p90 -131.25 159.99 36.19 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.993 0.738 . . . . 74.209999999999994 112.993 -174.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.426 ' ND2' ' ND1' ' A' ' 82' ' ' HIS . 41.2 m-80 -133.73 109.84 9.42 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.869 -0.605 . . . . 74.120000000000005 110.552 170.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.3 tp -82.67 104.04 12.63 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.878 0.371 . . . . 64.120000000000005 110.69 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.739 ' SD ' HG12 ' A' ' 54' ' ' ILE . 91.3 mmm -91.73 137.32 32.46 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.361 -0.381 . . . . 74.129999999999995 111.502 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -123.38 115.72 22.09 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.047 0.451 . . . . 73.310000000000002 111.168 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 44.3 t -105.61 107.53 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.106 -0.497 . . . . 73.5 110.537 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -112.21 117.44 32.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.743 0.306 . . . . 74.209999999999994 110.674 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.06 -111.23 3.18 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.831 -0.7 . . . . 62.340000000000003 112.809 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -112.51 17.02 19.61 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.9 0.381 . . . . 74.019999999999996 111.503 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.1 ptt-85 -133.93 140.94 47.12 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.097 0.475 . . . . 72.299999999999997 111.655 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.3 tt -124.32 147.53 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 116.389 -0.368 . . . . 73.310000000000002 111.881 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -150.96 168.81 23.4 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.889 0.376 . . . . 70.109999999999999 111.444 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.739 HG12 ' SD ' ' A' ' 45' ' ' MET . 26.4 mt -90.68 117.79 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.118 0.485 . . . . 74.200000000000003 110.155 168.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -81.13 -41.58 22.23 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.098 -0.501 . . . . 74.420000000000002 111.771 -176.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -159.46 138.53 11.08 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.759 0.281 . . . . 52.399999999999999 111.759 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -163.61 166.72 22.1 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.99 0.424 . . . . 53.140000000000001 111.198 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -111.19 63.66 0.61 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 120.967 0.413 . . . . 73.329999999999998 111.882 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.2 t -108.59 138.06 20.16 Favored Pre-proline 0 N--CA 1.477 0.918 0 O-C-N 122.051 -0.406 . . . . 63.32 111.013 175.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.49 ' HD2' ' HG2' ' A' ' 81' ' ' PRO . 36.6 Cg_endo -64.21 -27.14 64.39 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.769 2.313 . . . . 74.340000000000003 113.35 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.513 ' HB2' HG23 ' A' ' 63' ' ' VAL . 1.2 p30 -87.25 -43.53 12.12 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 111.945 0.35 . . . . 75.319999999999993 111.945 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 65.57 27.33 11.55 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.457 -0.338 . . . . 73.150000000000006 111.665 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.513 HG23 ' HB2' ' A' ' 61' ' ' ASP . 90.2 t -58.01 -41.68 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.037 0.446 . . . . 74.040000000000006 110.957 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.585 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -55.37 -48.02 72.07 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 116.036 -0.529 . . . . 44.119999999999997 113.074 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.7 t -62.45 -44.01 98.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 120.801 0.334 . . . . 62.539999999999999 111.372 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -59.74 -33.77 72.08 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.615 -0.266 . . . . 73.109999999999999 111.528 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.412 ' CE ' ' HA ' ' A' ' 67' ' ' MET . 5.3 mmt -57.9 -31.88 67.18 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.832 0.348 . . . . 64.040000000000006 111.902 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.96 -136.22 32.83 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.108 -0.567 . . . . 62.530000000000001 113.585 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -87.88 126.24 34.93 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.17 0.509 . . . . 74.140000000000001 111.879 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 34.4 mmtp -113.66 145.03 41.93 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.317 -0.623 . . . . 72.25 109.317 171.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.1 p -156.31 6.79 0.19 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.327 1.232 . . . . 75.319999999999993 114.327 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -130.12 156.26 44.83 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.67 -0.644 . . . . 72.420000000000002 112.179 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.06 126.5 27.72 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.004 -0.544 . . . . 53.049999999999997 111.239 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.37 -22.12 23.01 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.337 -0.458 . . . . 71.530000000000001 112.857 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.523 ' HB2' HD12 ' A' ' 88' ' ' ILE . 95.7 m-20 -68.2 131.58 45.64 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.964 0.411 . . . . 75.239999999999995 111.687 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.9 p -127.99 167.14 17.1 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.59 0.589 . . . . 63.240000000000002 112.59 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.588 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 40.0 mm -137.44 123.56 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.69 0.796 . . . . 74.140000000000001 109.885 177.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -113.99 117.76 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.256 0.465 . . . . 63.299999999999997 112.256 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 73.5 m -122.91 86.5 2.59 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.862 0.363 . . . . 63.439999999999998 111.309 174.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.59 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 92.2 mt -61.24 -53.95 58.02 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 112.804 0.668 . . . . 73.219999999999999 112.804 -175.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.59 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 17.1 Cg_exo -69.25 0.1 5.73 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.4 2.067 . . . . 71.430000000000007 113.362 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.426 ' ND1' ' ND2' ' A' ' 43' ' ' ASN . 65.1 m170 -119.1 -6.77 10.42 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 122.205 -0.309 . . . . 71.310000000000002 111.509 175.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.3 mttm 61.85 30.51 18.24 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.15 0.5 . . . . 73.219999999999999 111.762 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.51 138.84 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.101 -0.499 . . . . 61.32 111.346 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -141.71 125.8 17.33 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.115 -0.493 . . . . 74.010000000000005 110.886 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.588 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 57.5 t -116.6 135.44 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.561 0.219 . . . . 73.25 111.148 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.21 141.1 47.89 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.91 0.386 . . . . 71.430000000000007 111.278 176.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 75' ' ' ASP . 60.6 mt -101.5 115.97 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.17 0.509 . . . . 63.43 111.216 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -109.89 166.09 11.2 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.003 -0.544 . . . . 63.32 110.697 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.5 t -97.3 149.29 22.23 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.181 0.515 . . . . 63.109999999999999 111.32 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.5 p -80.37 -5.12 55.92 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.216 0.532 . . . . 74.129999999999995 110.973 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 . . . . . 0 C--O 1.235 0.298 0 CA-C-O 121.335 0.588 . . . . 73.519999999999996 111.528 179.589 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.469 ' HB2' ' OG1' ' A' ' 91' ' ' THR . 47.7 mt-10 . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 120.795 0.331 . . . . 65.25 110.749 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.0 m -123.67 142.17 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.095 0.474 . . . . 64.010000000000005 112.033 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 23' ' ' PRO . 27.5 m -119.93 140.19 44.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.278 -0.419 . . . . 72.25 111.224 177.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.94 114.53 26.37 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.893 0.378 . . . . 43.130000000000003 111.681 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.423 HG23 ' HG2' ' A' ' 21' ' ' GLU . 27.7 mm -98.69 110.79 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.338 -0.392 . . . . 65.530000000000001 110.979 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 12' ' ' ILE . 3.2 mp -101.42 125.69 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.06 0.457 . . . . 73.439999999999998 111.59 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 55.2 m -123.5 150.6 43.73 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.129 -0.487 . . . . 74.340000000000003 111.813 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.421 ' HG2' ' OD1' ' A' ' 15' ' ' ASN . 36.1 tt0 -129.01 135.24 48.68 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.412 0.285 . . . . 52.32 110.533 175.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.421 ' OD1' ' HG2' ' A' ' 14' ' ' GLN . 25.8 m120 59.64 8.66 1.34 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.859 0.464 . . . . 53.009999999999998 111.976 -174.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.95 -29.25 8.61 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 121.53 -0.367 . . . . 33.439999999999998 113.315 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -87.71 139.69 30.28 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.974 0.416 . . . . 65.310000000000002 111.486 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -71.22 130.54 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.316 -0.402 . . . . 64.310000000000002 111.115 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.466 HD11 HD13 ' A' ' 35' ' ' ILE . 34.2 pt -121.18 -29.24 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 112.897 0.703 . . . . 63.009999999999998 112.897 -176.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.506 ' HG3' HD11 ' A' ' 22' ' ' ILE . 9.2 tpm_? -151.29 123.19 8.1 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.125 0.488 . . . . 74.239999999999995 111.651 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.423 ' HG2' HG23 ' A' ' 11' ' ' ILE . 19.4 mt-10 -122.25 125.97 47.19 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.235 -0.439 . . . . 73.120000000000005 110.998 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.506 HD11 ' HG3' ' A' ' 20' ' ' ARG . 4.4 mp -120.63 123.62 27.97 Favored Pre-proline 0 N--CA 1.473 0.717 0 O-C-N 122.191 -0.318 . . . . 73.340000000000003 111.786 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.51 ' HA ' HG12 ' A' ' 9' ' ' VAL . 22.3 Cg_exo -66.27 111.88 2.16 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.257 1.971 . . . . 72.209999999999994 111.55 169.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 78.2 mt -75.65 -58.64 3.16 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.912 0.387 . . . . 74.150000000000006 111.244 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.451 HG21 ' HG2' ' A' ' 7' ' ' GLU . 35.8 m -60.5 118.83 6.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.836 0.351 . . . . 71.510000000000005 111.153 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 50' ' ' GLU . . . 98.49 -8.28 62.07 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.191 -0.528 . . . . 43.530000000000001 113.387 -176.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.41 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 54.2 t-80 -79.5 95.7 5.89 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.285 -0.538 . . . . 71.420000000000002 111.345 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.29 146.61 52.1 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.101 -0.5 . . . . 62.340000000000003 111.923 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.43 -158.57 53.27 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 116.1 -0.5 . . . . 72.439999999999998 114.183 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -118.39 151.34 37.95 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.834 0.349 . . . . 72.040000000000006 111.143 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -146.54 135.04 22.02 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.517 0.327 . . . . 74.420000000000002 110.462 -176.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -131.94 142.57 49.67 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.889 -0.507 . . . . 54.329999999999998 112.319 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -150.96 135.7 17.25 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.004 0.43 . . . . 73.019999999999996 111.431 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.8 m -98.74 127.65 44.74 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.396 -0.366 . . . . 70.129999999999995 111.139 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.466 HD13 HD11 ' A' ' 19' ' ' ILE . 68.8 mt -110.59 120.6 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 120.766 0.317 . . . . 73.310000000000002 111.377 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -97.41 128.72 44.44 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.116 0.484 . . . . 74.519999999999996 111.393 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.23 -114.48 3.66 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 116.261 -0.427 . . . . 65.340000000000003 112.787 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.651 ' HE2' ' HG3' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -99.17 141.82 31.45 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.911 0.355 . . . . 72.340000000000003 111.495 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.37 -100.63 0.19 Allowed Glycine 0 CA--C 1.531 1.068 0 CA-C-N 116.392 -0.367 . . . . 63.32 113.912 177.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.34 18.65 7.58 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.186 0.517 . . . . 73.099999999999994 111.664 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.651 ' HG3' ' HE2' ' A' ' 38' ' ' LYS . 12.5 mm100 -85.74 115.69 23.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.984 -0.553 . . . . 70.219999999999999 111.386 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -130.0 151.87 50.07 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.081 0.467 . . . . 62.310000000000002 112.189 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -127.66 116.8 20.84 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.061 -0.518 . . . . 74.209999999999994 110.639 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.6 tp -95.16 103.5 15.35 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.893 0.378 . . . . 72.329999999999998 110.501 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.665 ' SD ' HG12 ' A' ' 54' ' ' ILE . 92.5 mmm -92.33 136.74 32.95 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.232 -0.44 . . . . 64.209999999999994 111.274 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -124.55 115.35 20.71 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.953 0.406 . . . . 73.120000000000005 111.096 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.458 HG11 HG21 ' A' ' 22' ' ' ILE . 47.8 t -97.27 115.64 37.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.105 -0.498 . . . . 61.009999999999998 111.063 175.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -109.25 170.72 7.87 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.563 -0.29 . . . . 62.100000000000001 110.295 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 27' ' ' HIS . . . -37.53 95.33 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 N-CA-C 114.604 0.602 . . . . 61.43 114.604 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 31.4 mt-10 62.21 37.34 14.31 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.442 0.697 . . . . 75.310000000000002 112.682 176.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -165.21 161.95 19.67 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.381 -0.372 . . . . 75.230000000000004 111.017 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.3 tt -141.39 151.57 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 112.186 0.439 . . . . 72.099999999999994 112.186 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.436 ' HD3' ' CE2' ' A' ' 69' ' ' TRP . 14.1 ptt180 -152.18 168.97 23.61 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.905 0.383 . . . . 70.120000000000005 111.541 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.665 HG12 ' SD ' ' A' ' 45' ' ' MET . 46.3 mt -94.85 113.32 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.956 -0.387 . . . . 65.120000000000005 109.956 168.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -75.38 -46.73 31.2 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.736 0.303 . . . . 72.319999999999993 111.601 -177.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -143.15 140.36 30.76 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.834 0.349 . . . . 73.319999999999993 111.224 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -162.25 136.59 6.68 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.887 0.375 . . . . 65.25 111.271 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -107.8 51.36 0.74 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.208 0.527 . . . . 72.540000000000006 111.967 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.459 ' HG ' ' CD2' ' A' ' 82' ' ' HIS . 50.4 m -97.99 124.48 47.49 Favored Pre-proline 0 N--CA 1.473 0.719 0 O-C-N 122.141 -0.349 . . . . 60.200000000000003 110.213 172.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -52.78 -32.83 57.62 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.837 2.358 . . . . 65.549999999999997 113.226 -175.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -75.08 -31.46 61.22 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.365 -0.379 . . . . 74.109999999999999 111.857 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 28.3 mm-40 60.54 22.28 12.02 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.088 0.773 . . . . 72.299999999999997 113.088 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.5 t -53.36 -52.04 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 112.02 0.378 . . . . 71.010000000000005 112.02 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.94 -40.7 98.77 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.035 -0.602 . . . . 60.149999999999999 113.387 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.5 t -65.97 -33.7 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 120.998 0.428 . . . . 63.140000000000001 111.564 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 62' ' ' GLN . 67.5 mttm -70.71 -37.64 73.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.822 0.344 . . . . 65.310000000000002 111.398 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.3 mmt -60.35 -35.16 75.03 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.279 -0.418 . . . . 74.430000000000007 112.058 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.06 -119.51 8.05 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.251 -0.499 . . . . 51.32 113.948 175.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.436 ' CE2' ' HD3' ' A' ' 53' ' ' ARG . 69.3 m95 -94.92 138.93 32.02 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.173 0.434 . . . . 74.049999999999997 112.173 -175.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -131.23 151.4 51.51 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.195 -0.457 . . . . 63.43 110.233 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.4 p -164.97 15.74 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.368 0.877 . . . . 52.109999999999999 113.368 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.775 ' HE2' ' HA ' ' A' ' 72' ' ' LYS . 9.6 mmpt? -123.43 149.62 44.82 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.24 0.543 . . . . 64.25 112.069 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.64 109.49 1.42 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.029 -0.532 . . . . 62.030000000000001 110.587 176.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.24 -18.86 6.47 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 116.234 -0.439 . . . . 75.219999999999999 112.503 -176.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -69.84 115.35 8.96 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.779 0.323 . . . . 72.040000000000006 111.263 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 82.5 p -119.46 149.67 41.48 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.089 0.471 . . . . 60.25 111.465 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.434 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 46.9 mm -125.56 115.93 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.194 -0.457 . . . . 74.230000000000004 110.476 177.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.6 t -108.79 117.76 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 120.867 0.365 . . . . 42.350000000000001 111.777 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 71.0 m -120.82 84.54 2.25 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.086 0.469 . . . . 73.140000000000001 111.009 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.545 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 98.8 mt -57.98 -49.98 90.64 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 113.24 0.83 . . . . 63.409999999999997 113.24 -176.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 52.0 Cg_exo -56.7 -18.31 26.12 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 122.096 1.864 . . . . 70.319999999999993 113.519 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.459 ' CD2' ' HG ' ' A' ' 59' ' ' SER . 21.3 m170 -113.2 -4.78 13.71 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.7 0.286 . . . . 73.109999999999999 111.219 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 58.78 28.0 16.77 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.176 0.59 . . . . 72.299999999999997 112.292 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.1 t -101.9 133.88 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.02 0.438 . . . . 72.219999999999999 111.215 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -130.85 123.52 29.21 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.122 -0.49 . . . . 73.400000000000006 110.824 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.434 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 47.5 t -117.1 136.9 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 116.715 -0.221 . . . . 74.099999999999994 111.02 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -136.96 132.07 33.86 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.198 0.523 . . . . 73.409999999999997 111.092 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 62.1 mt -99.38 127.16 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.264 -0.426 . . . . 71.120000000000005 111.205 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -125.74 159.42 32.37 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.905 0.383 . . . . 71.340000000000003 111.617 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.1 t -79.66 149.78 31.14 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.253 -0.431 . . . . 55.340000000000003 111.059 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 7' ' ' GLU . 80.6 p -71.91 -21.45 61.62 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.864 0.364 . . . . 61.439999999999998 110.843 173.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 . . . . . 0 N--CA 1.469 0.525 0 CA-C-N 116.012 -0.54 . . . . 52.210000000000001 110.743 175.613 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.575 ' HA ' ' HB ' ' A' ' 25' ' ' THR . 42.7 mt-10 . . . . . 0 CA--C 1.541 0.621 0 N-CA-C 112.597 0.591 . . . . 55.420000000000002 112.597 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.485 HG22 ' OG1' ' A' ' 25' ' ' THR . 27.6 m -102.83 152.08 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.287 0.565 . . . . 53.450000000000003 111.77 176.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 23' ' ' PRO . 35.5 m -127.42 142.41 43.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.145 -0.48 . . . . 62.409999999999997 111.682 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.39 116.38 28.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.944 0.402 . . . . 53.43 111.237 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 34.4 mm -99.34 107.06 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.27 -0.423 . . . . 70.439999999999998 111.711 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.4 mp -96.7 129.03 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.049 0.452 . . . . 75.120000000000005 111.029 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 m -130.99 156.7 44.68 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.055 0.455 . . . . 73.439999999999998 111.75 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -149.77 142.86 24.97 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 116.239 -0.437 . . . . 75.209999999999994 110.428 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.2 m120 60.52 19.79 9.59 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.234 0.457 . . . . 74.439999999999998 112.234 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.36 4.13 68.68 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 120.994 -0.622 . . . . 62.399999999999999 114.034 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -126.62 149.41 49.5 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.355 0.577 . . . . 72.5 111.896 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.6 t -68.6 132.16 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.524 -0.307 . . . . 60.520000000000003 110.945 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.5 pt -122.58 -20.14 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.041 0.756 . . . . 62.219999999999999 113.041 -176.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -160.12 138.1 9.98 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.027 -0.421 . . . . 64.209999999999994 111.737 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -134.79 124.27 24.88 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 120.573 0.225 . . . . 71.519999999999996 111.362 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.96 126.51 26.31 Favored Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 111.63 0.233 . . . . 74.530000000000001 111.63 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.498 ' HA ' HG12 ' A' ' 9' ' ' VAL . 15.2 Cg_exo -69.12 117.84 5.3 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.694 2.263 . . . . 62.130000000000003 112.2 172.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.8 mt -84.79 -61.02 1.88 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.847 0.356 . . . . 73.319999999999993 111.826 -175.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.575 ' HB ' ' HA ' ' A' ' 7' ' ' GLU . 60.7 m -61.07 110.66 1.43 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.95 0.405 . . . . 74.510000000000005 111.985 -177.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.29 -15.69 35.73 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.235 -0.507 . . . . 73.230000000000004 112.993 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -70.58 128.71 37.05 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 122.663 0.385 . . . . 54.140000000000001 111.566 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -104.3 155.89 18.37 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.066 0.46 . . . . 73.319999999999993 112.016 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.53 -165.68 54.76 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 116.06 -0.518 . . . . 63.520000000000003 114.168 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -118.64 137.89 52.98 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.008 0.432 . . . . 73.400000000000006 110.667 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -143.53 115.53 8.33 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.788 0.328 . . . . 72.439999999999998 111.455 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -111.75 143.48 42.6 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.862 0.363 . . . . 64.239999999999995 111.954 -174.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -146.71 137.94 24.23 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.981 0.419 . . . . 53.229999999999997 111.201 176.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.9 m -105.06 119.94 40.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.009 0.433 . . . . 61.240000000000002 112.088 -175.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.52 ' N ' HD12 ' A' ' 35' ' ' ILE . 3.2 mp -92.43 106.19 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.945 0.403 . . . . 75.540000000000006 110.1 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.558 ' NZ ' ' HB2' ' A' ' 36' ' ' LYS . 9.6 mtmp? -86.88 128.05 35.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.079 0.466 . . . . 65.519999999999996 111.374 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.56 -178.62 38.2 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.243 -0.503 . . . . 64.329999999999998 113.183 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -66.22 93.85 0.23 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.214 0.53 . . . . 75.439999999999998 111.297 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.97 -121.4 5.42 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 116.077 -0.51 . . . . 73.329999999999998 112.33 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.82 12.09 29.37 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.144 0.497 . . . . 64.209999999999994 111.269 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -83.77 67.02 9.36 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.145 -0.48 . . . . 75.5 112.13 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -97.86 158.03 15.75 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.595 0.591 . . . . 73.409999999999997 112.595 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -131.36 133.41 45.27 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.461 0.704 . . . . 64.519999999999996 110.574 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.8 tp -105.46 107.38 18.33 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.79 0.329 . . . . 74.030000000000001 111.271 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.757 ' SD ' HG12 ' A' ' 54' ' ' ILE . 87.7 mmm -94.65 122.61 37.43 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.91 0.386 . . . . 73.019999999999996 111.124 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -108.14 117.67 34.75 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.791 0.329 . . . . 72.109999999999999 111.381 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.1 t -96.23 109.01 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.373 -0.376 . . . . 72.349999999999994 110.429 174.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.505 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 31.3 t70 -108.64 107.94 18.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.042 0.449 . . . . 61.329999999999998 110.344 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.3 -107.03 1.06 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.901 -0.666 . . . . 54.119999999999997 112.679 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -116.42 27.34 9.28 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.268 0.556 . . . . 73.450000000000003 111.668 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 17.3 ptt180 -142.76 148.03 36.53 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.043 -0.526 . . . . 74.209999999999994 110.898 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.5 tt -129.62 145.67 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 112.018 0.377 . . . . 71.109999999999999 112.018 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -149.69 168.96 22.14 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.885 0.374 . . . . 73.230000000000004 111.693 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.757 HG12 ' SD ' ' A' ' 45' ' ' MET . 35.3 mt -96.36 118.71 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.502 -0.317 . . . . 64.209999999999994 110.46 169.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -85.83 -36.37 20.07 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.912 0.387 . . . . 72.099999999999994 111.611 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -153.38 138.75 17.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.538 -0.301 . . . . 71.140000000000001 111.53 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.409 ' OD2' HG23 ' A' ' 65' ' ' VAL . 2.4 p30 -153.51 151.51 29.89 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.997 0.427 . . . . 73.209999999999994 110.596 175.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -102.01 74.94 1.49 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.019 0.438 . . . . 65.349999999999994 110.994 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.6 p -124.89 150.88 67.5 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-N 116.492 -0.322 . . . . 64.549999999999997 110.272 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.02 -29.17 40.79 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.356 2.037 . . . . 63.119999999999997 111.708 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.87 -35.82 25.92 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.397 -0.819 . . . . 74.230000000000004 111.89 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.481 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 27.2 mm-40 62.95 21.54 12.93 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.385 0.513 . . . . 73.540000000000006 112.385 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.555 ' O ' ' HG3' ' A' ' 67' ' ' MET . 89.6 t -57.8 -38.26 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.495 -0.321 . . . . 74.319999999999993 111.658 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.43 -57.22 14.22 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.642 -0.313 . . . . 61.329999999999998 113.45 -176.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.409 HG23 ' OD2' ' A' ' 57' ' ' ASP . 54.1 t -62.18 -34.85 65.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 120.952 0.406 . . . . 64.209999999999994 111.582 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 14.1 mptt -66.13 -28.38 68.76 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.467 0.543 . . . . 74.120000000000005 112.467 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.555 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 53.4 mtp -64.18 -24.12 67.56 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 122.064 -0.397 . . . . 74.439999999999998 111.708 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.34 -153.84 41.69 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 114.446 0.538 . . . . 51.439999999999998 114.446 173.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -80.82 142.21 33.92 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.125 0.488 . . . . 74.409999999999997 112.06 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 74.2 mmtt -125.61 133.87 52.1 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.01 -0.541 . . . . 55.140000000000001 109.672 175.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 54.0 p -155.77 28.35 0.38 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.171 1.174 . . . . 54.0 114.171 -170.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -160.33 162.32 33.45 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.773 0.657 . . . . 65.109999999999999 112.773 171.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.04 118.02 5.79 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.057 -0.52 . . . . 61.539999999999999 111.216 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 123.01 -17.16 8.12 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.267 -0.492 . . . . 31.34 112.682 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.538 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 64.5 m-20 -75.58 128.15 34.64 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 122.472 -0.428 . . . . 74.120000000000005 111.399 176.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 81.7 p -130.76 144.23 51.29 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.893 0.377 . . . . 71.040000000000006 111.702 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.557 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 45.5 mm -114.67 128.15 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 122.817 0.447 . . . . 54.350000000000001 110.348 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.15 115.83 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.033 0.444 . . . . 73.450000000000003 111.664 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 86.2 m -123.4 71.06 1.06 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.448 -0.342 . . . . 63.409999999999997 111.277 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.561 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 89.0 mt -53.15 -50.2 83.52 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 112.574 0.583 . . . . 55.229999999999997 112.574 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 53.2 Cg_exo -54.24 -20.76 20.46 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.15 1.9 . . . . 72.340000000000003 113.387 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -110.01 -1.73 17.46 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.263 0.468 . . . . 71.5 112.263 -175.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 63.41 17.39 10.27 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.539 0.336 . . . . 41.409999999999997 111.809 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.91 138.02 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.915 0.388 . . . . 62.299999999999997 111.652 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -141.93 131.4 23.8 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.374 -0.375 . . . . 62.549999999999997 110.791 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.557 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 47.5 t -127.38 145.76 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.573 0.225 . . . . 64.310000000000002 111.059 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -144.13 153.69 42.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.671 0.272 . . . . 63.130000000000003 110.883 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.477 HD12 ' HB2' ' A' ' 75' ' ' ASP . 59.5 mt -110.74 126.24 68.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.85 0.357 . . . . 64.420000000000002 111.051 175.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.05 177.77 6.43 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.348 -0.387 . . . . 72.010000000000005 110.248 176.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 28.4 t -107.07 151.47 25.31 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.213 0.53 . . . . 70.239999999999995 111.811 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.5 p -62.07 -23.99 66.83 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.759 -0.655 . . . . 72.230000000000004 111.182 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.473 ' HG2' ' OG ' ' A' ' 90' ' ' SER . 11.9 pt20 . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 120.932 0.396 . . . . 74.439999999999998 110.578 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 112.053 0.39 . . . . 64.319999999999993 112.053 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.4 m -115.96 152.68 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 121.288 0.566 . . . . 72.109999999999999 112.02 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 23' ' ' PRO . 27.8 m -127.0 148.51 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.122 -0.49 . . . . 75.129999999999995 111.647 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -102.67 115.47 30.65 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.984 0.421 . . . . 73.349999999999994 111.512 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.8 mm -100.4 116.51 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.339 -0.391 . . . . 74.109999999999999 111.146 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.506 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.0 mp -97.63 127.46 49.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.041 0.448 . . . . 61.509999999999998 111.288 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.4 p -124.35 153.03 42.42 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.223 0.535 . . . . 65.25 111.453 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -139.74 127.04 21.31 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.941 -0.572 . . . . 71.209999999999994 110.999 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 61.14 17.0 7.66 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.347 0.499 . . . . 75.150000000000006 112.347 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.16 -31.6 6.16 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.258 -0.496 . . . . 63.539999999999999 113.802 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -98.42 147.58 24.57 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 122.202 -0.587 . . . . 73.219999999999999 112.102 -177.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.17 134.77 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 122.3 -0.25 . . . . 71.209999999999994 110.493 173.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.3 pt -120.07 -29.81 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.785 0.661 . . . . 74.400000000000006 112.785 -177.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -152.95 141.0 20.33 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.879 0.371 . . . . 73.439999999999998 111.591 -176.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -131.3 124.93 31.5 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.771 0.319 . . . . 44.030000000000001 111.226 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 47' ' ' VAL . 4.1 mp -124.79 124.37 25.55 Favored Pre-proline 0 N--CA 1.474 0.772 0 CA-C-O 120.597 0.237 . . . . 73.409999999999997 111.467 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.425 ' HA ' HG12 ' A' ' 9' ' ' VAL . 60.2 Cg_endo -72.93 119.59 6.15 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.242 1.961 . . . . 71.140000000000001 111.812 172.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.8 mt -80.97 -63.06 1.49 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.073 0.463 . . . . 62.130000000000003 111.471 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.3 m -59.77 121.74 12.44 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.35 -0.386 . . . . 60.130000000000003 111.423 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.71 3.03 77.93 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.238 -0.506 . . . . 70.120000000000005 113.787 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.497 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 42.5 t-80 -77.51 129.12 35.27 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.305 -0.527 . . . . 73.129999999999995 111.235 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -94.31 137.52 33.37 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.989 0.423 . . . . 71.340000000000003 112.026 -177.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.89 -167.1 54.66 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 114.79 0.676 . . . . 74.209999999999994 114.79 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -118.66 122.45 42.56 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.861 0.464 . . . . 43.420000000000002 110.502 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -117.05 139.57 50.54 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 122.242 -0.286 . . . . 75.099999999999994 111.325 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -131.08 129.47 41.95 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.819 0.343 . . . . 73.420000000000002 111.311 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -138.98 141.93 38.37 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.896 0.379 . . . . 74.420000000000002 111.692 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.8 m -97.46 119.07 35.33 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.073 0.463 . . . . 40.039999999999999 111.767 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.7 mt -81.64 116.91 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.05 -0.523 . . . . 72.340000000000003 110.808 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -80.38 123.16 27.78 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.814 0.34 . . . . 74.310000000000002 111.664 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -110.85 -163.28 18.36 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.367 -0.444 . . . . 71.129999999999995 112.435 175.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -69.95 123.16 20.83 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 122.416 -0.461 . . . . 51.310000000000002 111.979 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.05 -103.74 0.43 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.343 -0.456 . . . . 64.450000000000003 113.673 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.41 -3.77 46.41 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.75 0.648 . . . . 63.329999999999998 112.75 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -76.07 133.55 40.29 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 111.799 0.296 . . . . 65.299999999999997 111.799 -176.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -158.2 163.82 37.12 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.899 0.38 . . . . 62.439999999999998 111.762 176.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -136.99 115.3 11.74 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.322 -0.399 . . . . 73.239999999999995 111.18 175.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 56' ' ' GLU . 42.3 tp -87.92 103.34 15.59 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.22 0.533 . . . . 72.209999999999994 110.814 177.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.812 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.1 mmm -92.86 144.71 25.01 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.9 -0.591 . . . . 60.520000000000003 111.468 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -130.16 126.68 38.05 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.944 0.402 . . . . 71.530000000000001 111.528 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.531 HG21 HG21 ' A' ' 22' ' ' ILE . 44.4 t -110.02 107.62 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.163 -0.472 . . . . 70.109999999999999 110.319 175.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 31.0 t70 -108.03 109.42 20.87 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.486 0.315 . . . . 74.310000000000002 110.42 -176.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' A' ' 27' ' ' HIS . . . 57.79 -110.36 2.33 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.775 -0.726 . . . . 54.5 112.355 -175.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -110.24 18.05 20.31 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 120.886 0.375 . . . . 74.310000000000002 111.888 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 33.7 ptt180 -131.89 147.04 52.45 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.819 0.342 . . . . 74.120000000000005 111.465 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.0 tt -130.36 147.92 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.149 0.499 . . . . 72.109999999999999 112.188 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -159.87 165.52 32.06 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.088 -0.506 . . . . 74.319999999999993 111.415 177.241 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.812 HG12 ' SD ' ' A' ' 45' ' ' MET . 58.0 mt -89.91 120.42 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.946 0.403 . . . . 71.010000000000005 110.569 174.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -87.47 -31.21 20.12 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.493 -0.321 . . . . 63.109999999999999 111.746 -175.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.448 ' HB3' HD23 ' A' ' 44' ' ' LEU . 39.5 tt0 -167.95 138.98 2.83 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.086 0.47 . . . . 43.43 112.157 -175.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -161.04 -178.17 6.59 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.236 -0.438 . . . . 73.239999999999995 110.477 174.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -115.01 42.12 2.26 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.595 0.591 . . . . 73.0 112.595 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.8 m -88.01 131.75 42.01 Favored Pre-proline 0 N--CA 1.475 0.793 0 O-C-N 121.919 -0.488 . . . . 65.239999999999995 110.067 173.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.62 -40.9 71.83 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.342 2.028 . . . . 71.409999999999997 112.978 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.9 -13.36 31.35 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.433 0.531 . . . . 61.009999999999998 112.433 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 40.02 67.96 0.43 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.294 0.568 . . . . 72.299999999999997 112.477 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.2 t -74.05 -46.83 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.141 -0.482 . . . . 72.219999999999999 111.553 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.639 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -56.3 -43.71 89.52 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.436 -0.411 . . . . 64.150000000000006 113.722 -178.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -61.44 -38.14 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.091 0.472 . . . . 74.239999999999995 111.722 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -71.26 -28.35 64.1 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.047 0.388 . . . . 73.510000000000005 112.047 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 25.6 mmt -57.34 -28.94 63.56 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.924 0.393 . . . . 72.340000000000003 112.026 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.6 -155.64 39.71 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.294 -0.479 . . . . 63.140000000000001 113.781 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -82.48 119.47 24.25 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.957 0.408 . . . . 75.209999999999994 111.841 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 75.2 mmtt -111.41 151.01 29.0 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.244 -0.435 . . . . 63.32 110.041 175.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 63.2 p -168.65 6.52 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.546 1.313 . . . . 75.340000000000003 114.546 -174.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -124.94 152.46 44.1 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.64 -0.663 . . . . 72.329999999999998 112.28 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.4 99.99 0.07 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.719 -0.673 . . . . 74.519999999999996 111.25 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.18 -19.91 2.66 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.933 -0.576 . . . . 74.310000000000002 112.526 -175.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.443 ' HB2' HD12 ' A' ' 88' ' ' ILE . 76.1 m-20 -76.63 134.72 39.24 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.804 0.335 . . . . 71.200000000000003 111.491 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.538 HG22 ' HA ' ' A' ' 87' ' ' GLU . 45.0 p -135.75 150.19 49.42 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.09 0.471 . . . . 74.540000000000006 111.665 176.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.462 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 50.2 mm -115.99 127.37 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.198 -0.455 . . . . 71.129999999999995 110.75 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -115.22 118.65 59.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.97 0.414 . . . . 64.510000000000005 111.874 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 90.1 m -121.75 75.77 1.22 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.411 -0.359 . . . . 64.530000000000001 111.331 176.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.541 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 91.9 mt -55.36 -50.65 85.51 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 113.133 0.79 . . . . 61.340000000000003 113.133 -176.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.541 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 46.7 Cg_exo -56.93 -17.15 22.88 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.889 1.726 . . . . 74.25 113.461 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 47.8 m170 -114.49 -4.11 12.92 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 122.184 -0.323 . . . . 73.25 111.751 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm 61.36 30.61 19.1 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.847 0.459 . . . . 74.310000000000002 111.923 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 80.0 t -110.0 138.75 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.832 0.349 . . . . 64.420000000000002 111.294 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -139.12 132.64 30.32 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.79 0.329 . . . . 72.439999999999998 111.308 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 47.7 t -121.29 134.29 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 122.332 -0.23 . . . . 75.010000000000005 111.142 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.538 ' HA ' HG22 ' A' ' 76' ' ' THR . 8.6 pt-20 -123.6 126.31 46.4 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.046 0.45 . . . . 72.120000000000005 111.709 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.443 HD12 ' HB2' ' A' ' 75' ' ' ASP . 59.8 mt -95.58 116.73 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.212 0.529 . . . . 71.530000000000001 110.432 175.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -127.77 160.54 31.42 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.178 0.513 . . . . 71.209999999999994 111.899 -172.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.3 t -87.62 149.13 24.49 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.065 0.46 . . . . 62.210000000000001 111.76 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.3 p -88.33 -15.49 35.55 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.075 -0.511 . . . . 73.310000000000002 111.26 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 . . . . . 0 N--CA 1.469 0.523 0 CA-C-N 116.013 -0.54 . . . . 75.239999999999995 111.7 -176.275 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.568 ' HA ' ' HB ' ' A' ' 25' ' ' THR . 46.0 mt-10 . . . . . 0 N--CA 1.467 0.379 0 CA-C-O 120.726 0.298 . . . . 72.310000000000002 110.876 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 34.5 m -102.76 161.82 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 113.282 0.845 . . . . 54.420000000000002 113.282 -174.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 23' ' ' PRO . 33.1 m -130.04 153.17 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 115.398 -0.819 . . . . 72.25 111.006 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.37 119.97 41.1 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.406 -0.361 . . . . 71.329999999999998 111.146 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.425 ' HB ' ' HG2' ' A' ' 87' ' ' GLU . 39.3 mm -101.02 111.4 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.591 -0.277 . . . . 65.129999999999995 110.949 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.481 ' N ' HD12 ' A' ' 12' ' ' ILE . 3.6 mp -100.98 111.11 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 120.941 0.4 . . . . 65.319999999999993 111.762 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.2 p -108.86 140.56 42.16 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.746 0.308 . . . . 65.420000000000002 110.405 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.555 ' HG3' HG22 ' A' ' 84' ' ' VAL . 7.6 tt0 -141.33 131.67 25.12 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.258 -0.276 . . . . 72.409999999999997 111.251 -177.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.8 m120 58.74 16.85 4.7 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 120.888 0.375 . . . . 41.340000000000003 111.961 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.09 -12.61 60.51 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.126 -0.559 . . . . 65.430000000000007 113.736 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 14' ' ' GLN . 21.5 pttp -109.61 132.87 53.74 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 117.273 0.536 . . . . 64.120000000000005 111.573 -178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.7 t -71.84 115.94 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.848 0.356 . . . . 54.200000000000003 110.719 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.9 pt -102.3 -23.1 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 113.156 0.799 . . . . 61.530000000000001 113.156 -173.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.6 tpp85 -157.45 126.99 6.03 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.769 0.655 . . . . 74.409999999999997 112.769 -173.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -118.01 119.18 34.0 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.629 -0.508 . . . . 62.140000000000001 109.629 173.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.59 126.33 26.49 Favored Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 112.989 0.737 . . . . 71.140000000000001 112.989 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.54 ' HA ' HG12 ' A' ' 9' ' ' VAL . 73.8 Cg_endo -76.24 111.79 3.34 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.389 2.059 . . . . 72.030000000000001 111.536 169.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.66 -69.32 0.61 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.232 0.456 . . . . 72.25 112.232 -174.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.568 ' HB ' ' HA ' ' A' ' 7' ' ' GLU . 6.7 m -59.41 124.58 20.49 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.002 0.43 . . . . 70.200000000000003 111.537 -176.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.06 -22.48 33.19 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.331 -0.462 . . . . 62.329999999999998 112.835 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -77.91 91.3 4.17 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.189 -0.595 . . . . 74.430000000000007 111.23 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -80.05 153.34 28.86 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.059 -0.518 . . . . 62.200000000000003 110.712 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.38 -162.91 27.25 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.051 -0.595 . . . . 63.539999999999999 112.971 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -118.18 145.0 45.27 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.197 0.522 . . . . 64.519999999999996 111.687 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.591 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 16.8 tp10 -139.75 139.32 36.47 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.915 -0.584 . . . . 60.009999999999998 110.209 176.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -141.66 133.4 27.15 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.865 0.364 . . . . 74.239999999999995 111.859 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -148.92 142.58 25.49 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.203 0.525 . . . . 62.119999999999997 111.772 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.8 m -98.29 115.11 27.72 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.119 -0.491 . . . . 71.019999999999996 111.729 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 60.3 mt -80.07 112.93 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.203 0.525 . . . . 72.430000000000007 111.188 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.2 mtmt -79.4 108.44 12.93 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.841 -0.618 . . . . 64.030000000000001 111.215 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.476 ' HA2' ' OE1' ' A' ' 14' ' ' GLN . . . -91.39 -86.08 1.44 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.178 -0.534 . . . . 34.020000000000003 113.722 -176.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -148.2 114.12 5.77 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.643 -0.328 . . . . 72.430000000000007 110.759 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.89 -107.9 1.5 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.119 -0.562 . . . . 74.310000000000002 112.937 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.97 -10.03 40.86 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.516 -0.402 . . . . 71.129999999999995 111.892 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -79.73 125.8 30.13 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.019 0.438 . . . . 74.010000000000005 111.925 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -145.67 172.54 13.12 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.084 -0.507 . . . . 73.329999999999998 111.308 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.439 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 15.6 m120 -136.99 110.44 7.94 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.554 -0.294 . . . . 75.019999999999996 110.681 173.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.3 tp -85.05 107.85 17.36 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.943 0.402 . . . . 73.439999999999998 110.908 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.795 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.9 mmm -100.67 150.94 22.22 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.001 0.429 . . . . 55.130000000000003 111.669 -176.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -138.84 130.84 28.0 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.209 -0.451 . . . . 75.030000000000001 111.84 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.591 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 30.4 t -113.08 107.66 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.313 -0.403 . . . . 64.340000000000003 110.492 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 8.8 t0 -130.93 140.13 50.15 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.517 0.199 . . . . 63.210000000000001 110.893 -176.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 51.87 51.08 41.55 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 114.385 0.514 . . . . 45.130000000000003 114.385 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 69.03 15.06 8.83 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.473 0.916 . . . . 61.020000000000003 113.473 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.444 ' HG3' ' HE3' ' A' ' 69' ' ' TRP . 3.6 ptp180 -147.52 166.9 25.89 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.721 -0.612 . . . . 70.409999999999997 112.58 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.1 tt -125.83 150.8 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.292 0.479 . . . . 74.239999999999995 112.292 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.485 ' HB3' ' HA ' ' A' ' 69' ' ' TRP . 1.8 ppt_? -155.68 159.16 39.33 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 111.192 177.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.795 HG12 ' SD ' ' A' ' 45' ' ' MET . 34.5 mt -85.85 115.99 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.153 0.502 . . . . 61.119999999999997 110.713 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -78.79 -34.73 45.24 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.879 -0.6 . . . . 72.230000000000004 111.895 -175.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -172.93 138.63 0.8 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.558 0.218 . . . . 71.319999999999993 111.276 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -152.75 149.93 28.87 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.93 0.395 . . . . 62.229999999999997 110.91 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -100.41 74.8 1.74 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.371 0.605 . . . . 75.239999999999995 111.599 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.0 p -124.11 149.92 61.79 Favored Pre-proline 0 N--CA 1.475 0.79 0 O-C-N 122.082 -0.387 . . . . 74.510000000000005 111.478 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.26 -23.27 45.25 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.37 2.047 . . . . 74.340000000000003 111.964 174.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.531 ' HB3' HG23 ' A' ' 63' ' ' VAL . 8.7 m-20 -73.06 -56.82 4.59 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.885 -0.598 . . . . 74.140000000000001 111.388 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 62.17 11.87 4.69 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.986 0.515 . . . . 75.120000000000005 112.296 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.531 HG23 ' HB3' ' A' ' 61' ' ' ASP . 59.9 t -56.62 -36.27 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.059 0.457 . . . . 73.230000000000004 111.177 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.567 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -58.04 -47.58 88.19 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.191 -0.528 . . . . 73.319999999999993 112.942 177.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.04 -41.84 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.195 0.521 . . . . 74.239999999999995 111.213 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -67.28 -29.28 68.85 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.213 0.449 . . . . 73.340000000000003 112.213 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 22.0 mmt -58.84 -42.26 88.87 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.726 0.298 . . . . 71.340000000000003 111.785 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.0 -139.37 28.28 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.311 -0.471 . . . . 73.439999999999998 113.112 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.485 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . 84.5 m95 -81.84 129.57 34.79 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.76 0.314 . . . . 54.119999999999997 111.491 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.454 ' HG3' HD11 ' A' ' 77' ' ' ILE . 74.7 mmtt -129.1 148.59 51.06 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.82 0.448 . . . . 52.43 110.292 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 51' ' ' ARG . 94.7 p -175.25 25.44 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.489 0.922 . . . . 71.540000000000006 113.489 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -120.16 144.56 47.61 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.614 -0.679 . . . . 75.329999999999998 111.394 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.16 96.26 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.094 0.473 . . . . 22.219999999999999 111.189 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.43 -26.42 1.99 Allowed Glycine 0 CA--C 1.525 0.697 0 CA-C-N 116.057 -0.52 . . . . 43.030000000000001 112.686 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.499 ' HB2' HD12 ' A' ' 88' ' ' ILE . 75.9 m-20 -64.57 135.35 55.89 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.876 0.37 . . . . 64.120000000000005 111.647 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.5 p -138.44 142.36 39.49 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.074 0.464 . . . . 61.329999999999998 111.617 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.454 HD11 ' HG3' ' A' ' 70' ' ' LYS . 38.7 mm -114.61 130.96 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.211 -0.449 . . . . 55.049999999999997 110.626 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.7 t -123.11 119.62 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 112.051 0.389 . . . . 63.039999999999999 112.051 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 97.8 m -121.77 88.79 3.0 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 120.733 0.302 . . . . 73.340000000000003 110.873 174.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.582 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 92.6 mt -59.25 -53.89 61.7 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 113.078 0.77 . . . . 62.140000000000001 113.078 -175.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 24.7 Cg_exo -62.81 -19.32 68.22 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.958 1.772 . . . . 65.439999999999998 113.007 -176.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -104.28 -5.04 22.22 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.483 -0.326 . . . . 73.239999999999995 111.683 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.1 mttm 58.16 34.29 24.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.811 0.445 . . . . 75.439999999999998 111.917 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.555 HG22 ' HG3' ' A' ' 14' ' ' GLN . 60.2 t -109.36 132.86 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.137 -0.483 . . . . 74.409999999999997 111.33 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -133.33 136.42 45.38 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.729 0.3 . . . . 63.030000000000001 110.695 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -132.9 139.49 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.8 -0.182 . . . . 75.0 111.214 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.425 ' HG2' ' HB ' ' A' ' 11' ' ' ILE . 10.1 pt-20 -126.15 154.52 43.06 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.794 0.331 . . . . 64.040000000000006 110.813 174.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.499 HD12 ' HB2' ' A' ' 75' ' ' ASP . 55.1 mt -118.24 123.09 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.094 0.473 . . . . 74.25 110.908 174.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -140.49 151.17 44.6 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.201 -0.454 . . . . 70.439999999999998 111.157 -175.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.516 ' OG ' ' HG2' ' A' ' 92' ' ' GLN . 22.9 t -74.2 149.82 40.68 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.064 0.459 . . . . 74.329999999999998 111.657 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.1 p -70.31 -21.22 62.95 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 116.25 -0.432 . . . . 75.340000000000003 111.837 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.516 ' HG2' ' OG ' ' A' ' 90' ' ' SER . 20.4 pt20 . . . . . 0 CA--C 1.537 0.48 0 CA-C-N 116.414 -0.357 . . . . 74.140000000000001 110.72 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.554 ' HG2' HG21 ' A' ' 25' ' ' THR . 42.1 mt-10 . . . . . 0 N--CA 1.465 0.306 0 N-CA-C 112.08 0.4 . . . . 74.140000000000001 112.08 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.478 HG23 ' HB2' ' A' ' 24' ' ' LEU . 31.3 m -125.54 139.16 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.164 0.506 . . . . 71.409999999999997 111.45 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.3 m -121.96 138.64 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 116.178 -0.465 . . . . 74.109999999999999 111.193 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.26 112.64 24.31 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.823 0.344 . . . . 72.010000000000005 111.333 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.2 mm -95.04 115.16 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.403 -0.362 . . . . 63.140000000000001 110.982 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.486 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.2 mp -97.25 114.64 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.047 0.451 . . . . 71.519999999999996 111.509 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.5 m -114.39 134.74 54.76 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.219 -0.446 . . . . 53.32 111.448 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -126.82 131.27 51.27 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 122.337 -0.227 . . . . 75.319999999999993 111.051 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 56.42 28.05 13.03 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.429 0.529 . . . . 73.439999999999998 112.429 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.12 21.57 41.43 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.253 -0.498 . . . . 60.32 114.34 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -146.78 140.33 25.75 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.308 0.554 . . . . 74.120000000000005 111.657 175.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.9 t -72.36 118.97 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.791 0.329 . . . . 75.299999999999997 111.014 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.1 pt -99.43 -23.44 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 112.219 0.451 . . . . 63.43 112.219 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -173.16 148.04 1.64 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.703 0.287 . . . . 75.319999999999993 111.014 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -131.33 127.37 37.52 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.179 0.514 . . . . 72.430000000000007 111.442 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.4 mp -113.67 116.12 45.95 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 116.358 -0.383 . . . . 62.25 111.418 -177.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.45 120.59 7.82 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.172 1.915 . . . . 72.439999999999998 111.757 172.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.478 ' HB2' HG23 ' A' ' 8' ' ' VAL . 86.9 mt -80.11 -48.89 12.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.056 0.455 . . . . 72.519999999999996 111.5 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.554 HG21 ' HG2' ' A' ' 7' ' ' GLU . 86.2 m -60.57 110.16 1.21 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.975 0.417 . . . . 74.030000000000001 111.805 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.73 0.53 60.55 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.059 -0.591 . . . . 73.340000000000003 113.465 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -72.51 86.49 1.17 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 117.159 0.48 . . . . 74.200000000000003 110.547 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -72.95 115.96 12.88 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.184 0.516 . . . . 72.329999999999998 111.953 -176.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.5 -166.49 14.37 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.145 -0.479 . . . . 54.200000000000003 113.952 177.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -116.89 136.6 52.83 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.763 0.425 . . . . 74.340000000000003 110.422 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -145.68 129.91 17.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.902 0.382 . . . . 53.530000000000001 111.592 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -121.72 147.6 45.7 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.6 -0.273 . . . . 73.439999999999998 111.561 -177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -147.99 143.69 27.45 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.966 0.412 . . . . 71.219999999999999 111.307 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -103.39 126.7 50.69 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.17 0.51 . . . . 65.510000000000005 112.216 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' A' ' 43' ' ' ASN . 60.7 mt -90.69 132.75 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.121 -0.491 . . . . 55.350000000000001 110.66 175.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.58 125.88 48.31 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.997 0.427 . . . . 64.209999999999994 111.223 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -113.42 -164.6 15.77 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.29 -0.481 . . . . 25.32 113.831 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -59.07 113.28 2.03 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.895 0.379 . . . . 74.439999999999998 112.011 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.54 -125.1 7.86 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.242 -0.504 . . . . 41.119999999999997 113.242 178.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.8 9.93 28.15 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.205 0.446 . . . . 51.100000000000001 112.205 -178.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.415 ' HA ' HD21 ' A' ' 58' ' ' ASN . 19.0 mm-40 -74.01 132.75 42.68 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.649 -0.251 . . . . 75.349999999999994 111.572 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -137.26 174.36 10.69 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.929 0.395 . . . . 64.540000000000006 111.125 174.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.489 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . 60.7 t30 -152.21 109.64 3.58 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.249 -0.282 . . . . 63.039999999999999 111.031 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.2 tp -86.6 105.12 16.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.96 0.41 . . . . 55.310000000000002 111.147 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.756 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.4 mmm -95.51 135.62 36.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.147 -0.479 . . . . 72.129999999999995 111.05 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.67 127.39 48.13 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.255 0.55 . . . . 72.310000000000002 111.96 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.3 t -112.44 107.87 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.03 -0.532 . . . . 61.200000000000003 110.586 176.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -112.33 112.35 23.87 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.763 0.316 . . . . 70.019999999999996 110.569 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 63.52 -121.46 23.99 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.938 -0.648 . . . . 64.329999999999998 112.506 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -106.25 25.81 10.58 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 122.469 -0.43 . . . . 72.340000000000003 111.668 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.8 ptt85 -140.92 145.52 36.18 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.204 0.526 . . . . 63.310000000000002 111.795 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.9 tt -123.72 153.94 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 116.1 -0.5 . . . . 54.020000000000003 111.479 -176.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -157.33 168.47 27.29 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.005 0.431 . . . . 74.140000000000001 111.424 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.756 HG12 ' SD ' ' A' ' 45' ' ' MET . 45.3 mt -91.54 123.92 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 109.749 -0.463 . . . . 73.219999999999999 109.749 168.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -93.49 -34.06 13.54 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.38 0.511 . . . . 71.450000000000003 112.38 -172.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -169.0 139.28 2.29 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.577 -0.283 . . . . 73.540000000000006 111.293 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -161.22 160.99 30.68 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.987 0.422 . . . . 71.430000000000007 111.536 176.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.415 HD21 ' HA ' ' A' ' 41' ' ' GLN . 18.0 p-10 -96.09 74.04 2.98 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.45 0.643 . . . . 75.519999999999996 111.858 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 84.2 p -125.7 148.84 63.49 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-N 116.381 -0.372 . . . . 70.340000000000003 110.92 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.46 -3.18 13.45 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.394 2.062 . . . . 73.239999999999995 112.639 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -110.49 -43.81 3.81 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.265 -0.425 . . . . 62.25 111.949 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.408 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 26.7 mm-40 63.47 30.42 15.3 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.854 0.359 . . . . 72.510000000000005 111.383 -177.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.2 t -52.56 -42.19 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 111.955 0.354 . . . . 70.209999999999994 111.955 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.625 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -55.38 -43.98 84.92 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.068 -0.587 . . . . 62.039999999999999 112.883 176.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.1 t -64.71 -39.22 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 120.854 0.359 . . . . 73.400000000000006 111.069 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.408 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 1.6 mptm? -65.05 -41.63 94.98 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.718 0.294 . . . . 73.299999999999997 111.402 177.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.9 mmt -57.43 -44.28 84.53 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.447 0.536 . . . . 71.030000000000001 112.447 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.96 -160.93 43.31 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 120.933 -0.651 . . . . 54.43 113.683 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -67.09 146.77 53.95 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.692 0.626 . . . . 74.299999999999997 112.692 -174.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.513 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 33.3 mmtm -135.63 140.67 44.74 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.89 -0.595 . . . . 65.5 110.33 177.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 82.2 p -164.84 11.06 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.29 0.848 . . . . 54.520000000000003 113.29 -176.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -114.13 153.9 28.73 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.938 -0.477 . . . . 71.519999999999996 111.653 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 90' ' ' SER . . . -69.11 91.34 0.5 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.211 0.529 . . . . 34.409999999999997 111.024 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.27 -22.33 2.41 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.893 -0.594 . . . . 65.200000000000003 112.337 -175.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.513 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 94.4 m-20 -63.36 142.86 58.23 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.938 0.399 . . . . 75.239999999999995 111.611 177.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.0 p -143.7 161.49 38.43 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.202 0.525 . . . . 71.239999999999995 111.645 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.3 mm -128.07 114.0 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.829 -0.623 . . . . 62.109999999999999 110.247 176.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.0 t -109.22 115.63 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.817 0.342 . . . . 71.510000000000005 111.442 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 74.2 m -123.34 88.09 2.86 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.699 0.285 . . . . 71.209999999999994 111.18 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.402 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 80.5 mt -62.65 -45.37 88.4 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 113.096 0.776 . . . . 74.010000000000005 113.096 -176.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 50.3 Cg_exo -53.74 -25.76 35.6 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 122.16 1.907 . . . . 71.329999999999998 113.556 179.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -112.39 -1.24 15.1 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.106 0.41 . . . . 63.509999999999998 112.106 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 59.88 33.56 21.59 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.964 0.411 . . . . 64.129999999999995 111.791 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 68.0 t -105.65 135.66 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.274 -0.421 . . . . 75.519999999999996 111.335 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -139.35 116.21 10.88 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.257 -0.429 . . . . 70.549999999999997 110.853 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.1 t -113.35 126.44 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.569 -0.287 . . . . 64.230000000000004 111.208 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -120.78 136.79 54.8 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.084 0.469 . . . . 72.409999999999997 111.467 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 62.9 mt -103.01 120.79 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.853 0.359 . . . . 71.25 111.331 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -124.4 147.06 48.51 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.106 -0.497 . . . . 73.299999999999997 111.064 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 48.1 t -92.45 150.28 20.89 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.188 0.518 . . . . 72.109999999999999 112.115 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' A' ' 7' ' ' GLU . 46.9 p -79.72 -13.78 59.21 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.895 -0.593 . . . . 73.209999999999994 110.783 174.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 . . . . . 0 CA--C 1.537 0.479 0 CA-C-N 116.108 -0.496 . . . . 72.239999999999995 111.077 177.467 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.4 ' HA ' ' CB ' ' A' ' 25' ' ' THR . 53.6 mt-10 . . . . . 0 N--CA 1.468 0.437 0 CA-C-O 121.137 0.494 . . . . 64.040000000000006 111.654 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.6 m -120.87 154.26 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 121.155 0.502 . . . . 73.439999999999998 112.031 -177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 23' ' ' PRO . 34.5 m -121.57 147.6 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.03 -0.532 . . . . 72.209999999999994 111.282 177.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.99 117.59 34.59 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.835 0.35 . . . . 72.109999999999999 111.527 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.9 mm -100.78 122.42 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.561 -0.291 . . . . 72.040000000000006 111.051 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.3 mp -107.8 113.88 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.051 0.453 . . . . 34.229999999999997 110.923 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.1 m -120.35 134.91 55.18 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.173 -0.467 . . . . 71.150000000000006 111.531 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -119.29 138.84 52.75 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.648 0.261 . . . . 63.119999999999997 110.919 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.1 m120 59.72 17.25 6.16 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.732 0.413 . . . . 72.540000000000006 111.98 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.3 3.4 63.28 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.118 -0.563 . . . . 75.109999999999999 113.827 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -124.84 140.33 53.03 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 117.238 0.519 . . . . 71.340000000000003 111.23 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.34 129.16 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.844 0.354 . . . . 73.040000000000006 111.689 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.5 pt -112.78 -31.49 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 116.414 -0.357 . . . . 73.010000000000005 111.663 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -157.62 144.94 18.43 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.681 0.277 . . . . 74.299999999999997 111.257 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -138.51 132.08 30.64 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 120.77 0.319 . . . . 75.019999999999996 110.739 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 22' ' ' ILE . 4.0 mp -126.3 119.39 23.41 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 120.567 0.222 . . . . 53.340000000000003 111.552 -177.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.458 ' HA ' HG12 ' A' ' 9' ' ' VAL . 43.1 Cg_endo -68.29 101.6 0.74 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.075 1.85 . . . . 62.130000000000003 111.535 172.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.18 -62.44 1.77 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.354 0.502 . . . . 73.340000000000003 112.354 -173.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.4 ' CB ' ' HA ' ' A' ' 7' ' ' GLU . 15.0 m -58.58 131.18 50.04 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.94 0.4 . . . . 72.129999999999995 111.443 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.62 -33.21 4.9 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.239 -0.505 . . . . 72.540000000000006 112.667 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -74.07 85.57 1.82 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.424 0.631 . . . . 71.409999999999997 110.82 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -86.74 167.62 14.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.68 -0.691 . . . . 65.120000000000005 111.633 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.73 -162.37 51.91 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 120.909 -0.662 . . . . 71.409999999999997 112.807 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -117.77 146.59 43.7 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.197 -0.59 . . . . 72.430000000000007 111.836 -176.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -161.19 116.92 2.16 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.818 -0.628 . . . . 52.399999999999999 110.285 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -113.86 145.96 40.7 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.822 0.344 . . . . 74.310000000000002 111.22 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -138.2 139.93 39.52 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.15 0.5 . . . . 71.299999999999997 111.481 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.4 m -98.87 121.2 40.52 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.955 -0.566 . . . . 72.340000000000003 112.077 -175.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 75.0 mt -91.58 123.37 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.121 -0.49 . . . . 75.140000000000001 111.31 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -103.07 124.39 48.45 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.508 0.194 . . . . 72.040000000000006 111.117 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -123.02 -143.23 6.32 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.064 -0.589 . . . . 64.010000000000005 113.679 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -60.93 106.78 0.62 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.183 0.438 . . . . 73.349999999999994 112.183 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.78 -116.88 8.17 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.216 -0.447 . . . . 74.319999999999993 113.454 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.78 6.72 48.13 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.031 0.382 . . . . 65.129999999999995 112.031 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -75.26 111.07 10.14 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.619 0.247 . . . . 74.109999999999999 111.563 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -127.12 164.89 20.61 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.016 0.436 . . . . 72.230000000000004 111.353 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.453 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 17.6 m120 -140.05 123.55 17.13 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.233 -0.439 . . . . 73.340000000000003 111.127 176.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 56' ' ' GLU . 62.7 tp -96.65 104.19 16.16 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.893 0.378 . . . . 70.140000000000001 110.84 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.756 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.4 mmm -94.38 128.8 41.14 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.24 -0.437 . . . . 65.129999999999995 111.237 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -115.13 118.81 34.41 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.942 0.401 . . . . 53.039999999999999 111.962 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.9 t -104.02 114.33 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.155 -0.475 . . . . 71.409999999999997 110.001 171.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -133.67 92.46 2.98 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.924 -0.485 . . . . 71.150000000000006 112.167 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.76 67.72 1.72 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.294 -0.479 . . . . 72.200000000000003 114.249 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 60.64 26.86 16.58 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.72 0.637 . . . . 53.009999999999998 112.72 175.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -149.27 150.66 32.92 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.565 0.346 . . . . 60.409999999999997 110.319 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.8 tt -134.62 151.81 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.191 0.441 . . . . 64.540000000000006 112.191 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -157.18 168.4 27.54 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.202 -0.454 . . . . 74.540000000000006 111.496 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.756 HG12 ' SD ' ' A' ' 45' ' ' MET . 54.4 mt -92.27 110.05 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.47 -0.567 . . . . 72.319999999999993 109.47 169.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -86.37 -39.1 16.75 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 111.841 0.311 . . . . 65.409999999999997 111.841 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 44' ' ' LEU . 10.8 tp10 -138.86 146.95 41.82 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.739 0.304 . . . . 74.040000000000006 110.695 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -168.5 140.15 2.73 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.575 0.35 . . . . 74.0 110.329 -174.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -106.6 38.01 2.18 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.413 0.523 . . . . 74.310000000000002 112.413 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.2 m -84.1 138.5 39.66 Favored Pre-proline 0 N--CA 1.471 0.595 0 O-C-N 122.058 -0.401 . . . . 75.319999999999993 110.016 172.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.54 -25.74 68.51 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.307 2.004 . . . . 74.099999999999994 112.777 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.499 ' HB3' HG23 ' A' ' 63' ' ' VAL . 10.9 m-20 -84.45 -32.38 24.07 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.31 -0.404 . . . . 50.130000000000003 111.957 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.518 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 87.8 mm-40 59.54 13.48 3.34 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.136 0.791 . . . . 73.430000000000007 113.136 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 61' ' ' ASP . 97.0 t -56.15 -41.34 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 112.479 0.548 . . . . 72.519999999999996 112.479 -176.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.48 -42.48 57.46 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.191 -0.528 . . . . 73.010000000000005 113.51 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.2 t -68.82 -33.59 60.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.189 0.519 . . . . 62.229999999999997 111.333 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.518 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 13.4 mptt -73.15 -28.12 62.05 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.313 0.486 . . . . 64.219999999999999 112.313 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.43 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 90.7 mmm -52.76 -47.17 67.64 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.342 0.497 . . . . 63.340000000000003 112.342 -177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.42 -163.94 20.0 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.054 -0.593 . . . . 72.150000000000006 113.416 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -76.48 138.94 40.6 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.029 0.443 . . . . 70.409999999999997 112.014 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -126.69 146.55 50.16 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.28 -0.418 . . . . 55.109999999999999 110.639 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 82.2 p -172.2 26.42 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 112.724 0.638 . . . . 50.149999999999999 112.724 -176.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -125.16 146.39 49.51 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.686 0.279 . . . . 70.299999999999997 111.32 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.15 96.65 0.05 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.079 0.466 . . . . 74.299999999999997 111.65 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 138.14 -19.7 3.24 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 116.093 -0.503 . . . . 72.040000000000006 112.918 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -63.96 120.16 11.45 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.108 0.48 . . . . 75.129999999999995 111.588 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 87' ' ' GLU . 32.5 p -128.96 141.92 51.1 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.077 0.465 . . . . 71.329999999999998 111.421 178.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 mm -122.58 127.64 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 116.269 -0.423 . . . . 55.020000000000003 110.687 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.6 t -119.71 119.32 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.836 0.35 . . . . 71.409999999999997 111.48 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 98.3 m -117.62 88.2 2.86 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.841 0.353 . . . . 73.439999999999998 110.6 173.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.512 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 96.2 mt -54.46 -50.83 83.01 Favored Pre-proline 0 CA--C 1.547 0.827 0 N-CA-C 113.314 0.857 . . . . 73.120000000000005 113.314 -175.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.512 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 75.5 Cg_exo -50.41 -34.52 41.74 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.156 1.904 . . . . 63.149999999999999 113.634 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -103.42 -3.92 24.79 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 111.976 0.361 . . . . 72.340000000000003 111.976 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.5 mttp 59.85 33.99 21.71 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.134 0.492 . . . . 44.399999999999999 112.276 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.7 t -101.12 133.18 45.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 116.218 -0.446 . . . . 74.530000000000001 111.084 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -130.58 125.61 34.61 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.079 -0.51 . . . . 62.140000000000001 110.689 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.436 HG22 HG13 ' A' ' 12' ' ' ILE . 47.7 t -118.19 124.1 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.68 -0.236 . . . . 75.430000000000007 111.183 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.477 ' HA ' HG22 ' A' ' 76' ' ' THR . 8.9 pt-20 -120.9 122.15 39.6 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.094 0.473 . . . . 74.310000000000002 111.467 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.9 mt -97.07 118.16 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 120.98 0.419 . . . . 72.540000000000006 110.537 175.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -129.53 150.18 50.98 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.114 0.483 . . . . 74.450000000000003 112.122 -173.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.6 t -77.48 150.51 34.9 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.925 -0.58 . . . . 54.43 112.448 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.2 p -85.13 0.18 52.51 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.899 -0.591 . . . . 73.310000000000002 111.315 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 121.458 0.647 . . . . 74.409999999999997 111.508 176.804 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.513 ' HA ' ' HB ' ' A' ' 25' ' ' THR . 46.0 mt-10 . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 120.784 0.326 . . . . 61.530000000000001 111.757 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.446 HG22 ' OG1' ' A' ' 25' ' ' THR . 32.7 m -111.3 151.03 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.073 0.463 . . . . 60.329999999999998 111.755 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 23' ' ' PRO . 27.4 m -129.46 141.39 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.168 -0.469 . . . . 64.510000000000005 111.488 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.89 115.27 27.08 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.444 -0.344 . . . . 52.539999999999999 111.243 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.4 mm -96.42 112.2 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.866 0.365 . . . . 71.109999999999999 111.098 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.544 HG13 HG22 ' A' ' 86' ' ' VAL . 2.7 mp -99.19 114.5 37.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 120.972 0.415 . . . . 71.439999999999998 111.303 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.0 m -113.07 139.71 48.47 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.798 0.333 . . . . 72.040000000000006 111.231 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.473 HE21 ' HA2' ' A' ' 37' ' ' GLY . 57.5 tt0 -128.9 135.45 49.07 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.587 -0.278 . . . . 75.530000000000001 111.2 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 57.01 10.27 0.76 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.981 0.734 . . . . 75.109999999999999 112.981 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.07 -6.5 28.97 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 121.256 -0.497 . . . . 73.439999999999998 113.882 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -112.76 145.08 41.2 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 117.13 0.465 . . . . 71.530000000000001 111.571 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.37 119.6 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 110.059 -0.349 . . . . 75.409999999999997 110.059 173.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.4 pt -108.51 -19.53 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 113.465 0.913 . . . . 75.140000000000001 113.465 -173.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -168.87 141.29 2.71 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.747 0.647 . . . . 72.319999999999993 112.747 -177.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -123.42 130.91 53.39 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.391 -0.368 . . . . 72.430000000000007 110.535 174.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.472 HG21 HG21 ' A' ' 47' ' ' VAL . 3.9 mp -121.24 124.43 27.32 Favored Pre-proline 0 N--CA 1.478 0.972 0 O-C-N 121.966 -0.459 . . . . 63.140000000000001 111.72 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.514 ' HA ' HG12 ' A' ' 9' ' ' VAL . 59.0 Cg_endo -73.24 121.22 7.04 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.418 2.079 . . . . 65.310000000000002 112.068 173.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.7 mt -92.96 -60.08 1.89 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.192 0.52 . . . . 62.539999999999999 111.796 -176.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.513 ' HB ' ' HA ' ' A' ' 7' ' ' GLU . 25.1 m -58.05 128.0 34.9 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.327 0.492 . . . . 75.299999999999997 112.327 -176.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.98 1.12 72.04 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 121.357 -0.449 . . . . 72.510000000000005 113.922 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -84.91 105.13 15.45 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.595 -0.356 . . . . 72.400000000000006 111.579 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.534 ' HB2' ' NZ ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -85.77 137.58 32.69 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.927 0.394 . . . . 70.349999999999994 110.913 175.226 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.86 178.89 22.19 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.173 -0.537 . . . . 65.430000000000007 113.572 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -118.46 139.63 51.11 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.907 0.384 . . . . 62.420000000000002 110.965 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -138.9 124.51 19.54 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.256 -0.429 . . . . 74.209999999999994 110.604 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.457 ' HG2' ' HA ' ' A' ' 46' ' ' GLU . 75.3 mt-30 -131.7 148.69 52.6 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.94 0.4 . . . . 73.230000000000004 112.003 -176.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -154.64 147.71 24.71 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.104 -0.498 . . . . 62.310000000000002 111.21 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.7 m -101.19 136.85 40.37 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.899 0.38 . . . . 71.409999999999997 111.528 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.524 ' HB ' ' HB3' ' A' ' 43' ' ' ASN . 58.4 mt -113.7 102.32 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.495 -0.32 . . . . 71.439999999999998 111.419 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -76.27 107.04 8.23 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.773 0.32 . . . . 70.510000000000005 111.141 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.473 ' HA2' HE21 ' A' ' 14' ' ' GLN . . . -89.03 -133.81 4.88 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.374 -0.441 . . . . 54.340000000000003 113.438 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.03 115.27 15.56 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.528 -0.396 . . . . 54.340000000000003 110.697 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.37 -136.72 25.26 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.266 -0.492 . . . . 71.019999999999996 113.135 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.16 3.65 34.06 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.161 0.505 . . . . 74.239999999999995 111.279 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.542 ' HB3' ' CD2' ' A' ' 82' ' ' HIS . 97.2 mt-30 -73.07 83.78 1.29 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.194 0.521 . . . . 65.349999999999994 111.795 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -89.92 165.44 14.09 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.063 -0.517 . . . . 74.319999999999993 111.406 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.524 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . 57.7 t30 -132.7 110.13 10.18 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.311 -0.404 . . . . 74.430000000000007 109.93 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.3 tp -95.52 103.82 15.71 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.382 0.61 . . . . 61.340000000000003 111.612 -176.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.65 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.1 mmm -93.93 141.61 28.32 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.374 -0.83 . . . . 64.099999999999994 111.76 -175.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.457 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 44.7 tt0 -127.07 119.65 27.07 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.99 0.424 . . . . 75.319999999999993 111.7 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.472 HG21 HG21 ' A' ' 22' ' ' ILE . 59.4 t -105.53 107.29 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.209 -0.451 . . . . 70.540000000000006 110.584 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.522 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 34.8 t70 -109.98 101.56 10.37 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.118 0.485 . . . . 52.200000000000003 110.848 -178.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.18 -109.68 3.04 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 120.784 -0.722 . . . . 53.32 112.886 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -108.14 19.16 20.29 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.852 0.358 . . . . 75.129999999999995 111.794 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 35.3 ptt180 -136.4 147.07 47.11 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.791 0.329 . . . . 73.329999999999998 111.507 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.3 tt -132.37 142.6 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-O 120.868 0.365 . . . . 74.140000000000001 111.719 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.51 ' HB3' ' HA ' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -160.67 168.8 24.14 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.849 0.357 . . . . 64.530000000000001 111.461 177.441 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.65 HG12 ' SD ' ' A' ' 45' ' ' MET . 71.6 mt -91.62 124.57 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.432 -0.349 . . . . 75.129999999999995 111.065 176.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -94.86 -33.16 12.93 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.865 0.364 . . . . 65.209999999999994 111.406 177.434 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -143.47 139.95 30.12 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.746 0.308 . . . . 72.430000000000007 110.748 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -168.07 145.76 4.3 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.991 0.425 . . . . 74.010000000000005 112.023 -173.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -109.79 51.06 0.77 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.081 -0.509 . . . . 70.230000000000004 111.954 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.463 ' HG ' ' CD2' ' A' ' 82' ' ' HIS . 31.4 m -107.05 121.81 43.56 Favored Pre-proline 0 N--CA 1.472 0.667 0 O-C-N 122.063 -0.398 . . . . 72.400000000000006 110.192 172.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.28 -30.82 73.91 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.436 2.091 . . . . 71.129999999999995 112.582 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.68 -36.5 67.91 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.693 -0.685 . . . . 75.510000000000005 111.712 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 59.26 16.76 5.19 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.041 0.756 . . . . 73.310000000000002 113.041 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 65.6 t -55.36 -51.61 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 N-CA-C 112.07 0.396 . . . . 72.030000000000001 112.07 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -56.98 -38.66 86.48 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.223 -0.513 . . . . 32.130000000000003 113.271 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 42.1 t -67.46 -43.77 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.991 0.424 . . . . 74.420000000000002 111.295 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.22 -27.16 68.87 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.031 -0.531 . . . . 74.329999999999998 112.112 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 14.3 mmt -50.45 -35.23 27.88 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.453 0.538 . . . . 73.540000000000006 112.453 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.05 -159.87 50.91 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.136 -0.554 . . . . 73.019999999999996 113.625 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.51 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . 89.1 m95 -70.82 114.71 9.17 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 111.968 0.359 . . . . 53.119999999999997 111.968 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 34.9 mmtp -105.78 150.65 25.35 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.68 -0.237 . . . . 73.349999999999994 110.619 175.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.437 ' O ' HG21 ' A' ' 8' ' ' VAL . 92.7 p -159.56 -26.83 0.07 Allowed 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.163 0.801 . . . . 70.439999999999998 113.163 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm -82.28 155.96 24.56 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.276 0.56 . . . . 74.450000000000003 112.264 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.51 110.74 3.26 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.108 -0.496 . . . . 54.439999999999998 110.675 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 121.71 -23.83 7.34 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.982 -0.447 . . . . 63.140000000000001 111.982 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.487 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 78.4 m-20 -65.41 129.23 38.99 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.87 0.367 . . . . 74.310000000000002 110.783 176.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.476 HG22 ' HA ' ' A' ' 87' ' ' GLU . 41.2 p -128.81 164.38 23.16 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.018 0.747 . . . . 54.509999999999998 113.018 -176.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.554 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 39.6 mm -128.15 125.63 64.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.063 -0.971 . . . . 73.099999999999994 109.735 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.8 t -117.32 117.59 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 112.291 0.478 . . . . 54.399999999999999 112.291 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 75.1 m -119.16 80.79 1.61 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.061 0.458 . . . . 71.420000000000002 110.65 174.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.442 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 76.3 mt -52.54 -59.91 7.63 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 113.597 0.962 . . . . 71.430000000000007 113.597 -174.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 38.9 Cg_endo -66.86 -9.5 24.98 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 121.917 1.744 . . . . 74.129999999999995 112.98 -176.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.542 ' CD2' ' HB3' ' A' ' 41' ' ' GLN . 24.3 m170 -104.49 -10.94 17.31 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.517 -0.31 . . . . 74.129999999999995 111.343 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.4 mttp 59.82 27.06 16.31 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.052 0.453 . . . . 71.120000000000005 112.032 -176.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.4 t -104.14 124.44 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.028 -0.533 . . . . 75.329999999999998 110.782 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -130.27 118.01 20.68 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.069 0.462 . . . . 70.030000000000001 111.119 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.554 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 35.9 t -107.76 124.62 63.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.136 -0.484 . . . . 33.439999999999998 110.858 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.476 ' HA ' HG22 ' A' ' 76' ' ' THR . 14.5 pt-20 -124.3 126.76 46.59 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.998 0.427 . . . . 73.230000000000004 111.58 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 63.5 mt -89.48 112.71 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 121.093 0.473 . . . . 64.310000000000002 110.984 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -116.63 152.36 34.36 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.24 -0.436 . . . . 73.439999999999998 111.25 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.9 t -89.41 124.93 34.92 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.946 0.403 . . . . 62.140000000000001 111.966 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.1 p -66.27 -28.38 68.66 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.295 0.569 . . . . 71.109999999999999 110.507 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 . . . . . 0 CA--C 1.533 0.312 0 CA-C-N 115.715 -0.675 . . . . 54.340000000000003 109.67 174.221 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.492 ' HG2' HG21 ' A' ' 25' ' ' THR . 29.6 mt-10 . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 112.365 0.506 . . . . 74.450000000000003 112.365 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 27.8 m -130.72 159.24 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.426 0.528 . . . . 75.299999999999997 112.426 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 23' ' ' PRO . 23.3 m -131.56 147.05 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 115.928 -0.578 . . . . 65.239999999999995 111.171 178.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.62 115.14 26.93 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.45 -0.341 . . . . 43.009999999999998 111.309 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.441 HD12 ' OE2' ' A' ' 21' ' ' GLU . 18.2 mm -99.47 104.8 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.831 0.348 . . . . 65.310000000000002 111.397 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 12' ' ' ILE . 3.3 mp -96.22 120.08 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.194 0.521 . . . . 61.329999999999998 111.257 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.6 m -121.94 144.36 48.91 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.087 -0.506 . . . . 70.329999999999998 111.31 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.412 ' HG3' HG22 ' A' ' 84' ' ' VAL . 59.3 tt0 -135.67 141.82 45.05 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.551 -0.295 . . . . 73.409999999999997 110.733 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 59.21 17.4 5.66 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 111.956 0.354 . . . . 64.319999999999993 111.956 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.69 -9.75 62.34 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 121.409 -0.424 . . . . 61.409999999999997 113.683 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -116.4 145.65 43.08 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 117.296 0.548 . . . . 64.219999999999999 111.657 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.7 t -71.99 128.33 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 120.942 0.401 . . . . 75.200000000000003 111.147 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.626 HD11 HD13 ' A' ' 35' ' ' ILE . 33.9 pt -112.17 -26.59 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.64 0.607 . . . . 75.129999999999995 112.64 -177.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -159.55 133.34 7.33 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.236 0.458 . . . . 70.530000000000001 112.236 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.441 ' OE2' HD12 ' A' ' 11' ' ' ILE . 44.8 mt-10 -124.94 115.49 20.67 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.683 0.277 . . . . 75.310000000000002 110.802 177.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.2 mp -104.22 129.86 24.38 Favored Pre-proline 0 N--CA 1.475 0.798 0 N-CA-C 111.852 0.316 . . . . 74.409999999999997 111.852 -175.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.562 ' HA ' HG12 ' A' ' 9' ' ' VAL . 67.7 Cg_endo -74.62 111.61 3.36 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.356 2.037 . . . . 71.450000000000003 112.194 171.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.63 -62.26 1.7 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.978 0.418 . . . . 51.399999999999999 111.749 -176.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.568 ' HA ' ' HG2' ' A' ' 50' ' ' GLU . 51.3 m -63.03 118.57 8.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.992 0.425 . . . . 72.540000000000006 112.07 -177.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.35 -15.73 55.92 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 116.154 -0.476 . . . . 61.32 112.81 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -77.11 79.13 3.64 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.19 0.519 . . . . 75.209999999999994 110.978 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.444 ' HB2' ' NZ ' ' A' ' 28' ' ' LYS . 10.4 mtmp? -75.18 105.1 6.03 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.291 0.567 . . . . 54.530000000000001 111.304 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.77 -169.63 24.31 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 115.971 -0.558 . . . . 71.219999999999999 112.655 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -117.84 148.0 42.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.841 0.353 . . . . 73.430000000000007 110.679 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -154.14 129.15 9.54 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.795 0.331 . . . . 72.519999999999996 111.671 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -124.71 153.65 42.04 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.759 0.314 . . . . 73.25 111.535 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -154.29 140.73 18.75 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.92 0.391 . . . . 61.439999999999998 110.708 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.5 m -108.94 111.93 23.88 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.974 0.416 . . . . 61.149999999999999 112.07 -172.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.626 HD13 HD11 ' A' ' 19' ' ' ILE . 57.8 mt -94.0 105.61 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.263 -0.426 . . . . 75.420000000000002 111.572 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -89.79 110.02 20.97 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.036 0.446 . . . . 64.150000000000006 111.307 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.43 -136.9 9.55 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 116.181 -0.463 . . . . 42.130000000000003 113.778 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -87.76 151.25 23.04 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.03 0.382 . . . . 74.400000000000006 112.03 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.79 36.74 92.44 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 116.098 -0.501 . . . . 71.0 113.479 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 61.99 10.72 3.78 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.388 0.514 . . . . 72.0 112.388 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.549 ' HA ' ' HB3' ' A' ' 58' ' ' ASN . 26.3 mt-30 -82.55 107.02 14.89 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.089 0.403 . . . . 71.420000000000002 112.089 -176.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -104.88 153.18 21.7 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 111.981 0.363 . . . . 63.399999999999999 111.981 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -111.72 130.23 55.85 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.998 -0.546 . . . . 60.450000000000003 110.222 171.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.4 tp -101.85 104.11 14.83 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.873 0.368 . . . . 75.200000000000003 110.925 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.753 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.5 mmm -88.73 141.33 28.6 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.559 -0.292 . . . . 64.409999999999997 111.286 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -136.09 119.01 16.29 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.155 0.502 . . . . 73.140000000000001 111.605 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.9 t -105.85 119.85 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 115.939 -0.573 . . . . 72.310000000000002 110.699 177.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -117.44 90.74 3.4 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.163 0.506 . . . . 74.420000000000002 110.206 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.97 -116.57 5.07 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.755 -0.736 . . . . 42.030000000000001 112.352 -174.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.568 ' HG2' ' HA ' ' A' ' 25' ' ' THR . 40.6 mt-10 -95.13 -15.17 23.56 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.036 0.446 . . . . 71.129999999999995 111.806 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.558 ' HA ' ' HB3' ' A' ' 71' ' ' SER . 26.7 ptt180 -97.74 135.29 39.73 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.993 0.425 . . . . 62.520000000000003 111.371 -176.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.6 tt -123.89 143.82 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.126 0.489 . . . . 73.329999999999998 111.463 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -144.96 169.21 18.52 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.32 -0.4 . . . . 62.549999999999997 110.709 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.753 HG12 ' SD ' ' A' ' 45' ' ' MET . 42.7 mt -96.93 122.17 48.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.351 -0.611 . . . . 75.120000000000005 109.351 167.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -86.67 -32.39 20.55 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.503 0.557 . . . . 70.120000000000005 112.503 -172.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -162.09 138.68 8.0 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.681 0.277 . . . . 64.140000000000001 111.383 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -133.04 144.61 50.15 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.313 0.578 . . . . 74.329999999999998 111.816 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.549 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . 48.5 t-20 -81.47 72.17 8.5 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.921 -1.14 . . . . 72.510000000000005 107.921 163.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.431 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 69.1 m -135.98 130.45 18.51 Favored Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 115.634 -0.712 . . . . 73.200000000000003 111.373 -174.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 59' ' ' SER . 26.8 Cg_exo -63.35 -27.66 71.51 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.79 2.327 . . . . 52.130000000000003 112.315 178.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.427 ' O ' ' HE2' ' A' ' 66' ' ' LYS . 4.3 m-20 -97.3 -15.47 20.75 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.68 -0.691 . . . . 60.450000000000003 112.15 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 27.0 mm-40 52.6 34.04 14.89 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.393 0.516 . . . . 70.430000000000007 112.393 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.9 t -53.35 -51.29 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 112.914 0.709 . . . . 73.200000000000003 112.914 -174.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -56.43 -55.06 31.63 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.149 -0.548 . . . . 51.340000000000003 113.373 -177.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.2 t -52.75 -41.81 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 111.914 0.339 . . . . 65.230000000000004 111.914 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 61' ' ' ASP . 67.9 mttm -64.29 -30.82 71.85 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 111.963 0.357 . . . . 70.310000000000002 111.963 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.8 mmt -61.2 -40.45 93.99 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.269 0.47 . . . . 72.450000000000003 112.269 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.45 -153.55 39.16 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.121 -0.562 . . . . 62.149999999999999 113.737 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -81.73 130.79 35.18 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.179 0.437 . . . . 71.409999999999997 112.179 -176.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HG3' HD11 ' A' ' 77' ' ' ILE . 75.4 mmtt -127.73 150.17 49.91 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.142 -0.481 . . . . 74.0 110.645 175.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.558 ' HB3' ' HA ' ' A' ' 51' ' ' ARG . 89.1 p -173.68 22.94 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.905 0.706 . . . . 52.439999999999998 112.905 -178.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -90.46 162.33 15.12 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.081 -0.387 . . . . 72.319999999999993 110.163 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.65 32.83 0.11 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 112.133 0.42 . . . . 45.130000000000003 112.133 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -177.24 29.4 0.07 OUTLIER Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.385 -0.436 . . . . 74.310000000000002 113.312 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -86.8 146.77 26.11 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.968 0.413 . . . . 72.239999999999995 111.243 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.6 p -133.81 141.33 47.41 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.061 0.458 . . . . 61.450000000000003 111.604 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.531 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 45.5 mm -125.2 109.64 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.341 -0.39 . . . . 73.030000000000001 110.417 177.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.04 116.6 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.067 0.46 . . . . 72.219999999999999 111.822 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 91.5 m -120.98 79.75 1.55 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.382 -0.372 . . . . 72.310000000000002 111.067 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.503 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 96.2 mt -57.13 -48.17 97.86 Favored Pre-proline 0 CA--C 1.55 0.958 0 N-CA-C 112.825 0.676 . . . . 71.409999999999997 112.825 -177.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 76.7 Cg_exo -51.42 -25.15 17.98 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 122.215 1.943 . . . . 64.230000000000004 113.613 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.527 ' NE2' ' HB3' ' A' ' 41' ' ' GLN . 16.0 m170 -111.52 -4.26 14.86 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.035 -0.416 . . . . 63.240000000000002 111.735 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 58.33 34.41 24.01 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.285 0.564 . . . . 74.140000000000001 111.782 -176.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.412 HG22 ' HG3' ' A' ' 14' ' ' GLN . 60.4 t -110.43 134.71 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 115.714 -0.675 . . . . 71.510000000000005 111.326 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -131.19 130.04 42.47 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.836 0.351 . . . . 71.120000000000005 110.885 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 50.3 t -119.23 120.62 64.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.717 0.294 . . . . 70.430000000000007 111.487 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -111.13 136.97 49.39 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 110.451 -0.203 . . . . 72.129999999999995 110.451 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.3 mt -105.61 112.17 37.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.985 0.421 . . . . 54.009999999999998 110.575 175.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -118.11 159.35 23.4 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.28 -0.418 . . . . 74.129999999999995 110.91 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 45.3 t -79.91 145.44 32.67 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.918 0.389 . . . . 75.209999999999994 111.444 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.8 p -67.75 -28.31 67.52 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.429 0.633 . . . . 75.420000000000002 110.265 174.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 . . . . . 0 CA--C 1.546 0.815 0 CA-C-N 114.934 -1.03 . . . . 72.109999999999999 110.749 179.151 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 CA--C 1.542 0.669 0 N-CA-C 113.06 0.763 . . . . 73.129999999999995 113.06 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 33.9 m -126.27 148.02 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.022 0.439 . . . . 74.230000000000004 111.055 173.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 23' ' ' PRO . 33.8 m -127.27 151.78 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.938 0.399 . . . . 63.350000000000001 111.679 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.77 118.21 36.45 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.112 -0.495 . . . . 62.130000000000003 110.878 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 31.0 mm -95.26 108.79 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 120.83 0.347 . . . . 74.439999999999998 110.992 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.2 mp -95.17 111.51 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 120.937 0.399 . . . . 73.129999999999995 111.123 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.9 p -113.7 147.19 38.63 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.971 0.415 . . . . 74.230000000000004 111.236 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -143.88 139.34 29.17 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.286 -0.416 . . . . 72.319999999999993 110.284 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 62.19 13.59 5.97 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.089 0.403 . . . . 62.329999999999998 112.089 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.02 -16.67 46.05 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 121.199 -0.524 . . . . 73.340000000000003 113.956 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.79 150.1 33.95 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 122.294 -0.533 . . . . 71.430000000000007 111.693 -178.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.77 120.92 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.412 -0.358 . . . . 62.439999999999998 110.834 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.0 pt -99.71 -27.96 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 112.102 0.408 . . . . 65.349999999999994 112.102 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.1 tpp85 -157.82 143.51 17.18 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 122.09 -0.381 . . . . 73.239999999999995 111.601 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -128.36 113.51 15.68 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.676 0.274 . . . . 73.019999999999996 110.871 176.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.53 HG21 HG21 ' A' ' 47' ' ' VAL . 3.0 mp -107.39 119.66 50.08 Favored Pre-proline 0 N--CA 1.473 0.722 0 O-C-N 122.27 -0.269 . . . . 71.349999999999994 111.632 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 22.0 Cg_exo -66.03 123.46 11.3 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.366 2.044 . . . . 74.530000000000001 111.781 172.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.2 mt -87.13 -54.55 4.26 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.158 0.504 . . . . 71.439999999999998 111.447 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.447 ' OG1' HG22 ' A' ' 8' ' ' VAL . 29.1 m -63.1 107.34 1.01 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.039 0.447 . . . . 73.349999999999994 111.764 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.41 ' H ' ' HG2' ' A' ' 50' ' ' GLU . . . 94.13 11.17 57.8 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.266 -0.493 . . . . 62.229999999999997 113.081 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.533 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 52.0 t-80 -72.98 87.12 1.33 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.08 0.467 . . . . 71.549999999999997 111.154 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -53.8 131.8 40.28 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.884 0.698 . . . . 72.230000000000004 112.884 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.38 -161.94 49.02 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 115.931 -0.577 . . . . 73.310000000000002 114.501 175.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -118.68 141.98 48.09 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.952 0.501 . . . . 71.329999999999998 109.91 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -142.91 125.08 15.38 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 122.25 -0.282 . . . . 72.400000000000006 111.626 -175.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -117.83 129.85 55.91 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.668 -0.242 . . . . 74.450000000000003 111.459 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -136.69 143.22 43.27 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.244 0.545 . . . . 74.349999999999994 111.795 176.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.0 m -101.8 121.52 42.24 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.979 -0.555 . . . . 53.43 111.921 -175.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 54.1 mt -92.86 104.94 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.529 -0.305 . . . . 63.119999999999997 110.451 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -101.16 113.8 27.16 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.956 0.407 . . . . 70.420000000000002 111.884 -176.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.8 -65.46 1.44 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.299 -0.476 . . . . 63.450000000000003 112.551 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -141.39 87.62 2.09 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.543 -0.387 . . . . 71.219999999999999 111.438 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.45 -86.82 0.01 OUTLIER Glycine 0 CA--C 1.53 1.017 0 N-CA-C 114.196 0.438 . . . . 63.329999999999998 114.196 177.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.41 -22.26 44.53 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.007 0.432 . . . . 73.420000000000002 111.612 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -82.56 95.37 7.73 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.235 -0.291 . . . . 75.209999999999994 110.904 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -144.59 160.74 40.66 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.354 0.502 . . . . 72.549999999999997 112.354 -177.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -129.75 144.71 51.43 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.022 -0.536 . . . . 72.409999999999997 110.605 174.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.8 tp -114.12 107.34 15.5 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.989 0.423 . . . . 54.329999999999998 111.025 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.758 ' SD ' HG12 ' A' ' 54' ' ' ILE . 84.2 mmm -94.6 140.11 30.29 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.179 -0.464 . . . . 70.349999999999994 111.351 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -130.58 120.86 24.65 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.985 0.421 . . . . 74.0 111.324 176.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.53 HG21 HG21 ' A' ' 22' ' ' ILE . 36.0 t -105.0 108.73 25.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.122 -0.49 . . . . 71.450000000000003 110.731 176.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -109.31 105.75 15.29 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.965 0.412 . . . . 64.239999999999995 110.338 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.533 ' O ' ' HB3' ' A' ' 27' ' ' HIS . . . 58.16 -114.98 6.34 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.837 -0.697 . . . . 65.510000000000005 113.048 -177.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' A' ' 26' ' ' GLY . 34.6 mt-10 -106.17 35.56 2.89 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.882 0.372 . . . . 70.129999999999995 111.649 -177.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -155.13 144.65 21.27 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.933 0.397 . . . . 73.140000000000001 111.444 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 tt -129.41 147.1 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 112.007 0.373 . . . . 52.130000000000003 112.007 -175.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.401 ' HD3' ' CE2' ' A' ' 69' ' ' TRP . 22.5 ptt180 -150.84 169.29 22.05 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.106 0.479 . . . . 63.350000000000001 111.428 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.758 HG12 ' SD ' ' A' ' 45' ' ' MET . 43.6 mt -105.6 116.29 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 116.282 -0.417 . . . . 71.129999999999995 110.756 173.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.476 ' NZ ' ' HB3' ' A' ' 55' ' ' LYS . 8.5 mtpm? -78.53 -40.4 35.2 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.269 0.557 . . . . 70.439999999999998 111.722 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -137.97 143.89 40.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.943 -0.571 . . . . 72.129999999999995 111.021 -173.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -161.0 126.14 3.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.384 0.611 . . . . 75.510000000000005 110.558 -178.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -100.89 67.95 1.25 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.589 -0.732 . . . . 61.530000000000001 110.813 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 53.4 p -129.97 150.99 77.49 Favored Pre-proline 0 N--CA 1.474 0.749 0 CA-C-N 116.294 -0.412 . . . . 73.319999999999993 111.105 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -63.88 -28.73 67.29 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.651 2.234 . . . . 71.439999999999998 112.752 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.47 ' HB3' HG23 ' A' ' 63' ' ' VAL . 5.1 m-20 -80.67 -36.91 31.76 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.876 -0.602 . . . . 73.430000000000007 112.513 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 63.69 20.59 12.3 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.341 0.497 . . . . 64.010000000000005 112.341 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 61' ' ' ASP . 64.6 t -59.76 -39.77 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 112.082 0.401 . . . . 64.329999999999998 112.082 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.93 -56.19 19.91 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.2 -0.454 . . . . 74.430000000000007 113.714 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.99 -38.06 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 O-C-N 122.66 -0.318 . . . . 61.200000000000003 111.683 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -59.79 -28.47 67.46 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.22 0.452 . . . . 61.439999999999998 112.22 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 23.0 mmt -57.56 -36.16 71.29 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.333 0.494 . . . . 54.439999999999998 112.333 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.87 -149.21 42.66 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.271 -0.49 . . . . 42.43 113.82 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.401 ' CE2' ' HD3' ' A' ' 53' ' ' ARG . 92.4 m95 -82.37 120.7 25.77 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.872 0.367 . . . . 71.319999999999993 111.964 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.671 ' HG3' HD11 ' A' ' 77' ' ' ILE . 75.2 mmtt -109.4 157.95 18.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.586 0.354 . . . . 61.130000000000003 110.925 175.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 88.0 p -163.76 -28.65 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.871 0.693 . . . . 61.350000000000001 112.871 -175.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -81.93 141.6 33.18 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.003 0.43 . . . . 72.230000000000004 112.094 -175.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.09 94.5 0.11 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.343 0.592 . . . . 74.150000000000006 110.704 175.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.7 -22.83 1.32 Allowed Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.908 -0.587 . . . . 43.130000000000003 112.139 -174.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.518 ' HB2' HD12 ' A' ' 88' ' ' ILE . 78.3 m-20 -62.84 123.95 19.78 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.942 0.401 . . . . 64.109999999999999 111.127 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.5 p -117.53 142.57 47.01 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.24 0.543 . . . . 70.409999999999997 112.01 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.671 HD11 ' HG3' ' A' ' 70' ' ' LYS . 29.8 mm -119.5 117.57 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.734 -0.666 . . . . 74.349999999999994 110.212 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.1 t -108.76 116.51 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 111.974 0.361 . . . . 72.140000000000001 111.974 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 70.9 m -122.15 71.21 0.99 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.933 0.396 . . . . 65.239999999999995 111.024 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.537 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 94.5 mt -55.39 -49.3 93.31 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 112.93 0.715 . . . . 63.049999999999997 112.93 -177.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 51.1 Cg_exo -56.28 -17.38 20.51 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.274 1.983 . . . . 72.0 113.7 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -114.75 -0.07 13.67 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.122 -0.361 . . . . 73.150000000000006 111.959 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 60.12 29.27 18.86 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.761 0.425 . . . . 52.329999999999998 111.955 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.28 135.82 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.919 0.39 . . . . 75.219999999999999 111.396 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -139.91 125.16 18.85 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.329 -0.396 . . . . 73.129999999999995 110.944 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 52.7 t -123.31 120.41 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 120.778 0.323 . . . . 72.129999999999995 111.341 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -122.38 144.44 49.03 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.956 0.408 . . . . 74.030000000000001 111.369 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 75' ' ' ASP . 60.1 mt -97.84 136.53 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.047 0.451 . . . . 62.030000000000001 111.515 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -149.81 150.54 32.14 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.343 -0.39 . . . . 71.430000000000007 111.189 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 46.1 t -78.53 150.68 32.81 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.326 0.491 . . . . 75.0 112.326 -178.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.3 p -68.52 -20.17 64.56 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.192 0.52 . . . . 72.510000000000005 111.298 175.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 . . . . . 0 CA--C 1.541 0.601 0 CA-C-N 115.728 -0.669 . . . . 53.32 111.323 -175.574 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.474 ' HB2' ' OG1' ' A' ' 91' ' ' THR . 40.8 mt-10 . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 112.429 0.529 . . . . 75.530000000000001 112.429 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.46 143.86 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.177 -0.465 . . . . 75.129999999999995 111.172 173.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 23' ' ' PRO . 31.0 m -125.07 141.84 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 120.962 0.411 . . . . 71.219999999999999 111.372 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.73 120.47 37.12 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.837 0.351 . . . . 62.109999999999999 111.564 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 17.8 mm -99.89 110.85 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.364 -0.38 . . . . 71.209999999999994 110.87 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.528 ' HA ' HG22 ' A' ' 86' ' ' VAL . 3.2 mp -95.59 119.38 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.025 0.441 . . . . 73.219999999999999 111.917 -177.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.4 t -121.27 139.12 53.82 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.095 0.474 . . . . 74.109999999999999 111.327 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.471 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 47.9 tt0 -121.24 116.95 25.85 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.385 -0.371 . . . . 74.129999999999995 110.686 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.42 ' OD1' ' HG2' ' A' ' 14' ' ' GLN . 22.4 m120 61.76 2.61 0.75 Allowed 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.574 0.583 . . . . 74.120000000000005 112.574 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.86 -6.55 8.93 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.113 -0.565 . . . . 62.229999999999997 113.865 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -108.85 126.5 53.11 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 117.43 0.615 . . . . 71.5 111.414 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.6 t -70.52 112.04 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.124 0.488 . . . . 75.349999999999994 110.852 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.6 pt -102.44 -23.43 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 112.712 0.634 . . . . 72.129999999999995 112.712 -175.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -152.57 136.47 16.3 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.666 0.269 . . . . 73.239999999999995 111.641 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -130.66 114.96 16.05 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.759 0.314 . . . . 73.510000000000005 110.374 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.4 mt -115.38 124.43 30.12 Favored Pre-proline 0 N--CA 1.472 0.636 0 N-CA-C 112.111 0.411 . . . . 75.420000000000002 112.111 -175.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.516 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 60.4 Cg_endo -72.66 112.37 3.47 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.239 1.96 . . . . 72.010000000000005 111.758 173.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.9 mt -77.22 -57.1 4.02 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.959 0.409 . . . . 71.219999999999999 111.544 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 m -62.46 122.85 16.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.947 0.403 . . . . 74.219999999999999 111.601 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.16 -11.77 71.28 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.104 -0.57 . . . . 71.129999999999995 112.792 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.516 ' HB2' ' O ' ' A' ' 23' ' ' PRO . 58.5 t-80 -67.78 129.04 38.69 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.869 0.366 . . . . 50.43 110.439 177.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.449 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -119.96 136.24 54.61 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 122.021 -0.424 . . . . 75.310000000000002 111.294 -177.385 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.34 -172.2 33.02 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.494 -0.384 . . . . 73.140000000000001 112.788 -177.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -116.9 127.38 54.2 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 122.351 -0.499 . . . . 61.130000000000003 110.208 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -124.61 117.02 23.36 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.955 0.407 . . . . 75.150000000000006 111.268 -175.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.551 ' HG2' ' HG3' ' A' ' 46' ' ' GLU . 30.7 mt-30 -115.32 134.99 54.61 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.737 0.303 . . . . 73.510000000000005 111.256 -175.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -145.2 140.25 27.77 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.961 0.41 . . . . 55.420000000000002 110.904 177.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.2 m -104.11 109.34 21.1 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.997 0.427 . . . . 74.030000000000001 111.911 -174.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 62.8 mt -80.51 97.4 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.1 0.476 . . . . 61.299999999999997 111.037 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -82.8 104.01 12.72 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.996 0.427 . . . . 75.129999999999995 111.199 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.471 ' HA2' ' NE2' ' A' ' 14' ' ' GLN . . . -78.83 -146.04 3.18 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.345 -0.455 . . . . 52.100000000000001 113.059 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -76.31 108.61 9.38 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.95 0.405 . . . . 65.120000000000005 111.272 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.51 -129.21 9.41 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.065 -0.588 . . . . 70.420000000000002 113.55 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.96 4.32 23.12 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.303 0.483 . . . . 53.549999999999997 112.303 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -80.9 73.63 7.9 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.145 0.498 . . . . 73.340000000000003 112.232 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -89.53 155.89 18.98 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.964 0.412 . . . . 72.219999999999999 111.793 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.549 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 16.3 m120 -132.14 110.19 10.49 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.219 -0.446 . . . . 73.209999999999994 110.631 173.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.4 tp -83.38 103.22 12.58 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.064 0.459 . . . . 72.310000000000002 110.909 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.807 ' SD ' HG12 ' A' ' 54' ' ' ILE . 85.9 mmm -94.79 139.7 30.91 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.118 -0.492 . . . . 71.430000000000007 111.107 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.551 ' HG3' ' HG2' ' A' ' 32' ' ' GLN . 33.7 tt0 -136.72 118.94 15.55 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.086 0.469 . . . . 51.450000000000003 111.766 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.8 t -100.81 112.88 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.219 -0.446 . . . . 71.340000000000003 110.186 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.555 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 35.6 t70 -108.11 100.36 9.69 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.039 0.447 . . . . 72.430000000000007 110.731 -177.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.78 -110.53 3.31 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.842 -0.694 . . . . 55.409999999999997 112.258 -174.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -114.5 33.26 5.43 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.313 0.578 . . . . 73.209999999999994 111.313 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 14.4 ptt180 -147.56 149.43 32.57 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.08 -0.509 . . . . 73.319999999999993 110.745 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.4 tt -123.29 148.47 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 120.791 0.329 . . . . 51.240000000000002 111.772 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -151.36 168.76 23.8 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.904 0.383 . . . . 74.200000000000003 111.47 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.807 HG12 ' SD ' ' A' ' 45' ' ' MET . 37.1 mt -104.64 118.35 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.842 0.353 . . . . 70.340000000000003 110.093 170.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -83.4 -35.05 25.37 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.452 -0.34 . . . . 72.340000000000003 111.897 -175.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -161.78 138.51 8.27 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.816 0.341 . . . . 64.530000000000001 111.632 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -140.9 178.52 7.3 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.01 0.433 . . . . 61.140000000000001 111.394 175.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -112.6 33.87 4.7 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.36 0.6 . . . . 53.439999999999998 111.461 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.7 m -89.69 146.47 35.6 Favored Pre-proline 0 N--CA 1.472 0.642 0 O-C-N 121.755 -0.591 . . . . 75.109999999999999 110.818 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.24 -32.57 73.4 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.488 2.125 . . . . 73.329999999999998 112.295 179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -96.42 -9.19 30.43 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.021 -0.536 . . . . 64.549999999999997 111.795 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.526 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 23.6 mm-40 57.5 38.51 28.09 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.01 0.433 . . . . 53.43 111.731 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.3 t -52.75 -36.68 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 116.159 -0.473 . . . . 75.349999999999994 112.103 -174.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -58.7 -54.16 40.16 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.053 -0.594 . . . . 60.210000000000001 112.766 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.2 -38.22 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-O 120.896 0.379 . . . . 70.319999999999993 111.895 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.526 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 5.4 mptp? -65.19 -28.44 69.39 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.395 0.516 . . . . 64.219999999999999 112.395 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 25.7 mmt -60.72 -34.83 74.99 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.041 0.386 . . . . 44.509999999999998 112.041 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.25 -144.15 38.77 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 114.391 0.516 . . . . 52.340000000000003 114.391 175.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -84.39 131.95 34.63 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.734 0.642 . . . . 75.420000000000002 112.734 -176.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.43 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 75.3 mmtt -127.2 136.12 51.6 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.941 -0.572 . . . . 74.430000000000007 110.971 177.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.1 p -168.42 17.49 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.307 0.484 . . . . 73.239999999999995 112.307 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -114.77 150.59 35.16 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.773 0.321 . . . . 72.409999999999997 111.116 -177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.28 108.97 0.77 Allowed 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.998 0.427 . . . . 64.129999999999995 110.452 173.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 119.03 -16.71 10.84 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.077 -0.583 . . . . 75.530000000000001 113.299 -178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.43 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 53.4 m-20 -62.41 133.56 55.21 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.152 0.476 . . . . 72.109999999999999 111.551 176.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.8 p -134.24 147.33 50.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.221 0.534 . . . . 60.450000000000003 111.845 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.557 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 41.5 mm -114.73 121.85 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.759 -0.655 . . . . 72.510000000000005 110.3 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.0 t -121.47 117.44 52.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.929 0.395 . . . . 73.200000000000003 111.681 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 97.2 m -116.26 90.03 3.24 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.653 -0.249 . . . . 64.209999999999994 110.618 175.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.568 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 98.0 mt -55.81 -55.52 40.12 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 113.202 0.816 . . . . 74.120000000000005 113.202 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 16.6 Cg_exo -67.4 -7.34 18.82 Favored 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 122.002 1.801 . . . . 71.299999999999997 112.933 -176.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -114.93 -12.75 12.0 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.423 -0.353 . . . . 62.229999999999997 111.355 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.9 mttm 59.16 31.79 21.55 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.934 0.493 . . . . 72.040000000000006 111.947 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.9 t -100.68 133.51 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.223 -0.444 . . . . 51.5 110.978 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -135.84 129.31 32.19 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.925 0.393 . . . . 43.420000000000002 111.053 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.557 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 60.9 t -131.3 113.58 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.476 -0.329 . . . . 55.299999999999997 111.207 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.0 pm0 -108.31 139.96 42.27 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.056 0.455 . . . . 60.509999999999998 111.371 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.8 mt -106.71 119.55 56.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.448 -0.342 . . . . 72.129999999999995 111.463 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.449 ' HE3' ' HB2' ' A' ' 89' ' ' LYS . 19.0 ptmt -118.18 162.38 18.33 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.915 0.388 . . . . 75.120000000000005 111.664 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.1 t -88.21 149.56 23.79 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 116.312 -0.404 . . . . 63.200000000000003 110.95 175.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 7' ' ' GLU . 38.8 p -85.0 -2.72 58.3 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.192 0.441 . . . . 62.450000000000003 112.192 -178.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 121.069 0.462 . . . . 65.430000000000007 111.798 -179.012 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 120.932 0.396 . . . . 74.5 111.995 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.38 160.28 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.08 0.466 . . . . 73.530000000000001 111.933 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 23' ' ' PRO . 35.5 m -135.14 141.47 42.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 122.615 0.366 . . . . 53.420000000000002 111.003 177.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.91 114.61 26.75 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.892 0.377 . . . . 50.109999999999999 111.561 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.0 mm -99.34 113.91 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 120.849 0.357 . . . . 64.109999999999999 111.192 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.512 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.2 mp -100.52 118.04 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.1 0.476 . . . . 74.010000000000005 111.17 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.3 m -121.56 147.75 45.41 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.883 0.373 . . . . 71.519999999999996 111.64 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -138.88 142.99 38.55 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.643 0.259 . . . . 75.510000000000005 110.843 175.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.9 m120 57.6 17.68 4.15 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.271 0.471 . . . . 74.510000000000005 112.271 -177.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.71 18.95 39.03 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.339 -0.457 . . . . 43.530000000000001 113.867 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.466 ' NZ ' ' HB3' ' A' ' 17' ' ' LYS . 0.5 OUTLIER -143.91 144.96 31.96 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.46 0.63 . . . . 75.219999999999999 111.616 177.458 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.0 t -70.03 120.95 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.827 0.346 . . . . 72.409999999999997 111.567 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 37.2 pt -107.94 -15.42 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 112.219 0.452 . . . . 73.549999999999997 112.219 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -170.14 142.53 2.29 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.408 0.283 . . . . 64.209999999999994 110.8 -177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.01 122.93 10.03 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.153 0.501 . . . . 71.510000000000005 111.898 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 22' ' ' ILE . 4.2 mp -117.6 121.54 31.83 Favored Pre-proline 0 N--CA 1.474 0.731 0 CA-C-N 116.431 -0.35 . . . . 51.240000000000002 111.609 -176.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.484 ' HA ' HG12 ' A' ' 9' ' ' VAL . 20.4 Cg_exo -66.52 103.15 0.65 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.169 1.913 . . . . 63.32 111.491 170.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.37 -59.33 4.14 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.409 -0.36 . . . . 72.230000000000004 111.926 -174.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.0 m -53.76 125.93 20.23 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.967 0.413 . . . . 71.209999999999994 111.996 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.01 -21.14 41.45 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.114 -0.565 . . . . 64.120000000000005 113.663 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -86.71 103.96 15.66 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 117.46 0.63 . . . . 74.239999999999995 112.24 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.419 ' HA ' ' HA2' ' A' ' 49' ' ' GLY . 23.7 pttm -86.64 -175.37 5.4 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.185 -0.461 . . . . 73.540000000000006 110.541 174.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.72 -164.13 54.17 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.015 -0.612 . . . . 63.219999999999999 114.072 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -119.26 131.17 55.75 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.959 0.409 . . . . 73.349999999999994 111.508 -176.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.455 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 10.5 tp10 -132.31 114.98 15.05 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.339 -0.391 . . . . 74.219999999999999 110.752 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -118.95 140.64 49.66 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 111.935 0.346 . . . . 75.510000000000005 111.935 -176.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -146.87 152.24 38.38 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.761 0.315 . . . . 61.310000000000002 111.261 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.6 m -113.8 117.63 32.0 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.267 0.556 . . . . 64.409999999999997 112.495 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 71.9 mt -86.38 108.26 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.849 -0.614 . . . . 73.299999999999997 111.079 177.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -92.78 105.15 17.33 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.711 0.291 . . . . 72.329999999999998 111.128 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.5 -66.84 1.19 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.289 -0.482 . . . . 74.120000000000005 114.177 -175.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -164.65 125.62 2.09 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.638 -0.33 . . . . 71.299999999999997 111.335 -176.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.36 -105.7 0.77 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.228 -0.51 . . . . 74.230000000000004 113.2 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.57 -1.18 28.7 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.184 0.439 . . . . 42.229999999999997 112.184 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -84.87 88.73 7.44 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.077 0.465 . . . . 64.319999999999993 112.008 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.441 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 47.8 p90 -113.05 168.4 9.73 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.054 -0.521 . . . . 72.329999999999998 110.798 174.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.563 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 20.0 m120 -135.75 112.68 10.29 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.317 0.247 . . . . 74.5 110.894 173.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 42.5 tp -87.61 109.94 20.02 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.828 0.347 . . . . 54.329999999999998 110.818 177.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.8 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.6 mmm -100.74 159.29 15.3 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.0 0.428 . . . . 70.549999999999997 111.979 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.482 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 40.5 tt0 -147.7 132.26 17.75 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.338 0.495 . . . . 73.219999999999999 112.338 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 58.8 t -118.15 107.63 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.126 0.571 . . . . 62.420000000000002 110.09 174.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 11.9 t70 -121.97 93.4 3.98 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.862 0.363 . . . . 54.310000000000002 111.592 -174.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 28' ' ' LYS . . . 67.79 75.36 0.49 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.187 -0.53 . . . . 62.43 114.315 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 60.56 17.19 7.15 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.683 0.994 . . . . 73.219999999999999 113.683 175.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.511 ' HG3' ' CE3' ' A' ' 69' ' ' TRP . 7.7 ptp180 -144.07 146.59 32.93 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.97 -0.457 . . . . 73.329999999999998 111.19 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 tt -127.29 148.09 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 121.096 0.474 . . . . 74.329999999999998 112.271 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.543 ' HB3' ' HA ' ' A' ' 69' ' ' TRP . 0.4 OUTLIER -159.6 168.88 25.02 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.181 -0.463 . . . . 74.200000000000003 111.454 176.297 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.8 HG12 ' SD ' ' A' ' 45' ' ' MET . 33.7 mt -93.38 130.2 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.925 0.393 . . . . 64.109999999999999 110.962 175.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.482 ' HD2' ' HB2' ' A' ' 46' ' ' GLU . 29.5 mtpp -80.94 -47.68 13.36 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.43 -0.35 . . . . 53.310000000000002 111.642 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -171.93 144.75 1.77 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.067 0.461 . . . . 65.120000000000005 111.77 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 3.9 p-10 -142.2 -177.32 5.19 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.262 -0.426 . . . . 71.400000000000006 110.647 176.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -116.78 83.81 2.03 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.481 0.658 . . . . 74.420000000000002 111.06 173.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.6 t -130.65 152.75 80.99 Favored Pre-proline 0 N--CA 1.474 0.741 0 CA-C-N 115.692 -0.686 . . . . 70.310000000000002 111.371 174.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.72 -13.91 24.46 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 121.868 1.712 . . . . 64.510000000000005 112.046 171.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.489 ' HB3' HG23 ' A' ' 63' ' ' VAL . 7.8 m-20 -102.68 -50.91 3.43 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.136 -0.484 . . . . 62.350000000000001 111.491 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 53.24 29.84 9.07 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.637 0.606 . . . . 63.520000000000003 112.637 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.489 HG23 ' HB3' ' A' ' 61' ' ' ASP . 41.5 t -58.55 -36.02 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.846 0.355 . . . . 64.129999999999995 111.549 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.434 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -57.09 -45.27 92.64 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 116.406 -0.361 . . . . 65.430000000000007 113.593 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 45.4 t -62.56 -40.02 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.34 0.59 . . . . 52.439999999999998 110.983 178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -69.52 -27.29 65.05 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.978 -0.556 . . . . 54.0 112.253 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 20.9 mmt -55.06 -39.24 69.0 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.127 0.418 . . . . 74.519999999999996 112.127 177.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.26 -175.6 54.88 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.202 -0.523 . . . . 71.219999999999999 114.186 175.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.543 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . 96.5 m95 -52.28 138.11 27.24 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.954 0.724 . . . . 73.109999999999999 112.954 -175.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -135.56 148.3 49.06 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.7 0.4 . . . . 72.109999999999999 110.743 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 89.2 p -170.7 18.97 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.802 0.668 . . . . 71.099999999999994 112.802 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -101.44 146.67 27.31 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.035 -0.416 . . . . 72.409999999999997 110.59 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.13 88.89 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.089 0.471 . . . . 65.150000000000006 111.037 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.85 -19.46 2.55 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.198 -0.525 . . . . 65.010000000000005 113.666 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.53 ' HB2' HD12 ' A' ' 88' ' ' ILE . 97.4 m-20 -57.09 139.56 52.01 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 117.573 0.686 . . . . 72.150000000000006 112.172 -178.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.3 p -138.79 144.89 39.55 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.95 0.405 . . . . 73.530000000000001 111.515 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.8 mm -122.9 127.94 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.3 -0.409 . . . . 75.230000000000004 110.315 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.9 t -111.7 117.22 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.013 0.435 . . . . 75.219999999999999 111.959 -177.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.554 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 74.8 m -114.03 76.44 0.99 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.128 0.49 . . . . 73.040000000000006 110.226 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.456 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 5.2 tt -54.75 -54.14 52.72 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 115.713 -0.676 . . . . 70.120000000000005 112.634 -173.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 80' ' ' LEU . 23.7 Cg_endo -59.73 -22.61 68.41 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 122.156 1.904 . . . . 73.109999999999999 113.287 -177.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -104.35 -2.13 25.93 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.488 -0.324 . . . . 74.439999999999998 111.385 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm 60.02 29.38 18.95 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.263 0.468 . . . . 72.019999999999996 112.263 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 48.4 t -106.15 141.75 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.925 0.393 . . . . 75.530000000000001 111.436 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -143.24 126.65 16.74 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.821 0.343 . . . . 73.430000000000007 110.984 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -115.35 133.4 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.569 -0.287 . . . . 75.040000000000006 111.182 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -132.42 136.75 46.97 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.064 0.459 . . . . 63.030000000000001 111.47 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.53 HD12 ' HB2' ' A' ' 75' ' ' ASP . 58.7 mt -106.4 110.86 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.311 -0.404 . . . . 74.129999999999995 110.797 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -117.58 164.64 14.63 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.248 0.462 . . . . 72.340000000000003 112.248 -174.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.9 t -85.12 149.73 25.34 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.189 -0.46 . . . . 74.310000000000002 112.209 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.2 p -77.69 -27.84 50.86 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.162 0.506 . . . . 74.120000000000005 110.989 174.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 . . . . . 0 CA--C 1.537 0.47 0 CA-C-N 116.171 -0.468 . . . . 75.219999999999999 110.951 177.228 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 121.038 0.447 . . . . 64.209999999999994 111.295 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 32.7 m -120.88 144.66 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.508 0.67 . . . . 21.100000000000001 112.37 -177.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 23' ' ' PRO . 34.6 m -125.39 134.2 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 115.677 -0.692 . . . . 72.420000000000002 110.815 177.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.43 114.52 25.13 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.794 0.331 . . . . 52.299999999999997 111.659 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.3 mm -97.25 137.49 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.551 -0.295 . . . . 73.319999999999993 110.474 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.9 mp -121.97 118.71 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.012 0.434 . . . . 72.340000000000003 111.055 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.6 p -112.98 153.02 28.7 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.178 0.513 . . . . 75.049999999999997 111.37 177.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -151.91 142.21 22.42 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.328 -0.396 . . . . 63.43 110.846 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 59.77 14.1 3.92 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.628 0.603 . . . . 71.109999999999999 112.628 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.68 10.69 43.0 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.032 -0.604 . . . . 71.450000000000003 114.166 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -146.13 151.06 37.06 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 117.264 0.532 . . . . 72.420000000000002 111.458 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.12 136.79 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.681 0.276 . . . . 65.049999999999997 110.899 175.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.1 pt -117.89 -22.07 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 112.14 0.422 . . . . 52.340000000000003 112.14 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -169.31 144.99 3.22 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.577 0.227 . . . . 75.019999999999996 111.315 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -137.69 128.06 26.37 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.85 0.357 . . . . 73.200000000000003 111.254 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.9 mp -123.83 119.63 26.8 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-N 116.579 -0.282 . . . . 72.140000000000001 111.704 -177.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.466 ' HA ' HG12 ' A' ' 9' ' ' VAL . 34.8 Cg_exo -61.97 132.0 37.52 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.406 2.07 . . . . 55.439999999999998 112.346 172.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' HB2' HG23 ' A' ' 8' ' ' VAL . 88.1 mt -96.3 -61.72 1.39 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.881 0.372 . . . . 74.230000000000004 111.465 -178.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.3 m -60.23 121.12 11.17 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.511 -0.313 . . . . 62.439999999999998 111.657 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.05 -8.24 80.18 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.095 -0.574 . . . . 45.140000000000001 113.126 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -78.3 86.42 4.39 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.289 0.566 . . . . 71.409999999999997 110.886 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -83.57 98.25 9.48 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.248 0.547 . . . . 72.299999999999997 111.113 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.88 -168.21 31.17 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.949 -0.568 . . . . 63.039999999999999 112.923 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -118.43 145.19 45.41 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 122.307 -0.526 . . . . 74.200000000000003 110.874 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.557 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 9.3 tp10 -144.82 117.49 8.65 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.566 -0.288 . . . . 63.130000000000003 110.574 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -127.6 129.85 47.99 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.728 0.299 . . . . 60.109999999999999 111.13 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -141.35 153.05 44.89 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.075 0.464 . . . . 73.219999999999999 111.297 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.6 m -112.49 116.7 30.68 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.948 0.404 . . . . 62.310000000000002 111.422 -175.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.2 mt -79.99 108.22 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.859 0.362 . . . . 70.420000000000002 111.022 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -99.86 111.13 23.46 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.298 -0.41 . . . . 54.229999999999997 111.146 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -110.69 -91.45 2.08 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.242 -0.504 . . . . 73.519999999999996 113.493 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.635 ' HE3' ' HA ' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -112.84 85.47 2.18 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.861 0.362 . . . . 72.510000000000005 111.494 -176.355 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.33 -97.71 0.02 OUTLIER Glycine 0 CA--C 1.529 0.93 0 CA-C-N 116.277 -0.419 . . . . 73.120000000000005 113.817 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.82 -31.53 72.54 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.929 0.395 . . . . 70.439999999999998 111.74 177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -72.82 94.17 1.77 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.129 0.418 . . . . 75.439999999999998 112.129 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -124.84 176.8 6.38 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.387 -0.369 . . . . 73.209999999999994 110.498 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -158.63 114.52 2.66 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.766 0.317 . . . . 74.140000000000001 110.92 174.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.6 tp -89.99 111.53 22.64 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.073 0.463 . . . . 45.039999999999999 111.477 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.633 ' SD ' HG12 ' A' ' 54' ' ' ILE . 94.3 mmm -97.56 138.1 35.49 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.146 -0.479 . . . . 64.0 111.384 -177.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -123.95 116.61 23.16 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.931 0.396 . . . . 72.209999999999994 111.78 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 40.2 t -107.47 112.46 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.232 -0.44 . . . . 74.329999999999998 110.652 176.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 20.5 t70 -109.04 101.95 10.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.05 0.452 . . . . 54.399999999999999 110.224 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.87 -106.02 1.17 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.846 -0.692 . . . . 72.430000000000007 112.772 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -111.51 17.41 20.07 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 120.973 0.416 . . . . 75.530000000000001 111.734 -176.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 19.9 ptt180 -130.42 141.96 50.52 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.316 -0.402 . . . . 74.420000000000002 111.049 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 tt -130.92 149.41 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 120.987 0.422 . . . . 73.019999999999996 111.717 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -157.02 168.89 26.13 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.953 0.406 . . . . 74.530000000000001 111.486 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.633 HG12 ' SD ' ' A' ' 45' ' ' MET . 60.5 mt -85.54 113.52 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 109.832 -0.433 . . . . 64.420000000000002 109.832 169.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -73.87 -49.66 23.97 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.94 0.4 . . . . 72.439999999999998 111.686 -177.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -162.69 138.61 7.24 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.181 0.437 . . . . 64.409999999999997 112.181 -175.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -165.43 -172.29 2.41 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.095 -0.502 . . . . 72.430000000000007 110.34 173.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -121.72 24.07 9.89 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.77 0.656 . . . . 72.219999999999999 112.77 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.3 t -77.18 125.93 85.91 Favored Pre-proline 0 N--CA 1.474 0.761 0 O-C-N 121.869 -0.519 . . . . 74.340000000000003 110.968 175.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -59.39 -13.58 21.2 Favored 'Trans proline' 0 N--CA 1.48 0.725 0 C-N-CA 122.998 2.465 . . . . 65.209999999999994 113.092 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.524 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.7 m-20 -83.77 -41.07 18.0 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.036 0.384 . . . . 72.200000000000003 112.036 175.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 53.75 32.56 15.05 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.147 0.425 . . . . 71.409999999999997 112.147 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.524 HG23 ' HB3' ' A' ' 61' ' ' ASP . 97.5 t -52.52 -51.74 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 112.55 0.574 . . . . 52.350000000000001 112.55 -173.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.579 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -62.73 -34.82 90.78 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.743 -0.742 . . . . 70.239999999999995 113.446 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.48 -44.67 98.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 120.945 0.402 . . . . 64.0 110.897 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -69.49 -37.7 77.33 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.427 -0.351 . . . . 71.349999999999994 111.112 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 21.3 mmt -61.63 -33.57 74.17 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.353 0.501 . . . . 64.25 112.353 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.39 -143.18 29.11 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.021 -0.609 . . . . 74.040000000000006 113.426 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -86.99 122.39 30.77 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.058 0.456 . . . . 75.140000000000001 112.066 -176.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HD2' ' CG ' ' A' ' 75' ' ' ASP . 74.1 mmtt -108.63 154.33 22.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.177 -0.465 . . . . 73.109999999999999 110.668 176.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 82.6 p -165.89 12.68 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.987 1.106 . . . . 72.200000000000003 113.987 -173.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -131.49 158.9 39.67 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.553 0.692 . . . . 63.149999999999999 112.457 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.527 ' HB2' ' HB2' ' A' ' 90' ' ' SER . . . -68.13 108.01 2.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.67 -0.695 . . . . 44.0 111.422 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.28 -16.61 4.89 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.35 -0.452 . . . . 65.530000000000001 112.398 -176.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.506 ' HB2' HD12 ' A' ' 88' ' ' ILE . 77.5 m-20 -72.21 106.15 4.29 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.029 0.442 . . . . 74.230000000000004 111.242 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.7 p -116.24 142.46 46.8 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.784 0.325 . . . . 74.430000000000007 111.779 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.9 mm -117.06 134.03 61.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 122.673 0.389 . . . . 72.209999999999994 110.828 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -112.19 117.34 54.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 111.895 0.332 . . . . 64.25 111.895 -177.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 86.7 m -122.0 68.37 0.93 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.856 0.36 . . . . 62.140000000000001 111.126 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.527 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 92.0 mt -53.07 -50.11 83.84 Favored Pre-proline 0 N--CA 1.476 0.847 0 N-CA-C 113.246 0.832 . . . . 62.530000000000001 113.246 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.527 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 50.7 Cg_exo -54.54 -24.65 37.17 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.021 1.814 . . . . 64.219999999999999 113.374 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -106.58 -1.88 22.45 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 111.869 0.322 . . . . 63.030000000000001 111.869 -179.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 59.69 30.93 20.54 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.989 0.423 . . . . 64.430000000000007 111.662 -176.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.2 t -112.12 137.17 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 116.079 -0.51 . . . . 43.549999999999997 111.178 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -135.81 143.04 44.95 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.528 -0.306 . . . . 63.5 110.291 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.1 t -129.36 120.1 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 122.288 -0.257 . . . . 44.32 111.067 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.22 116.94 25.86 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.456 0.646 . . . . 74.329999999999998 111.912 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.506 HD12 ' HB2' ' A' ' 75' ' ' ASP . 57.4 mt -88.78 114.53 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 122.009 -0.432 . . . . 63.119999999999997 110.894 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.415 ' HB2' ' NZ ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -109.85 172.46 6.84 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.942 0.401 . . . . 63.240000000000002 111.095 179.552 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 40.5 t -111.21 150.27 29.8 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.782 0.325 . . . . 62.119999999999997 110.891 175.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.1 p -77.01 -9.65 58.84 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.566 -0.288 . . . . 71.510000000000005 111.453 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 121.598 0.713 . . . . 74.430000000000007 112.402 -178.651 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ttt . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 111.689 0.255 . . . . 70.140000000000001 111.689 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.7 15.86 2.9 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.514 0.931 . . . . 73.0 113.514 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -86.52 89.34 7.87 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.809 -0.557 . . . . 73.540000000000006 111.448 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.0 p -124.73 113.1 17.51 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.049 0.452 . . . . 74.230000000000004 111.334 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.7 -15.61 52.0 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.182 -0.533 . . . . 43.109999999999999 113.583 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -75.77 66.22 2.02 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.5 0.667 . . . . 73.329999999999998 111.718 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.529 ' HA ' ' HB ' ' A' ' 25' ' ' THR . 42.9 mt-10 -64.03 99.35 0.26 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.153 -0.476 . . . . 73.049999999999997 112.083 -175.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 25.7 m -110.8 151.91 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 121.361 0.6 . . . . 60.420000000000002 112.184 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 23' ' ' PRO . 34.4 m -128.1 143.04 42.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 115.794 -0.639 . . . . 70.409999999999997 111.256 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.49 117.97 30.17 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.43 -0.35 . . . . 63.149999999999999 111.216 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.51 HD11 ' HE3' ' A' ' 89' ' ' LYS . 20.0 mm -92.45 112.92 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.464 -0.334 . . . . 70.230000000000004 111.21 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 12' ' ' ILE . 3.4 mp -98.31 119.13 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.091 0.472 . . . . 72.219999999999999 111.647 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.2 p -123.22 145.18 48.86 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.298 -0.41 . . . . 50.130000000000003 110.604 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 60.6 tt0 -140.28 141.85 35.77 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.128 -0.358 . . . . 72.420000000000002 111.329 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.0 m120 66.28 -12.76 0.18 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.784 0.661 . . . . 65.530000000000001 112.784 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 14' ' ' GLN . . . 119.25 26.07 2.55 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.525 -0.369 . . . . 74.519999999999996 112.731 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -147.96 146.55 29.01 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.479 -0.424 . . . . 75.140000000000001 111.156 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.6 t -74.29 121.41 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.904 0.383 . . . . 62.32 110.769 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 34.9 pt -109.97 -20.95 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 112.721 0.638 . . . . 74.310000000000002 112.721 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -170.66 153.04 3.96 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.485 0.183 . . . . 65.239999999999995 111.48 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -147.15 122.4 10.23 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.266 0.555 . . . . 73.510000000000005 111.546 175.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.521 HG21 HG21 ' A' ' 47' ' ' VAL . 2.5 mp -106.65 129.67 24.07 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-N 116.092 -0.504 . . . . 71.439999999999998 111.614 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.461 ' HA ' HG12 ' A' ' 9' ' ' VAL . 56.9 Cg_endo -70.76 126.9 13.13 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.366 2.044 . . . . 62.520000000000003 112.109 174.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.91 -62.43 1.32 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 111.901 0.334 . . . . 65.400000000000006 111.901 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.529 ' HB ' ' HA ' ' A' ' 7' ' ' GLU . 19.6 m -54.28 127.47 27.27 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.653 0.263 . . . . 64.409999999999997 111.567 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.01 -24.38 9.17 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.211 -0.518 . . . . 54.420000000000002 113.218 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -75.94 83.0 2.84 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.383 0.611 . . . . 64.549999999999997 110.93 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -83.77 164.08 19.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.708 -0.678 . . . . 70.230000000000004 111.416 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.19 -163.25 37.5 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 120.827 -0.701 . . . . 43.439999999999998 112.631 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -118.53 146.79 44.28 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.001 0.429 . . . . 64.319999999999993 111.775 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -150.13 142.24 24.03 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.163 -0.472 . . . . 74.5 110.857 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -132.05 147.82 52.46 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.043 0.386 . . . . 62.049999999999997 112.043 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -153.39 139.5 18.33 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.962 0.41 . . . . 74.140000000000001 111.439 174.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.6 m -102.45 114.51 28.77 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.127 0.418 . . . . 63.32 112.127 -175.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.1 mt -86.25 104.4 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 116.271 -0.422 . . . . 72.319999999999993 111.425 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -101.27 125.21 47.87 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.673 0.273 . . . . 63.329999999999998 111.106 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -121.29 -78.27 0.49 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.982 -0.628 . . . . 22.550000000000001 114.197 -176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.555 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -114.25 -169.86 1.61 Allowed 'General case' 0 CA--C 1.546 0.811 0 O-C-N 122.46 -0.435 . . . . 73.420000000000002 111.304 -173.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -44.67 100.04 0.02 OUTLIER Glycine 0 CA--C 1.528 0.879 0 N-CA-C 114.502 0.561 . . . . 74.5 114.502 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 67.0 -2.82 1.06 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.177 0.806 . . . . 54.020000000000003 113.177 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -86.56 112.58 21.7 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.871 0.367 . . . . 72.030000000000001 111.915 -175.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -139.99 163.51 32.48 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.284 -0.416 . . . . 61.210000000000001 111.649 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -135.4 113.52 11.28 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.479 -0.328 . . . . 75.540000000000006 111.291 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.4 tp -84.57 103.82 14.03 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.922 0.392 . . . . 72.0 110.169 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.646 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.7 mmm -95.91 146.37 24.64 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.265 -0.425 . . . . 71.439999999999998 111.322 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -132.92 122.94 25.07 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.102 0.477 . . . . 72.400000000000006 111.952 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.521 HG21 HG21 ' A' ' 22' ' ' ILE . 58.2 t -103.32 107.57 22.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.941 -0.572 . . . . 72.549999999999997 110.207 173.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.463 ' HB3' ' CH2' ' A' ' 69' ' ' TRP . 30.3 t70 -129.84 105.69 8.18 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.859 0.361 . . . . 63.539999999999999 111.543 -175.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . 74.66 55.1 5.61 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.302 -0.475 . . . . 74.400000000000006 114.013 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 63.62 23.53 13.59 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.775 0.657 . . . . 73.430000000000007 112.775 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 49' ' ' GLY . 7.9 ptt85 -148.5 149.18 31.19 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.806 0.336 . . . . 73.019999999999996 110.985 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.0 tt -123.29 148.69 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.148 0.499 . . . . 51.229999999999997 112.068 -174.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -152.94 168.88 24.33 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.851 -0.613 . . . . 71.319999999999993 110.821 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.646 HG12 ' SD ' ' A' ' 45' ' ' MET . 40.4 mt -84.91 110.67 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 120.977 0.418 . . . . 55.109999999999999 110.155 169.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -75.29 -29.94 60.23 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.31 -0.405 . . . . 71.099999999999994 111.096 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -175.47 138.65 0.41 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.243 -0.435 . . . . 73.549999999999997 111.431 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -161.68 156.42 23.01 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.175 0.512 . . . . 65.409999999999997 111.034 172.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -93.39 69.14 4.23 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.2 0.524 . . . . 63.420000000000002 111.867 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.3 p -127.33 140.61 38.42 Favored Pre-proline 0 N--CA 1.473 0.7 0 CA-C-N 116.46 -0.336 . . . . 41.030000000000001 110.692 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.67 -17.79 29.34 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.981 1.788 . . . . 74.109999999999999 111.987 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.536 ' HB3' HG23 ' A' ' 63' ' ' VAL . 2.2 m-20 -80.35 -52.9 7.14 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.607 -0.724 . . . . 65.230000000000004 111.755 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 57.45 29.31 16.8 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 120.649 0.261 . . . . 75.109999999999999 111.6 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 61' ' ' ASP . 65.5 t -53.82 -48.33 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 112.223 0.453 . . . . 53.210000000000001 112.223 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.557 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -59.89 -29.67 68.17 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 120.892 -0.67 . . . . 74.439999999999998 113.067 177.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 67.5 t -66.94 -40.24 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.752 0.31 . . . . 61.420000000000002 110.713 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -65.62 -37.17 85.83 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.032 0.444 . . . . 74.150000000000006 110.832 172.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.58 ' SD ' ' NZ ' ' A' ' 70' ' ' LYS . 23.2 mmt -58.35 -46.41 86.33 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.236 -0.438 . . . . 54.210000000000001 111.588 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.58 -143.49 38.77 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.322 -0.466 . . . . 54.030000000000001 113.74 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.463 ' CH2' ' HB3' ' A' ' 48' ' ' ASP . 82.4 m95 -69.6 105.22 2.6 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.365 0.506 . . . . 72.219999999999999 112.365 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.58 ' NZ ' ' SD ' ' A' ' 67' ' ' MET . 34.4 mmtp -111.85 138.96 47.75 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 116.297 -0.41 . . . . 71.150000000000006 110.429 174.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' A' ' 51' ' ' ARG . 98.8 p -157.49 9.83 0.19 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.339 1.237 . . . . 74.439999999999998 114.339 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -118.41 149.67 40.85 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.725 -0.609 . . . . 72.540000000000006 112.075 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.31 107.54 0.5 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.021 -0.536 . . . . 74.549999999999997 111.041 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 129.07 -20.91 5.3 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 116.125 -0.489 . . . . 72.049999999999997 112.52 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.556 ' HB2' HD12 ' A' ' 88' ' ' ILE . 55.7 m-20 -74.48 151.3 39.58 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.009 0.433 . . . . 73.430000000000007 111.297 175.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 65.8 p -141.43 158.14 44.25 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.327 0.584 . . . . 74.209999999999994 112.372 -176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 40.0 mm -132.1 116.12 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.493 -0.776 . . . . 62.439999999999998 109.434 173.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.1 t -124.83 117.18 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 113.003 0.742 . . . . 65.430000000000007 113.003 -173.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 68.8 m -122.97 89.13 3.05 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.34 -0.391 . . . . 64.239999999999995 110.947 170.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.0 mt -63.78 -38.92 41.7 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 113.575 0.954 . . . . 63.420000000000002 113.575 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.04 -21.14 25.96 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.878 1.719 . . . . 72.099999999999994 112.931 174.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -112.49 0.61 15.59 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.899 0.38 . . . . 74.140000000000001 110.776 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 92.6 mttt 55.09 34.56 22.83 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.609 0.764 . . . . 72.209999999999994 112.434 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -102.62 117.51 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.919 0.39 . . . . 71.340000000000003 111.305 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -119.92 123.15 42.86 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.426 -0.352 . . . . 73.310000000000002 110.545 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.565 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 48.1 t -123.24 132.63 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 120.57 0.224 . . . . 62.530000000000001 111.397 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -132.21 143.64 50.09 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.818 0.342 . . . . 73.450000000000003 110.938 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.556 HD12 ' HB2' ' A' ' 75' ' ' ASP . 57.2 mt -100.95 121.35 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.612 0.244 . . . . 62.439999999999998 111.505 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.51 ' HE3' HD11 ' A' ' 11' ' ' ILE . 22.9 pttp -124.25 152.04 43.46 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.829 0.347 . . . . 71.140000000000001 111.212 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 43.9 t -89.82 151.06 21.97 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.375 0.607 . . . . 71.510000000000005 112.15 -177.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.8 p -73.08 -32.48 65.03 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.994 -0.548 . . . . 73.219999999999999 111.552 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HG2' ' OG ' ' A' ' 90' ' ' SER . 16.2 pt20 -78.27 83.7 4.5 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.669 0.747 . . . . 54.119999999999997 112.459 -177.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 53.33 24.5 3.87 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.932 -1.031 . . . . 60.229999999999997 113.777 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.542 ' HB2' ' HB3' ' A' ' 90' ' ' SER . 1.1 t70 -69.98 83.71 0.5 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.642 0.734 . . . . 75.140000000000001 110.363 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.3 m -78.95 93.07 5.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.659 -0.7 . . . . 65.040000000000006 112.101 -173.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -95.3 161.12 14.22 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.359 -0.382 . . . . 71.450000000000003 110.102 172.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.59 111.1 8.43 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 120.917 0.389 . . . . 73.239999999999995 111.507 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -83.84 83.52 1.76 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.638 2.225 . . . . 75.540000000000006 113.028 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -74.78 105.22 5.74 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.998 0.428 . . . . 72.420000000000002 110.134 174.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.435 ' O ' HG22 ' A' ' 100' ' ' THR . 6.8 m -94.85 7.28 46.47 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.302 0.482 . . . . 73.25 112.302 -173.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -73.04 81.01 1.22 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.543 0.687 . . . . 74.439999999999998 110.615 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.1 pp -103.01 -177.2 3.3 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.506 -0.77 . . . . 73.409999999999997 112.488 -175.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.8 mm -92.23 137.19 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.084 -0.507 . . . . 73.040000000000006 111.477 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.9 m -56.25 159.55 6.0 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 113.014 0.746 . . . . 75.209999999999994 113.014 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -53.6 117.34 3.72 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.956 2.438 . . . . 64.549999999999997 112.564 174.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -81.12 129.14 34.43 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.065 0.459 . . . . 75.530000000000001 110.995 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.474 ' N ' HD12 ' A' ' 107' ' ' LEU . 5.9 mp -79.67 140.11 37.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.143 0.497 . . . . 72.299999999999997 111.348 -176.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.519 ' CD ' ' H ' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -80.4 94.28 6.14 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.663 0.744 . . . . 75.430000000000007 110.222 175.031 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 110' ' ' HIS . 14.1 p-80 -72.41 71.49 0.92 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.335 0.588 . . . . 55.0 112.177 -177.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 109' ' ' HIS . 7.1 t-80 174.21 18.12 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.1 -0.954 . . . . 42.399999999999999 110.108 175.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -65.26 100.2 0.45 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.413 0.625 . . . . 71.129999999999995 112.123 -174.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 176.16 -33.06 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.842 -1.072 . . . . 75.530000000000001 108.419 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -172.11 165.92 6.13 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 114.943 -1.026 . . . . 71.349999999999994 109.77 172.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 83.7 t60 . . . . . 0 C--O 1.252 1.211 0 CA-C-O 118.781 -0.628 . . . . 70.310000000000002 111.52 176.791 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.2 ttp . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 120.473 0.178 . . . . 54.329999999999998 111.155 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt 64.34 71.02 0.48 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.307 0.575 . . . . 54.130000000000003 111.019 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -158.81 117.45 2.97 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.993 -0.549 . . . . 72.430000000000007 111.47 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.1 t -109.42 138.5 45.69 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.4 -0.364 . . . . 60.310000000000002 110.908 174.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.98 -27.77 71.64 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.126 -0.559 . . . . 63.350000000000001 113.523 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -84.52 135.49 34.2 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.324 0.583 . . . . 60.420000000000002 111.714 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -111.16 112.9 25.02 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.089 -0.505 . . . . 74.030000000000001 110.714 175.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 26.8 m -123.28 145.01 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 112.592 0.59 . . . . 64.409999999999997 112.592 -176.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 23' ' ' PRO . 26.7 m -122.91 141.96 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 115.802 -0.635 . . . . 63.149999999999999 111.318 178.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.5 112.7 24.65 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.367 -0.379 . . . . 41.229999999999997 110.95 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.578 HG13 ' HD3' ' A' ' 89' ' ' LYS . 45.6 mm -95.43 115.99 35.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.727 0.298 . . . . 73.299999999999997 111.415 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.491 ' N ' HD12 ' A' ' 12' ' ' ILE . 3.3 mp -101.62 118.36 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.766 0.317 . . . . 73.400000000000006 111.043 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.9 m -117.2 138.11 51.91 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.885 0.374 . . . . 51.439999999999998 111.597 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -134.8 142.55 46.72 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 122.587 0.355 . . . . 65.450000000000003 110.183 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.6 m120 56.29 34.94 24.97 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.049 0.452 . . . . 74.329999999999998 111.793 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.85 21.19 79.03 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.372 -0.442 . . . . 63.32 114.094 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -144.5 143.82 31.05 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 122.479 -0.424 . . . . 72.209999999999994 111.518 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.75 124.24 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.843 0.354 . . . . 62.130000000000003 111.285 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 44.9 pt -111.43 -20.09 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 112.474 0.546 . . . . 42.210000000000001 112.474 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -157.81 145.47 18.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.909 0.385 . . . . 73.530000000000001 111.977 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.44 125.21 20.98 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.3 -0.409 . . . . 74.430000000000007 110.945 172.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.459 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 73.7 mt -126.99 124.78 24.05 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 112.253 0.464 . . . . 60.130000000000003 112.253 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 22' ' ' ILE . 6.7 Cg_exo -73.82 117.2 4.94 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.826 2.351 . . . . 74.239999999999995 112.293 175.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.57 -47.23 15.86 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.088 0.471 . . . . 73.530000000000001 111.149 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 84.8 m -58.9 117.03 4.18 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.929 -0.578 . . . . 73.040000000000006 112.024 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.34 3.05 88.93 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.242 -0.504 . . . . 72.439999999999998 113.713 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -71.15 129.48 39.05 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.286 0.565 . . . . 65.209999999999994 111.43 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.42 ' HB2' ' NZ ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -97.33 148.08 23.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.14 -0.482 . . . . 64.239999999999995 111.601 178.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.32 -164.8 54.46 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 114.814 0.686 . . . . 60.0 114.814 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 25.7 t-20 -118.6 125.83 50.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.945 0.498 . . . . 54.020000000000003 110.397 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -118.19 122.51 43.2 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.733 0.301 . . . . 51.32 111.512 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -120.11 139.27 52.83 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.937 0.398 . . . . 75.230000000000004 111.566 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -149.91 143.12 25.06 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.027 0.442 . . . . 71.109999999999999 111.209 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.0 m -101.59 110.06 21.98 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.174 0.511 . . . . 74.349999999999994 112.238 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 39.7 mt -80.1 90.76 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.917 0.389 . . . . 74.099999999999994 110.077 175.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -73.54 128.47 35.59 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.883 0.373 . . . . 74.150000000000006 111.674 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.48 -143.72 12.01 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 116.296 -0.411 . . . . 71.439999999999998 112.209 175.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -86.49 123.53 31.8 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 122.413 -0.463 . . . . 72.150000000000006 111.115 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.14 -137.02 19.92 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.372 -0.442 . . . . 60.020000000000003 113.548 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.67 4.85 30.57 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.092 0.473 . . . . 71.439999999999998 111.874 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.449 ' HB3' ' CD2' ' A' ' 82' ' ' HIS . 98.5 mt-30 -83.28 119.14 24.21 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.254 -0.43 . . . . 73.310000000000002 111.637 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -145.86 155.08 42.66 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.584 -0.28 . . . . 72.519999999999996 111.556 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.572 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 48.8 m-80 -114.75 110.04 19.12 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.374 -0.376 . . . . 64.329999999999998 111.017 173.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.1 tp -89.51 107.04 18.85 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.869 0.366 . . . . 71.540000000000006 110.489 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.694 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.1 mmm -95.12 146.93 23.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.87 0.367 . . . . 75.140000000000001 111.824 -175.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 42.6 tt0 -133.44 121.45 22.26 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.139 0.495 . . . . 74.310000000000002 111.341 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 30' ' ' ASN . 43.9 t -109.34 114.38 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.151 -0.477 . . . . 71.450000000000003 110.587 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.474 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 35.9 t70 -108.76 103.88 13.04 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.071 0.463 . . . . 54.219999999999999 110.704 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 63.14 -104.26 0.78 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 120.742 -0.742 . . . . 70.409999999999997 112.674 -175.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -113.75 18.59 17.34 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.018 0.377 . . . . 75.239999999999995 112.018 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 35.5 ptt180 -132.75 149.36 52.29 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.668 0.271 . . . . 75.150000000000006 111.242 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.1 tt -133.38 146.04 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 112.319 0.489 . . . . 75.340000000000003 112.319 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -148.03 169.28 20.27 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.147 -0.479 . . . . 74.409999999999997 110.86 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.694 HG12 ' SD ' ' A' ' 45' ' ' MET . 31.2 mt -85.88 108.89 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.05 0.452 . . . . 71.129999999999995 110.232 169.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 56.4 tttp -67.75 -45.66 74.31 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.285 0.564 . . . . 64.030000000000001 111.325 -178.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -152.49 157.89 41.79 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.029 -0.532 . . . . 75.209999999999994 110.168 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -160.62 167.69 26.5 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.038 0.446 . . . . 74.329999999999998 111.947 -175.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . 51.3 t-20 -130.7 70.81 1.45 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.1 0.476 . . . . 70.439999999999998 110.942 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.7 p -129.06 155.87 79.08 Favored Pre-proline 0 N--CA 1.477 0.905 0 O-C-N 122.117 -0.364 . . . . 70.349999999999994 111.766 175.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.26 -17.03 13.47 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.486 2.124 . . . . 63.350000000000001 112.888 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.542 ' HB2' HG23 ' A' ' 63' ' ' VAL . 5.9 p-10 -92.15 -47.19 7.37 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 111.917 0.34 . . . . 55.32 111.917 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.425 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 15.8 mm100 65.94 19.73 11.27 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.791 0.436 . . . . 71.010000000000005 111.912 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.542 HG23 ' HB2' ' A' ' 61' ' ' ASP . 97.1 t -55.14 -46.96 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.156 0.503 . . . . 64.099999999999994 111.11 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.498 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -57.74 -38.32 87.68 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.037 -0.602 . . . . 51.340000000000003 112.746 176.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.15 -30.25 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.106 0.479 . . . . 62.109999999999999 111.267 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.425 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 5.4 mptp? -73.9 -31.04 62.93 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.387 0.514 . . . . 73.420000000000002 112.387 177.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.1 mmt -54.38 -50.71 66.89 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.529 0.566 . . . . 75.120000000000005 112.529 -177.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.9 -149.62 21.01 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.913 -0.66 . . . . 44.420000000000002 113.58 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -80.95 120.3 24.58 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.279 0.561 . . . . 65.319999999999993 112.099 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 75.0 mmtt -116.66 150.53 37.98 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.568 -0.742 . . . . 71.430000000000007 110.21 175.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 93.1 p -164.15 9.64 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.306 1.225 . . . . 72.439999999999998 114.306 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -132.76 157.14 45.69 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.61 0.641 . . . . 72.010000000000005 112.422 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.68 112.71 1.91 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.801 -0.636 . . . . 74.030000000000001 111.616 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 130.24 -26.45 4.17 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 116.219 -0.446 . . . . 52.299999999999997 112.366 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.538 ' HB2' HD12 ' A' ' 88' ' ' ILE . 76.7 m-20 -69.38 126.2 29.02 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.835 0.35 . . . . 71.310000000000002 111.082 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 87' ' ' GLU . 47.0 p -132.02 145.37 51.4 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.947 0.403 . . . . 72.409999999999997 111.901 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.524 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 37.8 mm -114.65 130.05 69.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.377 -0.374 . . . . 64.239999999999995 110.606 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.7 t -112.96 118.65 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 112.047 0.388 . . . . 73.400000000000006 112.047 -177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.494 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 74.9 m -122.61 82.38 1.97 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.158 0.504 . . . . 74.120000000000005 110.92 173.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.468 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 84.1 mt -57.22 -58.67 16.37 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 113.565 0.95 . . . . 60.140000000000001 113.565 -173.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 59.8 Cg_endo -70.9 -2.14 10.53 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.88 1.72 . . . . 61.409999999999997 113.033 -175.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.449 ' CD2' ' HB3' ' A' ' 41' ' ' GLN . 37.9 m170 -109.97 -2.45 17.11 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.497 -0.319 . . . . 73.25 111.297 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 59.78 29.62 19.19 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.916 0.389 . . . . 72.349999999999994 111.744 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 57.5 t -115.37 134.05 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.104 0.478 . . . . 73.219999999999999 111.811 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -136.56 131.68 34.15 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.011 -0.541 . . . . 72.209999999999994 110.229 175.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.524 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 46.7 t -118.38 136.38 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.528 -0.305 . . . . 71.040000000000006 111.097 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.436 ' HA ' HG22 ' A' ' 76' ' ' THR . 11.9 pt-20 -133.09 125.2 29.06 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.201 0.524 . . . . 53.509999999999998 111.402 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.538 HD12 ' HB2' ' A' ' 75' ' ' ASP . 59.2 mt -89.73 116.96 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.863 0.363 . . . . 74.310000000000002 110.331 175.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.578 ' HD3' HG13 ' A' ' 11' ' ' ILE . 13.2 ptmt -131.66 147.5 52.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.363 -0.38 . . . . 64.120000000000005 111.238 -174.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 48.4 t -78.5 145.59 34.86 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.14 0.422 . . . . 60.439999999999998 112.14 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.5 p -86.21 -7.27 58.67 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.151 0.501 . . . . 71.540000000000006 110.825 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -96.52 -177.69 4.02 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.881 -0.6 . . . . 72.439999999999998 111.051 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.441 ' HD2' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -76.85 157.4 31.49 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.528 0.566 . . . . 75.409999999999997 112.528 -177.432 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.588 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 27.4 t0 -174.21 153.46 2.01 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.698 -0.683 . . . . 75.140000000000001 110.437 175.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.2 t -77.15 69.98 3.49 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.206 0.527 . . . . 61.350000000000001 111.714 -175.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.588 ' HE2' ' HB3' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -173.95 -179.97 1.83 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.999 -0.546 . . . . 73.030000000000001 111.118 -179.694 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 17.5 m-20 -106.19 130.2 23.35 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 120.45 0.167 . . . . 72.010000000000005 111.055 175.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 97' ' ' ASP . 32.7 Cg_exo -60.37 -34.76 93.07 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.757 2.305 . . . . 61.340000000000003 113.403 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -130.15 143.16 50.63 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.362 -0.381 . . . . 74.329999999999998 110.435 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 t -108.93 -4.43 16.76 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.255 0.835 . . . . 63.039999999999999 113.255 -172.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -78.64 142.44 37.2 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.13 0.49 . . . . 74.439999999999998 111.268 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.5 tp -106.49 104.18 13.81 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.196 0.522 . . . . 73.150000000000006 111.743 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 60.1 mt -86.22 99.42 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.233 0.539 . . . . 72.340000000000003 110.371 175.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.2 t -62.07 130.27 92.65 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 115.86 -0.609 . . . . 61.32 111.75 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -51.28 138.07 46.24 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.831 2.354 . . . . 73.219999999999999 113.251 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 63.63 64.19 0.81 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.705 0.764 . . . . 72.319999999999993 111.525 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.7 tt -123.41 91.4 3.47 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.194 -0.912 . . . . 72.140000000000001 108.823 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.87 82.71 5.05 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.259 0.552 . . . . 73.019999999999996 112.135 -173.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -90.31 93.63 9.41 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.13 -0.486 . . . . 74.319999999999993 110.187 174.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -130.2 -85.52 0.53 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.157 0.428 . . . . 72.040000000000006 112.157 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 27.1 m80 59.54 80.96 0.18 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.439 0.637 . . . . 62.439999999999998 112.109 -173.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -124.0 114.97 20.47 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.796 -0.638 . . . . 72.200000000000003 110.118 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -72.17 83.43 1.01 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.279 0.561 . . . . 73.019999999999996 112.353 -175.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 81.5 t60 . . . . . 0 C--O 1.251 1.14 0 CA-C-N 115.701 -0.681 . . . . 75.030000000000001 110.993 174.309 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtm . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.648 0.261 . . . . 71.219999999999999 111.566 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -175.36 161.55 2.77 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.279 -0.419 . . . . 75.329999999999998 110.658 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -89.77 100.8 13.53 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.93 0.395 . . . . 60.420000000000002 110.212 174.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.5 m -85.96 100.02 11.83 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.445 0.535 . . . . 74.329999999999998 112.445 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -131.49 9.45 5.57 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 116.15 -0.477 . . . . 51.329999999999998 112.007 173.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -106.43 44.05 1.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.927 0.491 . . . . 64.310000000000002 111.147 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.458 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 46.2 mt-10 -73.72 107.05 5.74 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.348 0.594 . . . . 72.329999999999998 112.448 -176.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 33.0 m -126.15 152.85 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.694 -0.684 . . . . 71.109999999999999 111.716 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 23' ' ' PRO . 34.1 m -126.63 144.65 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 116.095 -0.502 . . . . 74.200000000000003 111.3 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -102.83 109.81 21.52 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.86 0.362 . . . . 41.219999999999999 111.099 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.1 mm -95.19 104.23 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 120.702 0.287 . . . . 70.549999999999997 111.37 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.462 ' N ' HD12 ' A' ' 12' ' ' ILE . 3.7 mp -89.11 109.9 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.367 0.603 . . . . 74.450000000000003 110.916 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.2 p -116.95 127.43 54.2 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.929 -0.578 . . . . 61.340000000000003 111.043 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -119.1 146.53 45.03 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.673 0.273 . . . . 64.430000000000007 110.625 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.475 ' OD1' ' HD3' ' A' ' 83' ' ' LYS . 46.9 m-80 64.95 6.83 3.61 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.766 0.426 . . . . 74.030000000000001 111.796 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.79 -3.52 52.82 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.225 -0.512 . . . . 64.430000000000007 113.213 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -124.98 151.8 45.03 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.951 0.405 . . . . 73.019999999999996 111.583 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.3 126.15 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 120.905 0.383 . . . . 73.019999999999996 111.883 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 41.0 pt -111.86 -25.77 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 116.5 -0.318 . . . . 71.329999999999998 111.845 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.604 ' HA ' ' HE ' ' A' ' 20' ' ' ARG . 1.3 tpm_? -164.74 125.22 2.01 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.467 -0.333 . . . . 54.210000000000001 110.708 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -123.21 120.51 33.36 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.161 0.505 . . . . 70.219999999999999 110.965 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.41 HD12 ' CE1' ' A' ' 33' ' ' PHE . 73.6 mt -117.72 110.7 40.08 Favored Pre-proline 0 N--CA 1.47 0.525 0 N-CA-C 112.062 0.393 . . . . 73.310000000000002 112.062 -175.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.44 ' HA ' HG12 ' A' ' 9' ' ' VAL . 37.1 Cg_exo -59.46 117.69 4.46 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.533 2.155 . . . . 63.409999999999997 111.903 171.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.2 mt -74.53 -56.07 5.24 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.974 0.416 . . . . 73.299999999999997 111.524 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.458 ' OG1' ' HA ' ' A' ' 7' ' ' GLU . 11.3 m -56.61 133.57 53.77 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.16 -0.473 . . . . 71.510000000000005 111.736 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.32 -24.7 31.08 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 116.285 -0.416 . . . . 65.430000000000007 112.864 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -74.82 136.16 41.62 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.244 0.545 . . . . 64.540000000000006 111.627 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -124.11 145.98 48.92 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.109 -0.496 . . . . 73.129999999999995 110.859 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.66 -159.2 31.62 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.18 -0.533 . . . . 22.0 112.793 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -118.84 129.02 54.99 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 122.387 -0.478 . . . . 52.229999999999997 111.066 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.432 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 6.3 tp10 -123.5 135.08 53.86 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.328 -0.396 . . . . 62.219999999999999 110.302 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.402 ' HG2' ' HG3' ' A' ' 46' ' ' GLU . 35.7 mt-30 -134.55 129.69 35.43 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 122.089 -0.382 . . . . 60.140000000000001 111.526 -176.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.41 ' CE1' HD12 ' A' ' 22' ' ' ILE . 48.0 p90 -138.3 136.27 36.28 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.25 0.548 . . . . 73.420000000000002 111.72 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 30.9 m -104.12 114.2 28.27 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.074 -0.512 . . . . 72.049999999999997 112.165 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 54.8 mt -81.11 139.48 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 116.273 -0.421 . . . . 74.329999999999998 110.654 175.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -115.76 112.19 21.65 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.929 0.395 . . . . 74.109999999999999 112.042 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.15 -141.16 11.66 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 121.407 -0.425 . . . . 42.439999999999998 113.064 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -77.83 86.02 4.09 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.663 0.744 . . . . 64.329999999999998 111.856 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.17 -119.87 5.16 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 115.961 -0.563 . . . . 75.219999999999999 113.072 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.17 -0.93 23.89 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.073 0.397 . . . . 55.340000000000003 112.073 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -77.59 66.14 3.25 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.947 0.404 . . . . 71.430000000000007 111.728 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.49 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 17.1 p90 -95.32 167.05 11.58 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.535 -0.302 . . . . 73.040000000000006 111.106 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -140.47 110.67 6.61 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.659 -0.246 . . . . 73.430000000000007 111.164 174.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.6 tp -85.62 102.79 13.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.212 0.529 . . . . 61.329999999999998 110.542 177.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.701 ' SD ' HG12 ' A' ' 54' ' ' ILE . 94.5 mmm -97.03 141.49 30.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.004 -0.544 . . . . 71.400000000000006 110.751 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.846 ' HB3' HH21 ' A' ' 53' ' ' ARG . 35.4 tt0 -134.12 125.12 27.29 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.377 0.51 . . . . 63.119999999999997 112.377 -176.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 44.6 t -100.34 111.79 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.795 -0.639 . . . . 44.5 110.641 175.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.609 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 30.3 t70 -108.04 105.76 15.68 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.11 0.481 . . . . 64.219999999999999 110.035 -178.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.51 -104.49 1.07 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.658 -0.782 . . . . 73.040000000000006 111.898 -171.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -123.97 27.71 7.1 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.135 0.493 . . . . 73.219999999999999 111.448 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 34.1 ptt180 -134.6 154.45 51.49 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.039 0.535 . . . . 72.209999999999994 110.807 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.3 tt -142.37 143.33 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 112.91 0.707 . . . . 71.109999999999999 112.91 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.846 HH21 ' HB3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -161.03 168.55 24.25 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.162 -0.472 . . . . 70.109999999999999 111.875 169.294 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.701 HG12 ' SD ' ' A' ' 45' ' ' MET . 63.8 mt -69.04 121.27 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.387 -0.37 . . . . 62.200000000000003 111.173 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -82.19 -42.38 19.07 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.132 0.491 . . . . 45.329999999999998 111.016 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -166.21 138.76 3.92 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.651 -0.704 . . . . 62.229999999999997 110.689 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 1.7 p-10 -169.5 168.76 9.21 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.245 0.545 . . . . 75.510000000000005 111.472 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -97.19 45.16 1.04 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.214 -0.448 . . . . 63.119999999999997 111.994 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.1 t -97.72 122.92 53.65 Favored Pre-proline 0 N--CA 1.474 0.731 0 O-C-N 121.998 -0.439 . . . . 63.539999999999999 110.712 173.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -60.46 -27.35 84.69 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.506 2.137 . . . . 75.219999999999999 112.264 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -78.13 -34.26 50.02 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 116.005 -0.543 . . . . 64.409999999999997 111.609 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 54.66 36.18 25.49 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 111.963 0.357 . . . . 52.140000000000001 111.963 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.426 ' O ' ' HG2' ' A' ' 67' ' ' MET . 64.9 t -53.52 -52.5 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 112.733 0.642 . . . . 71.420000000000002 112.733 -174.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.594 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -64.19 -40.86 98.39 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.684 -0.77 . . . . 52.329999999999998 113.554 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 51.9 t -60.69 -39.6 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.27 0.557 . . . . 53.340000000000003 110.607 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -75.48 -28.27 59.15 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.95 -0.568 . . . . 74.230000000000004 111.928 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 18.1 mmt -67.16 -37.46 83.81 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 111.977 0.362 . . . . 75.420000000000002 111.977 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.94 -174.38 54.8 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 120.988 -0.625 . . . . 23.399999999999999 113.222 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.472 ' CE3' ' HG3' ' A' ' 53' ' ' ARG . 94.4 m95 -59.69 120.01 8.7 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.943 0.402 . . . . 73.439999999999998 112.016 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -115.82 127.21 54.89 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.239 0.542 . . . . 73.409999999999997 111.86 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.8 p -141.81 17.64 2.15 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.817 -0.629 . . . . 65.450000000000003 110.858 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -110.22 130.48 55.54 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.382 -0.372 . . . . 62.439999999999998 111.428 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.59 106.74 1.22 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.427 -0.351 . . . . 72.25 111.577 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.84 -36.65 1.74 Allowed Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.061 -0.59 . . . . 73.219999999999999 112.34 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -73.51 131.26 41.57 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.09 0.471 . . . . 71.120000000000005 111.179 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 69.3 p -120.87 152.17 38.75 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.963 0.411 . . . . 72.109999999999999 111.633 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.556 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 43.7 mm -114.25 110.45 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.309 -0.405 . . . . 71.040000000000006 110.204 177.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -107.27 116.66 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 112.35 0.5 . . . . 73.439999999999998 112.35 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 72.3 m -122.22 76.42 1.31 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.371 -0.377 . . . . 60.399999999999999 111.067 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.455 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 86.7 mt -57.21 -46.62 99.82 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 113.061 0.763 . . . . 74.219999999999999 113.061 -177.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.455 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 51.8 Cg_exo -55.64 -18.96 22.13 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.945 1.764 . . . . 61.32 113.364 177.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -112.65 -0.15 15.19 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.613 -0.267 . . . . 60.310000000000002 111.458 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.475 ' HD3' ' OD1' ' A' ' 15' ' ' ASN . 57.8 mttm 63.67 15.61 9.08 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.091 0.556 . . . . 71.219999999999999 112.433 -178.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.9 t -97.03 127.09 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.0 0.429 . . . . 75.420000000000002 111.832 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -130.62 113.22 13.92 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.222 -0.445 . . . . 73.340000000000003 110.633 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 46.2 t -100.79 117.02 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.042 0.449 . . . . 65.319999999999993 111.292 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -106.79 108.64 20.25 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.175 -0.466 . . . . 65.409999999999997 110.938 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 60.0 mt -91.91 121.06 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.149 0.5 . . . . 42.240000000000002 111.349 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -139.06 155.5 47.89 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.256 -0.429 . . . . 60.219999999999999 111.18 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 41.2 t -95.95 150.14 20.79 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.022 0.439 . . . . 74.299999999999997 112.042 -177.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.2 p -87.64 2.61 50.5 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.116 -0.493 . . . . 65.400000000000006 111.433 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -89.31 -167.37 1.85 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.084 0.469 . . . . 74.349999999999994 111.663 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.421 ' HB3' ' NZ ' ' A' ' 93' ' ' LYS . 2.5 mmmp? -76.48 104.58 7.07 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.949 0.404 . . . . 60.420000000000002 111.957 -175.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -124.8 161.38 26.59 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.803 -0.443 . . . . 71.530000000000001 109.803 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.2 t -128.65 14.4 6.48 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.627 0.603 . . . . 60.310000000000002 112.627 -174.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.436 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 4.4 mmmp? -71.93 137.66 47.53 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.866 0.365 . . . . 71.420000000000002 111.641 175.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.503 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 1.6 m-20 -62.51 164.82 10.67 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.191 -0.458 . . . . 65.109999999999999 110.538 173.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 97' ' ' ASP . 61.1 Cg_endo -71.94 27.29 0.25 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.236 1.957 . . . . 35.149999999999999 113.477 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.56 110.84 12.71 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.654 0.74 . . . . 73.329999999999998 111.295 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.1 t -143.89 87.35 1.91 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.744 0.783 . . . . 74.049999999999997 109.838 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -94.26 128.1 40.52 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.394 -0.821 . . . . 62.43 111.975 -173.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 102' ' ' LEU . 2.4 pt? -146.82 163.05 37.29 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.823 -0.626 . . . . 72.239999999999995 110.53 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 58.5 mt -118.2 99.92 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 121.069 0.461 . . . . 75.25 111.606 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.3 m -101.84 99.78 12.9 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 116.167 -0.469 . . . . 73.430000000000007 111.033 175.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.87 153.35 63.88 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.366 2.044 . . . . 74.120000000000005 113.332 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -93.81 106.93 18.87 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.103 -0.499 . . . . 61.140000000000001 110.94 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.473 HD23 ' HE2' ' A' ' 83' ' ' LYS . 3.2 mm? -95.09 -177.05 4.01 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.074 0.464 . . . . 75.140000000000001 111.51 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.85 132.71 53.95 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.597 -0.728 . . . . 65.299999999999997 112.179 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -76.72 64.81 2.37 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.26 0.552 . . . . 73.439999999999998 111.023 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -93.46 92.64 7.71 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 122.055 -0.403 . . . . 72.329999999999998 111.767 -174.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -105.29 130.47 53.41 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.767 0.318 . . . . 72.450000000000003 110.951 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -74.47 145.34 43.67 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.163 0.431 . . . . 74.400000000000006 112.163 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -75.72 -35.56 60.21 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.8 -0.815 . . . . 74.340000000000003 108.8 166.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 26.0 m80 . . . . . 0 C--O 1.249 1.06 0 CA-C-N 114.882 -1.053 . . . . 74.239999999999995 109.947 169.364 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtm . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.803 0.335 . . . . 52.030000000000001 111.656 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -159.23 84.53 0.79 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.553 0.692 . . . . 73.25 111.01 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -118.86 138.83 52.46 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.23 -0.441 . . . . 72.349999999999994 110.976 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.6 p -135.11 129.67 34.28 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.965 0.412 . . . . 74.150000000000006 111.837 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.0 -15.23 42.89 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.15 -0.548 . . . . 62.140000000000001 112.273 173.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.22 65.18 2.76 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.97 0.414 . . . . 55.399999999999999 111.246 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -92.36 116.97 29.44 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.968 0.413 . . . . 74.329999999999998 111.769 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 26.8 m -122.75 145.12 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.127 0.489 . . . . 63.229999999999997 111.876 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.86 146.99 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.017 -0.538 . . . . 75.209999999999994 111.29 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.0 112.89 25.45 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.33 -0.396 . . . . 61.140000000000001 111.106 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.8 mm -92.34 105.73 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.47 -0.332 . . . . 72.209999999999994 111.199 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 12' ' ' ILE . 4.1 mp -91.88 121.83 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 121.07 0.462 . . . . 73.340000000000003 111.276 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.0 m -121.51 157.1 31.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.358 -0.383 . . . . 71.420000000000002 111.491 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.437 ' HG2' ' OD1' ' A' ' 15' ' ' ASN . 53.7 tt0 -152.69 142.83 22.36 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.979 0.418 . . . . 63.329999999999998 111.345 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.437 ' OD1' ' HG2' ' A' ' 14' ' ' GLN . 29.9 m120 57.45 19.21 5.02 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.031 0.752 . . . . 75.540000000000006 113.031 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.47 -12.78 36.21 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.728 -0.749 . . . . 72.209999999999994 114.271 176.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -129.3 156.5 43.91 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 117.635 0.718 . . . . 73.230000000000004 112.068 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.63 133.54 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.826 0.346 . . . . 62.229999999999997 111.318 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.1 pt -111.92 -31.02 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 112.153 0.427 . . . . 74.329999999999998 112.153 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -157.19 133.17 9.51 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 111.979 0.363 . . . . 73.129999999999995 111.979 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -117.14 114.43 23.68 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 110.307 -0.256 . . . . 72.049999999999997 110.307 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 73.1 mt -115.0 116.04 42.85 Favored Pre-proline 0 N--CA 1.472 0.662 0 N-CA-C 111.826 0.306 . . . . 74.420000000000002 111.826 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.42 124.54 11.75 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.437 2.092 . . . . 70.140000000000001 112.474 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.402 ' HB2' HG23 ' A' ' 8' ' ' VAL . 88.7 mt -81.75 -56.49 3.96 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.995 0.426 . . . . 74.530000000000001 111.317 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.7 m -62.63 112.78 2.64 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.034 0.445 . . . . 63.119999999999997 111.501 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.02 7.77 57.22 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.128 -0.558 . . . . 60.25 113.199 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -85.1 122.91 29.99 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 117.004 0.402 . . . . 70.129999999999995 110.846 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.466 ' N ' ' HD2' ' A' ' 28' ' ' LYS . 11.1 mptt -91.24 140.85 29.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.045 0.45 . . . . 65.420000000000002 112.009 -176.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.94 -151.69 51.93 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 114.82 0.688 . . . . 41.329999999999998 114.82 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -117.3 143.71 45.64 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.882 0.473 . . . . 72.430000000000007 110.648 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -144.08 114.64 7.62 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.617 0.246 . . . . 71.019999999999996 111.007 -175.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -117.67 137.31 52.74 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.9 0.381 . . . . 63.109999999999999 111.434 -175.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -144.13 141.99 30.32 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.994 0.426 . . . . 73.430000000000007 111.484 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.2 m -99.89 118.0 35.4 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.033 0.444 . . . . 74.329999999999998 111.963 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.417 HD11 HG21 ' A' ' 12' ' ' ILE . 61.1 mt -92.63 97.01 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.326 -0.397 . . . . 70.439999999999998 110.701 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.62 148.01 31.83 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.029 0.442 . . . . 64.200000000000003 111.574 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -127.63 -152.14 7.83 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.45 -0.405 . . . . 71.420000000000002 112.361 177.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -70.94 123.62 22.44 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.24 0.543 . . . . 62.240000000000002 111.23 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.65 -134.71 22.59 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.325 -0.464 . . . . 52.310000000000002 112.722 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.85 15.47 16.55 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.996 0.427 . . . . 42.109999999999999 111.773 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.562 ' HB3' ' CD2' ' A' ' 82' ' ' HIS . 76.4 mt-30 -87.58 100.02 12.48 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.076 0.465 . . . . 75.319999999999993 111.526 -177.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -132.79 166.24 22.7 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.102 -0.499 . . . . 71.450000000000003 112.024 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -126.68 122.78 35.92 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.858 -0.61 . . . . 71.120000000000005 110.682 171.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.5 tp -92.26 110.44 21.83 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.724 0.297 . . . . 75.209999999999994 110.362 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.762 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.2 mmm -99.56 136.96 38.73 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.983 0.42 . . . . 63.329999999999998 111.869 -175.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -125.34 115.11 19.81 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.298 -0.41 . . . . 74.329999999999998 111.27 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.9 t -102.49 107.34 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.434 -0.348 . . . . 74.019999999999996 110.477 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -110.57 122.12 46.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.932 0.396 . . . . 63.149999999999999 110.987 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.4 -107.78 1.25 Allowed Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.125 -0.56 . . . . 61.439999999999998 112.32 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -120.86 25.5 9.64 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.06 0.457 . . . . 73.140000000000001 111.531 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -138.51 149.76 45.7 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.937 0.399 . . . . 64.310000000000002 111.517 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.6 tt -126.94 146.45 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 112.089 0.403 . . . . 74.299999999999997 112.089 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -148.74 168.77 22.01 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.985 0.422 . . . . 74.5 111.311 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.762 HG12 ' SD ' ' A' ' 45' ' ' MET . 33.8 mt -90.87 111.17 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.14 0.495 . . . . 54.509999999999998 110.086 169.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -74.45 -39.28 62.65 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.892 -0.595 . . . . 62.549999999999997 111.525 -175.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -149.93 148.87 29.63 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.275 -0.42 . . . . 73.530000000000001 110.142 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.29 130.73 9.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.353 0.597 . . . . 74.329999999999998 111.641 -175.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -96.28 64.35 2.27 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.326 0.584 . . . . 53.439999999999998 110.691 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 45.9 t -128.46 139.64 36.11 Favored Pre-proline 0 N--CA 1.473 0.677 0 CA-C-N 116.033 -0.531 . . . . 24.300000000000001 111.043 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 59' ' ' SER . 32.1 Cg_exo -58.27 -36.68 97.48 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.532 2.154 . . . . 71.439999999999998 112.749 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -76.5 -29.44 56.83 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.821 -0.627 . . . . 75.019999999999996 112.622 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 56.59 19.53 4.3 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.938 0.718 . . . . 71.109999999999999 112.938 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.5 t -53.94 -41.04 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 112.168 0.433 . . . . 72.200000000000003 112.168 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.558 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -57.83 -43.99 94.47 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.065 -0.588 . . . . 71.200000000000003 113.289 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.95 -37.83 81.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.006 0.431 . . . . 63.530000000000001 111.143 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -65.65 -40.27 92.31 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.309 0.485 . . . . 64.230000000000004 112.309 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.3 mmt -65.26 -41.28 94.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.828 0.347 . . . . 75.519999999999996 111.373 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.47 -129.75 28.43 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 114.367 0.507 . . . . 62.539999999999999 114.367 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -77.92 136.47 38.02 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.737 0.643 . . . . 71.340000000000003 112.737 -174.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 75.1 mmtt -132.58 144.26 50.26 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.902 -0.59 . . . . 72.209999999999994 109.883 173.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 95.4 p -162.0 13.57 0.08 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.363 0.875 . . . . 73.400000000000006 113.363 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -123.41 151.3 42.76 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.996 0.426 . . . . 64.530000000000001 112.056 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.64 111.62 1.49 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.26 0.552 . . . . 72.25 111.276 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 121.37 -21.53 8.12 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 121.314 -0.47 . . . . 62.329999999999998 112.435 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.527 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 80.1 m-20 -63.74 123.14 18.12 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.81 0.338 . . . . 62.420000000000002 111.226 176.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 65.8 p -130.65 141.93 50.43 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.403 0.621 . . . . 72.140000000000001 112.293 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.5 mm -114.8 118.37 58.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.833 -0.621 . . . . 75.019999999999996 110.258 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.3 t -112.31 115.73 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.924 0.392 . . . . 72.519999999999996 111.778 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 76.6 m -121.66 79.26 1.54 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.029 0.442 . . . . 51.32 110.825 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.498 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 93.1 mt -59.11 -47.02 99.29 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 113.091 0.775 . . . . 73.510000000000005 113.091 -175.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.498 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 50.7 Cg_exo -56.07 -17.36 19.42 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 122.255 1.97 . . . . 71.25 113.611 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.562 ' CD2' ' HB3' ' A' ' 41' ' ' GLN . 64.6 m170 -117.33 -1.81 11.7 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 122.14 -0.35 . . . . 64.540000000000006 111.612 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 66.4 mttm 59.37 28.33 17.66 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.071 -0.513 . . . . 73.420000000000002 112.194 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.7 t -100.56 132.89 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.487 -0.324 . . . . 65.409999999999997 111.061 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -136.68 118.21 14.85 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.004 0.431 . . . . 71.319999999999993 111.023 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.2 t -112.31 132.14 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 116.374 -0.375 . . . . 74.120000000000005 110.851 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -131.96 131.86 42.99 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.126 0.488 . . . . 53.100000000000001 111.367 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 58.4 mt -97.68 130.02 46.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.182 0.515 . . . . 74.519999999999996 111.307 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -137.74 153.96 49.67 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.058 -0.519 . . . . 61.240000000000002 110.932 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 47.7 t -89.86 149.89 22.46 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.09 -0.381 . . . . 64.129999999999995 111.264 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.2 p -65.8 -22.02 66.53 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.017 0.437 . . . . 71.430000000000007 110.807 175.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -94.97 161.94 13.94 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.194 0.521 . . . . 61.539999999999999 111.579 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp -67.51 149.16 50.53 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.434 0.531 . . . . 62.43 112.434 -175.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -97.59 115.37 27.75 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.016 0.436 . . . . 61.439999999999998 110.493 173.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 65.9 p -85.83 106.53 17.12 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.029 0.443 . . . . 72.010000000000005 111.009 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.528 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 9.2 mtpm? -116.23 178.74 4.21 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 122.196 0.998 . . . . 74.219999999999999 113.15 -175.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -68.74 147.77 97.96 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 114.122 -1.399 . . . . 63.100000000000001 112.304 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.12 -18.84 5.96 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.529 2.152 . . . . 63.509999999999998 112.869 173.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -128.8 94.42 3.84 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.636 0.255 . . . . 62.149999999999999 111.266 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.6 m -76.84 68.17 3.0 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.528 0.68 . . . . 64.120000000000005 109.938 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -126.74 -7.39 6.18 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.539 -0.755 . . . . 74.030000000000001 111.156 -175.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 102' ' ' LEU . 2.1 pp -144.34 153.07 41.6 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.989 -0.55 . . . . 73.430000000000007 111.178 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.2 mt -84.96 -47.46 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.114 0.483 . . . . 52.329999999999998 111.164 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.5 m -103.16 123.34 42.18 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.314 -0.403 . . . . 74.400000000000006 111.475 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.64 107.24 1.02 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.761 2.307 . . . . 73.400000000000006 112.571 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -121.17 175.91 5.87 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.109 0.48 . . . . 71.430000000000007 111.95 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 107' ' ' LEU . 2.9 mm? -90.17 -10.39 44.68 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.418 0.525 . . . . 75.299999999999997 112.418 -174.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -71.24 101.96 2.44 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.931 0.395 . . . . 74.209999999999994 112.008 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -81.17 70.82 8.09 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.182 0.515 . . . . 53.409999999999997 110.428 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -57.76 117.63 4.45 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.84 -0.618 . . . . 75.230000000000004 112.202 -174.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 73.12 2.97 4.54 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.646 -0.706 . . . . 63.229999999999997 112.278 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -118.11 105.01 11.39 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 122.032 -0.417 . . . . 74.530000000000001 111.259 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -88.95 -56.94 3.08 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.762 0.315 . . . . 74.019999999999996 111.719 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 C--O 1.254 1.313 0 CA-C-O 118.903 -0.57 . . . . 72.319999999999993 111.332 -178.697 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtm . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.006 0.431 . . . . 72.239999999999995 111.757 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 2' ' ' LYS . 38.4 mmtm -137.84 112.69 8.99 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.991 -0.549 . . . . 65.219999999999999 109.694 171.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -53.85 130.79 38.36 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.355 0.872 . . . . 74.109999999999999 113.355 -170.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.4 p -96.64 159.58 14.85 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.77 -0.65 . . . . 70.120000000000005 110.834 176.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.24 0.24 1.99 Allowed Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.85 -0.691 . . . . 13.15 113.391 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -82.28 78.66 8.91 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.892 0.377 . . . . 74.310000000000002 110.438 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.466 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 44.5 mt-10 -80.79 104.5 11.35 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.096 0.776 . . . . 75.329999999999998 113.096 -170.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 71' ' ' SER . 35.7 m -137.67 160.39 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 115.921 -0.581 . . . . 62.43 112.176 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 23' ' ' PRO . 29.8 m -131.43 146.54 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.064 -0.516 . . . . 71.010000000000005 110.788 176.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.97 116.53 30.37 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.918 0.39 . . . . 52.5 111.949 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.403 ' HB ' ' HG2' ' A' ' 87' ' ' GLU . 44.5 mm -97.21 124.58 50.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.486 -0.325 . . . . 65.239999999999995 110.613 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.507 ' N ' HD12 ' A' ' 12' ' ' ILE . 2.9 mp -104.55 111.81 35.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.755 0.312 . . . . 61.299999999999997 111.156 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 18' ' ' VAL . 60.4 m -109.04 126.1 52.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.092 0.472 . . . . 72.409999999999997 111.584 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -118.39 133.08 56.18 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.157 -0.339 . . . . 72.25 110.972 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 65.14 12.4 7.94 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.316 0.488 . . . . 74.109999999999999 112.316 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.04 10.52 34.33 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.359 -0.448 . . . . 52.310000000000002 113.857 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -144.15 146.04 32.49 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.397 0.599 . . . . 72.420000000000002 111.734 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.49 ' HB ' HD13 ' A' ' 102' ' ' LEU . 59.2 t -59.95 138.41 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 116.35 -0.386 . . . . 73.230000000000004 111.324 177.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 47.1 pt -125.78 -12.39 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.338 0.495 . . . . 73.430000000000007 112.338 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -173.76 142.24 0.89 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.812 0.339 . . . . 75.340000000000003 111.71 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -125.22 119.0 27.26 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 116.488 -0.324 . . . . 74.239999999999995 110.821 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.547 HG21 HG21 ' A' ' 47' ' ' VAL . 3.3 mp -115.53 125.13 29.1 Favored Pre-proline 0 N--CA 1.476 0.861 0 N-CA-C 111.741 0.275 . . . . 74.120000000000005 111.741 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.523 ' HA ' HG12 ' A' ' 9' ' ' VAL . 15.3 Cg_exo -69.51 123.02 9.76 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.817 2.345 . . . . 45.229999999999997 112.377 173.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.07 -57.28 3.16 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.873 0.368 . . . . 74.209999999999994 111.498 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.466 ' OG1' ' HA ' ' A' ' 7' ' ' GLU . 13.2 m -65.26 127.3 31.14 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.086 0.469 . . . . 71.230000000000004 111.441 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.62 -1.67 81.75 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.053 -0.594 . . . . 53.140000000000001 112.767 -174.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -92.5 90.49 7.19 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.281 -0.541 . . . . 74.430000000000007 111.535 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.68 169.47 18.22 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.145 -0.479 . . . . 52.43 111.17 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.18 -165.25 43.1 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 114.626 0.61 . . . . 73.540000000000006 114.626 175.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -118.44 126.04 51.21 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.998 0.519 . . . . 71.299999999999997 110.825 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -139.6 130.89 26.71 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.768 0.318 . . . . 53.450000000000003 111.08 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -122.8 153.71 39.18 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.042 0.449 . . . . 70.099999999999994 112.057 -173.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -150.33 138.22 20.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.912 0.387 . . . . 74.519999999999996 111.364 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.5 m -101.6 123.53 45.76 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.041 0.448 . . . . 62.210000000000001 112.169 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.8 mt -97.84 129.53 47.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.143 -0.48 . . . . 63.140000000000001 110.897 176.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -105.75 142.46 35.44 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.079 0.466 . . . . 75.049999999999997 111.827 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.29 -157.91 32.5 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 116.253 -0.431 . . . . 73.400000000000006 113.531 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -92.82 23.29 4.24 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.154 0.427 . . . . 71.349999999999994 112.154 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 175.14 -130.75 1.8 Allowed Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.331 -0.461 . . . . 62.240000000000002 112.139 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.03 67.43 3.87 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.415 0.626 . . . . 60.409999999999997 110.724 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -144.19 130.15 19.44 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.885 -0.598 . . . . 62.25 111.324 -175.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -147.84 144.62 28.28 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.697 0.284 . . . . 74.25 111.143 172.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -128.85 110.92 12.55 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.325 -0.398 . . . . 65.109999999999999 110.623 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.4 tp -87.04 104.85 16.72 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.894 0.378 . . . . 72.150000000000006 110.872 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.815 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.0 mmm -90.58 135.91 33.4 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.37 -0.377 . . . . 72.239999999999995 111.272 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -126.83 117.14 22.02 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.961 0.41 . . . . 72.430000000000007 111.986 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.547 HG21 HG21 ' A' ' 22' ' ' ILE . 21.9 t -101.17 107.45 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.065 -0.516 . . . . 63.009999999999998 110.238 175.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.46 ' HB3' ' CZ3' ' A' ' 69' ' ' TRP . 28.2 t70 -128.17 117.66 21.98 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.934 0.397 . . . . 44.109999999999999 111.424 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 60.33 60.75 8.01 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 121.205 -0.522 . . . . 50.219999999999999 114.169 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 57.76 18.33 4.77 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.914 1.079 . . . . 52.450000000000003 113.914 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.545 ' HD2' ' HB3' ' A' ' 69' ' ' TRP . 29.3 ptt180 -146.46 152.33 38.85 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.864 0.364 . . . . 72.209999999999994 110.899 174.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.5 tt -129.04 151.25 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.81 0.67 . . . . 65.140000000000001 112.81 -170.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.99 168.82 25.77 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.763 -0.653 . . . . 72.319999999999993 110.238 170.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.815 HG12 ' SD ' ' A' ' 45' ' ' MET . 59.4 mt -81.38 121.97 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.943 0.402 . . . . 74.030000000000001 110.387 174.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -84.35 -37.9 21.0 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 116.216 -0.447 . . . . 65.329999999999998 111.895 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -161.07 138.29 8.99 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.389 -0.369 . . . . 72.030000000000001 111.291 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.13 162.61 25.7 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.907 0.384 . . . . 64.319999999999993 110.51 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -98.59 64.45 1.52 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.567 0.699 . . . . 71.319999999999993 111.676 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.0 p -114.03 141.68 26.67 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-N 115.768 -0.651 . . . . 64.129999999999995 110.27 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.78 -23.24 26.39 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.183 1.922 . . . . 64.239999999999995 112.796 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.497 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.5 m-20 -87.63 -39.71 14.81 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.12 0.415 . . . . 71.420000000000002 112.12 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 61.04 23.24 13.43 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.513 0.56 . . . . 71.319999999999993 112.513 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.497 HG23 ' HB3' ' A' ' 61' ' ' ASP . 60.9 t -56.24 -34.79 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.898 0.38 . . . . 71.299999999999997 111.15 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.626 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -55.98 -47.1 82.28 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 116.275 -0.42 . . . . 62.009999999999998 113.17 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.2 t -73.77 -34.25 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.243 0.544 . . . . 74.140000000000001 110.956 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -60.22 -28.76 68.26 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.845 -0.616 . . . . 64.310000000000002 111.506 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 23.1 mmt -55.76 -34.27 65.07 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.327 0.491 . . . . 74.340000000000003 112.327 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.71 -163.64 53.64 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.977 -0.63 . . . . 50.5 113.425 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.545 ' HB3' ' HD2' ' A' ' 51' ' ' ARG . 94.0 m95 -73.39 110.32 7.58 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.853 0.359 . . . . 74.420000000000002 111.793 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -108.41 137.59 46.11 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.053 0.454 . . . . 72.510000000000005 111.674 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.404 ' O ' HG21 ' A' ' 8' ' ' VAL . 91.1 p -161.65 25.44 0.12 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.255 -0.43 . . . . 73.420000000000002 111.682 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -115.78 141.1 48.54 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.897 0.38 . . . . 72.140000000000001 111.599 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.4 106.64 1.16 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.978 0.418 . . . . 75.25 111.15 176.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 125.44 -7.24 7.98 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.011 -0.614 . . . . 74.319999999999993 113.342 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -92.71 142.0 27.84 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.138 0.494 . . . . 54.530000000000001 111.47 175.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.52 HG22 ' HA ' ' A' ' 87' ' ' GLU . 66.7 p -135.24 153.41 51.93 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.043 -0.526 . . . . 73.299999999999997 111.771 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 32.6 mm -112.97 128.33 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 116.346 -0.388 . . . . 73.340000000000003 110.351 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 50.5 t -115.39 120.1 63.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 112.191 0.441 . . . . 74.150000000000006 112.191 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.461 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 73.1 m -120.94 81.0 1.71 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.26 0.552 . . . . 71.519999999999996 110.3 171.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.445 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 4.3 tt -57.04 -53.75 61.88 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 115.498 -0.774 . . . . 74.099999999999994 112.253 -173.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 80' ' ' LEU . 44.1 Cg_endo -65.89 -9.62 23.79 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 122.26 1.973 . . . . 52.350000000000001 113.537 -176.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -114.34 -4.91 12.94 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 122.06 -0.4 . . . . 74.409999999999997 111.73 177.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 66.8 mttm 57.39 36.64 27.37 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.275 0.559 . . . . 63.130000000000003 111.481 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 59.4 t -111.69 138.71 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.875 -0.602 . . . . 62.549999999999997 110.979 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -140.93 148.42 40.38 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.358 -0.383 . . . . 64.530000000000001 110.475 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.439 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 57.3 t -139.46 113.79 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 122.257 -0.277 . . . . 74.430000000000007 111.439 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.52 ' HA ' HG22 ' A' ' 76' ' ' THR . 1.4 pm0 -106.92 126.7 52.66 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.343 0.592 . . . . 72.310000000000002 111.788 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.8 mt -95.71 122.3 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-O 121.024 0.44 . . . . 70.049999999999997 111.597 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.1 151.76 40.57 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.434 -0.348 . . . . 62.109999999999999 111.196 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.0 t -76.3 149.34 37.1 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.868 0.365 . . . . 74.209999999999994 111.905 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.442 HG22 HG13 ' A' ' 9' ' ' VAL . 27.5 p -77.09 -27.43 54.19 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.006 0.432 . . . . 64.430000000000007 111.246 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -69.77 -178.46 1.52 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.324 -0.398 . . . . 74.219999999999999 111.075 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -77.34 60.6 2.03 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.146 0.498 . . . . 61.100000000000001 111.536 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -67.47 107.7 2.56 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.765 -0.457 . . . . 61.439999999999998 109.765 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.3 m -62.72 81.24 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.054 0.454 . . . . 64.230000000000004 112.198 -173.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -132.04 169.13 16.78 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.265 0.555 . . . . 74.420000000000002 111.264 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.79 147.17 80.8 Favored Pre-proline 0 CA--C 1.545 0.755 0 CA-C-N 115.883 -0.599 . . . . 75.049999999999997 110.675 170.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.77 -70.04 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.259 1.973 . . . . 71.25 114.241 -174.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 55.12 16.92 1.74 Allowed 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.197 0.522 . . . . 62.439999999999998 112.099 -173.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.1 m -96.04 12.89 28.95 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.487 0.66 . . . . 71.219999999999999 110.396 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.6 87.89 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.485 0.66 . . . . 73.420000000000002 110.952 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.49 HD13 ' HB ' ' A' ' 18' ' ' VAL . 51.0 tp -81.67 100.26 9.36 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.387 0.613 . . . . 74.120000000000005 112.165 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 64.1 mt -92.49 110.38 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.081 -0.509 . . . . 62.43 110.131 172.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.2 m -61.67 139.85 95.25 Favored Pre-proline 0 CA--C 1.541 0.635 0 CA-C-O 120.511 0.196 . . . . 64.540000000000006 111.437 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.683 ' HB2' HD13 ' A' ' 107' ' ' LEU . 36.5 Cg_endo -63.47 145.68 92.42 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.575 2.183 . . . . 72.109999999999999 113.097 -177.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -85.11 15.56 4.08 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.899 0.333 . . . . 74.310000000000002 111.899 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 105' ' ' PRO . 10.0 mp -61.1 139.0 58.19 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.961 0.41 . . . . 53.240000000000002 111.498 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.41 119.92 14.42 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.375 -0.375 . . . . 72.420000000000002 111.079 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -61.72 125.83 25.2 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.335 0.588 . . . . 71.549999999999997 111.03 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.545 ' HA ' ' O ' ' A' ' 113' ' ' HIS . 96.9 m-70 -79.98 14.51 1.79 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.362 0.875 . . . . 74.329999999999998 113.362 -168.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -86.72 -51.58 6.02 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.893 0.378 . . . . 73.209999999999994 110.768 174.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -96.74 4.97 51.5 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.996 0.427 . . . . 72.109999999999999 111.073 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.545 ' O ' ' HA ' ' A' ' 110' ' ' HIS . 58.9 t-80 -155.59 93.39 1.48 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.174 -0.467 . . . . 72.329999999999998 110.176 177.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 . . . . . 0 C--O 1.254 1.313 0 CA-C-O 118.553 -0.736 . . . . 71.200000000000003 112.382 -173.568 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.5 mmm . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 112.408 0.521 . . . . 44.240000000000002 112.408 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.96 -33.2 75.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.3 0.571 . . . . 75.010000000000005 110.256 172.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -70.58 117.3 11.93 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.659 -0.7 . . . . 64.420000000000002 110.058 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.2 p -53.47 121.78 8.38 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.619 0.6 . . . . 74.099999999999994 112.619 -175.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -123.92 71.19 0.44 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.301 -0.476 . . . . 55.329999999999998 113.682 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.54 73.85 2.56 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 122.376 -0.485 . . . . 74.420000000000002 110.417 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -120.13 108.55 14.38 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.091 0.472 . . . . 70.209999999999994 111.894 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.567 HG23 ' HB2' ' A' ' 24' ' ' LEU . 30.8 m -110.1 144.82 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 121.287 0.565 . . . . 62.409999999999997 112.102 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.5 m -124.11 138.88 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.266 -0.425 . . . . 54.32 111.483 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.04 119.97 36.52 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.887 0.375 . . . . 54.5 111.288 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.6 mm -104.27 113.37 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.564 -0.289 . . . . 74.439999999999998 111.029 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 12' ' ' ILE . 3.1 mp -98.69 125.74 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 120.841 0.353 . . . . 75.400000000000006 110.894 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.5 t -128.8 152.63 48.26 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.068 0.461 . . . . 42.119999999999997 112.174 -176.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -146.91 142.87 28.05 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.017 -0.538 . . . . 65.200000000000003 110.734 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.7 14.02 5.79 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.407 0.521 . . . . 74.329999999999998 112.407 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.17 16.34 47.67 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.197 -0.525 . . . . 62.329999999999998 113.577 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -138.41 140.94 39.56 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.415 -0.462 . . . . 61.350000000000001 111.256 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -63.02 128.26 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 110.12 -0.326 . . . . 55.200000000000003 110.12 174.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.2 pt -109.23 -28.76 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 112.35 0.5 . . . . 74.030000000000001 112.35 -177.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -162.65 138.4 7.18 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.921 0.391 . . . . 71.340000000000003 111.494 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -124.48 119.45 29.17 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.591 -0.277 . . . . 71.140000000000001 111.493 -177.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.412 HG21 HG11 ' A' ' 47' ' ' VAL . 3.3 mp -112.81 116.17 47.92 Favored Pre-proline 0 N--CA 1.472 0.648 0 CA-C-O 120.626 0.251 . . . . 73.409999999999997 111.148 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.76 113.24 3.31 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.161 1.907 . . . . 52.25 111.579 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.567 ' HB2' HG23 ' A' ' 8' ' ' VAL . 85.4 mt -69.75 -58.68 3.61 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.853 0.316 . . . . 74.299999999999997 111.853 -175.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.6 m -54.15 131.04 40.39 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.133 0.492 . . . . 74.209999999999994 111.328 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.11 -16.14 56.36 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 121.089 -0.577 . . . . 60.240000000000002 113.975 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.506 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 60.3 t-80 -76.4 76.2 3.15 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.716 0.758 . . . . 74.219999999999999 110.86 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -78.23 92.75 4.51 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.972 -0.558 . . . . 74.540000000000006 111.43 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.8 -168.48 31.15 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 116.267 -0.424 . . . . 63.420000000000002 112.513 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -118.17 150.41 39.44 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.072 0.463 . . . . 71.340000000000003 111.42 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.536 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 12.4 tp10 -149.23 148.29 29.41 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.492 -0.322 . . . . 62.420000000000002 110.918 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -138.36 129.7 27.45 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.086 0.469 . . . . 72.420000000000002 111.689 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -145.82 131.86 19.29 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.209 0.528 . . . . 75.109999999999999 110.955 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.9 m -105.53 130.69 53.54 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.27 -0.423 . . . . 70.010000000000005 111.752 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.525 ' N ' HD12 ' A' ' 35' ' ' ILE . 3.2 mp -99.16 114.14 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.481 -0.327 . . . . 65.010000000000005 110.362 175.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -101.46 108.11 19.6 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.721 0.296 . . . . 73.340000000000003 111.505 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.68 -105.21 0.37 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.065 -0.588 . . . . 72.329999999999998 112.021 174.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -82.61 78.65 9.2 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 122.343 -0.504 . . . . 73.420000000000002 111.361 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.67 -87.23 0.01 OUTLIER Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.194 -0.457 . . . . 70.230000000000004 114.104 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.26 -21.17 62.13 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.136 0.421 . . . . 71.400000000000006 112.136 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -78.29 73.72 4.85 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.138 0.494 . . . . 72.319999999999993 111.25 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 58' ' ' ASN . 35.4 p90 -100.58 162.56 12.85 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.978 -0.555 . . . . 63.420000000000002 111.841 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -136.39 114.04 11.05 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.086 -0.507 . . . . 71.310000000000002 110.671 173.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.6 tp -89.64 103.28 15.94 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.989 0.423 . . . . 74.299999999999997 111.392 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.809 ' SD ' HG12 ' A' ' 54' ' ' ILE . 88.6 mmm -96.64 138.61 33.94 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.056 -0.52 . . . . 71.120000000000005 111.377 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -129.23 126.27 38.76 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.881 0.372 . . . . 75.439999999999998 111.466 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 56.4 t -110.54 115.25 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.067 0.46 . . . . 65.239999999999995 111.328 178.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.456 ' HB2' ' CH2' ' A' ' 69' ' ' TRP . 14.9 t70 -108.44 171.93 7.13 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.696 -0.483 . . . . 70.420000000000002 109.696 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 27' ' ' HIS . . . -37.27 90.38 0.01 OUTLIER Glycine 0 CA--C 1.535 1.282 0 N-CA-C 114.85 0.7 . . . . 34.109999999999999 114.85 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 66.08 32.09 8.47 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.506 0.722 . . . . 71.530000000000001 112.888 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.419 ' HG3' ' HB3' ' A' ' 48' ' ' ASP . 23.3 ptt180 -155.47 151.26 27.53 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 122.644 0.378 . . . . 71.140000000000001 111.144 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 tt -136.83 150.47 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 120.825 0.345 . . . . 63.229999999999997 111.919 -177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.552 ' NH2' ' HE3' ' A' ' 55' ' ' LYS . 21.4 ptt180 -155.62 168.58 26.69 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.222 0.535 . . . . 64.430000000000007 112.252 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.809 HG12 ' SD ' ' A' ' 45' ' ' MET . 62.1 mt -102.38 119.34 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.764 -0.653 . . . . 64.310000000000002 109.9 168.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.552 ' HE3' ' NH2' ' A' ' 53' ' ' ARG . 41.1 mtpt -78.57 -38.12 40.98 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.958 0.409 . . . . 72.140000000000001 110.728 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -169.63 138.78 1.93 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.518 -0.764 . . . . 70.420000000000002 111.425 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -142.37 161.56 37.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.975 -0.38 . . . . 74.129999999999995 109.975 170.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.439 ' HB2' ' CE1' ' A' ' 42' ' ' TYR . 61.2 t30 -84.95 66.29 9.66 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.152 0.501 . . . . 72.420000000000002 111.037 -176.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.3 t -129.05 145.75 57.89 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 116.224 -0.444 . . . . 73.219999999999999 111.146 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.52 -35.78 12.7 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.536 2.157 . . . . 62.219999999999999 113.16 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.467 ' HB2' HG23 ' A' ' 63' ' ' VAL . 1.6 p30 -77.59 -44.2 29.19 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.029 0.381 . . . . 75.109999999999999 112.029 -178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.513 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 24.7 mm-40 63.5 26.6 14.86 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.429 -0.351 . . . . 63.509999999999998 111.804 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.467 HG23 ' HB2' ' A' ' 61' ' ' ASP . 87.7 t -53.2 -41.61 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 120.849 0.357 . . . . 55.229999999999997 111.61 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.588 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -58.4 -38.48 90.78 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.32 -0.467 . . . . 74.430000000000007 113.258 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.35 -39.96 72.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.969 0.414 . . . . 74.530000000000001 111.06 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.513 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 4.6 mptp? -62.59 -29.91 70.95 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.364 -0.38 . . . . 60.520000000000003 111.301 176.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 21.2 mmt -61.2 -44.57 97.07 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.086 0.402 . . . . 70.340000000000003 112.086 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.26 -148.64 32.99 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.142 -0.552 . . . . 52.229999999999997 113.209 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.456 ' CH2' ' HB2' ' A' ' 48' ' ' ASP . 91.3 m95 -76.36 110.94 11.3 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.07 0.462 . . . . 75.230000000000004 111.867 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -103.88 143.78 32.38 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.379 -0.373 . . . . 73.439999999999998 110.885 175.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 64.2 p -169.19 18.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.502 0.556 . . . . 72.319999999999993 112.502 -173.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 72' ' ' LYS . 2.9 mptp? -116.86 144.93 43.93 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.82 0.343 . . . . 74.230000000000004 110.39 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.61 93.43 0.08 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.936 0.398 . . . . 74.109999999999999 111.346 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.09 -20.19 1.76 Allowed Glycine 0 CA--C 1.529 0.938 0 CA-C-N 116.029 -0.532 . . . . 52.229999999999997 113.364 -177.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.51 ' HB2' HD12 ' A' ' 88' ' ' ILE . 75.9 m-20 -66.25 135.35 54.33 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 117.096 0.448 . . . . 43.549999999999997 112.025 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.9 p -133.03 145.95 51.29 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.27 0.557 . . . . 73.349999999999994 111.692 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.53 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 35.0 mm -117.72 129.9 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 115.852 -0.613 . . . . 51.509999999999998 110.48 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.3 t -123.85 117.31 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 112.651 0.611 . . . . 61.219999999999999 112.651 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 90.3 m -115.77 81.22 1.56 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.244 0.545 . . . . 71.530000000000001 110.006 169.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.527 ' HB3' ' HD3' ' A' ' 81' ' ' PRO . 5.4 tt -55.76 -53.57 61.4 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 115.631 -0.713 . . . . 73.519999999999996 112.394 -172.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 80' ' ' LEU . 31.3 Cg_exo -60.04 -14.68 29.44 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.046 1.831 . . . . 72.299999999999997 113.381 -176.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -105.2 -3.65 22.69 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.994 0.368 . . . . 72.329999999999998 111.994 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.6 mttm 60.81 21.28 11.4 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 120.901 0.382 . . . . 75.430000000000007 111.491 -174.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.0 t -104.04 130.12 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 121.186 0.517 . . . . 54.219999999999999 111.365 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -135.93 136.57 40.55 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.002 -0.545 . . . . 75.519999999999996 111.061 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.53 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 46.4 t -128.7 144.56 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.396 -0.365 . . . . 73.319999999999993 110.519 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -143.6 144.74 32.05 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.204 0.526 . . . . 54.030000000000001 111.911 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.51 HD12 ' HB2' ' A' ' 75' ' ' ASP . 65.4 mt -106.18 111.7 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 115.941 -0.572 . . . . 74.540000000000006 111.096 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -118.09 143.06 46.77 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.022 -0.535 . . . . 74.519999999999996 110.654 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 22.8 t -85.54 122.87 30.29 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.861 -0.524 . . . . 73.519999999999996 110.471 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.661 HG23 ' HG2' ' A' ' 92' ' ' GLN . 9.7 t -77.86 -24.48 48.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.955 0.407 . . . . 73.030000000000001 111.352 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.661 ' HG2' HG23 ' A' ' 91' ' ' THR . 77.0 mm-40 -117.55 155.1 30.37 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.172 -0.467 . . . . 75.25 111.042 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.526 ' HB3' ' NZ ' ' A' ' 93' ' ' LYS . 4.8 mmmp? -97.78 129.31 44.79 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.171 0.51 . . . . 53.520000000000003 111.778 175.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -82.05 161.91 22.77 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.157 -0.474 . . . . 50.420000000000002 111.442 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 t -105.37 11.32 32.88 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.291 0.848 . . . . 64.040000000000006 113.291 -172.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -121.34 152.68 38.69 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.657 -0.652 . . . . 72.129999999999995 111.819 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -90.44 135.4 29.53 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 116.195 -0.457 . . . . 74.340000000000003 110.61 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.34 -5.37 16.42 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.569 2.179 . . . . 74.5 114.16 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -98.0 96.63 8.29 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.017 0.437 . . . . 70.5 111.34 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 59.8 p -106.13 133.14 51.3 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.562 -0.29 . . . . 75.109999999999999 111.657 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -140.32 162.24 35.76 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.213 0.53 . . . . 73.329999999999998 111.632 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.462 ' O ' HD12 ' A' ' 102' ' ' LEU . 0.5 OUTLIER -156.25 113.01 3.13 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.327 0.584 . . . . 74.450000000000003 111.82 177.043 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 50.6 mm -89.53 -42.79 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.342 0.591 . . . . 72.150000000000006 110.072 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.42 107.2 43.47 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.735 -0.666 . . . . 73.519999999999996 111.137 176.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.62 115.59 3.46 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.494 2.129 . . . . 74.420000000000002 112.644 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -126.09 159.88 31.64 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.815 0.34 . . . . 74.329999999999998 111.717 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 87.4 mt -68.55 159.95 30.88 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.856 0.36 . . . . 75.219999999999999 111.723 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.37 127.36 30.97 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.18 0.514 . . . . 65.219999999999999 109.673 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -79.08 27.49 0.24 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.738 1.014 . . . . 74.219999999999999 113.738 -168.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -58.11 -28.6 64.78 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.048 0.452 . . . . 73.140000000000001 111.289 171.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -89.48 121.84 32.09 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.348 -0.387 . . . . 74.420000000000002 111.29 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -125.25 147.19 49.19 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.861 0.362 . . . . 74.400000000000006 111.107 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -111.27 19.97 17.79 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.548 0.69 . . . . 73.349999999999994 110.393 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 . . . . . 0 C--O 1.254 1.32 0 CA-C-N 115.659 -0.7 . . . . 72.310000000000002 111.161 -179.833 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 111.83 0.307 . . . . 55.25 111.83 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -87.32 90.92 8.54 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.118 0.485 . . . . 75.420000000000002 111.32 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -87.55 86.69 7.24 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.026 0.441 . . . . 65.109999999999999 110.521 176.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.7 p -74.94 135.17 41.43 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.514 0.561 . . . . 70.030000000000001 112.514 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.05 -30.16 11.56 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.998 -0.546 . . . . 65.25 113.187 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -68.64 96.29 0.71 Allowed 'General case' 0 CA--C 1.536 0.427 0 O-C-N 122.557 -0.378 . . . . 72.25 111.626 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.441 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 42.9 mt-10 -91.29 102.97 15.68 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.121 0.486 . . . . 52.420000000000002 110.292 172.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.87 150.71 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 113.0 0.741 . . . . 65.230000000000004 113.0 -171.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.69 140.15 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 115.643 -0.708 . . . . 73.340000000000003 110.905 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.85 111.93 23.78 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.84 0.352 . . . . 62.32 111.431 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.1 mm -96.2 113.66 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.348 -0.387 . . . . 64.109999999999999 110.968 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.524 ' N ' HD12 ' A' ' 12' ' ' ILE . 2.9 mp -95.62 123.57 47.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.83 0.347 . . . . 41.329999999999998 111.387 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.6 p -125.58 146.61 49.61 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.008 0.432 . . . . 74.209999999999994 111.171 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.51 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 63.1 tt0 -130.9 131.25 44.39 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.544 -0.298 . . . . 62.119999999999997 110.204 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.1 m120 57.5 15.58 2.83 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.057 0.391 . . . . 61.020000000000003 112.057 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.98 -20.28 31.42 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.314 -0.469 . . . . 52.229999999999997 114.034 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -98.35 140.77 32.13 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.323 0.562 . . . . 60.420000000000002 111.85 -177.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.27 122.64 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.954 0.407 . . . . 65.510000000000005 111.529 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.8 pt -111.03 -19.4 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 112.953 0.723 . . . . 74.0 112.953 -175.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -167.81 144.47 4.17 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.001 0.371 . . . . 74.519999999999996 112.001 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -128.91 122.73 30.89 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.396 0.278 . . . . 73.439999999999998 111.329 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.419 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.7 mp -118.32 113.86 36.81 Favored Pre-proline 0 N--CA 1.477 0.888 0 N-CA-C 111.713 0.264 . . . . 61.299999999999997 111.713 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.69 124.96 11.63 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.223 1.949 . . . . 74.420000000000002 111.851 171.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.9 mt -92.13 -47.78 7.07 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.9 0.704 . . . . 62.229999999999997 112.9 -172.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 7' ' ' GLU . 14.8 m -59.53 121.73 12.28 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.303 0.483 . . . . 72.540000000000006 112.303 -175.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.79 5.82 88.52 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.442 -0.409 . . . . 62.299999999999997 113.437 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.48 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 41.6 t-80 -70.82 87.38 0.7 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.314 0.578 . . . . 65.530000000000001 111.267 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -64.17 123.77 19.94 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.62 0.6 . . . . 75.219999999999999 112.62 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.5 -164.04 20.97 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 114.189 0.436 . . . . 55.310000000000002 114.189 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -118.61 128.86 54.94 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.559 0.343 . . . . 74.019999999999996 111.213 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -130.48 114.68 15.81 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.096 0.474 . . . . 72.129999999999995 111.634 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.439 ' HG2' ' HG3' ' A' ' 46' ' ' GLU . 68.0 mt-30 -109.82 145.12 37.26 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.281 -0.418 . . . . 72.420000000000002 111.126 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -151.19 145.78 25.65 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.002 0.43 . . . . 74.109999999999999 111.787 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 28.7 m -103.88 113.63 27.3 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.736 0.643 . . . . 72.140000000000001 112.736 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 61.1 mt -88.39 109.04 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.114 -0.494 . . . . 63.450000000000003 110.604 173.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -79.61 106.33 11.55 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.166 -0.334 . . . . 73.319999999999993 111.66 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.51 ' HA2' ' NE2' ' A' ' 14' ' ' GLN . . . -73.42 -171.02 21.3 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 120.865 -0.683 . . . . 62.32 112.754 176.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.465 ' HD2' ' HD2' ' A' ' 83' ' ' LYS . 27.0 mtpp -66.85 99.42 0.62 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.973 0.416 . . . . 74.409999999999997 111.751 -177.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.37 -118.22 5.73 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.231 -0.509 . . . . 43.130000000000003 113.121 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.01 -4.95 38.82 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.389 0.515 . . . . 63.409999999999997 112.389 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.645 ' HA ' ' HB3' ' A' ' 58' ' ' ASN . 59.0 mt-30 -82.49 81.44 8.31 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.463 0.649 . . . . 73.420000000000002 111.738 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.417 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 22.8 p90 -84.09 166.34 17.76 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.679 -0.691 . . . . 73.430000000000007 111.88 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.462 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 22.3 m120 -136.34 109.89 7.99 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.724 0.409 . . . . 63.130000000000003 110.715 173.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.9 tp -90.56 103.54 16.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.097 0.475 . . . . 74.400000000000006 110.562 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.729 ' SD ' HG12 ' A' ' 54' ' ' ILE . 94.9 mmm -89.94 144.55 25.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.129 -0.487 . . . . 65.219999999999999 111.108 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.616 ' HB3' ' NH1' ' A' ' 53' ' ' ARG . 71.6 tt0 -132.99 126.6 32.32 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.179 0.514 . . . . 72.010000000000005 111.734 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.1 t -103.81 119.42 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 115.838 -0.619 . . . . 63.340000000000003 110.848 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.481 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 34.9 t70 -107.9 97.77 7.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.275 0.559 . . . . 72.209999999999994 109.782 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 27' ' ' HIS . . . 65.87 -104.67 1.06 Allowed Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.819 -0.705 . . . . 70.430000000000007 112.377 -175.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -112.95 15.57 19.65 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.868 0.366 . . . . 75.209999999999994 111.949 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 18.6 ptp180 -131.54 150.24 52.22 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.524 -0.307 . . . . 73.200000000000003 110.925 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.7 tt -139.72 145.2 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 112.681 0.623 . . . . 63.43 112.681 -175.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.616 ' NH1' ' HB3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -159.41 168.61 25.86 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 116.1 -0.5 . . . . 74.400000000000006 111.311 173.44 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.729 HG12 ' SD ' ' A' ' 45' ' ' MET . 55.2 mt -73.96 122.16 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.107 0.48 . . . . 62.409999999999997 111.409 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -82.14 -51.04 8.37 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.093 -0.503 . . . . 75.219999999999999 111.441 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -154.04 136.85 15.31 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.223 -0.444 . . . . 63.039999999999999 110.317 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -157.15 -177.14 6.39 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.513 0.673 . . . . 74.109999999999999 111.962 179.249 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.645 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . 55.1 t-20 -115.15 75.58 0.94 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.423 -0.808 . . . . 73.040000000000006 110.593 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.8 t -136.94 148.16 61.9 Favored Pre-proline 0 N--CA 1.472 0.627 0 O-C-N 122.15 -0.344 . . . . 70.310000000000002 111.445 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.07 -15.89 23.0 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.116 1.877 . . . . 70.310000000000002 111.673 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -105.87 -43.65 4.82 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.89 -0.595 . . . . 63.310000000000002 111.566 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 53.17 56.6 7.25 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.517 0.675 . . . . 64.25 110.662 -177.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.3 t -53.46 -46.58 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.378 -0.828 . . . . 64.349999999999994 112.772 -171.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.564 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -60.01 -31.31 72.21 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.869 -0.682 . . . . 75.329999999999998 113.228 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.75 -38.2 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.035 0.445 . . . . 71.25 110.47 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -76.3 -28.71 57.08 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.191 -0.459 . . . . 71.209999999999994 111.944 174.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 17.2 mmt -62.68 -47.49 83.45 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.583 0.586 . . . . 73.030000000000001 112.583 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.41 -165.32 27.44 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 120.811 -0.709 . . . . 51.439999999999998 113.202 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.403 ' CE3' ' HG3' ' A' ' 51' ' ' ARG . 98.7 m95 -76.26 115.23 15.79 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.378 0.608 . . . . 75.549999999999997 112.474 -176.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.769 ' HD3' ' HB3' ' A' ' 75' ' ' ASP . 11.5 mmpt? -94.73 143.57 26.34 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.806 -0.633 . . . . 73.120000000000005 110.299 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 89.0 p -167.27 12.18 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.428 1.27 . . . . 63.329999999999998 114.428 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -131.63 153.14 50.24 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.808 -0.557 . . . . 65.120000000000005 111.865 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.12 100.09 0.11 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.094 0.473 . . . . 65.519999999999996 111.841 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.44 -24.16 2.51 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 116.062 -0.517 . . . . 41.43 112.033 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.769 ' HB3' ' HD3' ' A' ' 70' ' ' LYS . 62.8 m-20 -68.32 127.46 33.04 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.783 0.325 . . . . 71.409999999999997 111.387 174.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 87' ' ' GLU . 76.6 p -136.01 148.68 48.51 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.968 0.413 . . . . 65.319999999999993 111.271 177.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.2 mm -113.22 110.59 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 120.924 0.392 . . . . 74.439999999999998 110.533 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.5 t -98.73 116.88 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 116.14 -0.482 . . . . 51.100000000000001 111.322 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 71.5 m -118.99 73.32 0.92 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.94 0.4 . . . . 61.340000000000003 110.964 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.538 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 90.9 mt -54.07 -50.18 85.78 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 112.613 0.598 . . . . 71.310000000000002 112.613 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 34.7 Cg_exo -59.91 -12.84 20.08 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.018 1.812 . . . . 74.030000000000001 113.386 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.411 ' ND1' ' OD1' ' A' ' 43' ' ' ASN . 11.8 m170 -116.65 -11.64 10.99 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.124 0.416 . . . . 74.209999999999994 112.124 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.465 ' HD2' ' HD2' ' A' ' 38' ' ' LYS . 63.8 mttm 64.01 29.51 14.29 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.257 0.551 . . . . 71.140000000000001 112.05 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.4 HG22 ' HG3' ' A' ' 14' ' ' GLN . 59.3 t -108.9 135.71 46.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 116.008 -0.542 . . . . 62.140000000000001 110.711 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -135.75 128.65 31.27 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.09 0.471 . . . . 73.200000000000003 111.11 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.18 130.6 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.587 -0.279 . . . . 74.209999999999994 111.133 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.574 ' HA ' HG22 ' A' ' 76' ' ' THR . 3.2 pt-20 -114.19 147.74 38.42 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.011 0.434 . . . . 71.310000000000002 111.303 175.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 57.3 mt -111.8 112.14 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.014 0.435 . . . . 73.120000000000005 110.226 171.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.461 ' HZ2' ' HB3' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -119.65 163.04 17.98 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.275 -0.421 . . . . 74.510000000000005 111.649 -174.243 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.7 t -86.11 149.34 25.2 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.622 0.601 . . . . 73.200000000000003 112.622 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.2 p -83.68 -16.93 43.17 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.97 -0.559 . . . . 55.310000000000002 110.725 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -81.58 -173.52 4.45 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.126 -0.488 . . . . 64.120000000000005 111.47 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -80.87 74.35 7.85 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.192 0.52 . . . . 63.009999999999998 111.58 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -119.58 113.46 20.74 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.753 -0.658 . . . . 74.340000000000003 110.825 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 77.3 p -104.15 12.76 33.49 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.208 0.528 . . . . 73.420000000000002 111.344 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -90.0 35.99 0.86 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.265 -0.425 . . . . 74.439999999999998 111.571 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.62 150.03 37.79 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 116.204 -0.453 . . . . 72.420000000000002 111.965 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.07 -29.86 11.36 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.342 2.028 . . . . 63.109999999999999 113.646 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -124.45 178.62 5.3 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.143 0.424 . . . . 72.120000000000005 112.143 -176.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 67.3 p -82.33 112.39 19.26 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.195 0.813 . . . . 73.25 113.195 -172.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -161.54 126.33 3.48 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.351 -0.386 . . . . 73.019999999999996 110.522 172.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.9 tp -111.41 116.49 31.02 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.172 0.51 . . . . 62.340000000000003 111.994 -176.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.4 mt -63.14 131.23 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.856 -0.611 . . . . 73.439999999999998 111.804 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.7 m -86.53 125.11 68.43 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-O 121.058 0.456 . . . . 72.239999999999995 111.344 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -87.21 39.23 0.58 Allowed 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.859 2.373 . . . . 54.119999999999997 113.377 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -71.82 85.02 0.93 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.123 0.487 . . . . 74.319999999999993 112.208 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 107' ' ' LEU . 2.5 pt? -80.55 -13.53 59.0 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.302 -0.408 . . . . 71.140000000000001 111.314 176.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -70.61 160.08 33.2 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.995 -0.548 . . . . 74.109999999999999 111.386 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -95.47 133.67 39.18 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.992 0.425 . . . . 64.129999999999995 111.558 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -94.94 110.17 22.09 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.475 -0.329 . . . . 73.420000000000002 110.543 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -53.13 -47.65 68.53 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.27 0.47 . . . . 70.519999999999996 112.27 -173.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -80.0 130.87 35.61 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.883 0.373 . . . . 73.340000000000003 111.826 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -85.49 154.47 21.77 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.394 -0.366 . . . . 74.109999999999999 110.704 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.521 -0.752 . . . . 63.109999999999999 111.365 178.348 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 120.551 0.215 . . . . 61.350000000000001 111.036 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -99.26 99.49 10.46 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.011 0.434 . . . . 74.340000000000003 110.273 171.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -98.53 10.91 39.88 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.493 0.553 . . . . 73.409999999999997 112.493 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 87.4 m -67.3 127.76 33.85 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.877 0.37 . . . . 73.409999999999997 110.764 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.74 65.86 2.63 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.115 -0.564 . . . . 33.130000000000003 114.403 -173.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -74.25 78.65 1.81 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.802 0.811 . . . . 72.409999999999997 109.996 171.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.407 ' HA ' ' CB ' ' A' ' 25' ' ' THR . 46.0 mt-10 -71.58 128.97 37.56 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.079 -0.964 . . . . 63.049999999999997 113.339 -170.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.01 158.82 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.508 -0.769 . . . . 71.310000000000002 111.648 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 23' ' ' PRO . 23.6 m -134.36 148.6 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 116.262 -0.426 . . . . 54.219999999999999 111.053 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.71 115.94 28.4 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.826 0.346 . . . . 64.299999999999997 111.568 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.0 mm -99.02 116.07 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.282 -0.417 . . . . 74.420000000000002 111.22 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.49 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.0 mp -99.85 115.46 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.023 0.44 . . . . 72.040000000000006 111.489 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 18' ' ' VAL . 66.9 m -113.88 146.12 40.48 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.014 0.435 . . . . 73.540000000000006 111.467 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -141.33 140.19 33.74 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.402 -0.363 . . . . 75.099999999999994 110.278 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 61.38 14.75 5.98 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.338 0.496 . . . . 72.230000000000004 112.338 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.77 -11.12 41.73 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.272 -0.49 . . . . 75.230000000000004 114.037 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -125.72 156.18 39.77 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.229 -0.571 . . . . 74.510000000000005 111.91 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 62.0 t -74.98 132.78 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.781 0.325 . . . . 75.450000000000003 111.334 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 43.1 pt -117.28 -27.08 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 N-CA-C 112.586 0.587 . . . . 73.040000000000006 112.586 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.529 ' HG3' HD11 ' A' ' 22' ' ' ILE . 3.1 tpm_? -154.3 131.83 11.34 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 122.315 -0.241 . . . . 64.25 111.141 -174.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -130.29 114.28 15.44 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.594 0.235 . . . . 73.420000000000002 111.502 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.529 HD11 ' HG3' ' A' ' 20' ' ' ARG . 3.7 mp -114.4 130.15 24.26 Favored Pre-proline 0 N--CA 1.476 0.874 0 CA-C-O 120.545 0.212 . . . . 72.010000000000005 111.432 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.533 ' HA ' HG12 ' A' ' 9' ' ' VAL . 57.5 Cg_endo -70.77 134.11 25.15 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.189 1.926 . . . . 74.140000000000001 112.404 173.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.7 mt -97.64 -65.5 0.96 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.901 0.382 . . . . 75.230000000000004 111.654 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.407 ' CB ' ' HA ' ' A' ' 7' ' ' GLU . 8.0 m -63.43 126.87 28.9 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.835 0.35 . . . . 60.020000000000003 111.451 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.34 12.25 84.08 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.965 -0.636 . . . . 50.509999999999998 112.97 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -90.85 104.22 16.83 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.087 0.47 . . . . 55.350000000000001 111.246 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -87.74 123.8 32.92 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.224 -0.443 . . . . 74.510000000000005 111.557 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.8 -169.74 14.79 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.253 -0.498 . . . . 54.020000000000003 113.539 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -118.49 150.36 39.74 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 122.703 -0.292 . . . . 64.510000000000005 110.893 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 13.6 tp10 -144.7 114.54 7.31 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.625 0.25 . . . . 72.519999999999996 110.908 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -118.33 137.87 52.79 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.863 0.363 . . . . 74.439999999999998 111.928 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -152.09 136.56 16.84 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.245 0.545 . . . . 73.0 111.82 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.3 m -96.06 116.1 28.45 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.148 -0.478 . . . . 70.530000000000001 111.484 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 42' ' ' TYR . 62.0 mt -80.71 103.97 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.566 -0.288 . . . . 73.430000000000007 110.809 176.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -92.67 111.35 22.91 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.032 0.444 . . . . 75.150000000000006 111.301 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.22 -154.11 7.03 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.248 -0.501 . . . . 74.430000000000007 112.764 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -93.43 90.55 6.77 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.203 -0.586 . . . . 74.310000000000002 111.064 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.63 75.95 1.28 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 121.239 -0.505 . . . . 15.4 113.986 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 72.96 -41.37 0.5 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.206 1.187 . . . . 71.099999999999994 114.206 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -50.85 108.23 0.23 Allowed 'General case' 0 N--CA 1.477 0.903 0 O-C-N 122.155 -0.341 . . . . 74.450000000000003 111.605 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 33.6 p90 -131.25 159.99 36.19 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.993 0.738 . . . . 74.209999999999994 112.993 -174.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.426 ' ND2' ' ND1' ' A' ' 82' ' ' HIS . 41.2 m-80 -133.73 109.84 9.42 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.869 -0.605 . . . . 74.120000000000005 110.552 170.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.3 tp -82.67 104.04 12.63 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.878 0.371 . . . . 64.120000000000005 110.69 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.739 ' SD ' HG12 ' A' ' 54' ' ' ILE . 91.3 mmm -91.73 137.32 32.46 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.361 -0.381 . . . . 74.129999999999995 111.502 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -123.38 115.72 22.09 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.047 0.451 . . . . 73.310000000000002 111.168 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 44.3 t -105.61 107.53 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.106 -0.497 . . . . 73.5 110.537 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -112.21 117.44 32.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.743 0.306 . . . . 74.209999999999994 110.674 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.06 -111.23 3.18 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.831 -0.7 . . . . 62.340000000000003 112.809 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -112.51 17.02 19.61 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.9 0.381 . . . . 74.019999999999996 111.503 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.1 ptt-85 -133.93 140.94 47.12 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.097 0.475 . . . . 72.299999999999997 111.655 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.3 tt -124.32 147.53 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 116.389 -0.368 . . . . 73.310000000000002 111.881 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -150.96 168.81 23.4 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.889 0.376 . . . . 70.109999999999999 111.444 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.739 HG12 ' SD ' ' A' ' 45' ' ' MET . 26.4 mt -90.68 117.79 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.118 0.485 . . . . 74.200000000000003 110.155 168.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -81.13 -41.58 22.23 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.098 -0.501 . . . . 74.420000000000002 111.771 -176.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -159.46 138.53 11.08 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.759 0.281 . . . . 52.399999999999999 111.759 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -163.61 166.72 22.1 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.99 0.424 . . . . 53.140000000000001 111.198 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -111.19 63.66 0.61 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 120.967 0.413 . . . . 73.329999999999998 111.882 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.2 t -108.59 138.06 20.16 Favored Pre-proline 0 N--CA 1.477 0.918 0 O-C-N 122.051 -0.406 . . . . 63.32 111.013 175.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.49 ' HD2' ' HG2' ' A' ' 81' ' ' PRO . 36.6 Cg_endo -64.21 -27.14 64.39 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.769 2.313 . . . . 74.340000000000003 113.35 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.513 ' HB2' HG23 ' A' ' 63' ' ' VAL . 1.2 p30 -87.25 -43.53 12.12 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 111.945 0.35 . . . . 75.319999999999993 111.945 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 65.57 27.33 11.55 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.457 -0.338 . . . . 73.150000000000006 111.665 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.513 HG23 ' HB2' ' A' ' 61' ' ' ASP . 90.2 t -58.01 -41.68 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.037 0.446 . . . . 74.040000000000006 110.957 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.585 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -55.37 -48.02 72.07 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 116.036 -0.529 . . . . 44.119999999999997 113.074 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.7 t -62.45 -44.01 98.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 120.801 0.334 . . . . 62.539999999999999 111.372 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -59.74 -33.77 72.08 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.615 -0.266 . . . . 73.109999999999999 111.528 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.412 ' CE ' ' HA ' ' A' ' 67' ' ' MET . 5.3 mmt -57.9 -31.88 67.18 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.832 0.348 . . . . 64.040000000000006 111.902 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.96 -136.22 32.83 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.108 -0.567 . . . . 62.530000000000001 113.585 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -87.88 126.24 34.93 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.17 0.509 . . . . 74.140000000000001 111.879 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 34.4 mmtp -113.66 145.03 41.93 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.317 -0.623 . . . . 72.25 109.317 171.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.1 p -156.31 6.79 0.19 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.327 1.232 . . . . 75.319999999999993 114.327 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -130.12 156.26 44.83 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.67 -0.644 . . . . 72.420000000000002 112.179 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.06 126.5 27.72 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.004 -0.544 . . . . 53.049999999999997 111.239 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.37 -22.12 23.01 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.337 -0.458 . . . . 71.530000000000001 112.857 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.523 ' HB2' HD12 ' A' ' 88' ' ' ILE . 95.7 m-20 -68.2 131.58 45.64 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.964 0.411 . . . . 75.239999999999995 111.687 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.9 p -127.99 167.14 17.1 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.59 0.589 . . . . 63.240000000000002 112.59 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.588 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 40.0 mm -137.44 123.56 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.69 0.796 . . . . 74.140000000000001 109.885 177.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -113.99 117.76 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.256 0.465 . . . . 63.299999999999997 112.256 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 73.5 m -122.91 86.5 2.59 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.862 0.363 . . . . 63.439999999999998 111.309 174.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.59 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 92.2 mt -61.24 -53.95 58.02 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 112.804 0.668 . . . . 73.219999999999999 112.804 -175.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.59 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 17.1 Cg_exo -69.25 0.1 5.73 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.4 2.067 . . . . 71.430000000000007 113.362 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.426 ' ND1' ' ND2' ' A' ' 43' ' ' ASN . 65.1 m170 -119.1 -6.77 10.42 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 122.205 -0.309 . . . . 71.310000000000002 111.509 175.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.3 mttm 61.85 30.51 18.24 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.15 0.5 . . . . 73.219999999999999 111.762 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.51 138.84 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.101 -0.499 . . . . 61.32 111.346 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -141.71 125.8 17.33 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.115 -0.493 . . . . 74.010000000000005 110.886 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.588 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 57.5 t -116.6 135.44 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.561 0.219 . . . . 73.25 111.148 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.21 141.1 47.89 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.91 0.386 . . . . 71.430000000000007 111.278 176.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 75' ' ' ASP . 60.6 mt -101.5 115.97 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.17 0.509 . . . . 63.43 111.216 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -109.89 166.09 11.2 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.003 -0.544 . . . . 63.32 110.697 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.5 t -97.3 149.29 22.23 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.181 0.515 . . . . 63.109999999999999 111.32 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.5 p -80.37 -5.12 55.92 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.216 0.532 . . . . 74.129999999999995 110.973 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -89.07 -83.5 0.23 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.335 0.588 . . . . 73.519999999999996 111.528 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -161.1 129.68 4.51 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.481 -0.781 . . . . 61.439999999999998 111.766 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -124.99 136.47 53.76 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.317 -0.401 . . . . 62.43 110.115 174.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 31.8 t -89.08 147.9 23.99 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.027 0.442 . . . . 61.43 111.201 -177.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -139.18 174.96 9.97 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.318 0.58 . . . . 62.229999999999997 112.389 -175.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -86.69 156.92 55.68 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 115.479 -0.782 . . . . 63.329999999999998 111.208 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.35 -32.72 72.08 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.342 2.028 . . . . 52.409999999999997 113.249 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.74 85.65 0.21 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.137 0.494 . . . . 71.420000000000002 111.847 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 21.4 m -100.92 75.72 1.71 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.981 0.419 . . . . 64.239999999999995 110.998 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -154.97 153.63 31.32 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.357 -0.383 . . . . 74.040000000000006 110.955 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.553 HD12 ' O ' ' A' ' 102' ' ' LEU . 0.9 OUTLIER -106.36 120.77 42.76 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.503 0.668 . . . . 61.100000000000001 112.366 -177.489 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 52.6 mt -88.96 -20.35 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.354 0.597 . . . . 54.149999999999999 110.379 173.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.7 m -69.33 144.86 95.26 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 115.805 -0.634 . . . . 71.530000000000001 112.074 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.19 105.89 1.94 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.28 1.986 . . . . 64.120000000000005 112.632 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -63.24 94.62 0.08 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.182 0.515 . . . . 55.530000000000001 111.501 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 87.4 mt -70.52 160.41 32.51 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.087 -0.506 . . . . 70.120000000000005 111.476 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.72 165.44 11.21 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.58 0.705 . . . . 71.010000000000005 112.619 -176.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -172.31 105.46 0.18 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.173 -0.921 . . . . 73.219999999999999 109.091 169.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -44.37 -43.45 7.6 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.466 0.913 . . . . 73.450000000000003 113.466 -169.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 59.91 21.69 10.68 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.652 0.739 . . . . 61.409999999999997 110.443 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -101.06 116.19 32.25 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.428 -0.805 . . . . 75.129999999999995 111.385 -174.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -83.56 176.24 9.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.234 0.54 . . . . 73.340000000000003 111.749 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 39.6 m80 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.605 -0.712 . . . . 74.409999999999997 110.927 175.751 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.652 0.263 . . . . 72.219999999999999 110.773 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 56.02 69.13 0.77 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.393 -0.367 . . . . 65.219999999999999 111.909 -176.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -129.72 95.11 3.9 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.801 0.334 . . . . 75.230000000000004 111.881 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 t -106.94 139.33 41.52 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.48 -0.327 . . . . 35.109999999999999 111.039 173.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.53 -31.34 56.78 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.443 -0.408 . . . . 65.109999999999999 113.565 -177.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -111.73 144.7 40.59 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.081 0.467 . . . . 75.019999999999996 111.866 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.469 ' HB2' ' OG1' ' A' ' 91' ' ' THR . 47.7 mt-10 -95.16 130.98 41.67 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.271 -0.422 . . . . 65.25 110.749 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.0 m -123.67 142.17 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.095 0.474 . . . . 64.010000000000005 112.033 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 23' ' ' PRO . 27.5 m -119.93 140.19 44.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.278 -0.419 . . . . 72.25 111.224 177.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.94 114.53 26.37 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.893 0.378 . . . . 43.130000000000003 111.681 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.423 HG23 ' HG2' ' A' ' 21' ' ' GLU . 27.7 mm -98.69 110.79 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.338 -0.392 . . . . 65.530000000000001 110.979 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 12' ' ' ILE . 3.2 mp -101.42 125.69 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.06 0.457 . . . . 73.439999999999998 111.59 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 55.2 m -123.5 150.6 43.73 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.129 -0.487 . . . . 74.340000000000003 111.813 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.421 ' HG2' ' OD1' ' A' ' 15' ' ' ASN . 36.1 tt0 -129.01 135.24 48.68 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.412 0.285 . . . . 52.32 110.533 175.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.421 ' OD1' ' HG2' ' A' ' 14' ' ' GLN . 25.8 m120 59.64 8.66 1.34 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.859 0.464 . . . . 53.009999999999998 111.976 -174.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.95 -29.25 8.61 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 121.53 -0.367 . . . . 33.439999999999998 113.315 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -87.71 139.69 30.28 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.974 0.416 . . . . 65.310000000000002 111.486 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -71.22 130.54 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.316 -0.402 . . . . 64.310000000000002 111.115 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.466 HD11 HD13 ' A' ' 35' ' ' ILE . 34.2 pt -121.18 -29.24 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 112.897 0.703 . . . . 63.009999999999998 112.897 -176.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.506 ' HG3' HD11 ' A' ' 22' ' ' ILE . 9.2 tpm_? -151.29 123.19 8.1 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.125 0.488 . . . . 74.239999999999995 111.651 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.423 ' HG2' HG23 ' A' ' 11' ' ' ILE . 19.4 mt-10 -122.25 125.97 47.19 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.235 -0.439 . . . . 73.120000000000005 110.998 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.506 HD11 ' HG3' ' A' ' 20' ' ' ARG . 4.4 mp -120.63 123.62 27.97 Favored Pre-proline 0 N--CA 1.473 0.717 0 O-C-N 122.191 -0.318 . . . . 73.340000000000003 111.786 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.51 ' HA ' HG12 ' A' ' 9' ' ' VAL . 22.3 Cg_exo -66.27 111.88 2.16 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.257 1.971 . . . . 72.209999999999994 111.55 169.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 78.2 mt -75.65 -58.64 3.16 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.912 0.387 . . . . 74.150000000000006 111.244 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.451 HG21 ' HG2' ' A' ' 7' ' ' GLU . 35.8 m -60.5 118.83 6.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.836 0.351 . . . . 71.510000000000005 111.153 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 50' ' ' GLU . . . 98.49 -8.28 62.07 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.191 -0.528 . . . . 43.530000000000001 113.387 -176.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.41 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 54.2 t-80 -79.5 95.7 5.89 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.285 -0.538 . . . . 71.420000000000002 111.345 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.29 146.61 52.1 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.101 -0.5 . . . . 62.340000000000003 111.923 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.43 -158.57 53.27 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 116.1 -0.5 . . . . 72.439999999999998 114.183 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -118.39 151.34 37.95 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.834 0.349 . . . . 72.040000000000006 111.143 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -146.54 135.04 22.02 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.517 0.327 . . . . 74.420000000000002 110.462 -176.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -131.94 142.57 49.67 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.889 -0.507 . . . . 54.329999999999998 112.319 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -150.96 135.7 17.25 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.004 0.43 . . . . 73.019999999999996 111.431 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.8 m -98.74 127.65 44.74 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.396 -0.366 . . . . 70.129999999999995 111.139 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.466 HD13 HD11 ' A' ' 19' ' ' ILE . 68.8 mt -110.59 120.6 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 120.766 0.317 . . . . 73.310000000000002 111.377 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -97.41 128.72 44.44 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.116 0.484 . . . . 74.519999999999996 111.393 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.23 -114.48 3.66 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 116.261 -0.427 . . . . 65.340000000000003 112.787 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.651 ' HE2' ' HG3' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -99.17 141.82 31.45 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.911 0.355 . . . . 72.340000000000003 111.495 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.37 -100.63 0.19 Allowed Glycine 0 CA--C 1.531 1.068 0 CA-C-N 116.392 -0.367 . . . . 63.32 113.912 177.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.34 18.65 7.58 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.186 0.517 . . . . 73.099999999999994 111.664 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.651 ' HG3' ' HE2' ' A' ' 38' ' ' LYS . 12.5 mm100 -85.74 115.69 23.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.984 -0.553 . . . . 70.219999999999999 111.386 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -130.0 151.87 50.07 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.081 0.467 . . . . 62.310000000000002 112.189 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -127.66 116.8 20.84 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.061 -0.518 . . . . 74.209999999999994 110.639 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.6 tp -95.16 103.5 15.35 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.893 0.378 . . . . 72.329999999999998 110.501 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.665 ' SD ' HG12 ' A' ' 54' ' ' ILE . 92.5 mmm -92.33 136.74 32.95 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.232 -0.44 . . . . 64.209999999999994 111.274 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -124.55 115.35 20.71 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.953 0.406 . . . . 73.120000000000005 111.096 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.458 HG11 HG21 ' A' ' 22' ' ' ILE . 47.8 t -97.27 115.64 37.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.105 -0.498 . . . . 61.009999999999998 111.063 175.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -109.25 170.72 7.87 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.563 -0.29 . . . . 62.100000000000001 110.295 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 27' ' ' HIS . . . -37.53 95.33 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 N-CA-C 114.604 0.602 . . . . 61.43 114.604 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 31.4 mt-10 62.21 37.34 14.31 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.442 0.697 . . . . 75.310000000000002 112.682 176.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -165.21 161.95 19.67 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.381 -0.372 . . . . 75.230000000000004 111.017 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.3 tt -141.39 151.57 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 112.186 0.439 . . . . 72.099999999999994 112.186 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.436 ' HD3' ' CE2' ' A' ' 69' ' ' TRP . 14.1 ptt180 -152.18 168.97 23.61 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.905 0.383 . . . . 70.120000000000005 111.541 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.665 HG12 ' SD ' ' A' ' 45' ' ' MET . 46.3 mt -94.85 113.32 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.956 -0.387 . . . . 65.120000000000005 109.956 168.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -75.38 -46.73 31.2 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.736 0.303 . . . . 72.319999999999993 111.601 -177.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -143.15 140.36 30.76 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.834 0.349 . . . . 73.319999999999993 111.224 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -162.25 136.59 6.68 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.887 0.375 . . . . 65.25 111.271 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -107.8 51.36 0.74 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.208 0.527 . . . . 72.540000000000006 111.967 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.459 ' HG ' ' CD2' ' A' ' 82' ' ' HIS . 50.4 m -97.99 124.48 47.49 Favored Pre-proline 0 N--CA 1.473 0.719 0 O-C-N 122.141 -0.349 . . . . 60.200000000000003 110.213 172.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -52.78 -32.83 57.62 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.837 2.358 . . . . 65.549999999999997 113.226 -175.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -75.08 -31.46 61.22 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.365 -0.379 . . . . 74.109999999999999 111.857 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 28.3 mm-40 60.54 22.28 12.02 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.088 0.773 . . . . 72.299999999999997 113.088 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.5 t -53.36 -52.04 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 112.02 0.378 . . . . 71.010000000000005 112.02 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.94 -40.7 98.77 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.035 -0.602 . . . . 60.149999999999999 113.387 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.5 t -65.97 -33.7 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 120.998 0.428 . . . . 63.140000000000001 111.564 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 62' ' ' GLN . 67.5 mttm -70.71 -37.64 73.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.822 0.344 . . . . 65.310000000000002 111.398 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.3 mmt -60.35 -35.16 75.03 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.279 -0.418 . . . . 74.430000000000007 112.058 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.06 -119.51 8.05 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.251 -0.499 . . . . 51.32 113.948 175.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.436 ' CE2' ' HD3' ' A' ' 53' ' ' ARG . 69.3 m95 -94.92 138.93 32.02 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.173 0.434 . . . . 74.049999999999997 112.173 -175.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -131.23 151.4 51.51 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.195 -0.457 . . . . 63.43 110.233 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.4 p -164.97 15.74 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.368 0.877 . . . . 52.109999999999999 113.368 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.775 ' HE2' ' HA ' ' A' ' 72' ' ' LYS . 9.6 mmpt? -123.43 149.62 44.82 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.24 0.543 . . . . 64.25 112.069 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.64 109.49 1.42 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.029 -0.532 . . . . 62.030000000000001 110.587 176.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.24 -18.86 6.47 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 116.234 -0.439 . . . . 75.219999999999999 112.503 -176.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -69.84 115.35 8.96 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.779 0.323 . . . . 72.040000000000006 111.263 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 82.5 p -119.46 149.67 41.48 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.089 0.471 . . . . 60.25 111.465 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.434 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 46.9 mm -125.56 115.93 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.194 -0.457 . . . . 74.230000000000004 110.476 177.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.6 t -108.79 117.76 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 120.867 0.365 . . . . 42.350000000000001 111.777 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 71.0 m -120.82 84.54 2.25 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.086 0.469 . . . . 73.140000000000001 111.009 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.545 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 98.8 mt -57.98 -49.98 90.64 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 113.24 0.83 . . . . 63.409999999999997 113.24 -176.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 52.0 Cg_exo -56.7 -18.31 26.12 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 122.096 1.864 . . . . 70.319999999999993 113.519 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.459 ' CD2' ' HG ' ' A' ' 59' ' ' SER . 21.3 m170 -113.2 -4.78 13.71 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.7 0.286 . . . . 73.109999999999999 111.219 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 58.78 28.0 16.77 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.176 0.59 . . . . 72.299999999999997 112.292 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.1 t -101.9 133.88 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.02 0.438 . . . . 72.219999999999999 111.215 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -130.85 123.52 29.21 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.122 -0.49 . . . . 73.400000000000006 110.824 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.434 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 47.5 t -117.1 136.9 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 116.715 -0.221 . . . . 74.099999999999994 111.02 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -136.96 132.07 33.86 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.198 0.523 . . . . 73.409999999999997 111.092 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 62.1 mt -99.38 127.16 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.264 -0.426 . . . . 71.120000000000005 111.205 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -125.74 159.42 32.37 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.905 0.383 . . . . 71.340000000000003 111.617 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.1 t -79.66 149.78 31.14 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.253 -0.431 . . . . 55.340000000000003 111.059 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 7' ' ' GLU . 80.6 p -71.91 -21.45 61.62 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.864 0.364 . . . . 61.439999999999998 110.843 173.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -70.51 170.02 12.96 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.012 -0.54 . . . . 52.210000000000001 110.743 175.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -65.58 106.03 1.35 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.682 0.753 . . . . 73.439999999999998 109.498 171.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -73.02 161.16 31.01 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.115 -0.493 . . . . 65.530000000000001 111.998 -170.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 98.4 p -92.8 -9.37 40.71 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.226 -0.443 . . . . 73.319999999999993 112.181 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -61.33 152.8 28.37 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.702 0.763 . . . . 74.299999999999997 112.845 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.458 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 1.0 OUTLIER -74.53 140.28 75.3 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 114.964 -1.016 . . . . 75.349999999999994 111.4 -176.275 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 97' ' ' ASP . 37.7 Cg_exo -63.81 78.05 0.15 Allowed 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.069 2.512 . . . . 75.230000000000004 112.775 177.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -76.03 136.52 39.95 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.322 -0.854 . . . . 64.549999999999997 111.702 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -161.66 20.82 0.11 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.514 -0.766 . . . . 64.230000000000004 109.833 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -102.19 114.81 29.29 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.479 -0.782 . . . . 71.25 111.207 -173.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.3 pp -136.43 169.87 16.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.055 0.455 . . . . 64.329999999999998 112.043 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 65.1 mt -104.35 114.56 44.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.242 -0.435 . . . . 73.409999999999997 110.779 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.7 p -64.21 119.32 54.91 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 120.943 0.402 . . . . 73.310000000000002 111.735 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.85 120.66 7.01 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.509 2.139 . . . . 64.120000000000005 112.646 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -71.1 97.84 1.56 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.796 0.331 . . . . 72.420000000000002 110.441 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.418 ' N ' HD23 ' A' ' 107' ' ' LEU . 2.3 pt? -57.26 138.87 54.22 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.153 0.501 . . . . 71.540000000000006 111.494 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -70.25 142.74 52.29 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.163 -0.471 . . . . 74.299999999999997 111.408 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -74.71 68.12 1.65 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.558 0.694 . . . . 74.209999999999994 109.555 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -81.87 -5.41 58.22 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.038 0.755 . . . . 75.409999999999997 113.038 -169.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -74.32 75.25 1.86 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.229 0.538 . . . . 74.129999999999995 111.216 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -94.84 135.52 36.25 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.311 -0.404 . . . . 74.439999999999998 110.7 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -75.2 -177.76 3.61 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.808 0.337 . . . . 65.530000000000001 111.359 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 . . . . . 0 C--O 1.252 1.221 0 CA-C-O 118.964 -0.541 . . . . 63.32 111.987 -178.112 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ptp . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.907 0.384 . . . . 62.130000000000003 111.324 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -139.0 114.1 9.45 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.369 -0.378 . . . . 64.230000000000004 111.262 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -77.66 151.05 34.45 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.832 0.349 . . . . 74.219999999999999 110.445 175.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.6 p -69.95 -40.22 75.57 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.747 0.647 . . . . 75.140000000000001 112.747 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.68 1.03 76.07 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.176 -0.535 . . . . 63.5 112.374 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -143.89 147.48 34.07 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 122.876 0.471 . . . . 73.219999999999999 109.874 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.575 ' HA ' ' HB ' ' A' ' 25' ' ' THR . 42.7 mt-10 -66.17 96.88 0.35 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.597 0.591 . . . . 55.420000000000002 112.597 -174.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.485 HG22 ' OG1' ' A' ' 25' ' ' THR . 27.6 m -102.83 152.08 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.287 0.565 . . . . 53.450000000000003 111.77 176.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 23' ' ' PRO . 35.5 m -127.42 142.41 43.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.145 -0.48 . . . . 62.409999999999997 111.682 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.39 116.38 28.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.944 0.402 . . . . 53.43 111.237 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 34.4 mm -99.34 107.06 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.27 -0.423 . . . . 70.439999999999998 111.711 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.4 mp -96.7 129.03 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.049 0.452 . . . . 75.120000000000005 111.029 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 m -130.99 156.7 44.68 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.055 0.455 . . . . 73.439999999999998 111.75 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -149.77 142.86 24.97 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 116.239 -0.437 . . . . 75.209999999999994 110.428 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.2 m120 60.52 19.79 9.59 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.234 0.457 . . . . 74.439999999999998 112.234 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.36 4.13 68.68 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 120.994 -0.622 . . . . 62.399999999999999 114.034 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -126.62 149.41 49.5 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.355 0.577 . . . . 72.5 111.896 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.6 t -68.6 132.16 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.524 -0.307 . . . . 60.520000000000003 110.945 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.5 pt -122.58 -20.14 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.041 0.756 . . . . 62.219999999999999 113.041 -176.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -160.12 138.1 9.98 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.027 -0.421 . . . . 64.209999999999994 111.737 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -134.79 124.27 24.88 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 120.573 0.225 . . . . 71.519999999999996 111.362 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.96 126.51 26.31 Favored Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 111.63 0.233 . . . . 74.530000000000001 111.63 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.498 ' HA ' HG12 ' A' ' 9' ' ' VAL . 15.2 Cg_exo -69.12 117.84 5.3 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.694 2.263 . . . . 62.130000000000003 112.2 172.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.8 mt -84.79 -61.02 1.88 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.847 0.356 . . . . 73.319999999999993 111.826 -175.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.575 ' HB ' ' HA ' ' A' ' 7' ' ' GLU . 60.7 m -61.07 110.66 1.43 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.95 0.405 . . . . 74.510000000000005 111.985 -177.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.29 -15.69 35.73 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.235 -0.507 . . . . 73.230000000000004 112.993 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -70.58 128.71 37.05 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 122.663 0.385 . . . . 54.140000000000001 111.566 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -104.3 155.89 18.37 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.066 0.46 . . . . 73.319999999999993 112.016 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.53 -165.68 54.76 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 116.06 -0.518 . . . . 63.520000000000003 114.168 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -118.64 137.89 52.98 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.008 0.432 . . . . 73.400000000000006 110.667 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -143.53 115.53 8.33 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.788 0.328 . . . . 72.439999999999998 111.455 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -111.75 143.48 42.6 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.862 0.363 . . . . 64.239999999999995 111.954 -174.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -146.71 137.94 24.23 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.981 0.419 . . . . 53.229999999999997 111.201 176.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.9 m -105.06 119.94 40.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.009 0.433 . . . . 61.240000000000002 112.088 -175.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.52 ' N ' HD12 ' A' ' 35' ' ' ILE . 3.2 mp -92.43 106.19 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.945 0.403 . . . . 75.540000000000006 110.1 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.558 ' NZ ' ' HB2' ' A' ' 36' ' ' LYS . 9.6 mtmp? -86.88 128.05 35.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.079 0.466 . . . . 65.519999999999996 111.374 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.56 -178.62 38.2 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.243 -0.503 . . . . 64.329999999999998 113.183 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -66.22 93.85 0.23 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.214 0.53 . . . . 75.439999999999998 111.297 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.97 -121.4 5.42 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 116.077 -0.51 . . . . 73.329999999999998 112.33 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.82 12.09 29.37 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.144 0.497 . . . . 64.209999999999994 111.269 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -83.77 67.02 9.36 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.145 -0.48 . . . . 75.5 112.13 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -97.86 158.03 15.75 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.595 0.591 . . . . 73.409999999999997 112.595 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -131.36 133.41 45.27 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.461 0.704 . . . . 64.519999999999996 110.574 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.8 tp -105.46 107.38 18.33 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.79 0.329 . . . . 74.030000000000001 111.271 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.757 ' SD ' HG12 ' A' ' 54' ' ' ILE . 87.7 mmm -94.65 122.61 37.43 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.91 0.386 . . . . 73.019999999999996 111.124 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -108.14 117.67 34.75 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.791 0.329 . . . . 72.109999999999999 111.381 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.1 t -96.23 109.01 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.373 -0.376 . . . . 72.349999999999994 110.429 174.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.505 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 31.3 t70 -108.64 107.94 18.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.042 0.449 . . . . 61.329999999999998 110.344 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.3 -107.03 1.06 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.901 -0.666 . . . . 54.119999999999997 112.679 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -116.42 27.34 9.28 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.268 0.556 . . . . 73.450000000000003 111.668 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 17.3 ptt180 -142.76 148.03 36.53 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.043 -0.526 . . . . 74.209999999999994 110.898 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.5 tt -129.62 145.67 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 112.018 0.377 . . . . 71.109999999999999 112.018 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -149.69 168.96 22.14 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.885 0.374 . . . . 73.230000000000004 111.693 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.757 HG12 ' SD ' ' A' ' 45' ' ' MET . 35.3 mt -96.36 118.71 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.502 -0.317 . . . . 64.209999999999994 110.46 169.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -85.83 -36.37 20.07 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.912 0.387 . . . . 72.099999999999994 111.611 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -153.38 138.75 17.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.538 -0.301 . . . . 71.140000000000001 111.53 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.409 ' OD2' HG23 ' A' ' 65' ' ' VAL . 2.4 p30 -153.51 151.51 29.89 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.997 0.427 . . . . 73.209999999999994 110.596 175.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -102.01 74.94 1.49 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.019 0.438 . . . . 65.349999999999994 110.994 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.6 p -124.89 150.88 67.5 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-N 116.492 -0.322 . . . . 64.549999999999997 110.272 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.02 -29.17 40.79 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.356 2.037 . . . . 63.119999999999997 111.708 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.87 -35.82 25.92 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.397 -0.819 . . . . 74.230000000000004 111.89 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.481 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 27.2 mm-40 62.95 21.54 12.93 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.385 0.513 . . . . 73.540000000000006 112.385 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.555 ' O ' ' HG3' ' A' ' 67' ' ' MET . 89.6 t -57.8 -38.26 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.495 -0.321 . . . . 74.319999999999993 111.658 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.43 -57.22 14.22 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.642 -0.313 . . . . 61.329999999999998 113.45 -176.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.409 HG23 ' OD2' ' A' ' 57' ' ' ASP . 54.1 t -62.18 -34.85 65.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 120.952 0.406 . . . . 64.209999999999994 111.582 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 14.1 mptt -66.13 -28.38 68.76 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.467 0.543 . . . . 74.120000000000005 112.467 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.555 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 53.4 mtp -64.18 -24.12 67.56 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 122.064 -0.397 . . . . 74.439999999999998 111.708 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.34 -153.84 41.69 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 114.446 0.538 . . . . 51.439999999999998 114.446 173.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -80.82 142.21 33.92 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.125 0.488 . . . . 74.409999999999997 112.06 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 74.2 mmtt -125.61 133.87 52.1 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.01 -0.541 . . . . 55.140000000000001 109.672 175.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 54.0 p -155.77 28.35 0.38 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.171 1.174 . . . . 54.0 114.171 -170.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -160.33 162.32 33.45 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.773 0.657 . . . . 65.109999999999999 112.773 171.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.04 118.02 5.79 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.057 -0.52 . . . . 61.539999999999999 111.216 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 123.01 -17.16 8.12 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.267 -0.492 . . . . 31.34 112.682 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.538 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 64.5 m-20 -75.58 128.15 34.64 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 122.472 -0.428 . . . . 74.120000000000005 111.399 176.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 81.7 p -130.76 144.23 51.29 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.893 0.377 . . . . 71.040000000000006 111.702 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.557 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 45.5 mm -114.67 128.15 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 122.817 0.447 . . . . 54.350000000000001 110.348 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.15 115.83 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.033 0.444 . . . . 73.450000000000003 111.664 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 86.2 m -123.4 71.06 1.06 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.448 -0.342 . . . . 63.409999999999997 111.277 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.561 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 89.0 mt -53.15 -50.2 83.52 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 112.574 0.583 . . . . 55.229999999999997 112.574 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 53.2 Cg_exo -54.24 -20.76 20.46 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.15 1.9 . . . . 72.340000000000003 113.387 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -110.01 -1.73 17.46 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.263 0.468 . . . . 71.5 112.263 -175.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 63.41 17.39 10.27 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.539 0.336 . . . . 41.409999999999997 111.809 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.91 138.02 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.915 0.388 . . . . 62.299999999999997 111.652 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -141.93 131.4 23.8 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.374 -0.375 . . . . 62.549999999999997 110.791 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.557 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 47.5 t -127.38 145.76 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.573 0.225 . . . . 64.310000000000002 111.059 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -144.13 153.69 42.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.671 0.272 . . . . 63.130000000000003 110.883 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.477 HD12 ' HB2' ' A' ' 75' ' ' ASP . 59.5 mt -110.74 126.24 68.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.85 0.357 . . . . 64.420000000000002 111.051 175.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.05 177.77 6.43 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.348 -0.387 . . . . 72.010000000000005 110.248 176.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 28.4 t -107.07 151.47 25.31 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.213 0.53 . . . . 70.239999999999995 111.811 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.5 p -62.07 -23.99 66.83 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.759 -0.655 . . . . 72.230000000000004 111.182 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.473 ' HG2' ' OG ' ' A' ' 90' ' ' SER . 11.9 pt20 -72.5 166.84 21.85 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.932 0.396 . . . . 74.439999999999998 110.578 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -59.97 148.13 36.41 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.136 0.493 . . . . 73.519999999999996 112.176 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -133.31 141.21 47.86 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.276 0.56 . . . . 71.150000000000006 111.293 172.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 66.7 p -82.11 134.01 35.31 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.029 -0.532 . . . . 75.430000000000007 112.0 -176.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.574 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 9.1 mtpm? -138.38 158.39 44.36 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.257 0.551 . . . . 64.109999999999999 112.164 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -97.05 149.0 35.21 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.817 -0.629 . . . . 53.409999999999997 109.83 171.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -51.67 -52.27 9.36 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.316 2.01 . . . . 60.439999999999998 111.966 175.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -141.31 130.35 23.29 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.406 0.622 . . . . 75.0 112.06 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 47.9 p -120.58 44.0 2.59 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.755 -0.657 . . . . 71.299999999999997 109.582 170.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 65.33 31.63 10.37 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.275 -0.875 . . . . 74.219999999999999 111.086 -172.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.9 tp -76.46 93.62 3.55 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.735 -0.666 . . . . 73.319999999999993 110.484 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 45.6 mm -74.7 89.38 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.275 0.56 . . . . 43.219999999999999 110.86 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.6 m -66.32 140.45 96.76 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.084 -0.507 . . . . 53.329999999999998 110.965 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.82 99.75 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.101 2.534 . . . . 62.530000000000001 114.245 -174.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -89.6 105.21 17.65 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.207 -0.451 . . . . 65.209999999999994 109.836 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -53.84 113.78 1.33 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.957 0.408 . . . . 71.340000000000003 111.989 -176.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -46.85 -50.06 19.14 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.715 -0.675 . . . . 75.420000000000002 111.813 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -164.49 168.6 18.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.908 -0.587 . . . . 65.140000000000001 110.959 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -69.34 144.57 53.45 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.138 0.494 . . . . 72.120000000000005 111.638 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -112.59 99.82 8.25 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.102 -0.499 . . . . 72.129999999999995 110.484 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -57.68 107.23 0.43 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.242 0.544 . . . . 72.340000000000003 111.106 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -84.52 -61.16 1.86 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.919 -0.582 . . . . 73.329999999999998 112.151 -173.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.894 -0.574 . . . . 51.439999999999998 112.003 -176.457 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 tpt . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 110.44 -0.207 . . . . 72.209999999999994 110.44 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt 55.63 71.28 0.56 Allowed 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.223 0.535 . . . . 74.519999999999996 111.277 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -111.65 122.65 48.38 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.173 -0.467 . . . . 71.219999999999999 111.381 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.8 m -106.1 138.99 41.33 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.963 0.411 . . . . 74.400000000000006 112.039 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.5 -64.85 1.78 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.253 -0.498 . . . . 52.350000000000001 112.438 175.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -123.15 151.69 41.88 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.508 0.323 . . . . 75.209999999999994 111.281 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -122.67 124.21 42.91 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.053 0.39 . . . . 64.319999999999993 112.053 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.4 m -115.96 152.68 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 121.288 0.566 . . . . 72.109999999999999 112.02 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 23' ' ' PRO . 27.8 m -127.0 148.51 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.122 -0.49 . . . . 75.129999999999995 111.647 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -102.67 115.47 30.65 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.984 0.421 . . . . 73.349999999999994 111.512 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.8 mm -100.4 116.51 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.339 -0.391 . . . . 74.109999999999999 111.146 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.506 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.0 mp -97.63 127.46 49.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.041 0.448 . . . . 61.509999999999998 111.288 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.4 p -124.35 153.03 42.42 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.223 0.535 . . . . 65.25 111.453 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -139.74 127.04 21.31 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.941 -0.572 . . . . 71.209999999999994 110.999 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 61.14 17.0 7.66 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.347 0.499 . . . . 75.150000000000006 112.347 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.16 -31.6 6.16 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.258 -0.496 . . . . 63.539999999999999 113.802 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -98.42 147.58 24.57 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 122.202 -0.587 . . . . 73.219999999999999 112.102 -177.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.17 134.77 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 122.3 -0.25 . . . . 71.209999999999994 110.493 173.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.3 pt -120.07 -29.81 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.785 0.661 . . . . 74.400000000000006 112.785 -177.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -152.95 141.0 20.33 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.879 0.371 . . . . 73.439999999999998 111.591 -176.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -131.3 124.93 31.5 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.771 0.319 . . . . 44.030000000000001 111.226 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 47' ' ' VAL . 4.1 mp -124.79 124.37 25.55 Favored Pre-proline 0 N--CA 1.474 0.772 0 CA-C-O 120.597 0.237 . . . . 73.409999999999997 111.467 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.425 ' HA ' HG12 ' A' ' 9' ' ' VAL . 60.2 Cg_endo -72.93 119.59 6.15 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.242 1.961 . . . . 71.140000000000001 111.812 172.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.8 mt -80.97 -63.06 1.49 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.073 0.463 . . . . 62.130000000000003 111.471 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.3 m -59.77 121.74 12.44 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.35 -0.386 . . . . 60.130000000000003 111.423 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.71 3.03 77.93 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.238 -0.506 . . . . 70.120000000000005 113.787 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.497 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 42.5 t-80 -77.51 129.12 35.27 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.305 -0.527 . . . . 73.129999999999995 111.235 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -94.31 137.52 33.37 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.989 0.423 . . . . 71.340000000000003 112.026 -177.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.89 -167.1 54.66 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 114.79 0.676 . . . . 74.209999999999994 114.79 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -118.66 122.45 42.56 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.861 0.464 . . . . 43.420000000000002 110.502 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -117.05 139.57 50.54 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 122.242 -0.286 . . . . 75.099999999999994 111.325 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -131.08 129.47 41.95 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.819 0.343 . . . . 73.420000000000002 111.311 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -138.98 141.93 38.37 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.896 0.379 . . . . 74.420000000000002 111.692 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.8 m -97.46 119.07 35.33 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.073 0.463 . . . . 40.039999999999999 111.767 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.7 mt -81.64 116.91 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.05 -0.523 . . . . 72.340000000000003 110.808 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -80.38 123.16 27.78 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.814 0.34 . . . . 74.310000000000002 111.664 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -110.85 -163.28 18.36 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.367 -0.444 . . . . 71.129999999999995 112.435 175.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -69.95 123.16 20.83 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 122.416 -0.461 . . . . 51.310000000000002 111.979 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.05 -103.74 0.43 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.343 -0.456 . . . . 64.450000000000003 113.673 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.41 -3.77 46.41 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.75 0.648 . . . . 63.329999999999998 112.75 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -76.07 133.55 40.29 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 111.799 0.296 . . . . 65.299999999999997 111.799 -176.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -158.2 163.82 37.12 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.899 0.38 . . . . 62.439999999999998 111.762 176.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -136.99 115.3 11.74 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.322 -0.399 . . . . 73.239999999999995 111.18 175.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 56' ' ' GLU . 42.3 tp -87.92 103.34 15.59 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.22 0.533 . . . . 72.209999999999994 110.814 177.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.812 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.1 mmm -92.86 144.71 25.01 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.9 -0.591 . . . . 60.520000000000003 111.468 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -130.16 126.68 38.05 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.944 0.402 . . . . 71.530000000000001 111.528 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.531 HG21 HG21 ' A' ' 22' ' ' ILE . 44.4 t -110.02 107.62 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.163 -0.472 . . . . 70.109999999999999 110.319 175.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 31.0 t70 -108.03 109.42 20.87 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.486 0.315 . . . . 74.310000000000002 110.42 -176.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' A' ' 27' ' ' HIS . . . 57.79 -110.36 2.33 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.775 -0.726 . . . . 54.5 112.355 -175.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -110.24 18.05 20.31 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 120.886 0.375 . . . . 74.310000000000002 111.888 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 33.7 ptt180 -131.89 147.04 52.45 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.819 0.342 . . . . 74.120000000000005 111.465 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.0 tt -130.36 147.92 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.149 0.499 . . . . 72.109999999999999 112.188 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -159.87 165.52 32.06 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.088 -0.506 . . . . 74.319999999999993 111.415 177.241 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.812 HG12 ' SD ' ' A' ' 45' ' ' MET . 58.0 mt -89.91 120.42 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.946 0.403 . . . . 71.010000000000005 110.569 174.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -87.47 -31.21 20.12 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.493 -0.321 . . . . 63.109999999999999 111.746 -175.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.448 ' HB3' HD23 ' A' ' 44' ' ' LEU . 39.5 tt0 -167.95 138.98 2.83 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.086 0.47 . . . . 43.43 112.157 -175.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -161.04 -178.17 6.59 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.236 -0.438 . . . . 73.239999999999995 110.477 174.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -115.01 42.12 2.26 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.595 0.591 . . . . 73.0 112.595 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.8 m -88.01 131.75 42.01 Favored Pre-proline 0 N--CA 1.475 0.793 0 O-C-N 121.919 -0.488 . . . . 65.239999999999995 110.067 173.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.62 -40.9 71.83 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.342 2.028 . . . . 71.409999999999997 112.978 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.9 -13.36 31.35 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.433 0.531 . . . . 61.009999999999998 112.433 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 40.02 67.96 0.43 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.294 0.568 . . . . 72.299999999999997 112.477 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.2 t -74.05 -46.83 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.141 -0.482 . . . . 72.219999999999999 111.553 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.639 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -56.3 -43.71 89.52 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.436 -0.411 . . . . 64.150000000000006 113.722 -178.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -61.44 -38.14 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.091 0.472 . . . . 74.239999999999995 111.722 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -71.26 -28.35 64.1 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.047 0.388 . . . . 73.510000000000005 112.047 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 25.6 mmt -57.34 -28.94 63.56 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.924 0.393 . . . . 72.340000000000003 112.026 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.6 -155.64 39.71 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.294 -0.479 . . . . 63.140000000000001 113.781 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -82.48 119.47 24.25 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.957 0.408 . . . . 75.209999999999994 111.841 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 75.2 mmtt -111.41 151.01 29.0 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.244 -0.435 . . . . 63.32 110.041 175.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 63.2 p -168.65 6.52 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.546 1.313 . . . . 75.340000000000003 114.546 -174.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -124.94 152.46 44.1 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.64 -0.663 . . . . 72.329999999999998 112.28 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.401 ' HB1' ' HD3' ' A' ' 96' ' ' LYS . . . -59.4 99.99 0.07 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.719 -0.673 . . . . 74.519999999999996 111.25 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.18 -19.91 2.66 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.933 -0.576 . . . . 74.310000000000002 112.526 -175.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.443 ' HB2' HD12 ' A' ' 88' ' ' ILE . 76.1 m-20 -76.63 134.72 39.24 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.804 0.335 . . . . 71.200000000000003 111.491 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.538 HG22 ' HA ' ' A' ' 87' ' ' GLU . 45.0 p -135.75 150.19 49.42 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.09 0.471 . . . . 74.540000000000006 111.665 176.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.462 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 50.2 mm -115.99 127.37 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.198 -0.455 . . . . 71.129999999999995 110.75 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -115.22 118.65 59.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.97 0.414 . . . . 64.510000000000005 111.874 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 90.1 m -121.75 75.77 1.22 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.411 -0.359 . . . . 64.530000000000001 111.331 176.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.541 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 91.9 mt -55.36 -50.65 85.51 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 113.133 0.79 . . . . 61.340000000000003 113.133 -176.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.541 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 46.7 Cg_exo -56.93 -17.15 22.88 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.889 1.726 . . . . 74.25 113.461 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 47.8 m170 -114.49 -4.11 12.92 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 122.184 -0.323 . . . . 73.25 111.751 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm 61.36 30.61 19.1 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.847 0.459 . . . . 74.310000000000002 111.923 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 80.0 t -110.0 138.75 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.832 0.349 . . . . 64.420000000000002 111.294 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -139.12 132.64 30.32 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.79 0.329 . . . . 72.439999999999998 111.308 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 47.7 t -121.29 134.29 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 122.332 -0.23 . . . . 75.010000000000005 111.142 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.538 ' HA ' HG22 ' A' ' 76' ' ' THR . 8.6 pt-20 -123.6 126.31 46.4 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.046 0.45 . . . . 72.120000000000005 111.709 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.443 HD12 ' HB2' ' A' ' 75' ' ' ASP . 59.8 mt -95.58 116.73 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.212 0.529 . . . . 71.530000000000001 110.432 175.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -127.77 160.54 31.42 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.178 0.513 . . . . 71.209999999999994 111.899 -172.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.3 t -87.62 149.13 24.49 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.065 0.46 . . . . 62.210000000000001 111.76 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.3 p -88.33 -15.49 35.55 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.075 -0.511 . . . . 73.310000000000002 111.26 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -107.83 -178.25 3.57 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.013 -0.54 . . . . 75.239999999999995 111.7 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -83.0 125.54 31.54 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.859 0.361 . . . . 73.340000000000003 111.767 177.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -162.14 172.41 15.88 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.964 0.412 . . . . 63.0 111.442 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 79.0 p -89.33 109.95 20.8 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.314 0.487 . . . . 70.329999999999998 112.314 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.401 ' HD3' ' HB1' ' A' ' 73' ' ' ALA . 35.2 mtmm -141.69 170.12 16.32 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.056 0.455 . . . . 71.129999999999995 111.632 176.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -100.22 111.81 63.02 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.041 -0.527 . . . . 75.120000000000005 111.02 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.73 -20.35 46.35 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.681 2.254 . . . . 74.209999999999994 112.681 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -122.32 132.07 54.22 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.009 -0.541 . . . . 64.230000000000004 110.61 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.1 m -153.32 123.15 6.85 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.132 0.419 . . . . 72.450000000000003 112.132 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -151.51 136.22 17.12 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.123 -0.489 . . . . 64.319999999999993 110.787 173.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.0 tp -153.34 83.72 1.19 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.385 0.612 . . . . 74.099999999999994 111.037 175.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 56.9 mt -84.5 105.73 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 116.277 -0.42 . . . . 75.540000000000006 110.558 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.5 m -80.59 139.86 51.29 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 112.71 0.633 . . . . 51.420000000000002 112.71 -174.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.97 145.82 96.6 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.751 2.3 . . . . 73.25 112.3 175.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -149.08 167.01 27.03 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.483 0.659 . . . . 73.140000000000001 112.693 -175.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 tt -71.66 131.07 42.64 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.347 -0.842 . . . . 54.409999999999997 112.026 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -71.29 121.63 18.81 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.089 0.471 . . . . 63.140000000000001 111.207 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -86.98 102.66 14.6 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.271 0.557 . . . . 74.019999999999996 111.549 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -122.88 145.35 48.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.983 0.421 . . . . 63.32 111.331 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -87.67 138.55 31.37 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.079 -0.509 . . . . 72.140000000000001 112.193 -172.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -94.59 130.67 40.94 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.24 -0.436 . . . . 73.230000000000004 111.183 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -104.2 -42.17 5.59 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.085 0.469 . . . . 72.219999999999999 110.692 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 . . . . . 0 C--O 1.251 1.15 0 CA-C-N 115.851 -0.613 . . . . 53.340000000000003 110.744 176.901 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.919 0.39 . . . . 72.450000000000003 111.797 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -82.6 83.5 7.59 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.974 0.416 . . . . 71.019999999999996 110.9 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -80.5 42.74 0.61 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.251 0.548 . . . . 74.019999999999996 111.767 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.6 m -73.77 117.3 15.37 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.83 -0.623 . . . . 73.430000000000007 111.772 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.49 -86.52 1.78 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.329 -0.462 . . . . 74.530000000000001 113.06 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -86.73 111.51 20.78 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.487 0.66 . . . . 73.099999999999994 112.152 -177.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.568 ' HA ' ' HB ' ' A' ' 25' ' ' THR . 46.0 mt-10 -87.98 99.65 12.31 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.178 -0.465 . . . . 72.310000000000002 110.876 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 34.5 m -102.76 161.82 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 113.282 0.845 . . . . 54.420000000000002 113.282 -174.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 23' ' ' PRO . 33.1 m -130.04 153.17 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 115.398 -0.819 . . . . 72.25 111.006 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.37 119.97 41.1 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.406 -0.361 . . . . 71.329999999999998 111.146 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.425 ' HB ' ' HG2' ' A' ' 87' ' ' GLU . 39.3 mm -101.02 111.4 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.591 -0.277 . . . . 65.129999999999995 110.949 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.481 ' N ' HD12 ' A' ' 12' ' ' ILE . 3.6 mp -100.98 111.11 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 120.941 0.4 . . . . 65.319999999999993 111.762 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.2 p -108.86 140.56 42.16 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.746 0.308 . . . . 65.420000000000002 110.405 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.555 ' HG3' HG22 ' A' ' 84' ' ' VAL . 7.6 tt0 -141.33 131.67 25.12 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.258 -0.276 . . . . 72.409999999999997 111.251 -177.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.8 m120 58.74 16.85 4.7 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 120.888 0.375 . . . . 41.340000000000003 111.961 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.09 -12.61 60.51 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.126 -0.559 . . . . 65.430000000000007 113.736 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 14' ' ' GLN . 21.5 pttp -109.61 132.87 53.74 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 117.273 0.536 . . . . 64.120000000000005 111.573 -178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.7 t -71.84 115.94 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.848 0.356 . . . . 54.200000000000003 110.719 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.9 pt -102.3 -23.1 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 113.156 0.799 . . . . 61.530000000000001 113.156 -173.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.6 tpp85 -157.45 126.99 6.03 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.769 0.655 . . . . 74.409999999999997 112.769 -173.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -118.01 119.18 34.0 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.629 -0.508 . . . . 62.140000000000001 109.629 173.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.59 126.33 26.49 Favored Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 112.989 0.737 . . . . 71.140000000000001 112.989 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.54 ' HA ' HG12 ' A' ' 9' ' ' VAL . 73.8 Cg_endo -76.24 111.79 3.34 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.389 2.059 . . . . 72.030000000000001 111.536 169.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.66 -69.32 0.61 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.232 0.456 . . . . 72.25 112.232 -174.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.568 ' HB ' ' HA ' ' A' ' 7' ' ' GLU . 6.7 m -59.41 124.58 20.49 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.002 0.43 . . . . 70.200000000000003 111.537 -176.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.06 -22.48 33.19 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.331 -0.462 . . . . 62.329999999999998 112.835 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -77.91 91.3 4.17 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.189 -0.595 . . . . 74.430000000000007 111.23 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -80.05 153.34 28.86 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.059 -0.518 . . . . 62.200000000000003 110.712 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.38 -162.91 27.25 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.051 -0.595 . . . . 63.539999999999999 112.971 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -118.18 145.0 45.27 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.197 0.522 . . . . 64.519999999999996 111.687 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.591 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 16.8 tp10 -139.75 139.32 36.47 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.915 -0.584 . . . . 60.009999999999998 110.209 176.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -141.66 133.4 27.15 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.865 0.364 . . . . 74.239999999999995 111.859 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -148.92 142.58 25.49 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.203 0.525 . . . . 62.119999999999997 111.772 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.8 m -98.29 115.11 27.72 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.119 -0.491 . . . . 71.019999999999996 111.729 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 60.3 mt -80.07 112.93 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.203 0.525 . . . . 72.430000000000007 111.188 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.2 mtmt -79.4 108.44 12.93 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.841 -0.618 . . . . 64.030000000000001 111.215 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.476 ' HA2' ' OE1' ' A' ' 14' ' ' GLN . . . -91.39 -86.08 1.44 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.178 -0.534 . . . . 34.020000000000003 113.722 -176.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -148.2 114.12 5.77 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.643 -0.328 . . . . 72.430000000000007 110.759 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.89 -107.9 1.5 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.119 -0.562 . . . . 74.310000000000002 112.937 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.97 -10.03 40.86 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.516 -0.402 . . . . 71.129999999999995 111.892 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -79.73 125.8 30.13 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.019 0.438 . . . . 74.010000000000005 111.925 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -145.67 172.54 13.12 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.084 -0.507 . . . . 73.329999999999998 111.308 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.439 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 15.6 m120 -136.99 110.44 7.94 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.554 -0.294 . . . . 75.019999999999996 110.681 173.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.3 tp -85.05 107.85 17.36 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.943 0.402 . . . . 73.439999999999998 110.908 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.795 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.9 mmm -100.67 150.94 22.22 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.001 0.429 . . . . 55.130000000000003 111.669 -176.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -138.84 130.84 28.0 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.209 -0.451 . . . . 75.030000000000001 111.84 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.591 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 30.4 t -113.08 107.66 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.313 -0.403 . . . . 64.340000000000003 110.492 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 8.8 t0 -130.93 140.13 50.15 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.517 0.199 . . . . 63.210000000000001 110.893 -176.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 51.87 51.08 41.55 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 114.385 0.514 . . . . 45.130000000000003 114.385 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 69.03 15.06 8.83 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.473 0.916 . . . . 61.020000000000003 113.473 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.444 ' HG3' ' HE3' ' A' ' 69' ' ' TRP . 3.6 ptp180 -147.52 166.9 25.89 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.721 -0.612 . . . . 70.409999999999997 112.58 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.1 tt -125.83 150.8 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.292 0.479 . . . . 74.239999999999995 112.292 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.485 ' HB3' ' HA ' ' A' ' 69' ' ' TRP . 1.8 ppt_? -155.68 159.16 39.33 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 111.192 177.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.795 HG12 ' SD ' ' A' ' 45' ' ' MET . 34.5 mt -85.85 115.99 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.153 0.502 . . . . 61.119999999999997 110.713 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -78.79 -34.73 45.24 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.879 -0.6 . . . . 72.230000000000004 111.895 -175.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -172.93 138.63 0.8 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.558 0.218 . . . . 71.319999999999993 111.276 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -152.75 149.93 28.87 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.93 0.395 . . . . 62.229999999999997 110.91 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -100.41 74.8 1.74 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.371 0.605 . . . . 75.239999999999995 111.599 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.0 p -124.11 149.92 61.79 Favored Pre-proline 0 N--CA 1.475 0.79 0 O-C-N 122.082 -0.387 . . . . 74.510000000000005 111.478 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.26 -23.27 45.25 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.37 2.047 . . . . 74.340000000000003 111.964 174.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.531 ' HB3' HG23 ' A' ' 63' ' ' VAL . 8.7 m-20 -73.06 -56.82 4.59 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.885 -0.598 . . . . 74.140000000000001 111.388 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 62.17 11.87 4.69 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.986 0.515 . . . . 75.120000000000005 112.296 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.531 HG23 ' HB3' ' A' ' 61' ' ' ASP . 59.9 t -56.62 -36.27 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.059 0.457 . . . . 73.230000000000004 111.177 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.567 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -58.04 -47.58 88.19 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.191 -0.528 . . . . 73.319999999999993 112.942 177.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.04 -41.84 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.195 0.521 . . . . 74.239999999999995 111.213 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -67.28 -29.28 68.85 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.213 0.449 . . . . 73.340000000000003 112.213 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 22.0 mmt -58.84 -42.26 88.87 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.726 0.298 . . . . 71.340000000000003 111.785 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.0 -139.37 28.28 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.311 -0.471 . . . . 73.439999999999998 113.112 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.485 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . 84.5 m95 -81.84 129.57 34.79 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.76 0.314 . . . . 54.119999999999997 111.491 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.454 ' HG3' HD11 ' A' ' 77' ' ' ILE . 74.7 mmtt -129.1 148.59 51.06 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.82 0.448 . . . . 52.43 110.292 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 51' ' ' ARG . 94.7 p -175.25 25.44 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.489 0.922 . . . . 71.540000000000006 113.489 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -120.16 144.56 47.61 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.614 -0.679 . . . . 75.329999999999998 111.394 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.16 96.26 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.094 0.473 . . . . 22.219999999999999 111.189 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.43 -26.42 1.99 Allowed Glycine 0 CA--C 1.525 0.697 0 CA-C-N 116.057 -0.52 . . . . 43.030000000000001 112.686 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.499 ' HB2' HD12 ' A' ' 88' ' ' ILE . 75.9 m-20 -64.57 135.35 55.89 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.876 0.37 . . . . 64.120000000000005 111.647 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.5 p -138.44 142.36 39.49 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.074 0.464 . . . . 61.329999999999998 111.617 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.454 HD11 ' HG3' ' A' ' 70' ' ' LYS . 38.7 mm -114.61 130.96 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.211 -0.449 . . . . 55.049999999999997 110.626 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.7 t -123.11 119.62 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 112.051 0.389 . . . . 63.039999999999999 112.051 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 97.8 m -121.77 88.79 3.0 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 120.733 0.302 . . . . 73.340000000000003 110.873 174.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.582 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 92.6 mt -59.25 -53.89 61.7 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 113.078 0.77 . . . . 62.140000000000001 113.078 -175.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 24.7 Cg_exo -62.81 -19.32 68.22 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.958 1.772 . . . . 65.439999999999998 113.007 -176.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -104.28 -5.04 22.22 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.483 -0.326 . . . . 73.239999999999995 111.683 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.1 mttm 58.16 34.29 24.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.811 0.445 . . . . 75.439999999999998 111.917 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.555 HG22 ' HG3' ' A' ' 14' ' ' GLN . 60.2 t -109.36 132.86 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.137 -0.483 . . . . 74.409999999999997 111.33 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -133.33 136.42 45.38 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.729 0.3 . . . . 63.030000000000001 110.695 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -132.9 139.49 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.8 -0.182 . . . . 75.0 111.214 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.425 ' HG2' ' HB ' ' A' ' 11' ' ' ILE . 10.1 pt-20 -126.15 154.52 43.06 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.794 0.331 . . . . 64.040000000000006 110.813 174.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.499 HD12 ' HB2' ' A' ' 75' ' ' ASP . 55.1 mt -118.24 123.09 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.094 0.473 . . . . 74.25 110.908 174.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.488 ' HE3' ' HG3' ' A' ' 96' ' ' LYS . 8.6 ptmt -140.49 151.17 44.6 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.201 -0.454 . . . . 70.439999999999998 111.157 -175.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.516 ' OG ' ' HG2' ' A' ' 92' ' ' GLN . 22.9 t -74.2 149.82 40.68 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.064 0.459 . . . . 74.329999999999998 111.657 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.1 p -70.31 -21.22 62.95 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 116.25 -0.432 . . . . 75.340000000000003 111.837 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.516 ' HG2' ' OG ' ' A' ' 90' ' ' SER . 20.4 pt20 -87.92 -170.09 2.85 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.414 -0.357 . . . . 74.140000000000001 110.72 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -61.92 115.82 4.36 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.276 0.56 . . . . 74.450000000000003 111.286 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.478 ' OD1' ' HG2' ' A' ' 96' ' ' LYS . 9.5 t70 -107.24 164.93 11.76 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.571 -0.74 . . . . 73.209999999999994 110.765 -174.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 64.3 p -84.06 30.84 0.5 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.302 -0.408 . . . . 62.32 111.818 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.488 ' HG3' ' HE3' ' A' ' 89' ' ' LYS . 48.5 mmtm -88.3 160.72 17.52 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.041 0.448 . . . . 74.140000000000001 111.503 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -83.79 147.73 52.55 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 116.289 -0.414 . . . . 73.140000000000001 111.718 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -86.12 10.24 3.74 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.817 2.345 . . . . 71.400000000000006 113.759 -177.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -82.45 17.23 1.8 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.268 0.47 . . . . 54.229999999999997 112.268 -178.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 82.7 p -110.94 153.85 24.93 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.248 0.462 . . . . 72.540000000000006 112.248 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.9 t70 71.04 101.83 0.06 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.865 -0.607 . . . . 64.019999999999996 112.554 173.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.7 pp -168.77 -176.1 2.61 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.723 -0.672 . . . . 74.510000000000005 110.93 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 65.3 mt -67.47 105.27 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.148 0.499 . . . . 72.409999999999997 111.244 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.1 p -69.28 131.14 90.5 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 116.141 -0.482 . . . . 74.430000000000007 111.759 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.07 107.04 1.64 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.579 2.186 . . . . 64.519999999999996 112.871 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -69.6 86.47 0.47 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.085 0.469 . . . . 62.530000000000001 110.93 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.419 HD23 ' H ' ' A' ' 107' ' ' LEU . 2.4 pt? -65.58 140.4 58.53 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.031 0.443 . . . . 75.109999999999999 111.807 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -70.76 81.03 0.62 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.186 0.517 . . . . 64.519999999999996 111.674 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -133.03 119.5 20.13 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.915 0.388 . . . . 73.299999999999997 110.359 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -72.92 116.26 13.21 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.491 0.552 . . . . 75.349999999999994 112.491 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -154.15 110.11 3.24 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.154 0.502 . . . . 64.420000000000002 110.775 173.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -60.97 105.79 0.51 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.05 0.452 . . . . 73.430000000000007 111.921 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -97.4 116.2 29.17 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.091 -0.504 . . . . 73.349999999999994 110.92 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.652 -0.69 . . . . 73.409999999999997 111.506 -179.468 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.0 mmm . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 112.077 0.399 . . . . 54.409999999999997 112.077 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.625 ' HA ' ' HE2' ' A' ' 2' ' ' LYS . 0.6 OUTLIER -79.0 99.47 6.87 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.045 0.45 . . . . 74.400000000000006 110.801 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -68.14 149.36 49.69 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.21 -0.45 . . . . 53.109999999999999 111.251 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.627 ' HB ' HG23 ' A' ' 25' ' ' THR . 25.1 m -61.41 128.04 34.41 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.671 -0.24 . . . . 73.219999999999999 111.159 178.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.19 -44.18 67.61 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.885 -0.674 . . . . 64.329999999999998 112.461 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.01 87.63 4.81 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.184 0.516 . . . . 75.530000000000001 110.437 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.554 ' HG2' HG21 ' A' ' 25' ' ' THR . 42.1 mt-10 -81.08 136.31 35.93 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.185 -0.462 . . . . 74.140000000000001 112.08 -175.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.478 HG23 ' HB2' ' A' ' 24' ' ' LEU . 31.3 m -125.54 139.16 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.164 0.506 . . . . 71.409999999999997 111.45 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.3 m -121.96 138.64 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 116.178 -0.465 . . . . 74.109999999999999 111.193 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.26 112.64 24.31 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.823 0.344 . . . . 72.010000000000005 111.333 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.2 mm -95.04 115.16 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.403 -0.362 . . . . 63.140000000000001 110.982 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.486 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.2 mp -97.25 114.64 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.047 0.451 . . . . 71.519999999999996 111.509 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.5 m -114.39 134.74 54.76 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.219 -0.446 . . . . 53.32 111.448 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -126.82 131.27 51.27 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 122.337 -0.227 . . . . 75.319999999999993 111.051 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 56.42 28.05 13.03 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.429 0.529 . . . . 73.439999999999998 112.429 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.12 21.57 41.43 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.253 -0.498 . . . . 60.32 114.34 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -146.78 140.33 25.75 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.308 0.554 . . . . 74.120000000000005 111.657 175.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.9 t -72.36 118.97 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.791 0.329 . . . . 75.299999999999997 111.014 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.1 pt -99.43 -23.44 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 112.219 0.451 . . . . 63.43 112.219 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -173.16 148.04 1.64 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.703 0.287 . . . . 75.319999999999993 111.014 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -131.33 127.37 37.52 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.179 0.514 . . . . 72.430000000000007 111.442 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.4 mp -113.67 116.12 45.95 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 116.358 -0.383 . . . . 62.25 111.418 -177.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.45 120.59 7.82 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.172 1.915 . . . . 72.439999999999998 111.757 172.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.478 ' HB2' HG23 ' A' ' 8' ' ' VAL . 86.9 mt -80.11 -48.89 12.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.056 0.455 . . . . 72.519999999999996 111.5 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.627 HG23 ' HB ' ' A' ' 4' ' ' THR . 86.2 m -60.57 110.16 1.21 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.975 0.417 . . . . 74.030000000000001 111.805 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.73 0.53 60.55 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.059 -0.591 . . . . 73.340000000000003 113.465 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -72.51 86.49 1.17 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 117.159 0.48 . . . . 74.200000000000003 110.547 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -72.95 115.96 12.88 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.184 0.516 . . . . 72.329999999999998 111.953 -176.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.5 -166.49 14.37 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.145 -0.479 . . . . 54.200000000000003 113.952 177.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -116.89 136.6 52.83 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.763 0.425 . . . . 74.340000000000003 110.422 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -145.68 129.91 17.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.902 0.382 . . . . 53.530000000000001 111.592 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -121.72 147.6 45.7 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.6 -0.273 . . . . 73.439999999999998 111.561 -177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -147.99 143.69 27.45 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.966 0.412 . . . . 71.219999999999999 111.307 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -103.39 126.7 50.69 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.17 0.51 . . . . 65.510000000000005 112.216 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' A' ' 43' ' ' ASN . 60.7 mt -90.69 132.75 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.121 -0.491 . . . . 55.350000000000001 110.66 175.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.58 125.88 48.31 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.997 0.427 . . . . 64.209999999999994 111.223 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -113.42 -164.6 15.77 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.29 -0.481 . . . . 25.32 113.831 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -59.07 113.28 2.03 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.895 0.379 . . . . 74.439999999999998 112.011 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.54 -125.1 7.86 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.242 -0.504 . . . . 41.119999999999997 113.242 178.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.8 9.93 28.15 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.205 0.446 . . . . 51.100000000000001 112.205 -178.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.415 ' HA ' HD21 ' A' ' 58' ' ' ASN . 19.0 mm-40 -74.01 132.75 42.68 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.649 -0.251 . . . . 75.349999999999994 111.572 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -137.26 174.36 10.69 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.929 0.395 . . . . 64.540000000000006 111.125 174.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.489 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . 60.7 t30 -152.21 109.64 3.58 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.249 -0.282 . . . . 63.039999999999999 111.031 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.2 tp -86.6 105.12 16.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.96 0.41 . . . . 55.310000000000002 111.147 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.756 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.4 mmm -95.51 135.62 36.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.147 -0.479 . . . . 72.129999999999995 111.05 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.67 127.39 48.13 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.255 0.55 . . . . 72.310000000000002 111.96 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.3 t -112.44 107.87 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.03 -0.532 . . . . 61.200000000000003 110.586 176.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -112.33 112.35 23.87 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.763 0.316 . . . . 70.019999999999996 110.569 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 63.52 -121.46 23.99 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.938 -0.648 . . . . 64.329999999999998 112.506 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -106.25 25.81 10.58 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 122.469 -0.43 . . . . 72.340000000000003 111.668 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.8 ptt85 -140.92 145.52 36.18 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.204 0.526 . . . . 63.310000000000002 111.795 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.9 tt -123.72 153.94 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 116.1 -0.5 . . . . 54.020000000000003 111.479 -176.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -157.33 168.47 27.29 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.005 0.431 . . . . 74.140000000000001 111.424 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.756 HG12 ' SD ' ' A' ' 45' ' ' MET . 45.3 mt -91.54 123.92 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 109.749 -0.463 . . . . 73.219999999999999 109.749 168.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -93.49 -34.06 13.54 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.38 0.511 . . . . 71.450000000000003 112.38 -172.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -169.0 139.28 2.29 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.577 -0.283 . . . . 73.540000000000006 111.293 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -161.22 160.99 30.68 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.987 0.422 . . . . 71.430000000000007 111.536 176.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.415 HD21 ' HA ' ' A' ' 41' ' ' GLN . 18.0 p-10 -96.09 74.04 2.98 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.45 0.643 . . . . 75.519999999999996 111.858 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 84.2 p -125.7 148.84 63.49 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-N 116.381 -0.372 . . . . 70.340000000000003 110.92 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.46 -3.18 13.45 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.394 2.062 . . . . 73.239999999999995 112.639 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -110.49 -43.81 3.81 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.265 -0.425 . . . . 62.25 111.949 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.408 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 26.7 mm-40 63.47 30.42 15.3 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.854 0.359 . . . . 72.510000000000005 111.383 -177.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.2 t -52.56 -42.19 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 111.955 0.354 . . . . 70.209999999999994 111.955 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.625 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -55.38 -43.98 84.92 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.068 -0.587 . . . . 62.039999999999999 112.883 176.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.1 t -64.71 -39.22 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 120.854 0.359 . . . . 73.400000000000006 111.069 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.408 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 1.6 mptm? -65.05 -41.63 94.98 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.718 0.294 . . . . 73.299999999999997 111.402 177.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.9 mmt -57.43 -44.28 84.53 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.447 0.536 . . . . 71.030000000000001 112.447 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.96 -160.93 43.31 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 120.933 -0.651 . . . . 54.43 113.683 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -67.09 146.77 53.95 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.692 0.626 . . . . 74.299999999999997 112.692 -174.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.513 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 33.3 mmtm -135.63 140.67 44.74 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.89 -0.595 . . . . 65.5 110.33 177.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 82.2 p -164.84 11.06 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.29 0.848 . . . . 54.520000000000003 113.29 -176.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -114.13 153.9 28.73 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.938 -0.477 . . . . 71.519999999999996 111.653 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 90' ' ' SER . . . -69.11 91.34 0.5 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.211 0.529 . . . . 34.409999999999997 111.024 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.27 -22.33 2.41 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.893 -0.594 . . . . 65.200000000000003 112.337 -175.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.513 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 94.4 m-20 -63.36 142.86 58.23 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.938 0.399 . . . . 75.239999999999995 111.611 177.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.0 p -143.7 161.49 38.43 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.202 0.525 . . . . 71.239999999999995 111.645 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.3 mm -128.07 114.0 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.829 -0.623 . . . . 62.109999999999999 110.247 176.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.0 t -109.22 115.63 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.817 0.342 . . . . 71.510000000000005 111.442 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 74.2 m -123.34 88.09 2.86 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.699 0.285 . . . . 71.209999999999994 111.18 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.402 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 80.5 mt -62.65 -45.37 88.4 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 113.096 0.776 . . . . 74.010000000000005 113.096 -176.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 50.3 Cg_exo -53.74 -25.76 35.6 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 122.16 1.907 . . . . 71.329999999999998 113.556 179.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -112.39 -1.24 15.1 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.106 0.41 . . . . 63.509999999999998 112.106 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 59.88 33.56 21.59 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.964 0.411 . . . . 64.129999999999995 111.791 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 68.0 t -105.65 135.66 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.274 -0.421 . . . . 75.519999999999996 111.335 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -139.35 116.21 10.88 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.257 -0.429 . . . . 70.549999999999997 110.853 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.1 t -113.35 126.44 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.569 -0.287 . . . . 64.230000000000004 111.208 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -120.78 136.79 54.8 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.084 0.469 . . . . 72.409999999999997 111.467 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 62.9 mt -103.01 120.79 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.853 0.359 . . . . 71.25 111.331 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -124.4 147.06 48.51 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.106 -0.497 . . . . 73.299999999999997 111.064 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 48.1 t -92.45 150.28 20.89 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.188 0.518 . . . . 72.109999999999999 112.115 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' A' ' 7' ' ' GLU . 46.9 p -79.72 -13.78 59.21 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.895 -0.593 . . . . 73.209999999999994 110.783 174.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -88.32 134.0 33.92 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.108 -0.496 . . . . 72.239999999999995 111.077 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.411 ' O ' ' HD2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -59.8 152.23 23.55 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.013 0.745 . . . . 70.430000000000007 113.013 -178.221 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -90.03 -177.58 5.22 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.557 -0.747 . . . . 72.030000000000001 112.058 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.3 t -165.81 166.92 17.37 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 116.222 -0.445 . . . . 24.239999999999998 111.47 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.95 162.46 40.3 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.423 -0.353 . . . . 73.439999999999998 111.821 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -95.34 115.41 65.42 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 111.687 0.254 . . . . 73.040000000000006 111.687 177.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.26 -24.72 50.53 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.462 2.108 . . . . 74.530000000000001 111.581 170.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -71.57 90.95 1.04 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.819 -0.628 . . . . 73.409999999999997 111.544 178.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.6 p -80.83 160.31 24.84 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.939 0.4 . . . . 74.25 111.268 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -89.15 124.97 34.84 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.101 0.477 . . . . 73.099999999999994 111.194 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.5 tp -95.49 110.4 22.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.467 -0.333 . . . . 65.530000000000001 110.675 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.2 mm -112.35 106.61 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.805 0.336 . . . . 73.239999999999995 111.171 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.4 t 54.2 96.17 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 112.91 0.707 . . . . 75.310000000000002 112.91 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -75.99 155.63 38.48 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.238 2.625 . . . . 73.439999999999998 112.311 172.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -69.22 148.92 49.16 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.236 0.541 . . . . 64.25 112.141 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 107' ' ' LEU . 3.1 mm? -93.79 -173.85 3.27 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.158 -0.474 . . . . 73.040000000000006 110.715 176.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.52 -168.81 1.7 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.776 0.322 . . . . 64.400000000000006 111.477 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -119.59 102.84 8.92 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.088 0.47 . . . . 75.25 111.125 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.65 92.22 0.46 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.621 0.6 . . . . 73.420000000000002 112.621 -177.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -120.08 -10.92 9.34 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.883 -0.599 . . . . 75.019999999999996 110.753 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -77.7 127.35 32.3 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.232 0.539 . . . . 75.219999999999999 112.177 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -164.72 121.42 1.54 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.492 -0.776 . . . . 72.200000000000003 110.386 176.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 . . . . . 0 C--O 1.249 1.05 0 N-CA-C 112.623 0.601 . . . . 74.030000000000001 112.623 -176.518 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.717 0.294 . . . . 72.010000000000005 111.607 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -91.85 101.07 13.66 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.812 0.339 . . . . 73.420000000000002 110.194 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -73.52 83.49 1.51 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.409 0.624 . . . . 73.109999999999999 111.102 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.541 HG21 HG23 ' A' ' 25' ' ' THR . 32.8 m -63.14 133.45 54.42 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.58 -0.736 . . . . 54.109999999999999 111.711 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.04 -51.23 46.73 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 121.339 -0.457 . . . . 54.049999999999997 114.087 -176.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -148.57 163.16 38.05 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 120.851 0.357 . . . . 74.129999999999995 111.74 -175.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.4 ' HA ' ' CB ' ' A' ' 25' ' ' THR . 53.6 mt-10 -91.24 107.03 18.93 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.137 0.494 . . . . 64.040000000000006 111.654 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.6 m -120.87 154.26 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 121.155 0.502 . . . . 73.439999999999998 112.031 -177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 23' ' ' PRO . 34.5 m -121.57 147.6 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.03 -0.532 . . . . 72.209999999999994 111.282 177.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.99 117.59 34.59 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.835 0.35 . . . . 72.109999999999999 111.527 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.9 mm -100.78 122.42 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.561 -0.291 . . . . 72.040000000000006 111.051 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.3 mp -107.8 113.88 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.051 0.453 . . . . 34.229999999999997 110.923 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.1 m -120.35 134.91 55.18 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.173 -0.467 . . . . 71.150000000000006 111.531 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -119.29 138.84 52.75 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.648 0.261 . . . . 63.119999999999997 110.919 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.1 m120 59.72 17.25 6.16 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.732 0.413 . . . . 72.540000000000006 111.98 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.3 3.4 63.28 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.118 -0.563 . . . . 75.109999999999999 113.827 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -124.84 140.33 53.03 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 117.238 0.519 . . . . 71.340000000000003 111.23 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.34 129.16 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.844 0.354 . . . . 73.040000000000006 111.689 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.5 pt -112.78 -31.49 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 116.414 -0.357 . . . . 73.010000000000005 111.663 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -157.62 144.94 18.43 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.681 0.277 . . . . 74.299999999999997 111.257 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -138.51 132.08 30.64 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 120.77 0.319 . . . . 75.019999999999996 110.739 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 22' ' ' ILE . 4.0 mp -126.3 119.39 23.41 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 120.567 0.222 . . . . 53.340000000000003 111.552 -177.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.458 ' HA ' HG12 ' A' ' 9' ' ' VAL . 43.1 Cg_endo -68.29 101.6 0.74 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.075 1.85 . . . . 62.130000000000003 111.535 172.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.18 -62.44 1.77 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.354 0.502 . . . . 73.340000000000003 112.354 -173.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.541 HG23 HG21 ' A' ' 4' ' ' THR . 15.0 m -58.58 131.18 50.04 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.94 0.4 . . . . 72.129999999999995 111.443 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.62 -33.21 4.9 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.239 -0.505 . . . . 72.540000000000006 112.667 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -74.07 85.57 1.82 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.424 0.631 . . . . 71.409999999999997 110.82 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -86.74 167.62 14.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.68 -0.691 . . . . 65.120000000000005 111.633 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.73 -162.37 51.91 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 120.909 -0.662 . . . . 71.409999999999997 112.807 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -117.77 146.59 43.7 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.197 -0.59 . . . . 72.430000000000007 111.836 -176.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -161.19 116.92 2.16 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.818 -0.628 . . . . 52.399999999999999 110.285 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -113.86 145.96 40.7 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.822 0.344 . . . . 74.310000000000002 111.22 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -138.2 139.93 39.52 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.15 0.5 . . . . 71.299999999999997 111.481 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.4 m -98.87 121.2 40.52 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.955 -0.566 . . . . 72.340000000000003 112.077 -175.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 75.0 mt -91.58 123.37 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.121 -0.49 . . . . 75.140000000000001 111.31 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -103.07 124.39 48.45 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.508 0.194 . . . . 72.040000000000006 111.117 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -123.02 -143.23 6.32 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.064 -0.589 . . . . 64.010000000000005 113.679 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -60.93 106.78 0.62 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.183 0.438 . . . . 73.349999999999994 112.183 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.78 -116.88 8.17 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.216 -0.447 . . . . 74.319999999999993 113.454 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.78 6.72 48.13 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.031 0.382 . . . . 65.129999999999995 112.031 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -75.26 111.07 10.14 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.619 0.247 . . . . 74.109999999999999 111.563 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -127.12 164.89 20.61 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.016 0.436 . . . . 72.230000000000004 111.353 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.453 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 17.6 m120 -140.05 123.55 17.13 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.233 -0.439 . . . . 73.340000000000003 111.127 176.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 56' ' ' GLU . 62.7 tp -96.65 104.19 16.16 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.893 0.378 . . . . 70.140000000000001 110.84 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.756 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.4 mmm -94.38 128.8 41.14 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.24 -0.437 . . . . 65.129999999999995 111.237 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -115.13 118.81 34.41 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.942 0.401 . . . . 53.039999999999999 111.962 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.9 t -104.02 114.33 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.155 -0.475 . . . . 71.409999999999997 110.001 171.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -133.67 92.46 2.98 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.924 -0.485 . . . . 71.150000000000006 112.167 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.76 67.72 1.72 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.294 -0.479 . . . . 72.200000000000003 114.249 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 60.64 26.86 16.58 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.72 0.637 . . . . 53.009999999999998 112.72 175.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -149.27 150.66 32.92 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.565 0.346 . . . . 60.409999999999997 110.319 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.8 tt -134.62 151.81 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.191 0.441 . . . . 64.540000000000006 112.191 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -157.18 168.4 27.54 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.202 -0.454 . . . . 74.540000000000006 111.496 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.756 HG12 ' SD ' ' A' ' 45' ' ' MET . 54.4 mt -92.27 110.05 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.47 -0.567 . . . . 72.319999999999993 109.47 169.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -86.37 -39.1 16.75 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 111.841 0.311 . . . . 65.409999999999997 111.841 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 44' ' ' LEU . 10.8 tp10 -138.86 146.95 41.82 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.739 0.304 . . . . 74.040000000000006 110.695 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -168.5 140.15 2.73 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.575 0.35 . . . . 74.0 110.329 -174.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -106.6 38.01 2.18 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.413 0.523 . . . . 74.310000000000002 112.413 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.2 m -84.1 138.5 39.66 Favored Pre-proline 0 N--CA 1.471 0.595 0 O-C-N 122.058 -0.401 . . . . 75.319999999999993 110.016 172.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.54 -25.74 68.51 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.307 2.004 . . . . 74.099999999999994 112.777 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.499 ' HB3' HG23 ' A' ' 63' ' ' VAL . 10.9 m-20 -84.45 -32.38 24.07 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.31 -0.404 . . . . 50.130000000000003 111.957 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.518 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 87.8 mm-40 59.54 13.48 3.34 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.136 0.791 . . . . 73.430000000000007 113.136 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 61' ' ' ASP . 97.0 t -56.15 -41.34 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 112.479 0.548 . . . . 72.519999999999996 112.479 -176.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.48 -42.48 57.46 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.191 -0.528 . . . . 73.010000000000005 113.51 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.2 t -68.82 -33.59 60.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.189 0.519 . . . . 62.229999999999997 111.333 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.518 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 13.4 mptt -73.15 -28.12 62.05 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.313 0.486 . . . . 64.219999999999999 112.313 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.43 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 90.7 mmm -52.76 -47.17 67.64 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.342 0.497 . . . . 63.340000000000003 112.342 -177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.42 -163.94 20.0 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.054 -0.593 . . . . 72.150000000000006 113.416 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -76.48 138.94 40.6 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.029 0.443 . . . . 70.409999999999997 112.014 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -126.69 146.55 50.16 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.28 -0.418 . . . . 55.109999999999999 110.639 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 82.2 p -172.2 26.42 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 112.724 0.638 . . . . 50.149999999999999 112.724 -176.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -125.16 146.39 49.51 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.686 0.279 . . . . 70.299999999999997 111.32 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.15 96.65 0.05 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.079 0.466 . . . . 74.299999999999997 111.65 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 138.14 -19.7 3.24 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 116.093 -0.503 . . . . 72.040000000000006 112.918 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -63.96 120.16 11.45 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.108 0.48 . . . . 75.129999999999995 111.588 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 87' ' ' GLU . 32.5 p -128.96 141.92 51.1 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.077 0.465 . . . . 71.329999999999998 111.421 178.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 mm -122.58 127.64 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 116.269 -0.423 . . . . 55.020000000000003 110.687 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.6 t -119.71 119.32 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.836 0.35 . . . . 71.409999999999997 111.48 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 98.3 m -117.62 88.2 2.86 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.841 0.353 . . . . 73.439999999999998 110.6 173.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.512 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 96.2 mt -54.46 -50.83 83.01 Favored Pre-proline 0 CA--C 1.547 0.827 0 N-CA-C 113.314 0.857 . . . . 73.120000000000005 113.314 -175.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.512 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 75.5 Cg_exo -50.41 -34.52 41.74 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.156 1.904 . . . . 63.149999999999999 113.634 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -103.42 -3.92 24.79 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 111.976 0.361 . . . . 72.340000000000003 111.976 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.5 mttp 59.85 33.99 21.71 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.134 0.492 . . . . 44.399999999999999 112.276 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.7 t -101.12 133.18 45.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 116.218 -0.446 . . . . 74.530000000000001 111.084 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -130.58 125.61 34.61 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.079 -0.51 . . . . 62.140000000000001 110.689 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.436 HG22 HG13 ' A' ' 12' ' ' ILE . 47.7 t -118.19 124.1 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.68 -0.236 . . . . 75.430000000000007 111.183 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.477 ' HA ' HG22 ' A' ' 76' ' ' THR . 8.9 pt-20 -120.9 122.15 39.6 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.094 0.473 . . . . 74.310000000000002 111.467 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.9 mt -97.07 118.16 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 120.98 0.419 . . . . 72.540000000000006 110.537 175.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -129.53 150.18 50.98 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.114 0.483 . . . . 74.450000000000003 112.122 -173.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.6 t -77.48 150.51 34.9 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.925 -0.58 . . . . 54.43 112.448 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.2 p -85.13 0.18 52.51 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.899 -0.591 . . . . 73.310000000000002 111.315 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -88.47 -177.82 5.71 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.458 0.647 . . . . 74.409999999999997 111.508 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.64 145.69 48.83 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.775 -0.648 . . . . 54.310000000000002 109.533 171.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -142.52 118.9 10.88 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.97 0.414 . . . . 74.239999999999995 111.383 -174.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.9 t -131.8 95.46 3.71 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.986 0.422 . . . . 72.439999999999998 111.122 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -103.7 97.68 7.67 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.421 0.629 . . . . 72.430000000000007 111.204 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -67.41 142.86 96.84 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 115.419 -0.81 . . . . 72.310000000000002 112.352 -174.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.42 -48.09 14.63 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.467 2.111 . . . . 74.200000000000003 112.52 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.41 ' O ' ' HB ' ' A' ' 100' ' ' THR . 0.9 OUTLIER -97.12 -95.16 0.21 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 116.458 -0.337 . . . . 74.340000000000003 111.57 176.811 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 99' ' ' ASP . 10.2 t 173.04 -28.7 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 111.92 0.341 . . . . 52.210000000000001 111.92 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -86.33 179.59 6.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.178 0.513 . . . . 72.049999999999997 112.067 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.3 pp -156.51 -171.69 3.79 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.138 -0.483 . . . . 62.009999999999998 111.581 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 62.2 mt -97.2 117.24 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.827 0.346 . . . . 51.409999999999997 110.755 175.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 13.4 p -65.92 133.37 94.87 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 112.13 0.419 . . . . 71.129999999999995 112.13 -175.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 104' ' ' VAL . 39.7 Cg_exo -58.99 172.43 1.67 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.718 2.279 . . . . 61.109999999999999 113.648 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.43 ' O ' ' HG3' ' A' ' 108' ' ' GLU . 30.3 p-10 -59.39 -174.42 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.56 0.578 . . . . 73.140000000000001 112.56 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 97.1 mt -57.08 99.84 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.104 -0.498 . . . . 74.299999999999997 111.549 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 106' ' ' ASN . 41.2 mt-10 -84.77 146.81 27.18 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.048 -0.523 . . . . 71.209999999999994 111.561 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -90.08 -15.83 30.91 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.432 0.53 . . . . 74.319999999999993 112.432 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -70.1 103.63 2.36 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.576 0.703 . . . . 72.409999999999997 111.538 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -86.58 98.72 11.24 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.847 -0.615 . . . . 73.510000000000005 110.791 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -55.48 118.24 4.29 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.91 0.386 . . . . 63.219999999999999 111.836 -176.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -58.61 146.13 37.15 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.088 -0.505 . . . . 72.239999999999995 111.69 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 66.4 m80 . . . . . 0 C--O 1.252 1.224 0 CA-C-O 118.582 -0.723 . . . . 72.430000000000007 111.406 179.983 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.5 mtm . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.726 0.298 . . . . 74.209999999999994 110.959 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.676 ' HA ' ' HE2' ' A' ' 2' ' ' LYS . 10.3 mmpt? -114.49 154.82 27.54 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.164 0.507 . . . . 71.219999999999999 111.962 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -111.15 114.4 27.62 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.148 -0.478 . . . . 41.439999999999998 110.646 174.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.2 t -140.11 135.89 32.99 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.352 -0.385 . . . . 71.209999999999994 111.259 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.36 -49.33 3.04 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 114.781 0.672 . . . . 54.100000000000001 114.781 -171.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -72.64 82.15 1.12 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.537 0.684 . . . . 72.209999999999994 112.092 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.513 ' HA ' ' HB ' ' A' ' 25' ' ' THR . 46.0 mt-10 -76.44 106.75 8.26 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.73 -0.668 . . . . 61.530000000000001 111.757 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.446 HG22 ' OG1' ' A' ' 25' ' ' THR . 32.7 m -111.3 151.03 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.073 0.463 . . . . 60.329999999999998 111.755 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 23' ' ' PRO . 27.4 m -129.46 141.39 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.168 -0.469 . . . . 64.510000000000005 111.488 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.89 115.27 27.08 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.444 -0.344 . . . . 52.539999999999999 111.243 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.4 mm -96.42 112.2 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.866 0.365 . . . . 71.109999999999999 111.098 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.544 HG13 HG22 ' A' ' 86' ' ' VAL . 2.7 mp -99.19 114.5 37.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 120.972 0.415 . . . . 71.439999999999998 111.303 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.0 m -113.07 139.71 48.47 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.798 0.333 . . . . 72.040000000000006 111.231 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.473 HE21 ' HA2' ' A' ' 37' ' ' GLY . 57.5 tt0 -128.9 135.45 49.07 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.587 -0.278 . . . . 75.530000000000001 111.2 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 57.01 10.27 0.76 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.981 0.734 . . . . 75.109999999999999 112.981 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.07 -6.5 28.97 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 121.256 -0.497 . . . . 73.439999999999998 113.882 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -112.76 145.08 41.2 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 117.13 0.465 . . . . 71.530000000000001 111.571 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.37 119.6 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 110.059 -0.349 . . . . 75.409999999999997 110.059 173.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.4 pt -108.51 -19.53 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 113.465 0.913 . . . . 75.140000000000001 113.465 -173.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -168.87 141.29 2.71 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.747 0.647 . . . . 72.319999999999993 112.747 -177.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -123.42 130.91 53.39 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.391 -0.368 . . . . 72.430000000000007 110.535 174.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.472 HG21 HG21 ' A' ' 47' ' ' VAL . 3.9 mp -121.24 124.43 27.32 Favored Pre-proline 0 N--CA 1.478 0.972 0 O-C-N 121.966 -0.459 . . . . 63.140000000000001 111.72 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.514 ' HA ' HG12 ' A' ' 9' ' ' VAL . 59.0 Cg_endo -73.24 121.22 7.04 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.418 2.079 . . . . 65.310000000000002 112.068 173.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.7 mt -92.96 -60.08 1.89 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.192 0.52 . . . . 62.539999999999999 111.796 -176.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.513 ' HB ' ' HA ' ' A' ' 7' ' ' GLU . 25.1 m -58.05 128.0 34.9 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.327 0.492 . . . . 75.299999999999997 112.327 -176.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.98 1.12 72.04 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 121.357 -0.449 . . . . 72.510000000000005 113.922 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -84.91 105.13 15.45 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.595 -0.356 . . . . 72.400000000000006 111.579 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.534 ' HB2' ' NZ ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -85.77 137.58 32.69 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.927 0.394 . . . . 70.349999999999994 110.913 175.226 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.86 178.89 22.19 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.173 -0.537 . . . . 65.430000000000007 113.572 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -118.46 139.63 51.11 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.907 0.384 . . . . 62.420000000000002 110.965 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -138.9 124.51 19.54 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.256 -0.429 . . . . 74.209999999999994 110.604 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.457 ' HG2' ' HA ' ' A' ' 46' ' ' GLU . 75.3 mt-30 -131.7 148.69 52.6 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.94 0.4 . . . . 73.230000000000004 112.003 -176.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -154.64 147.71 24.71 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.104 -0.498 . . . . 62.310000000000002 111.21 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.7 m -101.19 136.85 40.37 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.899 0.38 . . . . 71.409999999999997 111.528 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.524 ' HB ' ' HB3' ' A' ' 43' ' ' ASN . 58.4 mt -113.7 102.32 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.495 -0.32 . . . . 71.439999999999998 111.419 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -76.27 107.04 8.23 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.773 0.32 . . . . 70.510000000000005 111.141 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.473 ' HA2' HE21 ' A' ' 14' ' ' GLN . . . -89.03 -133.81 4.88 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.374 -0.441 . . . . 54.340000000000003 113.438 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.03 115.27 15.56 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.528 -0.396 . . . . 54.340000000000003 110.697 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.37 -136.72 25.26 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.266 -0.492 . . . . 71.019999999999996 113.135 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.16 3.65 34.06 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.161 0.505 . . . . 74.239999999999995 111.279 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.542 ' HB3' ' CD2' ' A' ' 82' ' ' HIS . 97.2 mt-30 -73.07 83.78 1.29 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.194 0.521 . . . . 65.349999999999994 111.795 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -89.92 165.44 14.09 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.063 -0.517 . . . . 74.319999999999993 111.406 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.524 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . 57.7 t30 -132.7 110.13 10.18 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.311 -0.404 . . . . 74.430000000000007 109.93 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.3 tp -95.52 103.82 15.71 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.382 0.61 . . . . 61.340000000000003 111.612 -176.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.65 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.1 mmm -93.93 141.61 28.32 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.374 -0.83 . . . . 64.099999999999994 111.76 -175.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.457 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 44.7 tt0 -127.07 119.65 27.07 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.99 0.424 . . . . 75.319999999999993 111.7 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.472 HG21 HG21 ' A' ' 22' ' ' ILE . 59.4 t -105.53 107.29 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.209 -0.451 . . . . 70.540000000000006 110.584 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.522 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 34.8 t70 -109.98 101.56 10.37 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.118 0.485 . . . . 52.200000000000003 110.848 -178.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.18 -109.68 3.04 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 120.784 -0.722 . . . . 53.32 112.886 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -108.14 19.16 20.29 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.852 0.358 . . . . 75.129999999999995 111.794 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 35.3 ptt180 -136.4 147.07 47.11 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.791 0.329 . . . . 73.329999999999998 111.507 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.3 tt -132.37 142.6 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-O 120.868 0.365 . . . . 74.140000000000001 111.719 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.51 ' HB3' ' HA ' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -160.67 168.8 24.14 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.849 0.357 . . . . 64.530000000000001 111.461 177.441 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.65 HG12 ' SD ' ' A' ' 45' ' ' MET . 71.6 mt -91.62 124.57 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.432 -0.349 . . . . 75.129999999999995 111.065 176.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -94.86 -33.16 12.93 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.865 0.364 . . . . 65.209999999999994 111.406 177.434 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -143.47 139.95 30.12 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.746 0.308 . . . . 72.430000000000007 110.748 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -168.07 145.76 4.3 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.991 0.425 . . . . 74.010000000000005 112.023 -173.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -109.79 51.06 0.77 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.081 -0.509 . . . . 70.230000000000004 111.954 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.463 ' HG ' ' CD2' ' A' ' 82' ' ' HIS . 31.4 m -107.05 121.81 43.56 Favored Pre-proline 0 N--CA 1.472 0.667 0 O-C-N 122.063 -0.398 . . . . 72.400000000000006 110.192 172.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.28 -30.82 73.91 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.436 2.091 . . . . 71.129999999999995 112.582 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.68 -36.5 67.91 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.693 -0.685 . . . . 75.510000000000005 111.712 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 59.26 16.76 5.19 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.041 0.756 . . . . 73.310000000000002 113.041 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 65.6 t -55.36 -51.61 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 N-CA-C 112.07 0.396 . . . . 72.030000000000001 112.07 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -56.98 -38.66 86.48 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.223 -0.513 . . . . 32.130000000000003 113.271 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 42.1 t -67.46 -43.77 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.991 0.424 . . . . 74.420000000000002 111.295 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.22 -27.16 68.87 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.031 -0.531 . . . . 74.329999999999998 112.112 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 14.3 mmt -50.45 -35.23 27.88 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.453 0.538 . . . . 73.540000000000006 112.453 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.05 -159.87 50.91 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.136 -0.554 . . . . 73.019999999999996 113.625 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.51 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . 89.1 m95 -70.82 114.71 9.17 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 111.968 0.359 . . . . 53.119999999999997 111.968 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 34.9 mmtp -105.78 150.65 25.35 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.68 -0.237 . . . . 73.349999999999994 110.619 175.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.437 ' O ' HG21 ' A' ' 8' ' ' VAL . 92.7 p -159.56 -26.83 0.07 Allowed 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.163 0.801 . . . . 70.439999999999998 113.163 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm -82.28 155.96 24.56 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.276 0.56 . . . . 74.450000000000003 112.264 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.51 110.74 3.26 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.108 -0.496 . . . . 54.439999999999998 110.675 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 121.71 -23.83 7.34 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.982 -0.447 . . . . 63.140000000000001 111.982 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.487 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 78.4 m-20 -65.41 129.23 38.99 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.87 0.367 . . . . 74.310000000000002 110.783 176.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.476 HG22 ' HA ' ' A' ' 87' ' ' GLU . 41.2 p -128.81 164.38 23.16 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.018 0.747 . . . . 54.509999999999998 113.018 -176.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.554 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 39.6 mm -128.15 125.63 64.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.063 -0.971 . . . . 73.099999999999994 109.735 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.8 t -117.32 117.59 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 112.291 0.478 . . . . 54.399999999999999 112.291 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 75.1 m -119.16 80.79 1.61 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.061 0.458 . . . . 71.420000000000002 110.65 174.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.442 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 76.3 mt -52.54 -59.91 7.63 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 113.597 0.962 . . . . 71.430000000000007 113.597 -174.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 38.9 Cg_endo -66.86 -9.5 24.98 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 121.917 1.744 . . . . 74.129999999999995 112.98 -176.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.542 ' CD2' ' HB3' ' A' ' 41' ' ' GLN . 24.3 m170 -104.49 -10.94 17.31 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.517 -0.31 . . . . 74.129999999999995 111.343 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.4 mttp 59.82 27.06 16.31 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.052 0.453 . . . . 71.120000000000005 112.032 -176.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.4 t -104.14 124.44 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.028 -0.533 . . . . 75.329999999999998 110.782 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -130.27 118.01 20.68 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.069 0.462 . . . . 70.030000000000001 111.119 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.554 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 35.9 t -107.76 124.62 63.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.136 -0.484 . . . . 33.439999999999998 110.858 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.476 ' HA ' HG22 ' A' ' 76' ' ' THR . 14.5 pt-20 -124.3 126.76 46.59 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.998 0.427 . . . . 73.230000000000004 111.58 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 63.5 mt -89.48 112.71 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 121.093 0.473 . . . . 64.310000000000002 110.984 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -116.63 152.36 34.36 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.24 -0.436 . . . . 73.439999999999998 111.25 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.9 t -89.41 124.93 34.92 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.946 0.403 . . . . 62.140000000000001 111.966 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.1 p -66.27 -28.38 68.66 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.295 0.569 . . . . 71.109999999999999 110.507 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -82.55 124.76 30.42 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.715 -0.675 . . . . 54.340000000000003 109.67 174.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.515 ' HD3' ' O ' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -42.37 120.85 1.75 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.708 0.766 . . . . 75.200000000000003 112.647 -176.402 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -90.48 177.22 6.43 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.929 0.714 . . . . 73.329999999999998 112.929 -173.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.5 t -164.15 104.55 0.88 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.288 -0.869 . . . . 65.0 110.111 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.541 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 9.0 mtpm? -123.24 164.27 19.06 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 122.2 1.0 . . . . 60.420000000000002 113.155 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -51.04 125.88 24.44 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 113.699 -1.592 . . . . 64.439999999999998 111.794 169.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.43 2.31 8.65 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.532 2.154 . . . . 74.329999999999998 112.578 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -79.09 69.84 5.34 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.239 0.542 . . . . 73.209999999999994 110.413 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 62.1 p -87.26 93.06 9.28 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.203 0.525 . . . . 64.319999999999993 112.352 -174.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -117.53 145.48 44.22 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.671 -0.492 . . . . 71.099999999999994 109.671 173.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.447 ' O ' HD12 ' A' ' 102' ' ' LEU . 2.1 pp -135.18 152.73 51.86 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.226 0.824 . . . . 75.349999999999994 113.226 -171.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.517 ' N ' HD12 ' A' ' 103' ' ' ILE . 2.6 mp -89.1 112.35 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 115.666 -0.697 . . . . 75.450000000000003 109.791 173.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.8 m -63.34 122.53 76.35 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 112.653 0.612 . . . . 74.420000000000002 112.653 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -85.8 106.61 0.88 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.706 2.271 . . . . 75.299999999999997 112.426 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -77.18 119.19 20.52 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 122.03 -0.419 . . . . 42.219999999999999 111.262 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 58.4 tp -79.57 101.53 8.35 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.023 0.44 . . . . 74.0 111.094 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -84.16 83.64 7.89 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.389 0.614 . . . . 71.329999999999998 111.821 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -80.43 79.55 7.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.281 0.562 . . . . 74.219999999999999 111.12 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -104.45 125.67 50.85 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.028 -0.533 . . . . 62.210000000000001 111.967 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -73.51 154.86 39.72 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.25 -0.432 . . . . 73.349999999999994 111.167 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -154.78 116.17 4.07 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.059 0.457 . . . . 74.349999999999994 111.927 -175.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -128.4 170.41 13.14 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.342 -0.39 . . . . 65.329999999999998 111.294 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 41.1 m80 . . . . . 0 C--O 1.256 1.435 0 CA-C-O 118.72 -0.657 . . . . 74.540000000000006 111.19 175.503 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.472 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.848 0.356 . . . . 71.25 111.359 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -87.73 116.99 26.26 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.896 -0.409 . . . . 74.340000000000003 109.896 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -54.8 131.18 43.41 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.437 0.532 . . . . 63.039999999999999 112.437 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.7 p -118.17 139.36 51.39 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.161 -0.472 . . . . 63.299999999999997 111.467 177.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.44 -6.79 46.98 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.022 -0.609 . . . . 43.229999999999997 113.02 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.26 86.44 5.65 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.634 0.254 . . . . 73.439999999999998 110.67 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.492 ' HG2' HG21 ' A' ' 25' ' ' THR . 29.6 mt-10 -84.51 120.58 26.49 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.365 0.506 . . . . 74.450000000000003 112.365 -175.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 27.8 m -130.72 159.24 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.426 0.528 . . . . 75.299999999999997 112.426 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 23' ' ' PRO . 23.3 m -131.56 147.05 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 115.928 -0.578 . . . . 65.239999999999995 111.171 178.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.62 115.14 26.93 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.45 -0.341 . . . . 43.009999999999998 111.309 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.441 HD12 ' OE2' ' A' ' 21' ' ' GLU . 18.2 mm -99.47 104.8 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.831 0.348 . . . . 65.310000000000002 111.397 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 12' ' ' ILE . 3.3 mp -96.22 120.08 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.194 0.521 . . . . 61.329999999999998 111.257 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.6 m -121.94 144.36 48.91 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.087 -0.506 . . . . 70.329999999999998 111.31 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.412 ' HG3' HG22 ' A' ' 84' ' ' VAL . 59.3 tt0 -135.67 141.82 45.05 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.551 -0.295 . . . . 73.409999999999997 110.733 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 59.21 17.4 5.66 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 111.956 0.354 . . . . 64.319999999999993 111.956 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.69 -9.75 62.34 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 121.409 -0.424 . . . . 61.409999999999997 113.683 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -116.4 145.65 43.08 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 117.296 0.548 . . . . 64.219999999999999 111.657 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.7 t -71.99 128.33 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 120.942 0.401 . . . . 75.200000000000003 111.147 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.626 HD11 HD13 ' A' ' 35' ' ' ILE . 33.9 pt -112.17 -26.59 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.64 0.607 . . . . 75.129999999999995 112.64 -177.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -159.55 133.34 7.33 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.236 0.458 . . . . 70.530000000000001 112.236 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.441 ' OE2' HD12 ' A' ' 11' ' ' ILE . 44.8 mt-10 -124.94 115.49 20.67 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.683 0.277 . . . . 75.310000000000002 110.802 177.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.2 mp -104.22 129.86 24.38 Favored Pre-proline 0 N--CA 1.475 0.798 0 N-CA-C 111.852 0.316 . . . . 74.409999999999997 111.852 -175.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.562 ' HA ' HG12 ' A' ' 9' ' ' VAL . 67.7 Cg_endo -74.62 111.61 3.36 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.356 2.037 . . . . 71.450000000000003 112.194 171.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.63 -62.26 1.7 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.978 0.418 . . . . 51.399999999999999 111.749 -176.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.568 ' HA ' ' HG2' ' A' ' 50' ' ' GLU . 51.3 m -63.03 118.57 8.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.992 0.425 . . . . 72.540000000000006 112.07 -177.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.35 -15.73 55.92 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 116.154 -0.476 . . . . 61.32 112.81 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -77.11 79.13 3.64 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.19 0.519 . . . . 75.209999999999994 110.978 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.444 ' HB2' ' NZ ' ' A' ' 28' ' ' LYS . 10.4 mtmp? -75.18 105.1 6.03 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.291 0.567 . . . . 54.530000000000001 111.304 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.77 -169.63 24.31 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 115.971 -0.558 . . . . 71.219999999999999 112.655 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -117.84 148.0 42.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.841 0.353 . . . . 73.430000000000007 110.679 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -154.14 129.15 9.54 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.795 0.331 . . . . 72.519999999999996 111.671 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -124.71 153.65 42.04 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.759 0.314 . . . . 73.25 111.535 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -154.29 140.73 18.75 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.92 0.391 . . . . 61.439999999999998 110.708 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.5 m -108.94 111.93 23.88 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.974 0.416 . . . . 61.149999999999999 112.07 -172.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.626 HD13 HD11 ' A' ' 19' ' ' ILE . 57.8 mt -94.0 105.61 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.263 -0.426 . . . . 75.420000000000002 111.572 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -89.79 110.02 20.97 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.036 0.446 . . . . 64.150000000000006 111.307 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.43 -136.9 9.55 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 116.181 -0.463 . . . . 42.130000000000003 113.778 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -87.76 151.25 23.04 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.03 0.382 . . . . 74.400000000000006 112.03 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.79 36.74 92.44 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 116.098 -0.501 . . . . 71.0 113.479 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 61.99 10.72 3.78 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.388 0.514 . . . . 72.0 112.388 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.549 ' HA ' ' HB3' ' A' ' 58' ' ' ASN . 26.3 mt-30 -82.55 107.02 14.89 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.089 0.403 . . . . 71.420000000000002 112.089 -176.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -104.88 153.18 21.7 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 111.981 0.363 . . . . 63.399999999999999 111.981 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -111.72 130.23 55.85 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.998 -0.546 . . . . 60.450000000000003 110.222 171.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.4 tp -101.85 104.11 14.83 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.873 0.368 . . . . 75.200000000000003 110.925 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.753 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.5 mmm -88.73 141.33 28.6 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.559 -0.292 . . . . 64.409999999999997 111.286 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -136.09 119.01 16.29 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.155 0.502 . . . . 73.140000000000001 111.605 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.9 t -105.85 119.85 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 115.939 -0.573 . . . . 72.310000000000002 110.699 177.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -117.44 90.74 3.4 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.163 0.506 . . . . 74.420000000000002 110.206 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.97 -116.57 5.07 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.755 -0.736 . . . . 42.030000000000001 112.352 -174.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.568 ' HG2' ' HA ' ' A' ' 25' ' ' THR . 40.6 mt-10 -95.13 -15.17 23.56 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.036 0.446 . . . . 71.129999999999995 111.806 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.558 ' HA ' ' HB3' ' A' ' 71' ' ' SER . 26.7 ptt180 -97.74 135.29 39.73 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.993 0.425 . . . . 62.520000000000003 111.371 -176.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.6 tt -123.89 143.82 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.126 0.489 . . . . 73.329999999999998 111.463 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -144.96 169.21 18.52 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.32 -0.4 . . . . 62.549999999999997 110.709 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.753 HG12 ' SD ' ' A' ' 45' ' ' MET . 42.7 mt -96.93 122.17 48.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.351 -0.611 . . . . 75.120000000000005 109.351 167.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -86.67 -32.39 20.55 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.503 0.557 . . . . 70.120000000000005 112.503 -172.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -162.09 138.68 8.0 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.681 0.277 . . . . 64.140000000000001 111.383 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -133.04 144.61 50.15 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.313 0.578 . . . . 74.329999999999998 111.816 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.549 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . 48.5 t-20 -81.47 72.17 8.5 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.921 -1.14 . . . . 72.510000000000005 107.921 163.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.431 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 69.1 m -135.98 130.45 18.51 Favored Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 115.634 -0.712 . . . . 73.200000000000003 111.373 -174.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 59' ' ' SER . 26.8 Cg_exo -63.35 -27.66 71.51 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.79 2.327 . . . . 52.130000000000003 112.315 178.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.427 ' O ' ' HE2' ' A' ' 66' ' ' LYS . 4.3 m-20 -97.3 -15.47 20.75 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.68 -0.691 . . . . 60.450000000000003 112.15 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 27.0 mm-40 52.6 34.04 14.89 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.393 0.516 . . . . 70.430000000000007 112.393 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.9 t -53.35 -51.29 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 112.914 0.709 . . . . 73.200000000000003 112.914 -174.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -56.43 -55.06 31.63 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.149 -0.548 . . . . 51.340000000000003 113.373 -177.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.2 t -52.75 -41.81 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 111.914 0.339 . . . . 65.230000000000004 111.914 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 61' ' ' ASP . 67.9 mttm -64.29 -30.82 71.85 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 111.963 0.357 . . . . 70.310000000000002 111.963 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.8 mmt -61.2 -40.45 93.99 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.269 0.47 . . . . 72.450000000000003 112.269 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.45 -153.55 39.16 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.121 -0.562 . . . . 62.149999999999999 113.737 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -81.73 130.79 35.18 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.179 0.437 . . . . 71.409999999999997 112.179 -176.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HG3' HD11 ' A' ' 77' ' ' ILE . 75.4 mmtt -127.73 150.17 49.91 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.142 -0.481 . . . . 74.0 110.645 175.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.558 ' HB3' ' HA ' ' A' ' 51' ' ' ARG . 89.1 p -173.68 22.94 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.905 0.706 . . . . 52.439999999999998 112.905 -178.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -90.46 162.33 15.12 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.081 -0.387 . . . . 72.319999999999993 110.163 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.65 32.83 0.11 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 112.133 0.42 . . . . 45.130000000000003 112.133 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -177.24 29.4 0.07 OUTLIER Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.385 -0.436 . . . . 74.310000000000002 113.312 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -86.8 146.77 26.11 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.968 0.413 . . . . 72.239999999999995 111.243 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.6 p -133.81 141.33 47.41 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.061 0.458 . . . . 61.450000000000003 111.604 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.531 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 45.5 mm -125.2 109.64 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.341 -0.39 . . . . 73.030000000000001 110.417 177.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.04 116.6 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.067 0.46 . . . . 72.219999999999999 111.822 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 91.5 m -120.98 79.75 1.55 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.382 -0.372 . . . . 72.310000000000002 111.067 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.503 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 96.2 mt -57.13 -48.17 97.86 Favored Pre-proline 0 CA--C 1.55 0.958 0 N-CA-C 112.825 0.676 . . . . 71.409999999999997 112.825 -177.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 76.7 Cg_exo -51.42 -25.15 17.98 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 122.215 1.943 . . . . 64.230000000000004 113.613 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.527 ' NE2' ' HB3' ' A' ' 41' ' ' GLN . 16.0 m170 -111.52 -4.26 14.86 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.035 -0.416 . . . . 63.240000000000002 111.735 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 58.33 34.41 24.01 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.285 0.564 . . . . 74.140000000000001 111.782 -176.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.412 HG22 ' HG3' ' A' ' 14' ' ' GLN . 60.4 t -110.43 134.71 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 115.714 -0.675 . . . . 71.510000000000005 111.326 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -131.19 130.04 42.47 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.836 0.351 . . . . 71.120000000000005 110.885 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 50.3 t -119.23 120.62 64.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.717 0.294 . . . . 70.430000000000007 111.487 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -111.13 136.97 49.39 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 110.451 -0.203 . . . . 72.129999999999995 110.451 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.3 mt -105.61 112.17 37.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.985 0.421 . . . . 54.009999999999998 110.575 175.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -118.11 159.35 23.4 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.28 -0.418 . . . . 74.129999999999995 110.91 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 45.3 t -79.91 145.44 32.67 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.918 0.389 . . . . 75.209999999999994 111.444 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.8 p -67.75 -28.31 67.52 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.429 0.633 . . . . 75.420000000000002 110.265 174.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -80.48 -138.85 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.934 -1.03 . . . . 72.109999999999999 110.749 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -70.97 142.67 51.01 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.44 0.638 . . . . 64.310000000000002 112.008 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -152.1 139.45 19.45 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.941 -0.572 . . . . 64.150000000000006 109.906 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.8 t -153.85 119.29 5.18 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.289 0.477 . . . . 73.310000000000002 112.289 -176.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -127.66 150.74 49.62 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.032 -0.531 . . . . 62.43 109.674 173.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -57.9 141.0 81.3 Favored Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 122.27 -0.269 . . . . 64.049999999999997 110.562 175.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -35.11 -55.31 0.59 Allowed 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 123.736 2.957 . . . . 75.230000000000004 114.055 -175.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -174.15 101.2 0.1 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.84 0.352 . . . . 74.329999999999998 110.63 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.2 t -159.45 151.56 20.87 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.333 0.587 . . . . 73.140000000000001 112.264 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -113.81 114.07 25.79 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.353 -0.84 . . . . 62.0 109.884 175.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.3 tp -116.71 118.18 31.84 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.042 0.449 . . . . 71.099999999999994 112.142 -174.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.0 mm -102.7 131.95 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.022 0.439 . . . . 55.299999999999997 111.033 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.7 m -103.68 146.95 33.47 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 116.371 -0.377 . . . . 41.119999999999997 111.526 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.99 144.02 80.49 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.765 2.31 . . . . 71.409999999999997 112.959 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -88.64 132.28 34.63 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.029 0.443 . . . . 72.420000000000002 111.215 -176.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 107' ' ' LEU . 2.2 pt? -86.95 155.6 20.13 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.092 0.472 . . . . 75.510000000000005 111.84 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -103.16 128.28 50.16 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.388 -0.369 . . . . 65.010000000000005 110.525 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -91.79 22.54 4.11 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.241 0.459 . . . . 74.519999999999996 112.241 -174.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -58.92 105.02 0.27 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 112.664 0.616 . . . . 61.240000000000002 112.664 -177.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -134.08 106.41 7.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.635 0.374 . . . . 75.340000000000003 110.355 173.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -101.27 60.97 0.92 Allowed 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.897 -0.502 . . . . 72.239999999999995 112.025 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -176.16 178.4 1.41 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.231 -0.441 . . . . 73.349999999999994 111.447 176.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 78.3 t60 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.476 -0.773 . . . . 60.100000000000001 111.182 173.584 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.769 0.318 . . . . 73.0 111.601 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.92 145.61 40.44 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.882 0.372 . . . . 61.119999999999997 110.68 173.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -88.42 90.69 8.5 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.162 0.506 . . . . 52.039999999999999 110.466 176.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.6 m -130.93 114.2 14.95 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.029 -0.532 . . . . 63.32 111.243 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -146.53 -40.36 0.04 OUTLIER Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.946 -0.645 . . . . 53.200000000000003 114.004 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -69.89 92.11 0.69 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.313 0.556 . . . . 55.109999999999999 111.036 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -73.47 114.89 12.21 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.06 0.763 . . . . 73.129999999999995 113.06 -173.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 33.9 m -126.27 148.02 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.022 0.439 . . . . 74.230000000000004 111.055 173.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 23' ' ' PRO . 33.8 m -127.27 151.78 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.938 0.399 . . . . 63.350000000000001 111.679 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.77 118.21 36.45 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.112 -0.495 . . . . 62.130000000000003 110.878 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 31.0 mm -95.26 108.79 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 120.83 0.347 . . . . 74.439999999999998 110.992 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 12' ' ' ILE . 3.2 mp -95.17 111.51 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 120.937 0.399 . . . . 73.129999999999995 111.123 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.9 p -113.7 147.19 38.63 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.971 0.415 . . . . 74.230000000000004 111.236 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -143.88 139.34 29.17 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.286 -0.416 . . . . 72.319999999999993 110.284 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 62.19 13.59 5.97 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.089 0.403 . . . . 62.329999999999998 112.089 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.02 -16.67 46.05 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 121.199 -0.524 . . . . 73.340000000000003 113.956 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.79 150.1 33.95 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 122.294 -0.533 . . . . 71.430000000000007 111.693 -178.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.77 120.92 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.412 -0.358 . . . . 62.439999999999998 110.834 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.0 pt -99.71 -27.96 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 112.102 0.408 . . . . 65.349999999999994 112.102 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.1 tpp85 -157.82 143.51 17.18 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 122.09 -0.381 . . . . 73.239999999999995 111.601 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -128.36 113.51 15.68 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.676 0.274 . . . . 73.019999999999996 110.871 176.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.53 HG21 HG21 ' A' ' 47' ' ' VAL . 3.0 mp -107.39 119.66 50.08 Favored Pre-proline 0 N--CA 1.473 0.722 0 O-C-N 122.27 -0.269 . . . . 71.349999999999994 111.632 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 22.0 Cg_exo -66.03 123.46 11.3 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.366 2.044 . . . . 74.530000000000001 111.781 172.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.2 mt -87.13 -54.55 4.26 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.158 0.504 . . . . 71.439999999999998 111.447 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.447 ' OG1' HG22 ' A' ' 8' ' ' VAL . 29.1 m -63.1 107.34 1.01 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.039 0.447 . . . . 73.349999999999994 111.764 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.41 ' H ' ' HG2' ' A' ' 50' ' ' GLU . . . 94.13 11.17 57.8 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.266 -0.493 . . . . 62.229999999999997 113.081 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.533 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 52.0 t-80 -72.98 87.12 1.33 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.08 0.467 . . . . 71.549999999999997 111.154 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -53.8 131.8 40.28 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.884 0.698 . . . . 72.230000000000004 112.884 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.38 -161.94 49.02 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 115.931 -0.577 . . . . 73.310000000000002 114.501 175.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -118.68 141.98 48.09 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.952 0.501 . . . . 71.329999999999998 109.91 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -142.91 125.08 15.38 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 122.25 -0.282 . . . . 72.400000000000006 111.626 -175.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -117.83 129.85 55.91 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.668 -0.242 . . . . 74.450000000000003 111.459 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -136.69 143.22 43.27 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.244 0.545 . . . . 74.349999999999994 111.795 176.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.0 m -101.8 121.52 42.24 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.979 -0.555 . . . . 53.43 111.921 -175.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 54.1 mt -92.86 104.94 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.529 -0.305 . . . . 63.119999999999997 110.451 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -101.16 113.8 27.16 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.956 0.407 . . . . 70.420000000000002 111.884 -176.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.8 -65.46 1.44 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.299 -0.476 . . . . 63.450000000000003 112.551 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -141.39 87.62 2.09 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.543 -0.387 . . . . 71.219999999999999 111.438 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.45 -86.82 0.01 OUTLIER Glycine 0 CA--C 1.53 1.017 0 N-CA-C 114.196 0.438 . . . . 63.329999999999998 114.196 177.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.41 -22.26 44.53 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.007 0.432 . . . . 73.420000000000002 111.612 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -82.56 95.37 7.73 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.235 -0.291 . . . . 75.209999999999994 110.904 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -144.59 160.74 40.66 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.354 0.502 . . . . 72.549999999999997 112.354 -177.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -129.75 144.71 51.43 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.022 -0.536 . . . . 72.409999999999997 110.605 174.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.8 tp -114.12 107.34 15.5 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.989 0.423 . . . . 54.329999999999998 111.025 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.758 ' SD ' HG12 ' A' ' 54' ' ' ILE . 84.2 mmm -94.6 140.11 30.29 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.179 -0.464 . . . . 70.349999999999994 111.351 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -130.58 120.86 24.65 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.985 0.421 . . . . 74.0 111.324 176.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.53 HG21 HG21 ' A' ' 22' ' ' ILE . 36.0 t -105.0 108.73 25.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.122 -0.49 . . . . 71.450000000000003 110.731 176.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -109.31 105.75 15.29 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.965 0.412 . . . . 64.239999999999995 110.338 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.533 ' O ' ' HB3' ' A' ' 27' ' ' HIS . . . 58.16 -114.98 6.34 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.837 -0.697 . . . . 65.510000000000005 113.048 -177.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' A' ' 26' ' ' GLY . 34.6 mt-10 -106.17 35.56 2.89 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.882 0.372 . . . . 70.129999999999995 111.649 -177.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -155.13 144.65 21.27 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.933 0.397 . . . . 73.140000000000001 111.444 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 tt -129.41 147.1 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 112.007 0.373 . . . . 52.130000000000003 112.007 -175.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.401 ' HD3' ' CE2' ' A' ' 69' ' ' TRP . 22.5 ptt180 -150.84 169.29 22.05 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.106 0.479 . . . . 63.350000000000001 111.428 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.758 HG12 ' SD ' ' A' ' 45' ' ' MET . 43.6 mt -105.6 116.29 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 116.282 -0.417 . . . . 71.129999999999995 110.756 173.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.476 ' NZ ' ' HB3' ' A' ' 55' ' ' LYS . 8.5 mtpm? -78.53 -40.4 35.2 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.269 0.557 . . . . 70.439999999999998 111.722 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -137.97 143.89 40.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.943 -0.571 . . . . 72.129999999999995 111.021 -173.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -161.0 126.14 3.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.384 0.611 . . . . 75.510000000000005 110.558 -178.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -100.89 67.95 1.25 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.589 -0.732 . . . . 61.530000000000001 110.813 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 53.4 p -129.97 150.99 77.49 Favored Pre-proline 0 N--CA 1.474 0.749 0 CA-C-N 116.294 -0.412 . . . . 73.319999999999993 111.105 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -63.88 -28.73 67.29 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.651 2.234 . . . . 71.439999999999998 112.752 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.47 ' HB3' HG23 ' A' ' 63' ' ' VAL . 5.1 m-20 -80.67 -36.91 31.76 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.876 -0.602 . . . . 73.430000000000007 112.513 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 63.69 20.59 12.3 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.341 0.497 . . . . 64.010000000000005 112.341 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 61' ' ' ASP . 64.6 t -59.76 -39.77 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 112.082 0.401 . . . . 64.329999999999998 112.082 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.93 -56.19 19.91 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.2 -0.454 . . . . 74.430000000000007 113.714 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.99 -38.06 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 O-C-N 122.66 -0.318 . . . . 61.200000000000003 111.683 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -59.79 -28.47 67.46 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.22 0.452 . . . . 61.439999999999998 112.22 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 23.0 mmt -57.56 -36.16 71.29 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.333 0.494 . . . . 54.439999999999998 112.333 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.87 -149.21 42.66 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.271 -0.49 . . . . 42.43 113.82 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.401 ' CE2' ' HD3' ' A' ' 53' ' ' ARG . 92.4 m95 -82.37 120.7 25.77 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.872 0.367 . . . . 71.319999999999993 111.964 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.671 ' HG3' HD11 ' A' ' 77' ' ' ILE . 75.2 mmtt -109.4 157.95 18.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.586 0.354 . . . . 61.130000000000003 110.925 175.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 88.0 p -163.76 -28.65 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.871 0.693 . . . . 61.350000000000001 112.871 -175.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -81.93 141.6 33.18 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.003 0.43 . . . . 72.230000000000004 112.094 -175.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.09 94.5 0.11 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.343 0.592 . . . . 74.150000000000006 110.704 175.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.652 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . 148.7 -22.83 1.32 Allowed Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.908 -0.587 . . . . 43.130000000000003 112.139 -174.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.518 ' HB2' HD12 ' A' ' 88' ' ' ILE . 78.3 m-20 -62.84 123.95 19.78 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.942 0.401 . . . . 64.109999999999999 111.127 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.5 p -117.53 142.57 47.01 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.24 0.543 . . . . 70.409999999999997 112.01 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.671 HD11 ' HG3' ' A' ' 70' ' ' LYS . 29.8 mm -119.5 117.57 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.734 -0.666 . . . . 74.349999999999994 110.212 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.1 t -108.76 116.51 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 111.974 0.361 . . . . 72.140000000000001 111.974 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 70.9 m -122.15 71.21 0.99 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.933 0.396 . . . . 65.239999999999995 111.024 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.537 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 94.5 mt -55.39 -49.3 93.31 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 112.93 0.715 . . . . 63.049999999999997 112.93 -177.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 51.1 Cg_exo -56.28 -17.38 20.51 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.274 1.983 . . . . 72.0 113.7 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -114.75 -0.07 13.67 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.122 -0.361 . . . . 73.150000000000006 111.959 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 60.12 29.27 18.86 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.761 0.425 . . . . 52.329999999999998 111.955 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.28 135.82 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.919 0.39 . . . . 75.219999999999999 111.396 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -139.91 125.16 18.85 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.329 -0.396 . . . . 73.129999999999995 110.944 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 52.7 t -123.31 120.41 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 120.778 0.323 . . . . 72.129999999999995 111.341 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -122.38 144.44 49.03 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.956 0.408 . . . . 74.030000000000001 111.369 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 75' ' ' ASP . 60.1 mt -97.84 136.53 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.047 0.451 . . . . 62.030000000000001 111.515 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -149.81 150.54 32.14 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.343 -0.39 . . . . 71.430000000000007 111.189 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 46.1 t -78.53 150.68 32.81 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.326 0.491 . . . . 75.0 112.326 -178.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.3 p -68.52 -20.17 64.56 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.192 0.52 . . . . 72.510000000000005 111.298 175.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -122.58 -167.88 1.65 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.728 -0.669 . . . . 53.32 111.323 -175.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -67.17 116.3 7.81 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.919 0.39 . . . . 75.420000000000002 111.576 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -135.74 156.6 48.57 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.166 -0.47 . . . . 71.209999999999994 110.839 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.4 m -119.44 101.18 7.77 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.707 0.289 . . . . 71.0 111.137 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.652 ' HD2' ' HA2' ' A' ' 74' ' ' GLY . 38.2 mtmt -78.95 -172.81 3.24 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.945 0.402 . . . . 65.299999999999997 111.356 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -58.79 141.75 84.86 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.331 -0.395 . . . . 65.109999999999999 110.737 172.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -55.74 -51.11 10.5 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.824 2.349 . . . . 64.329999999999998 113.07 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -84.46 100.63 11.46 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.173 0.511 . . . . 63.100000000000001 111.697 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 t -160.17 127.82 4.59 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.94 -0.573 . . . . 70.319999999999993 111.178 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -107.01 115.26 29.86 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.302 0.572 . . . . 71.340000000000003 112.132 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.439 HD23 ' N ' ' A' ' 102' ' ' LEU . 2.3 pt? -144.17 156.69 44.42 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.972 -0.558 . . . . 74.239999999999995 110.772 176.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.8 mt -126.41 110.0 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.039 0.447 . . . . 43.219999999999999 112.106 -177.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.7 t -89.33 112.91 54.21 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.279 -0.419 . . . . 74.140000000000001 109.894 170.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.44 -164.63 0.21 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.666 2.244 . . . . 73.019999999999996 113.492 -175.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -52.13 104.21 0.08 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.25 -0.432 . . . . 73.540000000000006 111.514 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.426 ' N ' HD23 ' A' ' 107' ' ' LEU . 2.3 pt? -55.07 146.53 18.0 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.115 0.483 . . . . 74.430000000000007 111.63 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -78.53 164.86 24.35 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.434 -0.348 . . . . 70.209999999999994 111.515 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -47.98 114.15 0.87 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.529 0.566 . . . . 63.229999999999997 112.529 -173.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -129.99 149.3 51.77 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.908 -0.587 . . . . 72.430000000000007 110.781 -178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -82.89 163.87 20.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.962 0.411 . . . . 75.329999999999998 111.632 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -97.29 114.34 26.09 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.918 0.39 . . . . 75.200000000000003 111.636 -175.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -133.94 116.01 15.08 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.488 -0.323 . . . . 62.130000000000003 111.396 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.3 p80 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.998 -0.525 . . . . 62.140000000000001 111.885 178.292 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.645 0.26 . . . . 51.439999999999998 111.485 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -87.81 -52.17 5.45 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.095 0.474 . . . . 71.400000000000006 111.369 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -70.62 119.02 14.17 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.071 0.462 . . . . 62.140000000000001 111.958 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.3 m -91.97 86.38 5.84 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.522 -0.547 . . . . 74.129999999999995 109.522 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.09 -86.02 0.54 Allowed Glycine 0 CA--C 1.524 0.613 0 C-N-CA 121.101 -0.571 . . . . 73.219999999999999 113.624 -173.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -129.11 93.53 3.61 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 122.738 -0.272 . . . . 63.200000000000003 111.016 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.474 ' HB2' ' OG1' ' A' ' 91' ' ' THR . 40.8 mt-10 -84.61 116.5 23.2 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.429 0.529 . . . . 75.530000000000001 112.429 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.46 143.86 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.177 -0.465 . . . . 75.129999999999995 111.172 173.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 23' ' ' PRO . 31.0 m -125.07 141.84 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 120.962 0.411 . . . . 71.219999999999999 111.372 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.73 120.47 37.12 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.837 0.351 . . . . 62.109999999999999 111.564 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 17.8 mm -99.89 110.85 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.364 -0.38 . . . . 71.209999999999994 110.87 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.528 ' HA ' HG22 ' A' ' 86' ' ' VAL . 3.2 mp -95.59 119.38 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.025 0.441 . . . . 73.219999999999999 111.917 -177.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.4 t -121.27 139.12 53.82 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.095 0.474 . . . . 74.109999999999999 111.327 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.471 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 47.9 tt0 -121.24 116.95 25.85 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.385 -0.371 . . . . 74.129999999999995 110.686 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.42 ' OD1' ' HG2' ' A' ' 14' ' ' GLN . 22.4 m120 61.76 2.61 0.75 Allowed 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.574 0.583 . . . . 74.120000000000005 112.574 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.86 -6.55 8.93 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.113 -0.565 . . . . 62.229999999999997 113.865 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -108.85 126.5 53.11 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 117.43 0.615 . . . . 71.5 111.414 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.6 t -70.52 112.04 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.124 0.488 . . . . 75.349999999999994 110.852 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.6 pt -102.44 -23.43 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 112.712 0.634 . . . . 72.129999999999995 112.712 -175.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -152.57 136.47 16.3 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.666 0.269 . . . . 73.239999999999995 111.641 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -130.66 114.96 16.05 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.759 0.314 . . . . 73.510000000000005 110.374 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.4 mt -115.38 124.43 30.12 Favored Pre-proline 0 N--CA 1.472 0.636 0 N-CA-C 112.111 0.411 . . . . 75.420000000000002 112.111 -175.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.516 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 60.4 Cg_endo -72.66 112.37 3.47 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.239 1.96 . . . . 72.010000000000005 111.758 173.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.9 mt -77.22 -57.1 4.02 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.959 0.409 . . . . 71.219999999999999 111.544 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 m -62.46 122.85 16.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.947 0.403 . . . . 74.219999999999999 111.601 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.16 -11.77 71.28 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.104 -0.57 . . . . 71.129999999999995 112.792 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.516 ' HB2' ' O ' ' A' ' 23' ' ' PRO . 58.5 t-80 -67.78 129.04 38.69 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.869 0.366 . . . . 50.43 110.439 177.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.449 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -119.96 136.24 54.61 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 122.021 -0.424 . . . . 75.310000000000002 111.294 -177.385 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.34 -172.2 33.02 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.494 -0.384 . . . . 73.140000000000001 112.788 -177.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -116.9 127.38 54.2 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 122.351 -0.499 . . . . 61.130000000000003 110.208 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -124.61 117.02 23.36 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.955 0.407 . . . . 75.150000000000006 111.268 -175.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.551 ' HG2' ' HG3' ' A' ' 46' ' ' GLU . 30.7 mt-30 -115.32 134.99 54.61 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.737 0.303 . . . . 73.510000000000005 111.256 -175.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -145.2 140.25 27.77 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.961 0.41 . . . . 55.420000000000002 110.904 177.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.2 m -104.11 109.34 21.1 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.997 0.427 . . . . 74.030000000000001 111.911 -174.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 62.8 mt -80.51 97.4 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.1 0.476 . . . . 61.299999999999997 111.037 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -82.8 104.01 12.72 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.996 0.427 . . . . 75.129999999999995 111.199 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.471 ' HA2' ' NE2' ' A' ' 14' ' ' GLN . . . -78.83 -146.04 3.18 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.345 -0.455 . . . . 52.100000000000001 113.059 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -76.31 108.61 9.38 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.95 0.405 . . . . 65.120000000000005 111.272 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.51 -129.21 9.41 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.065 -0.588 . . . . 70.420000000000002 113.55 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.96 4.32 23.12 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.303 0.483 . . . . 53.549999999999997 112.303 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -80.9 73.63 7.9 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.145 0.498 . . . . 73.340000000000003 112.232 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -89.53 155.89 18.98 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.964 0.412 . . . . 72.219999999999999 111.793 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.549 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 16.3 m120 -132.14 110.19 10.49 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.219 -0.446 . . . . 73.209999999999994 110.631 173.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.4 tp -83.38 103.22 12.58 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.064 0.459 . . . . 72.310000000000002 110.909 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.807 ' SD ' HG12 ' A' ' 54' ' ' ILE . 85.9 mmm -94.79 139.7 30.91 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.118 -0.492 . . . . 71.430000000000007 111.107 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.551 ' HG3' ' HG2' ' A' ' 32' ' ' GLN . 33.7 tt0 -136.72 118.94 15.55 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.086 0.469 . . . . 51.450000000000003 111.766 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.8 t -100.81 112.88 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.219 -0.446 . . . . 71.340000000000003 110.186 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.555 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 35.6 t70 -108.11 100.36 9.69 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.039 0.447 . . . . 72.430000000000007 110.731 -177.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.78 -110.53 3.31 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.842 -0.694 . . . . 55.409999999999997 112.258 -174.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -114.5 33.26 5.43 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.313 0.578 . . . . 73.209999999999994 111.313 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 14.4 ptt180 -147.56 149.43 32.57 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.08 -0.509 . . . . 73.319999999999993 110.745 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.4 tt -123.29 148.47 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 120.791 0.329 . . . . 51.240000000000002 111.772 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -151.36 168.76 23.8 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.904 0.383 . . . . 74.200000000000003 111.47 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.807 HG12 ' SD ' ' A' ' 45' ' ' MET . 37.1 mt -104.64 118.35 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.842 0.353 . . . . 70.340000000000003 110.093 170.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -83.4 -35.05 25.37 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.452 -0.34 . . . . 72.340000000000003 111.897 -175.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -161.78 138.51 8.27 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.816 0.341 . . . . 64.530000000000001 111.632 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -140.9 178.52 7.3 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.01 0.433 . . . . 61.140000000000001 111.394 175.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -112.6 33.87 4.7 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.36 0.6 . . . . 53.439999999999998 111.461 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.7 m -89.69 146.47 35.6 Favored Pre-proline 0 N--CA 1.472 0.642 0 O-C-N 121.755 -0.591 . . . . 75.109999999999999 110.818 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.24 -32.57 73.4 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.488 2.125 . . . . 73.329999999999998 112.295 179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -96.42 -9.19 30.43 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.021 -0.536 . . . . 64.549999999999997 111.795 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.526 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 23.6 mm-40 57.5 38.51 28.09 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.01 0.433 . . . . 53.43 111.731 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.3 t -52.75 -36.68 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 116.159 -0.473 . . . . 75.349999999999994 112.103 -174.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -58.7 -54.16 40.16 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.053 -0.594 . . . . 60.210000000000001 112.766 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.2 -38.22 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-O 120.896 0.379 . . . . 70.319999999999993 111.895 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.526 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 5.4 mptp? -65.19 -28.44 69.39 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.395 0.516 . . . . 64.219999999999999 112.395 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 25.7 mmt -60.72 -34.83 74.99 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.041 0.386 . . . . 44.509999999999998 112.041 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.25 -144.15 38.77 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 114.391 0.516 . . . . 52.340000000000003 114.391 175.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -84.39 131.95 34.63 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.734 0.642 . . . . 75.420000000000002 112.734 -176.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.43 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 75.3 mmtt -127.2 136.12 51.6 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.941 -0.572 . . . . 74.430000000000007 110.971 177.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.1 p -168.42 17.49 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.307 0.484 . . . . 73.239999999999995 112.307 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -114.77 150.59 35.16 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.773 0.321 . . . . 72.409999999999997 111.116 -177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.28 108.97 0.77 Allowed 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.998 0.427 . . . . 64.129999999999995 110.452 173.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 119.03 -16.71 10.84 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.077 -0.583 . . . . 75.530000000000001 113.299 -178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.43 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 53.4 m-20 -62.41 133.56 55.21 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.152 0.476 . . . . 72.109999999999999 111.551 176.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.8 p -134.24 147.33 50.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.221 0.534 . . . . 60.450000000000003 111.845 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.557 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 41.5 mm -114.73 121.85 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.759 -0.655 . . . . 72.510000000000005 110.3 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.0 t -121.47 117.44 52.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.929 0.395 . . . . 73.200000000000003 111.681 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 97.2 m -116.26 90.03 3.24 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.653 -0.249 . . . . 64.209999999999994 110.618 175.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.568 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 98.0 mt -55.81 -55.52 40.12 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 113.202 0.816 . . . . 74.120000000000005 113.202 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 16.6 Cg_exo -67.4 -7.34 18.82 Favored 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 122.002 1.801 . . . . 71.299999999999997 112.933 -176.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -114.93 -12.75 12.0 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.423 -0.353 . . . . 62.229999999999997 111.355 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.9 mttm 59.16 31.79 21.55 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.934 0.493 . . . . 72.040000000000006 111.947 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.9 t -100.68 133.51 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.223 -0.444 . . . . 51.5 110.978 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -135.84 129.31 32.19 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.925 0.393 . . . . 43.420000000000002 111.053 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.557 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 60.9 t -131.3 113.58 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.476 -0.329 . . . . 55.299999999999997 111.207 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.0 pm0 -108.31 139.96 42.27 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.056 0.455 . . . . 60.509999999999998 111.371 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.8 mt -106.71 119.55 56.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.448 -0.342 . . . . 72.129999999999995 111.463 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.449 ' HE3' ' HB2' ' A' ' 89' ' ' LYS . 19.0 ptmt -118.18 162.38 18.33 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.915 0.388 . . . . 75.120000000000005 111.664 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.1 t -88.21 149.56 23.79 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 116.312 -0.404 . . . . 63.200000000000003 110.95 175.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 7' ' ' GLU . 38.8 p -85.0 -2.72 58.3 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.192 0.441 . . . . 62.450000000000003 112.192 -178.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -72.82 -175.26 1.67 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.069 0.462 . . . . 65.430000000000007 111.798 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -68.99 73.4 0.28 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.39 -0.368 . . . . 61.409999999999997 111.975 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 63.6 136.43 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.175 0.805 . . . . 63.530000000000001 113.175 176.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.1 t -143.57 108.45 4.93 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.204 -0.453 . . . . 74.329999999999998 111.721 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -97.51 105.37 17.51 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.068 0.461 . . . . 72.019999999999996 110.561 173.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -87.97 160.96 45.4 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 115.893 -0.594 . . . . 62.420000000000002 112.302 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -49.42 -61.2 0.62 Allowed 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.719 2.946 . . . . 63.32 116.064 -169.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.63 151.56 42.23 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.556 0.947 . . . . 73.420000000000002 113.556 -170.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.0 t -112.15 170.7 7.98 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.573 -0.74 . . . . 73.230000000000004 111.788 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -90.32 44.24 1.19 Allowed 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.292 0.479 . . . . 71.219999999999999 112.292 -174.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.46 ' H ' HD23 ' A' ' 102' ' ' LEU . 2.7 pt? -71.82 123.96 23.78 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.197 0.522 . . . . 74.209999999999994 112.2 -177.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 65.9 mt -137.79 127.2 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 116.32 -0.4 . . . . 75.400000000000006 111.164 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.3 p -105.43 134.43 19.69 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 111.708 0.262 . . . . 61.020000000000003 111.708 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.84 149.48 60.37 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.856 2.371 . . . . 72.129999999999995 113.974 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -143.46 178.61 7.64 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.255 -0.429 . . . . 63.109999999999999 111.651 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.64 170.14 11.38 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.309 0.576 . . . . 71.540000000000006 112.378 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.82 159.31 37.72 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.024 -0.534 . . . . 54.539999999999999 111.008 176.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 112' ' ' HIS . 29.6 m-70 -100.56 109.96 22.09 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.242 -0.286 . . . . 73.420000000000002 111.157 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.406 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 16.1 t-80 -112.19 132.64 54.78 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 122.346 -0.221 . . . . 72.310000000000002 110.638 179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 110' ' ' HIS . 66.5 m-70 69.76 -29.97 0.19 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.248 0.619 . . . . 74.150000000000006 112.377 -172.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 109' ' ' HIS . 13.8 t60 -52.7 99.62 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.755 -0.461 . . . . 73.230000000000004 109.755 169.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -71.23 154.96 41.26 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.856 0.688 . . . . 64.150000000000006 112.856 -168.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 . . . . . 0 C--O 1.25 1.112 0 CA-C-N 115.913 -0.585 . . . . 62.32 111.323 175.259 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.631 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.357 0.599 . . . . 55.229999999999997 110.931 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -161.87 129.58 4.05 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.15 -0.477 . . . . 61.509999999999998 111.447 -176.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -73.82 79.69 1.6 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.105 0.478 . . . . 75.040000000000006 110.203 174.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.7 t -79.81 143.19 34.63 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.009 -0.541 . . . . 55.219999999999999 111.562 -177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.7 -60.01 1.11 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.276 -0.488 . . . . 33.409999999999997 113.649 -175.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -110.43 137.57 47.96 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.186 0.517 . . . . 64.340000000000003 112.092 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -93.53 115.66 28.16 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.035 -0.53 . . . . 74.5 111.995 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.38 160.28 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.08 0.466 . . . . 73.530000000000001 111.933 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 23' ' ' PRO . 35.5 m -135.14 141.47 42.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 122.615 0.366 . . . . 53.420000000000002 111.003 177.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.91 114.61 26.75 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.892 0.377 . . . . 50.109999999999999 111.561 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.0 mm -99.34 113.91 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 120.849 0.357 . . . . 64.109999999999999 111.192 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 12' ' ' ILE . 3.2 mp -100.52 118.04 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.1 0.476 . . . . 74.010000000000005 111.17 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.3 m -121.56 147.75 45.41 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.883 0.373 . . . . 71.519999999999996 111.64 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -138.88 142.99 38.55 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.643 0.259 . . . . 75.510000000000005 110.843 175.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.9 m120 57.6 17.68 4.15 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.271 0.471 . . . . 74.510000000000005 112.271 -177.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.71 18.95 39.03 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.339 -0.457 . . . . 43.530000000000001 113.867 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.466 ' HB3' ' NZ ' ' A' ' 17' ' ' LYS . 0.5 OUTLIER -143.91 144.96 31.96 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.46 0.63 . . . . 75.219999999999999 111.616 177.458 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.0 t -70.03 120.95 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.827 0.346 . . . . 72.409999999999997 111.567 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 37.2 pt -107.94 -15.42 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 112.219 0.452 . . . . 73.549999999999997 112.219 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -170.14 142.53 2.29 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.408 0.283 . . . . 64.209999999999994 110.8 -177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.01 122.93 10.03 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.153 0.501 . . . . 71.510000000000005 111.898 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 22' ' ' ILE . 4.2 mp -117.6 121.54 31.83 Favored Pre-proline 0 N--CA 1.474 0.731 0 CA-C-N 116.431 -0.35 . . . . 51.240000000000002 111.609 -176.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.484 ' HA ' HG12 ' A' ' 9' ' ' VAL . 20.4 Cg_exo -66.52 103.15 0.65 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.169 1.913 . . . . 63.32 111.491 170.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.37 -59.33 4.14 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.409 -0.36 . . . . 72.230000000000004 111.926 -174.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.0 m -53.76 125.93 20.23 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.967 0.413 . . . . 71.209999999999994 111.996 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.01 -21.14 41.45 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.114 -0.565 . . . . 64.120000000000005 113.663 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -86.71 103.96 15.66 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 117.46 0.63 . . . . 74.239999999999995 112.24 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.419 ' HA ' ' HA2' ' A' ' 49' ' ' GLY . 23.7 pttm -86.64 -175.37 5.4 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.185 -0.461 . . . . 73.540000000000006 110.541 174.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.72 -164.13 54.17 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.015 -0.612 . . . . 63.219999999999999 114.072 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -119.26 131.17 55.75 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.959 0.409 . . . . 73.349999999999994 111.508 -176.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.455 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 10.5 tp10 -132.31 114.98 15.05 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.339 -0.391 . . . . 74.219999999999999 110.752 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -118.95 140.64 49.66 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 111.935 0.346 . . . . 75.510000000000005 111.935 -176.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -146.87 152.24 38.38 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.761 0.315 . . . . 61.310000000000002 111.261 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.6 m -113.8 117.63 32.0 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.267 0.556 . . . . 64.409999999999997 112.495 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 71.9 mt -86.38 108.26 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.849 -0.614 . . . . 73.299999999999997 111.079 177.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -92.78 105.15 17.33 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.711 0.291 . . . . 72.329999999999998 111.128 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.5 -66.84 1.19 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.289 -0.482 . . . . 74.120000000000005 114.177 -175.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -164.65 125.62 2.09 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.638 -0.33 . . . . 71.299999999999997 111.335 -176.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.36 -105.7 0.77 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.228 -0.51 . . . . 74.230000000000004 113.2 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.57 -1.18 28.7 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.184 0.439 . . . . 42.229999999999997 112.184 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -84.87 88.73 7.44 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.077 0.465 . . . . 64.319999999999993 112.008 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.441 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 47.8 p90 -113.05 168.4 9.73 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.054 -0.521 . . . . 72.329999999999998 110.798 174.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.563 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 20.0 m120 -135.75 112.68 10.29 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.317 0.247 . . . . 74.5 110.894 173.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 42.5 tp -87.61 109.94 20.02 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.828 0.347 . . . . 54.329999999999998 110.818 177.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.8 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.6 mmm -100.74 159.29 15.3 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.0 0.428 . . . . 70.549999999999997 111.979 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.482 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 40.5 tt0 -147.7 132.26 17.75 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.338 0.495 . . . . 73.219999999999999 112.338 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 58.8 t -118.15 107.63 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.126 0.571 . . . . 62.420000000000002 110.09 174.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 11.9 t70 -121.97 93.4 3.98 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.862 0.363 . . . . 54.310000000000002 111.592 -174.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 28' ' ' LYS . . . 67.79 75.36 0.49 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.187 -0.53 . . . . 62.43 114.315 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 60.56 17.19 7.15 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.683 0.994 . . . . 73.219999999999999 113.683 175.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.511 ' HG3' ' CE3' ' A' ' 69' ' ' TRP . 7.7 ptp180 -144.07 146.59 32.93 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.97 -0.457 . . . . 73.329999999999998 111.19 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 tt -127.29 148.09 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 121.096 0.474 . . . . 74.329999999999998 112.271 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.543 ' HB3' ' HA ' ' A' ' 69' ' ' TRP . 0.4 OUTLIER -159.6 168.88 25.02 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.181 -0.463 . . . . 74.200000000000003 111.454 176.297 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.8 HG12 ' SD ' ' A' ' 45' ' ' MET . 33.7 mt -93.38 130.2 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.925 0.393 . . . . 64.109999999999999 110.962 175.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.482 ' HD2' ' HB2' ' A' ' 46' ' ' GLU . 29.5 mtpp -80.94 -47.68 13.36 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.43 -0.35 . . . . 53.310000000000002 111.642 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -171.93 144.75 1.77 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.067 0.461 . . . . 65.120000000000005 111.77 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 3.9 p-10 -142.2 -177.32 5.19 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.262 -0.426 . . . . 71.400000000000006 110.647 176.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -116.78 83.81 2.03 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.481 0.658 . . . . 74.420000000000002 111.06 173.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.6 t -130.65 152.75 80.99 Favored Pre-proline 0 N--CA 1.474 0.741 0 CA-C-N 115.692 -0.686 . . . . 70.310000000000002 111.371 174.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.72 -13.91 24.46 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 121.868 1.712 . . . . 64.510000000000005 112.046 171.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.489 ' HB3' HG23 ' A' ' 63' ' ' VAL . 7.8 m-20 -102.68 -50.91 3.43 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.136 -0.484 . . . . 62.350000000000001 111.491 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 53.24 29.84 9.07 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.637 0.606 . . . . 63.520000000000003 112.637 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.489 HG23 ' HB3' ' A' ' 61' ' ' ASP . 41.5 t -58.55 -36.02 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.846 0.355 . . . . 64.129999999999995 111.549 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.434 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -57.09 -45.27 92.64 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 116.406 -0.361 . . . . 65.430000000000007 113.593 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 45.4 t -62.56 -40.02 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.34 0.59 . . . . 52.439999999999998 110.983 178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -69.52 -27.29 65.05 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.978 -0.556 . . . . 54.0 112.253 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 20.9 mmt -55.06 -39.24 69.0 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.127 0.418 . . . . 74.519999999999996 112.127 177.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.26 -175.6 54.88 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.202 -0.523 . . . . 71.219999999999999 114.186 175.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.543 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . 96.5 m95 -52.28 138.11 27.24 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.954 0.724 . . . . 73.109999999999999 112.954 -175.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -135.56 148.3 49.06 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.7 0.4 . . . . 72.109999999999999 110.743 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 89.2 p -170.7 18.97 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.802 0.668 . . . . 71.099999999999994 112.802 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -101.44 146.67 27.31 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.035 -0.416 . . . . 72.409999999999997 110.59 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.13 88.89 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.089 0.471 . . . . 65.150000000000006 111.037 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.85 -19.46 2.55 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.198 -0.525 . . . . 65.010000000000005 113.666 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.53 ' HB2' HD12 ' A' ' 88' ' ' ILE . 97.4 m-20 -57.09 139.56 52.01 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 117.573 0.686 . . . . 72.150000000000006 112.172 -178.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.3 p -138.79 144.89 39.55 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.95 0.405 . . . . 73.530000000000001 111.515 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.8 mm -122.9 127.94 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.3 -0.409 . . . . 75.230000000000004 110.315 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.9 t -111.7 117.22 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.013 0.435 . . . . 75.219999999999999 111.959 -177.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.554 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 74.8 m -114.03 76.44 0.99 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.128 0.49 . . . . 73.040000000000006 110.226 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.456 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 5.2 tt -54.75 -54.14 52.72 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 115.713 -0.676 . . . . 70.120000000000005 112.634 -173.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 80' ' ' LEU . 23.7 Cg_endo -59.73 -22.61 68.41 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 122.156 1.904 . . . . 73.109999999999999 113.287 -177.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -104.35 -2.13 25.93 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.488 -0.324 . . . . 74.439999999999998 111.385 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm 60.02 29.38 18.95 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.263 0.468 . . . . 72.019999999999996 112.263 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 48.4 t -106.15 141.75 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.925 0.393 . . . . 75.530000000000001 111.436 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -143.24 126.65 16.74 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.821 0.343 . . . . 73.430000000000007 110.984 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -115.35 133.4 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.569 -0.287 . . . . 75.040000000000006 111.182 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -132.42 136.75 46.97 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.064 0.459 . . . . 63.030000000000001 111.47 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.53 HD12 ' HB2' ' A' ' 75' ' ' ASP . 58.7 mt -106.4 110.86 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.311 -0.404 . . . . 74.129999999999995 110.797 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -117.58 164.64 14.63 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.248 0.462 . . . . 72.340000000000003 112.248 -174.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.9 t -85.12 149.73 25.34 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.189 -0.46 . . . . 74.310000000000002 112.209 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.2 p -77.69 -27.84 50.86 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.162 0.506 . . . . 74.120000000000005 110.989 174.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -86.29 165.72 16.22 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.171 -0.468 . . . . 75.219999999999999 110.951 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -80.76 125.88 30.62 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.446 0.535 . . . . 63.450000000000003 112.446 -175.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -105.84 -178.29 3.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.064 -0.516 . . . . 72.409999999999997 110.47 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.9 t -88.9 49.17 1.74 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.345 0.593 . . . . 54.350000000000001 110.111 173.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -91.67 176.29 6.59 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.367 0.603 . . . . 75.340000000000003 112.244 -176.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.44 146.67 84.21 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 115.657 -0.701 . . . . 74.409999999999997 110.814 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.65 -52.89 7.06 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.282 1.988 . . . . 71.230000000000004 111.825 175.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -171.94 179.28 2.75 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.603 -0.726 . . . . 74.510000000000005 110.315 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.4 t -150.18 130.98 14.14 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.084 0.468 . . . . 74.400000000000006 111.514 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -129.75 133.55 47.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.376 -0.375 . . . . 73.409999999999997 110.899 178.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.7 pp -165.39 162.16 19.34 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.953 0.406 . . . . 43.240000000000002 111.332 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.1 mm -115.11 109.11 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.002 0.429 . . . . 73.239999999999995 110.975 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 34.5 m -75.38 142.26 74.57 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 120.832 0.349 . . . . 73.019999999999996 111.933 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 104' ' ' VAL . 27.3 Cg_exo -62.41 113.12 1.79 Allowed 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.5 2.133 . . . . 61.539999999999999 112.165 175.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -76.97 136.68 38.75 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.075 -0.512 . . . . 54.439999999999998 111.631 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.6 pp -85.99 162.68 18.39 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.931 0.396 . . . . 65.409999999999997 111.56 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -94.85 -178.51 4.53 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.162 0.506 . . . . 35.32 111.814 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -142.68 105.47 4.52 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.012 -0.54 . . . . 72.310000000000002 110.498 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -76.87 82.54 3.44 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.27 0.557 . . . . 74.349999999999994 110.25 176.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -134.1 149.51 51.11 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.036 -0.529 . . . . 73.010000000000005 111.708 -173.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -122.03 158.37 29.33 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.411 -0.359 . . . . 75.450000000000003 110.592 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -83.67 145.32 28.85 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.864 0.364 . . . . 71.319999999999993 111.843 -177.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 73.8 m80 . . . . . 0 C--O 1.253 1.254 0 CA-C-O 118.62 -0.705 . . . . 54.340000000000003 111.455 178.541 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 111.889 0.329 . . . . 71.329999999999998 111.889 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -117.24 111.72 19.81 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.259 0.466 . . . . 72.230000000000004 112.259 -173.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -127.11 108.36 10.84 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.864 0.364 . . . . 55.25 110.361 174.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 57.8 p -106.5 117.93 35.32 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.916 0.388 . . . . 74.340000000000003 111.866 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -82.0 -17.49 69.71 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.273 -0.489 . . . . 74.140000000000001 112.948 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.75 83.55 0.89 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.796 0.331 . . . . 72.140000000000001 111.332 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -79.82 104.89 10.71 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.038 0.447 . . . . 64.209999999999994 111.295 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 32.7 m -120.88 144.66 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.508 0.67 . . . . 21.100000000000001 112.37 -177.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 23' ' ' PRO . 34.6 m -125.39 134.2 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 115.677 -0.692 . . . . 72.420000000000002 110.815 177.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.43 114.52 25.13 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.794 0.331 . . . . 52.299999999999997 111.659 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.3 mm -97.25 137.49 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.551 -0.295 . . . . 73.319999999999993 110.474 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.9 mp -121.97 118.71 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.012 0.434 . . . . 72.340000000000003 111.055 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.6 p -112.98 153.02 28.7 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.178 0.513 . . . . 75.049999999999997 111.37 177.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -151.91 142.21 22.42 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.328 -0.396 . . . . 63.43 110.846 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 59.77 14.1 3.92 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.628 0.603 . . . . 71.109999999999999 112.628 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.68 10.69 43.0 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.032 -0.604 . . . . 71.450000000000003 114.166 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -146.13 151.06 37.06 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 117.264 0.532 . . . . 72.420000000000002 111.458 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.12 136.79 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.681 0.276 . . . . 65.049999999999997 110.899 175.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.1 pt -117.89 -22.07 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 112.14 0.422 . . . . 52.340000000000003 112.14 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -169.31 144.99 3.22 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.577 0.227 . . . . 75.019999999999996 111.315 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -137.69 128.06 26.37 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.85 0.357 . . . . 73.200000000000003 111.254 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.9 mp -123.83 119.63 26.8 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-N 116.579 -0.282 . . . . 72.140000000000001 111.704 -177.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.466 ' HA ' HG12 ' A' ' 9' ' ' VAL . 34.8 Cg_exo -61.97 132.0 37.52 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.406 2.07 . . . . 55.439999999999998 112.346 172.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' HB2' HG23 ' A' ' 8' ' ' VAL . 88.1 mt -96.3 -61.72 1.39 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.881 0.372 . . . . 74.230000000000004 111.465 -178.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.3 m -60.23 121.12 11.17 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.511 -0.313 . . . . 62.439999999999998 111.657 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.05 -8.24 80.18 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.095 -0.574 . . . . 45.140000000000001 113.126 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -78.3 86.42 4.39 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.289 0.566 . . . . 71.409999999999997 110.886 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -83.57 98.25 9.48 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.248 0.547 . . . . 72.299999999999997 111.113 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.88 -168.21 31.17 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.949 -0.568 . . . . 63.039999999999999 112.923 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -118.43 145.19 45.41 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 122.307 -0.526 . . . . 74.200000000000003 110.874 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.557 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 9.3 tp10 -144.82 117.49 8.65 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.566 -0.288 . . . . 63.130000000000003 110.574 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -127.6 129.85 47.99 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.728 0.299 . . . . 60.109999999999999 111.13 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -141.35 153.05 44.89 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.075 0.464 . . . . 73.219999999999999 111.297 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.6 m -112.49 116.7 30.68 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.948 0.404 . . . . 62.310000000000002 111.422 -175.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.2 mt -79.99 108.22 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.859 0.362 . . . . 70.420000000000002 111.022 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -99.86 111.13 23.46 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.298 -0.41 . . . . 54.229999999999997 111.146 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -110.69 -91.45 2.08 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.242 -0.504 . . . . 73.519999999999996 113.493 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.635 ' HE3' ' HA ' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -112.84 85.47 2.18 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.861 0.362 . . . . 72.510000000000005 111.494 -176.355 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.33 -97.71 0.02 OUTLIER Glycine 0 CA--C 1.529 0.93 0 CA-C-N 116.277 -0.419 . . . . 73.120000000000005 113.817 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.82 -31.53 72.54 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.929 0.395 . . . . 70.439999999999998 111.74 177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -72.82 94.17 1.77 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.129 0.418 . . . . 75.439999999999998 112.129 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -124.84 176.8 6.38 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.387 -0.369 . . . . 73.209999999999994 110.498 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -158.63 114.52 2.66 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.766 0.317 . . . . 74.140000000000001 110.92 174.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.6 tp -89.99 111.53 22.64 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.073 0.463 . . . . 45.039999999999999 111.477 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.633 ' SD ' HG12 ' A' ' 54' ' ' ILE . 94.3 mmm -97.56 138.1 35.49 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.146 -0.479 . . . . 64.0 111.384 -177.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -123.95 116.61 23.16 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.931 0.396 . . . . 72.209999999999994 111.78 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 40.2 t -107.47 112.46 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.232 -0.44 . . . . 74.329999999999998 110.652 176.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 20.5 t70 -109.04 101.95 10.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.05 0.452 . . . . 54.399999999999999 110.224 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.87 -106.02 1.17 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.846 -0.692 . . . . 72.430000000000007 112.772 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -111.51 17.41 20.07 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 120.973 0.416 . . . . 75.530000000000001 111.734 -176.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 19.9 ptt180 -130.42 141.96 50.52 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.316 -0.402 . . . . 74.420000000000002 111.049 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 tt -130.92 149.41 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 120.987 0.422 . . . . 73.019999999999996 111.717 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -157.02 168.89 26.13 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.953 0.406 . . . . 74.530000000000001 111.486 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.633 HG12 ' SD ' ' A' ' 45' ' ' MET . 60.5 mt -85.54 113.52 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 109.832 -0.433 . . . . 64.420000000000002 109.832 169.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -73.87 -49.66 23.97 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.94 0.4 . . . . 72.439999999999998 111.686 -177.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -162.69 138.61 7.24 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.181 0.437 . . . . 64.409999999999997 112.181 -175.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -165.43 -172.29 2.41 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.095 -0.502 . . . . 72.430000000000007 110.34 173.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -121.72 24.07 9.89 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.77 0.656 . . . . 72.219999999999999 112.77 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.3 t -77.18 125.93 85.91 Favored Pre-proline 0 N--CA 1.474 0.761 0 O-C-N 121.869 -0.519 . . . . 74.340000000000003 110.968 175.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -59.39 -13.58 21.2 Favored 'Trans proline' 0 N--CA 1.48 0.725 0 C-N-CA 122.998 2.465 . . . . 65.209999999999994 113.092 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.524 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.7 m-20 -83.77 -41.07 18.0 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.036 0.384 . . . . 72.200000000000003 112.036 175.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 53.75 32.56 15.05 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.147 0.425 . . . . 71.409999999999997 112.147 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.524 HG23 ' HB3' ' A' ' 61' ' ' ASP . 97.5 t -52.52 -51.74 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 112.55 0.574 . . . . 52.350000000000001 112.55 -173.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.579 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -62.73 -34.82 90.78 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.743 -0.742 . . . . 70.239999999999995 113.446 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.48 -44.67 98.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 120.945 0.402 . . . . 64.0 110.897 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -69.49 -37.7 77.33 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.427 -0.351 . . . . 71.349999999999994 111.112 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 21.3 mmt -61.63 -33.57 74.17 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.353 0.501 . . . . 64.25 112.353 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.39 -143.18 29.11 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.021 -0.609 . . . . 74.040000000000006 113.426 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -86.99 122.39 30.77 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.058 0.456 . . . . 75.140000000000001 112.066 -176.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HD2' ' CG ' ' A' ' 75' ' ' ASP . 74.1 mmtt -108.63 154.33 22.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.177 -0.465 . . . . 73.109999999999999 110.668 176.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 82.6 p -165.89 12.68 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.987 1.106 . . . . 72.200000000000003 113.987 -173.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -131.49 158.9 39.67 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.553 0.692 . . . . 63.149999999999999 112.457 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.527 ' HB2' ' HB2' ' A' ' 90' ' ' SER . . . -68.13 108.01 2.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.67 -0.695 . . . . 44.0 111.422 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.28 -16.61 4.89 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.35 -0.452 . . . . 65.530000000000001 112.398 -176.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.506 ' HB2' HD12 ' A' ' 88' ' ' ILE . 77.5 m-20 -72.21 106.15 4.29 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.029 0.442 . . . . 74.230000000000004 111.242 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.7 p -116.24 142.46 46.8 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.784 0.325 . . . . 74.430000000000007 111.779 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.9 mm -117.06 134.03 61.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 122.673 0.389 . . . . 72.209999999999994 110.828 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -112.19 117.34 54.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 111.895 0.332 . . . . 64.25 111.895 -177.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 86.7 m -122.0 68.37 0.93 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.856 0.36 . . . . 62.140000000000001 111.126 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.527 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 92.0 mt -53.07 -50.11 83.84 Favored Pre-proline 0 N--CA 1.476 0.847 0 N-CA-C 113.246 0.832 . . . . 62.530000000000001 113.246 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.527 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 50.7 Cg_exo -54.54 -24.65 37.17 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.021 1.814 . . . . 64.219999999999999 113.374 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -106.58 -1.88 22.45 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 111.869 0.322 . . . . 63.030000000000001 111.869 -179.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 59.69 30.93 20.54 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.989 0.423 . . . . 64.430000000000007 111.662 -176.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.2 t -112.12 137.17 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 116.079 -0.51 . . . . 43.549999999999997 111.178 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -135.81 143.04 44.95 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.528 -0.306 . . . . 63.5 110.291 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.1 t -129.36 120.1 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 122.288 -0.257 . . . . 44.32 111.067 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.22 116.94 25.86 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.456 0.646 . . . . 74.329999999999998 111.912 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.506 HD12 ' HB2' ' A' ' 75' ' ' ASP . 57.4 mt -88.78 114.53 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 122.009 -0.432 . . . . 63.119999999999997 110.894 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.415 ' HB2' ' NZ ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -109.85 172.46 6.84 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.942 0.401 . . . . 63.240000000000002 111.095 179.552 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 40.5 t -111.21 150.27 29.8 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.782 0.325 . . . . 62.119999999999997 110.891 175.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.1 p -77.01 -9.65 58.84 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.566 -0.288 . . . . 71.510000000000005 111.453 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -66.08 170.01 6.22 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.598 0.713 . . . . 74.430000000000007 112.402 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -86.58 139.82 30.46 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.469 -0.787 . . . . 64.319999999999993 110.357 173.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -143.98 176.48 9.25 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 122.118 -0.364 . . . . 71.530000000000001 110.845 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.4 t -105.43 -23.51 12.81 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.754 0.65 . . . . 53.43 112.754 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -83.93 143.8 29.6 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.36 0.6 . . . . 75.519999999999996 112.227 -174.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -109.44 122.47 39.37 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.82 -0.627 . . . . 75.099999999999994 110.923 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -84.87 -44.03 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.425 2.083 . . . . 75.049999999999997 113.946 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -96.35 162.85 13.32 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.481 0.548 . . . . 74.340000000000003 112.481 -172.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.2 p -107.07 -62.73 1.37 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.483 0.658 . . . . 73.299999999999997 110.511 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -93.34 124.17 37.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.225 -0.898 . . . . 61.520000000000003 110.903 176.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.4 tp -91.43 128.72 37.37 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.301 -0.409 . . . . 72.230000000000004 111.984 -176.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 51.3 mm -102.17 116.73 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.532 -0.304 . . . . 64.420000000000002 110.946 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 68.8 t -116.55 121.4 33.24 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 112.176 0.436 . . . . 73.319999999999993 112.176 -177.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.61 98.57 1.14 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 122.464 2.11 . . . . 75.099999999999994 112.446 175.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -123.02 26.73 7.97 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.179 0.437 . . . . 53.210000000000001 112.179 -177.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 107' ' ' LEU . 3.2 mm? -70.09 134.6 48.38 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.642 0.258 . . . . 75.540000000000006 111.441 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -121.49 139.95 52.82 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.401 0.519 . . . . 72.219999999999999 112.401 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -149.82 136.46 19.25 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.97 -0.559 . . . . 71.040000000000006 110.257 175.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -147.14 149.3 32.73 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.936 0.398 . . . . 71.230000000000004 112.01 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -135.72 141.94 44.97 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.413 -0.358 . . . . 73.420000000000002 111.135 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -87.82 94.07 9.65 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.988 0.423 . . . . 74.219999999999999 111.086 176.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -90.96 174.49 7.4 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.39 -0.368 . . . . 73.239999999999995 111.533 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 34.0 m170 . . . . . 0 C--O 1.253 1.274 0 CA-C-O 118.399 -0.81 . . . . 70.219999999999999 112.286 179.643 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.529 ' HA ' ' HB ' ' A' ' 25' ' ' THR . 42.9 mt-10 . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 112.083 0.401 . . . . 73.05 112.083 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 25.7 m -110.8 151.91 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 121.361 0.6 . . . . 60.42 112.184 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 23' ' ' PRO . 34.4 m -128.1 143.04 42.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 115.794 -0.639 . . . . 70.41 111.256 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.49 117.97 30.17 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.43 -0.35 . . . . 63.15 111.216 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.51 HD11 ' HE3' ' A' ' 89' ' ' LYS . 20.0 mm -92.45 112.92 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.464 -0.334 . . . . 70.23 111.21 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.466 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.4 mp -98.31 119.13 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.091 0.472 . . . . 72.22 111.647 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.2 p -123.22 145.18 48.86 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.298 -0.41 . . . . 50.13 110.604 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.47 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 60.6 tt0 -140.28 141.85 35.77 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.128 -0.358 . . . . 72.42 111.329 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.47 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 51.7 m-80 66.28 -12.76 0.18 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.784 0.661 . . . . 65.53 112.784 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 14' ' ' GLN . . . 119.25 26.07 2.55 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.525 -0.369 . . . . 74.52 112.731 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -147.96 146.55 29.01 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.479 -0.424 . . . . 75.14 111.156 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.6 t -74.29 121.41 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.904 0.383 . . . . 62.32 110.769 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 34.9 pt -109.97 -20.95 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 112.721 0.638 . . . . 74.31 112.721 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -170.66 153.04 3.96 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.485 0.183 . . . . 65.24 111.48 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -147.15 122.4 10.23 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.266 0.555 . . . . 73.51 111.546 175.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.521 HG21 HG21 ' A' ' 47' ' ' VAL . 2.5 mp -106.65 129.67 24.07 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-N 116.092 -0.504 . . . . 71.44 111.614 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.461 ' HA ' HG12 ' A' ' 9' ' ' VAL . 56.9 Cg_endo -70.76 126.9 13.13 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.366 2.044 . . . . 62.52 112.109 174.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.91 -62.43 1.32 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 111.901 0.334 . . . . 65.4 111.901 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.529 ' HB ' ' HA ' ' A' ' 7' ' ' GLU . 19.6 m -54.28 127.47 27.27 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.653 0.263 . . . . 64.41 111.567 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.01 -24.38 9.17 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.211 -0.518 . . . . 54.42 113.218 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -75.94 83.0 2.84 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.383 0.611 . . . . 64.55 110.93 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -83.77 164.08 19.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.708 -0.678 . . . . 70.23 111.416 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.19 -163.25 37.5 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 120.827 -0.701 . . . . 43.44 112.631 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -118.53 146.79 44.28 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.001 0.429 . . . . 64.32 111.775 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -150.13 142.24 24.03 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.163 -0.472 . . . . 74.5 110.857 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -132.05 147.82 52.46 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.043 0.386 . . . . 62.05 112.043 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -153.39 139.5 18.33 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.962 0.41 . . . . 74.14 111.439 174.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.6 m -102.45 114.51 28.77 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.127 0.418 . . . . 63.32 112.127 -175.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.1 mt -86.25 104.4 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 116.271 -0.422 . . . . 72.32 111.425 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -101.27 125.21 47.87 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.673 0.273 . . . . 63.33 111.106 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -121.29 -78.27 0.49 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.982 -0.628 . . . . 22.55 114.197 -176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -114.25 -169.86 1.61 Allowed 'General case' 0 CA--C 1.546 0.811 0 O-C-N 122.46 -0.435 . . . . 73.42 111.304 -173.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -44.67 100.04 0.02 OUTLIER Glycine 0 CA--C 1.528 0.879 0 N-CA-C 114.502 0.561 . . . . 74.5 114.502 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 67.0 -2.82 1.06 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.177 0.806 . . . . 54.02 113.177 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -86.56 112.58 21.7 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.871 0.367 . . . . 72.03 111.915 -175.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -139.99 163.51 32.48 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.284 -0.416 . . . . 61.21 111.649 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -135.4 113.52 11.28 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.479 -0.328 . . . . 75.54 111.291 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.4 tp -84.57 103.82 14.03 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.922 0.392 . . . . 72.0 110.169 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.646 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.7 mmm -95.91 146.37 24.64 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.265 -0.425 . . . . 71.44 111.322 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -132.92 122.94 25.07 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.102 0.477 . . . . 72.4 111.952 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.521 HG21 HG21 ' A' ' 22' ' ' ILE . 58.2 t -103.32 107.57 22.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.941 -0.572 . . . . 72.55 110.207 173.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.463 ' HB3' ' CH2' ' A' ' 69' ' ' TRP . 30.3 t70 -129.84 105.69 8.18 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.859 0.361 . . . . 63.54 111.543 -175.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . 74.66 55.1 5.61 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.302 -0.475 . . . . 74.4 114.013 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 63.62 23.53 13.59 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.775 0.657 . . . . 73.43 112.775 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 49' ' ' GLY . 7.9 ptt85 -148.5 149.18 31.19 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.806 0.336 . . . . 73.02 110.985 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.0 tt -123.29 148.69 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.148 0.499 . . . . 51.23 112.068 -174.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -152.94 168.88 24.33 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.851 -0.613 . . . . 71.32 110.821 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.646 HG12 ' SD ' ' A' ' 45' ' ' MET . 40.4 mt -84.91 110.67 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 120.977 0.418 . . . . 55.11 110.155 169.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -75.29 -29.94 60.23 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.31 -0.405 . . . . 71.1 111.096 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -175.47 138.65 0.41 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.243 -0.435 . . . . 73.55 111.431 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -161.68 156.42 23.01 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.175 0.512 . . . . 65.41 111.034 172.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -93.39 69.14 4.23 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.2 0.524 . . . . 63.42 111.867 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.3 p -127.33 140.61 38.42 Favored Pre-proline 0 N--CA 1.473 0.7 0 CA-C-N 116.46 -0.336 . . . . 41.03 110.692 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.67 -17.79 29.34 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.981 1.788 . . . . 74.11 111.987 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.536 ' HB3' HG23 ' A' ' 63' ' ' VAL . 2.2 m-20 -80.35 -52.9 7.14 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.607 -0.724 . . . . 65.23 111.755 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 57.45 29.31 16.8 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 120.649 0.261 . . . . 75.11 111.6 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 61' ' ' ASP . 65.5 t -53.82 -48.33 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 112.223 0.453 . . . . 53.21 112.223 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.557 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -59.89 -29.67 68.17 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 120.892 -0.67 . . . . 74.44 113.067 177.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 67.5 t -66.94 -40.24 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.752 0.31 . . . . 61.42 110.713 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -65.62 -37.17 85.83 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.032 0.444 . . . . 74.15 110.832 172.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.58 ' SD ' ' NZ ' ' A' ' 70' ' ' LYS . 23.2 mmt -58.35 -46.41 86.33 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.236 -0.438 . . . . 54.21 111.588 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.58 -143.49 38.77 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.322 -0.466 . . . . 54.03 113.74 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.463 ' CH2' ' HB3' ' A' ' 48' ' ' ASP . 82.4 m95 -69.6 105.22 2.6 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.365 0.506 . . . . 72.22 112.365 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.58 ' NZ ' ' SD ' ' A' ' 67' ' ' MET . 34.4 mmtp -111.85 138.96 47.75 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 116.297 -0.41 . . . . 71.15 110.429 174.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' A' ' 51' ' ' ARG . 98.8 p -157.49 9.83 0.19 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.339 1.237 . . . . 74.44 114.339 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -118.41 149.67 40.85 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.725 -0.609 . . . . 72.54 112.075 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.31 107.54 0.5 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.021 -0.536 . . . . 74.55 111.041 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 129.07 -20.91 5.3 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 116.125 -0.489 . . . . 72.05 112.52 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.556 ' HB2' HD12 ' A' ' 88' ' ' ILE . 55.7 m-20 -74.48 151.3 39.58 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.009 0.433 . . . . 73.43 111.297 175.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 65.8 p -141.43 158.14 44.25 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.327 0.584 . . . . 74.21 112.372 -176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 40.0 mm -132.1 116.12 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.493 -0.776 . . . . 62.44 109.434 173.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.1 t -124.83 117.18 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 113.003 0.742 . . . . 65.43 113.003 -173.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 68.8 m -122.97 89.13 3.05 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.34 -0.391 . . . . 64.24 110.947 170.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.0 mt -63.78 -38.92 41.7 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 113.575 0.954 . . . . 63.42 113.575 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.04 -21.14 25.96 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.878 1.719 . . . . 72.1 112.931 174.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -112.49 0.61 15.59 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.899 0.38 . . . . 74.14 110.776 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 92.6 mttt 55.09 34.56 22.83 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.609 0.764 . . . . 72.21 112.434 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -102.62 117.51 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.919 0.39 . . . . 71.34 111.305 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -119.92 123.15 42.86 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.426 -0.352 . . . . 73.31 110.545 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.565 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 48.1 t -123.24 132.63 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 120.57 0.224 . . . . 62.53 111.397 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -132.21 143.64 50.09 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.818 0.342 . . . . 73.45 110.938 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.556 HD12 ' HB2' ' A' ' 75' ' ' ASP . 57.2 mt -100.95 121.35 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.612 0.244 . . . . 62.44 111.505 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.51 ' HE3' HD11 ' A' ' 11' ' ' ILE . 22.9 pttp -124.25 152.04 43.46 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.829 0.347 . . . . 71.14 111.212 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 43.9 t -89.82 151.06 21.97 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.375 0.607 . . . . 71.51 112.15 -177.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.8 p -73.08 -32.48 65.03 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.994 -0.548 . . . . 73.22 111.552 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HG2' ' OG ' ' A' ' 90' ' ' SER . 16.2 pt20 . . . . . 0 CA--C 1.542 0.64 0 CA-C-O 121.669 0.747 . . . . 54.12 112.459 -177.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 N--CA 1.469 0.508 0 CA-C-O 120.589 0.233 . . . . 74.03 110.714 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 26.8 m -123.28 145.01 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 112.592 0.59 . . . . 64.41 112.592 -176.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 23' ' ' PRO . 26.7 m -122.91 141.96 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 115.802 -0.635 . . . . 63.15 111.318 178.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.5 112.7 24.65 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.367 -0.379 . . . . 41.23 110.95 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.578 HG13 ' HD3' ' A' ' 89' ' ' LYS . 45.6 mm -95.43 115.99 35.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.727 0.298 . . . . 73.3 111.415 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.491 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.3 mp -101.62 118.36 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.766 0.317 . . . . 73.4 111.043 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.9 m -117.2 138.11 51.91 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.885 0.374 . . . . 51.44 111.597 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.524 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 34.2 tt0 -134.8 142.55 46.72 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 122.587 0.355 . . . . 65.45 110.183 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.524 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 58.3 m-80 56.29 34.94 24.97 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.049 0.452 . . . . 74.33 111.793 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.85 21.19 79.03 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.372 -0.442 . . . . 63.32 114.094 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -144.5 143.82 31.05 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 122.479 -0.424 . . . . 72.21 111.518 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.75 124.24 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.843 0.354 . . . . 62.13 111.285 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 44.9 pt -111.43 -20.09 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 112.474 0.546 . . . . 42.21 112.474 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -157.81 145.47 18.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.909 0.385 . . . . 73.53 111.977 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.44 125.21 20.98 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.3 -0.409 . . . . 74.43 110.945 172.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.459 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 73.7 mt -126.99 124.78 24.05 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 112.253 0.464 . . . . 60.13 112.253 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 22' ' ' ILE . 6.7 Cg_exo -73.82 117.2 4.94 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.826 2.351 . . . . 74.24 112.293 175.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.57 -47.23 15.86 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.088 0.471 . . . . 73.53 111.149 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 84.8 m -58.9 117.03 4.18 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.929 -0.578 . . . . 73.04 112.024 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.34 3.05 88.93 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.242 -0.504 . . . . 72.44 113.713 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -71.15 129.48 39.05 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.286 0.565 . . . . 65.21 111.43 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.42 ' NZ ' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -97.33 148.08 23.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.14 -0.482 . . . . 64.24 111.601 178.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.32 -164.8 54.46 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 114.814 0.686 . . . . 60.0 114.814 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 25.7 t-20 -118.6 125.83 50.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.945 0.498 . . . . 54.02 110.397 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -118.19 122.51 43.2 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.733 0.301 . . . . 51.32 111.512 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -120.11 139.27 52.83 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.937 0.398 . . . . 75.23 111.566 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -149.91 143.12 25.06 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.027 0.442 . . . . 71.11 111.209 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.0 m -101.59 110.06 21.98 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.174 0.511 . . . . 74.35 112.238 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 39.7 mt -80.1 90.76 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.917 0.389 . . . . 74.1 110.077 175.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -73.54 128.47 35.59 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.883 0.373 . . . . 74.15 111.674 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.48 -143.72 12.01 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 116.296 -0.411 . . . . 71.44 112.209 175.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -86.49 123.53 31.8 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 122.413 -0.463 . . . . 72.15 111.115 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.14 -137.02 19.92 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.372 -0.442 . . . . 60.02 113.548 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.67 4.85 30.57 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.092 0.473 . . . . 71.44 111.874 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.449 ' HB3' ' CD2' ' A' ' 82' ' ' HIS . 23.9 mt-30 -83.28 119.14 24.21 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.254 -0.43 . . . . 73.31 111.637 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -145.86 155.08 42.66 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.584 -0.28 . . . . 72.52 111.556 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.572 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 18.6 m120 -114.75 110.04 19.12 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.374 -0.376 . . . . 64.33 111.017 173.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.1 tp -89.51 107.04 18.85 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.869 0.366 . . . . 71.54 110.489 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.694 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.1 mmm -95.12 146.93 23.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.87 0.367 . . . . 75.14 111.824 -175.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 42.6 tt0 -133.44 121.45 22.26 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.139 0.495 . . . . 74.31 111.341 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 30' ' ' ASN . 43.9 t -109.34 114.38 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.151 -0.477 . . . . 71.45 110.587 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.474 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 35.9 t70 -108.76 103.88 13.04 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.071 0.463 . . . . 54.22 110.704 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 63.14 -104.26 0.78 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 120.742 -0.742 . . . . 70.41 112.674 -175.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -113.75 18.59 17.34 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.018 0.377 . . . . 75.24 112.018 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 35.5 ptt180 -132.75 149.36 52.29 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.668 0.271 . . . . 75.15 111.242 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.1 tt -133.38 146.04 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 112.319 0.489 . . . . 75.34 112.319 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -148.03 169.28 20.27 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.147 -0.479 . . . . 74.41 110.86 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.694 HG12 ' SD ' ' A' ' 45' ' ' MET . 31.2 mt -85.88 108.89 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.05 0.452 . . . . 71.13 110.232 169.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 56.4 tttp -67.75 -45.66 74.31 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.285 0.564 . . . . 64.03 111.325 -178.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -152.49 157.89 41.79 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.029 -0.532 . . . . 75.21 110.168 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -160.62 167.69 26.5 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.038 0.446 . . . . 74.33 111.947 -175.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . 51.3 t-20 -130.7 70.81 1.45 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.1 0.476 . . . . 70.44 110.942 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.7 p -129.06 155.87 79.08 Favored Pre-proline 0 N--CA 1.477 0.905 0 O-C-N 122.117 -0.364 . . . . 70.35 111.766 175.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.26 -17.03 13.47 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.486 2.124 . . . . 63.35 112.888 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.542 ' HB2' HG23 ' A' ' 63' ' ' VAL . 5.9 p-10 -92.15 -47.19 7.37 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 111.917 0.34 . . . . 55.32 111.917 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.425 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 28.2 mm-40 65.94 19.73 11.27 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.791 0.436 . . . . 71.01 111.912 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.542 HG23 ' HB2' ' A' ' 61' ' ' ASP . 97.1 t -55.14 -46.96 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.156 0.503 . . . . 64.1 111.11 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.498 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -57.74 -38.32 87.68 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.037 -0.602 . . . . 51.34 112.746 176.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.15 -30.25 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.106 0.479 . . . . 62.11 111.267 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.425 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 5.4 mptp? -73.9 -31.04 62.93 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.387 0.514 . . . . 73.42 112.387 177.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.1 mmt -54.38 -50.71 66.89 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.529 0.566 . . . . 75.12 112.529 -177.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.9 -149.62 21.01 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.913 -0.66 . . . . 44.42 113.58 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -80.95 120.3 24.58 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.279 0.561 . . . . 65.32 112.099 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 75.0 mmtt -116.66 150.53 37.98 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.568 -0.742 . . . . 71.43 110.21 175.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 93.1 p -164.15 9.64 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.306 1.225 . . . . 72.44 114.306 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -132.76 157.14 45.69 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.61 0.641 . . . . 72.01 112.422 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.68 112.71 1.91 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.801 -0.636 . . . . 74.03 111.616 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 130.24 -26.45 4.17 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 116.219 -0.446 . . . . 52.3 112.366 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.538 ' HB2' HD12 ' A' ' 88' ' ' ILE . 76.7 m-20 -69.38 126.2 29.02 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.835 0.35 . . . . 71.31 111.082 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 87' ' ' GLU . 47.0 p -132.02 145.37 51.4 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.947 0.403 . . . . 72.41 111.901 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.524 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 37.8 mm -114.65 130.05 69.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.377 -0.374 . . . . 64.24 110.606 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.7 t -112.96 118.65 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 112.047 0.388 . . . . 73.4 112.047 -177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.494 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 74.9 m -122.61 82.38 1.97 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.158 0.504 . . . . 74.12 110.92 173.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.468 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 84.1 mt -57.22 -58.67 16.37 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 113.565 0.95 . . . . 60.14 113.565 -173.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 59.8 Cg_endo -70.9 -2.14 10.53 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.88 1.72 . . . . 61.41 113.033 -175.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.449 ' CD2' ' HB3' ' A' ' 41' ' ' GLN . 37.9 m170 -109.97 -2.45 17.11 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.497 -0.319 . . . . 73.25 111.297 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 59.78 29.62 19.19 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.916 0.389 . . . . 72.35 111.744 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 57.5 t -115.37 134.05 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.104 0.478 . . . . 73.22 111.811 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -136.56 131.68 34.15 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.011 -0.541 . . . . 72.21 110.229 175.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.524 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 46.7 t -118.38 136.38 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.528 -0.305 . . . . 71.04 111.097 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.436 ' HA ' HG22 ' A' ' 76' ' ' THR . 11.9 pt-20 -133.09 125.2 29.06 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.201 0.524 . . . . 53.51 111.402 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.538 HD12 ' HB2' ' A' ' 75' ' ' ASP . 59.2 mt -89.73 116.96 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.863 0.363 . . . . 74.31 110.331 175.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.578 ' HD3' HG13 ' A' ' 11' ' ' ILE . 13.2 ptmt -131.66 147.5 52.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.363 -0.38 . . . . 64.12 111.238 -174.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 48.4 t -78.5 145.59 34.86 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.14 0.422 . . . . 60.44 112.14 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.5 p -86.21 -7.27 58.67 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.151 0.501 . . . . 71.54 110.825 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 . . . . . 0 CA--C 1.537 0.477 0 CA-C-N 115.881 -0.6 . . . . 72.44 111.051 -178.631 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.458 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 46.2 mt-10 . . . . . 0 CA--C 1.539 0.542 0 CA-C-O 121.348 0.594 . . . . 72.33 112.448 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 33.0 m -126.15 152.85 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.694 -0.684 . . . . 71.11 111.716 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 23' ' ' PRO . 34.1 m -126.63 144.65 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 116.095 -0.502 . . . . 74.2 111.3 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -102.83 109.81 21.52 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.86 0.362 . . . . 41.22 111.099 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.1 mm -95.19 104.23 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 120.702 0.287 . . . . 70.55 111.37 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.7 mp -89.11 109.9 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.367 0.603 . . . . 74.45 110.916 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.2 p -116.95 127.43 54.2 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.929 -0.578 . . . . 61.34 111.043 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -119.1 146.53 45.03 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.673 0.273 . . . . 64.43 110.625 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.475 ' OD1' ' HD3' ' A' ' 83' ' ' LYS . 46.9 m-80 64.95 6.83 3.61 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.766 0.426 . . . . 74.03 111.796 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.79 -3.52 52.82 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.225 -0.512 . . . . 64.43 113.213 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -124.98 151.8 45.03 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.951 0.405 . . . . 73.02 111.583 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.3 126.15 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 120.905 0.383 . . . . 73.02 111.883 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 41.0 pt -111.86 -25.77 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 116.5 -0.318 . . . . 71.33 111.845 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.604 ' HA ' ' HE ' ' A' ' 20' ' ' ARG . 1.3 tpm_? -164.74 125.22 2.01 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.467 -0.333 . . . . 54.21 110.708 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -123.21 120.51 33.36 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.161 0.505 . . . . 70.22 110.965 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.41 HD12 ' CE1' ' A' ' 33' ' ' PHE . 73.6 mt -117.72 110.7 40.08 Favored Pre-proline 0 N--CA 1.47 0.525 0 N-CA-C 112.062 0.393 . . . . 73.31 112.062 -175.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.44 ' HA ' HG12 ' A' ' 9' ' ' VAL . 37.1 Cg_exo -59.46 117.69 4.46 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.533 2.155 . . . . 63.41 111.903 171.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.2 mt -74.53 -56.07 5.24 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.974 0.416 . . . . 73.3 111.524 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.458 ' OG1' ' HA ' ' A' ' 7' ' ' GLU . 11.3 m -56.61 133.57 53.77 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.16 -0.473 . . . . 71.51 111.736 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.32 -24.7 31.08 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 116.285 -0.416 . . . . 65.43 112.864 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -74.82 136.16 41.62 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.244 0.545 . . . . 64.54 111.627 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -124.11 145.98 48.92 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.109 -0.496 . . . . 73.13 110.859 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.66 -159.2 31.62 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.18 -0.533 . . . . 22.0 112.793 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -118.84 129.02 54.99 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 122.387 -0.478 . . . . 52.23 111.066 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.432 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 6.3 tp10 -123.5 135.08 53.86 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.328 -0.396 . . . . 62.22 110.302 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.402 ' HG2' ' HG3' ' A' ' 46' ' ' GLU . 35.7 mt-30 -134.55 129.69 35.43 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 122.089 -0.382 . . . . 60.14 111.526 -176.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.41 ' CE1' HD12 ' A' ' 22' ' ' ILE . 48.0 p90 -138.3 136.27 36.28 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.25 0.548 . . . . 73.42 111.72 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 30.9 m -104.12 114.2 28.27 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.074 -0.512 . . . . 72.05 112.165 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 54.8 mt -81.11 139.48 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 116.273 -0.421 . . . . 74.33 110.654 175.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -115.76 112.19 21.65 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.929 0.395 . . . . 74.11 112.042 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.15 -141.16 11.66 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 121.407 -0.425 . . . . 42.44 113.064 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -77.83 86.02 4.09 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.663 0.744 . . . . 64.33 111.856 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.17 -119.87 5.16 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 115.961 -0.563 . . . . 75.22 113.072 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.17 -0.93 23.89 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.073 0.397 . . . . 55.34 112.073 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -77.59 66.14 3.25 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.947 0.404 . . . . 71.43 111.728 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.49 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 17.1 p90 -95.32 167.05 11.58 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.535 -0.302 . . . . 73.04 111.106 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -140.47 110.67 6.61 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.659 -0.246 . . . . 73.43 111.164 174.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.6 tp -85.62 102.79 13.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.212 0.529 . . . . 61.33 110.542 177.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.701 ' SD ' HG12 ' A' ' 54' ' ' ILE . 94.5 mmm -97.03 141.49 30.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.004 -0.544 . . . . 71.4 110.751 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.846 ' HB3' HH21 ' A' ' 53' ' ' ARG . 35.4 tt0 -134.12 125.12 27.29 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.377 0.51 . . . . 63.12 112.377 -176.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 44.6 t -100.34 111.79 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.795 -0.639 . . . . 44.5 110.641 175.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.609 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 30.3 t70 -108.04 105.76 15.68 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.11 0.481 . . . . 64.22 110.035 -178.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.51 -104.49 1.07 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.658 -0.782 . . . . 73.04 111.898 -171.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -123.97 27.71 7.1 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.135 0.493 . . . . 73.22 111.448 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 34.1 ptt180 -134.6 154.45 51.49 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.039 0.535 . . . . 72.21 110.807 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.3 tt -142.37 143.33 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 112.91 0.707 . . . . 71.11 112.91 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.846 HH21 ' HB3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -161.03 168.55 24.25 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.162 -0.472 . . . . 70.11 111.875 169.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.701 HG12 ' SD ' ' A' ' 45' ' ' MET . 63.8 mt -69.04 121.27 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.387 -0.37 . . . . 62.2 111.173 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -82.19 -42.38 19.07 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.132 0.491 . . . . 45.33 111.016 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -166.21 138.76 3.92 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.651 -0.704 . . . . 62.23 110.689 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 1.7 p-10 -169.5 168.76 9.21 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.245 0.545 . . . . 75.51 111.472 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -97.19 45.16 1.04 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.214 -0.448 . . . . 63.12 111.994 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.1 t -97.72 122.92 53.65 Favored Pre-proline 0 N--CA 1.474 0.731 0 O-C-N 121.998 -0.439 . . . . 63.54 110.712 173.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -60.46 -27.35 84.69 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.506 2.137 . . . . 75.22 112.264 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -78.13 -34.26 50.02 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 116.005 -0.543 . . . . 64.41 111.609 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 54.66 36.18 25.49 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 111.963 0.357 . . . . 52.14 111.963 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.426 ' O ' ' HG2' ' A' ' 67' ' ' MET . 64.9 t -53.52 -52.5 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 112.733 0.642 . . . . 71.42 112.733 -174.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.594 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -64.19 -40.86 98.39 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.684 -0.77 . . . . 52.33 113.554 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 51.9 t -60.69 -39.6 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.27 0.557 . . . . 53.34 110.607 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -75.48 -28.27 59.15 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.95 -0.568 . . . . 74.23 111.928 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 18.1 mmt -67.16 -37.46 83.81 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 111.977 0.362 . . . . 75.42 111.977 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.94 -174.38 54.8 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 120.988 -0.625 . . . . 23.4 113.222 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.472 ' CE3' ' HG3' ' A' ' 53' ' ' ARG . 94.4 m95 -59.69 120.01 8.7 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.943 0.402 . . . . 73.44 112.016 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -115.82 127.21 54.89 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.239 0.542 . . . . 73.41 111.86 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.8 p -141.81 17.64 2.15 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.817 -0.629 . . . . 65.45 110.858 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -110.22 130.48 55.54 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.382 -0.372 . . . . 62.44 111.428 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.59 106.74 1.22 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.427 -0.351 . . . . 72.25 111.577 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.84 -36.65 1.74 Allowed Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.061 -0.59 . . . . 73.22 112.34 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -73.51 131.26 41.57 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.09 0.471 . . . . 71.12 111.179 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 69.3 p -120.87 152.17 38.75 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.963 0.411 . . . . 72.11 111.633 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.556 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 43.7 mm -114.25 110.45 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.309 -0.405 . . . . 71.04 110.204 177.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -107.27 116.66 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 112.35 0.5 . . . . 73.44 112.35 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 72.3 m -122.22 76.42 1.31 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.371 -0.377 . . . . 60.4 111.067 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.455 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 86.7 mt -57.21 -46.62 99.82 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 113.061 0.763 . . . . 74.22 113.061 -177.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.455 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 51.8 Cg_exo -55.64 -18.96 22.13 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.945 1.764 . . . . 61.32 113.364 177.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -112.65 -0.15 15.19 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.613 -0.267 . . . . 60.31 111.458 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.475 ' HD3' ' OD1' ' A' ' 15' ' ' ASN . 57.8 mttm 63.67 15.61 9.08 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.091 0.556 . . . . 71.22 112.433 -178.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.9 t -97.03 127.09 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.0 0.429 . . . . 75.42 111.832 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -130.62 113.22 13.92 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.222 -0.445 . . . . 73.34 110.633 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 46.2 t -100.79 117.02 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.042 0.449 . . . . 65.32 111.292 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -106.79 108.64 20.25 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.175 -0.466 . . . . 65.41 110.938 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 60.0 mt -91.91 121.06 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.149 0.5 . . . . 42.24 111.349 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -139.06 155.5 47.89 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.256 -0.429 . . . . 60.22 111.18 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 41.2 t -95.95 150.14 20.79 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.022 0.439 . . . . 74.3 112.042 -177.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.2 p -87.64 2.61 50.5 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.116 -0.493 . . . . 65.4 111.433 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 . . . . . 0 CA--C 1.541 0.615 0 CA-C-O 121.084 0.469 . . . . 74.35 111.663 -176.606 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 120.968 0.413 . . . . 74.33 111.769 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 26.8 m -122.75 145.12 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.127 0.489 . . . . 63.23 111.876 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.86 146.99 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.017 -0.538 . . . . 75.21 111.29 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.0 112.89 25.45 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.33 -0.396 . . . . 61.14 111.106 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.8 mm -92.34 105.73 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.47 -0.332 . . . . 72.21 111.199 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 12' ' ' ILE . 4.1 mp -91.88 121.83 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 121.07 0.462 . . . . 73.34 111.276 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.0 m -121.51 157.1 31.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.358 -0.383 . . . . 71.42 111.491 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.59 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 53.7 tt0 -152.69 142.83 22.36 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.979 0.418 . . . . 63.33 111.345 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.59 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 62.3 m-80 57.45 19.21 5.02 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.031 0.752 . . . . 75.54 113.031 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.47 -12.78 36.21 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.728 -0.749 . . . . 72.21 114.271 176.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -129.3 156.5 43.91 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 117.635 0.718 . . . . 73.23 112.068 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.63 133.54 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.826 0.346 . . . . 62.23 111.318 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.1 pt -111.92 -31.02 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 112.153 0.427 . . . . 74.33 112.153 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -157.19 133.17 9.51 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 111.979 0.363 . . . . 73.13 111.979 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -117.14 114.43 23.68 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 110.307 -0.256 . . . . 72.05 110.307 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 73.1 mt -115.0 116.04 42.85 Favored Pre-proline 0 N--CA 1.472 0.662 0 N-CA-C 111.826 0.306 . . . . 74.42 111.826 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.42 124.54 11.75 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.437 2.092 . . . . 70.14 112.474 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.402 ' HB2' HG23 ' A' ' 8' ' ' VAL . 88.7 mt -81.75 -56.49 3.96 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.995 0.426 . . . . 74.53 111.317 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.7 m -62.63 112.78 2.64 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.034 0.445 . . . . 63.12 111.501 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.02 7.77 57.22 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.128 -0.558 . . . . 60.25 113.199 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -85.1 122.91 29.99 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 117.004 0.402 . . . . 70.13 110.846 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 28' ' ' LYS . 11.1 mptt -91.24 140.85 29.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.045 0.45 . . . . 65.42 112.009 -176.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.94 -151.69 51.93 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 114.82 0.688 . . . . 41.33 114.82 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -117.3 143.71 45.64 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.882 0.473 . . . . 72.43 110.648 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -144.08 114.64 7.62 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.617 0.246 . . . . 71.02 111.007 -175.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -117.67 137.31 52.74 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.9 0.381 . . . . 63.11 111.434 -175.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -144.13 141.99 30.32 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.994 0.426 . . . . 73.43 111.484 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.2 m -99.89 118.0 35.4 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.033 0.444 . . . . 74.33 111.963 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.417 HD11 HG21 ' A' ' 12' ' ' ILE . 61.1 mt -92.63 97.01 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.326 -0.397 . . . . 70.44 110.701 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.62 148.01 31.83 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.029 0.442 . . . . 64.2 111.574 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -127.63 -152.14 7.83 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.45 -0.405 . . . . 71.42 112.361 177.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -70.94 123.62 22.44 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.24 0.543 . . . . 62.24 111.23 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.65 -134.71 22.59 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.325 -0.464 . . . . 52.31 112.722 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.85 15.47 16.55 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.996 0.427 . . . . 42.11 111.773 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.562 ' HB3' ' CD2' ' A' ' 82' ' ' HIS . 27.1 mt-30 -87.58 100.02 12.48 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.076 0.465 . . . . 75.32 111.526 -177.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -132.79 166.24 22.7 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.102 -0.499 . . . . 71.45 112.024 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -126.68 122.78 35.92 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.858 -0.61 . . . . 71.12 110.682 171.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.5 tp -92.26 110.44 21.83 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.724 0.297 . . . . 75.21 110.362 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.762 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.2 mmm -99.56 136.96 38.73 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.983 0.42 . . . . 63.33 111.869 -175.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -125.34 115.11 19.81 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.298 -0.41 . . . . 74.33 111.27 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.9 t -102.49 107.34 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.434 -0.348 . . . . 74.02 110.477 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -110.57 122.12 46.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.932 0.396 . . . . 63.15 110.987 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.4 -107.78 1.25 Allowed Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.125 -0.56 . . . . 61.44 112.32 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -120.86 25.5 9.64 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.06 0.457 . . . . 73.14 111.531 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -138.51 149.76 45.7 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.937 0.399 . . . . 64.31 111.517 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.6 tt -126.94 146.45 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 112.089 0.403 . . . . 74.3 112.089 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -148.74 168.77 22.01 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.985 0.422 . . . . 74.5 111.311 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.762 HG12 ' SD ' ' A' ' 45' ' ' MET . 33.8 mt -90.87 111.17 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.14 0.495 . . . . 54.51 110.086 169.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -74.45 -39.28 62.65 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.892 -0.595 . . . . 62.55 111.525 -175.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -149.93 148.87 29.63 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.275 -0.42 . . . . 73.53 110.142 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.29 130.73 9.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.353 0.597 . . . . 74.33 111.641 -175.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -96.28 64.35 2.27 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.326 0.584 . . . . 53.44 110.691 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 45.9 t -128.46 139.64 36.11 Favored Pre-proline 0 N--CA 1.473 0.677 0 CA-C-N 116.033 -0.531 . . . . 24.3 111.043 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 59' ' ' SER . 32.1 Cg_exo -58.27 -36.68 97.48 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.532 2.154 . . . . 71.44 112.749 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -76.5 -29.44 56.83 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.821 -0.627 . . . . 75.02 112.622 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 56.59 19.53 4.3 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.938 0.718 . . . . 71.11 112.938 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.5 t -53.94 -41.04 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 112.168 0.433 . . . . 72.2 112.168 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.558 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -57.83 -43.99 94.47 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.065 -0.588 . . . . 71.2 113.289 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.95 -37.83 81.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.006 0.431 . . . . 63.53 111.143 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -65.65 -40.27 92.31 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.309 0.485 . . . . 64.23 112.309 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.3 mmt -65.26 -41.28 94.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.828 0.347 . . . . 75.52 111.373 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.47 -129.75 28.43 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 114.367 0.507 . . . . 62.54 114.367 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -77.92 136.47 38.02 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.737 0.643 . . . . 71.34 112.737 -174.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 75.1 mmtt -132.58 144.26 50.26 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.902 -0.59 . . . . 72.21 109.883 173.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 95.4 p -162.0 13.57 0.08 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.363 0.875 . . . . 73.4 113.363 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -123.41 151.3 42.76 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.996 0.426 . . . . 64.53 112.056 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.64 111.62 1.49 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.26 0.552 . . . . 72.25 111.276 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 121.37 -21.53 8.12 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 121.314 -0.47 . . . . 62.33 112.435 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.527 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 80.1 m-20 -63.74 123.14 18.12 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.81 0.338 . . . . 62.42 111.226 176.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 65.8 p -130.65 141.93 50.43 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.403 0.621 . . . . 72.14 112.293 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.5 mm -114.8 118.37 58.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.833 -0.621 . . . . 75.02 110.258 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.3 t -112.31 115.73 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.924 0.392 . . . . 72.52 111.778 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 76.6 m -121.66 79.26 1.54 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.029 0.442 . . . . 51.32 110.825 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.498 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 93.1 mt -59.11 -47.02 99.29 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 113.091 0.775 . . . . 73.51 113.091 -175.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.498 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 50.7 Cg_exo -56.07 -17.36 19.42 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 122.255 1.97 . . . . 71.25 113.611 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.562 ' CD2' ' HB3' ' A' ' 41' ' ' GLN . 64.6 m170 -117.33 -1.81 11.7 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 122.14 -0.35 . . . . 64.54 111.612 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 66.4 mttm 59.37 28.33 17.66 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.071 -0.513 . . . . 73.42 112.194 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.7 t -100.56 132.89 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.487 -0.324 . . . . 65.41 111.061 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -136.68 118.21 14.85 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.004 0.431 . . . . 71.32 111.023 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.2 t -112.31 132.14 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 116.374 -0.375 . . . . 74.12 110.851 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -131.96 131.86 42.99 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.126 0.488 . . . . 53.1 111.367 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 58.4 mt -97.68 130.02 46.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.182 0.515 . . . . 74.52 111.307 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -137.74 153.96 49.67 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.058 -0.519 . . . . 61.24 110.932 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 47.7 t -89.86 149.89 22.46 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.09 -0.381 . . . . 64.13 111.264 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.2 p -65.8 -22.02 66.53 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.017 0.437 . . . . 71.43 110.807 175.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 121.194 0.521 . . . . 61.54 111.579 179.69 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.466 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 44.5 mt-10 . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 113.096 0.776 . . . . 75.33 113.096 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 71' ' ' SER . 35.7 m -137.67 160.39 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 115.921 -0.581 . . . . 62.43 112.176 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 23' ' ' PRO . 29.8 m -131.43 146.54 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.064 -0.516 . . . . 71.01 110.788 176.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.97 116.53 30.37 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.918 0.39 . . . . 52.5 111.949 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.403 ' HB ' ' HG2' ' A' ' 87' ' ' GLU . 44.5 mm -97.21 124.58 50.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.486 -0.325 . . . . 65.24 110.613 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.507 HD12 ' N ' ' A' ' 12' ' ' ILE . 2.9 mp -104.55 111.81 35.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.755 0.312 . . . . 61.3 111.156 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 18' ' ' VAL . 60.4 m -109.04 126.1 52.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.092 0.472 . . . . 72.41 111.584 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.41 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 62.8 tt0 -118.39 133.08 56.18 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.157 -0.339 . . . . 72.25 110.972 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.495 HD22 ' N ' ' A' ' 15' ' ' ASN . 0.8 OUTLIER 65.14 12.4 7.94 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.316 0.488 . . . . 74.11 112.316 177.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.04 10.52 34.33 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.359 -0.448 . . . . 52.31 113.857 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -144.15 146.04 32.49 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.397 0.599 . . . . 72.42 111.734 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 59.2 t -59.95 138.41 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 116.35 -0.386 . . . . 73.23 111.324 177.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 47.1 pt -125.78 -12.39 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.338 0.495 . . . . 73.43 112.338 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -173.76 142.24 0.89 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.812 0.339 . . . . 75.34 111.71 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -125.22 119.0 27.26 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 116.488 -0.324 . . . . 74.24 110.821 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.547 HG21 HG21 ' A' ' 47' ' ' VAL . 3.3 mp -115.53 125.13 29.1 Favored Pre-proline 0 N--CA 1.476 0.861 0 N-CA-C 111.741 0.275 . . . . 74.12 111.741 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.523 ' HA ' HG12 ' A' ' 9' ' ' VAL . 15.3 Cg_exo -69.51 123.02 9.76 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.817 2.345 . . . . 45.23 112.377 173.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.07 -57.28 3.16 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.873 0.368 . . . . 74.21 111.498 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.466 ' OG1' ' HA ' ' A' ' 7' ' ' GLU . 13.2 m -65.26 127.3 31.14 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.086 0.469 . . . . 71.23 111.441 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.62 -1.67 81.75 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.053 -0.594 . . . . 53.14 112.767 -174.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -92.5 90.49 7.19 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.281 -0.541 . . . . 74.43 111.535 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.68 169.47 18.22 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.145 -0.479 . . . . 52.43 111.17 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.18 -165.25 43.1 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 114.626 0.61 . . . . 73.54 114.626 175.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -118.44 126.04 51.21 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.998 0.519 . . . . 71.3 110.825 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -139.6 130.89 26.71 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.768 0.318 . . . . 53.45 111.08 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -122.8 153.71 39.18 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.042 0.449 . . . . 70.1 112.057 -173.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -150.33 138.22 20.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.912 0.387 . . . . 74.52 111.364 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.5 m -101.6 123.53 45.76 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.041 0.448 . . . . 62.21 112.169 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.8 mt -97.84 129.53 47.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.143 -0.48 . . . . 63.14 110.897 176.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -105.75 142.46 35.44 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.079 0.466 . . . . 75.05 111.827 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.29 -157.91 32.5 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 116.253 -0.431 . . . . 73.4 113.531 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -92.82 23.29 4.24 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.154 0.427 . . . . 71.35 112.154 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 175.14 -130.75 1.8 Allowed Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.331 -0.461 . . . . 62.24 112.139 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.03 67.43 3.87 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.415 0.626 . . . . 60.41 110.724 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -144.19 130.15 19.44 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.885 -0.598 . . . . 62.25 111.324 -175.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -147.84 144.62 28.28 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.697 0.284 . . . . 74.25 111.143 172.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -128.85 110.92 12.55 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.325 -0.398 . . . . 65.11 110.623 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.4 tp -87.04 104.85 16.72 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.894 0.378 . . . . 72.15 110.872 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.815 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.0 mmm -90.58 135.91 33.4 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.37 -0.377 . . . . 72.24 111.272 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -126.83 117.14 22.02 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.961 0.41 . . . . 72.43 111.986 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.547 HG21 HG21 ' A' ' 22' ' ' ILE . 21.9 t -101.17 107.45 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.065 -0.516 . . . . 63.01 110.238 175.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.46 ' HB3' ' CZ3' ' A' ' 69' ' ' TRP . 28.2 t70 -128.17 117.66 21.98 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.934 0.397 . . . . 44.11 111.424 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 60.33 60.75 8.01 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 121.205 -0.522 . . . . 50.22 114.169 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 57.76 18.33 4.77 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.914 1.079 . . . . 52.45 113.914 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.545 ' HD2' ' HB3' ' A' ' 69' ' ' TRP . 29.3 ptt180 -146.46 152.33 38.85 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.864 0.364 . . . . 72.21 110.899 174.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.5 tt -129.04 151.25 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.81 0.67 . . . . 65.14 112.81 -170.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.99 168.82 25.77 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.763 -0.653 . . . . 72.32 110.238 170.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.815 HG12 ' SD ' ' A' ' 45' ' ' MET . 59.4 mt -81.38 121.97 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.943 0.402 . . . . 74.03 110.387 174.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -84.35 -37.9 21.0 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 116.216 -0.447 . . . . 65.33 111.895 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -161.07 138.29 8.99 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.389 -0.369 . . . . 72.03 111.291 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.13 162.61 25.7 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.907 0.384 . . . . 64.32 110.51 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -98.59 64.45 1.52 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.567 0.699 . . . . 71.32 111.676 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.0 p -114.03 141.68 26.67 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-N 115.768 -0.651 . . . . 64.13 110.27 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.78 -23.24 26.39 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.183 1.922 . . . . 64.24 112.796 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.497 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.5 m-20 -87.63 -39.71 14.81 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.12 0.415 . . . . 71.42 112.12 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 61.04 23.24 13.43 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.513 0.56 . . . . 71.32 112.513 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.497 HG23 ' HB3' ' A' ' 61' ' ' ASP . 60.9 t -56.24 -34.79 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.898 0.38 . . . . 71.3 111.15 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.626 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -55.98 -47.1 82.28 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 116.275 -0.42 . . . . 62.01 113.17 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.2 t -73.77 -34.25 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.243 0.544 . . . . 74.14 110.956 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -60.22 -28.76 68.26 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.845 -0.616 . . . . 64.31 111.506 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 23.1 mmt -55.76 -34.27 65.07 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.327 0.491 . . . . 74.34 112.327 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.71 -163.64 53.64 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.977 -0.63 . . . . 50.5 113.425 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.545 ' HB3' ' HD2' ' A' ' 51' ' ' ARG . 94.0 m95 -73.39 110.32 7.58 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.853 0.359 . . . . 74.42 111.793 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -108.41 137.59 46.11 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.053 0.454 . . . . 72.51 111.674 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.404 ' O ' HG21 ' A' ' 8' ' ' VAL . 91.1 p -161.65 25.44 0.12 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.255 -0.43 . . . . 73.42 111.682 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -115.78 141.1 48.54 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.897 0.38 . . . . 72.14 111.599 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.4 106.64 1.16 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.978 0.418 . . . . 75.25 111.15 176.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 125.44 -7.24 7.98 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.011 -0.614 . . . . 74.32 113.342 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -92.71 142.0 27.84 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.138 0.494 . . . . 54.53 111.47 175.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.52 HG22 ' HA ' ' A' ' 87' ' ' GLU . 66.7 p -135.24 153.41 51.93 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.043 -0.526 . . . . 73.3 111.771 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 32.6 mm -112.97 128.33 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 116.346 -0.388 . . . . 73.34 110.351 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 50.5 t -115.39 120.1 63.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 112.191 0.441 . . . . 74.15 112.191 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.461 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 73.1 m -120.94 81.0 1.71 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.26 0.552 . . . . 71.52 110.3 171.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.445 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 4.3 tt -57.04 -53.75 61.88 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 115.498 -0.774 . . . . 74.1 112.253 -173.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 80' ' ' LEU . 44.1 Cg_endo -65.89 -9.62 23.79 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 122.26 1.973 . . . . 52.35 113.537 -176.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -114.34 -4.91 12.94 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 122.06 -0.4 . . . . 74.41 111.73 177.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 66.8 mttm 57.39 36.64 27.37 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.275 0.559 . . . . 63.13 111.481 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 59.4 t -111.69 138.71 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.875 -0.602 . . . . 62.55 110.979 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -140.93 148.42 40.38 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.358 -0.383 . . . . 64.53 110.475 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.439 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 57.3 t -139.46 113.79 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 122.257 -0.277 . . . . 74.43 111.439 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.52 ' HA ' HG22 ' A' ' 76' ' ' THR . 1.4 pm0 -106.92 126.7 52.66 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.343 0.592 . . . . 72.31 111.788 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.8 mt -95.71 122.3 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-O 121.024 0.44 . . . . 70.05 111.597 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.1 151.76 40.57 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.434 -0.348 . . . . 62.11 111.196 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.0 t -76.3 149.34 37.1 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.868 0.365 . . . . 74.21 111.905 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.442 HG22 HG13 ' A' ' 9' ' ' VAL . 27.5 p -77.09 -27.43 54.19 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.006 0.432 . . . . 64.43 111.246 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 . . . . . 0 CA--C 1.539 0.536 0 CA-C-N 116.324 -0.398 . . . . 74.22 111.075 177.576 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 N--CA 1.473 0.688 0 CA-C-O 121.091 0.472 . . . . 70.21 111.894 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.567 HG23 ' HB2' ' A' ' 24' ' ' LEU . 30.8 m -110.1 144.82 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 121.287 0.565 . . . . 62.41 112.102 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.5 m -124.11 138.88 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.266 -0.425 . . . . 54.32 111.483 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.04 119.97 36.52 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.887 0.375 . . . . 54.5 111.288 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.6 mm -104.27 113.37 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.564 -0.289 . . . . 74.44 111.029 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.515 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.1 mp -98.69 125.74 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 120.841 0.353 . . . . 75.4 110.894 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.5 t -128.8 152.63 48.26 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.068 0.461 . . . . 42.12 112.174 -176.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -146.91 142.87 28.05 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.017 -0.538 . . . . 65.2 110.734 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.7 14.02 5.79 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.407 0.521 . . . . 74.33 112.407 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.17 16.34 47.67 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.197 -0.525 . . . . 62.33 113.577 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -138.41 140.94 39.56 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.415 -0.462 . . . . 61.35 111.256 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -63.02 128.26 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 110.12 -0.326 . . . . 55.2 110.12 174.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.2 pt -109.23 -28.76 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 112.35 0.5 . . . . 74.03 112.35 -177.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -162.65 138.4 7.18 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.921 0.391 . . . . 71.34 111.494 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -124.48 119.45 29.17 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.591 -0.277 . . . . 71.14 111.493 -177.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.412 HG21 HG11 ' A' ' 47' ' ' VAL . 3.3 mp -112.81 116.17 47.92 Favored Pre-proline 0 N--CA 1.472 0.648 0 CA-C-O 120.626 0.251 . . . . 73.41 111.148 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.76 113.24 3.31 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.161 1.907 . . . . 52.25 111.579 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.567 ' HB2' HG23 ' A' ' 8' ' ' VAL . 85.4 mt -69.75 -58.68 3.61 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.853 0.316 . . . . 74.3 111.853 -175.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.6 m -54.15 131.04 40.39 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.133 0.492 . . . . 74.21 111.328 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.11 -16.14 56.36 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 121.089 -0.577 . . . . 60.24 113.975 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.506 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 60.3 t-80 -76.4 76.2 3.15 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.716 0.758 . . . . 74.22 110.86 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -78.23 92.75 4.51 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.972 -0.558 . . . . 74.54 111.43 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.8 -168.48 31.15 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 116.267 -0.424 . . . . 63.42 112.513 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -118.17 150.41 39.44 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.072 0.463 . . . . 71.34 111.42 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.536 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 12.4 tp10 -149.23 148.29 29.41 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.492 -0.322 . . . . 62.42 110.918 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -138.36 129.7 27.45 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.086 0.469 . . . . 72.42 111.689 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -145.82 131.86 19.29 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.209 0.528 . . . . 75.11 110.955 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.9 m -105.53 130.69 53.54 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.27 -0.423 . . . . 70.01 111.752 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.525 ' N ' HD12 ' A' ' 35' ' ' ILE . 3.2 mp -99.16 114.14 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.481 -0.327 . . . . 65.01 110.362 175.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -101.46 108.11 19.6 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.721 0.296 . . . . 73.34 111.505 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.68 -105.21 0.37 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.065 -0.588 . . . . 72.33 112.021 174.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -82.61 78.65 9.2 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 122.343 -0.504 . . . . 73.42 111.361 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.67 -87.23 0.01 OUTLIER Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.194 -0.457 . . . . 70.23 114.104 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.26 -21.17 62.13 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.136 0.421 . . . . 71.4 112.136 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -78.29 73.72 4.85 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.138 0.494 . . . . 72.32 111.25 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 58' ' ' ASN . 35.4 p90 -100.58 162.56 12.85 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.978 -0.555 . . . . 63.42 111.841 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -136.39 114.04 11.05 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.086 -0.507 . . . . 71.31 110.671 173.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.6 tp -89.64 103.28 15.94 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.989 0.423 . . . . 74.3 111.392 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.809 ' SD ' HG12 ' A' ' 54' ' ' ILE . 88.6 mmm -96.64 138.61 33.94 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.056 -0.52 . . . . 71.12 111.377 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -129.23 126.27 38.76 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.881 0.372 . . . . 75.44 111.466 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 56.4 t -110.54 115.25 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.067 0.46 . . . . 65.24 111.328 178.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.456 ' HB2' ' CH2' ' A' ' 69' ' ' TRP . 14.9 t70 -108.44 171.93 7.13 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.696 -0.483 . . . . 70.42 109.696 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 27' ' ' HIS . . . -37.27 90.38 0.01 OUTLIER Glycine 0 CA--C 1.535 1.282 0 N-CA-C 114.85 0.7 . . . . 34.11 114.85 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 66.08 32.09 8.47 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.506 0.722 . . . . 71.53 112.888 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.419 ' HG3' ' HB3' ' A' ' 48' ' ' ASP . 23.3 ptt180 -155.47 151.26 27.53 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 122.644 0.378 . . . . 71.14 111.144 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 tt -136.83 150.47 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 120.825 0.345 . . . . 63.23 111.919 -177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.552 ' NH2' ' HE3' ' A' ' 55' ' ' LYS . 21.4 ptt180 -155.62 168.58 26.69 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.222 0.535 . . . . 64.43 112.252 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.809 HG12 ' SD ' ' A' ' 45' ' ' MET . 62.1 mt -102.38 119.34 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.764 -0.653 . . . . 64.31 109.9 168.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.552 ' HE3' ' NH2' ' A' ' 53' ' ' ARG . 41.1 mtpt -78.57 -38.12 40.98 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.958 0.409 . . . . 72.14 110.728 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -169.63 138.78 1.93 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.518 -0.764 . . . . 70.42 111.425 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -142.37 161.56 37.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.975 -0.38 . . . . 74.13 109.975 170.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.439 ' HB2' ' CE1' ' A' ' 42' ' ' TYR . 61.2 t30 -84.95 66.29 9.66 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.152 0.501 . . . . 72.42 111.037 -176.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.3 t -129.05 145.75 57.89 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 116.224 -0.444 . . . . 73.22 111.146 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.52 -35.78 12.7 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.536 2.157 . . . . 62.22 113.16 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.467 ' HB2' HG23 ' A' ' 63' ' ' VAL . 1.6 p30 -77.59 -44.2 29.19 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.029 0.381 . . . . 75.11 112.029 -178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.513 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 24.7 mm-40 63.5 26.6 14.86 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.429 -0.351 . . . . 63.51 111.804 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.467 HG23 ' HB2' ' A' ' 61' ' ' ASP . 87.7 t -53.2 -41.61 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 120.849 0.357 . . . . 55.23 111.61 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.588 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -58.4 -38.48 90.78 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.32 -0.467 . . . . 74.43 113.258 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.35 -39.96 72.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.969 0.414 . . . . 74.53 111.06 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.513 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 4.6 mptp? -62.59 -29.91 70.95 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.364 -0.38 . . . . 60.52 111.301 176.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 21.2 mmt -61.2 -44.57 97.07 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.086 0.402 . . . . 70.34 112.086 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.26 -148.64 32.99 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.142 -0.552 . . . . 52.23 113.209 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.456 ' CH2' ' HB2' ' A' ' 48' ' ' ASP . 91.3 m95 -76.36 110.94 11.3 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.07 0.462 . . . . 75.23 111.867 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -103.88 143.78 32.38 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.379 -0.373 . . . . 73.44 110.885 175.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 64.2 p -169.19 18.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.502 0.556 . . . . 72.32 112.502 -173.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 72' ' ' LYS . 2.9 mptp? -116.86 144.93 43.93 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.82 0.343 . . . . 74.23 110.39 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.61 93.43 0.08 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.936 0.398 . . . . 74.11 111.346 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.09 -20.19 1.76 Allowed Glycine 0 CA--C 1.529 0.938 0 CA-C-N 116.029 -0.532 . . . . 52.23 113.364 -177.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.51 ' HB2' HD12 ' A' ' 88' ' ' ILE . 75.9 m-20 -66.25 135.35 54.33 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 117.096 0.448 . . . . 43.55 112.025 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.9 p -133.03 145.95 51.29 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.27 0.557 . . . . 73.35 111.692 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.53 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 35.0 mm -117.72 129.9 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 115.852 -0.613 . . . . 51.51 110.48 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.3 t -123.85 117.31 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 112.651 0.611 . . . . 61.22 112.651 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 90.3 m -115.77 81.22 1.56 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.244 0.545 . . . . 71.53 110.006 169.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.527 ' HB3' ' HD3' ' A' ' 81' ' ' PRO . 5.4 tt -55.76 -53.57 61.4 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 115.631 -0.713 . . . . 73.52 112.394 -172.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 80' ' ' LEU . 31.3 Cg_exo -60.04 -14.68 29.44 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.046 1.831 . . . . 72.3 113.381 -176.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -105.2 -3.65 22.69 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.994 0.368 . . . . 72.33 111.994 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.6 mttm 60.81 21.28 11.4 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 120.901 0.382 . . . . 75.43 111.491 -174.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.0 t -104.04 130.12 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 121.186 0.517 . . . . 54.22 111.365 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -135.93 136.57 40.55 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.002 -0.545 . . . . 75.52 111.061 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.53 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 46.4 t -128.7 144.56 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.396 -0.365 . . . . 73.32 110.519 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -143.6 144.74 32.05 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.204 0.526 . . . . 54.03 111.911 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.51 HD12 ' HB2' ' A' ' 75' ' ' ASP . 65.4 mt -106.18 111.7 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 115.941 -0.572 . . . . 74.54 111.096 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -118.09 143.06 46.77 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.022 -0.535 . . . . 74.52 110.654 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 22.8 t -85.54 122.87 30.29 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.861 -0.524 . . . . 73.52 110.471 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.661 HG23 ' HG2' ' A' ' 92' ' ' GLN . 9.7 t -77.86 -24.48 48.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.955 0.407 . . . . 73.03 111.352 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.661 ' HG2' HG23 ' A' ' 91' ' ' THR . 77.0 mm-40 . . . . . 0 CA--C 1.536 0.442 0 CA-C-N 116.172 -0.467 . . . . 75.25 111.042 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.441 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 42.9 mt-10 . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 121.121 0.486 . . . . 52.42 110.292 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.87 150.71 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 113.0 0.741 . . . . 65.23 113.0 -171.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.69 140.15 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 115.643 -0.708 . . . . 73.34 110.905 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.85 111.93 23.78 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.84 0.352 . . . . 62.32 111.431 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.1 mm -96.2 113.66 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.348 -0.387 . . . . 64.11 110.968 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 12' ' ' ILE . 2.9 mp -95.62 123.57 47.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.83 0.347 . . . . 41.33 111.387 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.6 p -125.58 146.61 49.61 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.008 0.432 . . . . 74.21 111.171 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.51 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 63.1 tt0 -130.9 131.25 44.39 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.544 -0.298 . . . . 62.12 110.204 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.486 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 56.5 m-80 57.5 15.58 2.83 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.057 0.391 . . . . 61.02 112.057 -175.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.98 -20.28 31.42 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.314 -0.469 . . . . 52.23 114.034 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -98.35 140.77 32.13 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.323 0.562 . . . . 60.42 111.85 -177.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.27 122.64 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.954 0.407 . . . . 65.51 111.529 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.8 pt -111.03 -19.4 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 112.953 0.723 . . . . 74.0 112.953 -175.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -167.81 144.47 4.17 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.001 0.371 . . . . 74.52 112.001 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -128.91 122.73 30.89 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.396 0.278 . . . . 73.44 111.329 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 22' ' ' ILE . 3.7 mp -118.32 113.86 36.81 Favored Pre-proline 0 N--CA 1.477 0.888 0 N-CA-C 111.713 0.264 . . . . 61.3 111.713 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.69 124.96 11.63 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.223 1.949 . . . . 74.42 111.851 171.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.9 mt -92.13 -47.78 7.07 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.9 0.704 . . . . 62.23 112.9 -172.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 7' ' ' GLU . 14.8 m -59.53 121.73 12.28 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.303 0.483 . . . . 72.54 112.303 -175.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.79 5.82 88.52 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.442 -0.409 . . . . 62.3 113.437 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.48 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 41.6 t-80 -70.82 87.38 0.7 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.314 0.578 . . . . 65.53 111.267 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -64.17 123.77 19.94 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.62 0.6 . . . . 75.22 112.62 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.5 -164.04 20.97 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 114.189 0.436 . . . . 55.31 114.189 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -118.61 128.86 54.94 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.559 0.343 . . . . 74.02 111.213 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -130.48 114.68 15.81 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.096 0.474 . . . . 72.13 111.634 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.439 ' HG2' ' HG3' ' A' ' 46' ' ' GLU . 68.0 mt-30 -109.82 145.12 37.26 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.281 -0.418 . . . . 72.42 111.126 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -151.19 145.78 25.65 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.002 0.43 . . . . 74.11 111.787 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 28.7 m -103.88 113.63 27.3 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.736 0.643 . . . . 72.14 112.736 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 61.1 mt -88.39 109.04 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.114 -0.494 . . . . 63.45 110.604 173.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -79.61 106.33 11.55 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.166 -0.334 . . . . 73.32 111.66 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.51 ' HA2' ' NE2' ' A' ' 14' ' ' GLN . . . -73.42 -171.02 21.3 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 120.865 -0.683 . . . . 62.32 112.754 176.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.465 ' HD2' ' HD2' ' A' ' 83' ' ' LYS . 27.0 mtpp -66.85 99.42 0.62 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.973 0.416 . . . . 74.41 111.751 -177.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.37 -118.22 5.73 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.231 -0.509 . . . . 43.13 113.121 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.01 -4.95 38.82 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.389 0.515 . . . . 63.41 112.389 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.645 ' HA ' ' HB3' ' A' ' 58' ' ' ASN . 14.0 mt-30 -82.49 81.44 8.31 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.463 0.649 . . . . 73.42 111.738 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.417 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 22.8 p90 -84.09 166.34 17.76 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.679 -0.691 . . . . 73.43 111.88 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.462 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 22.3 m120 -136.34 109.89 7.99 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.724 0.409 . . . . 63.13 110.715 173.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.9 tp -90.56 103.54 16.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.097 0.475 . . . . 74.4 110.562 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.729 ' SD ' HG12 ' A' ' 54' ' ' ILE . 94.9 mmm -89.94 144.55 25.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.129 -0.487 . . . . 65.22 111.108 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.616 ' HB3' ' NH1' ' A' ' 53' ' ' ARG . 71.6 tt0 -132.99 126.6 32.32 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.179 0.514 . . . . 72.01 111.734 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.1 t -103.81 119.42 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 115.838 -0.619 . . . . 63.34 110.848 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.481 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 34.9 t70 -107.9 97.77 7.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.275 0.559 . . . . 72.21 109.782 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 27' ' ' HIS . . . 65.87 -104.67 1.06 Allowed Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.819 -0.705 . . . . 70.43 112.377 -175.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -112.95 15.57 19.65 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.868 0.366 . . . . 75.21 111.949 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 18.6 ptp180 -131.54 150.24 52.22 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.524 -0.307 . . . . 73.2 110.925 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.7 tt -139.72 145.2 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 112.681 0.623 . . . . 63.43 112.681 -175.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.616 ' NH1' ' HB3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -159.41 168.61 25.86 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 116.1 -0.5 . . . . 74.4 111.311 173.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.729 HG12 ' SD ' ' A' ' 45' ' ' MET . 55.2 mt -73.96 122.16 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.107 0.48 . . . . 62.41 111.409 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -82.14 -51.04 8.37 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.093 -0.503 . . . . 75.22 111.441 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -154.04 136.85 15.31 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.223 -0.444 . . . . 63.04 110.317 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -157.15 -177.14 6.39 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.513 0.673 . . . . 74.11 111.962 179.249 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.645 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . 55.1 t-20 -115.15 75.58 0.94 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.423 -0.808 . . . . 73.04 110.593 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.8 t -136.94 148.16 61.9 Favored Pre-proline 0 N--CA 1.472 0.627 0 O-C-N 122.15 -0.344 . . . . 70.31 111.445 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.07 -15.89 23.0 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.116 1.877 . . . . 70.31 111.673 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -105.87 -43.65 4.82 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.89 -0.595 . . . . 63.31 111.566 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 53.17 56.6 7.25 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.517 0.675 . . . . 64.25 110.662 -177.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.3 t -53.46 -46.58 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.378 -0.828 . . . . 64.35 112.772 -171.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.564 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -60.01 -31.31 72.21 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.869 -0.682 . . . . 75.33 113.228 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.75 -38.2 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.035 0.445 . . . . 71.25 110.47 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -76.3 -28.71 57.08 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.191 -0.459 . . . . 71.21 111.944 174.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 17.2 mmt -62.68 -47.49 83.45 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.583 0.586 . . . . 73.03 112.583 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.41 -165.32 27.44 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 120.811 -0.709 . . . . 51.44 113.202 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.403 ' CE3' ' HG3' ' A' ' 51' ' ' ARG . 98.7 m95 -76.26 115.23 15.79 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.378 0.608 . . . . 75.55 112.474 -176.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.769 ' HD3' ' HB3' ' A' ' 75' ' ' ASP . 11.5 mmpt? -94.73 143.57 26.34 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.806 -0.633 . . . . 73.12 110.299 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 89.0 p -167.27 12.18 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.428 1.27 . . . . 63.33 114.428 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -131.63 153.14 50.24 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.808 -0.557 . . . . 65.12 111.865 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.12 100.09 0.11 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.094 0.473 . . . . 65.52 111.841 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.44 -24.16 2.51 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 116.062 -0.517 . . . . 41.43 112.033 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.769 ' HB3' ' HD3' ' A' ' 70' ' ' LYS . 62.8 m-20 -68.32 127.46 33.04 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.783 0.325 . . . . 71.41 111.387 174.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 87' ' ' GLU . 76.6 p -136.01 148.68 48.51 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.968 0.413 . . . . 65.32 111.271 177.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.2 mm -113.22 110.59 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 120.924 0.392 . . . . 74.44 110.533 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.5 t -98.73 116.88 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 116.14 -0.482 . . . . 51.1 111.322 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 71.5 m -118.99 73.32 0.92 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.94 0.4 . . . . 61.34 110.964 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.538 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 90.9 mt -54.07 -50.18 85.78 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 112.613 0.598 . . . . 71.31 112.613 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 34.7 Cg_exo -59.91 -12.84 20.08 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.018 1.812 . . . . 74.03 113.386 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.411 ' ND1' ' OD1' ' A' ' 43' ' ' ASN . 11.8 m170 -116.65 -11.64 10.99 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.124 0.416 . . . . 74.21 112.124 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.465 ' HD2' ' HD2' ' A' ' 38' ' ' LYS . 63.8 mttm 64.01 29.51 14.29 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.257 0.551 . . . . 71.14 112.05 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.4 HG22 ' HG3' ' A' ' 14' ' ' GLN . 59.3 t -108.9 135.71 46.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 116.008 -0.542 . . . . 62.14 110.711 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -135.75 128.65 31.27 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.09 0.471 . . . . 73.2 111.11 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.18 130.6 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.587 -0.279 . . . . 74.21 111.133 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.574 ' HA ' HG22 ' A' ' 76' ' ' THR . 3.2 pt-20 -114.19 147.74 38.42 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.011 0.434 . . . . 71.31 111.303 175.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 57.3 mt -111.8 112.14 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.014 0.435 . . . . 73.12 110.226 171.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.44 ' HB3' ' HZ2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -119.65 163.04 17.98 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.275 -0.421 . . . . 74.51 111.649 -174.243 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.7 t -86.11 149.34 25.2 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.622 0.601 . . . . 73.2 112.622 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.2 p -83.68 -16.93 43.17 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.97 -0.559 . . . . 55.31 110.725 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 . . . . . 0 CA--C 1.541 0.606 0 CA-C-N 116.126 -0.488 . . . . 64.12 111.47 179.995 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.407 ' HA ' ' CB ' ' A' ' 25' ' ' THR . 46.0 mt-10 . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 113.339 0.866 . . . . 63.05 113.339 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.01 158.82 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.508 -0.769 . . . . 71.31 111.648 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 23' ' ' PRO . 23.6 m -134.36 148.6 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 116.262 -0.426 . . . . 54.22 111.053 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.71 115.94 28.4 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.826 0.346 . . . . 64.3 111.568 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.0 mm -99.02 116.07 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.282 -0.417 . . . . 74.42 111.22 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.49 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.0 mp -99.85 115.46 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.023 0.44 . . . . 72.04 111.489 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 18' ' ' VAL . 66.9 m -113.88 146.12 40.48 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.014 0.435 . . . . 73.54 111.467 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -141.33 140.19 33.74 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.402 -0.363 . . . . 75.1 110.278 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 61.38 14.75 5.98 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.338 0.496 . . . . 72.23 112.338 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.77 -11.12 41.73 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.272 -0.49 . . . . 75.23 114.037 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -125.72 156.18 39.77 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.229 -0.571 . . . . 74.51 111.91 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 62.0 t -74.98 132.78 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.781 0.325 . . . . 75.45 111.334 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 43.1 pt -117.28 -27.08 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 N-CA-C 112.586 0.587 . . . . 73.04 112.586 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.529 ' HG3' HD11 ' A' ' 22' ' ' ILE . 3.1 tpm_? -154.3 131.83 11.34 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 122.315 -0.241 . . . . 64.25 111.141 -174.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -130.29 114.28 15.44 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.594 0.235 . . . . 73.42 111.502 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.529 HD11 ' HG3' ' A' ' 20' ' ' ARG . 3.7 mp -114.4 130.15 24.26 Favored Pre-proline 0 N--CA 1.476 0.874 0 CA-C-O 120.545 0.212 . . . . 72.01 111.432 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.533 ' HA ' HG12 ' A' ' 9' ' ' VAL . 57.5 Cg_endo -70.77 134.11 25.15 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.189 1.926 . . . . 74.14 112.404 173.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.7 mt -97.64 -65.5 0.96 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.901 0.382 . . . . 75.23 111.654 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.407 ' CB ' ' HA ' ' A' ' 7' ' ' GLU . 8.0 m -63.43 126.87 28.9 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.835 0.35 . . . . 60.02 111.451 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.34 12.25 84.08 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.965 -0.636 . . . . 50.51 112.97 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -90.85 104.22 16.83 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.087 0.47 . . . . 55.35 111.246 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -87.74 123.8 32.92 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.224 -0.443 . . . . 74.51 111.557 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.8 -169.74 14.79 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.253 -0.498 . . . . 54.02 113.539 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -118.49 150.36 39.74 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 122.703 -0.292 . . . . 64.51 110.893 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 13.6 tp10 -144.7 114.54 7.31 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.625 0.25 . . . . 72.52 110.908 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -118.33 137.87 52.79 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.863 0.363 . . . . 74.44 111.928 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -152.09 136.56 16.84 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.245 0.545 . . . . 73.0 111.82 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.3 m -96.06 116.1 28.45 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.148 -0.478 . . . . 70.53 111.484 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 42' ' ' TYR . 62.0 mt -80.71 103.97 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.566 -0.288 . . . . 73.43 110.809 176.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -92.67 111.35 22.91 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.032 0.444 . . . . 75.15 111.301 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.22 -154.11 7.03 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.248 -0.501 . . . . 74.43 112.764 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -93.43 90.55 6.77 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.203 -0.586 . . . . 74.31 111.064 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.63 75.95 1.28 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 121.239 -0.505 . . . . 15.4 113.986 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 72.96 -41.37 0.5 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.206 1.187 . . . . 71.1 114.206 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -50.85 108.23 0.23 Allowed 'General case' 0 N--CA 1.477 0.903 0 O-C-N 122.155 -0.341 . . . . 74.45 111.605 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 33.6 p90 -131.25 159.99 36.19 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.993 0.738 . . . . 74.21 112.993 -174.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.412 HD22 HD13 ' A' ' 54' ' ' ILE . 13.9 m120 -133.73 109.84 9.42 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.869 -0.605 . . . . 74.12 110.552 170.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.3 tp -82.67 104.04 12.63 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.878 0.371 . . . . 64.12 110.69 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.739 ' SD ' HG12 ' A' ' 54' ' ' ILE . 91.3 mmm -91.73 137.32 32.46 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.361 -0.381 . . . . 74.13 111.502 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -123.38 115.72 22.09 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.047 0.451 . . . . 73.31 111.168 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 44.3 t -105.61 107.53 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.106 -0.497 . . . . 73.5 110.537 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -112.21 117.44 32.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.743 0.306 . . . . 74.21 110.674 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.06 -111.23 3.18 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.831 -0.7 . . . . 62.34 112.809 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -112.51 17.02 19.61 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.9 0.381 . . . . 74.02 111.503 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.1 ptt-85 -133.93 140.94 47.12 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.097 0.475 . . . . 72.3 111.655 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.3 tt -124.32 147.53 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 116.389 -0.368 . . . . 73.31 111.881 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -150.96 168.81 23.4 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.889 0.376 . . . . 70.11 111.444 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.739 HG12 ' SD ' ' A' ' 45' ' ' MET . 26.4 mt -90.68 117.79 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.118 0.485 . . . . 74.2 110.155 168.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -81.13 -41.58 22.23 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.098 -0.501 . . . . 74.42 111.771 -176.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -159.46 138.53 11.08 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.759 0.281 . . . . 52.4 111.759 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -163.61 166.72 22.1 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.99 0.424 . . . . 53.14 111.198 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -111.19 63.66 0.61 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 120.967 0.413 . . . . 73.33 111.882 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.2 t -108.59 138.06 20.16 Favored Pre-proline 0 N--CA 1.477 0.918 0 O-C-N 122.051 -0.406 . . . . 63.32 111.013 175.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.49 ' HD2' ' HG2' ' A' ' 81' ' ' PRO . 36.6 Cg_endo -64.21 -27.14 64.39 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.769 2.313 . . . . 74.34 113.35 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.513 ' HB2' HG23 ' A' ' 63' ' ' VAL . 1.2 p30 -87.25 -43.53 12.12 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 111.945 0.35 . . . . 75.32 111.945 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 65.57 27.33 11.55 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.457 -0.338 . . . . 73.15 111.665 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.513 HG23 ' HB2' ' A' ' 61' ' ' ASP . 90.2 t -58.01 -41.68 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.037 0.446 . . . . 74.04 110.957 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.585 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -55.37 -48.02 72.07 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 116.036 -0.529 . . . . 44.12 113.074 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.7 t -62.45 -44.01 98.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 120.801 0.334 . . . . 62.54 111.372 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -59.74 -33.77 72.08 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.615 -0.266 . . . . 73.11 111.528 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.412 ' CE ' ' HA ' ' A' ' 67' ' ' MET . 5.3 mmt -57.9 -31.88 67.18 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.832 0.348 . . . . 64.04 111.902 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.96 -136.22 32.83 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.108 -0.567 . . . . 62.53 113.585 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -87.88 126.24 34.93 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.17 0.509 . . . . 74.14 111.879 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 34.4 mmtp -113.66 145.03 41.93 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.317 -0.623 . . . . 72.25 109.317 171.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.1 p -156.31 6.79 0.19 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.327 1.232 . . . . 75.32 114.327 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -130.12 156.26 44.83 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.67 -0.644 . . . . 72.42 112.179 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.06 126.5 27.72 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.004 -0.544 . . . . 53.05 111.239 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.37 -22.12 23.01 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.337 -0.458 . . . . 71.53 112.857 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.523 ' HB2' HD12 ' A' ' 88' ' ' ILE . 95.7 m-20 -68.2 131.58 45.64 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.964 0.411 . . . . 75.24 111.687 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.9 p -127.99 167.14 17.1 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.59 0.589 . . . . 63.24 112.59 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.588 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 40.0 mm -137.44 123.56 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.69 0.796 . . . . 74.14 109.885 177.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -113.99 117.76 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.256 0.465 . . . . 63.3 112.256 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 73.5 m -122.91 86.5 2.59 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.862 0.363 . . . . 63.44 111.309 174.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.59 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 92.2 mt -61.24 -53.95 58.02 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 112.804 0.668 . . . . 73.22 112.804 -175.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.59 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 17.1 Cg_exo -69.25 0.1 5.73 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.4 2.067 . . . . 71.43 113.362 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -119.1 -6.77 10.42 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 122.205 -0.309 . . . . 71.31 111.509 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.3 mttm 61.85 30.51 18.24 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.15 0.5 . . . . 73.22 111.762 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.51 138.84 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.101 -0.499 . . . . 61.32 111.346 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -141.71 125.8 17.33 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.115 -0.493 . . . . 74.01 110.886 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.588 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 57.5 t -116.6 135.44 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.561 0.219 . . . . 73.25 111.148 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.21 141.1 47.89 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.91 0.386 . . . . 71.43 111.278 176.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 75' ' ' ASP . 60.6 mt -101.5 115.97 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.17 0.509 . . . . 63.43 111.216 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -109.89 166.09 11.2 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.003 -0.544 . . . . 63.32 110.697 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.5 t -97.3 149.29 22.23 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.181 0.515 . . . . 63.11 111.32 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.5 p -80.37 -5.12 55.92 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.216 0.532 . . . . 74.13 110.973 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 . . . . . 0 C--O 1.235 0.298 0 CA-C-O 121.335 0.588 . . . . 73.52 111.528 179.589 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.469 ' HB2' ' OG1' ' A' ' 91' ' ' THR . 47.7 mt-10 . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 120.795 0.331 . . . . 65.25 110.749 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.0 m -123.67 142.17 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.095 0.474 . . . . 64.01 112.033 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 23' ' ' PRO . 27.5 m -119.93 140.19 44.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.278 -0.419 . . . . 72.25 111.224 177.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.94 114.53 26.37 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.893 0.378 . . . . 43.13 111.681 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.423 HG23 ' HG2' ' A' ' 21' ' ' GLU . 27.7 mm -98.69 110.79 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.338 -0.392 . . . . 65.53 110.979 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.499 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.2 mp -101.42 125.69 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.06 0.457 . . . . 73.44 111.59 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 55.2 m -123.5 150.6 43.73 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.129 -0.487 . . . . 74.34 111.813 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.581 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 36.1 tt0 -129.01 135.24 48.68 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.412 0.285 . . . . 52.32 110.533 175.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.581 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 53.9 m-80 59.64 8.66 1.34 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.859 0.464 . . . . 53.01 111.976 -174.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.95 -29.25 8.61 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 121.53 -0.367 . . . . 33.44 113.315 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -87.71 139.69 30.28 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.974 0.416 . . . . 65.31 111.486 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -71.22 130.54 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.316 -0.402 . . . . 64.31 111.115 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.466 HD11 HD13 ' A' ' 35' ' ' ILE . 34.2 pt -121.18 -29.24 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 112.897 0.703 . . . . 63.01 112.897 -176.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.506 ' HG3' HD11 ' A' ' 22' ' ' ILE . 9.2 tpm_? -151.29 123.19 8.1 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.125 0.488 . . . . 74.24 111.651 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.423 ' HG2' HG23 ' A' ' 11' ' ' ILE . 19.4 mt-10 -122.25 125.97 47.19 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.235 -0.439 . . . . 73.12 110.998 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.506 HD11 ' HG3' ' A' ' 20' ' ' ARG . 4.4 mp -120.63 123.62 27.97 Favored Pre-proline 0 N--CA 1.473 0.717 0 O-C-N 122.191 -0.318 . . . . 73.34 111.786 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.51 ' HA ' HG12 ' A' ' 9' ' ' VAL . 22.3 Cg_exo -66.27 111.88 2.16 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.257 1.971 . . . . 72.21 111.55 169.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 78.2 mt -75.65 -58.64 3.16 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.912 0.387 . . . . 74.15 111.244 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.451 HG21 ' HG2' ' A' ' 7' ' ' GLU . 35.8 m -60.5 118.83 6.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.836 0.351 . . . . 71.51 111.153 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 50' ' ' GLU . . . 98.49 -8.28 62.07 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.191 -0.528 . . . . 43.53 113.387 -176.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.41 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 54.2 t-80 -79.5 95.7 5.89 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.285 -0.538 . . . . 71.42 111.345 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.29 146.61 52.1 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.101 -0.5 . . . . 62.34 111.923 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.43 -158.57 53.27 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 116.1 -0.5 . . . . 72.44 114.183 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -118.39 151.34 37.95 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.834 0.349 . . . . 72.04 111.143 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -146.54 135.04 22.02 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.517 0.327 . . . . 74.42 110.462 -176.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -131.94 142.57 49.67 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.889 -0.507 . . . . 54.33 112.319 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -150.96 135.7 17.25 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.004 0.43 . . . . 73.02 111.431 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.8 m -98.74 127.65 44.74 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.396 -0.366 . . . . 70.13 111.139 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.466 HD13 HD11 ' A' ' 19' ' ' ILE . 68.8 mt -110.59 120.6 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 120.766 0.317 . . . . 73.31 111.377 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -97.41 128.72 44.44 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.116 0.484 . . . . 74.52 111.393 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.23 -114.48 3.66 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 116.261 -0.427 . . . . 65.34 112.787 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.651 ' HE2' ' HG3' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -99.17 141.82 31.45 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.911 0.355 . . . . 72.34 111.495 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.37 -100.63 0.19 Allowed Glycine 0 CA--C 1.531 1.068 0 CA-C-N 116.392 -0.367 . . . . 63.32 113.912 177.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.34 18.65 7.58 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.186 0.517 . . . . 73.1 111.664 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.651 ' HG3' ' HE2' ' A' ' 38' ' ' LYS . 12.5 mm100 -85.74 115.69 23.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.984 -0.553 . . . . 70.22 111.386 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -130.0 151.87 50.07 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.081 0.467 . . . . 62.31 112.189 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -127.66 116.8 20.84 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.061 -0.518 . . . . 74.21 110.639 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.6 tp -95.16 103.5 15.35 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.893 0.378 . . . . 72.33 110.501 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.665 ' SD ' HG12 ' A' ' 54' ' ' ILE . 92.5 mmm -92.33 136.74 32.95 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.232 -0.44 . . . . 64.21 111.274 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -124.55 115.35 20.71 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.953 0.406 . . . . 73.12 111.096 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.458 HG11 HG21 ' A' ' 22' ' ' ILE . 47.8 t -97.27 115.64 37.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.105 -0.498 . . . . 61.01 111.063 175.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -109.25 170.72 7.87 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.563 -0.29 . . . . 62.1 110.295 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 27' ' ' HIS . . . -37.53 95.33 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 N-CA-C 114.604 0.602 . . . . 61.43 114.604 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 31.4 mt-10 62.21 37.34 14.31 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.442 0.697 . . . . 75.31 112.682 176.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -165.21 161.95 19.67 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.381 -0.372 . . . . 75.23 111.017 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.3 tt -141.39 151.57 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 112.186 0.439 . . . . 72.1 112.186 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.436 ' HD3' ' CE2' ' A' ' 69' ' ' TRP . 14.1 ptt180 -152.18 168.97 23.61 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.905 0.383 . . . . 70.12 111.541 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.665 HG12 ' SD ' ' A' ' 45' ' ' MET . 46.3 mt -94.85 113.32 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.956 -0.387 . . . . 65.12 109.956 168.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -75.38 -46.73 31.2 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.736 0.303 . . . . 72.32 111.601 -177.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -143.15 140.36 30.76 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.834 0.349 . . . . 73.32 111.224 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -162.25 136.59 6.68 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.887 0.375 . . . . 65.25 111.271 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -107.8 51.36 0.74 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.208 0.527 . . . . 72.54 111.967 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.459 ' HG ' ' CD2' ' A' ' 82' ' ' HIS . 50.4 m -97.99 124.48 47.49 Favored Pre-proline 0 N--CA 1.473 0.719 0 O-C-N 122.141 -0.349 . . . . 60.2 110.213 172.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -52.78 -32.83 57.62 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.837 2.358 . . . . 65.55 113.226 -175.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -75.08 -31.46 61.22 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.365 -0.379 . . . . 74.11 111.857 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 28.3 mm-40 60.54 22.28 12.02 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.088 0.773 . . . . 72.3 113.088 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.5 t -53.36 -52.04 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 112.02 0.378 . . . . 71.01 112.02 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.94 -40.7 98.77 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.035 -0.602 . . . . 60.15 113.387 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.5 t -65.97 -33.7 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 120.998 0.428 . . . . 63.14 111.564 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 62' ' ' GLN . 67.5 mttm -70.71 -37.64 73.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.822 0.344 . . . . 65.31 111.398 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.3 mmt -60.35 -35.16 75.03 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.279 -0.418 . . . . 74.43 112.058 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.06 -119.51 8.05 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.251 -0.499 . . . . 51.32 113.948 175.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.436 ' CE2' ' HD3' ' A' ' 53' ' ' ARG . 69.3 m95 -94.92 138.93 32.02 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.173 0.434 . . . . 74.05 112.173 -175.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -131.23 151.4 51.51 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.195 -0.457 . . . . 63.43 110.233 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.4 p -164.97 15.74 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.368 0.877 . . . . 52.11 113.368 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.775 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 9.6 mmpt? -123.43 149.62 44.82 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.24 0.543 . . . . 64.25 112.069 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.64 109.49 1.42 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.029 -0.532 . . . . 62.03 110.587 176.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.24 -18.86 6.47 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 116.234 -0.439 . . . . 75.22 112.503 -176.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -69.84 115.35 8.96 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.779 0.323 . . . . 72.04 111.263 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 82.5 p -119.46 149.67 41.48 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.089 0.471 . . . . 60.25 111.465 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.434 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 46.9 mm -125.56 115.93 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.194 -0.457 . . . . 74.23 110.476 177.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.6 t -108.79 117.76 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 120.867 0.365 . . . . 42.35 111.777 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 71.0 m -120.82 84.54 2.25 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.086 0.469 . . . . 73.14 111.009 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.545 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 98.8 mt -57.98 -49.98 90.64 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 113.24 0.83 . . . . 63.41 113.24 -176.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 52.0 Cg_exo -56.7 -18.31 26.12 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 122.096 1.864 . . . . 70.32 113.519 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.459 ' CD2' ' HG ' ' A' ' 59' ' ' SER . 21.3 m170 -113.2 -4.78 13.71 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.7 0.286 . . . . 73.11 111.219 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 58.78 28.0 16.77 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.176 0.59 . . . . 72.3 112.292 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.1 t -101.9 133.88 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.02 0.438 . . . . 72.22 111.215 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -130.85 123.52 29.21 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.122 -0.49 . . . . 73.4 110.824 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.434 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 47.5 t -117.1 136.9 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 116.715 -0.221 . . . . 74.1 111.02 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -136.96 132.07 33.86 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.198 0.523 . . . . 73.41 111.092 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 62.1 mt -99.38 127.16 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.264 -0.426 . . . . 71.12 111.205 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -125.74 159.42 32.37 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.905 0.383 . . . . 71.34 111.617 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.1 t -79.66 149.78 31.14 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.253 -0.431 . . . . 55.34 111.059 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 7' ' ' GLU . 80.6 p -71.91 -21.45 61.62 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.864 0.364 . . . . 61.44 110.843 173.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 . . . . . 0 N--CA 1.469 0.525 0 CA-C-N 116.012 -0.54 . . . . 52.21 110.743 175.613 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.575 ' HA ' ' HB ' ' A' ' 25' ' ' THR . 42.7 mt-10 . . . . . 0 CA--C 1.541 0.621 0 N-CA-C 112.597 0.591 . . . . 55.42 112.597 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 27.6 m -102.83 152.08 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.287 0.565 . . . . 53.45 111.77 176.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 23' ' ' PRO . 35.5 m -127.42 142.41 43.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.145 -0.48 . . . . 62.41 111.682 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.39 116.38 28.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.944 0.402 . . . . 53.43 111.237 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 34.4 mm -99.34 107.06 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.27 -0.423 . . . . 70.44 111.711 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.4 mp -96.7 129.03 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.049 0.452 . . . . 75.12 111.029 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 m -130.99 156.7 44.68 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.055 0.455 . . . . 73.44 111.75 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.497 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 56.3 tt0 -149.77 142.86 24.97 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 116.239 -0.437 . . . . 75.21 110.428 178.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.497 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 44.7 m-80 60.52 19.79 9.59 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.234 0.457 . . . . 74.44 112.234 -177.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.36 4.13 68.68 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 120.994 -0.622 . . . . 62.4 114.034 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -126.62 149.41 49.5 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.355 0.577 . . . . 72.5 111.896 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.6 t -68.6 132.16 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.524 -0.307 . . . . 60.52 110.945 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.5 pt -122.58 -20.14 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.041 0.756 . . . . 62.22 113.041 -176.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -160.12 138.1 9.98 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.027 -0.421 . . . . 64.21 111.737 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -134.79 124.27 24.88 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 120.573 0.225 . . . . 71.52 111.362 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.96 126.51 26.31 Favored Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 111.63 0.233 . . . . 74.53 111.63 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.498 ' HA ' HG12 ' A' ' 9' ' ' VAL . 15.2 Cg_exo -69.12 117.84 5.3 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.694 2.263 . . . . 62.13 112.2 172.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.8 mt -84.79 -61.02 1.88 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.847 0.356 . . . . 73.32 111.826 -175.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.575 ' HB ' ' HA ' ' A' ' 7' ' ' GLU . 60.7 m -61.07 110.66 1.43 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.95 0.405 . . . . 74.51 111.985 -177.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.29 -15.69 35.73 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.235 -0.507 . . . . 73.23 112.993 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -70.58 128.71 37.05 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 122.663 0.385 . . . . 54.14 111.566 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -104.3 155.89 18.37 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.066 0.46 . . . . 73.32 112.016 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.53 -165.68 54.76 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 116.06 -0.518 . . . . 63.52 114.168 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -118.64 137.89 52.98 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.008 0.432 . . . . 73.4 110.667 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -143.53 115.53 8.33 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.788 0.328 . . . . 72.44 111.455 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -111.75 143.48 42.6 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.862 0.363 . . . . 64.24 111.954 -174.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -146.71 137.94 24.23 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.981 0.419 . . . . 53.23 111.201 176.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.9 m -105.06 119.94 40.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.009 0.433 . . . . 61.24 112.088 -175.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.52 ' N ' HD12 ' A' ' 35' ' ' ILE . 3.2 mp -92.43 106.19 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.945 0.403 . . . . 75.54 110.1 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.558 ' HB2' ' NZ ' ' A' ' 36' ' ' LYS . 9.6 mtmp? -86.88 128.05 35.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.079 0.466 . . . . 65.52 111.374 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.56 -178.62 38.2 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.243 -0.503 . . . . 64.33 113.183 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -66.22 93.85 0.23 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.214 0.53 . . . . 75.44 111.297 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.97 -121.4 5.42 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 116.077 -0.51 . . . . 73.33 112.33 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.82 12.09 29.37 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.144 0.497 . . . . 64.21 111.269 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -83.77 67.02 9.36 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.145 -0.48 . . . . 75.5 112.13 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -97.86 158.03 15.75 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.595 0.591 . . . . 73.41 112.595 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -131.36 133.41 45.27 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.461 0.704 . . . . 64.52 110.574 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.8 tp -105.46 107.38 18.33 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.79 0.329 . . . . 74.03 111.271 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.757 ' SD ' HG12 ' A' ' 54' ' ' ILE . 87.7 mmm -94.65 122.61 37.43 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.91 0.386 . . . . 73.02 111.124 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -108.14 117.67 34.75 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.791 0.329 . . . . 72.11 111.381 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.1 t -96.23 109.01 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.373 -0.376 . . . . 72.35 110.429 174.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.505 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 31.3 t70 -108.64 107.94 18.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.042 0.449 . . . . 61.33 110.344 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.3 -107.03 1.06 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.901 -0.666 . . . . 54.12 112.679 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -116.42 27.34 9.28 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.268 0.556 . . . . 73.45 111.668 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 17.3 ptt180 -142.76 148.03 36.53 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.043 -0.526 . . . . 74.21 110.898 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.5 tt -129.62 145.67 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 112.018 0.377 . . . . 71.11 112.018 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -149.69 168.96 22.14 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.885 0.374 . . . . 73.23 111.693 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.757 HG12 ' SD ' ' A' ' 45' ' ' MET . 35.3 mt -96.36 118.71 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.502 -0.317 . . . . 64.21 110.46 169.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -85.83 -36.37 20.07 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.912 0.387 . . . . 72.1 111.611 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -153.38 138.75 17.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.538 -0.301 . . . . 71.14 111.53 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.409 ' OD2' HG23 ' A' ' 65' ' ' VAL . 2.4 p30 -153.51 151.51 29.89 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.997 0.427 . . . . 73.21 110.596 175.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -102.01 74.94 1.49 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.019 0.438 . . . . 65.35 110.994 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.6 p -124.89 150.88 67.5 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-N 116.492 -0.322 . . . . 64.55 110.272 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.02 -29.17 40.79 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.356 2.037 . . . . 63.12 111.708 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.87 -35.82 25.92 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.397 -0.819 . . . . 74.23 111.89 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.481 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 27.2 mm-40 62.95 21.54 12.93 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.385 0.513 . . . . 73.54 112.385 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.555 ' O ' ' HG3' ' A' ' 67' ' ' MET . 89.6 t -57.8 -38.26 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.495 -0.321 . . . . 74.32 111.658 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.43 -57.22 14.22 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.642 -0.313 . . . . 61.33 113.45 -176.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.409 HG23 ' OD2' ' A' ' 57' ' ' ASP . 54.1 t -62.18 -34.85 65.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 120.952 0.406 . . . . 64.21 111.582 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 14.1 mptt -66.13 -28.38 68.76 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.467 0.543 . . . . 74.12 112.467 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.555 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 53.4 mtp -64.18 -24.12 67.56 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 122.064 -0.397 . . . . 74.44 111.708 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.34 -153.84 41.69 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 114.446 0.538 . . . . 51.44 114.446 173.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -80.82 142.21 33.92 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.125 0.488 . . . . 74.41 112.06 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 74.2 mmtt -125.61 133.87 52.1 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.01 -0.541 . . . . 55.14 109.672 175.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 54.0 p -155.77 28.35 0.38 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.171 1.174 . . . . 54.0 114.171 -170.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -160.33 162.32 33.45 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.773 0.657 . . . . 65.11 112.773 171.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.04 118.02 5.79 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.057 -0.52 . . . . 61.54 111.216 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 123.01 -17.16 8.12 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.267 -0.492 . . . . 31.34 112.682 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.538 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 64.5 m-20 -75.58 128.15 34.64 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 122.472 -0.428 . . . . 74.12 111.399 176.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 81.7 p -130.76 144.23 51.29 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.893 0.377 . . . . 71.04 111.702 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.557 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 45.5 mm -114.67 128.15 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 122.817 0.447 . . . . 54.35 110.348 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.15 115.83 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.033 0.444 . . . . 73.45 111.664 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 86.2 m -123.4 71.06 1.06 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.448 -0.342 . . . . 63.41 111.277 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.561 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 89.0 mt -53.15 -50.2 83.52 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 112.574 0.583 . . . . 55.23 112.574 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 53.2 Cg_exo -54.24 -20.76 20.46 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.15 1.9 . . . . 72.34 113.387 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -110.01 -1.73 17.46 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.263 0.468 . . . . 71.5 112.263 -175.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 63.41 17.39 10.27 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.539 0.336 . . . . 41.41 111.809 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.91 138.02 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.915 0.388 . . . . 62.3 111.652 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -141.93 131.4 23.8 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.374 -0.375 . . . . 62.55 110.791 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.557 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 47.5 t -127.38 145.76 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.573 0.225 . . . . 64.31 111.059 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -144.13 153.69 42.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.671 0.272 . . . . 63.13 110.883 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.477 HD12 ' HB2' ' A' ' 75' ' ' ASP . 59.5 mt -110.74 126.24 68.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.85 0.357 . . . . 64.42 111.051 175.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.05 177.77 6.43 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.348 -0.387 . . . . 72.01 110.248 176.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 28.4 t -107.07 151.47 25.31 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.213 0.53 . . . . 70.24 111.811 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.5 p -62.07 -23.99 66.83 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.759 -0.655 . . . . 72.23 111.182 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.473 ' HG2' ' OG ' ' A' ' 90' ' ' SER . 2.7 pt20 . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 120.932 0.396 . . . . 74.44 110.578 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 112.053 0.39 . . . . 64.32 112.053 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.4 m -115.96 152.68 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 121.288 0.566 . . . . 72.11 112.02 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 23' ' ' PRO . 27.8 m -127.0 148.51 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.122 -0.49 . . . . 75.13 111.647 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -102.67 115.47 30.65 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.984 0.421 . . . . 73.35 111.512 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.8 mm -100.4 116.51 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.339 -0.391 . . . . 74.11 111.146 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.506 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.0 mp -97.63 127.46 49.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.041 0.448 . . . . 61.51 111.288 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.4 p -124.35 153.03 42.42 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.223 0.535 . . . . 65.25 111.453 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -139.74 127.04 21.31 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.941 -0.572 . . . . 71.21 110.999 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.56 ' N ' HD22 ' A' ' 15' ' ' ASN . 0.8 OUTLIER 61.14 17.0 7.66 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.347 0.499 . . . . 75.15 112.347 178.061 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.16 -31.6 6.16 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.258 -0.496 . . . . 63.54 113.802 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -98.42 147.58 24.57 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 122.202 -0.587 . . . . 73.22 112.102 -177.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.17 134.77 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 122.3 -0.25 . . . . 71.21 110.493 173.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.3 pt -120.07 -29.81 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.785 0.661 . . . . 74.4 112.785 -177.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -152.95 141.0 20.33 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.879 0.371 . . . . 73.44 111.591 -176.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -131.3 124.93 31.5 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.771 0.319 . . . . 44.03 111.226 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 47' ' ' VAL . 4.1 mp -124.79 124.37 25.55 Favored Pre-proline 0 N--CA 1.474 0.772 0 CA-C-O 120.597 0.237 . . . . 73.41 111.467 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.425 ' HA ' HG12 ' A' ' 9' ' ' VAL . 60.2 Cg_endo -72.93 119.59 6.15 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.242 1.961 . . . . 71.14 111.812 172.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.8 mt -80.97 -63.06 1.49 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.073 0.463 . . . . 62.13 111.471 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.3 m -59.77 121.74 12.44 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.35 -0.386 . . . . 60.13 111.423 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.71 3.03 77.93 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.238 -0.506 . . . . 70.12 113.787 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.497 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 42.5 t-80 -77.51 129.12 35.27 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.305 -0.527 . . . . 73.13 111.235 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -94.31 137.52 33.37 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.989 0.423 . . . . 71.34 112.026 -177.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.89 -167.1 54.66 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 114.79 0.676 . . . . 74.21 114.79 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -118.66 122.45 42.56 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.861 0.464 . . . . 43.42 110.502 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -117.05 139.57 50.54 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 122.242 -0.286 . . . . 75.1 111.325 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -131.08 129.47 41.95 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.819 0.343 . . . . 73.42 111.311 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -138.98 141.93 38.37 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.896 0.379 . . . . 74.42 111.692 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.8 m -97.46 119.07 35.33 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.073 0.463 . . . . 40.04 111.767 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.7 mt -81.64 116.91 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.05 -0.523 . . . . 72.34 110.808 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -80.38 123.16 27.78 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.814 0.34 . . . . 74.31 111.664 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -110.85 -163.28 18.36 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.367 -0.444 . . . . 71.13 112.435 175.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -69.95 123.16 20.83 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 122.416 -0.461 . . . . 51.31 111.979 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.05 -103.74 0.43 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.343 -0.456 . . . . 64.45 113.673 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.41 -3.77 46.41 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.75 0.648 . . . . 63.33 112.75 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -76.07 133.55 40.29 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 111.799 0.296 . . . . 65.3 111.799 -176.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -158.2 163.82 37.12 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.899 0.38 . . . . 62.44 111.762 176.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -136.99 115.3 11.74 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.322 -0.399 . . . . 73.24 111.18 175.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 56' ' ' GLU . 42.3 tp -87.92 103.34 15.59 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.22 0.533 . . . . 72.21 110.814 177.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.812 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.1 mmm -92.86 144.71 25.01 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.9 -0.591 . . . . 60.52 111.468 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -130.16 126.68 38.05 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.944 0.402 . . . . 71.53 111.528 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.531 HG21 HG21 ' A' ' 22' ' ' ILE . 44.4 t -110.02 107.62 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.163 -0.472 . . . . 70.11 110.319 175.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 31.0 t70 -108.03 109.42 20.87 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.486 0.315 . . . . 74.31 110.42 -176.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' A' ' 27' ' ' HIS . . . 57.79 -110.36 2.33 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.775 -0.726 . . . . 54.5 112.355 -175.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -110.24 18.05 20.31 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 120.886 0.375 . . . . 74.31 111.888 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 33.7 ptt180 -131.89 147.04 52.45 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.819 0.342 . . . . 74.12 111.465 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.0 tt -130.36 147.92 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.149 0.499 . . . . 72.11 112.188 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -159.87 165.52 32.06 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.088 -0.506 . . . . 74.32 111.415 177.241 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.812 HG12 ' SD ' ' A' ' 45' ' ' MET . 58.0 mt -89.91 120.42 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.946 0.403 . . . . 71.01 110.569 174.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -87.47 -31.21 20.12 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.493 -0.321 . . . . 63.11 111.746 -175.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.448 ' HB3' HD23 ' A' ' 44' ' ' LEU . 39.5 tt0 -167.95 138.98 2.83 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.086 0.47 . . . . 43.43 112.157 -175.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -161.04 -178.17 6.59 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.236 -0.438 . . . . 73.24 110.477 174.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -115.01 42.12 2.26 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.595 0.591 . . . . 73.0 112.595 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.8 m -88.01 131.75 42.01 Favored Pre-proline 0 N--CA 1.475 0.793 0 O-C-N 121.919 -0.488 . . . . 65.24 110.067 173.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.62 -40.9 71.83 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.342 2.028 . . . . 71.41 112.978 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.9 -13.36 31.35 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.433 0.531 . . . . 61.01 112.433 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 40.02 67.96 0.43 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.294 0.568 . . . . 72.3 112.477 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.2 t -74.05 -46.83 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.141 -0.482 . . . . 72.22 111.553 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.639 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -56.3 -43.71 89.52 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.436 -0.411 . . . . 64.15 113.722 -178.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -61.44 -38.14 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.091 0.472 . . . . 74.24 111.722 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -71.26 -28.35 64.1 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.047 0.388 . . . . 73.51 112.047 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 25.6 mmt -57.34 -28.94 63.56 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.924 0.393 . . . . 72.34 112.026 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.6 -155.64 39.71 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.294 -0.479 . . . . 63.14 113.781 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -82.48 119.47 24.25 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.957 0.408 . . . . 75.21 111.841 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 75.2 mmtt -111.41 151.01 29.0 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.244 -0.435 . . . . 63.32 110.041 175.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 63.2 p -168.65 6.52 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.546 1.313 . . . . 75.34 114.546 -174.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -124.94 152.46 44.1 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.64 -0.663 . . . . 72.33 112.28 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.4 99.99 0.07 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.719 -0.673 . . . . 74.52 111.25 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.18 -19.91 2.66 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.933 -0.576 . . . . 74.31 112.526 -175.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.443 ' HB2' HD12 ' A' ' 88' ' ' ILE . 76.1 m-20 -76.63 134.72 39.24 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.804 0.335 . . . . 71.2 111.491 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.538 HG22 ' HA ' ' A' ' 87' ' ' GLU . 45.0 p -135.75 150.19 49.42 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.09 0.471 . . . . 74.54 111.665 176.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.462 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 50.2 mm -115.99 127.37 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.198 -0.455 . . . . 71.13 110.75 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -115.22 118.65 59.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.97 0.414 . . . . 64.51 111.874 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 90.1 m -121.75 75.77 1.22 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.411 -0.359 . . . . 64.53 111.331 176.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.541 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 91.9 mt -55.36 -50.65 85.51 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 113.133 0.79 . . . . 61.34 113.133 -176.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.541 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 46.7 Cg_exo -56.93 -17.15 22.88 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.889 1.726 . . . . 74.25 113.461 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 47.8 m170 -114.49 -4.11 12.92 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 122.184 -0.323 . . . . 73.25 111.751 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm 61.36 30.61 19.1 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.847 0.459 . . . . 74.31 111.923 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 80.0 t -110.0 138.75 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.832 0.349 . . . . 64.42 111.294 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -139.12 132.64 30.32 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.79 0.329 . . . . 72.44 111.308 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 47.7 t -121.29 134.29 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 122.332 -0.23 . . . . 75.01 111.142 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.538 ' HA ' HG22 ' A' ' 76' ' ' THR . 8.6 pt-20 -123.6 126.31 46.4 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.046 0.45 . . . . 72.12 111.709 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.443 HD12 ' HB2' ' A' ' 75' ' ' ASP . 59.8 mt -95.58 116.73 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.212 0.529 . . . . 71.53 110.432 175.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -127.77 160.54 31.42 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.178 0.513 . . . . 71.21 111.899 -172.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.3 t -87.62 149.13 24.49 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.065 0.46 . . . . 62.21 111.76 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.3 p -88.33 -15.49 35.55 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.075 -0.511 . . . . 73.31 111.26 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 . . . . . 0 N--CA 1.469 0.523 0 CA-C-N 116.013 -0.54 . . . . 75.24 111.7 -176.275 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.568 ' HA ' ' HB ' ' A' ' 25' ' ' THR . 46.0 mt-10 . . . . . 0 N--CA 1.467 0.379 0 CA-C-O 120.726 0.298 . . . . 72.31 110.876 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 34.5 m -102.76 161.82 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 113.282 0.845 . . . . 54.42 113.282 -174.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 23' ' ' PRO . 33.1 m -130.04 153.17 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 115.398 -0.819 . . . . 72.25 111.006 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.37 119.97 41.1 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.406 -0.361 . . . . 71.33 111.146 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.425 ' HB ' ' HG2' ' A' ' 87' ' ' GLU . 39.3 mm -101.02 111.4 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.591 -0.277 . . . . 65.13 110.949 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.481 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.6 mp -100.98 111.11 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 120.941 0.4 . . . . 65.32 111.762 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.2 p -108.86 140.56 42.16 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.746 0.308 . . . . 65.42 110.405 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.631 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 54.5 tt0 -141.33 131.67 25.12 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.258 -0.276 . . . . 72.41 111.251 -177.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.515 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 52.1 m-80 58.74 16.85 4.7 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 120.888 0.375 . . . . 41.34 111.961 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.09 -12.61 60.51 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.126 -0.559 . . . . 65.43 113.736 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 14' ' ' GLN . 21.5 pttp -109.61 132.87 53.74 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 117.273 0.536 . . . . 64.12 111.573 -178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.7 t -71.84 115.94 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.848 0.356 . . . . 54.2 110.719 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.9 pt -102.3 -23.1 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 113.156 0.799 . . . . 61.53 113.156 -173.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.6 tpp85 -157.45 126.99 6.03 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.769 0.655 . . . . 74.41 112.769 -173.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -118.01 119.18 34.0 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.629 -0.508 . . . . 62.14 109.629 173.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.59 126.33 26.49 Favored Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 112.989 0.737 . . . . 71.14 112.989 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.54 ' HA ' HG12 ' A' ' 9' ' ' VAL . 73.8 Cg_endo -76.24 111.79 3.34 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.389 2.059 . . . . 72.03 111.536 169.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.66 -69.32 0.61 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.232 0.456 . . . . 72.25 112.232 -174.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.568 ' HB ' ' HA ' ' A' ' 7' ' ' GLU . 6.7 m -59.41 124.58 20.49 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.002 0.43 . . . . 70.2 111.537 -176.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.06 -22.48 33.19 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.331 -0.462 . . . . 62.33 112.835 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -77.91 91.3 4.17 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.189 -0.595 . . . . 74.43 111.23 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -80.05 153.34 28.86 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.059 -0.518 . . . . 62.2 110.712 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.38 -162.91 27.25 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.051 -0.595 . . . . 63.54 112.971 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -118.18 145.0 45.27 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.197 0.522 . . . . 64.52 111.687 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.591 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 16.8 tp10 -139.75 139.32 36.47 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.915 -0.584 . . . . 60.01 110.209 176.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -141.66 133.4 27.15 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.865 0.364 . . . . 74.24 111.859 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -148.92 142.58 25.49 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.203 0.525 . . . . 62.12 111.772 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.8 m -98.29 115.11 27.72 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.119 -0.491 . . . . 71.02 111.729 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 60.3 mt -80.07 112.93 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.203 0.525 . . . . 72.43 111.188 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.2 mtmt -79.4 108.44 12.93 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.841 -0.618 . . . . 64.03 111.215 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.631 ' HA2' ' NE2' ' A' ' 14' ' ' GLN . . . -91.39 -86.08 1.44 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.178 -0.534 . . . . 34.02 113.722 -176.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -148.2 114.12 5.77 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.643 -0.328 . . . . 72.43 110.759 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.89 -107.9 1.5 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.119 -0.562 . . . . 74.31 112.937 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.97 -10.03 40.86 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.516 -0.402 . . . . 71.13 111.892 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -79.73 125.8 30.13 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.019 0.438 . . . . 74.01 111.925 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -145.67 172.54 13.12 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.084 -0.507 . . . . 73.33 111.308 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.439 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 15.6 m120 -136.99 110.44 7.94 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.554 -0.294 . . . . 75.02 110.681 173.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.3 tp -85.05 107.85 17.36 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.943 0.402 . . . . 73.44 110.908 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.795 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.9 mmm -100.67 150.94 22.22 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.001 0.429 . . . . 55.13 111.669 -176.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -138.84 130.84 28.0 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.209 -0.451 . . . . 75.03 111.84 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.591 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 30.4 t -113.08 107.66 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.313 -0.403 . . . . 64.34 110.492 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 8.8 t0 -130.93 140.13 50.15 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.517 0.199 . . . . 63.21 110.893 -176.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 51.87 51.08 41.55 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 114.385 0.514 . . . . 45.13 114.385 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 69.03 15.06 8.83 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.473 0.916 . . . . 61.02 113.473 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.444 ' HG3' ' HE3' ' A' ' 69' ' ' TRP . 3.6 ptp180 -147.52 166.9 25.89 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.721 -0.612 . . . . 70.41 112.58 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.1 tt -125.83 150.8 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.292 0.479 . . . . 74.24 112.292 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.485 ' HB3' ' HA ' ' A' ' 69' ' ' TRP . 1.8 ppt_? -155.68 159.16 39.33 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.146 -0.479 . . . . 74.44 111.192 177.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.795 HG12 ' SD ' ' A' ' 45' ' ' MET . 34.5 mt -85.85 115.99 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.153 0.502 . . . . 61.12 110.713 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -78.79 -34.73 45.24 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.879 -0.6 . . . . 72.23 111.895 -175.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -172.93 138.63 0.8 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.558 0.218 . . . . 71.32 111.276 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -152.75 149.93 28.87 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.93 0.395 . . . . 62.23 110.91 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -100.41 74.8 1.74 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.371 0.605 . . . . 75.24 111.599 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.0 p -124.11 149.92 61.79 Favored Pre-proline 0 N--CA 1.475 0.79 0 O-C-N 122.082 -0.387 . . . . 74.51 111.478 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.26 -23.27 45.25 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.37 2.047 . . . . 74.34 111.964 174.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.531 ' HB3' HG23 ' A' ' 63' ' ' VAL . 8.7 m-20 -73.06 -56.82 4.59 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.885 -0.598 . . . . 74.14 111.388 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 62.17 11.87 4.69 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.986 0.515 . . . . 75.12 112.296 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.531 HG23 ' HB3' ' A' ' 61' ' ' ASP . 59.9 t -56.62 -36.27 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.059 0.457 . . . . 73.23 111.177 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.567 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -58.04 -47.58 88.19 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.191 -0.528 . . . . 73.32 112.942 177.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.04 -41.84 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.195 0.521 . . . . 74.24 111.213 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -67.28 -29.28 68.85 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.213 0.449 . . . . 73.34 112.213 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 22.0 mmt -58.84 -42.26 88.87 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.726 0.298 . . . . 71.34 111.785 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.0 -139.37 28.28 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.311 -0.471 . . . . 73.44 113.112 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.485 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . 84.5 m95 -81.84 129.57 34.79 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.76 0.314 . . . . 54.12 111.491 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.454 ' HG3' HD11 ' A' ' 77' ' ' ILE . 74.7 mmtt -129.1 148.59 51.06 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.82 0.448 . . . . 52.43 110.292 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 51' ' ' ARG . 94.7 p -175.25 25.44 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.489 0.922 . . . . 71.54 113.489 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -120.16 144.56 47.61 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.614 -0.679 . . . . 75.33 111.394 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.16 96.26 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.094 0.473 . . . . 22.22 111.189 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.43 -26.42 1.99 Allowed Glycine 0 CA--C 1.525 0.697 0 CA-C-N 116.057 -0.52 . . . . 43.03 112.686 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.499 ' HB2' HD12 ' A' ' 88' ' ' ILE . 75.9 m-20 -64.57 135.35 55.89 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.876 0.37 . . . . 64.12 111.647 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.5 p -138.44 142.36 39.49 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.074 0.464 . . . . 61.33 111.617 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.454 HD11 ' HG3' ' A' ' 70' ' ' LYS . 38.7 mm -114.61 130.96 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.211 -0.449 . . . . 55.05 110.626 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.7 t -123.11 119.62 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 112.051 0.389 . . . . 63.04 112.051 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 97.8 m -121.77 88.79 3.0 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 120.733 0.302 . . . . 73.34 110.873 174.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.582 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 92.6 mt -59.25 -53.89 61.7 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 113.078 0.77 . . . . 62.14 113.078 -175.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 24.7 Cg_exo -62.81 -19.32 68.22 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.958 1.772 . . . . 65.44 113.007 -176.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -104.28 -5.04 22.22 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.483 -0.326 . . . . 73.24 111.683 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.1 mttm 58.16 34.29 24.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.811 0.445 . . . . 75.44 111.917 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.555 HG22 ' HG3' ' A' ' 14' ' ' GLN . 60.2 t -109.36 132.86 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.137 -0.483 . . . . 74.41 111.33 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -133.33 136.42 45.38 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.729 0.3 . . . . 63.03 110.695 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -132.9 139.49 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.8 -0.182 . . . . 75.0 111.214 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.425 ' HG2' ' HB ' ' A' ' 11' ' ' ILE . 10.1 pt-20 -126.15 154.52 43.06 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.794 0.331 . . . . 64.04 110.813 174.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.499 HD12 ' HB2' ' A' ' 75' ' ' ASP . 55.1 mt -118.24 123.09 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.094 0.473 . . . . 74.25 110.908 174.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -140.49 151.17 44.6 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.201 -0.454 . . . . 70.44 111.157 -175.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.516 ' OG ' ' HG2' ' A' ' 92' ' ' GLN . 22.9 t -74.2 149.82 40.68 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.064 0.459 . . . . 74.33 111.657 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.1 p -70.31 -21.22 62.95 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 116.25 -0.432 . . . . 75.34 111.837 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.516 ' HG2' ' OG ' ' A' ' 90' ' ' SER . 20.4 pt20 . . . . . 0 CA--C 1.537 0.48 0 CA-C-N 116.414 -0.357 . . . . 74.14 110.72 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.554 ' HG2' HG21 ' A' ' 25' ' ' THR . 42.1 mt-10 . . . . . 0 N--CA 1.465 0.306 0 N-CA-C 112.08 0.4 . . . . 74.14 112.08 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.478 HG23 ' HB2' ' A' ' 24' ' ' LEU . 31.3 m -125.54 139.16 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.164 0.506 . . . . 71.41 111.45 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.3 m -121.96 138.64 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 116.178 -0.465 . . . . 74.11 111.193 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.26 112.64 24.31 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.823 0.344 . . . . 72.01 111.333 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.2 mm -95.04 115.16 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.403 -0.362 . . . . 63.14 110.982 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.486 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.2 mp -97.25 114.64 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.047 0.451 . . . . 71.52 111.509 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.5 m -114.39 134.74 54.76 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.219 -0.446 . . . . 53.32 111.448 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.472 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 49.8 tt0 -126.82 131.27 51.27 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 122.337 -0.227 . . . . 75.32 111.051 177.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.521 ' N ' HD22 ' A' ' 15' ' ' ASN . 0.8 OUTLIER 56.42 28.05 13.03 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.429 0.529 . . . . 73.44 112.429 176.355 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.12 21.57 41.43 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.253 -0.498 . . . . 60.32 114.34 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -146.78 140.33 25.75 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.308 0.554 . . . . 74.12 111.657 175.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.9 t -72.36 118.97 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.791 0.329 . . . . 75.3 111.014 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.1 pt -99.43 -23.44 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 112.219 0.451 . . . . 63.43 112.219 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -173.16 148.04 1.64 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.703 0.287 . . . . 75.32 111.014 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -131.33 127.37 37.52 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.179 0.514 . . . . 72.43 111.442 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.4 mp -113.67 116.12 45.95 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 116.358 -0.383 . . . . 62.25 111.418 -177.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.45 120.59 7.82 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.172 1.915 . . . . 72.44 111.757 172.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.478 ' HB2' HG23 ' A' ' 8' ' ' VAL . 86.9 mt -80.11 -48.89 12.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.056 0.455 . . . . 72.52 111.5 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.554 HG21 ' HG2' ' A' ' 7' ' ' GLU . 86.2 m -60.57 110.16 1.21 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.975 0.417 . . . . 74.03 111.805 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.73 0.53 60.55 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.059 -0.591 . . . . 73.34 113.465 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -72.51 86.49 1.17 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 117.159 0.48 . . . . 74.2 110.547 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -72.95 115.96 12.88 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.184 0.516 . . . . 72.33 111.953 -176.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.5 -166.49 14.37 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.145 -0.479 . . . . 54.2 113.952 177.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -116.89 136.6 52.83 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.763 0.425 . . . . 74.34 110.422 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -145.68 129.91 17.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.902 0.382 . . . . 53.53 111.592 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -121.72 147.6 45.7 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.6 -0.273 . . . . 73.44 111.561 -177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -147.99 143.69 27.45 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.966 0.412 . . . . 71.22 111.307 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -103.39 126.7 50.69 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.17 0.51 . . . . 65.51 112.216 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' A' ' 43' ' ' ASN . 60.7 mt -90.69 132.75 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.121 -0.491 . . . . 55.35 110.66 175.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.58 125.88 48.31 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.997 0.427 . . . . 64.21 111.223 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -113.42 -164.6 15.77 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.29 -0.481 . . . . 25.32 113.831 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -59.07 113.28 2.03 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.895 0.379 . . . . 74.44 112.011 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.54 -125.1 7.86 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.242 -0.504 . . . . 41.12 113.242 178.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.8 9.93 28.15 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.205 0.446 . . . . 51.1 112.205 -178.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.415 ' HA ' HD21 ' A' ' 58' ' ' ASN . 19.0 mm-40 -74.01 132.75 42.68 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.649 -0.251 . . . . 75.35 111.572 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -137.26 174.36 10.69 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.929 0.395 . . . . 64.54 111.125 174.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.531 HD22 ' HB3' ' A' ' 57' ' ' ASP . 2.1 t-20 -152.21 109.64 3.58 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.249 -0.282 . . . . 63.04 111.031 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.2 tp -86.6 105.12 16.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.96 0.41 . . . . 55.31 111.147 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.756 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.4 mmm -95.51 135.62 36.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.147 -0.479 . . . . 72.13 111.05 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.67 127.39 48.13 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.255 0.55 . . . . 72.31 111.96 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.3 t -112.44 107.87 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.03 -0.532 . . . . 61.2 110.586 176.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -112.33 112.35 23.87 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.763 0.316 . . . . 70.02 110.569 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 63.52 -121.46 23.99 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.938 -0.648 . . . . 64.33 112.506 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -106.25 25.81 10.58 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 122.469 -0.43 . . . . 72.34 111.668 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.8 ptt85 -140.92 145.52 36.18 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.204 0.526 . . . . 63.31 111.795 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.9 tt -123.72 153.94 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 116.1 -0.5 . . . . 54.02 111.479 -176.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -157.33 168.47 27.29 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.005 0.431 . . . . 74.14 111.424 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.756 HG12 ' SD ' ' A' ' 45' ' ' MET . 45.3 mt -91.54 123.92 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 109.749 -0.463 . . . . 73.22 109.749 168.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -93.49 -34.06 13.54 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.38 0.511 . . . . 71.45 112.38 -172.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -169.0 139.28 2.29 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.577 -0.283 . . . . 73.54 111.293 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.531 ' HB3' HD22 ' A' ' 43' ' ' ASN . 6.8 p-10 -161.22 160.99 30.68 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.987 0.422 . . . . 71.43 111.536 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.415 HD21 ' HA ' ' A' ' 41' ' ' GLN . 18.0 p-10 -96.09 74.04 2.98 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.45 0.643 . . . . 75.52 111.858 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 84.2 p -125.7 148.84 63.49 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-N 116.381 -0.372 . . . . 70.34 110.92 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.46 -3.18 13.45 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.394 2.062 . . . . 73.24 112.639 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -110.49 -43.81 3.81 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.265 -0.425 . . . . 62.25 111.949 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.408 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 26.7 mm-40 63.47 30.42 15.3 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.854 0.359 . . . . 72.51 111.383 -177.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.2 t -52.56 -42.19 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 111.955 0.354 . . . . 70.21 111.955 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.625 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -55.38 -43.98 84.92 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.068 -0.587 . . . . 62.04 112.883 176.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.1 t -64.71 -39.22 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 120.854 0.359 . . . . 73.4 111.069 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.408 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 1.6 mptm? -65.05 -41.63 94.98 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.718 0.294 . . . . 73.3 111.402 177.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.9 mmt -57.43 -44.28 84.53 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.447 0.536 . . . . 71.03 112.447 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.96 -160.93 43.31 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 120.933 -0.651 . . . . 54.43 113.683 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -67.09 146.77 53.95 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.692 0.626 . . . . 74.3 112.692 -174.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.513 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 33.3 mmtm -135.63 140.67 44.74 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.89 -0.595 . . . . 65.5 110.33 177.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 82.2 p -164.84 11.06 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.29 0.848 . . . . 54.52 113.29 -176.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -114.13 153.9 28.73 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.938 -0.477 . . . . 71.52 111.653 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 90' ' ' SER . . . -69.11 91.34 0.5 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.211 0.529 . . . . 34.41 111.024 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.27 -22.33 2.41 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.893 -0.594 . . . . 65.2 112.337 -175.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.513 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 94.4 m-20 -63.36 142.86 58.23 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.938 0.399 . . . . 75.24 111.611 177.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.0 p -143.7 161.49 38.43 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.202 0.525 . . . . 71.24 111.645 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.3 mm -128.07 114.0 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.829 -0.623 . . . . 62.11 110.247 176.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.0 t -109.22 115.63 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.817 0.342 . . . . 71.51 111.442 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 74.2 m -123.34 88.09 2.86 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.699 0.285 . . . . 71.21 111.18 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.402 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 80.5 mt -62.65 -45.37 88.4 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 113.096 0.776 . . . . 74.01 113.096 -176.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 50.3 Cg_exo -53.74 -25.76 35.6 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 122.16 1.907 . . . . 71.33 113.556 179.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -112.39 -1.24 15.1 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.106 0.41 . . . . 63.51 112.106 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 59.88 33.56 21.59 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.964 0.411 . . . . 64.13 111.791 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 68.0 t -105.65 135.66 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.274 -0.421 . . . . 75.52 111.335 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -139.35 116.21 10.88 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.257 -0.429 . . . . 70.55 110.853 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.1 t -113.35 126.44 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.569 -0.287 . . . . 64.23 111.208 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -120.78 136.79 54.8 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.084 0.469 . . . . 72.41 111.467 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 62.9 mt -103.01 120.79 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.853 0.359 . . . . 71.25 111.331 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -124.4 147.06 48.51 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.106 -0.497 . . . . 73.3 111.064 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 48.1 t -92.45 150.28 20.89 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.188 0.518 . . . . 72.11 112.115 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' A' ' 7' ' ' GLU . 46.9 p -79.72 -13.78 59.21 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.895 -0.593 . . . . 73.21 110.783 174.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 . . . . . 0 CA--C 1.537 0.479 0 CA-C-N 116.108 -0.496 . . . . 72.24 111.077 177.467 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.4 ' HA ' ' CB ' ' A' ' 25' ' ' THR . 53.6 mt-10 . . . . . 0 N--CA 1.468 0.437 0 CA-C-O 121.137 0.494 . . . . 64.04 111.654 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.6 m -120.87 154.26 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 121.155 0.502 . . . . 73.44 112.031 -177.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 23' ' ' PRO . 34.5 m -121.57 147.6 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.03 -0.532 . . . . 72.21 111.282 177.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.99 117.59 34.59 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.835 0.35 . . . . 72.11 111.527 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.9 mm -100.78 122.42 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.561 -0.291 . . . . 72.04 111.051 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.3 mp -107.8 113.88 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.051 0.453 . . . . 34.23 110.923 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.1 m -120.35 134.91 55.18 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.173 -0.467 . . . . 71.15 111.531 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.531 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 62.8 tt0 -119.29 138.84 52.75 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.648 0.261 . . . . 63.12 110.919 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.531 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 54.7 m-80 59.72 17.25 6.16 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.732 0.413 . . . . 72.54 111.98 -177.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.3 3.4 63.28 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.118 -0.563 . . . . 75.11 113.827 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -124.84 140.33 53.03 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 117.238 0.519 . . . . 71.34 111.23 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.34 129.16 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.844 0.354 . . . . 73.04 111.689 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.5 pt -112.78 -31.49 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 116.414 -0.357 . . . . 73.01 111.663 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -157.62 144.94 18.43 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.681 0.277 . . . . 74.3 111.257 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -138.51 132.08 30.64 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 120.77 0.319 . . . . 75.02 110.739 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 22' ' ' ILE . 4.0 mp -126.3 119.39 23.41 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 120.567 0.222 . . . . 53.34 111.552 -177.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.458 ' HA ' HG12 ' A' ' 9' ' ' VAL . 43.1 Cg_endo -68.29 101.6 0.74 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.075 1.85 . . . . 62.13 111.535 172.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.18 -62.44 1.77 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.354 0.502 . . . . 73.34 112.354 -173.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.4 ' CB ' ' HA ' ' A' ' 7' ' ' GLU . 15.0 m -58.58 131.18 50.04 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.94 0.4 . . . . 72.13 111.443 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.62 -33.21 4.9 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.239 -0.505 . . . . 72.54 112.667 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -74.07 85.57 1.82 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.424 0.631 . . . . 71.41 110.82 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -86.74 167.62 14.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.68 -0.691 . . . . 65.12 111.633 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.73 -162.37 51.91 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 120.909 -0.662 . . . . 71.41 112.807 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.442 HD21 ' HG3' ' A' ' 46' ' ' GLU . 4.3 t-20 -117.77 146.59 43.7 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.197 -0.59 . . . . 72.43 111.836 -176.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -161.19 116.92 2.16 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.818 -0.628 . . . . 52.4 110.285 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -113.86 145.96 40.7 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.822 0.344 . . . . 74.31 111.22 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -138.2 139.93 39.52 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.15 0.5 . . . . 71.3 111.481 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.4 m -98.87 121.2 40.52 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.955 -0.566 . . . . 72.34 112.077 -175.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 75.0 mt -91.58 123.37 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.121 -0.49 . . . . 75.14 111.31 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -103.07 124.39 48.45 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.508 0.194 . . . . 72.04 111.117 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -123.02 -143.23 6.32 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.064 -0.589 . . . . 64.01 113.679 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -60.93 106.78 0.62 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.183 0.438 . . . . 73.35 112.183 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.78 -116.88 8.17 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.216 -0.447 . . . . 74.32 113.454 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.78 6.72 48.13 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.031 0.382 . . . . 65.13 112.031 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -75.26 111.07 10.14 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.619 0.247 . . . . 74.11 111.563 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -127.12 164.89 20.61 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.016 0.436 . . . . 72.23 111.353 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.453 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 17.6 m120 -140.05 123.55 17.13 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.233 -0.439 . . . . 73.34 111.127 176.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 56' ' ' GLU . 62.7 tp -96.65 104.19 16.16 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.893 0.378 . . . . 70.14 110.84 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.756 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.4 mmm -94.38 128.8 41.14 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.24 -0.437 . . . . 65.13 111.237 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.442 ' HG3' HD21 ' A' ' 30' ' ' ASN . 40.2 tt0 -115.13 118.81 34.41 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.942 0.401 . . . . 53.04 111.962 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.9 t -104.02 114.33 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.155 -0.475 . . . . 71.41 110.001 171.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -133.67 92.46 2.98 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.924 -0.485 . . . . 71.15 112.167 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.76 67.72 1.72 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.294 -0.479 . . . . 72.2 114.249 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 60.64 26.86 16.58 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.72 0.637 . . . . 53.01 112.72 175.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -149.27 150.66 32.92 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.565 0.346 . . . . 60.41 110.319 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.8 tt -134.62 151.81 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.191 0.441 . . . . 64.54 112.191 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -157.18 168.4 27.54 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.202 -0.454 . . . . 74.54 111.496 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.756 HG12 ' SD ' ' A' ' 45' ' ' MET . 54.4 mt -92.27 110.05 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.47 -0.567 . . . . 72.32 109.47 169.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -86.37 -39.1 16.75 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 111.841 0.311 . . . . 65.41 111.841 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 44' ' ' LEU . 10.8 tp10 -138.86 146.95 41.82 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.739 0.304 . . . . 74.04 110.695 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -168.5 140.15 2.73 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.575 0.35 . . . . 74.0 110.329 -174.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -106.6 38.01 2.18 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.413 0.523 . . . . 74.31 112.413 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.2 m -84.1 138.5 39.66 Favored Pre-proline 0 N--CA 1.471 0.595 0 O-C-N 122.058 -0.401 . . . . 75.32 110.016 172.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.54 -25.74 68.51 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.307 2.004 . . . . 74.1 112.777 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.499 ' HB3' HG23 ' A' ' 63' ' ' VAL . 10.9 m-20 -84.45 -32.38 24.07 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.31 -0.404 . . . . 50.13 111.957 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.518 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 87.8 mm-40 59.54 13.48 3.34 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.136 0.791 . . . . 73.43 113.136 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 61' ' ' ASP . 97.0 t -56.15 -41.34 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 112.479 0.548 . . . . 72.52 112.479 -176.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.48 -42.48 57.46 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.191 -0.528 . . . . 73.01 113.51 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.2 t -68.82 -33.59 60.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.189 0.519 . . . . 62.23 111.333 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.518 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 13.4 mptt -73.15 -28.12 62.05 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.313 0.486 . . . . 64.22 112.313 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.43 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 90.7 mmm -52.76 -47.17 67.64 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.342 0.497 . . . . 63.34 112.342 -177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.42 -163.94 20.0 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.054 -0.593 . . . . 72.15 113.416 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -76.48 138.94 40.6 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.029 0.443 . . . . 70.41 112.014 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -126.69 146.55 50.16 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.28 -0.418 . . . . 55.11 110.639 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 82.2 p -172.2 26.42 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 112.724 0.638 . . . . 50.15 112.724 -176.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -125.16 146.39 49.51 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.686 0.279 . . . . 70.3 111.32 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.15 96.65 0.05 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.079 0.466 . . . . 74.3 111.65 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 138.14 -19.7 3.24 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 116.093 -0.503 . . . . 72.04 112.918 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -63.96 120.16 11.45 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.108 0.48 . . . . 75.13 111.588 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 87' ' ' GLU . 32.5 p -128.96 141.92 51.1 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.077 0.465 . . . . 71.33 111.421 178.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 mm -122.58 127.64 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 116.269 -0.423 . . . . 55.02 110.687 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.6 t -119.71 119.32 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.836 0.35 . . . . 71.41 111.48 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 98.3 m -117.62 88.2 2.86 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.841 0.353 . . . . 73.44 110.6 173.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.512 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 96.2 mt -54.46 -50.83 83.01 Favored Pre-proline 0 CA--C 1.547 0.827 0 N-CA-C 113.314 0.857 . . . . 73.12 113.314 -175.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.512 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 75.5 Cg_exo -50.41 -34.52 41.74 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.156 1.904 . . . . 63.15 113.634 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -103.42 -3.92 24.79 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 111.976 0.361 . . . . 72.34 111.976 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.5 mttp 59.85 33.99 21.71 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.134 0.492 . . . . 44.4 112.276 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.7 t -101.12 133.18 45.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 116.218 -0.446 . . . . 74.53 111.084 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -130.58 125.61 34.61 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.079 -0.51 . . . . 62.14 110.689 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.436 HG22 HG13 ' A' ' 12' ' ' ILE . 47.7 t -118.19 124.1 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.68 -0.236 . . . . 75.43 111.183 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.477 ' HA ' HG22 ' A' ' 76' ' ' THR . 8.9 pt-20 -120.9 122.15 39.6 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.094 0.473 . . . . 74.31 111.467 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.9 mt -97.07 118.16 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 120.98 0.419 . . . . 72.54 110.537 175.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -129.53 150.18 50.98 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.114 0.483 . . . . 74.45 112.122 -173.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.6 t -77.48 150.51 34.9 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.925 -0.58 . . . . 54.43 112.448 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.2 p -85.13 0.18 52.51 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.899 -0.591 . . . . 73.31 111.315 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 121.458 0.647 . . . . 74.41 111.508 176.804 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.513 ' HA ' ' HB ' ' A' ' 25' ' ' THR . 46.0 mt-10 . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 120.784 0.326 . . . . 61.53 111.757 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.446 HG22 ' OG1' ' A' ' 25' ' ' THR . 32.7 m -111.3 151.03 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.073 0.463 . . . . 60.33 111.755 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 23' ' ' PRO . 27.4 m -129.46 141.39 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.168 -0.469 . . . . 64.51 111.488 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.89 115.27 27.08 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.444 -0.344 . . . . 52.54 111.243 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.4 mm -96.42 112.2 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.866 0.365 . . . . 71.11 111.098 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.544 HG13 HG22 ' A' ' 86' ' ' VAL . 2.7 mp -99.19 114.5 37.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 120.972 0.415 . . . . 71.44 111.303 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.0 m -113.07 139.71 48.47 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.798 0.333 . . . . 72.04 111.231 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.473 HE21 ' HA2' ' A' ' 37' ' ' GLY . 57.5 tt0 -128.9 135.45 49.07 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.587 -0.278 . . . . 75.53 111.2 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 57.01 10.27 0.76 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.981 0.734 . . . . 75.11 112.981 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.07 -6.5 28.97 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 121.256 -0.497 . . . . 73.44 113.882 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -112.76 145.08 41.2 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 117.13 0.465 . . . . 71.53 111.571 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.37 119.6 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 110.059 -0.349 . . . . 75.41 110.059 173.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.4 pt -108.51 -19.53 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 113.465 0.913 . . . . 75.14 113.465 -173.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -168.87 141.29 2.71 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.747 0.647 . . . . 72.32 112.747 -177.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -123.42 130.91 53.39 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.391 -0.368 . . . . 72.43 110.535 174.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.472 HG21 HG21 ' A' ' 47' ' ' VAL . 3.9 mp -121.24 124.43 27.32 Favored Pre-proline 0 N--CA 1.478 0.972 0 O-C-N 121.966 -0.459 . . . . 63.14 111.72 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.514 ' HA ' HG12 ' A' ' 9' ' ' VAL . 59.0 Cg_endo -73.24 121.22 7.04 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.418 2.079 . . . . 65.31 112.068 173.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.7 mt -92.96 -60.08 1.89 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.192 0.52 . . . . 62.54 111.796 -176.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.513 ' HB ' ' HA ' ' A' ' 7' ' ' GLU . 25.1 m -58.05 128.0 34.9 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.327 0.492 . . . . 75.3 112.327 -176.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.98 1.12 72.04 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 121.357 -0.449 . . . . 72.51 113.922 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -84.91 105.13 15.45 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.595 -0.356 . . . . 72.4 111.579 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.534 ' NZ ' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -85.77 137.58 32.69 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.927 0.394 . . . . 70.35 110.913 175.226 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.86 178.89 22.19 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.173 -0.537 . . . . 65.43 113.572 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -118.46 139.63 51.11 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.907 0.384 . . . . 62.42 110.965 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -138.9 124.51 19.54 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.256 -0.429 . . . . 74.21 110.604 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.457 ' HG2' ' HA ' ' A' ' 46' ' ' GLU . 75.3 mt-30 -131.7 148.69 52.6 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.94 0.4 . . . . 73.23 112.003 -176.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -154.64 147.71 24.71 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.104 -0.498 . . . . 62.31 111.21 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.7 m -101.19 136.85 40.37 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.899 0.38 . . . . 71.41 111.528 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.524 ' HB ' ' HB3' ' A' ' 43' ' ' ASN . 58.4 mt -113.7 102.32 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.495 -0.32 . . . . 71.44 111.419 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -76.27 107.04 8.23 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.773 0.32 . . . . 70.51 111.141 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.473 ' HA2' HE21 ' A' ' 14' ' ' GLN . . . -89.03 -133.81 4.88 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.374 -0.441 . . . . 54.34 113.438 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.03 115.27 15.56 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.528 -0.396 . . . . 54.34 110.697 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.37 -136.72 25.26 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.266 -0.492 . . . . 71.02 113.135 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.16 3.65 34.06 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.161 0.505 . . . . 74.24 111.279 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.542 ' HB3' ' CD2' ' A' ' 82' ' ' HIS . 24.6 mt-30 -73.07 83.78 1.29 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.194 0.521 . . . . 65.35 111.795 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -89.92 165.44 14.09 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.063 -0.517 . . . . 74.32 111.406 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.578 HD21 HD13 ' A' ' 54' ' ' ILE . 2.4 t-20 -132.7 110.13 10.18 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.311 -0.404 . . . . 74.43 109.93 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.3 tp -95.52 103.82 15.71 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.382 0.61 . . . . 61.34 111.612 -176.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.65 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.1 mmm -93.93 141.61 28.32 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.374 -0.83 . . . . 64.1 111.76 -175.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.457 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 44.7 tt0 -127.07 119.65 27.07 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.99 0.424 . . . . 75.32 111.7 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.472 HG21 HG21 ' A' ' 22' ' ' ILE . 59.4 t -105.53 107.29 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.209 -0.451 . . . . 70.54 110.584 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.522 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 34.8 t70 -109.98 101.56 10.37 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.118 0.485 . . . . 52.2 110.848 -178.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.18 -109.68 3.04 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 120.784 -0.722 . . . . 53.32 112.886 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -108.14 19.16 20.29 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.852 0.358 . . . . 75.13 111.794 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 35.3 ptt180 -136.4 147.07 47.11 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.791 0.329 . . . . 73.33 111.507 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.3 tt -132.37 142.6 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-O 120.868 0.365 . . . . 74.14 111.719 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.51 ' HB3' ' HA ' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -160.67 168.8 24.14 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.849 0.357 . . . . 64.53 111.461 177.441 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.65 HG12 ' SD ' ' A' ' 45' ' ' MET . 71.6 mt -91.62 124.57 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.432 -0.349 . . . . 75.13 111.065 176.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -94.86 -33.16 12.93 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.865 0.364 . . . . 65.21 111.406 177.434 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -143.47 139.95 30.12 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.746 0.308 . . . . 72.43 110.748 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -168.07 145.76 4.3 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.991 0.425 . . . . 74.01 112.023 -173.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -109.79 51.06 0.77 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.081 -0.509 . . . . 70.23 111.954 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.463 ' HG ' ' CD2' ' A' ' 82' ' ' HIS . 31.4 m -107.05 121.81 43.56 Favored Pre-proline 0 N--CA 1.472 0.667 0 O-C-N 122.063 -0.398 . . . . 72.4 110.192 172.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.28 -30.82 73.91 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.436 2.091 . . . . 71.13 112.582 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.68 -36.5 67.91 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.693 -0.685 . . . . 75.51 111.712 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 59.26 16.76 5.19 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.041 0.756 . . . . 73.31 113.041 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 65.6 t -55.36 -51.61 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 N-CA-C 112.07 0.396 . . . . 72.03 112.07 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -56.98 -38.66 86.48 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.223 -0.513 . . . . 32.13 113.271 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 42.1 t -67.46 -43.77 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.991 0.424 . . . . 74.42 111.295 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.22 -27.16 68.87 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.031 -0.531 . . . . 74.33 112.112 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 14.3 mmt -50.45 -35.23 27.88 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.453 0.538 . . . . 73.54 112.453 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.05 -159.87 50.91 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.136 -0.554 . . . . 73.02 113.625 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.51 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . 89.1 m95 -70.82 114.71 9.17 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 111.968 0.359 . . . . 53.12 111.968 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 34.9 mmtp -105.78 150.65 25.35 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.68 -0.237 . . . . 73.35 110.619 175.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.437 ' O ' HG21 ' A' ' 8' ' ' VAL . 92.7 p -159.56 -26.83 0.07 Allowed 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.163 0.801 . . . . 70.44 113.163 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm -82.28 155.96 24.56 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.276 0.56 . . . . 74.45 112.264 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.51 110.74 3.26 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.108 -0.496 . . . . 54.44 110.675 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 121.71 -23.83 7.34 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.982 -0.447 . . . . 63.14 111.982 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.487 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 78.4 m-20 -65.41 129.23 38.99 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.87 0.367 . . . . 74.31 110.783 176.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.476 HG22 ' HA ' ' A' ' 87' ' ' GLU . 41.2 p -128.81 164.38 23.16 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.018 0.747 . . . . 54.51 113.018 -176.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.554 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 39.6 mm -128.15 125.63 64.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.063 -0.971 . . . . 73.1 109.735 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.8 t -117.32 117.59 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 112.291 0.478 . . . . 54.4 112.291 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 75.1 m -119.16 80.79 1.61 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.061 0.458 . . . . 71.42 110.65 174.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.442 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 76.3 mt -52.54 -59.91 7.63 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 113.597 0.962 . . . . 71.43 113.597 -174.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 38.9 Cg_endo -66.86 -9.5 24.98 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 121.917 1.744 . . . . 74.13 112.98 -176.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.542 ' CD2' ' HB3' ' A' ' 41' ' ' GLN . 24.3 m170 -104.49 -10.94 17.31 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.517 -0.31 . . . . 74.13 111.343 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.4 mttp 59.82 27.06 16.31 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.052 0.453 . . . . 71.12 112.032 -176.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.4 t -104.14 124.44 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.028 -0.533 . . . . 75.33 110.782 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -130.27 118.01 20.68 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.069 0.462 . . . . 70.03 111.119 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.554 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 35.9 t -107.76 124.62 63.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.136 -0.484 . . . . 33.44 110.858 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.476 ' HA ' HG22 ' A' ' 76' ' ' THR . 14.5 pt-20 -124.3 126.76 46.59 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.998 0.427 . . . . 73.23 111.58 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 63.5 mt -89.48 112.71 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 121.093 0.473 . . . . 64.31 110.984 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -116.63 152.36 34.36 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.24 -0.436 . . . . 73.44 111.25 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.9 t -89.41 124.93 34.92 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.946 0.403 . . . . 62.14 111.966 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.1 p -66.27 -28.38 68.66 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.295 0.569 . . . . 71.11 110.507 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 . . . . . 0 CA--C 1.533 0.312 0 CA-C-N 115.715 -0.675 . . . . 54.34 109.67 174.221 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.492 ' HG2' HG21 ' A' ' 25' ' ' THR . 29.6 mt-10 . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 112.365 0.506 . . . . 74.45 112.365 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 27.8 m -130.72 159.24 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.426 0.528 . . . . 75.3 112.426 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 23' ' ' PRO . 23.3 m -131.56 147.05 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 115.928 -0.578 . . . . 65.24 111.171 178.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.62 115.14 26.93 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.45 -0.341 . . . . 43.01 111.309 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.441 HD12 ' OE2' ' A' ' 21' ' ' GLU . 18.2 mm -99.47 104.8 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.831 0.348 . . . . 65.31 111.397 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.502 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.3 mp -96.22 120.08 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.194 0.521 . . . . 61.33 111.257 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.6 m -121.94 144.36 48.91 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.087 -0.506 . . . . 70.33 111.31 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.412 ' HG3' HG22 ' A' ' 84' ' ' VAL . 59.3 tt0 -135.67 141.82 45.05 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.551 -0.295 . . . . 73.41 110.733 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 59.21 17.4 5.66 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 111.956 0.354 . . . . 64.32 111.956 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.69 -9.75 62.34 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 121.409 -0.424 . . . . 61.41 113.683 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -116.4 145.65 43.08 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 117.296 0.548 . . . . 64.22 111.657 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.7 t -71.99 128.33 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 120.942 0.401 . . . . 75.2 111.147 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.626 HD11 HD13 ' A' ' 35' ' ' ILE . 33.9 pt -112.17 -26.59 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.64 0.607 . . . . 75.13 112.64 -177.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -159.55 133.34 7.33 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.236 0.458 . . . . 70.53 112.236 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.441 ' OE2' HD12 ' A' ' 11' ' ' ILE . 44.8 mt-10 -124.94 115.49 20.67 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.683 0.277 . . . . 75.31 110.802 177.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.487 HD12 ' N ' ' A' ' 22' ' ' ILE . 3.2 mp -104.22 129.86 24.38 Favored Pre-proline 0 N--CA 1.475 0.798 0 N-CA-C 111.852 0.316 . . . . 74.41 111.852 -175.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.562 ' HA ' HG12 ' A' ' 9' ' ' VAL . 67.7 Cg_endo -74.62 111.61 3.36 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.356 2.037 . . . . 71.45 112.194 171.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.63 -62.26 1.7 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.978 0.418 . . . . 51.4 111.749 -176.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.568 ' HA ' ' HG2' ' A' ' 50' ' ' GLU . 51.3 m -63.03 118.57 8.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.992 0.425 . . . . 72.54 112.07 -177.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.35 -15.73 55.92 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 116.154 -0.476 . . . . 61.32 112.81 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -77.11 79.13 3.64 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.19 0.519 . . . . 75.21 110.978 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.444 ' NZ ' ' HB2' ' A' ' 28' ' ' LYS . 10.4 mtmp? -75.18 105.1 6.03 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.291 0.567 . . . . 54.53 111.304 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.77 -169.63 24.31 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 115.971 -0.558 . . . . 71.22 112.655 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -117.84 148.0 42.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.841 0.353 . . . . 73.43 110.679 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -154.14 129.15 9.54 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.795 0.331 . . . . 72.52 111.671 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -124.71 153.65 42.04 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.759 0.314 . . . . 73.25 111.535 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -154.29 140.73 18.75 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.92 0.391 . . . . 61.44 110.708 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.5 m -108.94 111.93 23.88 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.974 0.416 . . . . 61.15 112.07 -172.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.626 HD13 HD11 ' A' ' 19' ' ' ILE . 57.8 mt -94.0 105.61 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.263 -0.426 . . . . 75.42 111.572 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -89.79 110.02 20.97 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.036 0.446 . . . . 64.15 111.307 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.43 -136.9 9.55 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 116.181 -0.463 . . . . 42.13 113.778 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -87.76 151.25 23.04 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.03 0.382 . . . . 74.4 112.03 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.79 36.74 92.44 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 116.098 -0.501 . . . . 71.0 113.479 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 61.99 10.72 3.78 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.388 0.514 . . . . 72.0 112.388 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.549 ' HA ' ' HB3' ' A' ' 58' ' ' ASN . 26.3 mt-30 -82.55 107.02 14.89 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.089 0.403 . . . . 71.42 112.089 -176.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -104.88 153.18 21.7 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 111.981 0.363 . . . . 63.4 111.981 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -111.72 130.23 55.85 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.998 -0.546 . . . . 60.45 110.222 171.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.4 tp -101.85 104.11 14.83 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.873 0.368 . . . . 75.2 110.925 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.753 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.5 mmm -88.73 141.33 28.6 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.559 -0.292 . . . . 64.41 111.286 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -136.09 119.01 16.29 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.155 0.502 . . . . 73.14 111.605 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.9 t -105.85 119.85 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 115.939 -0.573 . . . . 72.31 110.699 177.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -117.44 90.74 3.4 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.163 0.506 . . . . 74.42 110.206 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.97 -116.57 5.07 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.755 -0.736 . . . . 42.03 112.352 -174.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.568 ' HG2' ' HA ' ' A' ' 25' ' ' THR . 40.6 mt-10 -95.13 -15.17 23.56 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.036 0.446 . . . . 71.13 111.806 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.558 ' HA ' ' HB3' ' A' ' 71' ' ' SER . 26.7 ptt180 -97.74 135.29 39.73 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.993 0.425 . . . . 62.52 111.371 -176.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.6 tt -123.89 143.82 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.126 0.489 . . . . 73.33 111.463 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -144.96 169.21 18.52 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.32 -0.4 . . . . 62.55 110.709 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.753 HG12 ' SD ' ' A' ' 45' ' ' MET . 42.7 mt -96.93 122.17 48.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.351 -0.611 . . . . 75.12 109.351 167.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -86.67 -32.39 20.55 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.503 0.557 . . . . 70.12 112.503 -172.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -162.09 138.68 8.0 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.681 0.277 . . . . 64.14 111.383 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -133.04 144.61 50.15 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.313 0.578 . . . . 74.33 111.816 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.549 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . 48.5 t-20 -81.47 72.17 8.5 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.921 -1.14 . . . . 72.51 107.921 163.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.431 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 69.1 m -135.98 130.45 18.51 Favored Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 115.634 -0.712 . . . . 73.2 111.373 -174.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 59' ' ' SER . 26.8 Cg_exo -63.35 -27.66 71.51 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.79 2.327 . . . . 52.13 112.315 178.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.427 ' O ' ' HE2' ' A' ' 66' ' ' LYS . 4.3 m-20 -97.3 -15.47 20.75 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.68 -0.691 . . . . 60.45 112.15 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 27.0 mm-40 52.6 34.04 14.89 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.393 0.516 . . . . 70.43 112.393 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.9 t -53.35 -51.29 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 112.914 0.709 . . . . 73.2 112.914 -174.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -56.43 -55.06 31.63 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.149 -0.548 . . . . 51.34 113.373 -177.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.2 t -52.75 -41.81 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 111.914 0.339 . . . . 65.23 111.914 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 61' ' ' ASP . 67.9 mttm -64.29 -30.82 71.85 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 111.963 0.357 . . . . 70.31 111.963 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.8 mmt -61.2 -40.45 93.99 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.269 0.47 . . . . 72.45 112.269 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.45 -153.55 39.16 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.121 -0.562 . . . . 62.15 113.737 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -81.73 130.79 35.18 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.179 0.437 . . . . 71.41 112.179 -176.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HG3' HD11 ' A' ' 77' ' ' ILE . 75.4 mmtt -127.73 150.17 49.91 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.142 -0.481 . . . . 74.0 110.645 175.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.558 ' HB3' ' HA ' ' A' ' 51' ' ' ARG . 89.1 p -173.68 22.94 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.905 0.706 . . . . 52.44 112.905 -178.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -90.46 162.33 15.12 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.081 -0.387 . . . . 72.32 110.163 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.65 32.83 0.11 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 112.133 0.42 . . . . 45.13 112.133 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -177.24 29.4 0.07 OUTLIER Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.385 -0.436 . . . . 74.31 113.312 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -86.8 146.77 26.11 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.968 0.413 . . . . 72.24 111.243 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.6 p -133.81 141.33 47.41 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.061 0.458 . . . . 61.45 111.604 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.531 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 45.5 mm -125.2 109.64 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.341 -0.39 . . . . 73.03 110.417 177.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.04 116.6 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.067 0.46 . . . . 72.22 111.822 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 91.5 m -120.98 79.75 1.55 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.382 -0.372 . . . . 72.31 111.067 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.503 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 96.2 mt -57.13 -48.17 97.86 Favored Pre-proline 0 CA--C 1.55 0.958 0 N-CA-C 112.825 0.676 . . . . 71.41 112.825 -177.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 76.7 Cg_exo -51.42 -25.15 17.98 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 122.215 1.943 . . . . 64.23 113.613 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.527 ' NE2' ' HB3' ' A' ' 41' ' ' GLN . 16.0 m170 -111.52 -4.26 14.86 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.035 -0.416 . . . . 63.24 111.735 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 58.33 34.41 24.01 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.285 0.564 . . . . 74.14 111.782 -176.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.412 HG22 ' HG3' ' A' ' 14' ' ' GLN . 60.4 t -110.43 134.71 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 115.714 -0.675 . . . . 71.51 111.326 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -131.19 130.04 42.47 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.836 0.351 . . . . 71.12 110.885 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 50.3 t -119.23 120.62 64.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.717 0.294 . . . . 70.43 111.487 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -111.13 136.97 49.39 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 110.451 -0.203 . . . . 72.13 110.451 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.3 mt -105.61 112.17 37.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.985 0.421 . . . . 54.01 110.575 175.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -118.11 159.35 23.4 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.28 -0.418 . . . . 74.13 110.91 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 45.3 t -79.91 145.44 32.67 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.918 0.389 . . . . 75.21 111.444 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.8 p -67.75 -28.31 67.52 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.429 0.633 . . . . 75.42 110.265 174.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 . . . . . 0 CA--C 1.546 0.815 0 CA-C-N 114.934 -1.03 . . . . 72.11 110.749 179.151 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 CA--C 1.542 0.669 0 N-CA-C 113.06 0.763 . . . . 73.13 113.06 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 33.9 m -126.27 148.02 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.022 0.439 . . . . 74.23 111.055 173.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 23' ' ' PRO . 33.8 m -127.27 151.78 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.938 0.399 . . . . 63.35 111.679 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.77 118.21 36.45 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.112 -0.495 . . . . 62.13 110.878 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 31.0 mm -95.26 108.79 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 120.83 0.347 . . . . 74.44 110.992 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.2 mp -95.17 111.51 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 120.937 0.399 . . . . 73.13 111.123 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.9 p -113.7 147.19 38.63 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.971 0.415 . . . . 74.23 111.236 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -143.88 139.34 29.17 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.286 -0.416 . . . . 72.32 110.284 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 62.19 13.59 5.97 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.089 0.403 . . . . 62.33 112.089 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.02 -16.67 46.05 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 121.199 -0.524 . . . . 73.34 113.956 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.79 150.1 33.95 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 122.294 -0.533 . . . . 71.43 111.693 -178.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.77 120.92 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.412 -0.358 . . . . 62.44 110.834 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.0 pt -99.71 -27.96 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 112.102 0.408 . . . . 65.35 112.102 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.1 tpp85 -157.82 143.51 17.18 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 122.09 -0.381 . . . . 73.24 111.601 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -128.36 113.51 15.68 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.676 0.274 . . . . 73.02 110.871 176.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.53 HG21 HG21 ' A' ' 47' ' ' VAL . 3.0 mp -107.39 119.66 50.08 Favored Pre-proline 0 N--CA 1.473 0.722 0 O-C-N 122.27 -0.269 . . . . 71.35 111.632 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 22.0 Cg_exo -66.03 123.46 11.3 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.366 2.044 . . . . 74.53 111.781 172.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.2 mt -87.13 -54.55 4.26 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.158 0.504 . . . . 71.44 111.447 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.447 ' OG1' HG22 ' A' ' 8' ' ' VAL . 29.1 m -63.1 107.34 1.01 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.039 0.447 . . . . 73.35 111.764 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.41 ' H ' ' HG2' ' A' ' 50' ' ' GLU . . . 94.13 11.17 57.8 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.266 -0.493 . . . . 62.23 113.081 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.533 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 52.0 t-80 -72.98 87.12 1.33 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.08 0.467 . . . . 71.55 111.154 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -53.8 131.8 40.28 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.884 0.698 . . . . 72.23 112.884 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.38 -161.94 49.02 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 115.931 -0.577 . . . . 73.31 114.501 175.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -118.68 141.98 48.09 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.952 0.501 . . . . 71.33 109.91 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -142.91 125.08 15.38 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 122.25 -0.282 . . . . 72.4 111.626 -175.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -117.83 129.85 55.91 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.668 -0.242 . . . . 74.45 111.459 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -136.69 143.22 43.27 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.244 0.545 . . . . 74.35 111.795 176.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.0 m -101.8 121.52 42.24 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.979 -0.555 . . . . 53.43 111.921 -175.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 54.1 mt -92.86 104.94 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.529 -0.305 . . . . 63.12 110.451 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -101.16 113.8 27.16 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.956 0.407 . . . . 70.42 111.884 -176.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.8 -65.46 1.44 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.299 -0.476 . . . . 63.45 112.551 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -141.39 87.62 2.09 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.543 -0.387 . . . . 71.22 111.438 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.45 -86.82 0.01 OUTLIER Glycine 0 CA--C 1.53 1.017 0 N-CA-C 114.196 0.438 . . . . 63.33 114.196 177.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.41 -22.26 44.53 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.007 0.432 . . . . 73.42 111.612 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -82.56 95.37 7.73 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.235 -0.291 . . . . 75.21 110.904 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -144.59 160.74 40.66 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.354 0.502 . . . . 72.55 112.354 -177.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -129.75 144.71 51.43 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.022 -0.536 . . . . 72.41 110.605 174.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.8 tp -114.12 107.34 15.5 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.989 0.423 . . . . 54.33 111.025 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.758 ' SD ' HG12 ' A' ' 54' ' ' ILE . 84.2 mmm -94.6 140.11 30.29 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.179 -0.464 . . . . 70.35 111.351 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -130.58 120.86 24.65 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.985 0.421 . . . . 74.0 111.324 176.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.53 HG21 HG21 ' A' ' 22' ' ' ILE . 36.0 t -105.0 108.73 25.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.122 -0.49 . . . . 71.45 110.731 176.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -109.31 105.75 15.29 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.965 0.412 . . . . 64.24 110.338 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.533 ' O ' ' HB3' ' A' ' 27' ' ' HIS . . . 58.16 -114.98 6.34 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.837 -0.697 . . . . 65.51 113.048 -177.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' A' ' 26' ' ' GLY . 34.6 mt-10 -106.17 35.56 2.89 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.882 0.372 . . . . 70.13 111.649 -177.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -155.13 144.65 21.27 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.933 0.397 . . . . 73.14 111.444 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 tt -129.41 147.1 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 112.007 0.373 . . . . 52.13 112.007 -175.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.401 ' HD3' ' CE2' ' A' ' 69' ' ' TRP . 22.5 ptt180 -150.84 169.29 22.05 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.106 0.479 . . . . 63.35 111.428 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.758 HG12 ' SD ' ' A' ' 45' ' ' MET . 43.6 mt -105.6 116.29 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 116.282 -0.417 . . . . 71.13 110.756 173.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HB3' ' NZ ' ' A' ' 55' ' ' LYS . 8.5 mtpm? -78.53 -40.4 35.2 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.269 0.557 . . . . 70.44 111.722 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -137.97 143.89 40.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.943 -0.571 . . . . 72.13 111.021 -173.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -161.0 126.14 3.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.384 0.611 . . . . 75.51 110.558 -178.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -100.89 67.95 1.25 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.589 -0.732 . . . . 61.53 110.813 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 53.4 p -129.97 150.99 77.49 Favored Pre-proline 0 N--CA 1.474 0.749 0 CA-C-N 116.294 -0.412 . . . . 73.32 111.105 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -63.88 -28.73 67.29 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.651 2.234 . . . . 71.44 112.752 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.47 ' HB3' HG23 ' A' ' 63' ' ' VAL . 5.1 m-20 -80.67 -36.91 31.76 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.876 -0.602 . . . . 73.43 112.513 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 63.69 20.59 12.3 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.341 0.497 . . . . 64.01 112.341 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 61' ' ' ASP . 64.6 t -59.76 -39.77 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 112.082 0.401 . . . . 64.33 112.082 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.93 -56.19 19.91 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.2 -0.454 . . . . 74.43 113.714 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.99 -38.06 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 O-C-N 122.66 -0.318 . . . . 61.2 111.683 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -59.79 -28.47 67.46 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.22 0.452 . . . . 61.44 112.22 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 23.0 mmt -57.56 -36.16 71.29 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.333 0.494 . . . . 54.44 112.333 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.87 -149.21 42.66 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.271 -0.49 . . . . 42.43 113.82 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.401 ' CE2' ' HD3' ' A' ' 53' ' ' ARG . 92.4 m95 -82.37 120.7 25.77 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.872 0.367 . . . . 71.32 111.964 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.671 ' HG3' HD11 ' A' ' 77' ' ' ILE . 75.2 mmtt -109.4 157.95 18.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.586 0.354 . . . . 61.13 110.925 175.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 88.0 p -163.76 -28.65 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.871 0.693 . . . . 61.35 112.871 -175.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -81.93 141.6 33.18 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.003 0.43 . . . . 72.23 112.094 -175.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.09 94.5 0.11 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.343 0.592 . . . . 74.15 110.704 175.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.7 -22.83 1.32 Allowed Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.908 -0.587 . . . . 43.13 112.139 -174.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.518 ' HB2' HD12 ' A' ' 88' ' ' ILE . 78.3 m-20 -62.84 123.95 19.78 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.942 0.401 . . . . 64.11 111.127 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.5 p -117.53 142.57 47.01 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.24 0.543 . . . . 70.41 112.01 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.671 HD11 ' HG3' ' A' ' 70' ' ' LYS . 29.8 mm -119.5 117.57 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.734 -0.666 . . . . 74.35 110.212 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.1 t -108.76 116.51 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 111.974 0.361 . . . . 72.14 111.974 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 70.9 m -122.15 71.21 0.99 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.933 0.396 . . . . 65.24 111.024 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.537 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 94.5 mt -55.39 -49.3 93.31 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 112.93 0.715 . . . . 63.05 112.93 -177.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 51.1 Cg_exo -56.28 -17.38 20.51 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.274 1.983 . . . . 72.0 113.7 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -114.75 -0.07 13.67 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.122 -0.361 . . . . 73.15 111.959 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 60.12 29.27 18.86 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.761 0.425 . . . . 52.33 111.955 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.28 135.82 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.919 0.39 . . . . 75.22 111.396 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -139.91 125.16 18.85 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.329 -0.396 . . . . 73.13 110.944 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 52.7 t -123.31 120.41 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 120.778 0.323 . . . . 72.13 111.341 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -122.38 144.44 49.03 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.956 0.408 . . . . 74.03 111.369 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 75' ' ' ASP . 60.1 mt -97.84 136.53 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.047 0.451 . . . . 62.03 111.515 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -149.81 150.54 32.14 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.343 -0.39 . . . . 71.43 111.189 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 46.1 t -78.53 150.68 32.81 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.326 0.491 . . . . 75.0 112.326 -178.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.3 p -68.52 -20.17 64.56 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.192 0.52 . . . . 72.51 111.298 175.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 . . . . . 0 CA--C 1.541 0.601 0 CA-C-N 115.728 -0.669 . . . . 53.32 111.323 -175.574 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.474 ' HB2' ' OG1' ' A' ' 91' ' ' THR . 40.8 mt-10 . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 112.429 0.529 . . . . 75.53 112.429 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.46 143.86 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.177 -0.465 . . . . 75.13 111.172 173.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 23' ' ' PRO . 31.0 m -125.07 141.84 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 120.962 0.411 . . . . 71.22 111.372 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.73 120.47 37.12 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.837 0.351 . . . . 62.11 111.564 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 17.8 mm -99.89 110.85 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.364 -0.38 . . . . 71.21 110.87 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.528 ' HA ' HG22 ' A' ' 86' ' ' VAL . 3.2 mp -95.59 119.38 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.025 0.441 . . . . 73.22 111.917 -177.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.4 t -121.27 139.12 53.82 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.095 0.474 . . . . 74.11 111.327 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.57 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 47.9 tt0 -121.24 116.95 25.85 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.385 -0.371 . . . . 74.13 110.686 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.57 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 43.5 m-80 61.76 2.61 0.75 Allowed 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.574 0.583 . . . . 74.12 112.574 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.86 -6.55 8.93 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.113 -0.565 . . . . 62.23 113.865 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -108.85 126.5 53.11 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 117.43 0.615 . . . . 71.5 111.414 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.6 t -70.52 112.04 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.124 0.488 . . . . 75.35 110.852 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.6 pt -102.44 -23.43 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 112.712 0.634 . . . . 72.13 112.712 -175.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -152.57 136.47 16.3 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.666 0.269 . . . . 73.24 111.641 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -130.66 114.96 16.05 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.759 0.314 . . . . 73.51 110.374 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.4 mt -115.38 124.43 30.12 Favored Pre-proline 0 N--CA 1.472 0.636 0 N-CA-C 112.111 0.411 . . . . 75.42 112.111 -175.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.516 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 60.4 Cg_endo -72.66 112.37 3.47 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.239 1.96 . . . . 72.01 111.758 173.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.9 mt -77.22 -57.1 4.02 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.959 0.409 . . . . 71.22 111.544 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 m -62.46 122.85 16.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.947 0.403 . . . . 74.22 111.601 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.16 -11.77 71.28 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.104 -0.57 . . . . 71.13 112.792 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.516 ' HB2' ' O ' ' A' ' 23' ' ' PRO . 58.5 t-80 -67.78 129.04 38.69 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.869 0.366 . . . . 50.43 110.439 177.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.449 ' HE3' ' HA ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -119.96 136.24 54.61 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 122.021 -0.424 . . . . 75.31 111.294 -177.385 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.34 -172.2 33.02 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.494 -0.384 . . . . 73.14 112.788 -177.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -116.9 127.38 54.2 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 122.351 -0.499 . . . . 61.13 110.208 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -124.61 117.02 23.36 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.955 0.407 . . . . 75.15 111.268 -175.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.551 ' HG2' ' HG3' ' A' ' 46' ' ' GLU . 30.7 mt-30 -115.32 134.99 54.61 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.737 0.303 . . . . 73.51 111.256 -175.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -145.2 140.25 27.77 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.961 0.41 . . . . 55.42 110.904 177.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.2 m -104.11 109.34 21.1 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.997 0.427 . . . . 74.03 111.911 -174.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 62.8 mt -80.51 97.4 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.1 0.476 . . . . 61.3 111.037 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -82.8 104.01 12.72 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.996 0.427 . . . . 75.13 111.199 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.471 ' HA2' ' NE2' ' A' ' 14' ' ' GLN . . . -78.83 -146.04 3.18 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.345 -0.455 . . . . 52.1 113.059 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -76.31 108.61 9.38 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.95 0.405 . . . . 65.12 111.272 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.51 -129.21 9.41 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.065 -0.588 . . . . 70.42 113.55 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.96 4.32 23.12 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.303 0.483 . . . . 53.55 112.303 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -80.9 73.63 7.9 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.145 0.498 . . . . 73.34 112.232 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -89.53 155.89 18.98 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.964 0.412 . . . . 72.22 111.793 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.549 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 16.3 m120 -132.14 110.19 10.49 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.219 -0.446 . . . . 73.21 110.631 173.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.4 tp -83.38 103.22 12.58 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.064 0.459 . . . . 72.31 110.909 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.807 ' SD ' HG12 ' A' ' 54' ' ' ILE . 85.9 mmm -94.79 139.7 30.91 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.118 -0.492 . . . . 71.43 111.107 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.551 ' HG3' ' HG2' ' A' ' 32' ' ' GLN . 33.7 tt0 -136.72 118.94 15.55 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.086 0.469 . . . . 51.45 111.766 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.8 t -100.81 112.88 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.219 -0.446 . . . . 71.34 110.186 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.555 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 35.6 t70 -108.11 100.36 9.69 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.039 0.447 . . . . 72.43 110.731 -177.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.78 -110.53 3.31 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.842 -0.694 . . . . 55.41 112.258 -174.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -114.5 33.26 5.43 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.313 0.578 . . . . 73.21 111.313 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 14.4 ptt180 -147.56 149.43 32.57 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.08 -0.509 . . . . 73.32 110.745 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.4 tt -123.29 148.47 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 120.791 0.329 . . . . 51.24 111.772 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -151.36 168.76 23.8 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.904 0.383 . . . . 74.2 111.47 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.807 HG12 ' SD ' ' A' ' 45' ' ' MET . 37.1 mt -104.64 118.35 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.842 0.353 . . . . 70.34 110.093 170.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -83.4 -35.05 25.37 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.452 -0.34 . . . . 72.34 111.897 -175.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -161.78 138.51 8.27 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.816 0.341 . . . . 64.53 111.632 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -140.9 178.52 7.3 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.01 0.433 . . . . 61.14 111.394 175.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -112.6 33.87 4.7 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.36 0.6 . . . . 53.44 111.461 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.7 m -89.69 146.47 35.6 Favored Pre-proline 0 N--CA 1.472 0.642 0 O-C-N 121.755 -0.591 . . . . 75.11 110.818 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.24 -32.57 73.4 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.488 2.125 . . . . 73.33 112.295 179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -96.42 -9.19 30.43 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.021 -0.536 . . . . 64.55 111.795 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.526 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 23.6 mm-40 57.5 38.51 28.09 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.01 0.433 . . . . 53.43 111.731 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.3 t -52.75 -36.68 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 116.159 -0.473 . . . . 75.35 112.103 -174.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -58.7 -54.16 40.16 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.053 -0.594 . . . . 60.21 112.766 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.2 -38.22 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-O 120.896 0.379 . . . . 70.32 111.895 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.526 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 5.4 mptp? -65.19 -28.44 69.39 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.395 0.516 . . . . 64.22 112.395 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 25.7 mmt -60.72 -34.83 74.99 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.041 0.386 . . . . 44.51 112.041 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.25 -144.15 38.77 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 114.391 0.516 . . . . 52.34 114.391 175.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -84.39 131.95 34.63 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.734 0.642 . . . . 75.42 112.734 -176.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.43 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 75.3 mmtt -127.2 136.12 51.6 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.941 -0.572 . . . . 74.43 110.971 177.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.1 p -168.42 17.49 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.307 0.484 . . . . 73.24 112.307 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -114.77 150.59 35.16 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.773 0.321 . . . . 72.41 111.116 -177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.28 108.97 0.77 Allowed 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.998 0.427 . . . . 64.13 110.452 173.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 119.03 -16.71 10.84 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.077 -0.583 . . . . 75.53 113.299 -178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.43 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 53.4 m-20 -62.41 133.56 55.21 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.152 0.476 . . . . 72.11 111.551 176.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.8 p -134.24 147.33 50.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.221 0.534 . . . . 60.45 111.845 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.557 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 41.5 mm -114.73 121.85 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.759 -0.655 . . . . 72.51 110.3 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.0 t -121.47 117.44 52.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.929 0.395 . . . . 73.2 111.681 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 97.2 m -116.26 90.03 3.24 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.653 -0.249 . . . . 64.21 110.618 175.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.568 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 98.0 mt -55.81 -55.52 40.12 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 113.202 0.816 . . . . 74.12 113.202 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 16.6 Cg_exo -67.4 -7.34 18.82 Favored 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 122.002 1.801 . . . . 71.3 112.933 -176.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -114.93 -12.75 12.0 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.423 -0.353 . . . . 62.23 111.355 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.9 mttm 59.16 31.79 21.55 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.934 0.493 . . . . 72.04 111.947 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.9 t -100.68 133.51 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.223 -0.444 . . . . 51.5 110.978 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -135.84 129.31 32.19 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.925 0.393 . . . . 43.42 111.053 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.557 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 60.9 t -131.3 113.58 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.476 -0.329 . . . . 55.3 111.207 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.0 pm0 -108.31 139.96 42.27 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.056 0.455 . . . . 60.51 111.371 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.8 mt -106.71 119.55 56.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.448 -0.342 . . . . 72.13 111.463 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.449 ' HE3' ' HB2' ' A' ' 89' ' ' LYS . 19.0 ptmt -118.18 162.38 18.33 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.915 0.388 . . . . 75.12 111.664 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.1 t -88.21 149.56 23.79 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 116.312 -0.404 . . . . 63.2 110.95 175.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 7' ' ' GLU . 38.8 p -85.0 -2.72 58.3 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.192 0.441 . . . . 62.45 112.192 -178.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 121.069 0.462 . . . . 65.43 111.798 -179.012 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 120.932 0.396 . . . . 74.5 111.995 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.38 160.28 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.08 0.466 . . . . 73.53 111.933 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 23' ' ' PRO . 35.5 m -135.14 141.47 42.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 122.615 0.366 . . . . 53.42 111.003 177.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.91 114.61 26.75 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.892 0.377 . . . . 50.11 111.561 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.0 mm -99.34 113.91 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 120.849 0.357 . . . . 64.11 111.192 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.512 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.2 mp -100.52 118.04 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.1 0.476 . . . . 74.01 111.17 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.3 m -121.56 147.75 45.41 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.883 0.373 . . . . 71.52 111.64 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.439 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 63.9 tt0 -138.88 142.99 38.55 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.643 0.259 . . . . 75.51 110.843 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.439 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 56.0 m-80 57.6 17.68 4.15 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.271 0.471 . . . . 74.51 112.271 -177.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.71 18.95 39.03 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.339 -0.457 . . . . 43.53 113.867 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.466 ' NZ ' ' HB3' ' A' ' 17' ' ' LYS . 0.5 OUTLIER -143.91 144.96 31.96 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.46 0.63 . . . . 75.22 111.616 177.458 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.0 t -70.03 120.95 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.827 0.346 . . . . 72.41 111.567 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 37.2 pt -107.94 -15.42 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 112.219 0.452 . . . . 73.55 112.219 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -170.14 142.53 2.29 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.408 0.283 . . . . 64.21 110.8 -177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.01 122.93 10.03 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.153 0.501 . . . . 71.51 111.898 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.469 HD12 ' N ' ' A' ' 22' ' ' ILE . 4.2 mp -117.6 121.54 31.83 Favored Pre-proline 0 N--CA 1.474 0.731 0 CA-C-N 116.431 -0.35 . . . . 51.24 111.609 -176.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.484 ' HA ' HG12 ' A' ' 9' ' ' VAL . 20.4 Cg_exo -66.52 103.15 0.65 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.169 1.913 . . . . 63.32 111.491 170.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.37 -59.33 4.14 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.409 -0.36 . . . . 72.23 111.926 -174.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.0 m -53.76 125.93 20.23 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.967 0.413 . . . . 71.21 111.996 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.01 -21.14 41.45 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.114 -0.565 . . . . 64.12 113.663 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -86.71 103.96 15.66 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 117.46 0.63 . . . . 74.24 112.24 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.419 ' HA ' ' HA2' ' A' ' 49' ' ' GLY . 23.7 pttm -86.64 -175.37 5.4 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.185 -0.461 . . . . 73.54 110.541 174.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.72 -164.13 54.17 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.015 -0.612 . . . . 63.22 114.072 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -119.26 131.17 55.75 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.959 0.409 . . . . 73.35 111.508 -176.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.455 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 10.5 tp10 -132.31 114.98 15.05 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.339 -0.391 . . . . 74.22 110.752 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -118.95 140.64 49.66 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 111.935 0.346 . . . . 75.51 111.935 -176.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -146.87 152.24 38.38 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.761 0.315 . . . . 61.31 111.261 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.6 m -113.8 117.63 32.0 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.267 0.556 . . . . 64.41 112.495 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 71.9 mt -86.38 108.26 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.849 -0.614 . . . . 73.3 111.079 177.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -92.78 105.15 17.33 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.711 0.291 . . . . 72.33 111.128 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.5 -66.84 1.19 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.289 -0.482 . . . . 74.12 114.177 -175.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -164.65 125.62 2.09 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.638 -0.33 . . . . 71.3 111.335 -176.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.36 -105.7 0.77 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.228 -0.51 . . . . 74.23 113.2 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.57 -1.18 28.7 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.184 0.439 . . . . 42.23 112.184 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -84.87 88.73 7.44 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.077 0.465 . . . . 64.32 112.008 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.441 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 47.8 p90 -113.05 168.4 9.73 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.054 -0.521 . . . . 72.33 110.798 174.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.563 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 20.0 m120 -135.75 112.68 10.29 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.317 0.247 . . . . 74.5 110.894 173.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 42.5 tp -87.61 109.94 20.02 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.828 0.347 . . . . 54.33 110.818 177.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.8 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.6 mmm -100.74 159.29 15.3 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.0 0.428 . . . . 70.55 111.979 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.482 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 40.5 tt0 -147.7 132.26 17.75 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.338 0.495 . . . . 73.22 112.338 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 58.8 t -118.15 107.63 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.126 0.571 . . . . 62.42 110.09 174.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 11.9 t70 -121.97 93.4 3.98 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.862 0.363 . . . . 54.31 111.592 -174.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 28' ' ' LYS . . . 67.79 75.36 0.49 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.187 -0.53 . . . . 62.43 114.315 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 60.56 17.19 7.15 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.683 0.994 . . . . 73.22 113.683 175.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.511 ' HG3' ' CE3' ' A' ' 69' ' ' TRP . 7.7 ptp180 -144.07 146.59 32.93 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.97 -0.457 . . . . 73.33 111.19 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 tt -127.29 148.09 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 121.096 0.474 . . . . 74.33 112.271 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.543 ' HB3' ' HA ' ' A' ' 69' ' ' TRP . 0.4 OUTLIER -159.6 168.88 25.02 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.181 -0.463 . . . . 74.2 111.454 176.297 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.8 HG12 ' SD ' ' A' ' 45' ' ' MET . 33.7 mt -93.38 130.2 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.925 0.393 . . . . 64.11 110.962 175.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.482 ' HD2' ' HB2' ' A' ' 46' ' ' GLU . 29.5 mtpp -80.94 -47.68 13.36 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.43 -0.35 . . . . 53.31 111.642 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -171.93 144.75 1.77 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.067 0.461 . . . . 65.12 111.77 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 3.9 p-10 -142.2 -177.32 5.19 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.262 -0.426 . . . . 71.4 110.647 176.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -116.78 83.81 2.03 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.481 0.658 . . . . 74.42 111.06 173.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.6 t -130.65 152.75 80.99 Favored Pre-proline 0 N--CA 1.474 0.741 0 CA-C-N 115.692 -0.686 . . . . 70.31 111.371 174.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.72 -13.91 24.46 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 121.868 1.712 . . . . 64.51 112.046 171.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.489 ' HB3' HG23 ' A' ' 63' ' ' VAL . 7.8 m-20 -102.68 -50.91 3.43 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.136 -0.484 . . . . 62.35 111.491 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 53.24 29.84 9.07 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.637 0.606 . . . . 63.52 112.637 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.489 HG23 ' HB3' ' A' ' 61' ' ' ASP . 41.5 t -58.55 -36.02 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.846 0.355 . . . . 64.13 111.549 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.434 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -57.09 -45.27 92.64 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 116.406 -0.361 . . . . 65.43 113.593 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 45.4 t -62.56 -40.02 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.34 0.59 . . . . 52.44 110.983 178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -69.52 -27.29 65.05 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.978 -0.556 . . . . 54.0 112.253 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 20.9 mmt -55.06 -39.24 69.0 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.127 0.418 . . . . 74.52 112.127 177.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.26 -175.6 54.88 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.202 -0.523 . . . . 71.22 114.186 175.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.543 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . 96.5 m95 -52.28 138.11 27.24 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.954 0.724 . . . . 73.11 112.954 -175.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -135.56 148.3 49.06 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.7 0.4 . . . . 72.11 110.743 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 89.2 p -170.7 18.97 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.802 0.668 . . . . 71.1 112.802 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -101.44 146.67 27.31 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.035 -0.416 . . . . 72.41 110.59 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.13 88.89 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.089 0.471 . . . . 65.15 111.037 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.85 -19.46 2.55 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.198 -0.525 . . . . 65.01 113.666 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.53 ' HB2' HD12 ' A' ' 88' ' ' ILE . 97.4 m-20 -57.09 139.56 52.01 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 117.573 0.686 . . . . 72.15 112.172 -178.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.3 p -138.79 144.89 39.55 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.95 0.405 . . . . 73.53 111.515 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.8 mm -122.9 127.94 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.3 -0.409 . . . . 75.23 110.315 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.9 t -111.7 117.22 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.013 0.435 . . . . 75.22 111.959 -177.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.554 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 74.8 m -114.03 76.44 0.99 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.128 0.49 . . . . 73.04 110.226 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.456 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 5.2 tt -54.75 -54.14 52.72 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 115.713 -0.676 . . . . 70.12 112.634 -173.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 80' ' ' LEU . 23.7 Cg_endo -59.73 -22.61 68.41 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 122.156 1.904 . . . . 73.11 113.287 -177.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -104.35 -2.13 25.93 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.488 -0.324 . . . . 74.44 111.385 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm 60.02 29.38 18.95 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.263 0.468 . . . . 72.02 112.263 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 48.4 t -106.15 141.75 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.925 0.393 . . . . 75.53 111.436 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -143.24 126.65 16.74 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.821 0.343 . . . . 73.43 110.984 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -115.35 133.4 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.569 -0.287 . . . . 75.04 111.182 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -132.42 136.75 46.97 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.064 0.459 . . . . 63.03 111.47 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.53 HD12 ' HB2' ' A' ' 75' ' ' ASP . 58.7 mt -106.4 110.86 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.311 -0.404 . . . . 74.13 110.797 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -117.58 164.64 14.63 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.248 0.462 . . . . 72.34 112.248 -174.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.9 t -85.12 149.73 25.34 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.189 -0.46 . . . . 74.31 112.209 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.2 p -77.69 -27.84 50.86 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.162 0.506 . . . . 74.12 110.989 174.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 . . . . . 0 CA--C 1.537 0.47 0 CA-C-N 116.171 -0.468 . . . . 75.22 110.951 177.228 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 121.038 0.447 . . . . 64.21 111.295 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 32.7 m -120.88 144.66 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.508 0.67 . . . . 21.1 112.37 -177.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 23' ' ' PRO . 34.6 m -125.39 134.2 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 115.677 -0.692 . . . . 72.42 110.815 177.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.43 114.52 25.13 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.794 0.331 . . . . 52.3 111.659 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.3 mm -97.25 137.49 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.551 -0.295 . . . . 73.32 110.474 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.9 mp -121.97 118.71 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.012 0.434 . . . . 72.34 111.055 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.6 p -112.98 153.02 28.7 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.178 0.513 . . . . 75.05 111.37 177.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -151.91 142.21 22.42 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.328 -0.396 . . . . 63.43 110.846 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 59.77 14.1 3.92 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.628 0.603 . . . . 71.11 112.628 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.68 10.69 43.0 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.032 -0.604 . . . . 71.45 114.166 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -146.13 151.06 37.06 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 117.264 0.532 . . . . 72.42 111.458 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.12 136.79 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.681 0.276 . . . . 65.05 110.899 175.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.1 pt -117.89 -22.07 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 112.14 0.422 . . . . 52.34 112.14 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -169.31 144.99 3.22 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.577 0.227 . . . . 75.02 111.315 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -137.69 128.06 26.37 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.85 0.357 . . . . 73.2 111.254 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.9 mp -123.83 119.63 26.8 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-N 116.579 -0.282 . . . . 72.14 111.704 -177.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.466 ' HA ' HG12 ' A' ' 9' ' ' VAL . 34.8 Cg_exo -61.97 132.0 37.52 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.406 2.07 . . . . 55.44 112.346 172.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' HB2' HG23 ' A' ' 8' ' ' VAL . 88.1 mt -96.3 -61.72 1.39 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.881 0.372 . . . . 74.23 111.465 -178.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.3 m -60.23 121.12 11.17 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.511 -0.313 . . . . 62.44 111.657 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.05 -8.24 80.18 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.095 -0.574 . . . . 45.14 113.126 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -78.3 86.42 4.39 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.289 0.566 . . . . 71.41 110.886 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -83.57 98.25 9.48 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.248 0.547 . . . . 72.3 111.113 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.88 -168.21 31.17 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.949 -0.568 . . . . 63.04 112.923 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -118.43 145.19 45.41 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 122.307 -0.526 . . . . 74.2 110.874 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.557 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 9.3 tp10 -144.82 117.49 8.65 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.566 -0.288 . . . . 63.13 110.574 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -127.6 129.85 47.99 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.728 0.299 . . . . 60.11 111.13 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -141.35 153.05 44.89 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.075 0.464 . . . . 73.22 111.297 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.6 m -112.49 116.7 30.68 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.948 0.404 . . . . 62.31 111.422 -175.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.2 mt -79.99 108.22 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.859 0.362 . . . . 70.42 111.022 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -99.86 111.13 23.46 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.298 -0.41 . . . . 54.23 111.146 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -110.69 -91.45 2.08 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.242 -0.504 . . . . 73.52 113.493 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.635 ' HE3' ' HA ' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -112.84 85.47 2.18 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.861 0.362 . . . . 72.51 111.494 -176.355 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.33 -97.71 0.02 OUTLIER Glycine 0 CA--C 1.529 0.93 0 CA-C-N 116.277 -0.419 . . . . 73.12 113.817 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.82 -31.53 72.54 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.929 0.395 . . . . 70.44 111.74 177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -72.82 94.17 1.77 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.129 0.418 . . . . 75.44 112.129 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -124.84 176.8 6.38 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.387 -0.369 . . . . 73.21 110.498 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -158.63 114.52 2.66 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.766 0.317 . . . . 74.14 110.92 174.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.6 tp -89.99 111.53 22.64 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.073 0.463 . . . . 45.04 111.477 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.633 ' SD ' HG12 ' A' ' 54' ' ' ILE . 94.3 mmm -97.56 138.1 35.49 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.146 -0.479 . . . . 64.0 111.384 -177.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -123.95 116.61 23.16 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.931 0.396 . . . . 72.21 111.78 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 40.2 t -107.47 112.46 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.232 -0.44 . . . . 74.33 110.652 176.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 20.5 t70 -109.04 101.95 10.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.05 0.452 . . . . 54.4 110.224 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.87 -106.02 1.17 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.846 -0.692 . . . . 72.43 112.772 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -111.51 17.41 20.07 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 120.973 0.416 . . . . 75.53 111.734 -176.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 19.9 ptt180 -130.42 141.96 50.52 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.316 -0.402 . . . . 74.42 111.049 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 tt -130.92 149.41 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 120.987 0.422 . . . . 73.02 111.717 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -157.02 168.89 26.13 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.953 0.406 . . . . 74.53 111.486 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.633 HG12 ' SD ' ' A' ' 45' ' ' MET . 60.5 mt -85.54 113.52 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 109.832 -0.433 . . . . 64.42 109.832 169.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -73.87 -49.66 23.97 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.94 0.4 . . . . 72.44 111.686 -177.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -162.69 138.61 7.24 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.181 0.437 . . . . 64.41 112.181 -175.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -165.43 -172.29 2.41 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.095 -0.502 . . . . 72.43 110.34 173.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -121.72 24.07 9.89 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.77 0.656 . . . . 72.22 112.77 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.3 t -77.18 125.93 85.91 Favored Pre-proline 0 N--CA 1.474 0.761 0 O-C-N 121.869 -0.519 . . . . 74.34 110.968 175.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -59.39 -13.58 21.2 Favored 'Trans proline' 0 N--CA 1.48 0.725 0 C-N-CA 122.998 2.465 . . . . 65.21 113.092 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.524 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.7 m-20 -83.77 -41.07 18.0 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.036 0.384 . . . . 72.2 112.036 175.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 53.75 32.56 15.05 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.147 0.425 . . . . 71.41 112.147 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.524 HG23 ' HB3' ' A' ' 61' ' ' ASP . 97.5 t -52.52 -51.74 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 112.55 0.574 . . . . 52.35 112.55 -173.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.579 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -62.73 -34.82 90.78 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.743 -0.742 . . . . 70.24 113.446 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.48 -44.67 98.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 120.945 0.402 . . . . 64.0 110.897 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -69.49 -37.7 77.33 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.427 -0.351 . . . . 71.35 111.112 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 21.3 mmt -61.63 -33.57 74.17 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.353 0.501 . . . . 64.25 112.353 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.39 -143.18 29.11 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.021 -0.609 . . . . 74.04 113.426 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -86.99 122.39 30.77 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.058 0.456 . . . . 75.14 112.066 -176.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HD2' ' CG ' ' A' ' 75' ' ' ASP . 74.1 mmtt -108.63 154.33 22.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.177 -0.465 . . . . 73.11 110.668 176.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 82.6 p -165.89 12.68 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.987 1.106 . . . . 72.2 113.987 -173.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -131.49 158.9 39.67 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.553 0.692 . . . . 63.15 112.457 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.527 ' HB2' ' HB2' ' A' ' 90' ' ' SER . . . -68.13 108.01 2.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.67 -0.695 . . . . 44.0 111.422 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.28 -16.61 4.89 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.35 -0.452 . . . . 65.53 112.398 -176.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.506 ' HB2' HD12 ' A' ' 88' ' ' ILE . 77.5 m-20 -72.21 106.15 4.29 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.029 0.442 . . . . 74.23 111.242 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.7 p -116.24 142.46 46.8 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.784 0.325 . . . . 74.43 111.779 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.9 mm -117.06 134.03 61.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 122.673 0.389 . . . . 72.21 110.828 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -112.19 117.34 54.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 111.895 0.332 . . . . 64.25 111.895 -177.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 86.7 m -122.0 68.37 0.93 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.856 0.36 . . . . 62.14 111.126 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.527 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 92.0 mt -53.07 -50.11 83.84 Favored Pre-proline 0 N--CA 1.476 0.847 0 N-CA-C 113.246 0.832 . . . . 62.53 113.246 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.527 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 50.7 Cg_exo -54.54 -24.65 37.17 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.021 1.814 . . . . 64.22 113.374 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -106.58 -1.88 22.45 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 111.869 0.322 . . . . 63.03 111.869 -179.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 59.69 30.93 20.54 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.989 0.423 . . . . 64.43 111.662 -176.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.2 t -112.12 137.17 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 116.079 -0.51 . . . . 43.55 111.178 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -135.81 143.04 44.95 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.528 -0.306 . . . . 63.5 110.291 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.1 t -129.36 120.1 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 122.288 -0.257 . . . . 44.32 111.067 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.22 116.94 25.86 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.456 0.646 . . . . 74.33 111.912 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.506 HD12 ' HB2' ' A' ' 75' ' ' ASP . 57.4 mt -88.78 114.53 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 122.009 -0.432 . . . . 63.12 110.894 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.415 ' NZ ' ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -109.85 172.46 6.84 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.942 0.401 . . . . 63.24 111.095 179.552 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 40.5 t -111.21 150.27 29.8 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.782 0.325 . . . . 62.12 110.891 175.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.1 p -77.01 -9.65 58.84 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.566 -0.288 . . . . 71.51 111.453 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 121.598 0.713 . . . . 74.43 112.402 -178.651 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ttt . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 111.689 0.255 . . . . 70.14 111.689 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.7 15.86 2.9 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.514 0.931 . . . . 73.0 113.514 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -86.52 89.34 7.87 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.809 -0.557 . . . . 73.54 111.448 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.0 p -124.73 113.1 17.51 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.049 0.452 . . . . 74.23 111.334 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.7 -15.61 52.0 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.182 -0.533 . . . . 43.11 113.583 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -75.77 66.22 2.02 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.5 0.667 . . . . 73.33 111.718 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.529 ' HA ' ' HB ' ' A' ' 25' ' ' THR . 42.9 mt-10 -64.03 99.35 0.26 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.153 -0.476 . . . . 73.05 112.083 -175.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 25.7 m -110.8 151.91 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 121.361 0.6 . . . . 60.42 112.184 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 23' ' ' PRO . 34.4 m -128.1 143.04 42.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 115.794 -0.639 . . . . 70.41 111.256 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.49 117.97 30.17 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.43 -0.35 . . . . 63.15 111.216 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.51 HD11 ' HE3' ' A' ' 89' ' ' LYS . 20.0 mm -92.45 112.92 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.464 -0.334 . . . . 70.23 111.21 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.466 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.4 mp -98.31 119.13 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.091 0.472 . . . . 72.22 111.647 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.2 p -123.22 145.18 48.86 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.298 -0.41 . . . . 50.13 110.604 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.47 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 60.6 tt0 -140.28 141.85 35.77 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.128 -0.358 . . . . 72.42 111.329 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.47 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 51.7 m-80 66.28 -12.76 0.18 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.784 0.661 . . . . 65.53 112.784 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 14' ' ' GLN . . . 119.25 26.07 2.55 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.525 -0.369 . . . . 74.52 112.731 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -147.96 146.55 29.01 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.479 -0.424 . . . . 75.14 111.156 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.6 t -74.29 121.41 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.904 0.383 . . . . 62.32 110.769 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 34.9 pt -109.97 -20.95 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 112.721 0.638 . . . . 74.31 112.721 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -170.66 153.04 3.96 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.485 0.183 . . . . 65.24 111.48 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -147.15 122.4 10.23 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.266 0.555 . . . . 73.51 111.546 175.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.521 HG21 HG21 ' A' ' 47' ' ' VAL . 2.5 mp -106.65 129.67 24.07 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-N 116.092 -0.504 . . . . 71.44 111.614 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.461 ' HA ' HG12 ' A' ' 9' ' ' VAL . 56.9 Cg_endo -70.76 126.9 13.13 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.366 2.044 . . . . 62.52 112.109 174.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.91 -62.43 1.32 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 111.901 0.334 . . . . 65.4 111.901 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.529 ' HB ' ' HA ' ' A' ' 7' ' ' GLU . 19.6 m -54.28 127.47 27.27 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.653 0.263 . . . . 64.41 111.567 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.01 -24.38 9.17 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.211 -0.518 . . . . 54.42 113.218 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -75.94 83.0 2.84 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.383 0.611 . . . . 64.55 110.93 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -83.77 164.08 19.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.708 -0.678 . . . . 70.23 111.416 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.19 -163.25 37.5 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 120.827 -0.701 . . . . 43.44 112.631 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -118.53 146.79 44.28 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.001 0.429 . . . . 64.32 111.775 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -150.13 142.24 24.03 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.163 -0.472 . . . . 74.5 110.857 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -132.05 147.82 52.46 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.043 0.386 . . . . 62.05 112.043 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -153.39 139.5 18.33 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.962 0.41 . . . . 74.14 111.439 174.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.6 m -102.45 114.51 28.77 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.127 0.418 . . . . 63.32 112.127 -175.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.1 mt -86.25 104.4 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 116.271 -0.422 . . . . 72.32 111.425 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -101.27 125.21 47.87 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.673 0.273 . . . . 63.33 111.106 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -121.29 -78.27 0.49 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.982 -0.628 . . . . 22.55 114.197 -176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -114.25 -169.86 1.61 Allowed 'General case' 0 CA--C 1.546 0.811 0 O-C-N 122.46 -0.435 . . . . 73.42 111.304 -173.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -44.67 100.04 0.02 OUTLIER Glycine 0 CA--C 1.528 0.879 0 N-CA-C 114.502 0.561 . . . . 74.5 114.502 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 67.0 -2.82 1.06 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.177 0.806 . . . . 54.02 113.177 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -86.56 112.58 21.7 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.871 0.367 . . . . 72.03 111.915 -175.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -139.99 163.51 32.48 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.284 -0.416 . . . . 61.21 111.649 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -135.4 113.52 11.28 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.479 -0.328 . . . . 75.54 111.291 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.4 tp -84.57 103.82 14.03 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.922 0.392 . . . . 72.0 110.169 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.646 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.7 mmm -95.91 146.37 24.64 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.265 -0.425 . . . . 71.44 111.322 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -132.92 122.94 25.07 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.102 0.477 . . . . 72.4 111.952 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.521 HG21 HG21 ' A' ' 22' ' ' ILE . 58.2 t -103.32 107.57 22.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.941 -0.572 . . . . 72.55 110.207 173.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.463 ' HB3' ' CH2' ' A' ' 69' ' ' TRP . 30.3 t70 -129.84 105.69 8.18 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.859 0.361 . . . . 63.54 111.543 -175.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . 74.66 55.1 5.61 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.302 -0.475 . . . . 74.4 114.013 178.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 63.62 23.53 13.59 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.775 0.657 . . . . 73.43 112.775 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 49' ' ' GLY . 7.9 ptt85 -148.5 149.18 31.19 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.806 0.336 . . . . 73.02 110.985 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.0 tt -123.29 148.69 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.148 0.499 . . . . 51.23 112.068 -174.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -152.94 168.88 24.33 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.851 -0.613 . . . . 71.32 110.821 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.646 HG12 ' SD ' ' A' ' 45' ' ' MET . 40.4 mt -84.91 110.67 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 120.977 0.418 . . . . 55.11 110.155 169.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -75.29 -29.94 60.23 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.31 -0.405 . . . . 71.1 111.096 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -175.47 138.65 0.41 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.243 -0.435 . . . . 73.55 111.431 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -161.68 156.42 23.01 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.175 0.512 . . . . 65.41 111.034 172.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -93.39 69.14 4.23 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.2 0.524 . . . . 63.42 111.867 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.3 p -127.33 140.61 38.42 Favored Pre-proline 0 N--CA 1.473 0.7 0 CA-C-N 116.46 -0.336 . . . . 41.03 110.692 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.67 -17.79 29.34 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.981 1.788 . . . . 74.11 111.987 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.536 ' HB3' HG23 ' A' ' 63' ' ' VAL . 2.2 m-20 -80.35 -52.9 7.14 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.607 -0.724 . . . . 65.23 111.755 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 57.45 29.31 16.8 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 120.649 0.261 . . . . 75.11 111.6 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 61' ' ' ASP . 65.5 t -53.82 -48.33 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 112.223 0.453 . . . . 53.21 112.223 -176.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.557 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -59.89 -29.67 68.17 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 120.892 -0.67 . . . . 74.44 113.067 177.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 67.5 t -66.94 -40.24 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.752 0.31 . . . . 61.42 110.713 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -65.62 -37.17 85.83 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.032 0.444 . . . . 74.15 110.832 172.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.58 ' SD ' ' NZ ' ' A' ' 70' ' ' LYS . 23.2 mmt -58.35 -46.41 86.33 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.236 -0.438 . . . . 54.21 111.588 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.58 -143.49 38.77 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.322 -0.466 . . . . 54.03 113.74 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.463 ' CH2' ' HB3' ' A' ' 48' ' ' ASP . 82.4 m95 -69.6 105.22 2.6 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.365 0.506 . . . . 72.22 112.365 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.58 ' NZ ' ' SD ' ' A' ' 67' ' ' MET . 34.4 mmtp -111.85 138.96 47.75 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 116.297 -0.41 . . . . 71.15 110.429 174.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' A' ' 51' ' ' ARG . 98.8 p -157.49 9.83 0.19 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.339 1.237 . . . . 74.44 114.339 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -118.41 149.67 40.85 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.725 -0.609 . . . . 72.54 112.075 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.31 107.54 0.5 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.021 -0.536 . . . . 74.55 111.041 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 129.07 -20.91 5.3 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 116.125 -0.489 . . . . 72.05 112.52 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.556 ' HB2' HD12 ' A' ' 88' ' ' ILE . 55.7 m-20 -74.48 151.3 39.58 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.009 0.433 . . . . 73.43 111.297 175.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 65.8 p -141.43 158.14 44.25 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.327 0.584 . . . . 74.21 112.372 -176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 40.0 mm -132.1 116.12 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.493 -0.776 . . . . 62.44 109.434 173.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.1 t -124.83 117.18 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 113.003 0.742 . . . . 65.43 113.003 -173.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 68.8 m -122.97 89.13 3.05 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.34 -0.391 . . . . 64.24 110.947 170.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.0 mt -63.78 -38.92 41.7 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 113.575 0.954 . . . . 63.42 113.575 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.04 -21.14 25.96 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.878 1.719 . . . . 72.1 112.931 174.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -112.49 0.61 15.59 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.899 0.38 . . . . 74.14 110.776 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 14' ' ' GLN . 92.6 mttt 55.09 34.56 22.83 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.609 0.764 . . . . 72.21 112.434 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -102.62 117.51 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.919 0.39 . . . . 71.34 111.305 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -119.92 123.15 42.86 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.426 -0.352 . . . . 73.31 110.545 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.565 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 48.1 t -123.24 132.63 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 120.57 0.224 . . . . 62.53 111.397 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -132.21 143.64 50.09 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.818 0.342 . . . . 73.45 110.938 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.556 HD12 ' HB2' ' A' ' 75' ' ' ASP . 57.2 mt -100.95 121.35 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.612 0.244 . . . . 62.44 111.505 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.51 ' HE3' HD11 ' A' ' 11' ' ' ILE . 22.9 pttp -124.25 152.04 43.46 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.829 0.347 . . . . 71.14 111.212 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 43.9 t -89.82 151.06 21.97 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.375 0.607 . . . . 71.51 112.15 -177.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.8 p -73.08 -32.48 65.03 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.994 -0.548 . . . . 73.22 111.552 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HG2' ' OG ' ' A' ' 90' ' ' SER . 16.2 pt20 -78.27 83.7 4.5 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.669 0.747 . . . . 54.12 112.459 -177.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 53.33 24.5 3.87 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.932 -1.031 . . . . 60.23 113.777 173.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.542 ' HB2' ' HB3' ' A' ' 90' ' ' SER . 1.1 t70 -69.98 83.71 0.5 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.642 0.734 . . . . 75.14 110.363 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.3 m -78.95 93.07 5.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.659 -0.7 . . . . 65.04 112.101 -173.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -95.3 161.12 14.22 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.359 -0.382 . . . . 71.45 110.102 172.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.59 111.1 8.43 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 120.917 0.389 . . . . 73.24 111.507 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -83.84 83.52 1.76 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.638 2.225 . . . . 75.54 113.028 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -74.78 105.22 5.74 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.998 0.428 . . . . 72.42 110.134 174.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 100' ' ' THR . 6.8 m -94.85 7.28 46.47 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.302 0.482 . . . . 73.25 112.302 -173.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -73.04 81.01 1.22 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.543 0.687 . . . . 74.44 110.615 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.1 pp -103.01 -177.2 3.3 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.506 -0.77 . . . . 73.41 112.488 -175.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.8 mm -92.23 137.19 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.084 -0.507 . . . . 73.04 111.477 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.9 m -56.25 159.55 6.0 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 113.014 0.746 . . . . 75.21 113.014 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -53.6 117.34 3.72 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.956 2.438 . . . . 64.55 112.564 174.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -81.12 129.14 34.43 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.065 0.459 . . . . 75.53 110.995 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 107' ' ' LEU . 5.9 mp -79.67 140.11 37.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.143 0.497 . . . . 72.3 111.348 -176.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.519 ' CD ' ' H ' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -80.4 94.28 6.14 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.663 0.744 . . . . 75.43 110.222 175.031 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 110' ' ' HIS . 14.1 p-80 -72.41 71.49 0.92 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.335 0.588 . . . . 55.0 112.177 -177.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 109' ' ' HIS . 7.1 t-80 174.21 18.12 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.1 -0.954 . . . . 42.4 110.108 175.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -65.26 100.2 0.45 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.413 0.625 . . . . 71.13 112.123 -174.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 176.16 -33.06 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.842 -1.072 . . . . 75.53 108.419 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -172.11 165.92 6.13 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 114.943 -1.026 . . . . 71.35 109.77 172.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 83.7 t60 . . . . . 0 C--O 1.252 1.211 0 CA-C-O 118.781 -0.628 . . . . 70.31 111.52 176.791 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.2 ttp . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 120.473 0.178 . . . . 54.33 111.155 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt 64.34 71.02 0.48 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.307 0.575 . . . . 54.13 111.019 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -158.81 117.45 2.97 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.993 -0.549 . . . . 72.43 111.47 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.1 t -109.42 138.5 45.69 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.4 -0.364 . . . . 60.31 110.908 174.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.98 -27.77 71.64 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.126 -0.559 . . . . 63.35 113.523 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -84.52 135.49 34.2 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.324 0.583 . . . . 60.42 111.714 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -111.16 112.9 25.02 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.089 -0.505 . . . . 74.03 110.714 175.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 26.8 m -123.28 145.01 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 112.592 0.59 . . . . 64.41 112.592 -176.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 23' ' ' PRO . 26.7 m -122.91 141.96 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 115.802 -0.635 . . . . 63.15 111.318 178.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.5 112.7 24.65 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.367 -0.379 . . . . 41.23 110.95 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.578 HG13 ' HD3' ' A' ' 89' ' ' LYS . 45.6 mm -95.43 115.99 35.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.727 0.298 . . . . 73.3 111.415 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.491 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.3 mp -101.62 118.36 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.766 0.317 . . . . 73.4 111.043 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.9 m -117.2 138.11 51.91 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.885 0.374 . . . . 51.44 111.597 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.524 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 34.2 tt0 -134.8 142.55 46.72 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 122.587 0.355 . . . . 65.45 110.183 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.524 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 58.3 m-80 56.29 34.94 24.97 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.049 0.452 . . . . 74.33 111.793 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.85 21.19 79.03 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.372 -0.442 . . . . 63.32 114.094 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -144.5 143.82 31.05 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 122.479 -0.424 . . . . 72.21 111.518 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.75 124.24 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.843 0.354 . . . . 62.13 111.285 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 44.9 pt -111.43 -20.09 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 112.474 0.546 . . . . 42.21 112.474 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -157.81 145.47 18.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.909 0.385 . . . . 73.53 111.977 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.44 125.21 20.98 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.3 -0.409 . . . . 74.43 110.945 172.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.459 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 73.7 mt -126.99 124.78 24.05 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 112.253 0.464 . . . . 60.13 112.253 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 22' ' ' ILE . 6.7 Cg_exo -73.82 117.2 4.94 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.826 2.351 . . . . 74.24 112.293 175.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.57 -47.23 15.86 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.088 0.471 . . . . 73.53 111.149 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 84.8 m -58.9 117.03 4.18 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.929 -0.578 . . . . 73.04 112.024 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.34 3.05 88.93 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.242 -0.504 . . . . 72.44 113.713 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -71.15 129.48 39.05 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.286 0.565 . . . . 65.21 111.43 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.42 ' NZ ' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -97.33 148.08 23.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.14 -0.482 . . . . 64.24 111.601 178.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.32 -164.8 54.46 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 114.814 0.686 . . . . 60.0 114.814 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 25.7 t-20 -118.6 125.83 50.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.945 0.498 . . . . 54.02 110.397 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -118.19 122.51 43.2 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.733 0.301 . . . . 51.32 111.512 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -120.11 139.27 52.83 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.937 0.398 . . . . 75.23 111.566 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -149.91 143.12 25.06 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.027 0.442 . . . . 71.11 111.209 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.0 m -101.59 110.06 21.98 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.174 0.511 . . . . 74.35 112.238 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 39.7 mt -80.1 90.76 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.917 0.389 . . . . 74.1 110.077 175.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -73.54 128.47 35.59 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.883 0.373 . . . . 74.15 111.674 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.48 -143.72 12.01 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 116.296 -0.411 . . . . 71.44 112.209 175.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -86.49 123.53 31.8 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 122.413 -0.463 . . . . 72.15 111.115 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.14 -137.02 19.92 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.372 -0.442 . . . . 60.02 113.548 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.67 4.85 30.57 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.092 0.473 . . . . 71.44 111.874 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.449 ' HB3' ' CD2' ' A' ' 82' ' ' HIS . 23.9 mt-30 -83.28 119.14 24.21 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.254 -0.43 . . . . 73.31 111.637 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -145.86 155.08 42.66 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.584 -0.28 . . . . 72.52 111.556 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.572 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 18.6 m120 -114.75 110.04 19.12 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.374 -0.376 . . . . 64.33 111.017 173.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.1 tp -89.51 107.04 18.85 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.869 0.366 . . . . 71.54 110.489 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.694 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.1 mmm -95.12 146.93 23.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.87 0.367 . . . . 75.14 111.824 -175.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 42.6 tt0 -133.44 121.45 22.26 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.139 0.495 . . . . 74.31 111.341 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 30' ' ' ASN . 43.9 t -109.34 114.38 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.151 -0.477 . . . . 71.45 110.587 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.474 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 35.9 t70 -108.76 103.88 13.04 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.071 0.463 . . . . 54.22 110.704 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 63.14 -104.26 0.78 Allowed Glycine 0 CA--C 1.53 0.976 0 C-N-CA 120.742 -0.742 . . . . 70.41 112.674 -175.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -113.75 18.59 17.34 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.018 0.377 . . . . 75.24 112.018 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 35.5 ptt180 -132.75 149.36 52.29 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.668 0.271 . . . . 75.15 111.242 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.1 tt -133.38 146.04 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 112.319 0.489 . . . . 75.34 112.319 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -148.03 169.28 20.27 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.147 -0.479 . . . . 74.41 110.86 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.694 HG12 ' SD ' ' A' ' 45' ' ' MET . 31.2 mt -85.88 108.89 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.05 0.452 . . . . 71.13 110.232 169.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 56.4 tttp -67.75 -45.66 74.31 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.285 0.564 . . . . 64.03 111.325 -178.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -152.49 157.89 41.79 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.029 -0.532 . . . . 75.21 110.168 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -160.62 167.69 26.5 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.038 0.446 . . . . 74.33 111.947 -175.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . 51.3 t-20 -130.7 70.81 1.45 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.1 0.476 . . . . 70.44 110.942 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.7 p -129.06 155.87 79.08 Favored Pre-proline 0 N--CA 1.477 0.905 0 O-C-N 122.117 -0.364 . . . . 70.35 111.766 175.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -78.26 -17.03 13.47 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.486 2.124 . . . . 63.35 112.888 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.542 ' HB2' HG23 ' A' ' 63' ' ' VAL . 5.9 p-10 -92.15 -47.19 7.37 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 111.917 0.34 . . . . 55.32 111.917 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.425 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 28.2 mm-40 65.94 19.73 11.27 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.791 0.436 . . . . 71.01 111.912 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.542 HG23 ' HB2' ' A' ' 61' ' ' ASP . 97.1 t -55.14 -46.96 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.156 0.503 . . . . 64.1 111.11 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.498 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -57.74 -38.32 87.68 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.037 -0.602 . . . . 51.34 112.746 176.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.15 -30.25 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.106 0.479 . . . . 62.11 111.267 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.425 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 5.4 mptp? -73.9 -31.04 62.93 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.387 0.514 . . . . 73.42 112.387 177.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.1 mmt -54.38 -50.71 66.89 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.529 0.566 . . . . 75.12 112.529 -177.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.9 -149.62 21.01 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.913 -0.66 . . . . 44.42 113.58 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -80.95 120.3 24.58 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.279 0.561 . . . . 65.32 112.099 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 75.0 mmtt -116.66 150.53 37.98 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.568 -0.742 . . . . 71.43 110.21 175.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 93.1 p -164.15 9.64 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.306 1.225 . . . . 72.44 114.306 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -132.76 157.14 45.69 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.61 0.641 . . . . 72.01 112.422 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.68 112.71 1.91 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.801 -0.636 . . . . 74.03 111.616 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 130.24 -26.45 4.17 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 116.219 -0.446 . . . . 52.3 112.366 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.538 ' HB2' HD12 ' A' ' 88' ' ' ILE . 76.7 m-20 -69.38 126.2 29.02 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.835 0.35 . . . . 71.31 111.082 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 87' ' ' GLU . 47.0 p -132.02 145.37 51.4 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.947 0.403 . . . . 72.41 111.901 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.524 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 37.8 mm -114.65 130.05 69.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.377 -0.374 . . . . 64.24 110.606 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.7 t -112.96 118.65 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 112.047 0.388 . . . . 73.4 112.047 -177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.494 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 74.9 m -122.61 82.38 1.97 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.158 0.504 . . . . 74.12 110.92 173.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.468 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 84.1 mt -57.22 -58.67 16.37 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 113.565 0.95 . . . . 60.14 113.565 -173.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 59.8 Cg_endo -70.9 -2.14 10.53 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.88 1.72 . . . . 61.41 113.033 -175.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.449 ' CD2' ' HB3' ' A' ' 41' ' ' GLN . 37.9 m170 -109.97 -2.45 17.11 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.497 -0.319 . . . . 73.25 111.297 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 59.78 29.62 19.19 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.916 0.389 . . . . 72.35 111.744 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 57.5 t -115.37 134.05 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.104 0.478 . . . . 73.22 111.811 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -136.56 131.68 34.15 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.011 -0.541 . . . . 72.21 110.229 175.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.524 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 46.7 t -118.38 136.38 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.528 -0.305 . . . . 71.04 111.097 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.436 ' HA ' HG22 ' A' ' 76' ' ' THR . 11.9 pt-20 -133.09 125.2 29.06 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.201 0.524 . . . . 53.51 111.402 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.538 HD12 ' HB2' ' A' ' 75' ' ' ASP . 59.2 mt -89.73 116.96 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.863 0.363 . . . . 74.31 110.331 175.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.578 ' HD3' HG13 ' A' ' 11' ' ' ILE . 13.2 ptmt -131.66 147.5 52.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.363 -0.38 . . . . 64.12 111.238 -174.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 48.4 t -78.5 145.59 34.86 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.14 0.422 . . . . 60.44 112.14 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.5 p -86.21 -7.27 58.67 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.151 0.501 . . . . 71.54 110.825 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -96.52 -177.69 4.02 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.881 -0.6 . . . . 72.44 111.051 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.441 ' O ' ' HD2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -76.85 157.4 31.49 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.528 0.566 . . . . 75.41 112.528 -177.432 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.588 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 27.4 t0 -174.21 153.46 2.01 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.698 -0.683 . . . . 75.14 110.437 175.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.2 t -77.15 69.98 3.49 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.206 0.527 . . . . 61.35 111.714 -175.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.588 ' HE2' ' HB3' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -173.95 -179.97 1.83 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.999 -0.546 . . . . 73.03 111.118 -179.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 17.5 m-20 -106.19 130.2 23.35 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 120.45 0.167 . . . . 72.01 111.055 175.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 97' ' ' ASP . 32.7 Cg_exo -60.37 -34.76 93.07 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.757 2.305 . . . . 61.34 113.403 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -130.15 143.16 50.63 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.362 -0.381 . . . . 74.33 110.435 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 t -108.93 -4.43 16.76 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.255 0.835 . . . . 63.04 113.255 -172.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -78.64 142.44 37.2 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.13 0.49 . . . . 74.44 111.268 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.5 tp -106.49 104.18 13.81 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.196 0.522 . . . . 73.15 111.743 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 60.1 mt -86.22 99.42 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.233 0.539 . . . . 72.34 110.371 175.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.2 t -62.07 130.27 92.65 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 115.86 -0.609 . . . . 61.32 111.75 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -51.28 138.07 46.24 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.831 2.354 . . . . 73.22 113.251 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 63.63 64.19 0.81 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.705 0.764 . . . . 72.32 111.525 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.7 tt -123.41 91.4 3.47 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.194 -0.912 . . . . 72.14 108.823 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.87 82.71 5.05 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.259 0.552 . . . . 73.02 112.135 -173.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -90.31 93.63 9.41 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.13 -0.486 . . . . 74.32 110.187 174.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -130.2 -85.52 0.53 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.157 0.428 . . . . 72.04 112.157 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 27.1 m80 59.54 80.96 0.18 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.439 0.637 . . . . 62.44 112.109 -173.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -124.0 114.97 20.47 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.796 -0.638 . . . . 72.2 110.118 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -72.17 83.43 1.01 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.279 0.561 . . . . 73.02 112.353 -175.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 81.5 t60 . . . . . 0 C--O 1.251 1.14 0 CA-C-N 115.701 -0.681 . . . . 75.03 110.993 174.309 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtm . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.648 0.261 . . . . 71.22 111.566 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -175.36 161.55 2.77 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.279 -0.419 . . . . 75.33 110.658 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -89.77 100.8 13.53 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.93 0.395 . . . . 60.42 110.212 174.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.5 m -85.96 100.02 11.83 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.445 0.535 . . . . 74.33 112.445 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -131.49 9.45 5.57 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 116.15 -0.477 . . . . 51.33 112.007 173.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -106.43 44.05 1.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.927 0.491 . . . . 64.31 111.147 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.458 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 46.2 mt-10 -73.72 107.05 5.74 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.348 0.594 . . . . 72.33 112.448 -176.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 33.0 m -126.15 152.85 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.694 -0.684 . . . . 71.11 111.716 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 23' ' ' PRO . 34.1 m -126.63 144.65 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 116.095 -0.502 . . . . 74.2 111.3 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -102.83 109.81 21.52 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.86 0.362 . . . . 41.22 111.099 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.1 mm -95.19 104.23 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 120.702 0.287 . . . . 70.55 111.37 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.7 mp -89.11 109.9 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.367 0.603 . . . . 74.45 110.916 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.2 p -116.95 127.43 54.2 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.929 -0.578 . . . . 61.34 111.043 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -119.1 146.53 45.03 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.673 0.273 . . . . 64.43 110.625 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.475 ' OD1' ' HD3' ' A' ' 83' ' ' LYS . 46.9 m-80 64.95 6.83 3.61 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.766 0.426 . . . . 74.03 111.796 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.79 -3.52 52.82 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.225 -0.512 . . . . 64.43 113.213 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -124.98 151.8 45.03 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.951 0.405 . . . . 73.02 111.583 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.3 126.15 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 120.905 0.383 . . . . 73.02 111.883 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 41.0 pt -111.86 -25.77 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 116.5 -0.318 . . . . 71.33 111.845 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.604 ' HA ' ' HE ' ' A' ' 20' ' ' ARG . 1.3 tpm_? -164.74 125.22 2.01 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.467 -0.333 . . . . 54.21 110.708 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -123.21 120.51 33.36 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.161 0.505 . . . . 70.22 110.965 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.41 HD12 ' CE1' ' A' ' 33' ' ' PHE . 73.6 mt -117.72 110.7 40.08 Favored Pre-proline 0 N--CA 1.47 0.525 0 N-CA-C 112.062 0.393 . . . . 73.31 112.062 -175.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.44 ' HA ' HG12 ' A' ' 9' ' ' VAL . 37.1 Cg_exo -59.46 117.69 4.46 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.533 2.155 . . . . 63.41 111.903 171.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.2 mt -74.53 -56.07 5.24 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.974 0.416 . . . . 73.3 111.524 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.458 ' OG1' ' HA ' ' A' ' 7' ' ' GLU . 11.3 m -56.61 133.57 53.77 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.16 -0.473 . . . . 71.51 111.736 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.32 -24.7 31.08 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 116.285 -0.416 . . . . 65.43 112.864 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -74.82 136.16 41.62 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.244 0.545 . . . . 64.54 111.627 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -124.11 145.98 48.92 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.109 -0.496 . . . . 73.13 110.859 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.66 -159.2 31.62 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.18 -0.533 . . . . 22.0 112.793 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -118.84 129.02 54.99 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 122.387 -0.478 . . . . 52.23 111.066 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.432 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 6.3 tp10 -123.5 135.08 53.86 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.328 -0.396 . . . . 62.22 110.302 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.402 ' HG2' ' HG3' ' A' ' 46' ' ' GLU . 35.7 mt-30 -134.55 129.69 35.43 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 122.089 -0.382 . . . . 60.14 111.526 -176.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.41 ' CE1' HD12 ' A' ' 22' ' ' ILE . 48.0 p90 -138.3 136.27 36.28 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.25 0.548 . . . . 73.42 111.72 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 30.9 m -104.12 114.2 28.27 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.074 -0.512 . . . . 72.05 112.165 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 54.8 mt -81.11 139.48 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 116.273 -0.421 . . . . 74.33 110.654 175.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -115.76 112.19 21.65 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.929 0.395 . . . . 74.11 112.042 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.15 -141.16 11.66 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 121.407 -0.425 . . . . 42.44 113.064 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -77.83 86.02 4.09 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.663 0.744 . . . . 64.33 111.856 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.17 -119.87 5.16 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 115.961 -0.563 . . . . 75.22 113.072 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.17 -0.93 23.89 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.073 0.397 . . . . 55.34 112.073 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -77.59 66.14 3.25 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.947 0.404 . . . . 71.43 111.728 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.49 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 17.1 p90 -95.32 167.05 11.58 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.535 -0.302 . . . . 73.04 111.106 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -140.47 110.67 6.61 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.659 -0.246 . . . . 73.43 111.164 174.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.6 tp -85.62 102.79 13.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.212 0.529 . . . . 61.33 110.542 177.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.701 ' SD ' HG12 ' A' ' 54' ' ' ILE . 94.5 mmm -97.03 141.49 30.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.004 -0.544 . . . . 71.4 110.751 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.846 ' HB3' HH21 ' A' ' 53' ' ' ARG . 35.4 tt0 -134.12 125.12 27.29 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.377 0.51 . . . . 63.12 112.377 -176.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 44.6 t -100.34 111.79 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.795 -0.639 . . . . 44.5 110.641 175.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.609 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 30.3 t70 -108.04 105.76 15.68 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.11 0.481 . . . . 64.22 110.035 -178.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.51 -104.49 1.07 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.658 -0.782 . . . . 73.04 111.898 -171.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -123.97 27.71 7.1 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.135 0.493 . . . . 73.22 111.448 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 34.1 ptt180 -134.6 154.45 51.49 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.039 0.535 . . . . 72.21 110.807 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.3 tt -142.37 143.33 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 112.91 0.707 . . . . 71.11 112.91 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.846 HH21 ' HB3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -161.03 168.55 24.25 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.162 -0.472 . . . . 70.11 111.875 169.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.701 HG12 ' SD ' ' A' ' 45' ' ' MET . 63.8 mt -69.04 121.27 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.387 -0.37 . . . . 62.2 111.173 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -82.19 -42.38 19.07 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.132 0.491 . . . . 45.33 111.016 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -166.21 138.76 3.92 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.651 -0.704 . . . . 62.23 110.689 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 1.7 p-10 -169.5 168.76 9.21 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.245 0.545 . . . . 75.51 111.472 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -97.19 45.16 1.04 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.214 -0.448 . . . . 63.12 111.994 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.1 t -97.72 122.92 53.65 Favored Pre-proline 0 N--CA 1.474 0.731 0 O-C-N 121.998 -0.439 . . . . 63.54 110.712 173.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -60.46 -27.35 84.69 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.506 2.137 . . . . 75.22 112.264 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -78.13 -34.26 50.02 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 116.005 -0.543 . . . . 64.41 111.609 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 54.66 36.18 25.49 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 111.963 0.357 . . . . 52.14 111.963 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.426 ' O ' ' HG2' ' A' ' 67' ' ' MET . 64.9 t -53.52 -52.5 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 112.733 0.642 . . . . 71.42 112.733 -174.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.594 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -64.19 -40.86 98.39 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.684 -0.77 . . . . 52.33 113.554 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 51.9 t -60.69 -39.6 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.27 0.557 . . . . 53.34 110.607 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -75.48 -28.27 59.15 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.95 -0.568 . . . . 74.23 111.928 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 18.1 mmt -67.16 -37.46 83.81 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 111.977 0.362 . . . . 75.42 111.977 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.94 -174.38 54.8 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 120.988 -0.625 . . . . 23.4 113.222 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.472 ' CE3' ' HG3' ' A' ' 53' ' ' ARG . 94.4 m95 -59.69 120.01 8.7 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.943 0.402 . . . . 73.44 112.016 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -115.82 127.21 54.89 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.239 0.542 . . . . 73.41 111.86 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.8 p -141.81 17.64 2.15 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.817 -0.629 . . . . 65.45 110.858 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -110.22 130.48 55.54 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.382 -0.372 . . . . 62.44 111.428 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.59 106.74 1.22 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.427 -0.351 . . . . 72.25 111.577 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.84 -36.65 1.74 Allowed Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.061 -0.59 . . . . 73.22 112.34 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -73.51 131.26 41.57 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.09 0.471 . . . . 71.12 111.179 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 69.3 p -120.87 152.17 38.75 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.963 0.411 . . . . 72.11 111.633 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.556 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 43.7 mm -114.25 110.45 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.309 -0.405 . . . . 71.04 110.204 177.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -107.27 116.66 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 112.35 0.5 . . . . 73.44 112.35 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 72.3 m -122.22 76.42 1.31 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.371 -0.377 . . . . 60.4 111.067 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.455 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 86.7 mt -57.21 -46.62 99.82 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 113.061 0.763 . . . . 74.22 113.061 -177.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.455 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 51.8 Cg_exo -55.64 -18.96 22.13 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.945 1.764 . . . . 61.32 113.364 177.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -112.65 -0.15 15.19 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.613 -0.267 . . . . 60.31 111.458 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.475 ' HD3' ' OD1' ' A' ' 15' ' ' ASN . 57.8 mttm 63.67 15.61 9.08 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.091 0.556 . . . . 71.22 112.433 -178.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.9 t -97.03 127.09 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.0 0.429 . . . . 75.42 111.832 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -130.62 113.22 13.92 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.222 -0.445 . . . . 73.34 110.633 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 46.2 t -100.79 117.02 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.042 0.449 . . . . 65.32 111.292 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -106.79 108.64 20.25 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.175 -0.466 . . . . 65.41 110.938 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 60.0 mt -91.91 121.06 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.149 0.5 . . . . 42.24 111.349 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -139.06 155.5 47.89 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.256 -0.429 . . . . 60.22 111.18 -174.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 41.2 t -95.95 150.14 20.79 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.022 0.439 . . . . 74.3 112.042 -177.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.2 p -87.64 2.61 50.5 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.116 -0.493 . . . . 65.4 111.433 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -89.31 -167.37 1.85 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.084 0.469 . . . . 74.35 111.663 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.421 ' NZ ' ' HB3' ' A' ' 93' ' ' LYS . 2.5 mmmp? -76.48 104.58 7.07 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.949 0.404 . . . . 60.42 111.957 -175.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -124.8 161.38 26.59 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.803 -0.443 . . . . 71.53 109.803 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.2 t -128.65 14.4 6.48 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.627 0.603 . . . . 60.31 112.627 -174.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.436 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 4.4 mmmp? -71.93 137.66 47.53 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.866 0.365 . . . . 71.42 111.641 175.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.503 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 1.6 m-20 -62.51 164.82 10.67 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.191 -0.458 . . . . 65.11 110.538 173.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 97' ' ' ASP . 61.1 Cg_endo -71.94 27.29 0.25 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.236 1.957 . . . . 35.15 113.477 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.56 110.84 12.71 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.654 0.74 . . . . 73.33 111.295 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.1 t -143.89 87.35 1.91 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.744 0.783 . . . . 74.05 109.838 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -94.26 128.1 40.52 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.394 -0.821 . . . . 62.43 111.975 -173.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.436 ' N ' HD23 ' A' ' 102' ' ' LEU . 2.4 pt? -146.82 163.05 37.29 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.823 -0.626 . . . . 72.24 110.53 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 58.5 mt -118.2 99.92 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 121.069 0.461 . . . . 75.25 111.606 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.3 m -101.84 99.78 12.9 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 116.167 -0.469 . . . . 73.43 111.033 175.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.87 153.35 63.88 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.366 2.044 . . . . 74.12 113.332 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -93.81 106.93 18.87 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.103 -0.499 . . . . 61.14 110.94 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.473 HD23 ' HE2' ' A' ' 83' ' ' LYS . 3.2 mm? -95.09 -177.05 4.01 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.074 0.464 . . . . 75.14 111.51 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -61.85 132.71 53.95 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.597 -0.728 . . . . 65.3 112.179 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -76.72 64.81 2.37 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.26 0.552 . . . . 73.44 111.023 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -93.46 92.64 7.71 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 122.055 -0.403 . . . . 72.33 111.767 -174.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -105.29 130.47 53.41 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.767 0.318 . . . . 72.45 110.951 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -74.47 145.34 43.67 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.163 0.431 . . . . 74.4 112.163 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -75.72 -35.56 60.21 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.8 -0.815 . . . . 74.34 108.8 166.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 26.0 m80 . . . . . 0 C--O 1.249 1.06 0 CA-C-N 114.882 -1.053 . . . . 74.24 109.947 169.364 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtm . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.803 0.335 . . . . 52.03 111.656 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -159.23 84.53 0.79 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.553 0.692 . . . . 73.25 111.01 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -118.86 138.83 52.46 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.23 -0.441 . . . . 72.35 110.976 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.6 p -135.11 129.67 34.28 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.965 0.412 . . . . 74.15 111.837 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.0 -15.23 42.89 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.15 -0.548 . . . . 62.14 112.273 173.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.22 65.18 2.76 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.97 0.414 . . . . 55.4 111.246 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -92.36 116.97 29.44 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.968 0.413 . . . . 74.33 111.769 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 26.8 m -122.75 145.12 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.127 0.489 . . . . 63.23 111.876 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.86 146.99 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.017 -0.538 . . . . 75.21 111.29 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.0 112.89 25.45 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.33 -0.396 . . . . 61.14 111.106 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.8 mm -92.34 105.73 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.47 -0.332 . . . . 72.21 111.199 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 12' ' ' ILE . 4.1 mp -91.88 121.83 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 121.07 0.462 . . . . 73.34 111.276 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.0 m -121.51 157.1 31.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.358 -0.383 . . . . 71.42 111.491 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.59 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 53.7 tt0 -152.69 142.83 22.36 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.979 0.418 . . . . 63.33 111.345 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.59 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 62.3 m-80 57.45 19.21 5.02 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.031 0.752 . . . . 75.54 113.031 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.47 -12.78 36.21 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.728 -0.749 . . . . 72.21 114.271 176.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -129.3 156.5 43.91 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 117.635 0.718 . . . . 73.23 112.068 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.63 133.54 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.826 0.346 . . . . 62.23 111.318 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.1 pt -111.92 -31.02 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 112.153 0.427 . . . . 74.33 112.153 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -157.19 133.17 9.51 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 111.979 0.363 . . . . 73.13 111.979 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -117.14 114.43 23.68 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 110.307 -0.256 . . . . 72.05 110.307 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 73.1 mt -115.0 116.04 42.85 Favored Pre-proline 0 N--CA 1.472 0.662 0 N-CA-C 111.826 0.306 . . . . 74.42 111.826 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.42 124.54 11.75 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.437 2.092 . . . . 70.14 112.474 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.402 ' HB2' HG23 ' A' ' 8' ' ' VAL . 88.7 mt -81.75 -56.49 3.96 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.995 0.426 . . . . 74.53 111.317 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.7 m -62.63 112.78 2.64 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.034 0.445 . . . . 63.12 111.501 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.02 7.77 57.22 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.128 -0.558 . . . . 60.25 113.199 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -85.1 122.91 29.99 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 117.004 0.402 . . . . 70.13 110.846 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 28' ' ' LYS . 11.1 mptt -91.24 140.85 29.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.045 0.45 . . . . 65.42 112.009 -176.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.94 -151.69 51.93 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 114.82 0.688 . . . . 41.33 114.82 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -117.3 143.71 45.64 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.882 0.473 . . . . 72.43 110.648 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -144.08 114.64 7.62 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.617 0.246 . . . . 71.02 111.007 -175.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -117.67 137.31 52.74 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.9 0.381 . . . . 63.11 111.434 -175.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -144.13 141.99 30.32 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.994 0.426 . . . . 73.43 111.484 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.2 m -99.89 118.0 35.4 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.033 0.444 . . . . 74.33 111.963 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.417 HD11 HG21 ' A' ' 12' ' ' ILE . 61.1 mt -92.63 97.01 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.326 -0.397 . . . . 70.44 110.701 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.62 148.01 31.83 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.029 0.442 . . . . 64.2 111.574 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -127.63 -152.14 7.83 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.45 -0.405 . . . . 71.42 112.361 177.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -70.94 123.62 22.44 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.24 0.543 . . . . 62.24 111.23 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.65 -134.71 22.59 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.325 -0.464 . . . . 52.31 112.722 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.85 15.47 16.55 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.996 0.427 . . . . 42.11 111.773 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.562 ' HB3' ' CD2' ' A' ' 82' ' ' HIS . 27.1 mt-30 -87.58 100.02 12.48 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.076 0.465 . . . . 75.32 111.526 -177.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -132.79 166.24 22.7 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.102 -0.499 . . . . 71.45 112.024 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -126.68 122.78 35.92 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.858 -0.61 . . . . 71.12 110.682 171.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.5 tp -92.26 110.44 21.83 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.724 0.297 . . . . 75.21 110.362 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.762 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.2 mmm -99.56 136.96 38.73 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.983 0.42 . . . . 63.33 111.869 -175.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -125.34 115.11 19.81 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.298 -0.41 . . . . 74.33 111.27 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.9 t -102.49 107.34 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.434 -0.348 . . . . 74.02 110.477 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -110.57 122.12 46.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.932 0.396 . . . . 63.15 110.987 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.4 -107.78 1.25 Allowed Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.125 -0.56 . . . . 61.44 112.32 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -120.86 25.5 9.64 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.06 0.457 . . . . 73.14 111.531 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -138.51 149.76 45.7 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.937 0.399 . . . . 64.31 111.517 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.6 tt -126.94 146.45 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 112.089 0.403 . . . . 74.3 112.089 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -148.74 168.77 22.01 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.985 0.422 . . . . 74.5 111.311 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.762 HG12 ' SD ' ' A' ' 45' ' ' MET . 33.8 mt -90.87 111.17 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.14 0.495 . . . . 54.51 110.086 169.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -74.45 -39.28 62.65 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.892 -0.595 . . . . 62.55 111.525 -175.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -149.93 148.87 29.63 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.275 -0.42 . . . . 73.53 110.142 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.29 130.73 9.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.353 0.597 . . . . 74.33 111.641 -175.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -96.28 64.35 2.27 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.326 0.584 . . . . 53.44 110.691 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 45.9 t -128.46 139.64 36.11 Favored Pre-proline 0 N--CA 1.473 0.677 0 CA-C-N 116.033 -0.531 . . . . 24.3 111.043 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 59' ' ' SER . 32.1 Cg_exo -58.27 -36.68 97.48 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.532 2.154 . . . . 71.44 112.749 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -76.5 -29.44 56.83 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.821 -0.627 . . . . 75.02 112.622 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 56.59 19.53 4.3 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.938 0.718 . . . . 71.11 112.938 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.5 t -53.94 -41.04 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 112.168 0.433 . . . . 72.2 112.168 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.558 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -57.83 -43.99 94.47 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.065 -0.588 . . . . 71.2 113.289 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.95 -37.83 81.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.006 0.431 . . . . 63.53 111.143 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -65.65 -40.27 92.31 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.309 0.485 . . . . 64.23 112.309 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.3 mmt -65.26 -41.28 94.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.828 0.347 . . . . 75.52 111.373 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.47 -129.75 28.43 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 114.367 0.507 . . . . 62.54 114.367 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -77.92 136.47 38.02 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.737 0.643 . . . . 71.34 112.737 -174.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 75.1 mmtt -132.58 144.26 50.26 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.902 -0.59 . . . . 72.21 109.883 173.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 95.4 p -162.0 13.57 0.08 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.363 0.875 . . . . 73.4 113.363 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -123.41 151.3 42.76 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.996 0.426 . . . . 64.53 112.056 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.64 111.62 1.49 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.26 0.552 . . . . 72.25 111.276 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 121.37 -21.53 8.12 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 121.314 -0.47 . . . . 62.33 112.435 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.527 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 80.1 m-20 -63.74 123.14 18.12 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.81 0.338 . . . . 62.42 111.226 176.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 65.8 p -130.65 141.93 50.43 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.403 0.621 . . . . 72.14 112.293 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.5 mm -114.8 118.37 58.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.833 -0.621 . . . . 75.02 110.258 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.3 t -112.31 115.73 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.924 0.392 . . . . 72.52 111.778 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 76.6 m -121.66 79.26 1.54 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.029 0.442 . . . . 51.32 110.825 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.498 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 93.1 mt -59.11 -47.02 99.29 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 113.091 0.775 . . . . 73.51 113.091 -175.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.498 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 50.7 Cg_exo -56.07 -17.36 19.42 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 122.255 1.97 . . . . 71.25 113.611 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.562 ' CD2' ' HB3' ' A' ' 41' ' ' GLN . 64.6 m170 -117.33 -1.81 11.7 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 122.14 -0.35 . . . . 64.54 111.612 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 66.4 mttm 59.37 28.33 17.66 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.071 -0.513 . . . . 73.42 112.194 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.7 t -100.56 132.89 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.487 -0.324 . . . . 65.41 111.061 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -136.68 118.21 14.85 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.004 0.431 . . . . 71.32 111.023 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.2 t -112.31 132.14 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 116.374 -0.375 . . . . 74.12 110.851 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -131.96 131.86 42.99 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.126 0.488 . . . . 53.1 111.367 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 58.4 mt -97.68 130.02 46.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.182 0.515 . . . . 74.52 111.307 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -137.74 153.96 49.67 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.058 -0.519 . . . . 61.24 110.932 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 47.7 t -89.86 149.89 22.46 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.09 -0.381 . . . . 64.13 111.264 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.2 p -65.8 -22.02 66.53 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.017 0.437 . . . . 71.43 110.807 175.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -94.97 161.94 13.94 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.194 0.521 . . . . 61.54 111.579 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp -67.51 149.16 50.53 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.434 0.531 . . . . 62.43 112.434 -175.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -97.59 115.37 27.75 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.016 0.436 . . . . 61.44 110.493 173.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 65.9 p -85.83 106.53 17.12 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.029 0.443 . . . . 72.01 111.009 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.528 ' HB3' ' NZ ' ' A' ' 96' ' ' LYS . 9.2 mtpm? -116.23 178.74 4.21 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 122.196 0.998 . . . . 74.22 113.15 -175.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -68.74 147.77 97.96 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 114.122 -1.399 . . . . 63.1 112.304 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.12 -18.84 5.96 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.529 2.152 . . . . 63.51 112.869 173.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -128.8 94.42 3.84 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.636 0.255 . . . . 62.15 111.266 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.6 m -76.84 68.17 3.0 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.528 0.68 . . . . 64.12 109.938 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -126.74 -7.39 6.18 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.539 -0.755 . . . . 74.03 111.156 -175.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 102' ' ' LEU . 2.1 pp -144.34 153.07 41.6 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.989 -0.55 . . . . 73.43 111.178 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.2 mt -84.96 -47.46 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.114 0.483 . . . . 52.33 111.164 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.5 m -103.16 123.34 42.18 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.314 -0.403 . . . . 74.4 111.475 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.64 107.24 1.02 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.761 2.307 . . . . 73.4 112.571 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -121.17 175.91 5.87 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.109 0.48 . . . . 71.43 111.95 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 107' ' ' LEU . 2.9 mm? -90.17 -10.39 44.68 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.418 0.525 . . . . 75.3 112.418 -174.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -71.24 101.96 2.44 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.931 0.395 . . . . 74.21 112.008 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -81.17 70.82 8.09 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.182 0.515 . . . . 53.41 110.428 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -57.76 117.63 4.45 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.84 -0.618 . . . . 75.23 112.202 -174.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 73.12 2.97 4.54 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.646 -0.706 . . . . 63.23 112.278 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -118.11 105.01 11.39 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 122.032 -0.417 . . . . 74.53 111.259 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -88.95 -56.94 3.08 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.762 0.315 . . . . 74.02 111.719 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 C--O 1.254 1.313 0 CA-C-O 118.903 -0.57 . . . . 72.32 111.332 -178.697 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtm . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.006 0.431 . . . . 72.24 111.757 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 2' ' ' LYS . 38.4 mmtm -137.84 112.69 8.99 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.991 -0.549 . . . . 65.22 109.694 171.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -53.85 130.79 38.36 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.355 0.872 . . . . 74.11 113.355 -170.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.4 p -96.64 159.58 14.85 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.77 -0.65 . . . . 70.12 110.834 176.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.24 0.24 1.99 Allowed Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.85 -0.691 . . . . 13.15 113.391 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -82.28 78.66 8.91 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.892 0.377 . . . . 74.31 110.438 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.466 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 44.5 mt-10 -80.79 104.5 11.35 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.096 0.776 . . . . 75.33 113.096 -170.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 71' ' ' SER . 35.7 m -137.67 160.39 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 115.921 -0.581 . . . . 62.43 112.176 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 23' ' ' PRO . 29.8 m -131.43 146.54 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.064 -0.516 . . . . 71.01 110.788 176.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.97 116.53 30.37 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.918 0.39 . . . . 52.5 111.949 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.403 ' HB ' ' HG2' ' A' ' 87' ' ' GLU . 44.5 mm -97.21 124.58 50.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.486 -0.325 . . . . 65.24 110.613 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.507 HD12 ' N ' ' A' ' 12' ' ' ILE . 2.9 mp -104.55 111.81 35.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.755 0.312 . . . . 61.3 111.156 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 18' ' ' VAL . 60.4 m -109.04 126.1 52.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.092 0.472 . . . . 72.41 111.584 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.41 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 62.8 tt0 -118.39 133.08 56.18 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.157 -0.339 . . . . 72.25 110.972 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.495 HD22 ' N ' ' A' ' 15' ' ' ASN . 0.8 OUTLIER 65.14 12.4 7.94 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.316 0.488 . . . . 74.11 112.316 177.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.04 10.52 34.33 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.359 -0.448 . . . . 52.31 113.857 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -144.15 146.04 32.49 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.397 0.599 . . . . 72.42 111.734 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.49 ' HB ' HD13 ' A' ' 102' ' ' LEU . 59.2 t -59.95 138.41 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 116.35 -0.386 . . . . 73.23 111.324 177.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 47.1 pt -125.78 -12.39 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.338 0.495 . . . . 73.43 112.338 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -173.76 142.24 0.89 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.812 0.339 . . . . 75.34 111.71 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -125.22 119.0 27.26 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 116.488 -0.324 . . . . 74.24 110.821 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.547 HG21 HG21 ' A' ' 47' ' ' VAL . 3.3 mp -115.53 125.13 29.1 Favored Pre-proline 0 N--CA 1.476 0.861 0 N-CA-C 111.741 0.275 . . . . 74.12 111.741 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.523 ' HA ' HG12 ' A' ' 9' ' ' VAL . 15.3 Cg_exo -69.51 123.02 9.76 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.817 2.345 . . . . 45.23 112.377 173.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.07 -57.28 3.16 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.873 0.368 . . . . 74.21 111.498 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.466 ' OG1' ' HA ' ' A' ' 7' ' ' GLU . 13.2 m -65.26 127.3 31.14 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.086 0.469 . . . . 71.23 111.441 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.62 -1.67 81.75 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.053 -0.594 . . . . 53.14 112.767 -174.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -92.5 90.49 7.19 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.281 -0.541 . . . . 74.43 111.535 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.68 169.47 18.22 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.145 -0.479 . . . . 52.43 111.17 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.18 -165.25 43.1 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 114.626 0.61 . . . . 73.54 114.626 175.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -118.44 126.04 51.21 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.998 0.519 . . . . 71.3 110.825 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -139.6 130.89 26.71 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.768 0.318 . . . . 53.45 111.08 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -122.8 153.71 39.18 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.042 0.449 . . . . 70.1 112.057 -173.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -150.33 138.22 20.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.912 0.387 . . . . 74.52 111.364 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.5 m -101.6 123.53 45.76 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.041 0.448 . . . . 62.21 112.169 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.8 mt -97.84 129.53 47.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.143 -0.48 . . . . 63.14 110.897 176.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -105.75 142.46 35.44 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.079 0.466 . . . . 75.05 111.827 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.29 -157.91 32.5 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 116.253 -0.431 . . . . 73.4 113.531 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -92.82 23.29 4.24 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.154 0.427 . . . . 71.35 112.154 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 175.14 -130.75 1.8 Allowed Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.331 -0.461 . . . . 62.24 112.139 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.03 67.43 3.87 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.415 0.626 . . . . 60.41 110.724 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -144.19 130.15 19.44 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.885 -0.598 . . . . 62.25 111.324 -175.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -147.84 144.62 28.28 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.697 0.284 . . . . 74.25 111.143 172.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -128.85 110.92 12.55 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.325 -0.398 . . . . 65.11 110.623 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.4 tp -87.04 104.85 16.72 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.894 0.378 . . . . 72.15 110.872 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.815 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.0 mmm -90.58 135.91 33.4 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.37 -0.377 . . . . 72.24 111.272 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -126.83 117.14 22.02 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.961 0.41 . . . . 72.43 111.986 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.547 HG21 HG21 ' A' ' 22' ' ' ILE . 21.9 t -101.17 107.45 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.065 -0.516 . . . . 63.01 110.238 175.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.46 ' HB3' ' CZ3' ' A' ' 69' ' ' TRP . 28.2 t70 -128.17 117.66 21.98 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.934 0.397 . . . . 44.11 111.424 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 60.33 60.75 8.01 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 121.205 -0.522 . . . . 50.22 114.169 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 57.76 18.33 4.77 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.914 1.079 . . . . 52.45 113.914 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.545 ' HD2' ' HB3' ' A' ' 69' ' ' TRP . 29.3 ptt180 -146.46 152.33 38.85 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.864 0.364 . . . . 72.21 110.899 174.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.5 tt -129.04 151.25 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.81 0.67 . . . . 65.14 112.81 -170.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.99 168.82 25.77 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.763 -0.653 . . . . 72.32 110.238 170.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.815 HG12 ' SD ' ' A' ' 45' ' ' MET . 59.4 mt -81.38 121.97 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.943 0.402 . . . . 74.03 110.387 174.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -84.35 -37.9 21.0 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 116.216 -0.447 . . . . 65.33 111.895 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -161.07 138.29 8.99 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.389 -0.369 . . . . 72.03 111.291 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.13 162.61 25.7 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.907 0.384 . . . . 64.32 110.51 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -98.59 64.45 1.52 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.567 0.699 . . . . 71.32 111.676 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.0 p -114.03 141.68 26.67 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-N 115.768 -0.651 . . . . 64.13 110.27 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.78 -23.24 26.39 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.183 1.922 . . . . 64.24 112.796 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.497 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.5 m-20 -87.63 -39.71 14.81 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.12 0.415 . . . . 71.42 112.12 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 61.04 23.24 13.43 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.513 0.56 . . . . 71.32 112.513 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.497 HG23 ' HB3' ' A' ' 61' ' ' ASP . 60.9 t -56.24 -34.79 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.898 0.38 . . . . 71.3 111.15 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.626 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -55.98 -47.1 82.28 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 116.275 -0.42 . . . . 62.01 113.17 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.2 t -73.77 -34.25 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.243 0.544 . . . . 74.14 110.956 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -60.22 -28.76 68.26 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.845 -0.616 . . . . 64.31 111.506 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 23.1 mmt -55.76 -34.27 65.07 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.327 0.491 . . . . 74.34 112.327 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.71 -163.64 53.64 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.977 -0.63 . . . . 50.5 113.425 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.545 ' HB3' ' HD2' ' A' ' 51' ' ' ARG . 94.0 m95 -73.39 110.32 7.58 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.853 0.359 . . . . 74.42 111.793 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -108.41 137.59 46.11 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.053 0.454 . . . . 72.51 111.674 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.404 ' O ' HG21 ' A' ' 8' ' ' VAL . 91.1 p -161.65 25.44 0.12 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.255 -0.43 . . . . 73.42 111.682 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -115.78 141.1 48.54 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.897 0.38 . . . . 72.14 111.599 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.4 106.64 1.16 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.978 0.418 . . . . 75.25 111.15 176.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 125.44 -7.24 7.98 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.011 -0.614 . . . . 74.32 113.342 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -92.71 142.0 27.84 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.138 0.494 . . . . 54.53 111.47 175.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.52 HG22 ' HA ' ' A' ' 87' ' ' GLU . 66.7 p -135.24 153.41 51.93 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.043 -0.526 . . . . 73.3 111.771 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 32.6 mm -112.97 128.33 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 116.346 -0.388 . . . . 73.34 110.351 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 50.5 t -115.39 120.1 63.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 112.191 0.441 . . . . 74.15 112.191 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.461 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 73.1 m -120.94 81.0 1.71 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.26 0.552 . . . . 71.52 110.3 171.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.445 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 4.3 tt -57.04 -53.75 61.88 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 115.498 -0.774 . . . . 74.1 112.253 -173.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 80' ' ' LEU . 44.1 Cg_endo -65.89 -9.62 23.79 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 122.26 1.973 . . . . 52.35 113.537 -176.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -114.34 -4.91 12.94 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 122.06 -0.4 . . . . 74.41 111.73 177.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 66.8 mttm 57.39 36.64 27.37 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.275 0.559 . . . . 63.13 111.481 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 59.4 t -111.69 138.71 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.875 -0.602 . . . . 62.55 110.979 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -140.93 148.42 40.38 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.358 -0.383 . . . . 64.53 110.475 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.439 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 57.3 t -139.46 113.79 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 122.257 -0.277 . . . . 74.43 111.439 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.52 ' HA ' HG22 ' A' ' 76' ' ' THR . 1.4 pm0 -106.92 126.7 52.66 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.343 0.592 . . . . 72.31 111.788 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.8 mt -95.71 122.3 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-O 121.024 0.44 . . . . 70.05 111.597 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.1 151.76 40.57 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.434 -0.348 . . . . 62.11 111.196 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.0 t -76.3 149.34 37.1 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.868 0.365 . . . . 74.21 111.905 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.442 HG22 HG13 ' A' ' 9' ' ' VAL . 27.5 p -77.09 -27.43 54.19 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.006 0.432 . . . . 64.43 111.246 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -69.77 -178.46 1.52 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.324 -0.398 . . . . 74.22 111.075 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -77.34 60.6 2.03 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.146 0.498 . . . . 61.1 111.536 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -67.47 107.7 2.56 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.765 -0.457 . . . . 61.44 109.765 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.3 m -62.72 81.24 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.054 0.454 . . . . 64.23 112.198 -173.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -132.04 169.13 16.78 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.265 0.555 . . . . 74.42 111.264 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.79 147.17 80.8 Favored Pre-proline 0 CA--C 1.545 0.755 0 CA-C-N 115.883 -0.599 . . . . 75.05 110.675 170.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.77 -70.04 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.259 1.973 . . . . 71.25 114.241 -174.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 55.12 16.92 1.74 Allowed 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.197 0.522 . . . . 62.44 112.099 -173.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.1 m -96.04 12.89 28.95 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.487 0.66 . . . . 71.22 110.396 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.6 87.89 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.485 0.66 . . . . 73.42 110.952 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.49 HD13 ' HB ' ' A' ' 18' ' ' VAL . 51.0 tp -81.67 100.26 9.36 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.387 0.613 . . . . 74.12 112.165 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 64.1 mt -92.49 110.38 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.081 -0.509 . . . . 62.43 110.131 172.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.2 m -61.67 139.85 95.25 Favored Pre-proline 0 CA--C 1.541 0.635 0 CA-C-O 120.511 0.196 . . . . 64.54 111.437 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.683 ' HB2' HD13 ' A' ' 107' ' ' LEU . 36.5 Cg_endo -63.47 145.68 92.42 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.575 2.183 . . . . 72.11 113.097 -177.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -85.11 15.56 4.08 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.899 0.333 . . . . 74.31 111.899 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 105' ' ' PRO . 10.0 mp -61.1 139.0 58.19 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.961 0.41 . . . . 53.24 111.498 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.41 119.92 14.42 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.375 -0.375 . . . . 72.42 111.079 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -61.72 125.83 25.2 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.335 0.588 . . . . 71.55 111.03 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.545 ' HA ' ' O ' ' A' ' 113' ' ' HIS . 96.9 m-70 -79.98 14.51 1.79 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.362 0.875 . . . . 74.33 113.362 -168.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -86.72 -51.58 6.02 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.893 0.378 . . . . 73.21 110.768 174.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -96.74 4.97 51.5 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.996 0.427 . . . . 72.11 111.073 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.545 ' O ' ' HA ' ' A' ' 110' ' ' HIS . 58.9 t-80 -155.59 93.39 1.48 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.174 -0.467 . . . . 72.33 110.176 177.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 . . . . . 0 C--O 1.254 1.313 0 CA-C-O 118.553 -0.736 . . . . 71.2 112.382 -173.568 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.5 mmm . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 112.408 0.521 . . . . 44.24 112.408 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.96 -33.2 75.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.3 0.571 . . . . 75.01 110.256 172.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -70.58 117.3 11.93 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.659 -0.7 . . . . 64.42 110.058 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.2 p -53.47 121.78 8.38 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.619 0.6 . . . . 74.1 112.619 -175.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -123.92 71.19 0.44 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.301 -0.476 . . . . 55.33 113.682 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.54 73.85 2.56 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 122.376 -0.485 . . . . 74.42 110.417 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -120.13 108.55 14.38 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.091 0.472 . . . . 70.21 111.894 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.567 HG23 ' HB2' ' A' ' 24' ' ' LEU . 30.8 m -110.1 144.82 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 121.287 0.565 . . . . 62.41 112.102 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.5 m -124.11 138.88 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.266 -0.425 . . . . 54.32 111.483 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.04 119.97 36.52 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.887 0.375 . . . . 54.5 111.288 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.6 mm -104.27 113.37 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.564 -0.289 . . . . 74.44 111.029 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.515 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.1 mp -98.69 125.74 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 120.841 0.353 . . . . 75.4 110.894 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.5 t -128.8 152.63 48.26 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.068 0.461 . . . . 42.12 112.174 -176.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -146.91 142.87 28.05 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.017 -0.538 . . . . 65.2 110.734 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.7 14.02 5.79 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.407 0.521 . . . . 74.33 112.407 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.17 16.34 47.67 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.197 -0.525 . . . . 62.33 113.577 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -138.41 140.94 39.56 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.415 -0.462 . . . . 61.35 111.256 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -63.02 128.26 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 110.12 -0.326 . . . . 55.2 110.12 174.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.2 pt -109.23 -28.76 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 112.35 0.5 . . . . 74.03 112.35 -177.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -162.65 138.4 7.18 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.921 0.391 . . . . 71.34 111.494 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -124.48 119.45 29.17 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.591 -0.277 . . . . 71.14 111.493 -177.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.412 HG21 HG11 ' A' ' 47' ' ' VAL . 3.3 mp -112.81 116.17 47.92 Favored Pre-proline 0 N--CA 1.472 0.648 0 CA-C-O 120.626 0.251 . . . . 73.41 111.148 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.76 113.24 3.31 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.161 1.907 . . . . 52.25 111.579 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.567 ' HB2' HG23 ' A' ' 8' ' ' VAL . 85.4 mt -69.75 -58.68 3.61 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.853 0.316 . . . . 74.3 111.853 -175.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.6 m -54.15 131.04 40.39 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.133 0.492 . . . . 74.21 111.328 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.11 -16.14 56.36 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 121.089 -0.577 . . . . 60.24 113.975 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.506 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 60.3 t-80 -76.4 76.2 3.15 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.716 0.758 . . . . 74.22 110.86 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -78.23 92.75 4.51 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.972 -0.558 . . . . 74.54 111.43 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.8 -168.48 31.15 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 116.267 -0.424 . . . . 63.42 112.513 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -118.17 150.41 39.44 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.072 0.463 . . . . 71.34 111.42 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.536 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 12.4 tp10 -149.23 148.29 29.41 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.492 -0.322 . . . . 62.42 110.918 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -138.36 129.7 27.45 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.086 0.469 . . . . 72.42 111.689 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -145.82 131.86 19.29 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.209 0.528 . . . . 75.11 110.955 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.9 m -105.53 130.69 53.54 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.27 -0.423 . . . . 70.01 111.752 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.525 ' N ' HD12 ' A' ' 35' ' ' ILE . 3.2 mp -99.16 114.14 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.481 -0.327 . . . . 65.01 110.362 175.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -101.46 108.11 19.6 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.721 0.296 . . . . 73.34 111.505 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.68 -105.21 0.37 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.065 -0.588 . . . . 72.33 112.021 174.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -82.61 78.65 9.2 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 122.343 -0.504 . . . . 73.42 111.361 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.67 -87.23 0.01 OUTLIER Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.194 -0.457 . . . . 70.23 114.104 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.26 -21.17 62.13 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.136 0.421 . . . . 71.4 112.136 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -78.29 73.72 4.85 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.138 0.494 . . . . 72.32 111.25 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 58' ' ' ASN . 35.4 p90 -100.58 162.56 12.85 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.978 -0.555 . . . . 63.42 111.841 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -136.39 114.04 11.05 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.086 -0.507 . . . . 71.31 110.671 173.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.6 tp -89.64 103.28 15.94 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.989 0.423 . . . . 74.3 111.392 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.809 ' SD ' HG12 ' A' ' 54' ' ' ILE . 88.6 mmm -96.64 138.61 33.94 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.056 -0.52 . . . . 71.12 111.377 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -129.23 126.27 38.76 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.881 0.372 . . . . 75.44 111.466 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 56.4 t -110.54 115.25 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.067 0.46 . . . . 65.24 111.328 178.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.456 ' HB2' ' CH2' ' A' ' 69' ' ' TRP . 14.9 t70 -108.44 171.93 7.13 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.696 -0.483 . . . . 70.42 109.696 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 27' ' ' HIS . . . -37.27 90.38 0.01 OUTLIER Glycine 0 CA--C 1.535 1.282 0 N-CA-C 114.85 0.7 . . . . 34.11 114.85 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 66.08 32.09 8.47 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.506 0.722 . . . . 71.53 112.888 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.419 ' HG3' ' HB3' ' A' ' 48' ' ' ASP . 23.3 ptt180 -155.47 151.26 27.53 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 122.644 0.378 . . . . 71.14 111.144 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 tt -136.83 150.47 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 120.825 0.345 . . . . 63.23 111.919 -177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.552 ' NH2' ' HE3' ' A' ' 55' ' ' LYS . 21.4 ptt180 -155.62 168.58 26.69 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.222 0.535 . . . . 64.43 112.252 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.809 HG12 ' SD ' ' A' ' 45' ' ' MET . 62.1 mt -102.38 119.34 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.764 -0.653 . . . . 64.31 109.9 168.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.552 ' HE3' ' NH2' ' A' ' 53' ' ' ARG . 41.1 mtpt -78.57 -38.12 40.98 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.958 0.409 . . . . 72.14 110.728 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -169.63 138.78 1.93 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.518 -0.764 . . . . 70.42 111.425 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -142.37 161.56 37.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.975 -0.38 . . . . 74.13 109.975 170.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.439 ' HB2' ' CE1' ' A' ' 42' ' ' TYR . 61.2 t30 -84.95 66.29 9.66 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.152 0.501 . . . . 72.42 111.037 -176.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.3 t -129.05 145.75 57.89 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 116.224 -0.444 . . . . 73.22 111.146 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.52 -35.78 12.7 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.536 2.157 . . . . 62.22 113.16 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.467 ' HB2' HG23 ' A' ' 63' ' ' VAL . 1.6 p30 -77.59 -44.2 29.19 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.029 0.381 . . . . 75.11 112.029 -178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.513 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 24.7 mm-40 63.5 26.6 14.86 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.429 -0.351 . . . . 63.51 111.804 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.467 HG23 ' HB2' ' A' ' 61' ' ' ASP . 87.7 t -53.2 -41.61 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 120.849 0.357 . . . . 55.23 111.61 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.588 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -58.4 -38.48 90.78 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.32 -0.467 . . . . 74.43 113.258 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.1 t -71.35 -39.96 72.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.969 0.414 . . . . 74.53 111.06 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.513 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 4.6 mptp? -62.59 -29.91 70.95 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.364 -0.38 . . . . 60.52 111.301 176.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 21.2 mmt -61.2 -44.57 97.07 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.086 0.402 . . . . 70.34 112.086 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.26 -148.64 32.99 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.142 -0.552 . . . . 52.23 113.209 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.456 ' CH2' ' HB2' ' A' ' 48' ' ' ASP . 91.3 m95 -76.36 110.94 11.3 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.07 0.462 . . . . 75.23 111.867 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -103.88 143.78 32.38 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.379 -0.373 . . . . 73.44 110.885 175.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 64.2 p -169.19 18.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.502 0.556 . . . . 72.32 112.502 -173.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 72' ' ' LYS . 2.9 mptp? -116.86 144.93 43.93 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.82 0.343 . . . . 74.23 110.39 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.61 93.43 0.08 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.936 0.398 . . . . 74.11 111.346 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.09 -20.19 1.76 Allowed Glycine 0 CA--C 1.529 0.938 0 CA-C-N 116.029 -0.532 . . . . 52.23 113.364 -177.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.51 ' HB2' HD12 ' A' ' 88' ' ' ILE . 75.9 m-20 -66.25 135.35 54.33 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 117.096 0.448 . . . . 43.55 112.025 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.9 p -133.03 145.95 51.29 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.27 0.557 . . . . 73.35 111.692 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.53 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 35.0 mm -117.72 129.9 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 115.852 -0.613 . . . . 51.51 110.48 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.3 t -123.85 117.31 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 112.651 0.611 . . . . 61.22 112.651 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 90.3 m -115.77 81.22 1.56 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.244 0.545 . . . . 71.53 110.006 169.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.527 ' HB3' ' HD3' ' A' ' 81' ' ' PRO . 5.4 tt -55.76 -53.57 61.4 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 115.631 -0.713 . . . . 73.52 112.394 -172.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 80' ' ' LEU . 31.3 Cg_exo -60.04 -14.68 29.44 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.046 1.831 . . . . 72.3 113.381 -176.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -105.2 -3.65 22.69 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.994 0.368 . . . . 72.33 111.994 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.6 mttm 60.81 21.28 11.4 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 120.901 0.382 . . . . 75.43 111.491 -174.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.0 t -104.04 130.12 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 121.186 0.517 . . . . 54.22 111.365 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -135.93 136.57 40.55 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.002 -0.545 . . . . 75.52 111.061 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.53 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 46.4 t -128.7 144.56 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.396 -0.365 . . . . 73.32 110.519 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -143.6 144.74 32.05 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.204 0.526 . . . . 54.03 111.911 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.51 HD12 ' HB2' ' A' ' 75' ' ' ASP . 65.4 mt -106.18 111.7 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 115.941 -0.572 . . . . 74.54 111.096 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -118.09 143.06 46.77 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.022 -0.535 . . . . 74.52 110.654 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 22.8 t -85.54 122.87 30.29 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.861 -0.524 . . . . 73.52 110.471 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.661 HG23 ' HG2' ' A' ' 92' ' ' GLN . 9.7 t -77.86 -24.48 48.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.955 0.407 . . . . 73.03 111.352 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.661 ' HG2' HG23 ' A' ' 91' ' ' THR . 77.0 mm-40 -117.55 155.1 30.37 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.172 -0.467 . . . . 75.25 111.042 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.526 ' NZ ' ' HB3' ' A' ' 93' ' ' LYS . 4.8 mmmp? -97.78 129.31 44.79 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.171 0.51 . . . . 53.52 111.778 175.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -82.05 161.91 22.77 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.157 -0.474 . . . . 50.42 111.442 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 t -105.37 11.32 32.88 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.291 0.848 . . . . 64.04 113.291 -172.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -121.34 152.68 38.69 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.657 -0.652 . . . . 72.13 111.819 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -90.44 135.4 29.53 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 116.195 -0.457 . . . . 74.34 110.61 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.34 -5.37 16.42 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.569 2.179 . . . . 74.5 114.16 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -98.0 96.63 8.29 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.017 0.437 . . . . 70.5 111.34 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 59.8 p -106.13 133.14 51.3 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.562 -0.29 . . . . 75.11 111.657 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -140.32 162.24 35.76 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.213 0.53 . . . . 73.33 111.632 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.462 ' O ' HD12 ' A' ' 102' ' ' LEU . 0.5 OUTLIER -156.25 113.01 3.13 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.327 0.584 . . . . 74.45 111.82 177.043 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 50.6 mm -89.53 -42.79 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.342 0.591 . . . . 72.15 110.072 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.42 107.2 43.47 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.735 -0.666 . . . . 73.52 111.137 176.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.62 115.59 3.46 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.494 2.129 . . . . 74.42 112.644 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -126.09 159.88 31.64 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.815 0.34 . . . . 74.33 111.717 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 87.4 mt -68.55 159.95 30.88 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.856 0.36 . . . . 75.22 111.723 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.37 127.36 30.97 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.18 0.514 . . . . 65.22 109.673 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -79.08 27.49 0.24 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.738 1.014 . . . . 74.22 113.738 -168.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -58.11 -28.6 64.78 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.048 0.452 . . . . 73.14 111.289 171.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -89.48 121.84 32.09 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.348 -0.387 . . . . 74.42 111.29 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -125.25 147.19 49.19 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.861 0.362 . . . . 74.4 111.107 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -111.27 19.97 17.79 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.548 0.69 . . . . 73.35 110.393 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 . . . . . 0 C--O 1.254 1.32 0 CA-C-N 115.659 -0.7 . . . . 72.31 111.161 -179.833 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 111.83 0.307 . . . . 55.25 111.83 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -87.32 90.92 8.54 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.118 0.485 . . . . 75.42 111.32 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -87.55 86.69 7.24 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.026 0.441 . . . . 65.11 110.521 176.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.7 p -74.94 135.17 41.43 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.514 0.561 . . . . 70.03 112.514 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.05 -30.16 11.56 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.998 -0.546 . . . . 65.25 113.187 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -68.64 96.29 0.71 Allowed 'General case' 0 CA--C 1.536 0.427 0 O-C-N 122.557 -0.378 . . . . 72.25 111.626 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.441 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 42.9 mt-10 -91.29 102.97 15.68 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.121 0.486 . . . . 52.42 110.292 172.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.87 150.71 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 113.0 0.741 . . . . 65.23 113.0 -171.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.69 140.15 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 115.643 -0.708 . . . . 73.34 110.905 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.85 111.93 23.78 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.84 0.352 . . . . 62.32 111.431 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.1 mm -96.2 113.66 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.348 -0.387 . . . . 64.11 110.968 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 12' ' ' ILE . 2.9 mp -95.62 123.57 47.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.83 0.347 . . . . 41.33 111.387 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.6 p -125.58 146.61 49.61 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.008 0.432 . . . . 74.21 111.171 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.51 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 63.1 tt0 -130.9 131.25 44.39 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.544 -0.298 . . . . 62.12 110.204 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.486 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 56.5 m-80 57.5 15.58 2.83 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.057 0.391 . . . . 61.02 112.057 -175.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.98 -20.28 31.42 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.314 -0.469 . . . . 52.23 114.034 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -98.35 140.77 32.13 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.323 0.562 . . . . 60.42 111.85 -177.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.27 122.64 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.954 0.407 . . . . 65.51 111.529 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.8 pt -111.03 -19.4 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 112.953 0.723 . . . . 74.0 112.953 -175.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -167.81 144.47 4.17 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.001 0.371 . . . . 74.52 112.001 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -128.91 122.73 30.89 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.396 0.278 . . . . 73.44 111.329 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 22' ' ' ILE . 3.7 mp -118.32 113.86 36.81 Favored Pre-proline 0 N--CA 1.477 0.888 0 N-CA-C 111.713 0.264 . . . . 61.3 111.713 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.69 124.96 11.63 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.223 1.949 . . . . 74.42 111.851 171.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.9 mt -92.13 -47.78 7.07 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.9 0.704 . . . . 62.23 112.9 -172.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 7' ' ' GLU . 14.8 m -59.53 121.73 12.28 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.303 0.483 . . . . 72.54 112.303 -175.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.79 5.82 88.52 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.442 -0.409 . . . . 62.3 113.437 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.48 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 41.6 t-80 -70.82 87.38 0.7 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.314 0.578 . . . . 65.53 111.267 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -64.17 123.77 19.94 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.62 0.6 . . . . 75.22 112.62 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.5 -164.04 20.97 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 114.189 0.436 . . . . 55.31 114.189 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -118.61 128.86 54.94 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.559 0.343 . . . . 74.02 111.213 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -130.48 114.68 15.81 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.096 0.474 . . . . 72.13 111.634 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.439 ' HG2' ' HG3' ' A' ' 46' ' ' GLU . 68.0 mt-30 -109.82 145.12 37.26 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.281 -0.418 . . . . 72.42 111.126 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -151.19 145.78 25.65 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.002 0.43 . . . . 74.11 111.787 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 28.7 m -103.88 113.63 27.3 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.736 0.643 . . . . 72.14 112.736 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 61.1 mt -88.39 109.04 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.114 -0.494 . . . . 63.45 110.604 173.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -79.61 106.33 11.55 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.166 -0.334 . . . . 73.32 111.66 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.51 ' HA2' ' NE2' ' A' ' 14' ' ' GLN . . . -73.42 -171.02 21.3 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 120.865 -0.683 . . . . 62.32 112.754 176.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.465 ' HD2' ' HD2' ' A' ' 83' ' ' LYS . 27.0 mtpp -66.85 99.42 0.62 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.973 0.416 . . . . 74.41 111.751 -177.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.37 -118.22 5.73 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.231 -0.509 . . . . 43.13 113.121 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.01 -4.95 38.82 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.389 0.515 . . . . 63.41 112.389 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.645 ' HA ' ' HB3' ' A' ' 58' ' ' ASN . 14.0 mt-30 -82.49 81.44 8.31 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.463 0.649 . . . . 73.42 111.738 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.417 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 22.8 p90 -84.09 166.34 17.76 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.679 -0.691 . . . . 73.43 111.88 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.462 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 22.3 m120 -136.34 109.89 7.99 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.724 0.409 . . . . 63.13 110.715 173.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.9 tp -90.56 103.54 16.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.097 0.475 . . . . 74.4 110.562 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.729 ' SD ' HG12 ' A' ' 54' ' ' ILE . 94.9 mmm -89.94 144.55 25.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.129 -0.487 . . . . 65.22 111.108 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.616 ' HB3' ' NH1' ' A' ' 53' ' ' ARG . 71.6 tt0 -132.99 126.6 32.32 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.179 0.514 . . . . 72.01 111.734 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.1 t -103.81 119.42 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 115.838 -0.619 . . . . 63.34 110.848 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.481 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 34.9 t70 -107.9 97.77 7.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.275 0.559 . . . . 72.21 109.782 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 27' ' ' HIS . . . 65.87 -104.67 1.06 Allowed Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.819 -0.705 . . . . 70.43 112.377 -175.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -112.95 15.57 19.65 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.868 0.366 . . . . 75.21 111.949 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 18.6 ptp180 -131.54 150.24 52.22 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.524 -0.307 . . . . 73.2 110.925 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.7 tt -139.72 145.2 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 112.681 0.623 . . . . 63.43 112.681 -175.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.616 ' NH1' ' HB3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -159.41 168.61 25.86 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 116.1 -0.5 . . . . 74.4 111.311 173.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.729 HG12 ' SD ' ' A' ' 45' ' ' MET . 55.2 mt -73.96 122.16 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.107 0.48 . . . . 62.41 111.409 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -82.14 -51.04 8.37 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.093 -0.503 . . . . 75.22 111.441 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -154.04 136.85 15.31 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.223 -0.444 . . . . 63.04 110.317 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -157.15 -177.14 6.39 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.513 0.673 . . . . 74.11 111.962 179.249 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.645 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . 55.1 t-20 -115.15 75.58 0.94 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.423 -0.808 . . . . 73.04 110.593 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.8 t -136.94 148.16 61.9 Favored Pre-proline 0 N--CA 1.472 0.627 0 O-C-N 122.15 -0.344 . . . . 70.31 111.445 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.07 -15.89 23.0 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.116 1.877 . . . . 70.31 111.673 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -105.87 -43.65 4.82 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.89 -0.595 . . . . 63.31 111.566 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 53.17 56.6 7.25 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.517 0.675 . . . . 64.25 110.662 -177.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.3 t -53.46 -46.58 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.378 -0.828 . . . . 64.35 112.772 -171.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.564 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -60.01 -31.31 72.21 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.869 -0.682 . . . . 75.33 113.228 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.75 -38.2 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.035 0.445 . . . . 71.25 110.47 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -76.3 -28.71 57.08 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.191 -0.459 . . . . 71.21 111.944 174.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 17.2 mmt -62.68 -47.49 83.45 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.583 0.586 . . . . 73.03 112.583 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.41 -165.32 27.44 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 120.811 -0.709 . . . . 51.44 113.202 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.403 ' CE3' ' HG3' ' A' ' 51' ' ' ARG . 98.7 m95 -76.26 115.23 15.79 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.378 0.608 . . . . 75.55 112.474 -176.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.769 ' HD3' ' HB3' ' A' ' 75' ' ' ASP . 11.5 mmpt? -94.73 143.57 26.34 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.806 -0.633 . . . . 73.12 110.299 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 89.0 p -167.27 12.18 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.428 1.27 . . . . 63.33 114.428 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -131.63 153.14 50.24 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.808 -0.557 . . . . 65.12 111.865 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.12 100.09 0.11 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.094 0.473 . . . . 65.52 111.841 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.44 -24.16 2.51 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 116.062 -0.517 . . . . 41.43 112.033 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.769 ' HB3' ' HD3' ' A' ' 70' ' ' LYS . 62.8 m-20 -68.32 127.46 33.04 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.783 0.325 . . . . 71.41 111.387 174.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 87' ' ' GLU . 76.6 p -136.01 148.68 48.51 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.968 0.413 . . . . 65.32 111.271 177.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.2 mm -113.22 110.59 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 120.924 0.392 . . . . 74.44 110.533 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.5 t -98.73 116.88 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 116.14 -0.482 . . . . 51.1 111.322 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 71.5 m -118.99 73.32 0.92 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.94 0.4 . . . . 61.34 110.964 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.538 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 90.9 mt -54.07 -50.18 85.78 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 112.613 0.598 . . . . 71.31 112.613 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 34.7 Cg_exo -59.91 -12.84 20.08 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.018 1.812 . . . . 74.03 113.386 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.411 ' ND1' ' OD1' ' A' ' 43' ' ' ASN . 11.8 m170 -116.65 -11.64 10.99 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.124 0.416 . . . . 74.21 112.124 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.465 ' HD2' ' HD2' ' A' ' 38' ' ' LYS . 63.8 mttm 64.01 29.51 14.29 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.257 0.551 . . . . 71.14 112.05 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.4 HG22 ' HG3' ' A' ' 14' ' ' GLN . 59.3 t -108.9 135.71 46.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 116.008 -0.542 . . . . 62.14 110.711 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -135.75 128.65 31.27 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.09 0.471 . . . . 73.2 111.11 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.18 130.6 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.587 -0.279 . . . . 74.21 111.133 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.574 ' HA ' HG22 ' A' ' 76' ' ' THR . 3.2 pt-20 -114.19 147.74 38.42 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.011 0.434 . . . . 71.31 111.303 175.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 57.3 mt -111.8 112.14 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.014 0.435 . . . . 73.12 110.226 171.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.461 ' HB3' ' HZ2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -119.65 163.04 17.98 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.275 -0.421 . . . . 74.51 111.649 -174.243 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.7 t -86.11 149.34 25.2 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.622 0.601 . . . . 73.2 112.622 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.2 p -83.68 -16.93 43.17 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.97 -0.559 . . . . 55.31 110.725 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -81.58 -173.52 4.45 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.126 -0.488 . . . . 64.12 111.47 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -80.87 74.35 7.85 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.192 0.52 . . . . 63.01 111.58 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -119.58 113.46 20.74 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.753 -0.658 . . . . 74.34 110.825 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 77.3 p -104.15 12.76 33.49 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.208 0.528 . . . . 73.42 111.344 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -90.0 35.99 0.86 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.265 -0.425 . . . . 74.44 111.571 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.62 150.03 37.79 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 116.204 -0.453 . . . . 72.42 111.965 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.07 -29.86 11.36 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.342 2.028 . . . . 63.11 113.646 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -124.45 178.62 5.3 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.143 0.424 . . . . 72.12 112.143 -176.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 67.3 p -82.33 112.39 19.26 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.195 0.813 . . . . 73.25 113.195 -172.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -161.54 126.33 3.48 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.351 -0.386 . . . . 73.02 110.522 172.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.9 tp -111.41 116.49 31.02 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.172 0.51 . . . . 62.34 111.994 -176.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.4 mt -63.14 131.23 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.856 -0.611 . . . . 73.44 111.804 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.7 m -86.53 125.11 68.43 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-O 121.058 0.456 . . . . 72.24 111.344 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -87.21 39.23 0.58 Allowed 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.859 2.373 . . . . 54.12 113.377 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -71.82 85.02 0.93 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.123 0.487 . . . . 74.32 112.208 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.483 ' H ' HD23 ' A' ' 107' ' ' LEU . 2.5 pt? -80.55 -13.53 59.0 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.302 -0.408 . . . . 71.14 111.314 176.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -70.61 160.08 33.2 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.995 -0.548 . . . . 74.11 111.386 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -95.47 133.67 39.18 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.992 0.425 . . . . 64.13 111.558 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -94.94 110.17 22.09 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.475 -0.329 . . . . 73.42 110.543 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -53.13 -47.65 68.53 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.27 0.47 . . . . 70.52 112.27 -173.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -80.0 130.87 35.61 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.883 0.373 . . . . 73.34 111.826 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -85.49 154.47 21.77 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.394 -0.366 . . . . 74.11 110.704 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.521 -0.752 . . . . 63.11 111.365 178.348 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 120.551 0.215 . . . . 61.35 111.036 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -99.26 99.49 10.46 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.011 0.434 . . . . 74.34 110.273 171.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -98.53 10.91 39.88 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.493 0.553 . . . . 73.41 112.493 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 87.4 m -67.3 127.76 33.85 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.877 0.37 . . . . 73.41 110.764 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.74 65.86 2.63 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.115 -0.564 . . . . 33.13 114.403 -173.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -74.25 78.65 1.81 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.802 0.811 . . . . 72.41 109.996 171.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.407 ' HA ' ' CB ' ' A' ' 25' ' ' THR . 46.0 mt-10 -71.58 128.97 37.56 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.079 -0.964 . . . . 63.05 113.339 -170.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.01 158.82 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.508 -0.769 . . . . 71.31 111.648 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 23' ' ' PRO . 23.6 m -134.36 148.6 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 116.262 -0.426 . . . . 54.22 111.053 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.71 115.94 28.4 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.826 0.346 . . . . 64.3 111.568 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.0 mm -99.02 116.07 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.282 -0.417 . . . . 74.42 111.22 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.49 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.0 mp -99.85 115.46 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.023 0.44 . . . . 72.04 111.489 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 18' ' ' VAL . 66.9 m -113.88 146.12 40.48 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.014 0.435 . . . . 73.54 111.467 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -141.33 140.19 33.74 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.402 -0.363 . . . . 75.1 110.278 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 61.38 14.75 5.98 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.338 0.496 . . . . 72.23 112.338 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.77 -11.12 41.73 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.272 -0.49 . . . . 75.23 114.037 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -125.72 156.18 39.77 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.229 -0.571 . . . . 74.51 111.91 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 62.0 t -74.98 132.78 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.781 0.325 . . . . 75.45 111.334 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 43.1 pt -117.28 -27.08 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 N-CA-C 112.586 0.587 . . . . 73.04 112.586 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.529 ' HG3' HD11 ' A' ' 22' ' ' ILE . 3.1 tpm_? -154.3 131.83 11.34 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 122.315 -0.241 . . . . 64.25 111.141 -174.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -130.29 114.28 15.44 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.594 0.235 . . . . 73.42 111.502 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.529 HD11 ' HG3' ' A' ' 20' ' ' ARG . 3.7 mp -114.4 130.15 24.26 Favored Pre-proline 0 N--CA 1.476 0.874 0 CA-C-O 120.545 0.212 . . . . 72.01 111.432 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.533 ' HA ' HG12 ' A' ' 9' ' ' VAL . 57.5 Cg_endo -70.77 134.11 25.15 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.189 1.926 . . . . 74.14 112.404 173.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.7 mt -97.64 -65.5 0.96 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.901 0.382 . . . . 75.23 111.654 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.407 ' CB ' ' HA ' ' A' ' 7' ' ' GLU . 8.0 m -63.43 126.87 28.9 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.835 0.35 . . . . 60.02 111.451 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.34 12.25 84.08 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.965 -0.636 . . . . 50.51 112.97 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -90.85 104.22 16.83 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.087 0.47 . . . . 55.35 111.246 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -87.74 123.8 32.92 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.224 -0.443 . . . . 74.51 111.557 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.8 -169.74 14.79 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.253 -0.498 . . . . 54.02 113.539 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -118.49 150.36 39.74 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 122.703 -0.292 . . . . 64.51 110.893 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 13.6 tp10 -144.7 114.54 7.31 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.625 0.25 . . . . 72.52 110.908 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -118.33 137.87 52.79 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.863 0.363 . . . . 74.44 111.928 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -152.09 136.56 16.84 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.245 0.545 . . . . 73.0 111.82 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.3 m -96.06 116.1 28.45 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.148 -0.478 . . . . 70.53 111.484 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 42' ' ' TYR . 62.0 mt -80.71 103.97 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.566 -0.288 . . . . 73.43 110.809 176.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -92.67 111.35 22.91 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.032 0.444 . . . . 75.15 111.301 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.22 -154.11 7.03 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.248 -0.501 . . . . 74.43 112.764 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -93.43 90.55 6.77 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.203 -0.586 . . . . 74.31 111.064 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.63 75.95 1.28 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 121.239 -0.505 . . . . 15.4 113.986 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 72.96 -41.37 0.5 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.206 1.187 . . . . 71.1 114.206 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -50.85 108.23 0.23 Allowed 'General case' 0 N--CA 1.477 0.903 0 O-C-N 122.155 -0.341 . . . . 74.45 111.605 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 33.6 p90 -131.25 159.99 36.19 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.993 0.738 . . . . 74.21 112.993 -174.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.412 HD22 HD13 ' A' ' 54' ' ' ILE . 13.9 m120 -133.73 109.84 9.42 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.869 -0.605 . . . . 74.12 110.552 170.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.3 tp -82.67 104.04 12.63 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.878 0.371 . . . . 64.12 110.69 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.739 ' SD ' HG12 ' A' ' 54' ' ' ILE . 91.3 mmm -91.73 137.32 32.46 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.361 -0.381 . . . . 74.13 111.502 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -123.38 115.72 22.09 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.047 0.451 . . . . 73.31 111.168 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 44.3 t -105.61 107.53 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.106 -0.497 . . . . 73.5 110.537 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -112.21 117.44 32.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.743 0.306 . . . . 74.21 110.674 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.06 -111.23 3.18 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.831 -0.7 . . . . 62.34 112.809 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -112.51 17.02 19.61 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.9 0.381 . . . . 74.02 111.503 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.1 ptt-85 -133.93 140.94 47.12 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.097 0.475 . . . . 72.3 111.655 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.3 tt -124.32 147.53 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 116.389 -0.368 . . . . 73.31 111.881 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -150.96 168.81 23.4 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.889 0.376 . . . . 70.11 111.444 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.739 HG12 ' SD ' ' A' ' 45' ' ' MET . 26.4 mt -90.68 117.79 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.118 0.485 . . . . 74.2 110.155 168.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -81.13 -41.58 22.23 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.098 -0.501 . . . . 74.42 111.771 -176.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -159.46 138.53 11.08 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.759 0.281 . . . . 52.4 111.759 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -163.61 166.72 22.1 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.99 0.424 . . . . 53.14 111.198 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -111.19 63.66 0.61 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 120.967 0.413 . . . . 73.33 111.882 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.2 t -108.59 138.06 20.16 Favored Pre-proline 0 N--CA 1.477 0.918 0 O-C-N 122.051 -0.406 . . . . 63.32 111.013 175.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.49 ' HD2' ' HG2' ' A' ' 81' ' ' PRO . 36.6 Cg_endo -64.21 -27.14 64.39 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.769 2.313 . . . . 74.34 113.35 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.513 ' HB2' HG23 ' A' ' 63' ' ' VAL . 1.2 p30 -87.25 -43.53 12.12 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 111.945 0.35 . . . . 75.32 111.945 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 65.57 27.33 11.55 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.457 -0.338 . . . . 73.15 111.665 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.513 HG23 ' HB2' ' A' ' 61' ' ' ASP . 90.2 t -58.01 -41.68 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.037 0.446 . . . . 74.04 110.957 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.585 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -55.37 -48.02 72.07 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 116.036 -0.529 . . . . 44.12 113.074 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.7 t -62.45 -44.01 98.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 120.801 0.334 . . . . 62.54 111.372 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -59.74 -33.77 72.08 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.615 -0.266 . . . . 73.11 111.528 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.412 ' CE ' ' HA ' ' A' ' 67' ' ' MET . 5.3 mmt -57.9 -31.88 67.18 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.832 0.348 . . . . 64.04 111.902 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.96 -136.22 32.83 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.108 -0.567 . . . . 62.53 113.585 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -87.88 126.24 34.93 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.17 0.509 . . . . 74.14 111.879 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 34.4 mmtp -113.66 145.03 41.93 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.317 -0.623 . . . . 72.25 109.317 171.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.1 p -156.31 6.79 0.19 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.327 1.232 . . . . 75.32 114.327 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -130.12 156.26 44.83 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.67 -0.644 . . . . 72.42 112.179 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.06 126.5 27.72 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.004 -0.544 . . . . 53.05 111.239 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.37 -22.12 23.01 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.337 -0.458 . . . . 71.53 112.857 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.523 ' HB2' HD12 ' A' ' 88' ' ' ILE . 95.7 m-20 -68.2 131.58 45.64 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.964 0.411 . . . . 75.24 111.687 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.9 p -127.99 167.14 17.1 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.59 0.589 . . . . 63.24 112.59 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.588 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 40.0 mm -137.44 123.56 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.69 0.796 . . . . 74.14 109.885 177.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -113.99 117.76 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.256 0.465 . . . . 63.3 112.256 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 73.5 m -122.91 86.5 2.59 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.862 0.363 . . . . 63.44 111.309 174.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.59 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 92.2 mt -61.24 -53.95 58.02 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 112.804 0.668 . . . . 73.22 112.804 -175.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.59 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 17.1 Cg_exo -69.25 0.1 5.73 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.4 2.067 . . . . 71.43 113.362 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -119.1 -6.77 10.42 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 122.205 -0.309 . . . . 71.31 111.509 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.3 mttm 61.85 30.51 18.24 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.15 0.5 . . . . 73.22 111.762 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.51 138.84 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.101 -0.499 . . . . 61.32 111.346 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -141.71 125.8 17.33 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.115 -0.493 . . . . 74.01 110.886 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.588 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 57.5 t -116.6 135.44 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.561 0.219 . . . . 73.25 111.148 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.21 141.1 47.89 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.91 0.386 . . . . 71.43 111.278 176.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 75' ' ' ASP . 60.6 mt -101.5 115.97 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.17 0.509 . . . . 63.43 111.216 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -109.89 166.09 11.2 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.003 -0.544 . . . . 63.32 110.697 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.5 t -97.3 149.29 22.23 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.181 0.515 . . . . 63.11 111.32 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.5 p -80.37 -5.12 55.92 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.216 0.532 . . . . 74.13 110.973 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -89.07 -83.5 0.23 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.335 0.588 . . . . 73.52 111.528 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -161.1 129.68 4.51 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.481 -0.781 . . . . 61.44 111.766 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -124.99 136.47 53.76 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.317 -0.401 . . . . 62.43 110.115 174.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 31.8 t -89.08 147.9 23.99 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.027 0.442 . . . . 61.43 111.201 -177.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -139.18 174.96 9.97 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.318 0.58 . . . . 62.23 112.389 -175.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -86.69 156.92 55.68 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 115.479 -0.782 . . . . 63.33 111.208 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.35 -32.72 72.08 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.342 2.028 . . . . 52.41 113.249 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.74 85.65 0.21 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.137 0.494 . . . . 71.42 111.847 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 21.4 m -100.92 75.72 1.71 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.981 0.419 . . . . 64.24 110.998 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -154.97 153.63 31.32 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.357 -0.383 . . . . 74.04 110.955 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.553 ' O ' HD12 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -106.36 120.77 42.76 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.503 0.668 . . . . 61.1 112.366 -177.489 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 52.6 mt -88.96 -20.35 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.354 0.597 . . . . 54.15 110.379 173.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.7 m -69.33 144.86 95.26 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 115.805 -0.634 . . . . 71.53 112.074 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.19 105.89 1.94 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.28 1.986 . . . . 64.12 112.632 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -63.24 94.62 0.08 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.182 0.515 . . . . 55.53 111.501 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 87.4 mt -70.52 160.41 32.51 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.087 -0.506 . . . . 70.12 111.476 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.72 165.44 11.21 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.58 0.705 . . . . 71.01 112.619 -176.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -172.31 105.46 0.18 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.173 -0.921 . . . . 73.22 109.091 169.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -44.37 -43.45 7.6 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.466 0.913 . . . . 73.45 113.466 -169.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 59.91 21.69 10.68 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.652 0.739 . . . . 61.41 110.443 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -101.06 116.19 32.25 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.428 -0.805 . . . . 75.13 111.385 -174.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -83.56 176.24 9.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.234 0.54 . . . . 73.34 111.749 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 39.6 m80 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.605 -0.712 . . . . 74.41 110.927 175.751 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.652 0.263 . . . . 72.22 110.773 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 56.02 69.13 0.77 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.393 -0.367 . . . . 65.22 111.909 -176.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -129.72 95.11 3.9 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.801 0.334 . . . . 75.23 111.881 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 t -106.94 139.33 41.52 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.48 -0.327 . . . . 35.11 111.039 173.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.53 -31.34 56.78 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.443 -0.408 . . . . 65.11 113.565 -177.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -111.73 144.7 40.59 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.081 0.467 . . . . 75.02 111.866 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.469 ' HB2' ' OG1' ' A' ' 91' ' ' THR . 47.7 mt-10 -95.16 130.98 41.67 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.271 -0.422 . . . . 65.25 110.749 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.0 m -123.67 142.17 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.095 0.474 . . . . 64.01 112.033 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 23' ' ' PRO . 27.5 m -119.93 140.19 44.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.278 -0.419 . . . . 72.25 111.224 177.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.94 114.53 26.37 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.893 0.378 . . . . 43.13 111.681 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.423 HG23 ' HG2' ' A' ' 21' ' ' GLU . 27.7 mm -98.69 110.79 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.338 -0.392 . . . . 65.53 110.979 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.499 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.2 mp -101.42 125.69 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.06 0.457 . . . . 73.44 111.59 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 55.2 m -123.5 150.6 43.73 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.129 -0.487 . . . . 74.34 111.813 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.581 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 36.1 tt0 -129.01 135.24 48.68 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.412 0.285 . . . . 52.32 110.533 175.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.581 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 53.9 m-80 59.64 8.66 1.34 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.859 0.464 . . . . 53.01 111.976 -174.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.95 -29.25 8.61 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 121.53 -0.367 . . . . 33.44 113.315 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -87.71 139.69 30.28 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.974 0.416 . . . . 65.31 111.486 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -71.22 130.54 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.316 -0.402 . . . . 64.31 111.115 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.466 HD11 HD13 ' A' ' 35' ' ' ILE . 34.2 pt -121.18 -29.24 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 112.897 0.703 . . . . 63.01 112.897 -176.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.506 ' HG3' HD11 ' A' ' 22' ' ' ILE . 9.2 tpm_? -151.29 123.19 8.1 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.125 0.488 . . . . 74.24 111.651 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.423 ' HG2' HG23 ' A' ' 11' ' ' ILE . 19.4 mt-10 -122.25 125.97 47.19 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.235 -0.439 . . . . 73.12 110.998 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.506 HD11 ' HG3' ' A' ' 20' ' ' ARG . 4.4 mp -120.63 123.62 27.97 Favored Pre-proline 0 N--CA 1.473 0.717 0 O-C-N 122.191 -0.318 . . . . 73.34 111.786 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.51 ' HA ' HG12 ' A' ' 9' ' ' VAL . 22.3 Cg_exo -66.27 111.88 2.16 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.257 1.971 . . . . 72.21 111.55 169.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 78.2 mt -75.65 -58.64 3.16 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.912 0.387 . . . . 74.15 111.244 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.451 HG21 ' HG2' ' A' ' 7' ' ' GLU . 35.8 m -60.5 118.83 6.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.836 0.351 . . . . 71.51 111.153 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 50' ' ' GLU . . . 98.49 -8.28 62.07 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.191 -0.528 . . . . 43.53 113.387 -176.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.41 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 54.2 t-80 -79.5 95.7 5.89 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.285 -0.538 . . . . 71.42 111.345 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.29 146.61 52.1 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.101 -0.5 . . . . 62.34 111.923 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.43 -158.57 53.27 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 116.1 -0.5 . . . . 72.44 114.183 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -118.39 151.34 37.95 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.834 0.349 . . . . 72.04 111.143 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -146.54 135.04 22.02 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.517 0.327 . . . . 74.42 110.462 -176.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -131.94 142.57 49.67 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.889 -0.507 . . . . 54.33 112.319 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -150.96 135.7 17.25 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.004 0.43 . . . . 73.02 111.431 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.8 m -98.74 127.65 44.74 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.396 -0.366 . . . . 70.13 111.139 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.466 HD13 HD11 ' A' ' 19' ' ' ILE . 68.8 mt -110.59 120.6 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 120.766 0.317 . . . . 73.31 111.377 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -97.41 128.72 44.44 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.116 0.484 . . . . 74.52 111.393 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.23 -114.48 3.66 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 116.261 -0.427 . . . . 65.34 112.787 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.651 ' HE2' ' HG3' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -99.17 141.82 31.45 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.911 0.355 . . . . 72.34 111.495 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.37 -100.63 0.19 Allowed Glycine 0 CA--C 1.531 1.068 0 CA-C-N 116.392 -0.367 . . . . 63.32 113.912 177.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.34 18.65 7.58 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.186 0.517 . . . . 73.1 111.664 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.651 ' HG3' ' HE2' ' A' ' 38' ' ' LYS . 12.5 mm100 -85.74 115.69 23.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.984 -0.553 . . . . 70.22 111.386 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -130.0 151.87 50.07 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.081 0.467 . . . . 62.31 112.189 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -127.66 116.8 20.84 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.061 -0.518 . . . . 74.21 110.639 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.6 tp -95.16 103.5 15.35 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.893 0.378 . . . . 72.33 110.501 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.665 ' SD ' HG12 ' A' ' 54' ' ' ILE . 92.5 mmm -92.33 136.74 32.95 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.232 -0.44 . . . . 64.21 111.274 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -124.55 115.35 20.71 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.953 0.406 . . . . 73.12 111.096 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.458 HG11 HG21 ' A' ' 22' ' ' ILE . 47.8 t -97.27 115.64 37.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.105 -0.498 . . . . 61.01 111.063 175.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -109.25 170.72 7.87 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.563 -0.29 . . . . 62.1 110.295 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 27' ' ' HIS . . . -37.53 95.33 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 N-CA-C 114.604 0.602 . . . . 61.43 114.604 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 31.4 mt-10 62.21 37.34 14.31 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.442 0.697 . . . . 75.31 112.682 176.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -165.21 161.95 19.67 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.381 -0.372 . . . . 75.23 111.017 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.3 tt -141.39 151.57 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 112.186 0.439 . . . . 72.1 112.186 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.436 ' HD3' ' CE2' ' A' ' 69' ' ' TRP . 14.1 ptt180 -152.18 168.97 23.61 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.905 0.383 . . . . 70.12 111.541 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.665 HG12 ' SD ' ' A' ' 45' ' ' MET . 46.3 mt -94.85 113.32 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.956 -0.387 . . . . 65.12 109.956 168.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -75.38 -46.73 31.2 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.736 0.303 . . . . 72.32 111.601 -177.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -143.15 140.36 30.76 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.834 0.349 . . . . 73.32 111.224 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -162.25 136.59 6.68 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.887 0.375 . . . . 65.25 111.271 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -107.8 51.36 0.74 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.208 0.527 . . . . 72.54 111.967 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.459 ' HG ' ' CD2' ' A' ' 82' ' ' HIS . 50.4 m -97.99 124.48 47.49 Favored Pre-proline 0 N--CA 1.473 0.719 0 O-C-N 122.141 -0.349 . . . . 60.2 110.213 172.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -52.78 -32.83 57.62 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.837 2.358 . . . . 65.55 113.226 -175.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -75.08 -31.46 61.22 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.365 -0.379 . . . . 74.11 111.857 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 28.3 mm-40 60.54 22.28 12.02 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.088 0.773 . . . . 72.3 113.088 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.5 t -53.36 -52.04 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 112.02 0.378 . . . . 71.01 112.02 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.94 -40.7 98.77 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.035 -0.602 . . . . 60.15 113.387 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.5 t -65.97 -33.7 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 120.998 0.428 . . . . 63.14 111.564 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 62' ' ' GLN . 67.5 mttm -70.71 -37.64 73.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.822 0.344 . . . . 65.31 111.398 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.3 mmt -60.35 -35.16 75.03 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.279 -0.418 . . . . 74.43 112.058 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.06 -119.51 8.05 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.251 -0.499 . . . . 51.32 113.948 175.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.436 ' CE2' ' HD3' ' A' ' 53' ' ' ARG . 69.3 m95 -94.92 138.93 32.02 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.173 0.434 . . . . 74.05 112.173 -175.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -131.23 151.4 51.51 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.195 -0.457 . . . . 63.43 110.233 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.4 p -164.97 15.74 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.368 0.877 . . . . 52.11 113.368 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.775 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 9.6 mmpt? -123.43 149.62 44.82 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.24 0.543 . . . . 64.25 112.069 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.64 109.49 1.42 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.029 -0.532 . . . . 62.03 110.587 176.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.24 -18.86 6.47 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 116.234 -0.439 . . . . 75.22 112.503 -176.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -69.84 115.35 8.96 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.779 0.323 . . . . 72.04 111.263 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 82.5 p -119.46 149.67 41.48 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.089 0.471 . . . . 60.25 111.465 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.434 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 46.9 mm -125.56 115.93 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.194 -0.457 . . . . 74.23 110.476 177.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.6 t -108.79 117.76 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 120.867 0.365 . . . . 42.35 111.777 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 71.0 m -120.82 84.54 2.25 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.086 0.469 . . . . 73.14 111.009 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.545 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 98.8 mt -57.98 -49.98 90.64 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 113.24 0.83 . . . . 63.41 113.24 -176.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 52.0 Cg_exo -56.7 -18.31 26.12 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 122.096 1.864 . . . . 70.32 113.519 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.459 ' CD2' ' HG ' ' A' ' 59' ' ' SER . 21.3 m170 -113.2 -4.78 13.71 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.7 0.286 . . . . 73.11 111.219 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 58.78 28.0 16.77 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.176 0.59 . . . . 72.3 112.292 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 82.1 t -101.9 133.88 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.02 0.438 . . . . 72.22 111.215 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -130.85 123.52 29.21 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.122 -0.49 . . . . 73.4 110.824 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.434 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 47.5 t -117.1 136.9 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 116.715 -0.221 . . . . 74.1 111.02 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -136.96 132.07 33.86 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.198 0.523 . . . . 73.41 111.092 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 62.1 mt -99.38 127.16 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.264 -0.426 . . . . 71.12 111.205 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -125.74 159.42 32.37 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.905 0.383 . . . . 71.34 111.617 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.1 t -79.66 149.78 31.14 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.253 -0.431 . . . . 55.34 111.059 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 7' ' ' GLU . 80.6 p -71.91 -21.45 61.62 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.864 0.364 . . . . 61.44 110.843 173.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -70.51 170.02 12.96 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.012 -0.54 . . . . 52.21 110.743 175.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -65.58 106.03 1.35 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.682 0.753 . . . . 73.44 109.498 171.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -73.02 161.16 31.01 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.115 -0.493 . . . . 65.53 111.998 -170.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 98.4 p -92.8 -9.37 40.71 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.226 -0.443 . . . . 73.32 112.181 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -61.33 152.8 28.37 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.702 0.763 . . . . 74.3 112.845 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.458 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 1.0 OUTLIER -74.53 140.28 75.3 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 114.964 -1.016 . . . . 75.35 111.4 -176.275 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 97' ' ' ASP . 37.7 Cg_exo -63.81 78.05 0.15 Allowed 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.069 2.512 . . . . 75.23 112.775 177.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -76.03 136.52 39.95 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.322 -0.854 . . . . 64.55 111.702 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -161.66 20.82 0.11 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.514 -0.766 . . . . 64.23 109.833 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -102.19 114.81 29.29 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.479 -0.782 . . . . 71.25 111.207 -173.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.3 pp -136.43 169.87 16.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.055 0.455 . . . . 64.33 112.043 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 65.1 mt -104.35 114.56 44.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.242 -0.435 . . . . 73.41 110.779 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.7 p -64.21 119.32 54.91 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 120.943 0.402 . . . . 73.31 111.735 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.85 120.66 7.01 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.509 2.139 . . . . 64.12 112.646 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -71.1 97.84 1.56 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.796 0.331 . . . . 72.42 110.441 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.418 HD23 ' N ' ' A' ' 107' ' ' LEU . 2.3 pt? -57.26 138.87 54.22 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.153 0.501 . . . . 71.54 111.494 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -70.25 142.74 52.29 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.163 -0.471 . . . . 74.3 111.408 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -74.71 68.12 1.65 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.558 0.694 . . . . 74.21 109.555 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -81.87 -5.41 58.22 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.038 0.755 . . . . 75.41 113.038 -169.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -74.32 75.25 1.86 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.229 0.538 . . . . 74.13 111.216 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -94.84 135.52 36.25 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.311 -0.404 . . . . 74.44 110.7 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -75.2 -177.76 3.61 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.808 0.337 . . . . 65.53 111.359 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 . . . . . 0 C--O 1.252 1.221 0 CA-C-O 118.964 -0.541 . . . . 63.32 111.987 -178.112 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ptp . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.907 0.384 . . . . 62.13 111.324 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -139.0 114.1 9.45 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.369 -0.378 . . . . 64.23 111.262 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -77.66 151.05 34.45 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.832 0.349 . . . . 74.22 110.445 175.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.6 p -69.95 -40.22 75.57 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.747 0.647 . . . . 75.14 112.747 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.68 1.03 76.07 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.176 -0.535 . . . . 63.5 112.374 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -143.89 147.48 34.07 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 122.876 0.471 . . . . 73.22 109.874 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.575 ' HA ' ' HB ' ' A' ' 25' ' ' THR . 42.7 mt-10 -66.17 96.88 0.35 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.597 0.591 . . . . 55.42 112.597 -174.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 27.6 m -102.83 152.08 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.287 0.565 . . . . 53.45 111.77 176.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 23' ' ' PRO . 35.5 m -127.42 142.41 43.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.145 -0.48 . . . . 62.41 111.682 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.39 116.38 28.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.944 0.402 . . . . 53.43 111.237 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 34.4 mm -99.34 107.06 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.27 -0.423 . . . . 70.44 111.711 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.4 mp -96.7 129.03 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.049 0.452 . . . . 75.12 111.029 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 m -130.99 156.7 44.68 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.055 0.455 . . . . 73.44 111.75 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.497 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 56.3 tt0 -149.77 142.86 24.97 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 116.239 -0.437 . . . . 75.21 110.428 178.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.497 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 44.7 m-80 60.52 19.79 9.59 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.234 0.457 . . . . 74.44 112.234 -177.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.36 4.13 68.68 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 120.994 -0.622 . . . . 62.4 114.034 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -126.62 149.41 49.5 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.355 0.577 . . . . 72.5 111.896 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.6 t -68.6 132.16 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.524 -0.307 . . . . 60.52 110.945 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.5 pt -122.58 -20.14 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.041 0.756 . . . . 62.22 113.041 -176.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -160.12 138.1 9.98 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.027 -0.421 . . . . 64.21 111.737 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -134.79 124.27 24.88 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 120.573 0.225 . . . . 71.52 111.362 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.96 126.51 26.31 Favored Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 111.63 0.233 . . . . 74.53 111.63 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.498 ' HA ' HG12 ' A' ' 9' ' ' VAL . 15.2 Cg_exo -69.12 117.84 5.3 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.694 2.263 . . . . 62.13 112.2 172.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.8 mt -84.79 -61.02 1.88 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.847 0.356 . . . . 73.32 111.826 -175.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.575 ' HB ' ' HA ' ' A' ' 7' ' ' GLU . 60.7 m -61.07 110.66 1.43 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.95 0.405 . . . . 74.51 111.985 -177.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.29 -15.69 35.73 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.235 -0.507 . . . . 73.23 112.993 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -70.58 128.71 37.05 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 122.663 0.385 . . . . 54.14 111.566 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -104.3 155.89 18.37 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.066 0.46 . . . . 73.32 112.016 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.53 -165.68 54.76 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 116.06 -0.518 . . . . 63.52 114.168 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -118.64 137.89 52.98 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.008 0.432 . . . . 73.4 110.667 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -143.53 115.53 8.33 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.788 0.328 . . . . 72.44 111.455 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -111.75 143.48 42.6 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.862 0.363 . . . . 64.24 111.954 -174.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -146.71 137.94 24.23 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.981 0.419 . . . . 53.23 111.201 176.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.9 m -105.06 119.94 40.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.009 0.433 . . . . 61.24 112.088 -175.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.52 ' N ' HD12 ' A' ' 35' ' ' ILE . 3.2 mp -92.43 106.19 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.945 0.403 . . . . 75.54 110.1 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.558 ' HB2' ' NZ ' ' A' ' 36' ' ' LYS . 9.6 mtmp? -86.88 128.05 35.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.079 0.466 . . . . 65.52 111.374 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.56 -178.62 38.2 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.243 -0.503 . . . . 64.33 113.183 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -66.22 93.85 0.23 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.214 0.53 . . . . 75.44 111.297 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.97 -121.4 5.42 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 116.077 -0.51 . . . . 73.33 112.33 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.82 12.09 29.37 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.144 0.497 . . . . 64.21 111.269 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -83.77 67.02 9.36 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.145 -0.48 . . . . 75.5 112.13 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -97.86 158.03 15.75 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.595 0.591 . . . . 73.41 112.595 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -131.36 133.41 45.27 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.461 0.704 . . . . 64.52 110.574 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.8 tp -105.46 107.38 18.33 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.79 0.329 . . . . 74.03 111.271 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.757 ' SD ' HG12 ' A' ' 54' ' ' ILE . 87.7 mmm -94.65 122.61 37.43 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.91 0.386 . . . . 73.02 111.124 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -108.14 117.67 34.75 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.791 0.329 . . . . 72.11 111.381 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.1 t -96.23 109.01 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.373 -0.376 . . . . 72.35 110.429 174.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.505 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 31.3 t70 -108.64 107.94 18.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.042 0.449 . . . . 61.33 110.344 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.3 -107.03 1.06 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.901 -0.666 . . . . 54.12 112.679 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -116.42 27.34 9.28 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.268 0.556 . . . . 73.45 111.668 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 17.3 ptt180 -142.76 148.03 36.53 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.043 -0.526 . . . . 74.21 110.898 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.5 tt -129.62 145.67 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 112.018 0.377 . . . . 71.11 112.018 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -149.69 168.96 22.14 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.885 0.374 . . . . 73.23 111.693 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.757 HG12 ' SD ' ' A' ' 45' ' ' MET . 35.3 mt -96.36 118.71 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.502 -0.317 . . . . 64.21 110.46 169.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -85.83 -36.37 20.07 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.912 0.387 . . . . 72.1 111.611 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -153.38 138.75 17.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.538 -0.301 . . . . 71.14 111.53 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.409 ' OD2' HG23 ' A' ' 65' ' ' VAL . 2.4 p30 -153.51 151.51 29.89 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.997 0.427 . . . . 73.21 110.596 175.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -102.01 74.94 1.49 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.019 0.438 . . . . 65.35 110.994 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.6 p -124.89 150.88 67.5 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-N 116.492 -0.322 . . . . 64.55 110.272 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.02 -29.17 40.79 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.356 2.037 . . . . 63.12 111.708 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.87 -35.82 25.92 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.397 -0.819 . . . . 74.23 111.89 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.481 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 27.2 mm-40 62.95 21.54 12.93 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.385 0.513 . . . . 73.54 112.385 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.555 ' O ' ' HG3' ' A' ' 67' ' ' MET . 89.6 t -57.8 -38.26 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.495 -0.321 . . . . 74.32 111.658 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.43 -57.22 14.22 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.642 -0.313 . . . . 61.33 113.45 -176.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.409 HG23 ' OD2' ' A' ' 57' ' ' ASP . 54.1 t -62.18 -34.85 65.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 120.952 0.406 . . . . 64.21 111.582 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 14.1 mptt -66.13 -28.38 68.76 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.467 0.543 . . . . 74.12 112.467 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.555 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 53.4 mtp -64.18 -24.12 67.56 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 122.064 -0.397 . . . . 74.44 111.708 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.34 -153.84 41.69 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 114.446 0.538 . . . . 51.44 114.446 173.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -80.82 142.21 33.92 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.125 0.488 . . . . 74.41 112.06 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 74.2 mmtt -125.61 133.87 52.1 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.01 -0.541 . . . . 55.14 109.672 175.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 54.0 p -155.77 28.35 0.38 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.171 1.174 . . . . 54.0 114.171 -170.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -160.33 162.32 33.45 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.773 0.657 . . . . 65.11 112.773 171.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.04 118.02 5.79 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.057 -0.52 . . . . 61.54 111.216 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 123.01 -17.16 8.12 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.267 -0.492 . . . . 31.34 112.682 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.538 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 64.5 m-20 -75.58 128.15 34.64 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 122.472 -0.428 . . . . 74.12 111.399 176.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 81.7 p -130.76 144.23 51.29 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.893 0.377 . . . . 71.04 111.702 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.557 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 45.5 mm -114.67 128.15 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 122.817 0.447 . . . . 54.35 110.348 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.15 115.83 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.033 0.444 . . . . 73.45 111.664 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 86.2 m -123.4 71.06 1.06 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.448 -0.342 . . . . 63.41 111.277 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.561 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 89.0 mt -53.15 -50.2 83.52 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 112.574 0.583 . . . . 55.23 112.574 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 53.2 Cg_exo -54.24 -20.76 20.46 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.15 1.9 . . . . 72.34 113.387 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -110.01 -1.73 17.46 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.263 0.468 . . . . 71.5 112.263 -175.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 63.41 17.39 10.27 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.539 0.336 . . . . 41.41 111.809 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.91 138.02 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.915 0.388 . . . . 62.3 111.652 -176.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -141.93 131.4 23.8 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.374 -0.375 . . . . 62.55 110.791 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.557 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 47.5 t -127.38 145.76 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.573 0.225 . . . . 64.31 111.059 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -144.13 153.69 42.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.671 0.272 . . . . 63.13 110.883 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.477 HD12 ' HB2' ' A' ' 75' ' ' ASP . 59.5 mt -110.74 126.24 68.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.85 0.357 . . . . 64.42 111.051 175.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.05 177.77 6.43 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.348 -0.387 . . . . 72.01 110.248 176.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 28.4 t -107.07 151.47 25.31 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.213 0.53 . . . . 70.24 111.811 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.5 p -62.07 -23.99 66.83 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.759 -0.655 . . . . 72.23 111.182 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.473 ' HG2' ' OG ' ' A' ' 90' ' ' SER . 2.7 pt20 -72.5 166.84 21.85 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.932 0.396 . . . . 74.44 110.578 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -59.97 148.13 36.41 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.136 0.493 . . . . 73.52 112.176 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -133.31 141.21 47.86 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.276 0.56 . . . . 71.15 111.293 172.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 66.7 p -82.11 134.01 35.31 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.029 -0.532 . . . . 75.43 112.0 -176.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.574 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 9.1 mtpm? -138.38 158.39 44.36 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.257 0.551 . . . . 64.11 112.164 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -97.05 149.0 35.21 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.817 -0.629 . . . . 53.41 109.83 171.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -51.67 -52.27 9.36 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.316 2.01 . . . . 60.44 111.966 175.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -141.31 130.35 23.29 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.406 0.622 . . . . 75.0 112.06 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 47.9 p -120.58 44.0 2.59 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.755 -0.657 . . . . 71.3 109.582 170.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 65.33 31.63 10.37 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.275 -0.875 . . . . 74.22 111.086 -172.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.9 tp -76.46 93.62 3.55 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.735 -0.666 . . . . 73.32 110.484 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 45.6 mm -74.7 89.38 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.275 0.56 . . . . 43.22 110.86 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.6 m -66.32 140.45 96.76 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.084 -0.507 . . . . 53.33 110.965 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.82 99.75 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.101 2.534 . . . . 62.53 114.245 -174.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -89.6 105.21 17.65 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.207 -0.451 . . . . 65.21 109.836 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -53.84 113.78 1.33 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.957 0.408 . . . . 71.34 111.989 -176.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -46.85 -50.06 19.14 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.715 -0.675 . . . . 75.42 111.813 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -164.49 168.6 18.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.908 -0.587 . . . . 65.14 110.959 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -69.34 144.57 53.45 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.138 0.494 . . . . 72.12 111.638 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -112.59 99.82 8.25 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.102 -0.499 . . . . 72.13 110.484 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -57.68 107.23 0.43 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.242 0.544 . . . . 72.34 111.106 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -84.52 -61.16 1.86 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.919 -0.582 . . . . 73.33 112.151 -173.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.894 -0.574 . . . . 51.44 112.003 -176.457 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 tpt . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 110.44 -0.207 . . . . 72.21 110.44 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt 55.63 71.28 0.56 Allowed 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.223 0.535 . . . . 74.52 111.277 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -111.65 122.65 48.38 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.173 -0.467 . . . . 71.22 111.381 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.8 m -106.1 138.99 41.33 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.963 0.411 . . . . 74.4 112.039 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.5 -64.85 1.78 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.253 -0.498 . . . . 52.35 112.438 175.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -123.15 151.69 41.88 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.508 0.323 . . . . 75.21 111.281 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -122.67 124.21 42.91 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.053 0.39 . . . . 64.32 112.053 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.4 m -115.96 152.68 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 121.288 0.566 . . . . 72.11 112.02 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 23' ' ' PRO . 27.8 m -127.0 148.51 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.122 -0.49 . . . . 75.13 111.647 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -102.67 115.47 30.65 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.984 0.421 . . . . 73.35 111.512 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.8 mm -100.4 116.51 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.339 -0.391 . . . . 74.11 111.146 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.506 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.0 mp -97.63 127.46 49.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.041 0.448 . . . . 61.51 111.288 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.4 p -124.35 153.03 42.42 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.223 0.535 . . . . 65.25 111.453 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -139.74 127.04 21.31 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.941 -0.572 . . . . 71.21 110.999 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.56 ' N ' HD22 ' A' ' 15' ' ' ASN . 0.8 OUTLIER 61.14 17.0 7.66 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.347 0.499 . . . . 75.15 112.347 178.061 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.16 -31.6 6.16 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.258 -0.496 . . . . 63.54 113.802 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -98.42 147.58 24.57 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 122.202 -0.587 . . . . 73.22 112.102 -177.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -70.17 134.77 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 122.3 -0.25 . . . . 71.21 110.493 173.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.3 pt -120.07 -29.81 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.785 0.661 . . . . 74.4 112.785 -177.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -152.95 141.0 20.33 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.879 0.371 . . . . 73.44 111.591 -176.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -131.3 124.93 31.5 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.771 0.319 . . . . 44.03 111.226 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 47' ' ' VAL . 4.1 mp -124.79 124.37 25.55 Favored Pre-proline 0 N--CA 1.474 0.772 0 CA-C-O 120.597 0.237 . . . . 73.41 111.467 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.425 ' HA ' HG12 ' A' ' 9' ' ' VAL . 60.2 Cg_endo -72.93 119.59 6.15 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.242 1.961 . . . . 71.14 111.812 172.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.8 mt -80.97 -63.06 1.49 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.073 0.463 . . . . 62.13 111.471 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.3 m -59.77 121.74 12.44 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.35 -0.386 . . . . 60.13 111.423 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.71 3.03 77.93 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.238 -0.506 . . . . 70.12 113.787 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.497 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 42.5 t-80 -77.51 129.12 35.27 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.305 -0.527 . . . . 73.13 111.235 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -94.31 137.52 33.37 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.989 0.423 . . . . 71.34 112.026 -177.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.89 -167.1 54.66 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 114.79 0.676 . . . . 74.21 114.79 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -118.66 122.45 42.56 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.861 0.464 . . . . 43.42 110.502 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -117.05 139.57 50.54 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 122.242 -0.286 . . . . 75.1 111.325 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -131.08 129.47 41.95 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.819 0.343 . . . . 73.42 111.311 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -138.98 141.93 38.37 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.896 0.379 . . . . 74.42 111.692 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.8 m -97.46 119.07 35.33 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.073 0.463 . . . . 40.04 111.767 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.7 mt -81.64 116.91 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.05 -0.523 . . . . 72.34 110.808 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -80.38 123.16 27.78 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.814 0.34 . . . . 74.31 111.664 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -110.85 -163.28 18.36 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.367 -0.444 . . . . 71.13 112.435 175.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -69.95 123.16 20.83 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 122.416 -0.461 . . . . 51.31 111.979 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.05 -103.74 0.43 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.343 -0.456 . . . . 64.45 113.673 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.41 -3.77 46.41 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.75 0.648 . . . . 63.33 112.75 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -76.07 133.55 40.29 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 111.799 0.296 . . . . 65.3 111.799 -176.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -158.2 163.82 37.12 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.899 0.38 . . . . 62.44 111.762 176.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -136.99 115.3 11.74 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.322 -0.399 . . . . 73.24 111.18 175.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 56' ' ' GLU . 42.3 tp -87.92 103.34 15.59 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.22 0.533 . . . . 72.21 110.814 177.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.812 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.1 mmm -92.86 144.71 25.01 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.9 -0.591 . . . . 60.52 111.468 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -130.16 126.68 38.05 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.944 0.402 . . . . 71.53 111.528 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.531 HG21 HG21 ' A' ' 22' ' ' ILE . 44.4 t -110.02 107.62 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.163 -0.472 . . . . 70.11 110.319 175.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 31.0 t70 -108.03 109.42 20.87 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.486 0.315 . . . . 74.31 110.42 -176.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' A' ' 27' ' ' HIS . . . 57.79 -110.36 2.33 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.775 -0.726 . . . . 54.5 112.355 -175.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -110.24 18.05 20.31 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 120.886 0.375 . . . . 74.31 111.888 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 33.7 ptt180 -131.89 147.04 52.45 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.819 0.342 . . . . 74.12 111.465 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.0 tt -130.36 147.92 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.149 0.499 . . . . 72.11 112.188 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -159.87 165.52 32.06 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.088 -0.506 . . . . 74.32 111.415 177.241 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.812 HG12 ' SD ' ' A' ' 45' ' ' MET . 58.0 mt -89.91 120.42 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.946 0.403 . . . . 71.01 110.569 174.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -87.47 -31.21 20.12 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.493 -0.321 . . . . 63.11 111.746 -175.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.448 ' HB3' HD23 ' A' ' 44' ' ' LEU . 39.5 tt0 -167.95 138.98 2.83 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.086 0.47 . . . . 43.43 112.157 -175.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -161.04 -178.17 6.59 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.236 -0.438 . . . . 73.24 110.477 174.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -115.01 42.12 2.26 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.595 0.591 . . . . 73.0 112.595 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.8 m -88.01 131.75 42.01 Favored Pre-proline 0 N--CA 1.475 0.793 0 O-C-N 121.919 -0.488 . . . . 65.24 110.067 173.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.62 -40.9 71.83 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.342 2.028 . . . . 71.41 112.978 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.9 -13.36 31.35 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.433 0.531 . . . . 61.01 112.433 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 40.02 67.96 0.43 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.294 0.568 . . . . 72.3 112.477 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.2 t -74.05 -46.83 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.141 -0.482 . . . . 72.22 111.553 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.639 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -56.3 -43.71 89.52 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.436 -0.411 . . . . 64.15 113.722 -178.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -61.44 -38.14 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.091 0.472 . . . . 74.24 111.722 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -71.26 -28.35 64.1 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.047 0.388 . . . . 73.51 112.047 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 25.6 mmt -57.34 -28.94 63.56 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.924 0.393 . . . . 72.34 112.026 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.6 -155.64 39.71 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.294 -0.479 . . . . 63.14 113.781 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -82.48 119.47 24.25 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.957 0.408 . . . . 75.21 111.841 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 75.2 mmtt -111.41 151.01 29.0 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.244 -0.435 . . . . 63.32 110.041 175.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 63.2 p -168.65 6.52 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.546 1.313 . . . . 75.34 114.546 -174.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -124.94 152.46 44.1 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.64 -0.663 . . . . 72.33 112.28 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.401 ' HB1' ' HD3' ' A' ' 96' ' ' LYS . . . -59.4 99.99 0.07 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.719 -0.673 . . . . 74.52 111.25 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.18 -19.91 2.66 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.933 -0.576 . . . . 74.31 112.526 -175.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.443 ' HB2' HD12 ' A' ' 88' ' ' ILE . 76.1 m-20 -76.63 134.72 39.24 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.804 0.335 . . . . 71.2 111.491 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.538 HG22 ' HA ' ' A' ' 87' ' ' GLU . 45.0 p -135.75 150.19 49.42 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.09 0.471 . . . . 74.54 111.665 176.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.462 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 50.2 mm -115.99 127.37 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.198 -0.455 . . . . 71.13 110.75 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -115.22 118.65 59.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.97 0.414 . . . . 64.51 111.874 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 90.1 m -121.75 75.77 1.22 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.411 -0.359 . . . . 64.53 111.331 176.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.541 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 91.9 mt -55.36 -50.65 85.51 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 113.133 0.79 . . . . 61.34 113.133 -176.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.541 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 46.7 Cg_exo -56.93 -17.15 22.88 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.889 1.726 . . . . 74.25 113.461 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 47.8 m170 -114.49 -4.11 12.92 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 122.184 -0.323 . . . . 73.25 111.751 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm 61.36 30.61 19.1 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.847 0.459 . . . . 74.31 111.923 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 80.0 t -110.0 138.75 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.832 0.349 . . . . 64.42 111.294 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -139.12 132.64 30.32 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.79 0.329 . . . . 72.44 111.308 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 47.7 t -121.29 134.29 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 122.332 -0.23 . . . . 75.01 111.142 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.538 ' HA ' HG22 ' A' ' 76' ' ' THR . 8.6 pt-20 -123.6 126.31 46.4 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.046 0.45 . . . . 72.12 111.709 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.443 HD12 ' HB2' ' A' ' 75' ' ' ASP . 59.8 mt -95.58 116.73 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.212 0.529 . . . . 71.53 110.432 175.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -127.77 160.54 31.42 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.178 0.513 . . . . 71.21 111.899 -172.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.3 t -87.62 149.13 24.49 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.065 0.46 . . . . 62.21 111.76 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.3 p -88.33 -15.49 35.55 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.075 -0.511 . . . . 73.31 111.26 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -107.83 -178.25 3.57 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.013 -0.54 . . . . 75.24 111.7 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -83.0 125.54 31.54 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.859 0.361 . . . . 73.34 111.767 177.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -162.14 172.41 15.88 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.964 0.412 . . . . 63.0 111.442 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 79.0 p -89.33 109.95 20.8 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.314 0.487 . . . . 70.33 112.314 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.401 ' HD3' ' HB1' ' A' ' 73' ' ' ALA . 35.2 mtmm -141.69 170.12 16.32 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.056 0.455 . . . . 71.13 111.632 176.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -100.22 111.81 63.02 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.041 -0.527 . . . . 75.12 111.02 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.73 -20.35 46.35 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.681 2.254 . . . . 74.21 112.681 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -122.32 132.07 54.22 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.009 -0.541 . . . . 64.23 110.61 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.1 m -153.32 123.15 6.85 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.132 0.419 . . . . 72.45 112.132 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -151.51 136.22 17.12 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.123 -0.489 . . . . 64.32 110.787 173.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.0 tp -153.34 83.72 1.19 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.385 0.612 . . . . 74.1 111.037 175.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 56.9 mt -84.5 105.73 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 116.277 -0.42 . . . . 75.54 110.558 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.5 m -80.59 139.86 51.29 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 112.71 0.633 . . . . 51.42 112.71 -174.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.97 145.82 96.6 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.751 2.3 . . . . 73.25 112.3 175.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -149.08 167.01 27.03 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.483 0.659 . . . . 73.14 112.693 -175.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 tt -71.66 131.07 42.64 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.347 -0.842 . . . . 54.41 112.026 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -71.29 121.63 18.81 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.089 0.471 . . . . 63.14 111.207 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -86.98 102.66 14.6 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.271 0.557 . . . . 74.02 111.549 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -122.88 145.35 48.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.983 0.421 . . . . 63.32 111.331 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -87.67 138.55 31.37 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.079 -0.509 . . . . 72.14 112.193 -172.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -94.59 130.67 40.94 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.24 -0.436 . . . . 73.23 111.183 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -104.2 -42.17 5.59 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.085 0.469 . . . . 72.22 110.692 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 . . . . . 0 C--O 1.251 1.15 0 CA-C-N 115.851 -0.613 . . . . 53.34 110.744 176.901 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.919 0.39 . . . . 72.45 111.797 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -82.6 83.5 7.59 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.974 0.416 . . . . 71.02 110.9 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -80.5 42.74 0.61 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.251 0.548 . . . . 74.02 111.767 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.6 m -73.77 117.3 15.37 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.83 -0.623 . . . . 73.43 111.772 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.49 -86.52 1.78 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.329 -0.462 . . . . 74.53 113.06 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -86.73 111.51 20.78 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.487 0.66 . . . . 73.1 112.152 -177.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.568 ' HA ' ' HB ' ' A' ' 25' ' ' THR . 46.0 mt-10 -87.98 99.65 12.31 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.178 -0.465 . . . . 72.31 110.876 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 34.5 m -102.76 161.82 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 113.282 0.845 . . . . 54.42 113.282 -174.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 23' ' ' PRO . 33.1 m -130.04 153.17 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 115.398 -0.819 . . . . 72.25 111.006 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.37 119.97 41.1 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.406 -0.361 . . . . 71.33 111.146 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.425 ' HB ' ' HG2' ' A' ' 87' ' ' GLU . 39.3 mm -101.02 111.4 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.591 -0.277 . . . . 65.13 110.949 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.481 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.6 mp -100.98 111.11 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 120.941 0.4 . . . . 65.32 111.762 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.2 p -108.86 140.56 42.16 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.746 0.308 . . . . 65.42 110.405 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.631 ' NE2' ' HA2' ' A' ' 37' ' ' GLY . 54.5 tt0 -141.33 131.67 25.12 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.258 -0.276 . . . . 72.41 111.251 -177.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.515 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 52.1 m-80 58.74 16.85 4.7 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 120.888 0.375 . . . . 41.34 111.961 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.09 -12.61 60.51 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.126 -0.559 . . . . 65.43 113.736 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 14' ' ' GLN . 21.5 pttp -109.61 132.87 53.74 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 117.273 0.536 . . . . 64.12 111.573 -178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.7 t -71.84 115.94 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.848 0.356 . . . . 54.2 110.719 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.9 pt -102.3 -23.1 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 113.156 0.799 . . . . 61.53 113.156 -173.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.6 tpp85 -157.45 126.99 6.03 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.769 0.655 . . . . 74.41 112.769 -173.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -118.01 119.18 34.0 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.629 -0.508 . . . . 62.14 109.629 173.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.59 126.33 26.49 Favored Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 112.989 0.737 . . . . 71.14 112.989 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.54 ' HA ' HG12 ' A' ' 9' ' ' VAL . 73.8 Cg_endo -76.24 111.79 3.34 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.389 2.059 . . . . 72.03 111.536 169.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.66 -69.32 0.61 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.232 0.456 . . . . 72.25 112.232 -174.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.568 ' HB ' ' HA ' ' A' ' 7' ' ' GLU . 6.7 m -59.41 124.58 20.49 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.002 0.43 . . . . 70.2 111.537 -176.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.06 -22.48 33.19 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.331 -0.462 . . . . 62.33 112.835 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -77.91 91.3 4.17 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.189 -0.595 . . . . 74.43 111.23 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -80.05 153.34 28.86 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.059 -0.518 . . . . 62.2 110.712 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.38 -162.91 27.25 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.051 -0.595 . . . . 63.54 112.971 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -118.18 145.0 45.27 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.197 0.522 . . . . 64.52 111.687 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.591 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 16.8 tp10 -139.75 139.32 36.47 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.915 -0.584 . . . . 60.01 110.209 176.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -141.66 133.4 27.15 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.865 0.364 . . . . 74.24 111.859 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -148.92 142.58 25.49 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.203 0.525 . . . . 62.12 111.772 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.8 m -98.29 115.11 27.72 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.119 -0.491 . . . . 71.02 111.729 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 60.3 mt -80.07 112.93 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.203 0.525 . . . . 72.43 111.188 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.2 mtmt -79.4 108.44 12.93 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.841 -0.618 . . . . 64.03 111.215 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.631 ' HA2' ' NE2' ' A' ' 14' ' ' GLN . . . -91.39 -86.08 1.44 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.178 -0.534 . . . . 34.02 113.722 -176.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -148.2 114.12 5.77 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.643 -0.328 . . . . 72.43 110.759 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.89 -107.9 1.5 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.119 -0.562 . . . . 74.31 112.937 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.97 -10.03 40.86 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.516 -0.402 . . . . 71.13 111.892 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -79.73 125.8 30.13 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.019 0.438 . . . . 74.01 111.925 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -145.67 172.54 13.12 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.084 -0.507 . . . . 73.33 111.308 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.439 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 15.6 m120 -136.99 110.44 7.94 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.554 -0.294 . . . . 75.02 110.681 173.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.3 tp -85.05 107.85 17.36 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.943 0.402 . . . . 73.44 110.908 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.795 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.9 mmm -100.67 150.94 22.22 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.001 0.429 . . . . 55.13 111.669 -176.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -138.84 130.84 28.0 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.209 -0.451 . . . . 75.03 111.84 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.591 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 30.4 t -113.08 107.66 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.313 -0.403 . . . . 64.34 110.492 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 8.8 t0 -130.93 140.13 50.15 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.517 0.199 . . . . 63.21 110.893 -176.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 51.87 51.08 41.55 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 114.385 0.514 . . . . 45.13 114.385 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 69.03 15.06 8.83 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.473 0.916 . . . . 61.02 113.473 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.444 ' HG3' ' HE3' ' A' ' 69' ' ' TRP . 3.6 ptp180 -147.52 166.9 25.89 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.721 -0.612 . . . . 70.41 112.58 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.1 tt -125.83 150.8 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.292 0.479 . . . . 74.24 112.292 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.485 ' HB3' ' HA ' ' A' ' 69' ' ' TRP . 1.8 ppt_? -155.68 159.16 39.33 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.146 -0.479 . . . . 74.44 111.192 177.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.795 HG12 ' SD ' ' A' ' 45' ' ' MET . 34.5 mt -85.85 115.99 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.153 0.502 . . . . 61.12 110.713 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -78.79 -34.73 45.24 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.879 -0.6 . . . . 72.23 111.895 -175.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -172.93 138.63 0.8 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.558 0.218 . . . . 71.32 111.276 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -152.75 149.93 28.87 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.93 0.395 . . . . 62.23 110.91 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -100.41 74.8 1.74 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.371 0.605 . . . . 75.24 111.599 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.0 p -124.11 149.92 61.79 Favored Pre-proline 0 N--CA 1.475 0.79 0 O-C-N 122.082 -0.387 . . . . 74.51 111.478 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.26 -23.27 45.25 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.37 2.047 . . . . 74.34 111.964 174.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.531 ' HB3' HG23 ' A' ' 63' ' ' VAL . 8.7 m-20 -73.06 -56.82 4.59 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.885 -0.598 . . . . 74.14 111.388 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 62.17 11.87 4.69 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.986 0.515 . . . . 75.12 112.296 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.531 HG23 ' HB3' ' A' ' 61' ' ' ASP . 59.9 t -56.62 -36.27 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.059 0.457 . . . . 73.23 111.177 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.567 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -58.04 -47.58 88.19 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.191 -0.528 . . . . 73.32 112.942 177.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.04 -41.84 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.195 0.521 . . . . 74.24 111.213 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -67.28 -29.28 68.85 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.213 0.449 . . . . 73.34 112.213 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 22.0 mmt -58.84 -42.26 88.87 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.726 0.298 . . . . 71.34 111.785 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.0 -139.37 28.28 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.311 -0.471 . . . . 73.44 113.112 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.485 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . 84.5 m95 -81.84 129.57 34.79 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.76 0.314 . . . . 54.12 111.491 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.454 ' HG3' HD11 ' A' ' 77' ' ' ILE . 74.7 mmtt -129.1 148.59 51.06 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.82 0.448 . . . . 52.43 110.292 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 51' ' ' ARG . 94.7 p -175.25 25.44 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.489 0.922 . . . . 71.54 113.489 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -120.16 144.56 47.61 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.614 -0.679 . . . . 75.33 111.394 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.16 96.26 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.094 0.473 . . . . 22.22 111.189 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.43 -26.42 1.99 Allowed Glycine 0 CA--C 1.525 0.697 0 CA-C-N 116.057 -0.52 . . . . 43.03 112.686 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.499 ' HB2' HD12 ' A' ' 88' ' ' ILE . 75.9 m-20 -64.57 135.35 55.89 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.876 0.37 . . . . 64.12 111.647 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.5 p -138.44 142.36 39.49 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.074 0.464 . . . . 61.33 111.617 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.454 HD11 ' HG3' ' A' ' 70' ' ' LYS . 38.7 mm -114.61 130.96 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.211 -0.449 . . . . 55.05 110.626 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.7 t -123.11 119.62 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 112.051 0.389 . . . . 63.04 112.051 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 97.8 m -121.77 88.79 3.0 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 120.733 0.302 . . . . 73.34 110.873 174.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.582 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 92.6 mt -59.25 -53.89 61.7 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 113.078 0.77 . . . . 62.14 113.078 -175.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 24.7 Cg_exo -62.81 -19.32 68.22 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.958 1.772 . . . . 65.44 113.007 -176.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -104.28 -5.04 22.22 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.483 -0.326 . . . . 73.24 111.683 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.1 mttm 58.16 34.29 24.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.811 0.445 . . . . 75.44 111.917 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.555 HG22 ' HG3' ' A' ' 14' ' ' GLN . 60.2 t -109.36 132.86 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.137 -0.483 . . . . 74.41 111.33 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -133.33 136.42 45.38 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.729 0.3 . . . . 63.03 110.695 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -132.9 139.49 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.8 -0.182 . . . . 75.0 111.214 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.425 ' HG2' ' HB ' ' A' ' 11' ' ' ILE . 10.1 pt-20 -126.15 154.52 43.06 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.794 0.331 . . . . 64.04 110.813 174.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.499 HD12 ' HB2' ' A' ' 75' ' ' ASP . 55.1 mt -118.24 123.09 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.094 0.473 . . . . 74.25 110.908 174.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.488 ' HE3' ' HG3' ' A' ' 96' ' ' LYS . 8.6 ptmt -140.49 151.17 44.6 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.201 -0.454 . . . . 70.44 111.157 -175.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.516 ' OG ' ' HG2' ' A' ' 92' ' ' GLN . 22.9 t -74.2 149.82 40.68 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.064 0.459 . . . . 74.33 111.657 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.1 p -70.31 -21.22 62.95 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 116.25 -0.432 . . . . 75.34 111.837 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.516 ' HG2' ' OG ' ' A' ' 90' ' ' SER . 20.4 pt20 -87.92 -170.09 2.85 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.414 -0.357 . . . . 74.14 110.72 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -61.92 115.82 4.36 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.276 0.56 . . . . 74.45 111.286 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.478 ' OD1' ' HG2' ' A' ' 96' ' ' LYS . 9.5 t70 -107.24 164.93 11.76 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.571 -0.74 . . . . 73.21 110.765 -174.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 64.3 p -84.06 30.84 0.5 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.302 -0.408 . . . . 62.32 111.818 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.488 ' HG3' ' HE3' ' A' ' 89' ' ' LYS . 48.5 mmtm -88.3 160.72 17.52 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.041 0.448 . . . . 74.14 111.503 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -83.79 147.73 52.55 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 116.289 -0.414 . . . . 73.14 111.718 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -86.12 10.24 3.74 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.817 2.345 . . . . 71.4 113.759 -177.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -82.45 17.23 1.8 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.268 0.47 . . . . 54.23 112.268 -178.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 82.7 p -110.94 153.85 24.93 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.248 0.462 . . . . 72.54 112.248 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.9 t70 71.04 101.83 0.06 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.865 -0.607 . . . . 64.02 112.554 173.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.7 pp -168.77 -176.1 2.61 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.723 -0.672 . . . . 74.51 110.93 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 65.3 mt -67.47 105.27 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.148 0.499 . . . . 72.41 111.244 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.1 p -69.28 131.14 90.5 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 116.141 -0.482 . . . . 74.43 111.759 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.07 107.04 1.64 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.579 2.186 . . . . 64.52 112.871 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -69.6 86.47 0.47 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.085 0.469 . . . . 62.53 110.93 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.419 ' H ' HD23 ' A' ' 107' ' ' LEU . 2.4 pt? -65.58 140.4 58.53 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.031 0.443 . . . . 75.11 111.807 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -70.76 81.03 0.62 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.186 0.517 . . . . 64.52 111.674 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -133.03 119.5 20.13 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.915 0.388 . . . . 73.3 110.359 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -72.92 116.26 13.21 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.491 0.552 . . . . 75.35 112.491 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -154.15 110.11 3.24 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.154 0.502 . . . . 64.42 110.775 173.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -60.97 105.79 0.51 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.05 0.452 . . . . 73.43 111.921 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -97.4 116.2 29.17 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.091 -0.504 . . . . 73.35 110.92 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.652 -0.69 . . . . 73.41 111.506 -179.468 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.0 mmm . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 112.077 0.399 . . . . 54.41 112.077 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.625 ' HA ' ' HE2' ' A' ' 2' ' ' LYS . 0.6 OUTLIER -79.0 99.47 6.87 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.045 0.45 . . . . 74.4 110.801 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -68.14 149.36 49.69 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.21 -0.45 . . . . 53.11 111.251 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.627 ' HB ' HG23 ' A' ' 25' ' ' THR . 25.1 m -61.41 128.04 34.41 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.671 -0.24 . . . . 73.22 111.159 178.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.19 -44.18 67.61 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.885 -0.674 . . . . 64.33 112.461 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.01 87.63 4.81 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.184 0.516 . . . . 75.53 110.437 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.554 ' HG2' HG21 ' A' ' 25' ' ' THR . 42.1 mt-10 -81.08 136.31 35.93 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.185 -0.462 . . . . 74.14 112.08 -175.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.478 HG23 ' HB2' ' A' ' 24' ' ' LEU . 31.3 m -125.54 139.16 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.164 0.506 . . . . 71.41 111.45 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.3 m -121.96 138.64 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 116.178 -0.465 . . . . 74.11 111.193 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.26 112.64 24.31 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.823 0.344 . . . . 72.01 111.333 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.2 mm -95.04 115.16 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.403 -0.362 . . . . 63.14 110.982 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.486 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.2 mp -97.25 114.64 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.047 0.451 . . . . 71.52 111.509 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.5 m -114.39 134.74 54.76 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.219 -0.446 . . . . 53.32 111.448 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.472 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 49.8 tt0 -126.82 131.27 51.27 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 122.337 -0.227 . . . . 75.32 111.051 177.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.521 HD22 ' N ' ' A' ' 15' ' ' ASN . 0.8 OUTLIER 56.42 28.05 13.03 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.429 0.529 . . . . 73.44 112.429 176.355 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.12 21.57 41.43 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.253 -0.498 . . . . 60.32 114.34 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -146.78 140.33 25.75 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.308 0.554 . . . . 74.12 111.657 175.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.9 t -72.36 118.97 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.791 0.329 . . . . 75.3 111.014 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.1 pt -99.43 -23.44 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 112.219 0.451 . . . . 63.43 112.219 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -173.16 148.04 1.64 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.703 0.287 . . . . 75.32 111.014 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -131.33 127.37 37.52 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.179 0.514 . . . . 72.43 111.442 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.428 HD12 ' N ' ' A' ' 22' ' ' ILE . 3.4 mp -113.67 116.12 45.95 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 116.358 -0.383 . . . . 62.25 111.418 -177.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.45 120.59 7.82 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.172 1.915 . . . . 72.44 111.757 172.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.478 ' HB2' HG23 ' A' ' 8' ' ' VAL . 86.9 mt -80.11 -48.89 12.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.056 0.455 . . . . 72.52 111.5 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.627 HG23 ' HB ' ' A' ' 4' ' ' THR . 86.2 m -60.57 110.16 1.21 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.975 0.417 . . . . 74.03 111.805 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.73 0.53 60.55 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.059 -0.591 . . . . 73.34 113.465 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -72.51 86.49 1.17 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 117.159 0.48 . . . . 74.2 110.547 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -72.95 115.96 12.88 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.184 0.516 . . . . 72.33 111.953 -176.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.5 -166.49 14.37 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.145 -0.479 . . . . 54.2 113.952 177.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -116.89 136.6 52.83 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.763 0.425 . . . . 74.34 110.422 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -145.68 129.91 17.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.902 0.382 . . . . 53.53 111.592 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -121.72 147.6 45.7 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.6 -0.273 . . . . 73.44 111.561 -177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -147.99 143.69 27.45 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.966 0.412 . . . . 71.22 111.307 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -103.39 126.7 50.69 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.17 0.51 . . . . 65.51 112.216 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' A' ' 43' ' ' ASN . 60.7 mt -90.69 132.75 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.121 -0.491 . . . . 55.35 110.66 175.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.58 125.88 48.31 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.997 0.427 . . . . 64.21 111.223 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -113.42 -164.6 15.77 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.29 -0.481 . . . . 25.32 113.831 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -59.07 113.28 2.03 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.895 0.379 . . . . 74.44 112.011 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.54 -125.1 7.86 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.242 -0.504 . . . . 41.12 113.242 178.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.8 9.93 28.15 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.205 0.446 . . . . 51.1 112.205 -178.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.415 ' HA ' HD21 ' A' ' 58' ' ' ASN . 19.0 mm-40 -74.01 132.75 42.68 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.649 -0.251 . . . . 75.35 111.572 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -137.26 174.36 10.69 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.929 0.395 . . . . 64.54 111.125 174.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.531 HD22 ' HB3' ' A' ' 57' ' ' ASP . 2.1 t-20 -152.21 109.64 3.58 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.249 -0.282 . . . . 63.04 111.031 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.2 tp -86.6 105.12 16.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.96 0.41 . . . . 55.31 111.147 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.756 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.4 mmm -95.51 135.62 36.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.147 -0.479 . . . . 72.13 111.05 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.67 127.39 48.13 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.255 0.55 . . . . 72.31 111.96 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.3 t -112.44 107.87 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.03 -0.532 . . . . 61.2 110.586 176.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -112.33 112.35 23.87 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.763 0.316 . . . . 70.02 110.569 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 63.52 -121.46 23.99 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.938 -0.648 . . . . 64.33 112.506 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -106.25 25.81 10.58 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 122.469 -0.43 . . . . 72.34 111.668 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.8 ptt85 -140.92 145.52 36.18 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.204 0.526 . . . . 63.31 111.795 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.9 tt -123.72 153.94 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 116.1 -0.5 . . . . 54.02 111.479 -176.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -157.33 168.47 27.29 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.005 0.431 . . . . 74.14 111.424 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.756 HG12 ' SD ' ' A' ' 45' ' ' MET . 45.3 mt -91.54 123.92 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 109.749 -0.463 . . . . 73.22 109.749 168.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -93.49 -34.06 13.54 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.38 0.511 . . . . 71.45 112.38 -172.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -169.0 139.28 2.29 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.577 -0.283 . . . . 73.54 111.293 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.531 ' HB3' HD22 ' A' ' 43' ' ' ASN . 6.8 p-10 -161.22 160.99 30.68 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.987 0.422 . . . . 71.43 111.536 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.415 HD21 ' HA ' ' A' ' 41' ' ' GLN . 18.0 p-10 -96.09 74.04 2.98 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.45 0.643 . . . . 75.52 111.858 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 84.2 p -125.7 148.84 63.49 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-N 116.381 -0.372 . . . . 70.34 110.92 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.46 -3.18 13.45 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.394 2.062 . . . . 73.24 112.639 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -110.49 -43.81 3.81 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.265 -0.425 . . . . 62.25 111.949 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.408 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 26.7 mm-40 63.47 30.42 15.3 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.854 0.359 . . . . 72.51 111.383 -177.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.2 t -52.56 -42.19 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 111.955 0.354 . . . . 70.21 111.955 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.625 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -55.38 -43.98 84.92 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.068 -0.587 . . . . 62.04 112.883 176.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.1 t -64.71 -39.22 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 120.854 0.359 . . . . 73.4 111.069 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.408 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 1.6 mptm? -65.05 -41.63 94.98 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.718 0.294 . . . . 73.3 111.402 177.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.9 mmt -57.43 -44.28 84.53 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.447 0.536 . . . . 71.03 112.447 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.96 -160.93 43.31 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 120.933 -0.651 . . . . 54.43 113.683 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -67.09 146.77 53.95 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.692 0.626 . . . . 74.3 112.692 -174.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.513 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 33.3 mmtm -135.63 140.67 44.74 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.89 -0.595 . . . . 65.5 110.33 177.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 82.2 p -164.84 11.06 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.29 0.848 . . . . 54.52 113.29 -176.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -114.13 153.9 28.73 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.938 -0.477 . . . . 71.52 111.653 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 90' ' ' SER . . . -69.11 91.34 0.5 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.211 0.529 . . . . 34.41 111.024 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.27 -22.33 2.41 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.893 -0.594 . . . . 65.2 112.337 -175.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.513 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 94.4 m-20 -63.36 142.86 58.23 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.938 0.399 . . . . 75.24 111.611 177.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.0 p -143.7 161.49 38.43 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.202 0.525 . . . . 71.24 111.645 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.3 mm -128.07 114.0 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.829 -0.623 . . . . 62.11 110.247 176.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.0 t -109.22 115.63 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.817 0.342 . . . . 71.51 111.442 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 74.2 m -123.34 88.09 2.86 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.699 0.285 . . . . 71.21 111.18 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.402 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 80.5 mt -62.65 -45.37 88.4 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 113.096 0.776 . . . . 74.01 113.096 -176.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 50.3 Cg_exo -53.74 -25.76 35.6 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 122.16 1.907 . . . . 71.33 113.556 179.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -112.39 -1.24 15.1 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.106 0.41 . . . . 63.51 112.106 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 59.88 33.56 21.59 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.964 0.411 . . . . 64.13 111.791 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 68.0 t -105.65 135.66 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.274 -0.421 . . . . 75.52 111.335 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -139.35 116.21 10.88 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.257 -0.429 . . . . 70.55 110.853 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.1 t -113.35 126.44 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.569 -0.287 . . . . 64.23 111.208 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -120.78 136.79 54.8 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.084 0.469 . . . . 72.41 111.467 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 62.9 mt -103.01 120.79 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.853 0.359 . . . . 71.25 111.331 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -124.4 147.06 48.51 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.106 -0.497 . . . . 73.3 111.064 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 48.1 t -92.45 150.28 20.89 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.188 0.518 . . . . 72.11 112.115 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' A' ' 7' ' ' GLU . 46.9 p -79.72 -13.78 59.21 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.895 -0.593 . . . . 73.21 110.783 174.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -88.32 134.0 33.92 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.108 -0.496 . . . . 72.24 111.077 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.411 ' O ' ' HD2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -59.8 152.23 23.55 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.013 0.745 . . . . 70.43 113.013 -178.221 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -90.03 -177.58 5.22 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.557 -0.747 . . . . 72.03 112.058 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.3 t -165.81 166.92 17.37 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 116.222 -0.445 . . . . 24.24 111.47 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.95 162.46 40.3 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.423 -0.353 . . . . 73.44 111.821 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -95.34 115.41 65.42 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 111.687 0.254 . . . . 73.04 111.687 177.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.26 -24.72 50.53 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.462 2.108 . . . . 74.53 111.581 170.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -71.57 90.95 1.04 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.819 -0.628 . . . . 73.41 111.544 178.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.6 p -80.83 160.31 24.84 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.939 0.4 . . . . 74.25 111.268 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -89.15 124.97 34.84 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.101 0.477 . . . . 73.1 111.194 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.5 tp -95.49 110.4 22.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.467 -0.333 . . . . 65.53 110.675 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.2 mm -112.35 106.61 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.805 0.336 . . . . 73.24 111.171 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.4 t 54.2 96.17 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 112.91 0.707 . . . . 75.31 112.91 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -75.99 155.63 38.48 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.238 2.625 . . . . 73.44 112.311 172.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -69.22 148.92 49.16 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.236 0.541 . . . . 64.25 112.141 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 107' ' ' LEU . 3.1 mm? -93.79 -173.85 3.27 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.158 -0.474 . . . . 73.04 110.715 176.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.52 -168.81 1.7 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.776 0.322 . . . . 64.4 111.477 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -119.59 102.84 8.92 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.088 0.47 . . . . 75.25 111.125 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.65 92.22 0.46 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.621 0.6 . . . . 73.42 112.621 -177.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -120.08 -10.92 9.34 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.883 -0.599 . . . . 75.02 110.753 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -77.7 127.35 32.3 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.232 0.539 . . . . 75.22 112.177 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -164.72 121.42 1.54 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.492 -0.776 . . . . 72.2 110.386 176.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 . . . . . 0 C--O 1.249 1.05 0 N-CA-C 112.623 0.601 . . . . 74.03 112.623 -176.518 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.717 0.294 . . . . 72.01 111.607 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -91.85 101.07 13.66 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.812 0.339 . . . . 73.42 110.194 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -73.52 83.49 1.51 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.409 0.624 . . . . 73.11 111.102 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.541 HG21 HG23 ' A' ' 25' ' ' THR . 32.8 m -63.14 133.45 54.42 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.58 -0.736 . . . . 54.11 111.711 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.04 -51.23 46.73 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 121.339 -0.457 . . . . 54.05 114.087 -176.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -148.57 163.16 38.05 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 120.851 0.357 . . . . 74.13 111.74 -175.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.4 ' HA ' ' CB ' ' A' ' 25' ' ' THR . 53.6 mt-10 -91.24 107.03 18.93 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.137 0.494 . . . . 64.04 111.654 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.6 m -120.87 154.26 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 121.155 0.502 . . . . 73.44 112.031 -177.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 23' ' ' PRO . 34.5 m -121.57 147.6 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.03 -0.532 . . . . 72.21 111.282 177.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.99 117.59 34.59 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.835 0.35 . . . . 72.11 111.527 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.9 mm -100.78 122.42 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.561 -0.291 . . . . 72.04 111.051 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.3 mp -107.8 113.88 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.051 0.453 . . . . 34.23 110.923 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.1 m -120.35 134.91 55.18 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.173 -0.467 . . . . 71.15 111.531 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.531 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 62.8 tt0 -119.29 138.84 52.75 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.648 0.261 . . . . 63.12 110.919 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.531 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 54.7 m-80 59.72 17.25 6.16 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.732 0.413 . . . . 72.54 111.98 -177.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.3 3.4 63.28 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.118 -0.563 . . . . 75.11 113.827 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -124.84 140.33 53.03 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 117.238 0.519 . . . . 71.34 111.23 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.34 129.16 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.844 0.354 . . . . 73.04 111.689 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.5 pt -112.78 -31.49 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 116.414 -0.357 . . . . 73.01 111.663 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -157.62 144.94 18.43 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.681 0.277 . . . . 74.3 111.257 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -138.51 132.08 30.64 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 120.77 0.319 . . . . 75.02 110.739 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 22' ' ' ILE . 4.0 mp -126.3 119.39 23.41 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 120.567 0.222 . . . . 53.34 111.552 -177.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.458 ' HA ' HG12 ' A' ' 9' ' ' VAL . 43.1 Cg_endo -68.29 101.6 0.74 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.075 1.85 . . . . 62.13 111.535 172.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.18 -62.44 1.77 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.354 0.502 . . . . 73.34 112.354 -173.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.541 HG23 HG21 ' A' ' 4' ' ' THR . 15.0 m -58.58 131.18 50.04 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.94 0.4 . . . . 72.13 111.443 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.62 -33.21 4.9 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.239 -0.505 . . . . 72.54 112.667 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -74.07 85.57 1.82 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.424 0.631 . . . . 71.41 110.82 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -86.74 167.62 14.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.68 -0.691 . . . . 65.12 111.633 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.73 -162.37 51.91 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 120.909 -0.662 . . . . 71.41 112.807 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.442 HD21 ' HG3' ' A' ' 46' ' ' GLU . 4.3 t-20 -117.77 146.59 43.7 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.197 -0.59 . . . . 72.43 111.836 -176.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -161.19 116.92 2.16 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.818 -0.628 . . . . 52.4 110.285 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -113.86 145.96 40.7 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.822 0.344 . . . . 74.31 111.22 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -138.2 139.93 39.52 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.15 0.5 . . . . 71.3 111.481 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.4 m -98.87 121.2 40.52 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.955 -0.566 . . . . 72.34 112.077 -175.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 75.0 mt -91.58 123.37 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.121 -0.49 . . . . 75.14 111.31 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -103.07 124.39 48.45 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.508 0.194 . . . . 72.04 111.117 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -123.02 -143.23 6.32 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.064 -0.589 . . . . 64.01 113.679 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -60.93 106.78 0.62 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.183 0.438 . . . . 73.35 112.183 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.78 -116.88 8.17 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.216 -0.447 . . . . 74.32 113.454 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.78 6.72 48.13 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.031 0.382 . . . . 65.13 112.031 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -75.26 111.07 10.14 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.619 0.247 . . . . 74.11 111.563 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -127.12 164.89 20.61 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.016 0.436 . . . . 72.23 111.353 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.453 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 17.6 m120 -140.05 123.55 17.13 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.233 -0.439 . . . . 73.34 111.127 176.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 56' ' ' GLU . 62.7 tp -96.65 104.19 16.16 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.893 0.378 . . . . 70.14 110.84 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.756 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.4 mmm -94.38 128.8 41.14 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.24 -0.437 . . . . 65.13 111.237 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.442 ' HG3' HD21 ' A' ' 30' ' ' ASN . 40.2 tt0 -115.13 118.81 34.41 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.942 0.401 . . . . 53.04 111.962 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.9 t -104.02 114.33 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.155 -0.475 . . . . 71.41 110.001 171.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -133.67 92.46 2.98 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.924 -0.485 . . . . 71.15 112.167 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.76 67.72 1.72 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.294 -0.479 . . . . 72.2 114.249 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 60.64 26.86 16.58 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.72 0.637 . . . . 53.01 112.72 175.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -149.27 150.66 32.92 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.565 0.346 . . . . 60.41 110.319 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.8 tt -134.62 151.81 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.191 0.441 . . . . 64.54 112.191 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -157.18 168.4 27.54 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.202 -0.454 . . . . 74.54 111.496 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.756 HG12 ' SD ' ' A' ' 45' ' ' MET . 54.4 mt -92.27 110.05 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 109.47 -0.567 . . . . 72.32 109.47 169.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -86.37 -39.1 16.75 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 111.841 0.311 . . . . 65.41 111.841 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 44' ' ' LEU . 10.8 tp10 -138.86 146.95 41.82 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.739 0.304 . . . . 74.04 110.695 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -168.5 140.15 2.73 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.575 0.35 . . . . 74.0 110.329 -174.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -106.6 38.01 2.18 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.413 0.523 . . . . 74.31 112.413 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.2 m -84.1 138.5 39.66 Favored Pre-proline 0 N--CA 1.471 0.595 0 O-C-N 122.058 -0.401 . . . . 75.32 110.016 172.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.54 -25.74 68.51 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.307 2.004 . . . . 74.1 112.777 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.499 ' HB3' HG23 ' A' ' 63' ' ' VAL . 10.9 m-20 -84.45 -32.38 24.07 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.31 -0.404 . . . . 50.13 111.957 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.518 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 87.8 mm-40 59.54 13.48 3.34 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.136 0.791 . . . . 73.43 113.136 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 61' ' ' ASP . 97.0 t -56.15 -41.34 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 112.479 0.548 . . . . 72.52 112.479 -176.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.48 -42.48 57.46 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.191 -0.528 . . . . 73.01 113.51 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.2 t -68.82 -33.59 60.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.189 0.519 . . . . 62.23 111.333 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.518 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 13.4 mptt -73.15 -28.12 62.05 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.313 0.486 . . . . 64.22 112.313 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.43 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 90.7 mmm -52.76 -47.17 67.64 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.342 0.497 . . . . 63.34 112.342 -177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.42 -163.94 20.0 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.054 -0.593 . . . . 72.15 113.416 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -76.48 138.94 40.6 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.029 0.443 . . . . 70.41 112.014 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -126.69 146.55 50.16 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.28 -0.418 . . . . 55.11 110.639 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 82.2 p -172.2 26.42 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 112.724 0.638 . . . . 50.15 112.724 -176.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -125.16 146.39 49.51 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.686 0.279 . . . . 70.3 111.32 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.15 96.65 0.05 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.079 0.466 . . . . 74.3 111.65 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 138.14 -19.7 3.24 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 116.093 -0.503 . . . . 72.04 112.918 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -63.96 120.16 11.45 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.108 0.48 . . . . 75.13 111.588 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 87' ' ' GLU . 32.5 p -128.96 141.92 51.1 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.077 0.465 . . . . 71.33 111.421 178.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 mm -122.58 127.64 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 116.269 -0.423 . . . . 55.02 110.687 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.6 t -119.71 119.32 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.836 0.35 . . . . 71.41 111.48 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 98.3 m -117.62 88.2 2.86 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.841 0.353 . . . . 73.44 110.6 173.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.512 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 96.2 mt -54.46 -50.83 83.01 Favored Pre-proline 0 CA--C 1.547 0.827 0 N-CA-C 113.314 0.857 . . . . 73.12 113.314 -175.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.512 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 75.5 Cg_exo -50.41 -34.52 41.74 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.156 1.904 . . . . 63.15 113.634 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -103.42 -3.92 24.79 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 111.976 0.361 . . . . 72.34 111.976 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.5 mttp 59.85 33.99 21.71 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.134 0.492 . . . . 44.4 112.276 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 63.7 t -101.12 133.18 45.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 116.218 -0.446 . . . . 74.53 111.084 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -130.58 125.61 34.61 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.079 -0.51 . . . . 62.14 110.689 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.436 HG22 HG13 ' A' ' 12' ' ' ILE . 47.7 t -118.19 124.1 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.68 -0.236 . . . . 75.43 111.183 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.477 ' HA ' HG22 ' A' ' 76' ' ' THR . 8.9 pt-20 -120.9 122.15 39.6 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.094 0.473 . . . . 74.31 111.467 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.9 mt -97.07 118.16 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 120.98 0.419 . . . . 72.54 110.537 175.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -129.53 150.18 50.98 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.114 0.483 . . . . 74.45 112.122 -173.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.6 t -77.48 150.51 34.9 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.925 -0.58 . . . . 54.43 112.448 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.2 p -85.13 0.18 52.51 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.899 -0.591 . . . . 73.31 111.315 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -88.47 -177.82 5.71 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.458 0.647 . . . . 74.41 111.508 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.64 145.69 48.83 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.775 -0.648 . . . . 54.31 109.533 171.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -142.52 118.9 10.88 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.97 0.414 . . . . 74.24 111.383 -174.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.9 t -131.8 95.46 3.71 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.986 0.422 . . . . 72.44 111.122 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -103.7 97.68 7.67 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.421 0.629 . . . . 72.43 111.204 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -67.41 142.86 96.84 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 115.419 -0.81 . . . . 72.31 112.352 -174.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.42 -48.09 14.63 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.467 2.111 . . . . 74.2 112.52 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.41 ' O ' ' HB ' ' A' ' 100' ' ' THR . 0.9 OUTLIER -97.12 -95.16 0.21 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 116.458 -0.337 . . . . 74.34 111.57 176.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 99' ' ' ASP . 10.2 t 173.04 -28.7 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 111.92 0.341 . . . . 52.21 111.92 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -86.33 179.59 6.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.178 0.513 . . . . 72.05 112.067 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.3 pp -156.51 -171.69 3.79 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.138 -0.483 . . . . 62.01 111.581 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 62.2 mt -97.2 117.24 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.827 0.346 . . . . 51.41 110.755 175.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 13.4 p -65.92 133.37 94.87 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 112.13 0.419 . . . . 71.13 112.13 -175.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 104' ' ' VAL . 39.7 Cg_exo -58.99 172.43 1.67 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.718 2.279 . . . . 61.11 113.648 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.54 HD22 ' N ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -59.39 -174.42 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.56 0.578 . . . . 73.14 112.56 179.335 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 97.1 mt -57.08 99.84 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.104 -0.498 . . . . 74.3 111.549 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 106' ' ' ASN . 41.2 mt-10 -84.77 146.81 27.18 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.048 -0.523 . . . . 71.21 111.561 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -90.08 -15.83 30.91 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.432 0.53 . . . . 74.32 112.432 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -70.1 103.63 2.36 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.576 0.703 . . . . 72.41 111.538 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -86.58 98.72 11.24 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.847 -0.615 . . . . 73.51 110.791 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -55.48 118.24 4.29 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.91 0.386 . . . . 63.22 111.836 -176.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -58.61 146.13 37.15 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.088 -0.505 . . . . 72.24 111.69 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 66.4 m80 . . . . . 0 C--O 1.252 1.224 0 CA-C-O 118.582 -0.723 . . . . 72.43 111.406 179.983 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.5 mtm . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.726 0.298 . . . . 74.21 110.959 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.676 ' HA ' ' HE2' ' A' ' 2' ' ' LYS . 10.3 mmpt? -114.49 154.82 27.54 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.164 0.507 . . . . 71.22 111.962 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -111.15 114.4 27.62 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.148 -0.478 . . . . 41.44 110.646 174.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.2 t -140.11 135.89 32.99 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.352 -0.385 . . . . 71.21 111.259 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.36 -49.33 3.04 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 114.781 0.672 . . . . 54.1 114.781 -171.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -72.64 82.15 1.12 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.537 0.684 . . . . 72.21 112.092 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.513 ' HA ' ' HB ' ' A' ' 25' ' ' THR . 46.0 mt-10 -76.44 106.75 8.26 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.73 -0.668 . . . . 61.53 111.757 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.446 HG22 ' OG1' ' A' ' 25' ' ' THR . 32.7 m -111.3 151.03 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.073 0.463 . . . . 60.33 111.755 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 23' ' ' PRO . 27.4 m -129.46 141.39 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.168 -0.469 . . . . 64.51 111.488 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.89 115.27 27.08 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.444 -0.344 . . . . 52.54 111.243 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.4 mm -96.42 112.2 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.866 0.365 . . . . 71.11 111.098 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.544 HG13 HG22 ' A' ' 86' ' ' VAL . 2.7 mp -99.19 114.5 37.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 120.972 0.415 . . . . 71.44 111.303 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.0 m -113.07 139.71 48.47 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.798 0.333 . . . . 72.04 111.231 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.473 HE21 ' HA2' ' A' ' 37' ' ' GLY . 57.5 tt0 -128.9 135.45 49.07 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.587 -0.278 . . . . 75.53 111.2 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 57.01 10.27 0.76 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.981 0.734 . . . . 75.11 112.981 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.07 -6.5 28.97 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 121.256 -0.497 . . . . 73.44 113.882 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -112.76 145.08 41.2 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 117.13 0.465 . . . . 71.53 111.571 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.37 119.6 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 110.059 -0.349 . . . . 75.41 110.059 173.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.4 pt -108.51 -19.53 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 113.465 0.913 . . . . 75.14 113.465 -173.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -168.87 141.29 2.71 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.747 0.647 . . . . 72.32 112.747 -177.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -123.42 130.91 53.39 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.391 -0.368 . . . . 72.43 110.535 174.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.472 HG21 HG21 ' A' ' 47' ' ' VAL . 3.9 mp -121.24 124.43 27.32 Favored Pre-proline 0 N--CA 1.478 0.972 0 O-C-N 121.966 -0.459 . . . . 63.14 111.72 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.514 ' HA ' HG12 ' A' ' 9' ' ' VAL . 59.0 Cg_endo -73.24 121.22 7.04 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.418 2.079 . . . . 65.31 112.068 173.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.7 mt -92.96 -60.08 1.89 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.192 0.52 . . . . 62.54 111.796 -176.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.513 ' HB ' ' HA ' ' A' ' 7' ' ' GLU . 25.1 m -58.05 128.0 34.9 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.327 0.492 . . . . 75.3 112.327 -176.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.98 1.12 72.04 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 121.357 -0.449 . . . . 72.51 113.922 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -84.91 105.13 15.45 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.595 -0.356 . . . . 72.4 111.579 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.534 ' NZ ' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -85.77 137.58 32.69 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.927 0.394 . . . . 70.35 110.913 175.226 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.86 178.89 22.19 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.173 -0.537 . . . . 65.43 113.572 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -118.46 139.63 51.11 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.907 0.384 . . . . 62.42 110.965 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -138.9 124.51 19.54 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.256 -0.429 . . . . 74.21 110.604 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.457 ' HG2' ' HA ' ' A' ' 46' ' ' GLU . 75.3 mt-30 -131.7 148.69 52.6 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.94 0.4 . . . . 73.23 112.003 -176.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -154.64 147.71 24.71 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.104 -0.498 . . . . 62.31 111.21 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.7 m -101.19 136.85 40.37 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.899 0.38 . . . . 71.41 111.528 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.524 ' HB ' ' HB3' ' A' ' 43' ' ' ASN . 58.4 mt -113.7 102.32 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.495 -0.32 . . . . 71.44 111.419 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -76.27 107.04 8.23 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.773 0.32 . . . . 70.51 111.141 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.473 ' HA2' HE21 ' A' ' 14' ' ' GLN . . . -89.03 -133.81 4.88 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.374 -0.441 . . . . 54.34 113.438 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.03 115.27 15.56 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.528 -0.396 . . . . 54.34 110.697 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.37 -136.72 25.26 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.266 -0.492 . . . . 71.02 113.135 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.16 3.65 34.06 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.161 0.505 . . . . 74.24 111.279 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.542 ' HB3' ' CD2' ' A' ' 82' ' ' HIS . 24.6 mt-30 -73.07 83.78 1.29 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.194 0.521 . . . . 65.35 111.795 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -89.92 165.44 14.09 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.063 -0.517 . . . . 74.32 111.406 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.578 HD21 HD13 ' A' ' 54' ' ' ILE . 2.4 t-20 -132.7 110.13 10.18 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.311 -0.404 . . . . 74.43 109.93 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.3 tp -95.52 103.82 15.71 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.382 0.61 . . . . 61.34 111.612 -176.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.65 ' SD ' HG12 ' A' ' 54' ' ' ILE . 90.1 mmm -93.93 141.61 28.32 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.374 -0.83 . . . . 64.1 111.76 -175.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.457 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 44.7 tt0 -127.07 119.65 27.07 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.99 0.424 . . . . 75.32 111.7 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.472 HG21 HG21 ' A' ' 22' ' ' ILE . 59.4 t -105.53 107.29 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.209 -0.451 . . . . 70.54 110.584 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.522 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 34.8 t70 -109.98 101.56 10.37 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.118 0.485 . . . . 52.2 110.848 -178.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.18 -109.68 3.04 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 120.784 -0.722 . . . . 53.32 112.886 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -108.14 19.16 20.29 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.852 0.358 . . . . 75.13 111.794 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 35.3 ptt180 -136.4 147.07 47.11 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.791 0.329 . . . . 73.33 111.507 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.3 tt -132.37 142.6 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-O 120.868 0.365 . . . . 74.14 111.719 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.51 ' HB3' ' HA ' ' A' ' 69' ' ' TRP . 0.3 OUTLIER -160.67 168.8 24.14 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.849 0.357 . . . . 64.53 111.461 177.441 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.65 HG12 ' SD ' ' A' ' 45' ' ' MET . 71.6 mt -91.62 124.57 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.432 -0.349 . . . . 75.13 111.065 176.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -94.86 -33.16 12.93 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.865 0.364 . . . . 65.21 111.406 177.434 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -143.47 139.95 30.12 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.746 0.308 . . . . 72.43 110.748 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -168.07 145.76 4.3 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.991 0.425 . . . . 74.01 112.023 -173.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -109.79 51.06 0.77 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.081 -0.509 . . . . 70.23 111.954 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.463 ' HG ' ' CD2' ' A' ' 82' ' ' HIS . 31.4 m -107.05 121.81 43.56 Favored Pre-proline 0 N--CA 1.472 0.667 0 O-C-N 122.063 -0.398 . . . . 72.4 110.192 172.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.28 -30.82 73.91 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.436 2.091 . . . . 71.13 112.582 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.68 -36.5 67.91 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.693 -0.685 . . . . 75.51 111.712 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 59.26 16.76 5.19 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.041 0.756 . . . . 73.31 113.041 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 65.6 t -55.36 -51.61 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 N-CA-C 112.07 0.396 . . . . 72.03 112.07 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -56.98 -38.66 86.48 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.223 -0.513 . . . . 32.13 113.271 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 42.1 t -67.46 -43.77 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.991 0.424 . . . . 74.42 111.295 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.22 -27.16 68.87 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.031 -0.531 . . . . 74.33 112.112 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 14.3 mmt -50.45 -35.23 27.88 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.453 0.538 . . . . 73.54 112.453 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.05 -159.87 50.91 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.136 -0.554 . . . . 73.02 113.625 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.51 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . 89.1 m95 -70.82 114.71 9.17 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 111.968 0.359 . . . . 53.12 111.968 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 34.9 mmtp -105.78 150.65 25.35 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.68 -0.237 . . . . 73.35 110.619 175.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.437 ' O ' HG21 ' A' ' 8' ' ' VAL . 92.7 p -159.56 -26.83 0.07 Allowed 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.163 0.801 . . . . 70.44 113.163 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm -82.28 155.96 24.56 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.276 0.56 . . . . 74.45 112.264 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.51 110.74 3.26 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.108 -0.496 . . . . 54.44 110.675 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 121.71 -23.83 7.34 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.982 -0.447 . . . . 63.14 111.982 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.487 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 78.4 m-20 -65.41 129.23 38.99 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.87 0.367 . . . . 74.31 110.783 176.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.476 HG22 ' HA ' ' A' ' 87' ' ' GLU . 41.2 p -128.81 164.38 23.16 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.018 0.747 . . . . 54.51 113.018 -176.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.554 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 39.6 mm -128.15 125.63 64.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.063 -0.971 . . . . 73.1 109.735 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.8 t -117.32 117.59 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 112.291 0.478 . . . . 54.4 112.291 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 75.1 m -119.16 80.79 1.61 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.061 0.458 . . . . 71.42 110.65 174.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.442 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 76.3 mt -52.54 -59.91 7.63 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 113.597 0.962 . . . . 71.43 113.597 -174.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 38.9 Cg_endo -66.86 -9.5 24.98 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 121.917 1.744 . . . . 74.13 112.98 -176.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.542 ' CD2' ' HB3' ' A' ' 41' ' ' GLN . 24.3 m170 -104.49 -10.94 17.31 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.517 -0.31 . . . . 74.13 111.343 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.4 mttp 59.82 27.06 16.31 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.052 0.453 . . . . 71.12 112.032 -176.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.4 t -104.14 124.44 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.028 -0.533 . . . . 75.33 110.782 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -130.27 118.01 20.68 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.069 0.462 . . . . 70.03 111.119 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.554 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 35.9 t -107.76 124.62 63.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.136 -0.484 . . . . 33.44 110.858 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.476 ' HA ' HG22 ' A' ' 76' ' ' THR . 14.5 pt-20 -124.3 126.76 46.59 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.998 0.427 . . . . 73.23 111.58 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 63.5 mt -89.48 112.71 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 121.093 0.473 . . . . 64.31 110.984 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -116.63 152.36 34.36 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.24 -0.436 . . . . 73.44 111.25 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.9 t -89.41 124.93 34.92 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.946 0.403 . . . . 62.14 111.966 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.1 p -66.27 -28.38 68.66 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.295 0.569 . . . . 71.11 110.507 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -82.55 124.76 30.42 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.715 -0.675 . . . . 54.34 109.67 174.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.515 ' HD3' ' O ' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -42.37 120.85 1.75 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.708 0.766 . . . . 75.2 112.647 -176.402 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -90.48 177.22 6.43 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.929 0.714 . . . . 73.33 112.929 -173.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.5 t -164.15 104.55 0.88 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.288 -0.869 . . . . 65.0 110.111 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.541 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 9.0 mtpm? -123.24 164.27 19.06 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 122.2 1.0 . . . . 60.42 113.155 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -51.04 125.88 24.44 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 113.699 -1.592 . . . . 64.44 111.794 169.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.43 2.31 8.65 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.532 2.154 . . . . 74.33 112.578 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -79.09 69.84 5.34 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.239 0.542 . . . . 73.21 110.413 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 62.1 p -87.26 93.06 9.28 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.203 0.525 . . . . 64.32 112.352 -174.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -117.53 145.48 44.22 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.671 -0.492 . . . . 71.1 109.671 173.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.447 ' O ' HD12 ' A' ' 102' ' ' LEU . 2.1 pp -135.18 152.73 51.86 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.226 0.824 . . . . 75.35 113.226 -171.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.517 HD12 ' N ' ' A' ' 103' ' ' ILE . 2.6 mp -89.1 112.35 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 115.666 -0.697 . . . . 75.45 109.791 173.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.8 m -63.34 122.53 76.35 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 112.653 0.612 . . . . 74.42 112.653 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -85.8 106.61 0.88 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.706 2.271 . . . . 75.3 112.426 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -77.18 119.19 20.52 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 122.03 -0.419 . . . . 42.22 111.262 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 58.4 tp -79.57 101.53 8.35 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.023 0.44 . . . . 74.0 111.094 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -84.16 83.64 7.89 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.389 0.614 . . . . 71.33 111.821 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -80.43 79.55 7.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.281 0.562 . . . . 74.22 111.12 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -104.45 125.67 50.85 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.028 -0.533 . . . . 62.21 111.967 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -73.51 154.86 39.72 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.25 -0.432 . . . . 73.35 111.167 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -154.78 116.17 4.07 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.059 0.457 . . . . 74.35 111.927 -175.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -128.4 170.41 13.14 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.342 -0.39 . . . . 65.33 111.294 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 41.1 m80 . . . . . 0 C--O 1.256 1.435 0 CA-C-O 118.72 -0.657 . . . . 74.54 111.19 175.503 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.472 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.848 0.356 . . . . 71.25 111.359 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -87.73 116.99 26.26 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.896 -0.409 . . . . 74.34 109.896 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -54.8 131.18 43.41 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.437 0.532 . . . . 63.04 112.437 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.7 p -118.17 139.36 51.39 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.161 -0.472 . . . . 63.3 111.467 177.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.44 -6.79 46.98 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.022 -0.609 . . . . 43.23 113.02 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.26 86.44 5.65 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.634 0.254 . . . . 73.44 110.67 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.492 ' HG2' HG21 ' A' ' 25' ' ' THR . 29.6 mt-10 -84.51 120.58 26.49 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.365 0.506 . . . . 74.45 112.365 -175.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 27.8 m -130.72 159.24 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.426 0.528 . . . . 75.3 112.426 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 23' ' ' PRO . 23.3 m -131.56 147.05 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 115.928 -0.578 . . . . 65.24 111.171 178.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.62 115.14 26.93 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.45 -0.341 . . . . 43.01 111.309 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.441 HD12 ' OE2' ' A' ' 21' ' ' GLU . 18.2 mm -99.47 104.8 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.831 0.348 . . . . 65.31 111.397 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.502 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.3 mp -96.22 120.08 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.194 0.521 . . . . 61.33 111.257 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.6 m -121.94 144.36 48.91 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.087 -0.506 . . . . 70.33 111.31 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.412 ' HG3' HG22 ' A' ' 84' ' ' VAL . 59.3 tt0 -135.67 141.82 45.05 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.551 -0.295 . . . . 73.41 110.733 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 59.21 17.4 5.66 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 111.956 0.354 . . . . 64.32 111.956 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.69 -9.75 62.34 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 121.409 -0.424 . . . . 61.41 113.683 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -116.4 145.65 43.08 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 117.296 0.548 . . . . 64.22 111.657 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.7 t -71.99 128.33 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 120.942 0.401 . . . . 75.2 111.147 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.626 HD11 HD13 ' A' ' 35' ' ' ILE . 33.9 pt -112.17 -26.59 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.64 0.607 . . . . 75.13 112.64 -177.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -159.55 133.34 7.33 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.236 0.458 . . . . 70.53 112.236 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.441 ' OE2' HD12 ' A' ' 11' ' ' ILE . 44.8 mt-10 -124.94 115.49 20.67 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.683 0.277 . . . . 75.31 110.802 177.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.487 HD12 ' N ' ' A' ' 22' ' ' ILE . 3.2 mp -104.22 129.86 24.38 Favored Pre-proline 0 N--CA 1.475 0.798 0 N-CA-C 111.852 0.316 . . . . 74.41 111.852 -175.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.562 ' HA ' HG12 ' A' ' 9' ' ' VAL . 67.7 Cg_endo -74.62 111.61 3.36 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.356 2.037 . . . . 71.45 112.194 171.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.63 -62.26 1.7 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.978 0.418 . . . . 51.4 111.749 -176.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.568 ' HA ' ' HG2' ' A' ' 50' ' ' GLU . 51.3 m -63.03 118.57 8.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.992 0.425 . . . . 72.54 112.07 -177.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.35 -15.73 55.92 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 116.154 -0.476 . . . . 61.32 112.81 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -77.11 79.13 3.64 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.19 0.519 . . . . 75.21 110.978 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.444 ' NZ ' ' HB2' ' A' ' 28' ' ' LYS . 10.4 mtmp? -75.18 105.1 6.03 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.291 0.567 . . . . 54.53 111.304 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.77 -169.63 24.31 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 115.971 -0.558 . . . . 71.22 112.655 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -117.84 148.0 42.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.841 0.353 . . . . 73.43 110.679 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -154.14 129.15 9.54 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.795 0.331 . . . . 72.52 111.671 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -124.71 153.65 42.04 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.759 0.314 . . . . 73.25 111.535 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -154.29 140.73 18.75 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.92 0.391 . . . . 61.44 110.708 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.5 m -108.94 111.93 23.88 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.974 0.416 . . . . 61.15 112.07 -172.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.626 HD13 HD11 ' A' ' 19' ' ' ILE . 57.8 mt -94.0 105.61 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.263 -0.426 . . . . 75.42 111.572 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -89.79 110.02 20.97 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.036 0.446 . . . . 64.15 111.307 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.43 -136.9 9.55 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 116.181 -0.463 . . . . 42.13 113.778 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -87.76 151.25 23.04 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.03 0.382 . . . . 74.4 112.03 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.79 36.74 92.44 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 116.098 -0.501 . . . . 71.0 113.479 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 61.99 10.72 3.78 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.388 0.514 . . . . 72.0 112.388 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.549 ' HA ' ' HB3' ' A' ' 58' ' ' ASN . 26.3 mt-30 -82.55 107.02 14.89 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.089 0.403 . . . . 71.42 112.089 -176.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -104.88 153.18 21.7 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 111.981 0.363 . . . . 63.4 111.981 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -111.72 130.23 55.85 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.998 -0.546 . . . . 60.45 110.222 171.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.4 tp -101.85 104.11 14.83 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.873 0.368 . . . . 75.2 110.925 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.753 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.5 mmm -88.73 141.33 28.6 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.559 -0.292 . . . . 64.41 111.286 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -136.09 119.01 16.29 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.155 0.502 . . . . 73.14 111.605 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.9 t -105.85 119.85 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 115.939 -0.573 . . . . 72.31 110.699 177.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -117.44 90.74 3.4 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.163 0.506 . . . . 74.42 110.206 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.97 -116.57 5.07 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.755 -0.736 . . . . 42.03 112.352 -174.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.568 ' HG2' ' HA ' ' A' ' 25' ' ' THR . 40.6 mt-10 -95.13 -15.17 23.56 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.036 0.446 . . . . 71.13 111.806 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.558 ' HA ' ' HB3' ' A' ' 71' ' ' SER . 26.7 ptt180 -97.74 135.29 39.73 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.993 0.425 . . . . 62.52 111.371 -176.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.6 tt -123.89 143.82 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.126 0.489 . . . . 73.33 111.463 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -144.96 169.21 18.52 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.32 -0.4 . . . . 62.55 110.709 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.753 HG12 ' SD ' ' A' ' 45' ' ' MET . 42.7 mt -96.93 122.17 48.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.351 -0.611 . . . . 75.12 109.351 167.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -86.67 -32.39 20.55 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.503 0.557 . . . . 70.12 112.503 -172.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -162.09 138.68 8.0 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.681 0.277 . . . . 64.14 111.383 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -133.04 144.61 50.15 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.313 0.578 . . . . 74.33 111.816 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.549 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . 48.5 t-20 -81.47 72.17 8.5 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.921 -1.14 . . . . 72.51 107.921 163.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.431 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 69.1 m -135.98 130.45 18.51 Favored Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 115.634 -0.712 . . . . 73.2 111.373 -174.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 59' ' ' SER . 26.8 Cg_exo -63.35 -27.66 71.51 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.79 2.327 . . . . 52.13 112.315 178.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.427 ' O ' ' HE2' ' A' ' 66' ' ' LYS . 4.3 m-20 -97.3 -15.47 20.75 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.68 -0.691 . . . . 60.45 112.15 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 27.0 mm-40 52.6 34.04 14.89 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.393 0.516 . . . . 70.43 112.393 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.9 t -53.35 -51.29 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 112.914 0.709 . . . . 73.2 112.914 -174.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -56.43 -55.06 31.63 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.149 -0.548 . . . . 51.34 113.373 -177.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.2 t -52.75 -41.81 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 111.914 0.339 . . . . 65.23 111.914 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 61' ' ' ASP . 67.9 mttm -64.29 -30.82 71.85 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 111.963 0.357 . . . . 70.31 111.963 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.8 mmt -61.2 -40.45 93.99 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.269 0.47 . . . . 72.45 112.269 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.45 -153.55 39.16 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.121 -0.562 . . . . 62.15 113.737 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -81.73 130.79 35.18 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.179 0.437 . . . . 71.41 112.179 -176.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HG3' HD11 ' A' ' 77' ' ' ILE . 75.4 mmtt -127.73 150.17 49.91 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.142 -0.481 . . . . 74.0 110.645 175.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.558 ' HB3' ' HA ' ' A' ' 51' ' ' ARG . 89.1 p -173.68 22.94 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.905 0.706 . . . . 52.44 112.905 -178.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -90.46 162.33 15.12 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.081 -0.387 . . . . 72.32 110.163 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.65 32.83 0.11 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 112.133 0.42 . . . . 45.13 112.133 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -177.24 29.4 0.07 OUTLIER Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.385 -0.436 . . . . 74.31 113.312 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -86.8 146.77 26.11 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.968 0.413 . . . . 72.24 111.243 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.6 p -133.81 141.33 47.41 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.061 0.458 . . . . 61.45 111.604 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.531 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 45.5 mm -125.2 109.64 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.341 -0.39 . . . . 73.03 110.417 177.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.04 116.6 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.067 0.46 . . . . 72.22 111.822 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 91.5 m -120.98 79.75 1.55 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.382 -0.372 . . . . 72.31 111.067 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.503 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 96.2 mt -57.13 -48.17 97.86 Favored Pre-proline 0 CA--C 1.55 0.958 0 N-CA-C 112.825 0.676 . . . . 71.41 112.825 -177.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 76.7 Cg_exo -51.42 -25.15 17.98 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 122.215 1.943 . . . . 64.23 113.613 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.527 ' NE2' ' HB3' ' A' ' 41' ' ' GLN . 16.0 m170 -111.52 -4.26 14.86 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.035 -0.416 . . . . 63.24 111.735 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 58.33 34.41 24.01 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.285 0.564 . . . . 74.14 111.782 -176.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.412 HG22 ' HG3' ' A' ' 14' ' ' GLN . 60.4 t -110.43 134.71 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 115.714 -0.675 . . . . 71.51 111.326 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -131.19 130.04 42.47 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.836 0.351 . . . . 71.12 110.885 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 50.3 t -119.23 120.62 64.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.717 0.294 . . . . 70.43 111.487 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -111.13 136.97 49.39 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 110.451 -0.203 . . . . 72.13 110.451 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.3 mt -105.61 112.17 37.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.985 0.421 . . . . 54.01 110.575 175.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -118.11 159.35 23.4 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.28 -0.418 . . . . 74.13 110.91 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 45.3 t -79.91 145.44 32.67 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.918 0.389 . . . . 75.21 111.444 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.8 p -67.75 -28.31 67.52 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.429 0.633 . . . . 75.42 110.265 174.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -80.48 -138.85 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.934 -1.03 . . . . 72.11 110.749 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -70.97 142.67 51.01 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.44 0.638 . . . . 64.31 112.008 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -152.1 139.45 19.45 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.941 -0.572 . . . . 64.15 109.906 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.8 t -153.85 119.29 5.18 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.289 0.477 . . . . 73.31 112.289 -176.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -127.66 150.74 49.62 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.032 -0.531 . . . . 62.43 109.674 173.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -57.9 141.0 81.3 Favored Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 122.27 -0.269 . . . . 64.05 110.562 175.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -35.11 -55.31 0.59 Allowed 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 123.736 2.957 . . . . 75.23 114.055 -175.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -174.15 101.2 0.1 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.84 0.352 . . . . 74.33 110.63 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.2 t -159.45 151.56 20.87 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.333 0.587 . . . . 73.14 112.264 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -113.81 114.07 25.79 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.353 -0.84 . . . . 62.0 109.884 175.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.3 tp -116.71 118.18 31.84 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.042 0.449 . . . . 71.1 112.142 -174.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.0 mm -102.7 131.95 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.022 0.439 . . . . 55.3 111.033 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.7 m -103.68 146.95 33.47 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 116.371 -0.377 . . . . 41.12 111.526 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.99 144.02 80.49 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.765 2.31 . . . . 71.41 112.959 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -88.64 132.28 34.63 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.029 0.443 . . . . 72.42 111.215 -176.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.412 ' H ' HD23 ' A' ' 107' ' ' LEU . 2.2 pt? -86.95 155.6 20.13 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.092 0.472 . . . . 75.51 111.84 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -103.16 128.28 50.16 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.388 -0.369 . . . . 65.01 110.525 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -91.79 22.54 4.11 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.241 0.459 . . . . 74.52 112.241 -174.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.92 105.02 0.27 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 112.664 0.616 . . . . 61.24 112.664 -177.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -134.08 106.41 7.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.635 0.374 . . . . 75.34 110.355 173.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -101.27 60.97 0.92 Allowed 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.897 -0.502 . . . . 72.24 112.025 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -176.16 178.4 1.41 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.231 -0.441 . . . . 73.35 111.447 176.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 78.3 t60 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.476 -0.773 . . . . 60.1 111.182 173.584 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.769 0.318 . . . . 73.0 111.601 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.92 145.61 40.44 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.882 0.372 . . . . 61.12 110.68 173.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -88.42 90.69 8.5 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.162 0.506 . . . . 52.04 110.466 176.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.6 m -130.93 114.2 14.95 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.029 -0.532 . . . . 63.32 111.243 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -146.53 -40.36 0.04 OUTLIER Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.946 -0.645 . . . . 53.2 114.004 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -69.89 92.11 0.69 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.313 0.556 . . . . 55.11 111.036 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -73.47 114.89 12.21 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.06 0.763 . . . . 73.13 113.06 -173.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 33.9 m -126.27 148.02 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.022 0.439 . . . . 74.23 111.055 173.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 23' ' ' PRO . 33.8 m -127.27 151.78 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.938 0.399 . . . . 63.35 111.679 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.77 118.21 36.45 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.112 -0.495 . . . . 62.13 110.878 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 31.0 mm -95.26 108.79 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 120.83 0.347 . . . . 74.44 110.992 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.2 mp -95.17 111.51 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 120.937 0.399 . . . . 73.13 111.123 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.9 p -113.7 147.19 38.63 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.971 0.415 . . . . 74.23 111.236 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -143.88 139.34 29.17 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.286 -0.416 . . . . 72.32 110.284 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 62.19 13.59 5.97 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.089 0.403 . . . . 62.33 112.089 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.02 -16.67 46.05 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 121.199 -0.524 . . . . 73.34 113.956 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.79 150.1 33.95 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 122.294 -0.533 . . . . 71.43 111.693 -178.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.77 120.92 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.412 -0.358 . . . . 62.44 110.834 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.0 pt -99.71 -27.96 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 112.102 0.408 . . . . 65.35 112.102 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.1 tpp85 -157.82 143.51 17.18 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 122.09 -0.381 . . . . 73.24 111.601 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -128.36 113.51 15.68 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.676 0.274 . . . . 73.02 110.871 176.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.53 HG21 HG21 ' A' ' 47' ' ' VAL . 3.0 mp -107.39 119.66 50.08 Favored Pre-proline 0 N--CA 1.473 0.722 0 O-C-N 122.27 -0.269 . . . . 71.35 111.632 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 22.0 Cg_exo -66.03 123.46 11.3 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.366 2.044 . . . . 74.53 111.781 172.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.2 mt -87.13 -54.55 4.26 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.158 0.504 . . . . 71.44 111.447 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.447 ' OG1' HG22 ' A' ' 8' ' ' VAL . 29.1 m -63.1 107.34 1.01 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.039 0.447 . . . . 73.35 111.764 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.41 ' H ' ' HG2' ' A' ' 50' ' ' GLU . . . 94.13 11.17 57.8 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.266 -0.493 . . . . 62.23 113.081 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.533 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 52.0 t-80 -72.98 87.12 1.33 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.08 0.467 . . . . 71.55 111.154 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -53.8 131.8 40.28 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.884 0.698 . . . . 72.23 112.884 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.38 -161.94 49.02 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 115.931 -0.577 . . . . 73.31 114.501 175.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -118.68 141.98 48.09 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.952 0.501 . . . . 71.33 109.91 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -142.91 125.08 15.38 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 122.25 -0.282 . . . . 72.4 111.626 -175.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -117.83 129.85 55.91 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.668 -0.242 . . . . 74.45 111.459 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -136.69 143.22 43.27 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.244 0.545 . . . . 74.35 111.795 176.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.0 m -101.8 121.52 42.24 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.979 -0.555 . . . . 53.43 111.921 -175.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 54.1 mt -92.86 104.94 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.529 -0.305 . . . . 63.12 110.451 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -101.16 113.8 27.16 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.956 0.407 . . . . 70.42 111.884 -176.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.8 -65.46 1.44 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.299 -0.476 . . . . 63.45 112.551 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -141.39 87.62 2.09 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.543 -0.387 . . . . 71.22 111.438 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.45 -86.82 0.01 OUTLIER Glycine 0 CA--C 1.53 1.017 0 N-CA-C 114.196 0.438 . . . . 63.33 114.196 177.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.41 -22.26 44.53 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.007 0.432 . . . . 73.42 111.612 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -82.56 95.37 7.73 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.235 -0.291 . . . . 75.21 110.904 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -144.59 160.74 40.66 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.354 0.502 . . . . 72.55 112.354 -177.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -129.75 144.71 51.43 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.022 -0.536 . . . . 72.41 110.605 174.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.8 tp -114.12 107.34 15.5 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.989 0.423 . . . . 54.33 111.025 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.758 ' SD ' HG12 ' A' ' 54' ' ' ILE . 84.2 mmm -94.6 140.11 30.29 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.179 -0.464 . . . . 70.35 111.351 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -130.58 120.86 24.65 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.985 0.421 . . . . 74.0 111.324 176.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.53 HG21 HG21 ' A' ' 22' ' ' ILE . 36.0 t -105.0 108.73 25.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.122 -0.49 . . . . 71.45 110.731 176.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -109.31 105.75 15.29 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.965 0.412 . . . . 64.24 110.338 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.533 ' O ' ' HB3' ' A' ' 27' ' ' HIS . . . 58.16 -114.98 6.34 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.837 -0.697 . . . . 65.51 113.048 -177.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' A' ' 26' ' ' GLY . 34.6 mt-10 -106.17 35.56 2.89 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.882 0.372 . . . . 70.13 111.649 -177.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -155.13 144.65 21.27 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.933 0.397 . . . . 73.14 111.444 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 tt -129.41 147.1 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 112.007 0.373 . . . . 52.13 112.007 -175.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.401 ' HD3' ' CE2' ' A' ' 69' ' ' TRP . 22.5 ptt180 -150.84 169.29 22.05 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.106 0.479 . . . . 63.35 111.428 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.758 HG12 ' SD ' ' A' ' 45' ' ' MET . 43.6 mt -105.6 116.29 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 116.282 -0.417 . . . . 71.13 110.756 173.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.476 ' NZ ' ' HB3' ' A' ' 55' ' ' LYS . 8.5 mtpm? -78.53 -40.4 35.2 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.269 0.557 . . . . 70.44 111.722 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -137.97 143.89 40.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.943 -0.571 . . . . 72.13 111.021 -173.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -161.0 126.14 3.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.384 0.611 . . . . 75.51 110.558 -178.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -100.89 67.95 1.25 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.589 -0.732 . . . . 61.53 110.813 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 53.4 p -129.97 150.99 77.49 Favored Pre-proline 0 N--CA 1.474 0.749 0 CA-C-N 116.294 -0.412 . . . . 73.32 111.105 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -63.88 -28.73 67.29 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.651 2.234 . . . . 71.44 112.752 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.47 ' HB3' HG23 ' A' ' 63' ' ' VAL . 5.1 m-20 -80.67 -36.91 31.76 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.876 -0.602 . . . . 73.43 112.513 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 63.69 20.59 12.3 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.341 0.497 . . . . 64.01 112.341 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 61' ' ' ASP . 64.6 t -59.76 -39.77 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 112.082 0.401 . . . . 64.33 112.082 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.93 -56.19 19.91 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.2 -0.454 . . . . 74.43 113.714 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.99 -38.06 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 O-C-N 122.66 -0.318 . . . . 61.2 111.683 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -59.79 -28.47 67.46 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.22 0.452 . . . . 61.44 112.22 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 23.0 mmt -57.56 -36.16 71.29 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.333 0.494 . . . . 54.44 112.333 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.87 -149.21 42.66 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.271 -0.49 . . . . 42.43 113.82 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.401 ' CE2' ' HD3' ' A' ' 53' ' ' ARG . 92.4 m95 -82.37 120.7 25.77 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.872 0.367 . . . . 71.32 111.964 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.671 ' HG3' HD11 ' A' ' 77' ' ' ILE . 75.2 mmtt -109.4 157.95 18.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.586 0.354 . . . . 61.13 110.925 175.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 88.0 p -163.76 -28.65 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.871 0.693 . . . . 61.35 112.871 -175.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -81.93 141.6 33.18 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.003 0.43 . . . . 72.23 112.094 -175.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.09 94.5 0.11 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.343 0.592 . . . . 74.15 110.704 175.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.652 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . 148.7 -22.83 1.32 Allowed Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.908 -0.587 . . . . 43.13 112.139 -174.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.518 ' HB2' HD12 ' A' ' 88' ' ' ILE . 78.3 m-20 -62.84 123.95 19.78 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.942 0.401 . . . . 64.11 111.127 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.5 p -117.53 142.57 47.01 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.24 0.543 . . . . 70.41 112.01 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.671 HD11 ' HG3' ' A' ' 70' ' ' LYS . 29.8 mm -119.5 117.57 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.734 -0.666 . . . . 74.35 110.212 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.1 t -108.76 116.51 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 111.974 0.361 . . . . 72.14 111.974 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 70.9 m -122.15 71.21 0.99 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.933 0.396 . . . . 65.24 111.024 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.537 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 94.5 mt -55.39 -49.3 93.31 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 112.93 0.715 . . . . 63.05 112.93 -177.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 51.1 Cg_exo -56.28 -17.38 20.51 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.274 1.983 . . . . 72.0 113.7 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -114.75 -0.07 13.67 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.122 -0.361 . . . . 73.15 111.959 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 60.12 29.27 18.86 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.761 0.425 . . . . 52.33 111.955 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.28 135.82 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.919 0.39 . . . . 75.22 111.396 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -139.91 125.16 18.85 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.329 -0.396 . . . . 73.13 110.944 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 52.7 t -123.31 120.41 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 120.778 0.323 . . . . 72.13 111.341 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -122.38 144.44 49.03 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.956 0.408 . . . . 74.03 111.369 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 75' ' ' ASP . 60.1 mt -97.84 136.53 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.047 0.451 . . . . 62.03 111.515 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -149.81 150.54 32.14 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.343 -0.39 . . . . 71.43 111.189 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 46.1 t -78.53 150.68 32.81 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.326 0.491 . . . . 75.0 112.326 -178.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.3 p -68.52 -20.17 64.56 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.192 0.52 . . . . 72.51 111.298 175.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -122.58 -167.88 1.65 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.728 -0.669 . . . . 53.32 111.323 -175.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -67.17 116.3 7.81 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.919 0.39 . . . . 75.42 111.576 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -135.74 156.6 48.57 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.166 -0.47 . . . . 71.21 110.839 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.4 m -119.44 101.18 7.77 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.707 0.289 . . . . 71.0 111.137 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.652 ' HD2' ' HA2' ' A' ' 74' ' ' GLY . 38.2 mtmt -78.95 -172.81 3.24 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.945 0.402 . . . . 65.3 111.356 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -58.79 141.75 84.86 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.331 -0.395 . . . . 65.11 110.737 172.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -55.74 -51.11 10.5 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.824 2.349 . . . . 64.33 113.07 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -84.46 100.63 11.46 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.173 0.511 . . . . 63.1 111.697 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 t -160.17 127.82 4.59 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.94 -0.573 . . . . 70.32 111.178 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -107.01 115.26 29.86 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.302 0.572 . . . . 71.34 112.132 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.439 ' N ' HD23 ' A' ' 102' ' ' LEU . 2.3 pt? -144.17 156.69 44.42 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.972 -0.558 . . . . 74.24 110.772 176.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.8 mt -126.41 110.0 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.039 0.447 . . . . 43.22 112.106 -177.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.7 t -89.33 112.91 54.21 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.279 -0.419 . . . . 74.14 109.894 170.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.44 -164.63 0.21 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.666 2.244 . . . . 73.02 113.492 -175.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -52.13 104.21 0.08 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.25 -0.432 . . . . 73.54 111.514 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.426 HD23 ' N ' ' A' ' 107' ' ' LEU . 2.3 pt? -55.07 146.53 18.0 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.115 0.483 . . . . 74.43 111.63 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -78.53 164.86 24.35 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.434 -0.348 . . . . 70.21 111.515 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -47.98 114.15 0.87 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.529 0.566 . . . . 63.23 112.529 -173.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -129.99 149.3 51.77 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.908 -0.587 . . . . 72.43 110.781 -178.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -82.89 163.87 20.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.962 0.411 . . . . 75.33 111.632 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -97.29 114.34 26.09 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.918 0.39 . . . . 75.2 111.636 -175.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -133.94 116.01 15.08 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.488 -0.323 . . . . 62.13 111.396 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.3 p80 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.998 -0.525 . . . . 62.14 111.885 178.292 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.645 0.26 . . . . 51.44 111.485 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -87.81 -52.17 5.45 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.095 0.474 . . . . 71.4 111.369 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -70.62 119.02 14.17 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.071 0.462 . . . . 62.14 111.958 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.3 m -91.97 86.38 5.84 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.522 -0.547 . . . . 74.13 109.522 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.09 -86.02 0.54 Allowed Glycine 0 CA--C 1.524 0.613 0 C-N-CA 121.101 -0.571 . . . . 73.22 113.624 -173.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -129.11 93.53 3.61 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 122.738 -0.272 . . . . 63.2 111.016 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.474 ' HB2' ' OG1' ' A' ' 91' ' ' THR . 40.8 mt-10 -84.61 116.5 23.2 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.429 0.529 . . . . 75.53 112.429 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.46 143.86 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.177 -0.465 . . . . 75.13 111.172 173.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 23' ' ' PRO . 31.0 m -125.07 141.84 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 120.962 0.411 . . . . 71.22 111.372 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.73 120.47 37.12 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.837 0.351 . . . . 62.11 111.564 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 17.8 mm -99.89 110.85 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.364 -0.38 . . . . 71.21 110.87 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.528 ' HA ' HG22 ' A' ' 86' ' ' VAL . 3.2 mp -95.59 119.38 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.025 0.441 . . . . 73.22 111.917 -177.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.4 t -121.27 139.12 53.82 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.095 0.474 . . . . 74.11 111.327 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.57 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 47.9 tt0 -121.24 116.95 25.85 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.385 -0.371 . . . . 74.13 110.686 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.57 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 43.5 m-80 61.76 2.61 0.75 Allowed 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.574 0.583 . . . . 74.12 112.574 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.86 -6.55 8.93 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.113 -0.565 . . . . 62.23 113.865 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -108.85 126.5 53.11 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 117.43 0.615 . . . . 71.5 111.414 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.6 t -70.52 112.04 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.124 0.488 . . . . 75.35 110.852 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.6 pt -102.44 -23.43 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 112.712 0.634 . . . . 72.13 112.712 -175.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -152.57 136.47 16.3 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.666 0.269 . . . . 73.24 111.641 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -130.66 114.96 16.05 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.759 0.314 . . . . 73.51 110.374 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.4 mt -115.38 124.43 30.12 Favored Pre-proline 0 N--CA 1.472 0.636 0 N-CA-C 112.111 0.411 . . . . 75.42 112.111 -175.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.516 ' O ' ' HB2' ' A' ' 27' ' ' HIS . 60.4 Cg_endo -72.66 112.37 3.47 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.239 1.96 . . . . 72.01 111.758 173.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.9 mt -77.22 -57.1 4.02 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.959 0.409 . . . . 71.22 111.544 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 m -62.46 122.85 16.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.947 0.403 . . . . 74.22 111.601 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.16 -11.77 71.28 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.104 -0.57 . . . . 71.13 112.792 -176.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.516 ' HB2' ' O ' ' A' ' 23' ' ' PRO . 58.5 t-80 -67.78 129.04 38.69 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.869 0.366 . . . . 50.43 110.439 177.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.449 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -119.96 136.24 54.61 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 122.021 -0.424 . . . . 75.31 111.294 -177.385 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.34 -172.2 33.02 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.494 -0.384 . . . . 73.14 112.788 -177.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -116.9 127.38 54.2 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 122.351 -0.499 . . . . 61.13 110.208 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -124.61 117.02 23.36 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.955 0.407 . . . . 75.15 111.268 -175.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.551 ' HG2' ' HG3' ' A' ' 46' ' ' GLU . 30.7 mt-30 -115.32 134.99 54.61 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.737 0.303 . . . . 73.51 111.256 -175.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -145.2 140.25 27.77 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.961 0.41 . . . . 55.42 110.904 177.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.2 m -104.11 109.34 21.1 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.997 0.427 . . . . 74.03 111.911 -174.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 62.8 mt -80.51 97.4 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.1 0.476 . . . . 61.3 111.037 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -82.8 104.01 12.72 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.996 0.427 . . . . 75.13 111.199 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.471 ' HA2' ' NE2' ' A' ' 14' ' ' GLN . . . -78.83 -146.04 3.18 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.345 -0.455 . . . . 52.1 113.059 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -76.31 108.61 9.38 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.95 0.405 . . . . 65.12 111.272 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.51 -129.21 9.41 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.065 -0.588 . . . . 70.42 113.55 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.96 4.32 23.12 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.303 0.483 . . . . 53.55 112.303 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -80.9 73.63 7.9 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.145 0.498 . . . . 73.34 112.232 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -89.53 155.89 18.98 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.964 0.412 . . . . 72.22 111.793 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.549 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 16.3 m120 -132.14 110.19 10.49 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.219 -0.446 . . . . 73.21 110.631 173.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.4 tp -83.38 103.22 12.58 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.064 0.459 . . . . 72.31 110.909 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.807 ' SD ' HG12 ' A' ' 54' ' ' ILE . 85.9 mmm -94.79 139.7 30.91 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.118 -0.492 . . . . 71.43 111.107 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.551 ' HG3' ' HG2' ' A' ' 32' ' ' GLN . 33.7 tt0 -136.72 118.94 15.55 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.086 0.469 . . . . 51.45 111.766 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.8 t -100.81 112.88 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.219 -0.446 . . . . 71.34 110.186 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.555 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 35.6 t70 -108.11 100.36 9.69 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.039 0.447 . . . . 72.43 110.731 -177.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.78 -110.53 3.31 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.842 -0.694 . . . . 55.41 112.258 -174.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -114.5 33.26 5.43 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.313 0.578 . . . . 73.21 111.313 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 14.4 ptt180 -147.56 149.43 32.57 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.08 -0.509 . . . . 73.32 110.745 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.4 tt -123.29 148.47 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 120.791 0.329 . . . . 51.24 111.772 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -151.36 168.76 23.8 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.904 0.383 . . . . 74.2 111.47 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.807 HG12 ' SD ' ' A' ' 45' ' ' MET . 37.1 mt -104.64 118.35 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.842 0.353 . . . . 70.34 110.093 170.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -83.4 -35.05 25.37 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.452 -0.34 . . . . 72.34 111.897 -175.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -161.78 138.51 8.27 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.816 0.341 . . . . 64.53 111.632 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -140.9 178.52 7.3 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.01 0.433 . . . . 61.14 111.394 175.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -112.6 33.87 4.7 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.36 0.6 . . . . 53.44 111.461 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.7 m -89.69 146.47 35.6 Favored Pre-proline 0 N--CA 1.472 0.642 0 O-C-N 121.755 -0.591 . . . . 75.11 110.818 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.24 -32.57 73.4 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.488 2.125 . . . . 73.33 112.295 179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -96.42 -9.19 30.43 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.021 -0.536 . . . . 64.55 111.795 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.526 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 23.6 mm-40 57.5 38.51 28.09 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.01 0.433 . . . . 53.43 111.731 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.3 t -52.75 -36.68 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 116.159 -0.473 . . . . 75.35 112.103 -174.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -58.7 -54.16 40.16 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.053 -0.594 . . . . 60.21 112.766 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.2 -38.22 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-O 120.896 0.379 . . . . 70.32 111.895 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.526 ' HD3' ' O ' ' A' ' 62' ' ' GLN . 5.4 mptp? -65.19 -28.44 69.39 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.395 0.516 . . . . 64.22 112.395 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 25.7 mmt -60.72 -34.83 74.99 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.041 0.386 . . . . 44.51 112.041 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.25 -144.15 38.77 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 114.391 0.516 . . . . 52.34 114.391 175.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -84.39 131.95 34.63 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.734 0.642 . . . . 75.42 112.734 -176.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.43 ' HD2' ' HB3' ' A' ' 75' ' ' ASP . 75.3 mmtt -127.2 136.12 51.6 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.941 -0.572 . . . . 74.43 110.971 177.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.1 p -168.42 17.49 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.307 0.484 . . . . 73.24 112.307 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -114.77 150.59 35.16 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.773 0.321 . . . . 72.41 111.116 -177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.28 108.97 0.77 Allowed 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.998 0.427 . . . . 64.13 110.452 173.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 119.03 -16.71 10.84 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.077 -0.583 . . . . 75.53 113.299 -178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.43 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 53.4 m-20 -62.41 133.56 55.21 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.152 0.476 . . . . 72.11 111.551 176.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.8 p -134.24 147.33 50.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.221 0.534 . . . . 60.45 111.845 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.557 ' HB ' ' HB ' ' A' ' 86' ' ' VAL . 41.5 mm -114.73 121.85 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.759 -0.655 . . . . 72.51 110.3 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.0 t -121.47 117.44 52.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.929 0.395 . . . . 73.2 111.681 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 97.2 m -116.26 90.03 3.24 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.653 -0.249 . . . . 64.21 110.618 175.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.568 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 98.0 mt -55.81 -55.52 40.12 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 113.202 0.816 . . . . 74.12 113.202 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 16.6 Cg_exo -67.4 -7.34 18.82 Favored 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 122.002 1.801 . . . . 71.3 112.933 -176.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -114.93 -12.75 12.0 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.423 -0.353 . . . . 62.23 111.355 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.9 mttm 59.16 31.79 21.55 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.934 0.493 . . . . 72.04 111.947 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.9 t -100.68 133.51 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.223 -0.444 . . . . 51.5 110.978 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -135.84 129.31 32.19 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.925 0.393 . . . . 43.42 111.053 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.557 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 60.9 t -131.3 113.58 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.476 -0.329 . . . . 55.3 111.207 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.0 pm0 -108.31 139.96 42.27 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.056 0.455 . . . . 60.51 111.371 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.8 mt -106.71 119.55 56.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.448 -0.342 . . . . 72.13 111.463 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.449 ' HE3' ' HB2' ' A' ' 89' ' ' LYS . 19.0 ptmt -118.18 162.38 18.33 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.915 0.388 . . . . 75.12 111.664 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.1 t -88.21 149.56 23.79 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 116.312 -0.404 . . . . 63.2 110.95 175.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 7' ' ' GLU . 38.8 p -85.0 -2.72 58.3 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.192 0.441 . . . . 62.45 112.192 -178.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -72.82 -175.26 1.67 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.069 0.462 . . . . 65.43 111.798 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -68.99 73.4 0.28 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.39 -0.368 . . . . 61.41 111.975 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 63.6 136.43 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.175 0.805 . . . . 63.53 113.175 176.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.1 t -143.57 108.45 4.93 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.204 -0.453 . . . . 74.33 111.721 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -97.51 105.37 17.51 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.068 0.461 . . . . 72.02 110.561 173.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -87.97 160.96 45.4 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 115.893 -0.594 . . . . 62.42 112.302 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -49.42 -61.2 0.62 Allowed 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.719 2.946 . . . . 63.32 116.064 -169.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.63 151.56 42.23 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.556 0.947 . . . . 73.42 113.556 -170.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.0 t -112.15 170.7 7.98 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.573 -0.74 . . . . 73.23 111.788 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -90.32 44.24 1.19 Allowed 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.292 0.479 . . . . 71.22 112.292 -174.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.46 ' H ' HD23 ' A' ' 102' ' ' LEU . 2.7 pt? -71.82 123.96 23.78 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.197 0.522 . . . . 74.21 112.2 -177.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 65.9 mt -137.79 127.2 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 116.32 -0.4 . . . . 75.4 111.164 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.3 p -105.43 134.43 19.69 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 111.708 0.262 . . . . 61.02 111.708 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.84 149.48 60.37 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.856 2.371 . . . . 72.13 113.974 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -143.46 178.61 7.64 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.255 -0.429 . . . . 63.11 111.651 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.64 170.14 11.38 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.309 0.576 . . . . 71.54 112.378 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.82 159.31 37.72 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.024 -0.534 . . . . 54.54 111.008 176.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 112' ' ' HIS . 29.6 m-70 -100.56 109.96 22.09 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.242 -0.286 . . . . 73.42 111.157 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.406 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 16.1 t-80 -112.19 132.64 54.78 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 122.346 -0.221 . . . . 72.31 110.638 179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 110' ' ' HIS . 66.5 m-70 69.76 -29.97 0.19 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.248 0.619 . . . . 74.15 112.377 -172.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 109' ' ' HIS . 13.8 t60 -52.7 99.62 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.755 -0.461 . . . . 73.23 109.755 169.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -71.23 154.96 41.26 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.856 0.688 . . . . 64.15 112.856 -168.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 . . . . . 0 C--O 1.25 1.112 0 CA-C-N 115.913 -0.585 . . . . 62.32 111.323 175.259 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.631 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.357 0.599 . . . . 55.23 110.931 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -161.87 129.58 4.05 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.15 -0.477 . . . . 61.51 111.447 -176.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -73.82 79.69 1.6 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.105 0.478 . . . . 75.04 110.203 174.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.7 t -79.81 143.19 34.63 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.009 -0.541 . . . . 55.22 111.562 -177.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.7 -60.01 1.11 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.276 -0.488 . . . . 33.41 113.649 -175.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -110.43 137.57 47.96 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.186 0.517 . . . . 64.34 112.092 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -93.53 115.66 28.16 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.035 -0.53 . . . . 74.5 111.995 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.38 160.28 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.08 0.466 . . . . 73.53 111.933 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 23' ' ' PRO . 35.5 m -135.14 141.47 42.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 122.615 0.366 . . . . 53.42 111.003 177.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.91 114.61 26.75 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.892 0.377 . . . . 50.11 111.561 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.0 mm -99.34 113.91 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 120.849 0.357 . . . . 64.11 111.192 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.512 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.2 mp -100.52 118.04 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.1 0.476 . . . . 74.01 111.17 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.3 m -121.56 147.75 45.41 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.883 0.373 . . . . 71.52 111.64 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.439 ' HG2' ' ND2' ' A' ' 15' ' ' ASN . 63.9 tt0 -138.88 142.99 38.55 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.643 0.259 . . . . 75.51 110.843 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.439 ' ND2' ' HG2' ' A' ' 14' ' ' GLN . 56.0 m-80 57.6 17.68 4.15 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.271 0.471 . . . . 74.51 112.271 -177.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.71 18.95 39.03 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.339 -0.457 . . . . 43.53 113.867 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.466 ' NZ ' ' HB3' ' A' ' 17' ' ' LYS . 0.5 OUTLIER -143.91 144.96 31.96 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.46 0.63 . . . . 75.22 111.616 177.458 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.0 t -70.03 120.95 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.827 0.346 . . . . 72.41 111.567 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 37.2 pt -107.94 -15.42 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 112.219 0.452 . . . . 73.55 112.219 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -170.14 142.53 2.29 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.408 0.283 . . . . 64.21 110.8 -177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.01 122.93 10.03 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.153 0.501 . . . . 71.51 111.898 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.469 HD12 ' N ' ' A' ' 22' ' ' ILE . 4.2 mp -117.6 121.54 31.83 Favored Pre-proline 0 N--CA 1.474 0.731 0 CA-C-N 116.431 -0.35 . . . . 51.24 111.609 -176.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.484 ' HA ' HG12 ' A' ' 9' ' ' VAL . 20.4 Cg_exo -66.52 103.15 0.65 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.169 1.913 . . . . 63.32 111.491 170.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.37 -59.33 4.14 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.409 -0.36 . . . . 72.23 111.926 -174.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.0 m -53.76 125.93 20.23 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.967 0.413 . . . . 71.21 111.996 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.01 -21.14 41.45 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.114 -0.565 . . . . 64.12 113.663 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -86.71 103.96 15.66 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 117.46 0.63 . . . . 74.24 112.24 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.419 ' HA ' ' HA2' ' A' ' 49' ' ' GLY . 23.7 pttm -86.64 -175.37 5.4 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.185 -0.461 . . . . 73.54 110.541 174.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.72 -164.13 54.17 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.015 -0.612 . . . . 63.22 114.072 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -119.26 131.17 55.75 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.959 0.409 . . . . 73.35 111.508 -176.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.455 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 10.5 tp10 -132.31 114.98 15.05 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.339 -0.391 . . . . 74.22 110.752 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -118.95 140.64 49.66 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 111.935 0.346 . . . . 75.51 111.935 -176.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -146.87 152.24 38.38 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.761 0.315 . . . . 61.31 111.261 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.6 m -113.8 117.63 32.0 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.267 0.556 . . . . 64.41 112.495 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 43' ' ' ASN . 71.9 mt -86.38 108.26 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.849 -0.614 . . . . 73.3 111.079 177.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -92.78 105.15 17.33 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.711 0.291 . . . . 72.33 111.128 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.5 -66.84 1.19 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.289 -0.482 . . . . 74.12 114.177 -175.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -164.65 125.62 2.09 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.638 -0.33 . . . . 71.3 111.335 -176.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.36 -105.7 0.77 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.228 -0.51 . . . . 74.23 113.2 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.57 -1.18 28.7 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.184 0.439 . . . . 42.23 112.184 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -84.87 88.73 7.44 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.077 0.465 . . . . 64.32 112.008 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.441 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 47.8 p90 -113.05 168.4 9.73 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.054 -0.521 . . . . 72.33 110.798 174.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.563 ' HB2' ' HB ' ' A' ' 35' ' ' ILE . 20.0 m120 -135.75 112.68 10.29 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.317 0.247 . . . . 74.5 110.894 173.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 42.5 tp -87.61 109.94 20.02 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.828 0.347 . . . . 54.33 110.818 177.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.8 ' SD ' HG12 ' A' ' 54' ' ' ILE . 89.6 mmm -100.74 159.29 15.3 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.0 0.428 . . . . 70.55 111.979 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.482 ' HB2' ' HD2' ' A' ' 55' ' ' LYS . 40.5 tt0 -147.7 132.26 17.75 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.338 0.495 . . . . 73.22 112.338 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 58.8 t -118.15 107.63 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.126 0.571 . . . . 62.42 110.09 174.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 11.9 t70 -121.97 93.4 3.98 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.862 0.363 . . . . 54.31 111.592 -174.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 28' ' ' LYS . . . 67.79 75.36 0.49 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.187 -0.53 . . . . 62.43 114.315 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 60.56 17.19 7.15 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.683 0.994 . . . . 73.22 113.683 175.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.511 ' HG3' ' CE3' ' A' ' 69' ' ' TRP . 7.7 ptp180 -144.07 146.59 32.93 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.97 -0.457 . . . . 73.33 111.19 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 tt -127.29 148.09 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 121.096 0.474 . . . . 74.33 112.271 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.543 ' HB3' ' HA ' ' A' ' 69' ' ' TRP . 0.4 OUTLIER -159.6 168.88 25.02 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.181 -0.463 . . . . 74.2 111.454 176.297 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.8 HG12 ' SD ' ' A' ' 45' ' ' MET . 33.7 mt -93.38 130.2 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.925 0.393 . . . . 64.11 110.962 175.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.482 ' HD2' ' HB2' ' A' ' 46' ' ' GLU . 29.5 mtpp -80.94 -47.68 13.36 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.43 -0.35 . . . . 53.31 111.642 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -171.93 144.75 1.77 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.067 0.461 . . . . 65.12 111.77 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 3.9 p-10 -142.2 -177.32 5.19 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.262 -0.426 . . . . 71.4 110.647 176.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -116.78 83.81 2.03 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.481 0.658 . . . . 74.42 111.06 173.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.6 t -130.65 152.75 80.99 Favored Pre-proline 0 N--CA 1.474 0.741 0 CA-C-N 115.692 -0.686 . . . . 70.31 111.371 174.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.72 -13.91 24.46 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 121.868 1.712 . . . . 64.51 112.046 171.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.489 ' HB3' HG23 ' A' ' 63' ' ' VAL . 7.8 m-20 -102.68 -50.91 3.43 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.136 -0.484 . . . . 62.35 111.491 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 53.24 29.84 9.07 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.637 0.606 . . . . 63.52 112.637 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.489 HG23 ' HB3' ' A' ' 61' ' ' ASP . 41.5 t -58.55 -36.02 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.846 0.355 . . . . 64.13 111.549 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.434 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -57.09 -45.27 92.64 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 116.406 -0.361 . . . . 65.43 113.593 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 45.4 t -62.56 -40.02 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.34 0.59 . . . . 52.44 110.983 178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -69.52 -27.29 65.05 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.978 -0.556 . . . . 54.0 112.253 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 20.9 mmt -55.06 -39.24 69.0 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.127 0.418 . . . . 74.52 112.127 177.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.26 -175.6 54.88 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.202 -0.523 . . . . 71.22 114.186 175.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.543 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . 96.5 m95 -52.28 138.11 27.24 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.954 0.724 . . . . 73.11 112.954 -175.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -135.56 148.3 49.06 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.7 0.4 . . . . 72.11 110.743 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 89.2 p -170.7 18.97 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.802 0.668 . . . . 71.1 112.802 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -101.44 146.67 27.31 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.035 -0.416 . . . . 72.41 110.59 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.13 88.89 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.089 0.471 . . . . 65.15 111.037 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.85 -19.46 2.55 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.198 -0.525 . . . . 65.01 113.666 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.53 ' HB2' HD12 ' A' ' 88' ' ' ILE . 97.4 m-20 -57.09 139.56 52.01 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 117.573 0.686 . . . . 72.15 112.172 -178.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.3 p -138.79 144.89 39.55 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.95 0.405 . . . . 73.53 111.515 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.8 mm -122.9 127.94 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.3 -0.409 . . . . 75.23 110.315 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.9 t -111.7 117.22 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.013 0.435 . . . . 75.22 111.959 -177.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.554 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 74.8 m -114.03 76.44 0.99 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.128 0.49 . . . . 73.04 110.226 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.456 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 5.2 tt -54.75 -54.14 52.72 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 115.713 -0.676 . . . . 70.12 112.634 -173.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 80' ' ' LEU . 23.7 Cg_endo -59.73 -22.61 68.41 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 122.156 1.904 . . . . 73.11 113.287 -177.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -104.35 -2.13 25.93 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.488 -0.324 . . . . 74.44 111.385 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm 60.02 29.38 18.95 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.263 0.468 . . . . 72.02 112.263 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 79' ' ' CYS . 48.4 t -106.15 141.75 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.925 0.393 . . . . 75.53 111.436 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -143.24 126.65 16.74 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.821 0.343 . . . . 73.43 110.984 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -115.35 133.4 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.569 -0.287 . . . . 75.04 111.182 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -132.42 136.75 46.97 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.064 0.459 . . . . 63.03 111.47 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.53 HD12 ' HB2' ' A' ' 75' ' ' ASP . 58.7 mt -106.4 110.86 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.311 -0.404 . . . . 74.13 110.797 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -117.58 164.64 14.63 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.248 0.462 . . . . 72.34 112.248 -174.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.9 t -85.12 149.73 25.34 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.189 -0.46 . . . . 74.31 112.209 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.2 p -77.69 -27.84 50.86 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.162 0.506 . . . . 74.12 110.989 174.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -86.29 165.72 16.22 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.171 -0.468 . . . . 75.22 110.951 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -80.76 125.88 30.62 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.446 0.535 . . . . 63.45 112.446 -175.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -105.84 -178.29 3.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.064 -0.516 . . . . 72.41 110.47 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.9 t -88.9 49.17 1.74 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.345 0.593 . . . . 54.35 110.111 173.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -91.67 176.29 6.59 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.367 0.603 . . . . 75.34 112.244 -176.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.44 146.67 84.21 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 115.657 -0.701 . . . . 74.41 110.814 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.65 -52.89 7.06 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.282 1.988 . . . . 71.23 111.825 175.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -171.94 179.28 2.75 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.603 -0.726 . . . . 74.51 110.315 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.4 t -150.18 130.98 14.14 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.084 0.468 . . . . 74.4 111.514 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -129.75 133.55 47.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.376 -0.375 . . . . 73.41 110.899 178.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.7 pp -165.39 162.16 19.34 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.953 0.406 . . . . 43.24 111.332 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.1 mm -115.11 109.11 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.002 0.429 . . . . 73.24 110.975 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 34.5 m -75.38 142.26 74.57 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 120.832 0.349 . . . . 73.02 111.933 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 104' ' ' VAL . 27.3 Cg_exo -62.41 113.12 1.79 Allowed 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.5 2.133 . . . . 61.54 112.165 175.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -76.97 136.68 38.75 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.075 -0.512 . . . . 54.44 111.631 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.6 pp -85.99 162.68 18.39 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.931 0.396 . . . . 65.41 111.56 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -94.85 -178.51 4.53 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.162 0.506 . . . . 35.32 111.814 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -142.68 105.47 4.52 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.012 -0.54 . . . . 72.31 110.498 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -76.87 82.54 3.44 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.27 0.557 . . . . 74.35 110.25 176.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -134.1 149.51 51.11 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.036 -0.529 . . . . 73.01 111.708 -173.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -122.03 158.37 29.33 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.411 -0.359 . . . . 75.45 110.592 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -83.67 145.32 28.85 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.864 0.364 . . . . 71.32 111.843 -177.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 73.8 m80 . . . . . 0 C--O 1.253 1.254 0 CA-C-O 118.62 -0.705 . . . . 54.34 111.455 178.541 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 111.889 0.329 . . . . 71.33 111.889 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -117.24 111.72 19.81 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.259 0.466 . . . . 72.23 112.259 -173.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -127.11 108.36 10.84 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.864 0.364 . . . . 55.25 110.361 174.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 57.8 p -106.5 117.93 35.32 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.916 0.388 . . . . 74.34 111.866 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -82.0 -17.49 69.71 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.273 -0.489 . . . . 74.14 112.948 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.75 83.55 0.89 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.796 0.331 . . . . 72.14 111.332 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -79.82 104.89 10.71 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.038 0.447 . . . . 64.21 111.295 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 32.7 m -120.88 144.66 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.508 0.67 . . . . 21.1 112.37 -177.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 23' ' ' PRO . 34.6 m -125.39 134.2 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 115.677 -0.692 . . . . 72.42 110.815 177.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.43 114.52 25.13 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.794 0.331 . . . . 52.3 111.659 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.3 mm -97.25 137.49 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.551 -0.295 . . . . 73.32 110.474 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.9 mp -121.97 118.71 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.012 0.434 . . . . 72.34 111.055 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.6 p -112.98 153.02 28.7 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.178 0.513 . . . . 75.05 111.37 177.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -151.91 142.21 22.42 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.328 -0.396 . . . . 63.43 110.846 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 59.77 14.1 3.92 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.628 0.603 . . . . 71.11 112.628 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.68 10.69 43.0 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.032 -0.604 . . . . 71.45 114.166 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -146.13 151.06 37.06 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 117.264 0.532 . . . . 72.42 111.458 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.12 136.79 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.681 0.276 . . . . 65.05 110.899 175.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.1 pt -117.89 -22.07 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 112.14 0.422 . . . . 52.34 112.14 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -169.31 144.99 3.22 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.577 0.227 . . . . 75.02 111.315 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -137.69 128.06 26.37 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.85 0.357 . . . . 73.2 111.254 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.9 mp -123.83 119.63 26.8 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-N 116.579 -0.282 . . . . 72.14 111.704 -177.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.466 ' HA ' HG12 ' A' ' 9' ' ' VAL . 34.8 Cg_exo -61.97 132.0 37.52 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.406 2.07 . . . . 55.44 112.346 172.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' HB2' HG23 ' A' ' 8' ' ' VAL . 88.1 mt -96.3 -61.72 1.39 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.881 0.372 . . . . 74.23 111.465 -178.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.3 m -60.23 121.12 11.17 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.511 -0.313 . . . . 62.44 111.657 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.05 -8.24 80.18 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.095 -0.574 . . . . 45.14 113.126 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -78.3 86.42 4.39 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.289 0.566 . . . . 71.41 110.886 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -83.57 98.25 9.48 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.248 0.547 . . . . 72.3 111.113 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.88 -168.21 31.17 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.949 -0.568 . . . . 63.04 112.923 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -118.43 145.19 45.41 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 122.307 -0.526 . . . . 74.2 110.874 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.557 ' HB3' ' HB ' ' A' ' 47' ' ' VAL . 9.3 tp10 -144.82 117.49 8.65 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.566 -0.288 . . . . 63.13 110.574 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -127.6 129.85 47.99 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.728 0.299 . . . . 60.11 111.13 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -141.35 153.05 44.89 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.075 0.464 . . . . 73.22 111.297 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.6 m -112.49 116.7 30.68 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.948 0.404 . . . . 62.31 111.422 -175.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.2 mt -79.99 108.22 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.859 0.362 . . . . 70.42 111.022 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -99.86 111.13 23.46 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.298 -0.41 . . . . 54.23 111.146 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -110.69 -91.45 2.08 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.242 -0.504 . . . . 73.52 113.493 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.635 ' HE3' ' HA ' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -112.84 85.47 2.18 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.861 0.362 . . . . 72.51 111.494 -176.355 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.33 -97.71 0.02 OUTLIER Glycine 0 CA--C 1.529 0.93 0 CA-C-N 116.277 -0.419 . . . . 73.12 113.817 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.82 -31.53 72.54 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.929 0.395 . . . . 70.44 111.74 177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -72.82 94.17 1.77 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.129 0.418 . . . . 75.44 112.129 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -124.84 176.8 6.38 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.387 -0.369 . . . . 73.21 110.498 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -158.63 114.52 2.66 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.766 0.317 . . . . 74.14 110.92 174.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.6 tp -89.99 111.53 22.64 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.073 0.463 . . . . 45.04 111.477 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.633 ' SD ' HG12 ' A' ' 54' ' ' ILE . 94.3 mmm -97.56 138.1 35.49 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.146 -0.479 . . . . 64.0 111.384 -177.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -123.95 116.61 23.16 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.931 0.396 . . . . 72.21 111.78 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 40.2 t -107.47 112.46 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.232 -0.44 . . . . 74.33 110.652 176.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 20.5 t70 -109.04 101.95 10.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.05 0.452 . . . . 54.4 110.224 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.87 -106.02 1.17 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.846 -0.692 . . . . 72.43 112.772 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -111.51 17.41 20.07 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 120.973 0.416 . . . . 75.53 111.734 -176.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 19.9 ptt180 -130.42 141.96 50.52 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.316 -0.402 . . . . 74.42 111.049 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 tt -130.92 149.41 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 120.987 0.422 . . . . 73.02 111.717 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -157.02 168.89 26.13 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.953 0.406 . . . . 74.53 111.486 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.633 HG12 ' SD ' ' A' ' 45' ' ' MET . 60.5 mt -85.54 113.52 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 109.832 -0.433 . . . . 64.42 109.832 169.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -73.87 -49.66 23.97 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.94 0.4 . . . . 72.44 111.686 -177.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -162.69 138.61 7.24 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.181 0.437 . . . . 64.41 112.181 -175.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -165.43 -172.29 2.41 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.095 -0.502 . . . . 72.43 110.34 173.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -121.72 24.07 9.89 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.77 0.656 . . . . 72.22 112.77 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.3 t -77.18 125.93 85.91 Favored Pre-proline 0 N--CA 1.474 0.761 0 O-C-N 121.869 -0.519 . . . . 74.34 110.968 175.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -59.39 -13.58 21.2 Favored 'Trans proline' 0 N--CA 1.48 0.725 0 C-N-CA 122.998 2.465 . . . . 65.21 113.092 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.524 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.7 m-20 -83.77 -41.07 18.0 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.036 0.384 . . . . 72.2 112.036 175.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 53.75 32.56 15.05 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.147 0.425 . . . . 71.41 112.147 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.524 HG23 ' HB3' ' A' ' 61' ' ' ASP . 97.5 t -52.52 -51.74 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 112.55 0.574 . . . . 52.35 112.55 -173.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.579 ' HA3' HD12 ' A' ' 54' ' ' ILE . . . -62.73 -34.82 90.78 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.743 -0.742 . . . . 70.24 113.446 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.48 -44.67 98.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 120.945 0.402 . . . . 64.0 110.897 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -69.49 -37.7 77.33 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.427 -0.351 . . . . 71.35 111.112 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 21.3 mmt -61.63 -33.57 74.17 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.353 0.501 . . . . 64.25 112.353 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.39 -143.18 29.11 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.021 -0.609 . . . . 74.04 113.426 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -86.99 122.39 30.77 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.058 0.456 . . . . 75.14 112.066 -176.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HD2' ' CG ' ' A' ' 75' ' ' ASP . 74.1 mmtt -108.63 154.33 22.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.177 -0.465 . . . . 73.11 110.668 176.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 82.6 p -165.89 12.68 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.987 1.106 . . . . 72.2 113.987 -173.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -131.49 158.9 39.67 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.553 0.692 . . . . 63.15 112.457 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.527 ' HB2' ' HB2' ' A' ' 90' ' ' SER . . . -68.13 108.01 2.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.67 -0.695 . . . . 44.0 111.422 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.28 -16.61 4.89 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.35 -0.452 . . . . 65.53 112.398 -176.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.506 ' HB2' HD12 ' A' ' 88' ' ' ILE . 77.5 m-20 -72.21 106.15 4.29 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.029 0.442 . . . . 74.23 111.242 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.7 p -116.24 142.46 46.8 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.784 0.325 . . . . 74.43 111.779 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.9 mm -117.06 134.03 61.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 122.673 0.389 . . . . 72.21 110.828 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -112.19 117.34 54.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 111.895 0.332 . . . . 64.25 111.895 -177.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 86.7 m -122.0 68.37 0.93 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.856 0.36 . . . . 62.14 111.126 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.527 ' HB2' ' HD3' ' A' ' 81' ' ' PRO . 92.0 mt -53.07 -50.11 83.84 Favored Pre-proline 0 N--CA 1.476 0.847 0 N-CA-C 113.246 0.832 . . . . 62.53 113.246 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.527 ' HD3' ' HB2' ' A' ' 80' ' ' LEU . 50.7 Cg_exo -54.54 -24.65 37.17 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.021 1.814 . . . . 64.22 113.374 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -106.58 -1.88 22.45 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 111.869 0.322 . . . . 63.03 111.869 -179.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 59.69 30.93 20.54 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.989 0.423 . . . . 64.43 111.662 -176.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.2 t -112.12 137.17 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 116.079 -0.51 . . . . 43.55 111.178 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -135.81 143.04 44.95 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.528 -0.306 . . . . 63.5 110.291 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.1 t -129.36 120.1 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 122.288 -0.257 . . . . 44.32 111.067 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.22 116.94 25.86 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.456 0.646 . . . . 74.33 111.912 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.506 HD12 ' HB2' ' A' ' 75' ' ' ASP . 57.4 mt -88.78 114.53 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 122.009 -0.432 . . . . 63.12 110.894 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.415 ' NZ ' ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -109.85 172.46 6.84 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.942 0.401 . . . . 63.24 111.095 179.552 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 40.5 t -111.21 150.27 29.8 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.782 0.325 . . . . 62.12 110.891 175.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.1 p -77.01 -9.65 58.84 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.566 -0.288 . . . . 71.51 111.453 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -66.08 170.01 6.22 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.598 0.713 . . . . 74.43 112.402 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -86.58 139.82 30.46 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.469 -0.787 . . . . 64.32 110.357 173.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -143.98 176.48 9.25 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 122.118 -0.364 . . . . 71.53 110.845 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.4 t -105.43 -23.51 12.81 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.754 0.65 . . . . 53.43 112.754 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -83.93 143.8 29.6 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.36 0.6 . . . . 75.52 112.227 -174.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -109.44 122.47 39.37 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.82 -0.627 . . . . 75.1 110.923 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -84.87 -44.03 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.425 2.083 . . . . 75.05 113.946 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -96.35 162.85 13.32 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.481 0.548 . . . . 74.34 112.481 -172.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.2 p -107.07 -62.73 1.37 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.483 0.658 . . . . 73.3 110.511 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -93.34 124.17 37.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.225 -0.898 . . . . 61.52 110.903 176.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.4 tp -91.43 128.72 37.37 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.301 -0.409 . . . . 72.23 111.984 -176.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 51.3 mm -102.17 116.73 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.532 -0.304 . . . . 64.42 110.946 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 68.8 t -116.55 121.4 33.24 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 112.176 0.436 . . . . 73.32 112.176 -177.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.61 98.57 1.14 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 122.464 2.11 . . . . 75.1 112.446 175.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -123.02 26.73 7.97 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.179 0.437 . . . . 53.21 112.179 -177.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 107' ' ' LEU . 3.2 mm? -70.09 134.6 48.38 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.642 0.258 . . . . 75.54 111.441 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -121.49 139.95 52.82 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.401 0.519 . . . . 72.22 112.401 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -149.82 136.46 19.25 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.97 -0.559 . . . . 71.04 110.257 175.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -147.14 149.3 32.73 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.936 0.398 . . . . 71.23 112.01 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -135.72 141.94 44.97 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.413 -0.358 . . . . 73.42 111.135 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -87.82 94.07 9.65 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.988 0.423 . . . . 74.22 111.086 176.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -90.96 174.49 7.4 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.39 -0.368 . . . . 73.24 111.533 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 34.0 m170 . . . . . 0 C--O 1.253 1.274 0 CA-C-O 118.399 -0.81 . . . . 70.22 112.286 179.643 . . . . . . . . 0 0 . 1 stop_ save_